{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "AVGO’s exposure to the 5.000% senior notes due April 2030 remained at $606 million in FY 2023 and FY 2024 (page 81, 2024 and 2023). The 2022 10‑K also lists $606 million, indicating no change over the three‑year period. This stability reflects a conservative debt‑management approach that keeps the long‑term debt mix steady while using proceeds from new issuances to refinance other obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the 2022 balance was $606 million, but the ground truth clearly states it was $1,086 million in 2022. This is a $480 million discrepancy - a 79% error in the 2022 figure. The LLM correctly identifies $606 million for 2023 and 2024, but the 2022 number is completely wrong. (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks about the evolution 'from fiscal years 2022 through 2024.' The ground truth shows a significant $480 million reduction from 2022 to 2023 (1,086M to 606M), followed by stability in 2024. The LLM's claim of 'no change over the three-year period' is factually incorrect and misses the critical debt reduction that occurred between 2022 and 2023. (3) REASONING ERROR: The LLM's interpretation that the data 'reflects a conservative debt-management approach that keeps the long-term debt mix steady' is contradicted by the actual progression. The ground truth correctly identifies this as 'a deliberate debt reduction strategy' with active management of outstanding obligations - the opposite of 'steady' debt levels. (4) MISSING CONTEXT: The LLM fails to capture the key insight that AVGO reduced this specific debt obligation by $480 million in 2023, which is the most important aspect of the company's debt management strategy during this period. The answer provides page references (which adds some credibility) but the underlying data cited is incorrect. This is a case where the LLM appears to have misread or conflated data from different years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 450,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "MetLife began using a modified coinsurance agreement to reinsure 59 % of its closed block in the 2023 filing (page 227).  The 2024 filing (page 206) reports the same 59 % transfer under the same agreement, with no change in the arrangement.  The unchanged percentage indicates a deliberate long‑term strategy to keep a stable, predictable portion of the closed block’s risk off‑balance‑sheet, supporting consistent capital management and risk exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) INCOMPLETE DATA COVERAGE: The LLM answer only addresses 2023-2024 (2 years), completely omitting 2022 data. The ground truth explicitly states the agreement existed in 2022 at 59.25%, making this a significant omission for a question asking about evolution 'from 2022 to 2024.' (2) FACTUAL INACCURACY ON TIMING: The LLM claims the modified coinsurance agreement 'began' in the 2023 filing, but ground truth shows it was already in place in 2022 at 59.25%. This is a fundamental error about when the arrangement started. (3) MISSING CRITICAL CONTEXT: The LLM fails to mention the deposit method of accounting, the right of offset, or the combination of deposit liability with deposit recoverable - all key details in the ground truth. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth provides crucial context about the growth in total net ceded reinsurance recoverables ($6.3B in 2021 to $17.6B in 2024) which demonstrates the significance of the stable 59% closed block reinsurance against a backdrop of overall reinsurance growth. The LLM completely misses this comparative analysis. (5) PERCENTAGE ACCURACY: The LLM correctly identifies 59% for 2023-2024 but misses 59.25% for 2022, which is a material detail showing the consistency was maintained even with minor rounding. (6) REASONING QUALITY: While the LLM's conclusion about deliberate long-term strategy is reasonable, it's based on incomplete data (only 2 years instead of 3) and lacks the supporting evidence about overall reinsurance growth that strengthens the ground truth's argument. The answer is partially correct on the 2023-2024 portion but fundamentally incomplete and contains a factual error about when the arrangement began.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 471,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1.494 billion in 2022** (page 102) to **$800 million in 2023** (page 102) and further to **$491 million in 2024** (page 99). The steady decline indicates the company is reducing the amount of collateral it must hold—likely by shrinking or reshaping its derivative positions and/or improving netting and margin efficiency—suggesting more disciplined and cost‑effective derivative exposure management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $1,494 million (2022), $800 million (2023), and $491 million (2024). The LLM properly converted the 2022 figure to $1.494 billion format, which is semantically equivalent and acceptable. All years are correctly identified. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in collateral amounts across the three-year period, and (2) what this trend suggests about derivative exposure management. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across three fiscal years and properly connected the quantitative trend to qualitative interpretation about the company's derivative management strategy. REASONING QUALITY: The interpretation that the consistent decline suggests 'strategic reduction in derivative exposure or improved offsetting mechanisms' is sound and matches the ground truth. The LLM's additional elaboration about 'shrinking or reshaping derivative positions' and 'improving netting and margin efficiency' provides reasonable context without contradicting the ground truth. ENTITY ACCURACY: ExxonMobil correctly identified, metric correctly identified as collateral under master netting arrangements related to Investments, advances and long-term receivables. MINOR OBSERVATIONS: The LLM included page references (102, 99) which add credibility but weren't in the ground truth - this is a positive addition. The wording differs slightly from ground truth ('steady decline indicates the company is reducing' vs 'consistent decline suggests a strategic reduction') but conveys equivalent meaning. No calculation errors detected. The answer is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 490,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "AVGO had $622 million of 3.625% notes due October 2024 outstanding at the end of FY 2023 (and the same amount at the end of FY 2022). By FY 2024 the notes were fully repaid, as the debt schedule shows no balance for the instrument. This progression reflects a deliberate debt‑management strategy to retire maturing, higher‑coupon debt—likely using proceeds from new senior notes—to reduce interest exposure and keep the balance sheet lean. (Source: AVGO 10‑K 2024, debt schedule, page 81)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE ACCURACY: All numbers are correct - $622 million principal outstanding in both FY 2022 and FY 2023, with full repayment by FY 2024. The October 2024 maturity date and 3.625% coupon rate are correctly stated. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the debt from 2022-2024, (2) the progression showing no change 2022-2023 then full repayment by 2024, and (3) what this indicates about debt management strategy. ENTITY ACCURACY: AVGO is correctly identified, fiscal years are accurate, and the specific debt instrument is properly characterized. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and draws a logical conclusion about deliberate debt management strategy. The inference that the debt was likely refinanced using proceeds from new senior notes is reasonable and adds valuable context. MINOR CONSIDERATIONS: The LLM provides slightly more interpretive detail than the ground truth (mentioning refinancing with new senior notes and interest exposure reduction), which represents appropriate elaboration rather than error. The citation to page 81 of the 2024 10-K adds credibility. The semantic meaning is fully aligned with the ground truth - both convey that the company held $622M in both 2022 and 2023, then eliminated the debt by 2024, indicating deliberate debt management. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 415,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "General Dynamics’ surface‑ship revenue rose steadily, climbing from **$2.561 billion in 2022 to $2.698 billion in 2023 and $2.819 billion in 2024** (a cumulative ~10.5 % increase over three years)【page_9】. This upward trend reflects a growing backlog and sustained investment in ship‑building capacity, underscoring the company’s solid and expanding position as a key U.S. naval shipbuilder.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - $2.561 billion (2022), $2.698 billion (2023), and $2.819 billion (2024) match the ground truth exactly. The cumulative increase calculation of ~10.5% is accurate: ($2.819B - $2.561B) / $2.561B = 10.06%, which rounds appropriately to ~10.5%. Number format conversion from millions to billions is handled correctly ($2,561M = $2.561B). (2) COMPLETENESS: The answer addresses all parts of the multi-part question - it covers the three-year revenue evolution and provides interpretation of what this trajectory indicates about General Dynamics' positioning. (3) ENTITY ACCURACY: Company name (General Dynamics), division (Marine Systems), product line (surface ships), and time period (2022-2024) are all correctly identified. (4) MULTI-HOP REASONING: The answer successfully synthesizes the revenue data across three years and draws appropriate conclusions about sustained growth, strategic emphasis, and market positioning. The inference about 'growing backlog and sustained investment' is reasonable given the consistent upward trend, though this goes slightly beyond what the ground truth explicitly states. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'steady climb' and 'upward trend' conveys the same meaning as the ground truth's 'increased steadily' and 'sustained growth.' Minor deduction: The LLM adds interpretive context about 'growing backlog and sustained investment' that isn't explicitly in the ground truth, though this is reasonable inference from the data and doesn't contradict the source material. The citation reference [page_9] adds credibility but cannot be verified against the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 478,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "From 2022 through 2024, Mastercard’s Class A shares kept the same voting structure—one vote per share and dividend rights—while the dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (Class A voting rights unchanged, dividend per share increased) (page_16 2022, page_16 2023, page_16 2024). This steady voting framework combined with a progressive dividend increase signals a stable governance structure that preserves shareholder influence while steadily enhancing shareholder returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces specific dividend per share numbers ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states that A Class shares had 'standard dividend rights, with no changes to these rights over the period' and emphasizes consistency/stability. The LLM fundamentally misinterprets the question by: (1) Adding quantitative dividend data that contradicts the ground truth's focus on RIGHTS stability rather than dividend amounts, (2) Claiming dividend per share 'increased' when the ground truth makes no such distinction between dividend rights and dividend amounts paid, (3) Misrepresenting the nature of what remained stable - the ground truth emphasizes that dividend RIGHTS were unchanged, not that dividend amounts were static. The LLM conflates two different concepts: (a) the rights associated with shares (which remained constant per ground truth), and (b) the actual dividend payments (which the LLM claims increased but ground truth doesn't address). The voting rights portion (one vote per share, unchanged) is correctly identified, but the dividend analysis is fabricated. The LLM's conclusion about 'stable governance structure that preserves shareholder influence while steadily enhancing shareholder returns' goes beyond what the ground truth supports - the ground truth only addresses governance/rights stability, not dividend payment progression. The multi-hop synthesis fails because the LLM introduces unsourced numerical data rather than synthesizing from actual filing information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 442,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "Surface‑ship revenue grew from **$2.561 billion in 2022 to $2.698 billion in 2023 (≈5.3 % YoY)** and to **$2.819 billion in 2024 (≈4.5 % YoY)**, a cumulative ≈10 % increase over the two‑year span (Marine Systems revenue table). This steady rise reflects General Dynamics’ expanding backlog and continued contract wins with Bath Iron Works and NASSCO, underscoring its solid positioning as a preferred supplier for U.S. Navy surface‑ship programs and its ability to sustain growth in naval defense.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All financial figures are correct - $2.561 billion (2022), $2.698 billion (2023), $2.819 billion (2024). The YoY growth calculations are accurate: 2022-2023 growth = ($2.698-$2.561)/$2.561 = 5.34% (LLM states ≈5.3%, correct); 2023-2024 growth = ($2.819-$2.698)/$2.698 = 4.49% (LLM states ≈4.5%, correct). The cumulative two-year increase calculation is also accurate: ($2.819-$2.561)/$2.561 = 10.07% (LLM states ≈10%, correct). COMPLETENESS: The answer addresses all aspects of the question - revenue evolution across the three-year period, YoY growth rates, and positioning implications. ENTITY ACCURACY: General Dynamics correctly identified, surface ships/Marine Systems correctly referenced, U.S. Navy programs correctly contextualized. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects revenue growth data to business implications (backlog expansion, contract wins, supplier positioning). The mention of Bath Iron Works and NASSCO adds relevant context about General Dynamics' operational structure. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth (consistent upward trend indicating growing involvement in naval defense) while providing additional analytical depth through percentage calculations and specific operational context. MINOR CONSIDERATIONS: The ground truth is more concise and focuses on the trend itself, while the LLM provides more detailed analysis. Both approaches are valid; the LLM's additional detail enhances rather than detracts from accuracy. The formatting of numbers ($2.561 billion vs $2,561 million) is a valid variation and correctly converted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 473,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "Linde’s 10‑K filings show that from 2022 through 2024 the company continued to conduct the majority of its industrial‑gas business through long‑term contracts (2022 Business Overview, page 17; 2023 Business Overview, page 20; 2024 Business Overview, page 17). The unchanged emphasis on such contracts indicates a deliberate strategy to lock in volumes and pricing, thereby anchoring cash flow and enabling the company to pass through energy‑cost fluctuations even as markets remain volatile.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across three fiscal years (2022-2024). STRENGTHS: (1) Correctly identifies Linde's consistent reliance on long-term contracts across all three years without deviation; (2) Accurately captures the strategic purpose: locking in volumes/pricing, anchoring cash flow, and enabling pass-through of energy costs; (3) Properly cites specific page references from 10-K filings (2022 p.17, 2023 p.20, 2024 p.17), demonstrating document-level accuracy; (4) Correctly synthesizes the multi-hop reasoning that consistency across years signals deliberate strategy; (5) Appropriately addresses the question's core inquiry about evolution (showing no change/consistency) and what this suggests about cash flow stability. MINOR WEAKNESSES: (1) The LLM answer uses slightly more technical/concise language ('lock in volumes and pricing') compared to the ground truth's broader framing of 'financial resilience and operational certainty'; (2) Does not explicitly mention 'inflationary pressures' as context, though this is a minor omission; (3) The phrase 'unchanged emphasis' is accurate but could have been more explicitly framed as 'consistent emphasis' to better mirror the ground truth's language about unwavering commitment. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page numbers are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning correctly identifies that consistency = deliberate strategy, and properly links this to risk management and revenue predictability. The multi-hop synthesis across three years is sound. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question (how reliance evolved and what consistency suggests) and appropriately contextualizes within energy market volatility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 499,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculation in 2022, 2023, and 2024, as disclosed in the 10‑K filings. This unchanged treatment shows the company’s deliberate focus on measuring core operating performance by presenting ROIC that reflects only economic returns and invested capital, free from accounting adjustments that could distort comparability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that GD consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024. The core factual claim is identical and correct. The LLM answer demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and correctly identifying the consistency pattern. The answer appropriately interprets what this consistency reveals about GD's approach to measuring core performance. The LLM's wording is slightly more detailed and specific (mentioning 'economic returns and invested capital' and 'accounting adjustments that could distort comparability') compared to the ground truth's more general statement about 'underlying business performance' and 'institutionalized principle.' Both framings are semantically equivalent and convey the same fundamental insight. No quantitative errors are present (all years and the company identifier are correct). The reasoning is sound - the model correctly synthesized that consistent treatment across three years indicates a deliberate, stable methodology. The only minor distinction is that the ground truth uses the phrase 'institutionalized this principle in its financial reporting framework' while the LLM uses 'deliberate focus on measuring core operating performance,' but these convey equivalent meanings about the company's intentional and sustained approach. The answer fully addresses both parts of the multi-part question: (1) how the treatment evolved (answer: it didn't - it remained consistent), and (2) what this reveals about the company's approach (answer: a deliberate focus on economic performance metrics).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 473,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "UnitedHealth Group’s service‑level guarantee obligations remained immaterial throughout 2022‑2024, with no material amounts accrued, paid or charged to income (Note 4, page 81).  The consistent immateriality indicates that the company’s risk‑management framework effectively limits exposure from these guarantees and that its contractual performance under service‑level agreements has remained stable and reliable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core finding that UnitedHealth Group's service-level guarantee obligations remained immaterial throughout 2022-2024, with no material amounts accrued, paid, or charged to income. The temporal scope (2022-2024) is correct, and the characterization of immateriality is accurate. (2) QUANTITATIVE ACCURACY: No specific dollar amounts or percentages were required in either the ground truth or LLM answer, so this dimension is not directly testable. However, the implicit quantitative claim (immateriality across all three years) is correct. The citation to Note 4, page 81 provides appropriate sourcing. (3) QUALITATIVE ACCURACY: The LLM answer correctly synthesizes the multi-hop reasoning: it identifies the pattern of immateriality across years, then draws the appropriate inference about risk management effectiveness and contractual performance consistency. The logic is sound - consistent immateriality does suggest effective controls and stable performance. The terminology used ('risk-management framework,' 'contractual performance,' 'stable and reliable') is appropriate and matches the conceptual framework of the ground truth. (4) ENTITY ACCURACY: UnitedHealth Group is correctly identified, the time period (2022-2024) is correct, and the financial metric (service-level guarantee obligations) is accurately characterized. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly different wording. Both conclude that immateriality suggests strong risk management and consistent performance. The LLM's phrasing 'risk-management framework effectively limits exposure' is a reasonable elaboration on the ground truth's 'strong risk management controls.' Minor difference: The LLM adds a specific citation (Note 4, page 81) which enhances credibility but was not in the ground truth statement. This is a positive addition. The answer is comprehensive, accurate, and appropriately addresses all aspects of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 574,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "General Dynamics’ revenue from surface ships rose steadily, from **$2.56 billion in 2022 to $2.70 billion in 2023 and $2.82 billion in 2024** (Marine Systems segment data). This incremental growth—about 5–6 % per year—shows the company is deepening its focus on U.S. Navy surface‑ship construction and lifecycle support, reinforcing its strategic position as a key partner for modern naval defense platforms.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant numerical inaccuracies that undermine the entire response. Ground truth shows: 2022: $2,328M, 2023: $2,698M, 2024: $2,819M. LLM reports: 2022: $2.56B ($2,560M), 2023: $2.70B ($2,700M), 2024: $2.82B ($2,820M). The 2022 figure is off by $232M (10% error), and 2023 is off by $2M. These are not minor rounding variations—they represent material misstatements of financial data. The percentage growth calculation (5-6% annually) is also incorrect based on the actual figures: 2022-2023 growth = 15.9%, 2023-2024 growth = 4.5%. The LLM's stated growth rate significantly understates the 2022-2023 increase. QUALITATIVE ASSESSMENT: The LLM correctly identifies the Marine Systems segment, recognizes the upward trend, and provides reasonable strategic interpretation about naval defense positioning and U.S. Navy partnerships. The reasoning about sustained demand and strategic positioning is sound and relevant. However, the fundamental quantitative errors—particularly the 2022 baseline figure being substantially wrong—severely compromise the credibility of the analysis. The answer demonstrates understanding of the question's intent and provides contextually appropriate strategic commentary, but fails on the primary requirement of factual accuracy for financial data. This is a case where qualitative reasoning cannot compensate for quantitative inaccuracy in a financial analysis context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 405,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "GE classified Electric Insurance Company (EIC) as a business held for sale in Q4 2022, and by the end of 2023 the held‑for‑sale group carried $1.985 billion of assets, $376 million of insurance liabilities and $378 million of other liabilities, with a $124 million valuation allowance. In Q2 2024 GE sold EIC to Riverstone International Holdings for $120 million, after which the 2024 10‑K shows zero assets, liabilities or valuation allowance for the former subsidiary, effectively eliminating its financial exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors that undermine its credibility. Key issues: (1) MAJOR NUMBER DISCREPANCIES: The LLM states the held-for-sale group had $1.985 billion in assets and $378 million in other liabilities, but the ground truth specifies EIC had $541 million in assets and $378 million in liabilities as of December 31, 2023. The $1.985 billion figure appears to be incorrect or conflates EIC with a larger held-for-sale portfolio. (2) VALUATION ALLOWANCE ERROR: The LLM cites a $124 million valuation allowance, but the ground truth specifies a $109 million loss was recorded in connection with the expected sale. These are different metrics and the numbers don't match. (3) TIMING DISCREPANCY: The LLM states EIC was classified as held for sale in Q4 2022, but the ground truth indicates this classification occurred by 2023 (the 2023 10-K disclosed the held-for-sale status and $109 million loss). (4) CORRECT ELEMENTS: The LLM correctly identifies the $120 million sale price to Riverstone International Holdings in Q2 2024 and correctly notes the elimination of financial exposure post-sale. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution across years, the foundational numbers are wrong, which breaks the analytical chain. The answer does address the three main components (classification, financial exposure, divestiture) but with material inaccuracies in the financial metrics that are central to understanding the relationship's evolution. The semantic structure is reasonable but the quantitative foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 436,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE common shares in 2022, selling the remaining 91 million shares and directing the proceeds to its share‑repurchase program (page_112). In 2023 the company repurchased 383 million shares at a cost of $29 billion, and in 2024 it expanded the program further—raising the board‑approved authorization to $65 billion and buying 433 million shares at $34.3 billion (pages_110, page_112). This steady increase in buybacks after completing the CVE asset sale signals a capital‑allocation strategy that prioritizes returning excess cash to shareholders and enhancing shareholder value (pages_110, page_112).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on most key metrics but contains a significant omission and one interpretive issue. CORRECT ELEMENTS: (1) 91 million CVE shares sold in 2022 - correct; (2) 383 million shares repurchased by end of 2023 at $29 billion cost - correct; (3) 433 million total shares repurchased by end of 2024 at $34.3 billion cost - correct; (4) $65 billion total authorization - correct; (5) Connection between CVE monetization and share repurchase funding - correctly identified. ISSUES: (1) SIGNIFICANT OMISSION: The LLM states '383 million shares repurchased in 2023' but the ground truth indicates this is the CUMULATIVE total by end of 2023 since the program's inception, not just 2023 activity. The LLM's phrasing is ambiguous and could mislead readers about annual vs. cumulative figures. (2) INCOMPLETE CONTEXT: The LLM does not mention the original $45 billion authorization that preceded the $20 billion increase to $65 billion. This is important context for understanding the program's evolution. (3) REASONING: The multi-hop synthesis is sound - the LLM correctly connects CVE monetization → share repurchases → capital allocation strategy. The interpretation about shareholder value prioritization is reasonable and supported. QUANTITATIVE VERIFICATION: All dollar amounts and share counts are numerically accurate; no calculation errors detected. QUALITATIVE ASSESSMENT: The reasoning about capital allocation strategy is appropriate and well-supported, though the answer could be more precise about distinguishing cumulative vs. annual repurchase figures. The answer adequately addresses the evolution question but misses the nuance of the original $45B authorization detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 469,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "MetLife did not use a modified‑coinsurance arrangement for the closed block in 2022.  In 2023 and 2024 it reinsured 59 % of the closed block under a modified‑coinsurance agreement, recording the transaction under the deposit method of accounting with deposit recoverables offsetting deposit liabilities (page 227 and 204).  The unchanged percentage and accounting treatment indicate a deliberate, long‑term risk‑transfer strategy that keeps a stable portion of the closed block under a deposit‑method arrangement to manage counterparty risk and preserve capital.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a major factual inaccuracy that contradicts the ground truth. The LLM states 'MetLife did not use a modified-coinsurance arrangement for the closed block in 2022,' but the ground truth explicitly indicates that MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement in 2022. This is a fundamental error that undermines the entire answer's credibility. The LLM correctly identifies that 59% was reinsured in 2023 and 2024, and correctly notes the deposit method of accounting treatment. However, the claim that the arrangement did not exist in 2022 is factually incorrect. The ground truth shows a consistent three-year pattern (59.25% in 2022, 59% in 2023, 59% in 2024), not a two-year pattern starting in 2023 as the LLM suggests. The LLM's interpretation of the strategy as 'stable' is reasonable given what it claims, but this interpretation is based on incomplete and inaccurate data. The reasoning about deposit method accounting and offset treatment is correct, but the failure to recognize the 2022 baseline represents a significant gap in multi-hop synthesis across the three-year period. The answer demonstrates partial understanding of the accounting mechanics but fails on the core quantitative evolution of the arrangement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 367,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "The Target MasterCard Credit Card’s penetration (as reported in the RedCard Penetration metric) fell from **20.5 % in 2022 to 19.8 % in 2023 and 18.6 % in 2024**【page_27】. This steady decline indicates that a smaller share of Target purchases are being paid with the card, suggesting that consumer engagement with Target’s financial products is gradually weakening over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified all three penetration rate percentages (20.5% in 2022, 19.8% in 2023, 18.6% in 2024) and accurately characterized the trend as a steady decline. The numeric data is factually accurate and properly formatted. WEAKNESSES: The LLM answer is incomplete relative to the ground truth. It fails to address several key contextual elements: (1) Does not mention the rebranding from RedCards to Target Circle Cards in 2024, which is significant context for understanding the trend; (2) Does not discuss the continued incentives like the 5% discount that persisted despite the decline; (3) Does not explicitly note that the rebranding failed to reverse the decline, which is an important analytical insight. The LLM's reasoning about 'consumer engagement gradually weakening' is sound and aligns with the ground truth interpretation, but it lacks the depth and completeness of the original answer. The answer addresses the 'how did it evolve' part of the question well but only partially addresses 'what does this trend suggest' by omitting the rebranding context and its implications. The citation reference [page_27] adds credibility but doesn't compensate for the missing contextual information. For a multi-hop question requiring synthesis of trend data with strategic context (rebranding), the answer is partially successful but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 382,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "Colgate‑Palmolive Co. remained in PMI’s peer group in 2022, 2023 and 2024—its inclusion was unchanged each year. This consistency shows PMI’s benchmarking strategy is deliberately stable, using a fixed set of criteria (global presence, consumer‑product focus, and comparable size) to keep a consistent peer set for performance comparison.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core findings from the ground truth. STRENGTHS: (1) Correctly identifies that Colgate-Palmolive remained in PMI's peer group across all three years (2022, 2023, 2024) with no changes; (2) Accurately states the four key criteria for peer group selection (global presence, consumer-product focus, comparable net revenues, and market capitalization); (3) Properly synthesizes the multi-hop reasoning that consistency in peer group membership reflects a stable benchmarking methodology; (4) Uses appropriate terminology and conveys the strategic intent of PMI's benchmarking approach. MINOR WEAKNESSES: (1) The LLM answer mentions 'comparable size' rather than explicitly stating both 'net revenues' and 'market capitalization' as separate criteria—while semantically equivalent, the ground truth lists these as distinct characteristics; (2) The phrase 'deliberately stable' and 'fixed set of criteria' are reasonable interpretations but add slight editorial language not explicitly in the ground truth; (3) The answer could have been slightly more explicit about the three-year span demonstrating 'ongoing strategic alignment' as stated in the original. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; no calculations required; entity names (Philip Morris International, Colgate-Palmolive Co.) are accurate. MULTI-HOP REASONING: The answer correctly synthesizes information about peer group membership across multiple years and connects this to PMI's benchmarking strategy. The logical flow from consistent inclusion to stable methodology is sound. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth despite slightly different wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 477,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "AMD’s revenue‑recognition policy for development and IP licensing agreements has remained unchanged from 2022 through 2024.  The policy continues to treat a combined development‑and‑IP arrangement as a single performance obligation unless the license component is distinct, in which case the license is recognized at a point in time; standalone IP licenses are always recognized at a point in time, with no variable‑consideration estimates.  This consistency shows that AMD’s accounting approach for these agreements has been stable and unchanged over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core findings from the ground truth. Strengths: (1) Correctly identifies that AMD's revenue recognition policy remained unchanged/consistent from 2022-2024; (2) Accurately describes the two-part test for distinctness (capable of being distinct AND distinct in context); (3) Correctly states that non-distinct licenses are combined with development services and recognized over time, while distinct licenses are recognized at a point in time; (4) Accurately notes that standalone IP licenses are recognized at a point in time; (5) Correctly identifies no variable consideration estimates across the period; (6) Properly concludes the policy was stable and uniform. Minor weaknesses: (1) The phrasing 'combined development-and-IP arrangement as a single performance obligation unless the license component is distinct' could be slightly clearer - the ground truth emphasizes the evaluation criteria more explicitly (capable of being distinct AND distinct in context); (2) The answer is slightly more concise than the ground truth, omitting the explicit mention that the evaluation was based on two specific criteria, though the substance is captured; (3) Does not explicitly state 'in all three years' though the timeframe is clear. The multi-hop reasoning is sound - the answer correctly synthesizes information across the 2022-2024 period and identifies the consistency pattern. No numerical errors or calculation issues. The answer directly addresses all parts of the question regarding policy evolution, the distinction between combined and standalone arrangements, and what this reveals about consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 455,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "Colgate‑Palmolive Co. appears in PMI’s peer‑group list in every filing from 2022 through 2024 (see the peer‑group tables on page 21 for 2022 and page 26 for 2023 and 2024). The peer‑group composition—including Colgate‑Palmolive—has not changed across these years, indicating that PMI deliberately benchmarks itself against large global consumer‑products firms rather than only tobacco peers. This consistency reflects PMI’s strategic framing of its competitive positioning as a broad consumer‑products company focused on smoke‑free and other consumer goods markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that Colgate-Palmolive Co. appears in PM's peer group across all three years (2022-2024), matching the ground truth; (2) Accurately states the peer group composition remained unchanged across the reporting periods; (3) Provides specific page references (page 21 for 2022, page 26 for 2023 and 2024) that add credibility; (4) Correctly synthesizes the multi-hop reasoning that this consistency reflects PM's strategic positioning as a broad consumer-products company; (5) Properly identifies the company as PMI (Philip Morris International) rather than just PM; (6) Accurately captures the strategic implication that PM benchmarks against large global consumer-products firms rather than only tobacco peers. MINOR ISSUES: (1) The LLM uses 'PMI' while the ground truth uses 'PM' - these are equivalent references to the same company, so this is not a factual error; (2) The LLM's explanation of strategic framing emphasizes 'smoke-free and other consumer goods markets' which is a reasonable inference but goes slightly beyond what the ground truth explicitly states about 'alignment with leading global consumer staples firms'; (3) The answer could have been slightly more explicit about the 3-year consistency being notable for demonstrating a 'stable methodology' as mentioned in the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and multiple filings to demonstrate consistency and draw conclusions about strategic positioning. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and the consistency claim are accurate. Page numbers are provided but cannot be independently verified from the ground truth provided. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly different emphasis and wording, but the core facts and conclusions align well.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 534,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "From 2022 through 2024 AMD applied the same revenue‑recognition policy for combined development and IP‑licensing arrangements. The company evaluates whether the licensing component is distinct; if it is not distinct, the services and license are combined into a single performance obligation and revenue is recognized over time, whereas if the license is distinct it is treated as a separate obligation and revenue is recognized at a point in time when the customer can benefit. No variable consideration is involved, and the policy did not change across the three fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the question about AMD's revenue recognition policy evolution from 2022-2024. Strengths: (1) Correctly identifies that the policy remained consistent/unchanged across all three years, matching the ground truth assertion of 'no material changes'; (2) Accurately describes the two-criterion framework for assessing distinctness (capable of being distinct AND distinct in context); (3) Correctly explains the dual treatment: non-distinct licenses combined with development services as single performance obligation recognized over time, versus distinct licenses recognized at point in time; (4) Accurately notes the absence of variable consideration; (5) Properly synthesizes the multi-hop information about policy consistency across 2022-2024. Minor observation: The LLM uses slightly different phrasing ('treated as a separate obligation' vs ground truth's 'recognized at a point in time when the customer could benefit from the license') but the semantic meaning is equivalent and accurate. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information across three fiscal years and identifying the consistent policy framework. No quantitative errors present. The response is appropriately scoped and directly answers all aspects of the question regarding performance obligations and timing of revenue recognition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 389,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE common shares in 2022, selling the remaining 91 million shares and using the proceeds to fund a large share‑repurchase program that year (87.7 million shares repurchased)【page_112】. In 2023 and 2024 no further CVE shares were monetized, and share repurchases fell to roughly 48–49 million shares (48.6 million in 2023, 49.1 million in 2024)【page_112】, while the Board expanded the repurchase authorization to $65 billion in 2024【page_112】. This progression shows a disciplined capital‑allocation strategy: a one‑time monetization to boost shareholder returns, followed by a sustainable, moderate repurchase program funded from operating cash flow and supported by an expanded authorization.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant numerical discrepancies that undermine its credibility. Ground truth states cumulative repurchases of 383 million shares at $29 billion by end of 2023, and 433 million shares at $34.3 billion by end of 2024. The LLM claims only 48.6 million shares repurchased in 2023 and 49.1 million in 2024, which are annual figures that don't align with the cumulative totals in the ground truth. The LLM correctly identifies the 91 million CVE shares sold in Q1 2022 and the 87.7 million shares repurchased in 2022, but then dramatically understates subsequent repurchase activity. The ground truth indicates 433M - 383M = 50 million shares repurchased in 2024 (approximately matching the LLM's 49.1M figure for that year alone), but the 2023 figure of 48.6M appears to be annual, not cumulative. MISSING CRITICAL CONTEXT: The LLM fails to mention the $29 billion cost through 2023 and $34.3 billion total cost through 2024, which are essential to understanding the capital allocation strategy's magnitude. The ground truth emphasizes the 'escalating focus' and 'continued emphasis on returning capital to shareholders,' but the LLM's framing of 'sustainable, moderate repurchase program' may understate the scale. CORRECT ELEMENTS: The LLM correctly identifies the 2024 $65 billion authorization expansion, the completion of CVE monetization in 2022, and the general strategic narrative of disciplined capital allocation. The reasoning about one-time monetization followed by sustainable repurchases is sound. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize information across years but fails to properly integrate the cumulative repurchase totals and dollar amounts that are central to understanding the 'multi-year progression' requested in the question. The answer reads as incomplete without the financial magnitude context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 513,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "Across 2022‑24 Honeywell’s risk disclosures consistently flag that each business—Aerospace Technologies, Industrial Automation, Building Automation, Energy & Sustainability Solutions, and Safety & Productivity Solutions—faces new entrants, non‑traditional players and product commoditization (2022‑page 30‑33; 2023‑page 30‑34; 2024‑page 28‑32). While the wording of the competitive‑landscape risk has not materially changed, the company has intensified its strategic response, announcing a 2024 realignment of its segments, repositioning charges and planned spin‑offs to sharpen focus and defend market share. This evolution signals that competitive pressures are viewed as increasingly acute, prompting Honeywell to restructure and invest in new technologies to maintain margins and growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES: (1) ENTITY ACCURACY PROBLEM: The LLM answer lists 'Aerospace Technologies' and 'Energy & Sustainability Solutions' as segments facing competitive pressures, but the ground truth specifically identifies 'Honeywell Building Technologies' and 'Safety and Productivity Solutions' in 2022, and 'Building Automation and Industrial Automation' in 2024. The LLM appears to have included incorrect segment names not mentioned in the ground truth. (2) INCOMPLETE SEGMENT COVERAGE: The ground truth focuses on specific segments (Building Technologies/Building Automation, Safety and Productivity Solutions, Industrial Automation), but the LLM lists five segments without clear evidence these are all mentioned in the original filings for competitive landscape risks. (3) FACTUAL DIVERGENCE ON EVOLUTION: The ground truth emphasizes a 'deepening concern' with 'added emphasis on new technologies that may lead to product commoditization' by 2024, suggesting intensification. The LLM states 'the wording of the competitive-landscape risk has not materially changed,' which contradicts the ground truth's assertion of added emphasis on commoditization concerns. (4) STRATEGIC RESPONSE ADDITION: The LLM introduces information about '2024 realignment of segments, repositioning charges and planned spin-offs' which is not mentioned in the ground truth answer. While this may be factually accurate from filings, it goes beyond what the ground truth synthesized and could represent unsupported claims. (5) PAGE REFERENCES: The LLM provides specific page ranges (2022-page 30-33; 2023-page 30-34; 2024-page 28-32) that cannot be verified against the ground truth, and these may be inaccurate. (6) CORE LOGIC: The LLM's conclusion about 'increasingly acute' pressures is reasonable but the reasoning path differs from ground truth's emphasis on 'persistent and potentially intensifying' pressure with specific focus on commoditization threats. STRENGTHS: The answer correctly identifies the 3-year timeframe (2022-2024), recognizes multiple business segments face competitive pressures, and concludes that strategic response is needed. The general theme of increasing market pressure is aligned with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 591,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "From 2022 through 2024, Mastercard’s Class A shares continued to carry one vote per share and dividend rights, with the declared dividend per share rising from $2.04 in 2022 to $2.37 in 2023 and to $2.74 in 2024 (page 96, 100, 94). The voting structure remained unchanged across the three years (page 96, 100, 94). This 3‑year consistency shows that Mastercard maintains a stable governance framework while progressively enhancing shareholder value, underscoring a shareholder‑friendly strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) The LLM introduces dividend per share amounts ($2.04, $2.37, $2.74) that are NOT present in the ground truth answer. The original answer explicitly states there were 'no changes in the description of these rights over the three-year period' - it focuses on the RIGHTS STRUCTURE (voting and dividend eligibility), not actual dividend payment amounts. The LLM conflates two different concepts: the structural right to receive dividends vs. the actual dividend amounts paid. (2) The ground truth emphasizes consistency in the DESCRIPTION of rights (one vote per share, dividend rights eligibility), while the LLM shifts focus to dividend payment amounts, which represents a fundamental misunderstanding of what the question asks about. (3) The LLM's conclusion about 'progressively enhancing shareholder value' through increasing dividend payments is an inference not supported by the ground truth, which makes no mention of dividend amount changes. (4) The page citations (96, 100, 94) cannot be verified against the ground truth but appear to be fabricated specificity. (5) MULTI-HOP REASONING: The question asks about evolution of rights and what consistency reveals about governance strategy. The LLM partially addresses the governance strategy aspect but introduces incorrect financial data that contradicts the core finding of the ground truth (no changes). The LLM does correctly identify that voting structure remained unchanged, but this is overshadowed by the introduction of unsubstantiated dividend payment figures. The answer demonstrates a misreading of what 'dividend rights' means in a governance context versus actual dividend payments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 459,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation exposure swung from a loss to a growing gain.  In FY 2022 the swaps produced a $92 million loss in operating expenses, which turned into a $58 million gain in FY 2023 and further increased to a $91 million gain in FY 2024, reflecting a shift from negative to positive impact and an expanding derivative exposure over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: FY 2022 loss of $92 million, FY 2023 gain of $58 million, and FY 2024 gain of $91 million. The multi-hop synthesis is sound, correctly tracking the evolution across three fiscal years and identifying the key trajectory from loss to gains. The answer properly identifies the instrument (Total Return Swaps-Deferred Compensation), the company (Cisco), and the relevant metric (gains/losses in operating expenses). The reasoning is logical and captures the significant reversal from negative to positive financial impact. Minor differences from ground truth: (1) The LLM uses slightly different phrasing ('swung from a loss to a growing gain' vs. 'shifted significantly') but conveys the same meaning; (2) The LLM adds the phrase 'expanding derivative exposure' which is a reasonable interpretation but not explicitly stated in the ground truth; (3) The LLM specifies 'operating expenses' context which aligns with the ground truth. The answer is semantically equivalent to the original, with all core facts accurate and the multi-hop reasoning properly synthesized across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 336,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "From 2022 to 2024, Johnson & Johnson expanded its talc‑liability reserve from $2 billion to $9 billion in 2023 and to a present‑value of $11.6 billion by year‑end 2024, recording a cumulative $5 billion charge. Legally, LTL Management LLC filed a voluntary Chapter 11 petition in 2021, re‑filed LTL 2 in 2023 (which was dismissed in July 2023), and the company shifted to a pre‑packaged Chapter 11 plan in 2024 (present‑value $6.475 billion) while creating Texas entities that filed their own petitions. Concurrently, the company reached an agreement in principle with a multi‑state group of attorneys general in January 2024 and finalized those settlements in June 2024, and also negotiated a global settlement with Imerys and Cyprus in July 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth, while also missing key elements from the original answer.\n\nMAJOR ERRORS:\n\n1. RESERVE AMOUNTS: The LLM claims reserves expanded to $9 billion in 2023 and $11.6 billion by end-2024. The ground truth only mentions a $2 billion reserve established in 2022. The LLM provides specific numbers ($9B, $11.6B, $5B cumulative charge, $6.475B present-value) that are not corroborated by the ground truth and appear to be fabricated or from unreliable sources.\n\n2. BANKRUPTCY TIMELINE ERRORS: The LLM states LTL filed in 2021, but the ground truth clearly indicates the filing occurred in 2022. The LLM also claims LTL 2 was dismissed in July 2023, but the ground truth states the Third Circuit reversed the bankruptcy court's decision and the case was dismissed, with LTL then re-filing (LTL 2) and securing a preliminary injunction that limited discovery until August 2023. The sequence and timing are confused.\n\n3. UNSUPPORTED CLAIMS: The LLM introduces multiple elements not in the ground truth:\n   - A \"pre-packaged Chapter 11 plan in 2024\"\n   - \"Texas entities that filed their own petitions\"\n   - \"Agreement in principle with multi-state attorneys general in January 2024\"\n   - \"Global settlement with Imerys and Cyprus in July 2024\"\n   These details either contradict or significantly expand beyond the ground truth without verification.\n\n4. MISSING KEY INFORMATION: The LLM fails to clearly articulate the core strategic evolution described in the ground truth: the shift from exclusive reliance on bankruptcy protection (2022-2023) to a dual strategy combining legal appeals with negotiated settlements (2024). While the LLM mentions both approaches, it doesn't clearly convey this strategic pivot.\n\n5. SETTLEMENT DETAILS: The ground truth specifies a \"multi-state settlement with 42 states and the District of Columbia\" finalized in 2024. The LLM mentions \"multi-state group of attorneys general\" but doesn't specify the 42 states figure, and adds unverified details about Imerys and Cyprus settlements.\n\nPARTIAL CREDIT:\n- The LLM correctly identifies that JNJ established reserves and that LTL Management LLC was involved in bankruptcy filings\n- The LLM correctly notes a shift toward settlements alongside legal strategies\n- The general timeline framework (2022-2024) is correct\n\nThe answer demonstrates some understanding of the question's multi-hop nature but fails on factual accuracy, introduces unsupported claims, and contains specific numeric errors that are critical in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 700,
        "total_tokens": 2083
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "Broadcom’s 3.125% senior notes due January 2025 had an outstanding principal balance of **$495 million in FY 2022**, and this amount remained unchanged in FY 2023 and FY 2024 (the 2023 and 2024 10‑K debt schedules both list $495 million as of November 3 2024 and October 29 2023). The unchanged balance indicates that the company has neither issued additional principal nor redeemed the notes, reflecting a conservative debt‑management approach that preserves liquidity and avoids refinancing risk for this long‑term instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. STRENGTHS: (1) All key financial figures are correct - $495 million principal balance is accurately stated for all three fiscal years (2022, 2023, 2024). (2) The dates are properly identified (November 3, 2024 and October 29, 2023 as fiscal year-end dates). (3) The multi-hop synthesis is sound - the answer correctly traces the debt instrument across three fiscal years and identifies the pattern of no change. (4) The interpretation of debt management strategy is reasonable and supported by the facts - the unchanged balance does indicate neither issuance nor redemption. (5) The answer provides appropriate context about liquidity preservation and refinancing risk avoidance. MINOR CONSIDERATIONS: (1) The LLM provides slightly more interpretive detail about 'conservative debt-management approach' and 'preserves liquidity' compared to the ground truth's more neutral 'consistent approach to managing this portion of its capital structure' - however, this is a reasonable inference from the data and not factually incorrect. (2) The ground truth uses simpler language ('did not retire or issue additional portions') while the LLM uses 'neither issued additional principal nor redeemed' - these are semantically equivalent. (3) The LLM explicitly cites the specific fiscal year-end dates from the 10-K filings, which adds credibility and detail beyond the ground truth. All quantitative data matches perfectly, the entity identification (Broadcom, AVGO, 3.125% notes due January 2025) is correct, and the reasoning properly synthesizes information across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 448,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "Cisco’s 3.50% note due June 15, 2025 had an effective rate of **1.29 % in FY 2022** (page 90), **6.38 % in FY 2023** (page 89), and **6.66 % in FY 2024** (page 89). The jump from a low‑discounted issuance to a higher‑rate environment shows that Cisco’s borrowing cost for this debt rose sharply over the three years, reflecting higher market rates and the note’s conversion from a discount to a premium‑priced instrument.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a FY 2022 effective rate of 1.29%, which contradicts the ground truth value of 3.20%. This is a significant factual error on a key metric. The FY 2023 (6.38%) and FY 2024 (6.66%) figures are correct. (2) MULTI-HOP SYNTHESIS - The LLM correctly identifies the three-year progression and attempts to explain the trend, but the incorrect starting point undermines the entire analysis. The ground truth shows a progression from 3.20% → 6.38% → 6.66%, while the LLM shows 1.29% → 6.38% → 6.66%. This changes the narrative of the trend significantly. (3) REASONING QUALITY - The LLM's interpretation about 'conversion from discount to premium-priced instrument' is speculative and not supported by the ground truth explanation, which attributes the increase to market conditions or credit profile changes. (4) ENTITY ACCURACY - Company (Cisco), note details (3.50%, June 15, 2025), and fiscal years are correctly identified. (5) COMPLETENESS - The answer addresses all parts of the question but with a fundamental error in the FY 2022 data point. The 1.29% figure appears to be either a transcription error or data from a different security/metric. This single error cascades through the entire analysis, making the core factual foundation incorrect despite getting 2 of 3 data points right.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 378,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "Capital One’s total senior and subordinated notes were $30.8 billion in 2022 (Table 8.1, 2022 10‑K, p.186), rose to $31.2 billion in 2023 (Table 8.1, 2023 10‑K, p.186), and fell slightly to $30.7 billion in 2024 (Table 9.1, 2024 10‑K, p.188). The debt level has remained essentially flat, while the company has shifted from a mix of fixed‑ and floating‑rate debt (1.01% floating in 2022, 6.75% floating in 2023) to all‑fixed debt with a weighted‑average rate of 4.45% in 2024, indicating a strategy to lock in lower rates and reduce interest‑rate exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) NUMBERS INCORRECT: The LLM states 2022 total was $30.8B, but ground truth shows $27.219B - a $3.6B discrepancy (13% error). The 2023 figure of $31.2B is approximately correct (ground truth: $31.248B), and 2024 of $30.7B matches ground truth ($30.696B). This means 2 of 3 year-end figures are wrong. (2) INTEREST RATE DATA CONTRADICTS GROUND TRUTH: The LLM provides floating-rate percentages (1.01% in 2022, 6.75% in 2023) and a weighted-average rate of 4.45% in 2024, which do NOT match the ground truth weighted average rates of 2.76% (2022), 4.48% (2023), and 4.84% (2024). The 4.45% figure is close to but still incorrect for 2024. The floating-rate percentages appear to be misinterpreted or from wrong tables. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM correctly identifies the general trend (capital raise in 2023, slight decline in 2024) but misses the critical insight from ground truth: the 2022 baseline was significantly lower ($27.2B vs claimed $30.8B), making the 2023 increase far more dramatic (14.8% growth vs ~1.3% as implied by LLM numbers). (4) STRATEGIC INTERPRETATION PARTIALLY CORRECT: The LLM correctly identifies the shift toward fixed-rate financing and interest-rate risk reduction, which aligns with ground truth. However, the specific rate progression is wrong, and the characterization of 'locking in lower rates' is misleading given the actual rate increases from 2.76% to 4.84%. (5) CITATION ISSUES: The LLM cites specific tables and pages, but the numbers don't match ground truth, suggesting either fabricated citations or misreading of source documents. The fundamental error in the 2022 baseline ($30.8B vs $27.219B) is a critical failure that cascades through the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 501,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "Colgate‑Palmolive cut the share of its U.S. pension‑plan fixed‑income holdings in U.S. treasuries and agency securities from about **40 % in 2022** (page 102) to roughly **30 % in 2023** (page 100) and kept that **30 % level in 2024** (page 99). This trend shows a deliberate move away from a heavily treasury‑centric mix toward a more diversified fixed‑income strategy, likely aimed at improving yield or risk‑adjusted returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All percentages are correct - 40% in 2022, 30% in 2023, and 30% in 2024 match the ground truth exactly. The year-over-year progression is accurately captured. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the allocation evolution from 2022-2024, (2) the specific percentages at each year, and (3) the strategic implications. ENTITY ACCURACY: Colgate-Palmolive is correctly identified, the U.S. pension plan is properly specified, and the fixed income portfolio category is accurate. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the trend (40% → 30% → 30%), recognizes it as a deliberate strategic shift, and provides reasonable interpretation (move toward diversification, yield-seeking behavior). The characterization as a \"deliberate move away from a heavily treasury-centric mix\" aligns well with the ground truth's description of \"strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds.\" SEMANTIC EQUIVALENCE: The LLM's phrasing \"improving yield or risk-adjusted returns\" is semantically equivalent to the ground truth's \"shift in risk tolerance or yield-seeking behavior.\" The inclusion of page references (102, 100, 99) adds credibility and specificity. MINOR CONSIDERATIONS: The LLM uses slightly different language (\"cut the share\" vs. \"decreased\") but this is stylistic variation that enhances clarity without sacrificing accuracy. The answer is well-structured and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 452,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "GE classified its captive industrial insurance subsidiary, Electric Insurance Company, as a held‑for‑sale asset in Q4 2022 (assets $541 million, liabilities $378 million) and recorded a $124 million valuation allowance in 2023. By Q2 2024 the allowance was removed and the company was sold to Riverstone International Holdings for $120 million【page_48】. This sequence shows GE’s deliberate divestiture of non‑core insurance operations to streamline its portfolio and concentrate on its core aerospace, energy and healthcare businesses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative of GE's divestiture of Electric Insurance Company but contains several significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) EIC was classified as held-for-sale, (2) Sale completed to Riverstone International Holdings for $120 million, (3) Strategic rationale of divesting non-core insurance operations is accurate, (4) Timeline progression from 2022-2024 is correct. QUANTITATIVE ERRORS: (1) The LLM states a '$124 million valuation allowance in 2023' but the ground truth indicates a '$109 million loss' - this is a $15 million discrepancy (13.8% error), (2) The LLM provides balance sheet figures (assets $541M, liabilities $378M) not mentioned in ground truth, which cannot be verified and may be incorrect, (3) The ground truth mentions 'net claim reserves of $0.2 billion as of December 31, 2021' which the LLM omits entirely. TIMING ISSUES: The LLM states 'Q4 2022' for held-for-sale classification, but ground truth indicates this occurred by 2023, suggesting the LLM may have the timing wrong. The LLM correctly identifies Q2 2024 for sale completion. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across three years and connects it to strategic direction, though the quantitative foundation is weakened by the valuation allowance discrepancy. The reasoning about portfolio streamlining and focus on core businesses is sound and matches ground truth intent. MISSING CONTEXT: The LLM omits the 2021 reserve information and doesn't clearly distinguish between the 2022 classification and 2023 loss recording, which are separate events in the ground truth narrative. The reference to 'healthcare' in the final clause is reasonable but not explicitly confirmed in the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 488,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "Apple continued to disclose the 4.45% Notes due 2044 in each of its 2022, 2023, and 2024 10‑K filings as part of the 2014 issuance (Exhibit 4.4 in the 2022 and 2024 filings and the same exhibit in the 2023 filing).  The terms, interest rate, and maturity remained unchanged across all three reports, indicating a deliberate long‑term debt strategy that prioritizes stable, long‑dated, fixed‑rate financing to lock in rates, match long‑term cash flows, and preserve financial flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key numeric values are accurate - 4.45% interest rate, 2044 maturity date, 2014 issuance date are all correct. (2) The multi-hop synthesis across three years (2022, 2023, 2024) is sound and properly identifies the consistent disclosure pattern. (3) The exhibit references (Exhibit 4.4) add specificity and demonstrate knowledge of filing structure. (4) The interpretation of the pattern as indicating 'stable long-term capital structure' and 'no material changes or retirements' aligns with the ground truth conclusion. (5) The LLM goes beyond the ground truth by providing strategic interpretation (locking in rates, matching cash flows, preserving flexibility), which is reasonable inference from the data. MINOR CONSIDERATIONS: (1) The ground truth uses simpler language ('stable long-term capital structure and no material changes') while the LLM provides more detailed strategic rationale. This is not incorrect but represents added interpretation rather than direct fact. (2) The phrase 'deliberate long-term debt strategy' is reasonable inference but not explicitly stated in ground truth. (3) The LLM's statement about 'terms, interest rate, and maturity remained unchanged' is accurate and adds helpful specificity. VERIFICATION: All dates (2022, 2023, 2024, 2014, 2044), the 4.45% rate, and the consistency narrative are factually correct. The multi-hop reasoning correctly synthesizes information across three filing years. No calculation errors present. The answer fully addresses the question's multi-part structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 440,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose from **$27.2 billion** at year‑end 2022 (COF_10k_2022 page 189) to **$31.2 billion** in 2023 (COF_10k_2023 page 178), then fell modestly to **$30.7 billion** in 2024 (COF_10k_2024 page 189). The 2023 increase reflects additional debt issuance to fund growth or refinance, while the 2024 decline signals a partial drawdown or refinancing at lower rates (weighted‑average rates 4.48 % in 2022–23 and 4.45 % in 2024). Overall, the company keeps its cost of debt near 4.5 % while modestly adjusting leverage, indicating a deliberate strategy to balance growth financing with favorable interest‑rate conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN WEIGHTED-AVERAGE INTEREST RATES: The LLM provides incorrect interest rate data. Ground truth shows weighted-average rates of 2.76% (2022) and 4.84% (2024), but LLM states 4.48% for 2022-23 and 4.45% for 2024. These are significantly different numbers (off by ~2 percentage points for 2022 and ~0.4 percentage points for 2024), representing a major factual error on a key metric for assessing interest rate positioning. CORRECT ELEMENTS: The carrying values are accurate ($27.2B in 2022, $31.2B in 2023, $30.7B in 2024), and the directional narrative about debt issuance and refinancing is reasonable. REASONING ISSUES: The LLM's interpretation that rates were 'favorable' in 2024 at 4.45% contradicts the ground truth showing rates rose to 4.84%, which would indicate the company locked in higher rates amid rising rate environment. The LLM's conclusion about 'favorable interest-rate conditions' in 2024 is inconsistent with the actual rate trajectory. MULTI-HOP SYNTHESIS: The LLM correctly synthesized the three-year progression of carrying values and attempted to connect this to capital structure strategy, but the incorrect interest rate data undermines the core analytical conclusion about the company's interest rate positioning strategy. The ground truth emphasizes a strategic shift to fixed-rate financing locking in higher rates, while the LLM suggests rates remained stable near 4.5%, missing this critical strategic insight. COMPLETENESS: The answer addresses the evolution of carrying values and attempts to explain capital structure strategy, but the interest rate analysis—central to understanding positioning—is materially incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 456,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "Adobe positioned Frame.io in 2022 as a cloud‑native collaboration platform tightly coupled with Premiere Pro and After Effects, offering real‑time upload, review, frame‑accurate commenting and Camera‑to‑Cloud for on‑set footage (see 2022 page 12–13). By 2023 the platform’s role broadened to include Photoshop, Lightroom and Workfront, expanding its support for still images, design files, PDFs and video workflows beyond post‑production (2023 page 12–13). In 2024 the positioning remained consistent, with Frame.io still core to Adobe’s creative collaboration ecosystem and integrated with the same set of Creative Cloud apps, available in Adobe GenStudio alongside Express and Firefly Services (2024 page 12).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) MAJOR ERROR - 2022 positioning: The LLM claims Frame.io was positioned as a 'cloud-native collaboration platform tightly coupled with Premiere Pro and After Effects' in 2022, but the ground truth states it was merely 'listed as a registered trademark' in 2022 with no detailed feature descriptions. The LLM incorrectly attributes 2023-level detail to 2022. (2) MAJOR ERROR - 2023 positioning: The LLM claims Photoshop, Lightroom, and Workfront integration occurred in 2023, but the ground truth indicates these integrations happened in 2024. This is a critical chronological error that reverses the timeline. (3) MAJOR ERROR - 2024 positioning: The LLM states positioning 'remained consistent' in 2024 with 'the same set of Creative Cloud apps,' but the ground truth shows 2024 represented an expansion with 'integration into additional Adobe apps' and inclusion in Adobe GenStudio. The LLM mischaracterizes 2024 as maintaining status quo rather than showing expansion. (4) MISSING CONTEXT - The LLM fails to capture the clear trajectory described in the ground truth: from trademark recognition (2022) → detailed feature positioning (2023) → expanded integration and strategic emphasis (2024). (5) PAGE REFERENCES - The LLM provides specific page citations (2022 page 12-13, 2023 page 12-13, 2024 page 12) that cannot be verified and may be fabricated. (6) SEMANTIC ISSUES - The LLM's characterization of 'positioning remained consistent' directly contradicts the ground truth's emphasis on 'clear trajectory of deeper integration.' The multi-hop synthesis across years is fundamentally flawed, with the 2022-2023-2024 progression incorrectly sequenced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 479,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "Lowe’s repeated disclosure of the 4.550% Notes due April 5, 2049 in its 2022‑2024 10‑Ks shows a deliberate long‑term financing strategy: the company keeps a moderate‑coupon, 30‑plus‑year debt instrument on its books to lock in a stable cost of capital while extending its maturity profile into the mid‑2040s. This disciplined approach spreads refinancing risk across a diversified mix of maturities, indicating that Lowe’s is managing its debt horizon to support long‑term growth and maintain capital‑structure flexibility (see exhibits 4.16 on pages 73, 75, 76 and 82).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Lowe's debt strategy and correctly identifies key elements: (1) The 4.550% coupon rate is accurate; (2) The April 5, 2049 maturity date is correct; (3) The characterization as '30-plus-year debt' is accurate (2022-2049 = ~27 years, 2024-2049 = ~25 years, so 'plus-year' is reasonable); (4) The core insight about maintaining long-dated debt without early redemption aligns with the ground truth. STRENGTHS: The LLM answer goes beyond the ground truth by providing additional strategic context (spreading refinancing risk, supporting long-term growth, maintaining capital-structure flexibility), which adds value. The reasoning about locking in stable cost of capital and extending maturity profile is sound and well-articulated. WEAKNESSES: (1) The citation references (exhibits 4.16 on pages 73, 75, 76, 82) cannot be verified from the provided context and appear to be potentially fabricated or hallucinated specifics; (2) The phrase 'mid-2040s' is slightly imprecise (2049 is late 2040s, not mid-2040s); (3) The answer could have more explicitly stated the absence of modifications/repayments across the three-year period, which is a key element of the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across three years (2022-2024) and connects the consistent disclosure to strategic implications. The logic is sound and the conclusions are reasonable. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth regarding stability, long-term debt management, and interest rate risk management, though with different emphasis and additional strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 462,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "The 3.125 % notes due January 2025 had an outstanding principal of $495 million at the end of FY 2022, and that amount remained unchanged at $495 million at the end of FY 2023 and FY 2024【page_81】.  The unchanged balance indicates that Broadcom has neither repaid nor issued additional principal on this instrument, reflecting a strategy of keeping the maturity profile intact while using other debt facilities for refinancing or capital‑allocation purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) QUANTITATIVE ACCURACY: All numbers are correct - the $495 million principal balance is accurately stated for all three fiscal years (2022, 2023, 2024), with no calculation errors. The debt instrument details (3.125% notes due January 2025) are correctly identified. (2) COMPLETENESS: The answer addresses all parts of the multi-hop question: it tracks the evolution across three fiscal years, identifies the consistency of the balance, and explains what this indicates about debt management strategy. (3) ENTITY ACCURACY: Broadcom (AVGO) is correctly identified, the specific debt instrument is properly characterized, and all fiscal years are accurate. (4) REASONING & SYNTHESIS: The multi-hop reasoning is sound - the model correctly synthesized that the unchanged balance across three years indicates no repayments or new issuances, and logically inferred this reflects a deliberate debt management strategy. The LLM's interpretation that Broadcom 'kept the maturity profile intact while using other debt facilities for refinancing or capital-allocation purposes' is a reasonable inference that aligns with the ground truth's characterization of 'deliberate debt management strategy.' (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with slightly different wording but equivalent meaning. Minor difference: The ground truth mentions 'leveraging its predictability in interest expense and maturity timing' while the LLM focuses on 'keeping the maturity profile intact while using other debt facilities' - both are valid interpretations of the same underlying strategy, though the LLM's framing is slightly more specific about the operational implication. No material factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 493,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "In 2022 IBM disclosed the 0.950% Notes due 2025 as a separate line item in its debt schedule and incorporated the instrument definition. The 2023 10‑K continued that treatment, explicitly incorporating the 2017 8‑K instrument definition for the 0.950% Notes (page 20). By the 2024 10‑K the notes remained listed as a registered security (page 1) but no new instrument definition was added, indicating the terms had not changed. This steady, detailed disclosure reflects IBM’s strategy of maintaining a low‑interest, long‑term debt mix and its ongoing commitment to transparent, consistent reporting.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on verifiable facts but falls short on a critical element of the ground truth. STRENGTHS: (1) Correctly identifies the 0.950% Notes due 2025 across all three years (2022-2024); (2) Accurately references the May 2017 Form 8-K incorporation by reference; (3) Properly notes the 2023 10-K continued the same disclosure pattern; (4) Correctly identifies the notes as a registered security in 2024; (5) All dates and percentages are accurate; (6) The reasoning about consistent disclosure and transparency is sound. CRITICAL OMISSION: The LLM answer completely misses the key evolution highlighted in the ground truth - that in 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under ticker IBM25B. This represents a significant shift from 'disclosure' to 'active market visibility and tradability,' which is the central narrative arc of the ground truth answer. The LLM characterizes 2024 as merely 'listed as a registered security' without capturing the NYSE listing and ticker symbol, which represents a material change in the instrument's status. REASONING QUALITY: The LLM's interpretation of the progression as reflecting 'a low-interest, long-term debt mix' and 'transparent, consistent reporting' is reasonable but less insightful than the ground truth's emphasis on the transition to public trading. The LLM focuses on consistency rather than evolution, missing the strategic shift the ground truth identifies. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years but fails to identify the qualitative change in 2024 that distinguishes it from prior years. The answer treats 2024 as a continuation rather than a transition point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 473,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "In all three Form 10‑K filings, BNY Mellon lists KPMG LLP’s PCAOB firm identification number as **185**. The same number appears in the 2022, 2023, and 2024 filings (see Item 14 in each year’s proxy), showing that the identification number has remained unchanged across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies KPMG LLP's PCAOB firm identification number as 185 and accurately confirms it remained consistent across all three years (2022, 2023, and 2024). The numeric value is correct and matches the ground truth exactly. The answer properly addresses all parts of the multi-hop question by: (1) identifying the correct PCAOB number, (2) confirming consistency across all three specified years, and (3) synthesizing this information across multiple filings. The reasoning is sound and the conclusion about unchanged regulatory identification is accurate. Minor note: The LLM answer adds context by mentioning 'BNY Mellon' and 'Item 14 in each year's proxy,' which provides helpful sourcing information but goes slightly beyond the original question's scope. This additional context is not incorrect but represents a minor elaboration. The answer demonstrates proper multi-hop synthesis by connecting the PCAOB identification number across three separate annual filings. All factual information is accurate with no calculation errors or entity misidentifications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 311,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "Capital One’s fixed‑unsecured senior debt grew from $19.975 B in 2022 (0.80‑4.25% rates, 2.91% weighted average) to $27.168 B in 2023 (0.80‑7.62% rates, 4.45% weighted average) and then slightly declined to $26.930 B in 2024 (1.65‑7.62% rates, 4.84% weighted average) while extending maturities from 2022‑2032 to 2024‑2034 and then to 2025‑2035 (see pages 178‑180 for 2023 and 188‑190 for 2024). This trend—higher rates, longer maturities, and a steady total senior‑and‑subordinated notes balance—shows Capital One proactively locking in rates on longer‑dated debt to manage refinancing risk amid a tightening monetary environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. Verification of key numbers: (1) 2022 Fixed Unsecured Senior Debt: $19.975B matches ground truth $19,975M (format variation acceptable); (2) 2024 amount: $26.930B matches ground truth exactly; (3) 2022 weighted-average rate: 2.91% matches ground truth; (4) 2024 weighted-average rate: 4.84% matches ground truth. The LLM additionally provides intermediate 2023 data ($27.168B at 4.45% weighted average) which enriches the multi-year trend analysis beyond the ground truth's 2022-2024 comparison. The interest rate ranges (0.80-4.25% in 2022, 0.80-7.62% in 2023, 1.65-7.62% in 2024) and maturity extension timeline (2022-2032 to 2024-2034 to 2025-2035) add valuable context not contradicted by ground truth. The reasoning correctly synthesizes the strategic shift: higher rates, longer maturities, and refinancing risk management in response to monetary tightening. The slight 2023-2024 decline ($27.168B to $26.930B) is accurately captured. Citation references to specific pages (178-180 for 2023, 188-190 for 2024) demonstrate source documentation. The only minor consideration is that the ground truth focuses on 2022-2024 endpoints, while the LLM provides intermediate 2023 data—this is additive rather than contradictory and strengthens the multi-year trend analysis. All calculations are accurate, entity identification (Capital One, Fixed Unsecured Senior Debt, Total Senior and Subordinated Notes) is correct, and the semantic meaning aligns perfectly with the ground truth's conclusion about strategic capital structure decisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 446,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "From 2022 through 2024 AMD applied the same revenue‑recognition framework for development‑and‑IP licensing agreements: it first determines whether the license is distinct; if not, the license is combined with development services and revenue is recognized over time, whereas a distinct license is recognized at a point in time when the customer can benefit (no variable consideration is involved)【page_59】【page_63】【page_64】. This unchanged methodology shows that AMD is maintaining a disciplined, GAAP‑aligned approach to monetizing its IP, treating licensing as a separate, point‑in‑time revenue stream when appropriate and thereby supporting a stable, long‑term strategy for diversifying revenue beyond product sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the consistent revenue recognition methodology across 2022-2024, with accurate description of the two-path approach (distinct vs. non-distinct licenses); (2) Accurately states that distinct licenses are recognized at a point in time when customer can benefit, while non-distinct licenses are combined with development services and recognized over time; (3) Correctly notes the absence of variable consideration in these arrangements; (4) Properly synthesizes the multi-hop information (methodology consistency across three years → strategic implications); (5) Appropriately interprets consistency as indicating a mature, stable, and deliberate approach to IP monetization; (6) Includes proper citations to source pages (59, 63, 64); (7) Maintains semantic equivalence with ground truth while using slightly different phrasing (e.g., 'GAAP-aligned approach' vs. 'well-defined policy framework'). MINOR CONSIDERATIONS: (1) The LLM adds interpretive language about 'disciplined, GAAP-aligned approach' and 'diversifying revenue beyond product sales' which, while reasonable inferences, go slightly beyond what the ground truth explicitly states—however, these are reasonable strategic interpretations consistent with the data; (2) The phrasing is slightly more concise than the ground truth but captures all essential information. NO FACTUAL ERRORS: All numbers, dates, methodological descriptions, and logical connections are accurate. The answer successfully addresses both parts of the multi-part question: (1) how the methodology evolved (answer: it didn't—remained consistent), and (2) what this implies about strategy (answer: stable, mature, deliberate approach to IP monetization).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 493,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "Capital One’s total senior and subordinated notes rose from **$24.1 B** at December 31 2022 to **$31.2 B** at December 31 2023, then eased slightly to **$30.7 B** at December 31 2024 (Table 8.1 2022 & 2023, Table 9.1 2024).  The weighted‑average interest rate on these notes climbed from **2.91 %** in 2022 to **4.45 %** in 2023 and **4.84 %** in 2024, while floating‑rate debt was largely retired (1,597 M → 349 M → 0 M) (same tables).  This pattern indicates a strategy to keep the debt base roughly flat, shift toward fixed‑rate financing, and accept higher rates to lock in longer maturities and better manage interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM reports 2022 total senior and subordinated notes as $24.1B, but the ground truth states $27,219 million ($27.219B). This is a significant discrepancy of approximately $3.1B or 11% error. The 2023 figure of $31.2B matches ground truth ($31,248M). The 2024 figure of $30.7B matches ground truth ($30,696M). The weighted-average interest rates are all correct: 2.91% (2022), 4.45% (2023), 4.84% (2024). FLOATING-RATE DEBT DISCREPANCY: The LLM states floating-rate debt as 1,597M → 349M → 0M, but ground truth indicates 1,709M → 349M → 0M for 2022-2024. The 2022 figure is off by $112M. The 2023 and 2024 figures are correct. REASONING AND SYNTHESIS: The LLM correctly identifies the strategic shift toward fixed-rate financing and away from floating-rate debt, which aligns with ground truth analysis. The interpretation about locking in rates and managing interest-rate risk is sound and semantically equivalent to the ground truth explanation. COMPLETENESS: The answer addresses all major components of the question: total notes evolution, interest rate progression, floating-rate debt reduction, and strategic implications. ENTITY ACCURACY: Capital One (COF) correctly identified, years 2022-2024 correct, metrics properly labeled. The primary weakness is the incorrect 2022 baseline figure for total senior and subordinated notes, which undermines the accuracy of the overall trend analysis despite the correct directional movement and subsequent year figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 413,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "Capital One’s fixed unsecured senior debt grew from $19.98 B in 2022 to $27.17 B in 2023, then fell slightly to $26.93 B in 2024 (millions of dollars)【page_186】【page_188】.  The weighted‑average interest rate jumped from 2.91 % in 2022 to 4.84 % in 2023 and remained at 4.84 % in 2024【page_186】【page_188】.  This pattern indicates the company is refinancing older, lower‑rate debt with newer fixed‑rate debt at higher rates, keeping overall debt levels relatively stable while adjusting its cost structure in a tightening market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN WEIGHTED-AVERAGE INTEREST RATE FOR 2023: The LLM states the rate was 4.84% in 2023, but the ground truth shows it was 4.45% in 2023, only reaching 4.84% in 2024. This is a significant factual error that undermines the accuracy of the answer. CORRECT ELEMENTS: (1) Carrying values are accurate: $19.98B (2022), $27.17B (2023), $26.93B (2024) - proper format conversion from millions. (2) The 2024 weighted-average interest rate of 4.84% is correct. (3) The overall trend description of debt growth then slight decline is correct. (4) The multi-hop synthesis across years is properly structured. INCORRECT ELEMENTS: (1) The 2023 weighted-average interest rate should be 4.45%, not 4.84%. This is a material error that affects the trend analysis. (2) The statement that the rate 'remained at 4.84% in 2024' is misleading because it implies no change from 2023, when in fact there was a 0.39 percentage point increase from 2023 to 2024. REASONING QUALITY: The qualitative interpretation about refinancing and debt strategy is reasonable and aligns with the data pattern, though it's based on partially incorrect numbers. The conclusion about 'adjusting cost structure in a tightening market' is sound but would be more accurate if it reflected the progressive rate increases (2.91% → 4.45% → 4.84%). The answer demonstrates good multi-hop synthesis but is undermined by the critical interest rate error for 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 395,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "AMD’s policy on development‑and‑IP licensing has not changed between 2022 and 2024.  For combined development‑and‑IP arrangements the company still evaluates whether the license is distinct; if it is not, the license is combined with the development services and revenue is recognized over time, whereas a distinct license is recognized at a point in time.  Stand‑alone IP‑licensing deals are always recognized at a point in time, and no variable‑consideration estimates are applied to either type of arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that AMD's policy remained unchanged from 2022-2024, matching the ground truth's assertion of 'consistent' and 'stable' application; (2) Accurately describes the distinction between combined vs. standalone arrangements - non-distinct licenses combined with development services recognized over time, distinct licenses at point in time; (3) Correctly states standalone IP licenses are recognized at point in time; (4) Accurately notes no variable consideration estimates applied to either arrangement type; (5) No quantitative errors or date inaccuracies. Minor considerations: (1) The LLM answer is slightly more concise than the ground truth, omitting the phrase 'despite evolving market conditions and ongoing customer arrangements' - however, this is contextual elaboration rather than a factual omission; (2) The LLM uses 'stand‑alone' (with special character) vs. 'standalone' but this is purely formatting and doesn't affect accuracy; (3) The LLM answer is more direct and structured, presenting the policy clearly without the narrative framing of the ground truth, but both convey identical substantive information. The multi-hop reasoning is sound - the answer correctly synthesizes the policy across three years and distinguishes between the two types of arrangements. All entities (AMD, development/IP licensing, combined vs. standalone arrangements) are correctly identified. The semantic equivalence is strong - both answers convey that the policy was stable and consistent across the period with the same technical details about recognition timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 457,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "Short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024 (Table 8.1, 2023 10‑K; Table 9.1, 2024 10‑K). Long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023, before declining to $44.99 billion in 2024 (Table 8.1, 2023 10‑K; Table 9.1, 2024 10‑K). The trend shows a deliberate shift toward reducing long‑term debt while keeping short‑term borrowings low; the weighted‑average interest rates on long‑term debt stayed around 4–5 % and the company uses interest‑rate swaps and other derivatives (Note 9) to hedge rate exposure, indicating a conservative debt‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it largely incorrect:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - LLM states short-term borrowings were $883M (2022), $538M (2023), $562M (2024)\n   - LLM states long-term debt was $47.8B (2022), $49.3B (2023), $44.99B (2024)\n   - Ground truth shows TOTAL short-term borrowings + long-term debt: $43.086B (2022), $48.715B (2023), $45.551B (2024)\n   - The LLM's long-term debt figures alone ($47.8B, $49.3B, $44.99B) are inconsistent with ground truth totals when short-term borrowings are added\n   - LLM's 2022 calculation: $883M + $47.8B = $48.683B (contradicts ground truth $43.086B)\n   - LLM's 2023 calculation: $538M + $49.3B = $49.838B (contradicts ground truth $48.715B)\n   - LLM's 2024 calculation: $562M + $44.99B = $45.552B (approximately matches ground truth $45.551B, but only by coincidence given other errors)\n\n2. INTEREST RATE ACCURACY FAILURES:\n   - LLM states weighted-average interest rates \"stayed around 4-5%\"\n   - Ground truth shows specific rates: 2.76% (2022), 4.48% (2023), 4.84% (2024)\n   - LLM's characterization of \"4-5%\" is inaccurate for 2022 (should be 2.76%)\n   - This represents a major misstatement of the interest rate trend\n\n3. TREND ANALYSIS ISSUES:\n   - LLM correctly identifies a reduction in long-term debt from 2023 to 2024\n   - However, LLM misses the critical insight that TOTAL debt increased from 2022 to 2023 (ground truth: $43.086B → $48.715B)\n   - LLM's narrative of \"deliberate shift toward reducing long-term debt\" misses the initial expansion phase\n   - Ground truth reveals a more nuanced strategy: expand debt in 2023, then reduce in 2024\n\n4. MULTI-HOP REASONING:\n   - LLM fails to properly synthesize short-term and long-term debt components into total debt figures\n   - LLM mentions hedging strategies and derivatives but doesn't connect this to the rising interest rate exposure documented in ground truth\n   - The connection between rising rates (2.76% → 4.84%) and shift to fixed-rate debt is missing\n\n5. CONTEXTUAL RELEVANCE:\n   - Question asks about evolution from 2022-2024 and what trend reveals about debt management\n   - LLM provides some relevant information about hedging but misses the key strategic insight: initial debt expansion amid rising rates, followed by deleveraging\n   - The characterization as \"conservative\" is questionable given the 2022-2023 debt increase\n\nCONCLUSION: The LLM answer contains multiple material factual errors in both absolute numbers and the interest rate trend. While some structural elements are present (mentioning hedging, derivatives), the core quantitative foundation is flawed, leading to incorrect conclusions about debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 730,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "From 2022 through 2024 AMD’s policy on development‑and‑IP licensing agreements did not change.  The company continues to treat such arrangements as either a single or multiple performance obligation; if the license component is not distinct it is combined with the development services and revenue is recognized over time, whereas a distinct license is recognized at a point in time (2022 p. 59; 2023 p. 63; 2024 p. 61).  Standalone IP licensing is always recognized at a point in time, with no variable‑consideration estimates.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core finding that AMD's revenue recognition policy for development and IP licensing agreements remained consistent from 2022 to 2024. The answer accurately identifies the key policy elements: (1) combined arrangements assessed for distinctness, (2) non-distinct licenses recognized over time, (3) distinct licenses recognized at a point in time, and (4) standalone IP licensing always recognized at a point in time with no variable consideration. The page references (2022 p. 59; 2023 p. 63; 2024 p. 61) are appropriately cited and demonstrate multi-hop synthesis across three years of filings. The quantitative accuracy is high—no numerical errors are present. However, the LLM answer is somewhat more concise than the ground truth and omits a few contextual details: (1) it doesn't explicitly mention that there was 'no material change in variable consideration treatment' across the three years (though it does state 'no variable-consideration estimates'), (2) it doesn't reference the business context shift toward Gaming segment emphasis in 2023-2024 mentioned in the ground truth, and (3) it doesn't explicitly state that the company 'reiterated the same framework' across years, though the answer does convey consistency. The semantic meaning is equivalent—both answers conclude the policy was stable and consistent. The reasoning is sound and the multi-hop synthesis across three years is correct. The omission of contextual business information (Gaming segment) is a minor gap but doesn't affect the core factual accuracy of the accounting policy itself.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 444,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock appears in the exhibit lists of Visa’s 2022, 2023 and 2024 10‑K filings (see page 109 in 2023/24 and page 114 in 2022).  Its repeated inclusion indicates that the instrument has not been retired or materially altered and remains an active component of Visa’s capital structure, underscoring its stability and ongoing relevance for future financing or conversion rights.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core concept that the Certificate of Designations of Series B Convertible Participating Preferred Stock appears consistently across Visa's 2022, 2023, and 2024 filings, and appropriately concludes this indicates stability and ongoing relevance. However, there are significant quantitative accuracy issues: (1) The LLM provides specific page numbers (page 109 for 2023/24, page 114 for 2022) that cannot be verified against the ground truth and may be inaccurate. The ground truth does not cite specific page numbers, only exhibit numbers. (2) The LLM fails to mention the critical exhibit number references (Exhibit 4.5 for 2022, Exhibit 4.4 for 2023 and 2024) that are central to the ground truth answer. (3) Most importantly, the LLM omits the key factual detail that all three years reference the same filing date of June 21, 2016, which is crucial evidence of the instrument's static nature and lack of modification. The qualitative reasoning is sound - the LLM correctly interprets that consistent inclusion indicates the instrument has not been retired or materially altered. However, the answer lacks the specific documentary evidence (exhibit numbers and the identical 2016 filing date) that substantiates this conclusion. The answer is partially correct in its overall assessment but incomplete in supporting details and contains potentially inaccurate page number citations that were not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 403,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "Across 2022‑2024, RTX’s ownership and program‑share positions in the IAE collaboration stayed the same: a 61 % program‑share interest and 49.5 % ownership in IAE, and a 59 % program‑share and 59 % ownership in IAE LLC, with net program shares of 57 % and 51 % after sub‑collaborator adjustments【page_110】【page_101】【page_102】. This unchanged, majority stake and continued consolidation as a variable‑interest entity keep Pratt & Whitney’s economic exposure firmly tied to the V2500 engine program, underscoring its strategic role as the primary beneficiary and key decision‑maker in that line.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces incorrect figures not present in the ground truth. Specifically, it claims '59% program-share and 59% ownership in IAE LLC' and 'net program shares of 57% and 51% after sub-collaborator adjustments' - the ground truth only mentions 57% net program share, not a separate 51% figure. The introduction of 'IAE LLC' with different percentages appears to be fabricated or confused with different entities. (2) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the core 61% program-share interest and 49.5% ownership that remained constant across 2022-2024, it adds unverified additional metrics that contradict or confuse the ground truth narrative. (3) REASONING FLAW - The ground truth emphasizes that consistency in stake/exposure indicates NO strategic repositioning, while the LLM's framing about 'consolidation as a variable-interest entity' and 'primary beneficiary' status introduces interpretive claims not supported by the ground truth answer. (4) CORRECT ELEMENTS - The LLM does correctly identify: (a) the 61% program-share interest remained constant, (b) the 49.5% ownership remained constant, (c) the 57% net program share after sub-collaborator participation, and (d) that positions remained unchanged across the three-year period. However, the addition of unverified percentages (59%, 51%) and the IAE LLC reference significantly undermines credibility. The answer partially addresses the multi-year progression question but introduces factual inaccuracies that would mislead readers about RTX's actual stake structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 441,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "Medtronic continued to use the Non‑Employee Director Deferred Unit Award Agreement in each of the fiscal years 2022, 2023, and 2024, as evidenced by the inclusion of Exhibit 10.42 (and 10.52) in the 10‑K filings for those years (see page 114). The consistent use of this deferred‑unit mechanism across three consecutive years indicates that the company views deferred unit awards as a core component of its long‑term director‑compensation strategy, reinforcing alignment with shareholder interests over time.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial understanding but contains significant factual errors that undermine its credibility. CORRECT ELEMENTS: (1) The answer correctly identifies that Medtronic used the Non-Employee Director Deferred Unit Award Agreement across fiscal years 2022, 2023, and 2024; (2) The semantic interpretation that this represents a stable, consistent strategy is sound and aligns with the ground truth; (3) The general reasoning about long-term director compensation alignment is appropriate. CRITICAL ERRORS: (1) EXHIBIT NUMBER DISCREPANCY - The LLM cites 'Exhibit 10.42 (and 10.52)' but the ground truth specifies Exhibit 10.41 for 2022 and Exhibit 10.52 for both 2023 and 2024. The citation of 10.42 is factually incorrect; (2) The LLM provides a page reference ('page 114') that cannot be verified against the ground truth and appears to be fabricated or inaccurate; (3) INCOMPLETE SYNTHESIS - The ground truth explicitly notes that the agreement was 'tied to the 2008 Stock Award and Incentive Plan' and remained unchanged despite 'broader updates and amendments to other award agreements under the 2013 plan.' The LLM answer fails to capture this critical distinction about plan continuity and the contrast with other agreements that were updated; (4) MISSING KEY DETAIL - The ground truth emphasizes that the deferred unit award 'remained unchanged in structure and plan origin' and was NOT transitioned to newer plan versions, which is a crucial insight about the strategy. The LLM answer lacks this specificity. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to capture the nuanced comparison between the stable deferred unit agreement and the evolving landscape of other compensation agreements. The answer is somewhat superficial in its analysis. QUANTITATIVE ACCURACY: The exhibit number errors (10.42 vs 10.41) represent factual inaccuracies in citing source documents, which is critical in SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 536,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "Lockheed Martin has continued to use variable‑interest‑rate swaps to convert fixed‑rate borrowings into variable‑rate borrowings as a fair‑value hedge, a practice described in the 2022, 2023 and 2024 10‑Ks (see 2022 10‑K, page 66; 2023 10‑K, page 95; 2024 10‑K, page 52).  The aggregate notional amount of outstanding swaps remained unchanged at $1.3 billion in 2022, 2023 and 2024 (2023 10‑K, page 95; 2024 10‑K, page 52), indicating a deliberate, steady‑state hedging strategy that keeps swap exposure aligned with the company’s fixed‑rate debt rather than expanding or contracting it in response to market shifts.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that LMT's notional amount of interest rate swaps was $500 million in 2022, increased to $1.3 billion in 2023, and remained at $1.3 billion in 2024. However, the LLM answer claims the notional amount was 'unchanged at $1.3 billion in 2022, 2023 and 2024.' This is factually incorrect - the 2022 figure was $500 million, not $1.3 billion. This represents a 160% error in the 2022 baseline figure. The LLM also mischaracterizes the evolution as a 'steady-state hedging strategy' when the ground truth explicitly describes a 'significant' increase and 'tripling of exposure' from 2022 to 2023. The LLM's interpretation that the strategy remained 'unchanged' throughout all three years is contradicted by the actual progression documented in the filings. While the LLM correctly identifies that swaps were used to convert fixed-rate borrowings to variable-rate borrowings and correctly cites the 10-K pages, these correct contextual details cannot offset the major quantitative inaccuracy regarding the 2022 notional amount. The LLM failed to capture the key insight that the question asks about - the evolution and progression of the swap strategy, which showed a dramatic increase from 2022 to 2023 followed by stabilization. Instead, the LLM presents a false narrative of consistency across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 401,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "AbbVie’s 10‑K filings for 2022 (p. 46‑48), 2023 (p. 27) and 2024 (p. 27) all contain the same language that stockholders may only remove directors “for cause.” No amendments or changes were made to this clause over the three years. The unchanged provision signals a deliberate, long‑term posture to deter hostile takeovers by making director removal difficult and thereby protecting the board’s independence.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that the director removal 'for cause' provision remained unchanged across all three years (2022-2024), matching the ground truth; (2) Accurately cites the specific page numbers from 10-K filings (p. 46-48 for 2022, p. 27 for 2023 and 2024), demonstrating proper document sourcing; (3) Correctly identifies the provision as an anti-takeover defense mechanism; (4) Properly synthesizes the multi-hop information across three years to show consistency; (5) Accurately characterizes the strategic intent (deterring hostile takeovers, protecting board independence). MINOR WEAKNESSES: (1) The LLM answer is somewhat more concise than the ground truth and omits mention of other related provisions (staggered board terms, supermajority voting requirements) that the ground truth explicitly references as part of the 'broader set of anti-takeover provisions.' While the question asks about 'governance provisions' (plural), the LLM focuses primarily on the director removal provision; (2) The phrase 'making director removal difficult and thereby protecting the board's independence' is slightly less nuanced than the ground truth's reference to 'insulating the board from activist pressures and hostile takeovers' - though semantically similar; (3) Does not explicitly mention the 'certificate of incorporation and by-laws' as the source documents, though this is a minor omission. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; page numbers cited appear reasonable for 10-K filings; no calculations required. MULTI-HOP REASONING: The answer correctly synthesizes information across three separate years and documents to establish the consistency pattern. The logical conclusion about strategic posture is sound and well-supported. Overall, this is a strong answer that captures the essential facts and reasoning, with only minor gaps in comprehensiveness regarding the broader governance framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 548,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "AbbVie’s money‑market‑fund and time‑deposit balance fell from **$21 million** at December 31 2022 (page 111) to **$10 million** at December 31 2023 (page 79) and stayed at **$10 million** at December 31 2024 (page 84). The drop and subsequent plateau indicate the company is trimming idle short‑term cash, likely reallocating those funds to other short‑term instruments or operational uses, and maintaining a modest, stable liquidity cushion to manage its fluctuating cash balances.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the core numbers that directly contradict the ground truth. (1) YEAR 2022: LLM states $21 million, but ground truth shows $12 million - this is a 75% overstatement. (2) YEAR 2023: LLM states $10 million, but ground truth shows $21 million - this is a 52% understatement. (3) YEAR 2024: LLM correctly states $10 million, matching ground truth. The LLM has essentially reversed the 2022 and 2023 values, creating an inverted trend narrative. (4) CASH AND EQUIVALENTS CONTEXT: The LLM completely omits the broader cash position context ($8,449M in 2022, $9,201M in 2023, $5,524M in 2024) that the ground truth includes to show the relationship between money market allocations and overall liquidity. (5) TREND ANALYSIS: Because the numbers are wrong, the trend interpretation is backwards. The ground truth shows an INCREASE from 2022 to 2023 ($12M to $21M), then a DECREASE to 2024 ($21M to $10M). The LLM describes a continuous decline from 2022 onward, which is factually incorrect. (6) MULTI-HOP SYNTHESIS: The LLM fails to synthesize the relationship between fluctuating total cash balances and the allocation strategy across the three-year period. The ground truth correctly identifies that the company initially increased money market placement despite rising overall cash, then retreated - a more nuanced liquidity management story than the LLM's simple 'trimming idle cash' narrative. The reasoning about 'reallocating funds' and 'maintaining a modest, stable liquidity cushion' is somewhat plausible but is built on incorrect foundational numbers, making the entire analysis unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 460,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "AbbVie’s 2022 Form 10‑K (page 46) notes that “stockholders may only remove directors for cause.” The same wording appears unchanged in the 2023 Form 10‑K (page 27) and again in the 2024 Form 10‑K (page 27). The unchanged provision—part of a broader anti‑takeover framework—shows a deliberate long‑term strategy to preserve board independence and make it difficult for hostile bidders to replace directors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. STRENGTHS: (1) Correctly identifies the consistent provision across all three years (2022, 2023, 2024) that stockholders may only remove directors for cause; (2) Accurately cites specific page numbers (page 46 for 2022, page 27 for 2023 and 2024) from the respective 10-K filings; (3) Properly synthesizes the multi-hop information showing consistency across years; (4) Correctly interprets this governance mechanism as part of an anti-takeover defense strategy; (5) Accurately conveys the strategic intent to preserve board independence and deter hostile bidders. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the phrase 'broader set of governance mechanisms' and 'activist interventions,' though these are minor contextual details rather than factual errors; (2) The ground truth emphasizes 'repeated emphasis' and 'deliberate and sustained effort' with slightly more elaborate language, but the LLM captures the essential meaning of consistency and strategic intent. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) are correctly identified; page numbers are accurate; no calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings to demonstrate consistency and draw conclusions about long-term strategy. The logical connection between the unchanged provision and anti-takeover strategy is sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM's phrasing 'unchanged provision' and 'deliberate long-term strategy' conveys the same meaning as the ground truth's 'consistently maintained' and 'deliberate and sustained effort.' The answer fully addresses both parts of the question: (1) how the provision evolved (remained unchanged), and (2) what this suggests about strategy (deter hostile takeovers).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 513,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "In the 2022 10‑K (page 9) Intel did not yet reference PowerVia, indicating it was not part of the roadmap. By the 2023 10‑K (page 14) the company positioned PowerVia as a breakthrough backside‑power technology for the upcoming Intel 20A node, expected to deliver up to 15 % performance‑per‑watt improvement over Intel 3. In the 2024 10‑K (page 12) PowerVia had moved to the next‑generation Intel 18A node, with high‑volume manufacturing slated for 2025, underscoring Intel’s strategy to embed backside power delivery as a core enabler for density and power‑efficiency gains in its advanced process nodes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop evolution of Intel's PowerVia strategy across three years. STRENGTHS: (1) Correctly identifies the timeline progression: 2022 (not referenced), 2023 (Intel 20A positioning), 2024 (Intel 18A with 2025 HVM target). (2) Accurately captures the 15% performance-per-watt improvement metric mentioned for Intel 20A. (3) Properly synthesizes the strategic pivot from initial introduction to refined roadmap alignment. (4) Correctly identifies the core strategic intent around backside power delivery for advanced nodes. (5) Provides specific page references (9, 14, 12) showing document-level verification. MINOR CONSIDERATIONS: (1) The LLM states Intel 'did not yet reference PowerVia' in 2022, while the ground truth says it was 'first introduced' in 2022 - this is a subtle distinction. The LLM's interpretation (not referenced in 10-K) may be technically accurate regarding SEC filing documentation, though the ground truth suggests earlier strategic introduction. (2) The LLM adds the specific 15% metric which, while accurate and helpful, goes slightly beyond the ground truth's more general framing. (3) The LLM's characterization of the shift as moving to 'next-generation Intel 18A' is accurate but the ground truth uses 'realignment within a more refined roadmap' - semantically equivalent but different emphasis. QUANTITATIVE VERIFICATION: The 15% performance-per-watt figure is specific and appears accurate. The 2025 HVM date for Intel 18A is correctly stated. Node designations (20A, 18A, Intel 3) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the progression and strategic implications. The connection between backside power delivery benefits and the roadmap evolution is logically sound. OVERALL: This is a high-quality answer that accurately addresses the question with proper multi-hop synthesis, though there is a minor interpretive difference regarding 2022 positioning that prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 565,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "MDT’s Black‑Scholes volatility assumption rose modestly over the three‑year period: 23.04 % in 2022, 24.05 % in 2023, and 24.29 % in 2024【page_82】. The gradual uptick reflects a cautious, market‑responsive approach—MDT updates its blended historical‑plus‑implied volatility estimate annually to capture changing market risk while maintaining a conservative valuation framework for its non‑qualified options.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific volatility percentages (23.04% in 2022, 24.05% in 2023, 24.29% in 2024) that cannot be verified against the ground truth, which does not provide these exact numerical values. The ground truth focuses on the METHODOLOGY evolution (historical only → blended historical and implied → continued blended approach), not on the specific volatility percentages themselves. The LLM's claim about specific percentage values is a critical factual assertion that lacks support in the provided ground truth and represents potential hallucination of precise numbers. However, the LLM correctly identifies that MDT moved from a historical-only approach to a blended historical-plus-implied volatility methodology, which aligns with the ground truth's core narrative. The LLM also correctly characterizes this as a 'market-responsive approach' and notes the annual updates, which are semantically consistent with the ground truth's description of 'aligning option valuations more closely with real-time market expectations.' The reasoning about the evolution being gradual and market-sensitive is sound and matches the ground truth's intent. The major weakness is the introduction of unverified specific percentages, which violates the principle of strict accuracy on quantitative data. The answer addresses the multi-year progression and the company's valuation approach, but the numerical specificity without ground truth support significantly undermines credibility. The qualitative reasoning about methodology evolution is largely correct, but the quantitative claims are problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 440,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "In 2022 Intel described PowerVia as a future breakthrough for the Intel 20A node, promising up to a 15 % performance‑per‑watt improvement (2022 page 9). By 2023 the company reiterated PowerVia as a key backside‑power technology for 20A, underscoring its role in power‑efficiency gains (2023 page 14). In 2024 PowerVia was moved into the Intel 18A node—Intel’s current advanced process—set for high‑volume production with the Panther Lake family, showing that PowerVia has evolved from a planned feature to a core enabler of Intel’s advanced process roadmap and IDM 2.0 strategy (2024 page 10).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PowerVia's evolution across 2022-2024 with mostly accurate information. STRENGTHS: (1) Correctly identifies PowerVia introduction in 2022 for Intel 20A, (2) Accurately notes 2023 reiteration of PowerVia's role in 20A, (3) Correctly states 2024 transition to Intel 18A with Panther Lake production planned for 2025, (4) Properly synthesizes the multi-hop progression showing PowerVia's persistence across node transitions, (5) Appropriately connects PowerVia to IDM 2.0 strategy. WEAKNESSES: (1) The 15% performance-per-watt improvement figure is attributed to 2022 in the LLM answer, but ground truth indicates this was emphasized in 2023 as part of the 20A/RibbonFET integration story - this is a minor temporal attribution issue, (2) The LLM answer omits the explicit mention of RibbonFET integration with PowerVia, which was highlighted in the ground truth as a key 2023 development, (3) The phrase 'Intel's current advanced process' for 18A could be slightly misleading as it suggests 18A is already in production, when it's actually the future node. QUANTITATIVE ACCURACY: The 15% figure is correct but potentially misattributed to 2022 rather than 2023. MULTI-HOP REASONING: The answer successfully synthesizes information across three years showing the progression and strategic importance, though it could be more explicit about the cancellation of 20A productization. The conclusion that PowerVia 'evolved from a planned feature to a core enabler' accurately captures the essence of the ground truth narrative. Overall, the answer is substantially correct with minor omissions and one potential temporal attribution issue.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 459,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "From 2022 to 2024 Medtronic’s Black‑Scholes assumptions for non‑qualified options shifted to higher risk‑free rates (0.90 % → 4.16 %), slightly higher volatility (23.04 % → 24.29 %) and higher dividend yields (1.95 % → 3.18 %), while the expected life stayed essentially flat at 6 years, rising only to 6.1 years in 2024. These changes indicate a more conservative, market‑aligned view of price risk and a modestly longer expected exercise horizon, suggesting the company believes employees may exercise options slightly later and that volatility is higher than previously estimated. The net effect was a drop in weighted‑average fair value from $22.83 m in 2022 to $17.76 m in 2023, with a modest rebound to $18.49 m in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific numerical data (risk-free rates, volatility percentages, dividend yields, expected life, and fair values) that cannot be verified against the ground truth provided. The ground truth does not contain any specific numerical values for Black-Scholes assumptions or fair values - it only describes the qualitative evolution of the methodology (shift from historical volatility alone to incorporating implied volatility based on market-traded options in 2023-2024). Critical issues: (1) The LLM provides precise figures (0.90% → 4.16% for risk-free rates, 23.04% → 24.29% for volatility, $22.83M → $17.76M → $18.49M for fair values) that are not mentioned in the ground truth and cannot be independently verified from the provided context. (2) The LLM's characterization of the shift as 'higher risk-free rates' and 'slightly higher volatility' contradicts the ground truth's emphasis on the key methodological change: the incorporation of implied volatility from market-traded options alongside historical volatility. (3) The ground truth emphasizes that the major evolution was the shift toward 'market-informed approach' and 'aligning internal assumptions more closely with external market signals' starting in 2023, which the LLM answer does not adequately address. (4) The LLM's focus on quantitative parameter changes (rates, volatility percentages) misses the qualitative insight about the methodology shift that is central to the ground truth answer. (5) The LLM's interpretation that changes suggest 'employees may exercise options slightly later' is not supported by the ground truth. While the LLM demonstrates some understanding of Black-Scholes components and attempts multi-hop reasoning across years, it appears to have fabricated specific numerical values rather than synthesizing information from the actual filings, which is a fundamental failure in accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 515,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral posted under master‑netting arrangements – which is reported within the “Other assets, including intangibles – net” line of the balance sheet – fell sharply from **$1.494 billion in 2022 to $491 million in 2024** (a drop of roughly $1.0 billion)【page_102】【page_99】. This decline reflects a substantial reduction in the margin collateral required for its derivative positions, suggesting that the company has either scaled back its derivative exposure, improved netting efficiency, or shifted to more cleared instruments, thereby managing its derivative risk more effectively.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures and overall trend, but has a significant omission. STRENGTHS: (1) The 2022 starting value of $1.494 billion is correct (matches ground truth $1,494 million). (2) The 2024 ending value of $491 million is correct. (3) The calculation of the total decline (~$1.0 billion) is accurate. (4) The interpretation of the trend as reflecting reduced derivative exposure and improved risk management is sound and aligns with ground truth reasoning. (5) The answer appropriately cites source pages. WEAKNESSES: (1) CRITICAL OMISSION: The LLM answer completely omits the 2023 intermediate value of $800 million, which is explicitly stated in the ground truth. The ground truth shows a three-year progression (2022→2023→2024), while the LLM only provides the endpoints. This is a material omission for a multi-hop question asking about change 'from 2022 to 2024' - the intermediate year provides important context about the trajectory. (2) The LLM's phrasing 'fell sharply from $1.494 billion in 2022 to $491 million in 2024' could be interpreted as a direct two-year comparison, which technically answers the question but misses the fuller picture. (3) Minor: The LLM uses slightly different language for the trend interpretation ('scaled back derivative exposure, improved netting efficiency, or shifted to more cleared instruments') versus ground truth ('strategic reduction in derivative-related exposure or active management of margin requirements'), but both convey similar meanings. The quantitative accuracy is high for the numbers provided, but the omission of the 2023 data point reduces overall completeness and the ability to fully assess the trend pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 468,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "NextEra’s fair‑value exposure to gas options fell sharply after 2022, from $356 million (assets) and $347 million (liabilities) in 2022 to $100 million (assets) and $97 million (liabilities) in both 2023 and 2024【page_86】.  The implied volatility assumptions shifted in the opposite direction: asset volatilities rose from 17 % to 20 %, while liability volatilities fell from 295 % to 233 %【page_84】.  These changes indicate a deliberate reduction in gas‑option exposure and a more conservative, risk‑averse hedging stance that relies on higher expected volatility for asset positions but lower for liability positions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) VOLATILITY NUMBERS ARE COMPLETELY WRONG: The LLM states asset volatilities rose from 17% to 20% and liability volatilities fell from 295% to 233%. The ground truth shows implied volatility for options was 36% in 2022, 50% in 2023, and 52% in 2024 - a consistent INCREASE, not the mixed directional changes claimed. The LLM's volatility figures (17%, 20%, 295%, 233%) do not match ground truth at all and appear to be fabricated or from incorrect sources. (2) FAIR VALUE NUMBERS ARE PARTIALLY CORRECT: The LLM correctly states $356M assets and $347M liabilities in 2022, and $100M assets/$97M liabilities in 2023. However, the LLM claims these same values ($100M/$97M) continued into 2024, when ground truth shows 2024 had $100M assets and $102M liabilities (not $97M). This is a factual error. (3) DIRECTIONAL INTERPRETATION IS INVERTED: The LLM claims volatility 'shifted in the opposite direction' with asset volatilities rising and liability volatilities falling. This contradicts the ground truth which shows a consistent increase in implied volatility across the period (36%→50%→52%), indicating INCREASING perceived market volatility, not the mixed pattern the LLM describes. (4) MULTI-HOP SYNTHESIS FAILED: The LLM failed to correctly synthesize the relationship between declining fair values and changing volatility assumptions. The ground truth indicates declining fair values paired with increasing volatility, which the LLM misrepresented. (5) REASONING IS FLAWED: The conclusion about 'higher expected volatility for asset positions but lower for liability positions' is not supported by the ground truth data and appears to be an incorrect inference from the wrong volatility numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 471,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 35A stayed unchanged: the face amount remained $750,000 and the annual debt service stayed $19,875 (interest rate 2.65 % with a maturity of 07/15/30). This stability shows the company’s long‑term debt strategy focuses on predictable, low‑interest obligations and a steady debt profile rather than expanding or restructuring its debt mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: face amount of $750,000, annual debt service of $19,875, interest rate of 2.65%, and maturity date of 07/15/30 are all accurate. The answer correctly identifies that these figures remained unchanged from 2022 through 2024, properly synthesizing the multi-year comparison required by the question. The LLM goes beyond the ground truth by providing additional context (interest rate and maturity date) that adds value without introducing errors. The reasoning about SPG's long-term debt strategy is sound and semantically equivalent to the ground truth - both conclude that the stability indicates a focus on predictable debt servicing obligations. The only minor distinction is that the LLM characterizes the strategy as focusing on 'low-interest obligations' and 'steady debt profile rather than expanding or restructuring,' which is a reasonable inference from the data but slightly more interpretive than the ground truth's more neutral 'prioritizing predictability.' This additional interpretation is reasonable and not contradicted by the facts. The answer fully addresses all parts of the multi-part question: evolution of face amount (stable), evolution of annual debt service (stable), and what this reveals about strategy (predictability and stability). Entity identification is correct (SPG, Unsecured Notes - 35A), and the multi-hop synthesis across three years is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 409,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "Texas Instruments has consistently described analog and embedded‑processing products as its core business in each filing (2022 page 19; 2023 page 19; 2024 page 19).  Embedded‑processing revenue rose modestly from $3.26 bn in 2022 to $3.37 bn in 2023, then fell to $2.53 bn in 2024, while its operating‑profit margin dropped from 38.4 % to 13.9 % (2022 page 20; 2023 page 20; 2024 page 20).  This 3‑year trend shows TI remains committed to embedded processing but is confronting margin pressure, prompting a shift toward higher‑margin analog and broader portfolio strategies—underscoring its long‑term positioning as a diversified, manufacturing‑centric semiconductor leader.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial metrics and revenue figures that cannot be verified against the ground truth knowledge graph provided. The ground truth focuses on qualitative strategic consistency (embedded processing described consistently across 2022-2024 as a core competitive advantage), while the LLM introduces quantitative claims about embedded processing revenue ($3.26B in 2022, $3.37B in 2023, $2.53B in 2024) and operating profit margins (38.4% to 13.9%) that are not mentioned in the original answer. Without access to the actual 10-K filings, these specific numbers cannot be verified. The LLM's interpretation that the revenue decline and margin pressure indicate a 'shift toward higher-margin analog and broader portfolio strategies' represents an inference not explicitly stated in the ground truth. The LLM correctly identifies that TI maintains commitment to embedded processing and positions it as foundational to the company's strategy, which aligns with the ground truth's emphasis on consistency. However, the LLM's answer diverges significantly by introducing financial performance metrics and interpreting them as evidence of strategic shifts, whereas the ground truth emphasizes strategic stability and consistency in messaging across the three-year period. The LLM's conclusion about 'margin pressure prompting a shift' is a reasonable inference but goes beyond what the ground truth explicitly states about the company's positioning. The answer is partially correct in maintaining the core narrative of embedded processing importance but introduces unverified quantitative claims and different interpretive framing than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 457,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "From 2022 through 2023, Comcast’s wireless services were sold only as part of bundled broadband packages and offered three data‑plan choices—unlimited, shared, or pay‑per‑GB—across multiple lines per account (2022 p. 5; 2023 p. 7). In 2024 the company kept the bundled‑service positioning but added a new prepaid unlimited data plan under the NOW brand, expanding the payment options while still offering the same unlimited, shared, or per‑GB choices (2024 p. 5). Thus, the strategy evolved from a static bundled offering to a more flexible, prepaid‑friendly model without altering the core bundled structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about CMCSA's shared data plan strategy evolution from 2022-2024. STRENGTHS: (1) All factual claims are correct - the answer accurately identifies the three data plan options (unlimited, shared, per-GB) available in 2022-2023, correctly notes the bundled positioning throughout the period, and accurately describes the 2024 introduction of prepaid unlimited plans under the NOW brand. (2) Quantitative accuracy is perfect - no numeric errors, dates are correct (2022, 2023, 2024), and the 24-month device financing mentioned in ground truth is not contradicted (LLM simply doesn't mention it, which is acceptable). (3) Multi-hop synthesis is sound - the answer correctly synthesizes information across three years and identifies the strategic evolution from static to more flexible offerings. (4) Entity identification is correct - CMCSA/Comcast properly identified, wireless services correctly contextualized within broadband bundles. (5) The characterization of evolution is accurate - from 'static bundled offering' to 'more flexible, prepaid-friendly model' captures the strategic shift while maintaining core bundled structure. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth and doesn't explicitly mention device financing options, but this represents a difference in emphasis rather than factual error. The semantic meaning is equivalent - both answers convey that shared data plans remained a core offering while the company expanded flexibility through prepaid options in 2024. The page citations (2022 p. 5; 2023 p. 7; 2024 p. 5) add credibility and specificity. Overall, this is a high-quality answer that correctly synthesizes multi-year information and accurately characterizes strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 500,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock rose from **$51.354 billion** in 2022 to **$60.429 billion** in 2023 and further to **$71.431 billion** in 2024, reflecting a steady increase in treasury‑stock purchases each year. This trend shows the company is actively using excess cash to buy back shares, underscoring a capital‑allocation strategy that prioritizes returning value to shareholders and supporting the share price.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers for all three years. Ground truth shows treasury stock values as negative numbers (in parentheses, indicating contra-equity accounts): $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. The LLM incorrectly reports these as positive values: $51.354 billion in 2022, $60.429 billion in 2023, and $71.431 billion in 2024. The 2022 figure is completely wrong ($51.354B vs. $36.658B), and the sign convention is inverted throughout. While the 2023 and 2024 figures match the absolute values from ground truth, the LLM appears to have confused the starting point and misrepresented the accounting treatment. QUALITATIVE ASSESSMENT: The reasoning about capital allocation strategy and shareholder value return is sound and semantically appropriate. The LLM correctly identifies the trend of increasing treasury stock purchases and appropriately interprets this as a buyback strategy. However, this correct reasoning cannot overcome the severe quantitative errors. MULTI-HOP SYNTHESIS: The answer does synthesize information across three years and connects it to capital allocation strategy, which is appropriate for the question. CONCLUSION: The answer fails on the primary metric of factual accuracy regarding specific financial numbers, which are critical in financial analysis. The incorrect 2022 baseline figure and misrepresentation of the accounting convention (negative vs. positive) represent fundamental errors that would mislead stakeholders.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 432,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "Repair and other services revenue fell from $1.169 B in 2022 to $1.132 B in 2023 and stayed flat at $1.132 B in 2024, a decline of about $37 M followed by a plateau【page_9】. This pattern shows the service business has not expanded over the period, indicating a stagnating trajectory and limited growth opportunities for General Dynamics’ Marine Systems segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. All numbers are accurate: $1.169B (2022), $1.132B (2023), $1.132B (2024), and the $37M decline calculation is correct. The multi-hop synthesis correctly identifies the pattern of decline followed by stagnation. However, there are minor issues: (1) The LLM specifies 'Marine Systems segment' which adds unnecessary specificity not mentioned in the ground truth - while not incorrect, it narrows the scope beyond what was stated. (2) The percentage decline calculation (3.2% from 2022-2024) is not explicitly mentioned in the LLM answer, though the ground truth includes this metric. (3) The phrase 'limited growth opportunities for General Dynamics' Marine Systems segment' adds interpretive language beyond the ground truth's more neutral 'stagnation or potential contraction in the company's service business segment.' The core answer is semantically equivalent and factually sound, correctly capturing the revenue trajectory and its implications. The reasoning about stagnation and lack of expansion is logically sound and well-supported by the data presented. The answer appropriately addresses both parts of the question (how revenue changed and what the pattern reveals), though with slightly different emphasis than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 374,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "Across the three years, CVS’s residential mortgage‑backed‑security (RMBS) exposure fell sharply.  In 2022 the RMBS fair value was $721 million with unrealized losses of $89 million; in 2023 it dropped to $614 million and unrealized losses to $60 million (page 149).  By 2024 the RMBS fair value reported in separate accounts was only $71 million, with no unrealized losses disclosed (page 160).  This downward trend indicates a deliberate shift away from RMBS, reducing interest‑rate‑sensitive risk and tightening the company’s overall risk profile in this asset class.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2022 figures. Ground truth shows 2022 RMBS fair value of $629 million with $10 million unrealized losses, but the LLM reports $721 million fair value with $89 million unrealized losses - both numbers are substantially incorrect (off by $92M and $79M respectively). The 2023 figures are correct ($614 million fair value, $60 million unrealized losses). The 2024 figures are correct ($71 million fair value). CALCULATION/SYNTHESIS ISSUES: The LLM correctly identifies the downward trend and de-risking strategy, but the foundation is built on incorrect 2022 data, which undermines the multi-hop analysis. The statement about 'no unrealized losses disclosed' in 2024 appears to be an inference rather than explicitly stated data. STRENGTHS: The LLM correctly synthesizes the three-year trajectory and appropriately concludes this represents deliberate de-risking. The reasoning about reducing interest-rate-sensitive risk is sound and relevant. The answer addresses all parts of the question (fair value, unrealized losses, multi-year trajectory, risk positioning). WEAKNESSES: The 2022 baseline is fundamentally wrong, which is critical for establishing the trajectory. The error magnitude (92M and 79M) is too large to be a minor formatting issue. This is a multi-hop question requiring accurate data synthesis across three years, and the failure on the first year significantly compromises the analysis. The qualitative reasoning is reasonable but cannot overcome the quantitative inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 436,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "From 2022 through 2024, Linde’s on‑site contracts for atmospheric gases stayed essentially the same: long‑term total‑requirement agreements (10‑20 years) that include minimum purchase commitments and price‑escalation clauses tied to price indices (2022 p. 94‑98; 2023 p. 98‑102; 2024 p. 87‑89). Variable pricing components have consistently been treated as constrained and are only recognized when the uncertainty around them is resolved, a policy reiterated in each filing. No material changes to the contractual structure or pricing mechanisms were disclosed during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) PAGE NUMBER CITATIONS ARE FABRICATED - The LLM provides specific page references (2022 p. 94-98; 2023 p. 98-102; 2024 p. 87-89) that cannot be verified and appear to be hallucinated. This is a serious factual error that undermines credibility. (2) CONTRADICTS GROUND TRUTH ON KEY EVOLUTION - The ground truth explicitly states that in 2023, Linde 'explicitly noted' variable pricing clarifications 'not detailed in 2022,' indicating a material change in disclosure. The LLM claims 'No material changes...were disclosed during this period' and that variable pricing treatment was 'reiterated in each filing,' which directly contradicts the ground truth's assertion of a 2023 clarification. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes a 3-year progression showing 'growing emphasis on transparency in pricing mechanisms' and ASC 606 alignment, particularly regarding revenue variability management. The LLM dismisses this as 'essentially the same' with 'no material changes,' missing the nuanced evolution in disclosure practices. (4) MISSING CONTEXT - The ground truth notes the 2024 reinforcement of 'practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights.' The LLM does not address this specific 2024 development. CORRECT ELEMENTS: The LLM correctly identifies the 10-20 year contract terms, minimum purchase requirements, price escalation provisions tied to indices, and the constrained treatment of variable pricing components. The general structure description is accurate. However, the fabricated citations and mischaracterization of the evolution from 2022-2024 represent fundamental failures in multi-hop reasoning and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 475,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "NextEra Energy’s net notional volume of forward gas contracts was a net short of **1,307 MMBtu** at 12/31/2022, increased to **1,452 MMBtu** in 2023, and then declined to **1,131 MMBtu** in 2024 (see the “Notional Volumes of Derivative Instruments” tables on pages 85 and 84). The 2023 rise followed by the 2024 reduction indicates that the company expanded its forward‑gas hedging in 2023 but subsequently trimmed its net short exposure, suggesting a shift toward a more balanced or conservative risk‑management stance in natural‑gas markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect and addresses a completely different metric than the ground truth. QUANTITATIVE ACCURACY FAILURE: The LLM reports notional volumes in MMBtu (1,307, 1,452, 1,131 MMBtu) while the ground truth provides net exposure in dollar amounts ($160M, $300M, $250M). These are entirely different metrics - notional volume measures quantity of contracts, while net exposure measures financial value. The LLM's numbers cannot be verified against the ground truth because they measure different things. ENTITY/METRIC CONFUSION: The question asks about 'net exposure to forward gas contracts' which the ground truth correctly interprets as the net financial position (assets minus liabilities). The LLM misidentifies this as 'net notional volume' and reports in physical units (MMBtu) rather than financial exposure ($M). MULTI-HOP REASONING FAILURE: The question requires synthesizing three years of data (2022-2024) to identify a trend. While the LLM does provide three data points across the correct years, they measure the wrong variable entirely. The ground truth shows: 2022=$160M → 2023=$300M (87.5% increase) → 2024=$250M (16.7% decrease). The LLM's trend (1,307→1,452→1,131 MMBtu) is directionally similar but irrelevant since it's measuring notional volume, not financial exposure. SEMANTIC MISMATCH: The LLM's conclusion about 'expanded hedging' and 'trimmed net short exposure' may be reasonable interpretations of notional volume trends, but they don't answer the actual question about financial risk positioning. The ground truth's interpretation of 'strategic shift toward greater gas market exposure' is based on dollar exposure, not contract volume. MISSING CRITICAL DATA: The LLM completely omits the asset/liability breakdown ($191M/$31M for 2022, $377M/$77M for 2023, $296M/$46M for 2024) that is essential to understanding the company's actual financial exposure. This is a fundamental failure to answer the question as posed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 536,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "Across 2022, 2023, and 2024, Broadcom consistently positioned industrial fiber optics as a core element of its industrial portfolio, listed alongside optocouplers, sensors, motion encoders, LEDs, and Ethernet ICs and used in factory automation, renewable‑energy, automotive‑electronics, and medical‑system applications (2022 page 7; 2023 page 7; 2024 page 7). The description and application markets for industrial fiber optics remained unchanged in each filing, indicating a stable emphasis within the broader industrial product line.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies AVGO/Broadcom as the company and accurately captures that Industrial Fiber Optics remained a stable, core product across 2022-2024. However, there are significant issues with completeness and accuracy of product/application details: (1) CORRECT: The answer properly identifies the stable positioning across three years and mentions optocouplers, sensors, and Ethernet ICs. (2) INCORRECT/INCOMPLETE: The LLM conflates product lists across years. The ground truth shows 2022 included 'motion encoders' and 'LED devices' as separate items, while 2024 lists 'motion control subsystems' instead. The LLM incorrectly combines these as if they were consistent across all years ('motion encoders, LEDs, and Ethernet ICs'). (3) APPLICATION MARKETS: The LLM mentions 'factory automation, renewable-energy, automotive-electronics, and medical-system applications' but the ground truth shows medical systems were specifically mentioned in 2022 alongside defense and aerospace, while 2023-2024 focused on factory automation, renewable energy, and automotive electronics. The LLM doesn't clearly distinguish this evolution. (4) MISSING CONTEXT: The ground truth emphasizes that 2022 described a 'broad variety of industrial products' across diverse applications (defense, aerospace, electric vehicles), while the LLM doesn't capture this broader 2022 positioning context. (5) CITATION ISSUE: The LLM cites '2022 page 7; 2023 page 7; 2024 page 7' but provides no verification these pages exist or contain the stated information. The core conclusion about stability is correct, but the execution lacks precision in distinguishing year-to-year variations in product groupings and application emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 469,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Unsecured Notes – 31B stayed unchanged: the interest rate remained 3.25 %, the face amount stayed at $750,000, and the annual debt service was $24,375 with a maturity of 11/30/26. This constancy shows that Simon Property Group is locking in a low‑rate, long‑dated debt instrument and keeping its debt profile stable rather than frequently refinancing or altering the note’s terms.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error in the face amount. The ground truth states the face amount is $750,000,000 (750 million dollars), but the LLM answer states it as $750,000 (750 thousand dollars) - an error of three orders of magnitude. This is a fundamental mistake that significantly undermines the answer's credibility. The annual debt service is also incorrectly stated as $24,375 instead of $24,375,000 - again missing the thousands designation. These are not minor formatting variations but represent actual numerical errors that distort the financial picture. CORRECT ELEMENTS: The interest rate of 3.25% is correct, the consistency across 2022-2024 is correctly identified, the maturity date of 11/30/26 is appropriately added (not contradicting ground truth), and the overall interpretation about stable debt strategy is reasonable. MULTI-HOP REASONING: The LLM correctly synthesized the three-year trend and drew appropriate conclusions about debt strategy stability. However, the quantitative errors undermine the credibility of this reasoning. COMPLETENESS: The answer addresses the evolution question and provides strategic interpretation, though the numerical inaccuracies make the analysis unreliable. The semantic interpretation about 'locking in low-rate debt' is sound, but cannot overcome the magnitude of the numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 388,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "Texas Instruments’ aggregate expense for U.S. defined‑contribution plans rose from $70 million in 2022 to $75 million in 2023 and $76 million in 2024【page_43】. This modest upward trend shows a stable, slightly increasing investment in employee retirement benefits, indicating the company is maintaining or modestly expanding its support for its employees’ retirement plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three year values are correct ($70M in 2022, $75M in 2023, $76M in 2024). The trend description accurately reflects the data progression. The ground truth mentions an 8.6% increase calculation from 2022 to 2024, which the LLM does not explicitly state, but this is a minor omission rather than an error. ENTITY ACCURACY: Texas Instruments correctly identified, U.S. defined contribution plans correctly specified, all three years (2022-2024) properly addressed. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by: (1) extracting three separate year values from SEC filings, (2) comparing them chronologically, (3) drawing appropriate conclusions about the trend. The characterization as 'modest upward trend' and 'stable, slightly increasing investment' accurately reflects the data pattern. SEMANTIC EQUIVALENCE: The LLM's interpretation that this shows 'maintaining or modestly expanding support' is semantically equivalent to the ground truth's 'steady and slightly growing commitment.' MINOR GAPS: The LLM does not calculate or mention the specific 8.6% increase percentage from 2022 to 2024, which the ground truth includes. However, the qualitative assessment of the trend is accurate and appropriate. The inclusion of a page reference (【page_43】) adds credibility. Overall, this is a high-quality response that correctly addresses all core aspects of the multi-hop question with accurate financial data and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 428,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "GD has consistently excluded goodwill impairments and non‑economic accounting changes from its ROIC calculations in 2022, 2023, and 2024 (see page 49 of each filing). This unchanged policy shows the company’s deliberate focus on a performance metric that reflects underlying operating performance and ensures comparability across periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC calculations across 2022, 2023, and 2024 - matching the ground truth's core finding. (2) Accurately conveys the consistency of methodology across all three years. (3) Provides appropriate interpretation that this reflects a disciplined, stable approach to performance evaluation. (4) Adds helpful specificity by mentioning 'goodwill impairments' as an example of excluded items and citing page 49 as source reference, which demonstrates document-specific knowledge. (5) The reasoning about ensuring comparability across periods is sound and relevant. MINOR CONSIDERATIONS: (1) The ground truth uses the phrase 'non-economic accounting changes' while the LLM expands this to 'goodwill impairments and non-economic accounting changes' - while goodwill impairments are indeed a type of non-economic accounting change, the LLM's more specific categorization goes slightly beyond what the ground truth explicitly states, though it's not contradictory. (2) The LLM's reference to 'page 49 of each filing' is specific but cannot be verified against the ground truth provided. This specificity is helpful but introduces a minor risk if the page numbers are incorrect. (3) The LLM answer is slightly more detailed and specific than the ground truth, which could be viewed as either an enhancement or a minor deviation depending on interpretation. Overall, the answer correctly synthesizes the multi-hop information (consistency across three years) and accurately conveys the methodology's implications for performance evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 461,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "Separate Accounts assets fell from **$3.313 billion** at 12/31/2022 to **$3.204 billion** at 12/31/2023, then rose to **$3.311 billion** at 12/31/2024. The modest 3‑year swing—roughly a 3 % dip followed by a rebound to near‑2022 levels—indicates that CVS is maintaining a relatively constant capital base in its long‑term insurance product portfolio, with only minor portfolio adjustments rather than a strategic expansion or contraction.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth across all three years: (1) 2022: LLM states $3.313 billion vs. ground truth $5,087 million ($5.087 billion) - a massive 35% understatement; (2) 2023: LLM states $3.204 billion vs. ground truth $3,250 million - minor error but directionally wrong; (3) 2024: LLM correctly states $3.311 billion matching ground truth $3,311 million. The LLM's narrative interpretation is fundamentally flawed because it's based on incorrect starting data. The ground truth shows a dramatic 36% decline from 2022 to 2023 ($5,087M to $3,250M), followed by marginal recovery in 2024 ($3,250M to $3,311M). The LLM incorrectly characterizes this as a 'modest 3-year swing' and 'roughly a 3% dip' when the actual trend is a severe 2023 contraction followed by stabilization. The LLM's conclusion about 'maintaining a relatively constant capital base' is semantically opposite to the ground truth's assessment of 'significant decline in 2023 followed by marginal recovery.' The multi-hop reasoning fails because the foundation numbers are wrong, leading to an entirely incorrect interpretation of CVS's investment positioning in long-term insurance products. Only the 2024 figure is accurate; the 2022 figure is off by approximately $1.8 billion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 373,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "Target’s Credit Card Program Agreement, originally dated October 22, 2012, was amended in 2015 and 2019. In 2022 a third amendment was executed on November 1, 2022, and in 2023 a letter agreement was signed on March 8, 2023. These updates were incorporated into Target’s 2024 Form 10‑K as exhibits 10.21.3+ (the third amendment) and 10.21.4+ (the letter agreement), marking the latest contractual milestones.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) DATES - The LLM claims a third amendment was executed on November 1, 2022, and a letter agreement on March 8, 2023, but the ground truth shows only two amendments: the first dated February 24, 2015, and the second dated November 19, 2019. The LLM fabricated dates and amendment numbers not present in the source material. (2) AMENDMENT COUNT - The LLM incorrectly identifies a 'third amendment' when the ground truth only references two amendments through 2024. (3) EXHIBIT REFERENCES - The LLM cites specific exhibit numbers (10.21.3+ and 10.21.4+) that cannot be verified against the ground truth and appear to be invented. (4) TIMELINE ACCURACY - The ground truth clearly states the agreement was 'referenced in its original form' in 2022, with amendments from 2015 and 2019 being the documented updates. The LLM's claim of 2022 and 2023 amendments contradicts this. (5) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize information across years, it does so incorrectly by introducing false contractual milestones. The core relationship evolution described in the ground truth (original agreement 2012, first amendment 2015, second amendment 2019, maintained through 2024) is fundamentally misrepresented. The answer demonstrates poor factual accuracy on the primary quantitative elements (dates and amendment sequence) that are critical to answering this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 408,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "From 2022 to 2024 Linde’s rare‑gas output remained a co‑product of its industrial‑gas plants, but the company sharpened its technological edge by adopting non‑cryogenic air‑separation technologies and expanding its portfolio of proprietary, patented processes (page_4).  Its Engineering business now designs and builds the same air‑separation plants that produce oxygen, nitrogen, argon and rare gases, integrating rare‑gas output with hydrogen, helium and CO₂ production and digital services that boost plant efficiency (page_5; page_4).  This shift moves rare gases from a passive by‑product to a strategically integrated, high‑value component of Linde’s broader gas‑production and engineering platform (page_98).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures several key elements of Linde's rare gas evolution from 2022-2024 and demonstrates solid multi-hop reasoning across the filing documents. STRENGTHS: (1) Correctly identifies the shift from cryogenic to non-cryogenic air separation technologies, which aligns with the ground truth's emphasis on technological differentiation; (2) Accurately notes rare gases as co-products/byproducts of air separation; (3) Properly synthesizes the integration of rare gases with other product lines (hydrogen, helium, CO2, digital services), which matches the ground truth's point about integration-driven approach; (4) Correctly identifies specific rare gases (oxygen, nitrogen, argon) and mentions VPSA-adjacent technologies; (5) Appropriately emphasizes the shift from passive byproduct to strategic component. WEAKNESSES: (1) Does not explicitly mention the specific rare gases highlighted in ground truth (krypton, neon, xenon) - only mentions oxygen, nitrogen, argon which are noble gases but not the rare gases specifically called out; (2) Missing the temporal progression detail about 2023's emphasis on proprietary technologies and long-term contracts with price escalation clauses; (3) Does not explicitly mention VPSA and membrane separation technologies by name (though the answer implies technological innovation); (4) The answer references page numbers (page_4, page_5, page_98) which suggests citation but these cannot be verified against the ground truth; (5) Slightly less emphasis on the 2023 intermediate step showing the gradual evolution. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are provided in either answer, so this dimension is not directly testable. The temporal framing (2022-2024) is correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple aspects - technological evolution, product integration, business model shift - demonstrating appropriate multi-hop synthesis. The connection between Engineering business design and rare gas production is a valid integration point. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - Linde elevated rare gases from commodity byproduct to strategic, technology-enabled component. The wording differs but the fundamental narrative matches.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 611,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: it was $1.494 billion at December 31 2022, dropped to $800 million at December 31 2023, and fell further to $491 million at December 31 2024【page_102】【page_99】. This downward trend indicates that the company has reduced the collateral (and therefore the margin) required for its derivative positions tied to equity‑company advances, suggesting a lower exposure to derivative liabilities linked to those relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - $1.494 billion (2022), $800 million (2023), and $491 million (2024). The LLM properly converted the ground truth format ($1,494 million) to $1.494 billion, which is an acceptable format variation. All dates are accurate (December 31 for each year). COMPLETENESS: The answer addresses both parts of the multi-hop question: (1) the evolution of collateral amounts across the three-year period, and (2) what this trend suggests about derivative liability exposure. ENTITY ACCURACY: ExxonMobil is correctly identified, the metric (collateral under master netting arrangements related to equity company advances) is accurately described, and all fiscal years are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the consistent downward trend and logically connects this to reduced derivative liability exposure. The interpretation that this reflects de-risking or portfolio optimization is reasonable and aligns with the ground truth's characterization. SEMANTIC EQUIVALENCE: The LLM's phrasing 'reduced the collateral (and therefore the margin) required for its derivative positions' conveys the same meaning as the ground truth's 'strategic reduction in exposure to derivative liabilities.' The explanation of lower exposure to derivative liabilities is semantically equivalent to the ground truth. MINOR CONSIDERATIONS: The LLM includes citation references (page numbers) which add credibility but weren't in the ground truth - this is a positive addition. The only minor difference is the LLM's slightly more technical explanation of the relationship between collateral and margin, which is accurate and appropriate for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 493,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "NEER’s net generating capacity committed under long‑term bilateral contracts rose from 94 % in 2022 to 94 % in both 2023 and 2024 (up from 92 % in 2021)【page_19】. The steady, high contract coverage shows the company is deliberately locking in revenue and hedging price risk, underscoring a robust risk‑mitigation strategy in competitive wholesale markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides fundamentally incorrect percentages. Ground truth states 92% in 2022, 94% in 2023, and 94% in 2024. The LLM claims 94% in 2022, which directly contradicts the ground truth. The LLM also incorrectly references 2021 data (92%) which is not part of the question's 2022-2024 timeframe. This is a major factual error. (2) TREND ANALYSIS - The ground truth explicitly states a 'steady increase from 92% to 94%' showing evolution over the period. The LLM describes it as 'steady, high contract coverage' but misses the key trend of the 2-percentage-point increase from 2022 to 2023. By stating 94% in 2022, the LLM eliminates the documented upward trend entirely. (3) MULTI-HOP REASONING - The question asks about evolution 'from 2022 through 2024.' The LLM fails to properly synthesize the three-year progression. It should show: 2022 (92%) → 2023 (94%) → 2024 (94%), demonstrating the strategic shift. Instead, it presents incorrect baseline data. (4) COMPLETENESS - While the LLM does address risk mitigation strategy and revenue stability concepts (which are correct qualitatively), the foundational quantitative data is wrong, undermining the entire analysis. (5) ENTITY ACCURACY - NEER is correctly identified, but the fiscal year data is incorrect. The reference to 2021 is extraneous and confusing. The core issue is that the LLM has inverted or misread the 2022 baseline figure, which is the critical starting point for evaluating the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 418,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "The 3.125% notes due January 2025 had an outstanding principal balance of **$495 million** at the end of fiscal 2022, and that balance remained unchanged at **$495 million** at the end of fiscal 2023 and again at the end of fiscal 2024 (see the debt schedule in page 81 of the 2024 and 2023 10‑Ks).  This steady balance shows that AVGO has not issued additional principal or repaid the notes, indicating a conservative debt‑management approach that keeps this fixed‑rate instrument on the books as a stable, long‑term financing source without early refinancing or repayment.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct - $495 million principal balance is accurately stated for all three fiscal years (2022, 2023, 2024). (2) The factual assertion that the balance remained unchanged across the three-year period is accurate. (3) The citation to page 81 of the 2024 and 2023 10-Ks provides appropriate sourcing. (4) Number formatting is consistent and clear.\n\nWEAKNESSES: (1) The interpretation of AVGO's debt management strategy differs from the ground truth. The LLM characterizes it as a 'conservative debt-management approach' and 'stable, long-term financing source without early refinancing or repayment,' whereas the ground truth suggests AVGO 'may be planning to refinance or use cash reserves to settle the obligation.' These are subtly different interpretations - the LLM's framing emphasizes stability and lack of action, while the ground truth acknowledges the approaching maturity (January 2025) and suggests proactive planning for settlement/refinancing. (2) The LLM answer does not explicitly acknowledge that the notes are approaching maturity, which is a key contextual detail that makes the unchanged balance more significant. The ground truth specifically notes 'despite approaching maturity,' which is an important qualifier. (3) The LLM's characterization of this as a 'long-term financing source' is somewhat misleading given the January 2025 maturity date was imminent at fiscal year-end 2024.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the consistent principal balance. However, the reasoning about what this reveals about debt management strategy is less robust than the ground truth, which more accurately captures the strategic implications of maintaining an unchanged balance on a soon-to-mature obligation.\n\nOVERALL: The quantitative facts are entirely correct, but the qualitative interpretation of what the unchanged balance reveals about debt strategy is somewhat misaligned with the ground truth's more nuanced understanding of the approaching maturity and implied refinancing/settlement planning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 570,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "Simon’s Unsecured Notes ‑ 37B stayed unchanged over the three‑year period: in 2022, 2023 and 2024 the note carried a 2.25 % interest rate, a $700,000 face amount and a maturity of 01/15/32 (2032)【page_50】【page_50】【page_51】. The lack of any adjustment in rate, principal or maturity indicates the company’s long‑term debt strategy is to maintain a stable, predictable financing structure rather than frequently re‑issue or refinance this instrument.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. All key financial metrics are accurate: 2.25% interest rate, $700,000,000 face amount (LLM states $700,000 which appears to be a formatting error - should be $700,000,000 or $700M), and maturity date of January 15, 2032. The answer correctly identifies that the notes remained unchanged across all three years (2022-2024), which is the core factual finding. The multi-hop synthesis is sound - the model correctly identified the same instrument across three years and compared the key terms. The reasoning about debt strategy is appropriate and well-supported: the stability of terms does indicate a focus on predictable financing costs and long-term liability alignment. However, there is one notable issue: the LLM states '$700,000 face amount' when the ground truth clearly states '$700,000,000' (a $700 million difference). This appears to be a transcription or formatting error in the LLM response, as the context and reasoning suggest the model understood the correct magnitude, but the written number is incorrect. The qualitative analysis of the company's debt strategy is slightly less detailed than the ground truth (which mentions alignment with real estate portfolio cash flows), but the core insight about maintaining stable, predictable financing is captured. The answer is well-structured and includes source citations. The quantitative accuracy score is reduced from 10 to 9 due to the face amount notation error, and the overall correctness score is 8 rather than 9 due to this material numeric discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 438,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "TI’s Melaka, Malaysia site has remained an analog‑only facility throughout the three‑year period.  The 2022 filing lists the Melaka plant as partially owned/leased (†) and shows an “X” only in the Analog column, while the 2023 and 2024 filings list it as fully leased (*) with the same analog‑only designation and no embedded‑processing activity.  This steady, unchanged footprint indicates that TI continues to focus on analog products in Melaka, with no expansion into embedded processing over 2022‑2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses all key aspects of the question. STRENGTHS: (1) Correctly identifies the core finding that Melaka remained analog-only throughout 2022-2024 with no embedded processing expansion; (2) Accurately captures the three-year consistency pattern; (3) Properly synthesizes multi-hop information across three fiscal years; (4) Correctly identifies the company (Texas Instruments/TI) and location (Melaka, Malaysia); (5) Appropriately interprets the 'X' designation as indicating presence in analog column. ADDITIONAL DETAIL: The LLM answer adds valuable supplementary information about ownership/lease status changes (partially owned/leased with † in 2022 vs. fully leased with * in 2023-2024) that, while not explicitly mentioned in the ground truth answer, represents accurate filing details that enhance rather than contradict the core answer. This demonstrates deeper engagement with the source documents. MINOR CONSIDERATIONS: The ground truth answer is more concise and focused strictly on the analog vs. embedded processing question, while the LLM answer includes the ownership/lease notation details. This is not an error but rather additional context that strengthens the answer. The semantic meaning is fully aligned with the ground truth - both conclude that Melaka maintained a stable, analog-only operational strategy with no embedded processing activity across the three-year period. All factual claims are accurate, the multi-hop reasoning across three years is sound, and the conclusion about TI's targeted investment strategy in analog capabilities is well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 446,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "Mastercard’s multi‑layered security framework—built on a robust cyber‑security program, EMV‑type technical standards, third‑party assessments, and continuous monitoring—has been scaled to match the growth of its real‑time payment network. In 2022 the framework protected a real‑time payments infrastructure operating in 12 markets (page 11, 2022). By 2023 it had expanded to 13 markets and added AI‑governance, privacy‑by‑design and enhanced real‑time clearing controls (page 11, 2023). In 2024 the approach further evolved to include enterprise resilience, advanced threat intelligence and the Mastercard Intelligence Center, extending security coverage to more than 15 markets as the real‑time payment infrastructure grew (page 11, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Mastercard's security framework across 2022-2024, accurately captures the market expansion from 12 to 13 markets between 2022-2023, and appropriately mentions key security components (EMV standards, tokenization, fraud scoring, third-party assessments). The answer demonstrates sound multi-hop reasoning by synthesizing security evolution with real-time payment infrastructure expansion. The semantic equivalence is strong - the answer conveys the same general narrative as the ground truth. CRITICAL ERRORS: (1) QUANTITATIVE DISCREPANCY: The LLM claims expansion to 'more than 15 markets' in 2024, but the ground truth does not specify this number for 2024 - it only confirms expansion to 13 markets by 2023. This is a factual error on a key metric. (2) MISSING CRITICAL DETAIL: The LLM fails to mention the China joint venture expansion in 2024, which is explicitly highlighted in the ground truth as a significant development requiring security framework scaling. This is a material omission for a multi-hop question about evolution through 2024. (3) ADDED DETAILS NOT IN GROUND TRUTH: The LLM introduces 'AI-governance,' 'privacy-by-design,' 'enterprise resilience,' 'advanced threat intelligence,' and 'Mastercard Intelligence Center' - while these may be reasonable security concepts, they are not explicitly mentioned in the ground truth and appear to be inferred or hallucinated. (4) PAGE REFERENCES: The LLM provides specific page citations (page 11 for each year) which cannot be verified against the ground truth and may be fabricated. ASSESSMENT: The answer demonstrates adequate understanding of the question's multi-hop nature and provides a coherent narrative, but contains a significant quantitative error (15 markets vs. unspecified in ground truth) and omits the important China expansion detail. The addition of unverified security features suggests some hallucination, though the core framework evolution is captured reasonably well.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 544,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "General Dynamics increased LAV production for the Canadian Army from 399 units in 2022 to 449 units in 2023, then cut the output to 360 units in 2024 【GD_10k_2022.pdf page_11】【GD_10k_2023.pdf page_10】【GD_10k_2024.pdf page_11】. This rise followed by a decline suggests the company is maintaining a strong focus on the LAV program while adjusting production volumes—likely reallocating resources or responding to contract changes—to balance its broader defense portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect data that directly contradicts the ground truth. Specific issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM states production volumes as 399 units in 2022, 449 units in 2023, and 360 units in 2024. The ground truth shows 360 units in 2022, 399 units in 2023, and 449 units in 2024. The LLM has completely reversed the chronological progression - it shows a rise then decline, when the actual data shows consistent growth. (2) YEAR ASSIGNMENT ERRORS: All three years are assigned incorrect production volumes. 2022 should be 360 (LLM says 399), 2023 should be 399 (LLM says 449), 2024 should be 449 (LLM says 360). (3) NARRATIVE CONTRADICTION: The LLM's interpretation of 'rise followed by decline' is the opposite of the actual trend of consistent growth. This fundamentally misrepresents the company's strategic direction. (4) MULTI-HOP SYNTHESIS FAILURE: While the LLM attempted to cite sources across three years of 10-K filings, it failed to correctly synthesize the actual data from those documents. (5) STRATEGIC INTERPRETATION ERROR: The ground truth indicates 'consistent and growing strategic emphasis' while the LLM suggests 'adjusting production volumes' and 'reallocating resources,' which is an incorrect characterization of what the data actually shows. The LLM answer is factually incorrect on all three data points and provides an inverted interpretation of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 401,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "CVS increased its target allocation to hedge‑fund limited partnership investments from **3 % of pension‑plan assets in 2022 to 4 % in 2024**—a 1‑percentage‑point rise (the allocation stayed at 3 % in 2023 before the uptick). Over the three‑year span the company has kept the hedge‑fund exposure modest but steadily higher, indicating a cautious but deliberate shift toward alternative investments to diversify returns and manage risk within its pension portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer is fundamentally incorrect on the core quantitative data. The ground truth specifies absolute dollar amounts ($214M in 2022, $225M in 2023, $252M in 2024), but the LLM provides percentage allocations (3% in 2022, 3% in 2023, 4% in 2024) instead. These are completely different metrics. The question explicitly asks about 'allocation to hedge fund limited partnership investments through pension plan assets,' which the ground truth correctly interprets as dollar amounts. The LLM's percentage figures appear to be target allocation percentages rather than actual investment amounts, representing a fundamental misunderstanding of what metric was being requested. CALCULATION VERIFICATION: The ground truth shows a 17.8% increase from $214M to $252M over three years, which is mathematically correct ($252M - $214M = $38M; $38M / $214M = 17.8%). The LLM's percentage-point increase (3% to 4%) is mathematically trivial and doesn't match the ground truth's trajectory at all. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the pension fund investment data across the three-year period. While the LLM correctly identifies the general trend direction (upward), it uses entirely wrong numbers. ENTITY/METRIC ACCURACY: The LLM confused allocation percentages with absolute dollar amounts—a critical distinction in financial analysis. The ground truth clearly establishes dollar values; the LLM provides percentages. SEMANTIC EQUIVALENCE: There is no semantic equivalence here; these are different financial metrics entirely. The question asks about actual investment amounts, not target allocation percentages. The LLM's qualitative interpretation about 'cautious but deliberate shift' is reasonable, but it's built on incorrect quantitative foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 487,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "The penetration rate of Target’s MasterCard credit card fell from **20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024** (the company tracks this as “RedCard Penetration” or “Target Circle Card Penetration” for the credit‑card portfolio)【page_27】【page_29】. This gradual decline suggests that while the card remains widely used, its share of total purchases is slowing, indicating a plateau in consumer adoption and engagement relative to overall sales growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN FINAL YEAR DATA: The LLM states the 2024 penetration rate as 18.6%, but the ground truth clearly indicates it should be 17.8%. This is a significant factual error on a key metric. The 2022 (20.5%) and 2023 (19.8%) figures are correct. The discrepancy of 0.8 percentage points in the final year is material and undermines the accuracy of the trend analysis. QUANTITATIVE ACCURACY: The error in the 2024 figure (18.6% vs. 17.8%) represents a 4.5% relative error in that data point, which is substantial for financial metrics. The first two years are accurate. QUALITATIVE ACCURACY: The LLM's reasoning about the trend is partially sound - it correctly identifies a 'gradual decline' and notes that 'while the card remains widely used, its share of total purchases is slowing.' However, the interpretation is somewhat weaker than the ground truth. The ground truth provides more nuanced analysis: it explains that RedCard sales increased in dollar terms but total sales grew faster (diluting proportional use), and offers specific hypotheses about shifting consumer preferences, increased competition, and reduced sensitivity to the 5% discount incentive. The LLM's answer is more generic. COMPLETENESS: The LLM addresses the evolution of penetration rates and attempts to interpret what the trend suggests about consumer adoption and engagement, but the incorrect 2024 figure compromises the validity of the trend analysis. The ground truth's explanation of the mechanism (dollar sales growth vs. percentage penetration) is missing from the LLM answer. ENTITY ACCURACY: Correctly identifies Target MasterCard/RedCard/Circle Card terminology. MULTI-HOP REASONING: The LLM successfully synthesizes information across years but fails on the critical final data point, which is essential for accurate trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 496,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "From 2022 to 2024 the fair‑value exposure for FPL Cost‑Recovery Clauses grew markedly: it was $1 million in 2022, $12 million in 2023, and $38 million in 2024.  \n- **2022:** The net $1 million came from $6 million of significant unobservable inputs offset by a $5 million negative from significant other observable inputs.  \n- **2023:** The net $12 million was driven by $24 million of significant unobservable inputs and $12 million of significant other observable inputs (negative), giving a net of $12 million.  \n- **2024:** The net $38 million was largely from $34 million of significant unobservable inputs and $4 million of significant other observable inputs, showing a shift from a small net positive in 2022 to a larger net positive dominated by unobservable inputs, with observable inputs moving from negative to positive.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All dollar amounts are correct - $1M (2022), $12M (2023), $38M (2024) for total fair values. The component breakdowns are accurate: 2022 shows +$6M unobservable and -$5M observable; 2023 shows +$24M unobservable and -$12M observable; 2024 shows +$34M unobservable and +$4M observable. The arithmetic is correct (e.g., $6M - $5M = $1M for 2022; $24M - $12M = $12M for 2023; $34M + $4M = $38M for 2024). ENTITY ACCURACY: NextEra Energy and FPL Cost Recovery Clauses are correctly identified. All years (2022, 2023, 2024) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes the three-year evolution, correctly identifying the trend of growing fair value exposure and the shift in composition from negative observable inputs to positive observable inputs while unobservable inputs consistently dominate. The conclusion about 'growing reliance on unobservable inputs' is logically sound and well-supported. COMPLETENESS: The answer addresses all aspects of the question - total fair value contributions, the shift between input types, and the evolution across the three-year period. MINOR OBSERVATION: The LLM uses slightly different phrasing than the ground truth (e.g., 'net $1 million came from' vs. 'total fair value was $1 million') but this is semantically equivalent and actually enhances clarity. The explanation of the shift from negative to positive observable inputs is a valuable analytical addition that aligns with the ground truth's observation about the 'strengthening fair value position.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 442,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "From 2022‑2024 Nike’s filings consistently list Anta as a key competitor, but Nike has reinforced its edge by maintaining a strong focus on product innovation—highlighting technologies such as Nike Air, Zoom, Flyknit and newer developments like Nike Adapt—and by expanding brand‑engagement through digital commerce, direct‑to‑consumer stores, athlete partnerships and sustainability initiatives (page_6, page_8). Over this period, Nike’s investment in R&D and digital experiences has deepened, strengthening its differentiation from Anta, which remains a regional player but lacks the same breadth of global technology and direct‑to‑consumer strategy (page_6, page_8).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Anta as a named competitor across the period and acknowledges Nike's competitive positioning. (2) The mention of specific Nike technologies (Air, Zoom, Flyknit, Adapt) and digital engagement strategies (DTC, athlete partnerships) is factually reasonable and relevant. (3) The general narrative of Nike maintaining innovation focus is directionally correct. (4) No obvious numerical errors or date misstatements. WEAKNESSES: (1) CRITICAL OMISSION - The LLM fails to capture the key temporal evolution that the ground truth emphasizes: the strategic SHIFT from 2022 (emphasis on quality, performance, reliability, style/design) to 2023 (elevation of 'innovation and development' ahead of performance) to 2024 (further solidification of innovation focus). The LLM presents this as a continuous state rather than an evolving strategic repositioning. (2) The ground truth explicitly notes that NKE 'elevated the importance of innovation and development' in 2023 'in response to competitive pressures' - this causal relationship and temporal specificity is missing from the LLM answer. (3) The LLM characterizes Anta as 'a regional player' lacking 'breadth of global technology' - while this may be true, the ground truth is more nuanced, noting that Anta is 'gaining traction through localized and digitally native strategies,' suggesting a more sophisticated competitive threat than the LLM portrays. (4) The LLM answer lacks the year-by-year breakdown that demonstrates the evolution of competitive positioning. It reads as a static comparison rather than a dynamic evolution from 2022-2024. (5) The page references (page_6, page_8) are provided but cannot be verified against the ground truth knowledge graph. MULTI-HOP REASONING: The LLM attempts to synthesize information across years and companies but fails to properly sequence the strategic evolution that is central to the question. The question specifically asks 'how has...evolved' (temporal change), and the LLM provides a more static characterization. SEMANTIC EQUIVALENCE: While some elements align (innovation focus, digital engagement, Anta as competitor), the core insight about strategic evolution across three distinct years is lost.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 599,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "From 2022 through 2024 Texas Instruments reported no shares available for future issuance under the 2003 Director Compensation Plan.  In each year’s equity‑compensation table the only plans with remaining shares were the 2009 LTIP, 2014 ESPP and 2018 Director Plan (2022/2023) or the 2024 LTIP, 2014 ESPP and 2018 Director Plan (2024) – the 2003 plan is absent (pages 63, 61, 57).  This trend shows that TI has effectively retired the 2003 plan for new director awards and relies on newer plans for director compensation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERROR - The LLM claims 'no shares available for future issuance under the 2003 Director Compensation Plan' from 2022-2024, but the ground truth explicitly states the plan was 'still referenced as active, with shares being issued under it' in 2022. This is a direct contradiction on a core factual claim. (2) INCOMPLETE EVOLUTION TRACKING - The ground truth describes a clear evolution: 2022 (active with shares), 2023 (no longer listed with remaining shares but still referenced), 2024 (no longer mentioned). The LLM flattens this to a single claim that applies uniformly across all three years, missing the temporal progression that is central to the question. (3) MISCHARACTERIZATION OF TREND - The ground truth indicates a 'gradual phase-out' with a 'strategic shift toward updated incentive structures while honoring existing commitments.' The LLM's characterization of 'effectively retired' is too absolute and doesn't capture the nuance of the transition. (4) PARTIAL CREDIT FOR CORRECT ELEMENTS - The LLM correctly identifies that newer plans (2024 LTIP, 2018 Director Plan) replaced the 2003 plan, and correctly notes the 2003 plan's absence from later years' compensation tables. The page references (63, 61, 57) appear reasonable though cannot be verified. (5) REASONING QUALITY - While the LLM's conclusion about retirement of the plan for new awards is directionally correct, the failure to document the year-by-year evolution and the false claim about 2022 availability significantly undermines the answer's reliability. The multi-hop synthesis is incomplete because it doesn't properly track the temporal changes across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 481,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "From 2022 through 2024, Comcast’s advertising business consistently integrated data‑driven services, offering technology, tools, data‑driven services and marketplace solutions to media clients. In 2023 the company expanded its platform footprint with the launch of the NOW streaming service and continued to leverage the X1 and Sky Q platforms, which integrate streaming content from DTC services such as Peacock, Disney+ and Netflix. The filings do not disclose additional specific technology, tool, or marketplace‑solution enhancements beyond these platform upgrades.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about CMCSA's data-driven advertising evolution from 2022-2024. STRENGTHS: (1) Correctly identifies CMCSA/Comcast as the subject company; (2) Acknowledges the 2022-2024 timeframe; (3) Mentions data-driven services and marketplace solutions; (4) References specific platforms (X1, Sky Q, Peacock, Disney+, Netflix) which are factually accurate. CRITICAL WEAKNESSES: (1) The answer diverges substantially from the ground truth by focusing heavily on NOW streaming service and content integration rather than advertising technology enhancements - the ground truth emphasizes cloud-based platforms, integrated search functionality, and representation agreements for advertising reach/targeting; (2) Fails to capture the 2023 expansion of data-driven services integration into the advertising ecosystem specifically; (3) Does not mention cloud-based platforms or integrated search functionality across content sources, which are key elements in the ground truth; (4) Omits discussion of strengthened representation agreements with third parties (domestic and international) mentioned in 2024 evolution; (5) Concludes that 'filings do not disclose additional specific technology, tool, or marketplace-solution enhancements' - this directly contradicts the ground truth which details specific enhancements across all three years. The LLM appears to have conflated advertising platform features with content streaming capabilities, missing the distinction between advertising technology evolution and content delivery platform upgrades. The answer demonstrates incomplete multi-hop synthesis across the 2022-2024 period and fails to capture the strategic shift toward integrated, technology-enabled advertising solutions leveraging cloud infrastructure and data analytics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 498,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "CVS’s commercial mortgage‑backed‑security (CMBS) holdings fell sharply: the fair value dropped from $1.17 billion with $155 million unrealized losses in 2022 to $675 million with $100 million unrealized losses in 2023—about a 42 % decline in value and a 35 % decline in losses【page_148】【page_150】.  In 2024 the company’s separate‑account CMBS fair value fell to $3 million (down 50 % from 2023) and no unrealized losses were reported【page_160】, indicating a continued trimming of exposure.  The trend points to a more conservative risk posture in CMBS, with CVS reducing its balance‑sheet exposure and limiting potential loss volatility.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains major factual inaccuracies that fundamentally undermine its credibility. (1) 2022 CMBS Fair Value: LLM states $1.17 billion, but ground truth shows $574 million—a 104% overstatement. (2) 2022 Unrealized Losses: LLM states $155 million, but ground truth shows $12 million—a 1,192% overstatement. (3) 2023 Fair Value: LLM correctly states $675 million (matches ground truth). (4) 2023 Unrealized Losses: LLM correctly states $100 million (matches ground truth). (5) 2024 Fair Value: LLM states $3 million, but ground truth shows $6 million—a 50% understatement. (6) 2024 Unrealized Losses: LLM correctly states no significant losses (matches ground truth). (7) Percentage Calculations: The 42% decline calculation is based on incorrect 2022 baseline ($1.17B vs actual $574M), making the percentage meaningless. The 50% decline from 2023 to 2024 is directionally correct but based on wrong 2024 figure ($3M vs $6M). MULTI-HOP REASONING: While the LLM correctly identifies the overall trend of de-risking and reduction in CMBS exposure, this correct conclusion is built on fundamentally flawed numerical foundations. The reasoning about 'conservative risk posture' and 'limiting potential loss volatility' is sound in principle but lacks credibility given the data errors. COMPLETENESS: The answer addresses all three years (2022-2024) and discusses both fair value and unrealized losses, but the accuracy of these discussions is severely compromised. The semantic interpretation of the trend (de-risking) is correct, but the supporting evidence is largely incorrect. ENTITY ACCURACY: CVS is correctly identified, CMBS is correctly identified, and years are correct. The fundamental issue is the numerical data, not entity identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 488,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "Target’s 10‑K filings for 2022, 2023 and 2024 all list merchandise discounts as part of the employee benefit package, with no change in scope (all employees) or disclosed discount value. The consistent inclusion of this benefit across three years indicates that Target treats merchandise discounts as a core, stable component of its compensation strategy rather than a variable or evolving benefit.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental misunderstanding of the question and fails to address the core inquiry about how merchandise discounts evolved across the three years. CRITICAL ISSUES: (1) The LLM claims 'no change in scope...or disclosed discount value' across 2022-2024, which directly contradicts the ground truth that shows clear evolution in how these benefits were framed and presented within an expanding benefits ecosystem. (2) The LLM completely misses the multi-year progression narrative that is central to the question—the ground truth shows merchandise discounts remained consistent but were increasingly contextualized within broader benefits enhancements (wage expansion from $15/hour to $15-$24/hour, addition of 401(k) matching, tuition reimbursement, mental health services, virtual healthcare). (3) The LLM's conclusion that merchandise discounts are 'stable' and 'not variable or evolving' is technically accurate about the discount itself, but this narrow interpretation ignores the strategic evolution in how Target positioned and contextualized this benefit within its overall compensation strategy. (4) The LLM provides no analysis of the broader benefits strategy shift toward 'holistic employee well-being' that the ground truth identifies. WHAT WAS CORRECT: The LLM correctly identifies that merchandise discounts were included in all three years' filings and that they remained a core benefit. WHAT WAS MISSING: The LLM fails to synthesize the multi-hop information about how the benefits package evolved contextually around the merchandise discount benefit, missing the strategic narrative about layering modern benefits while maintaining traditional perks. The answer reads as a narrow, literal interpretation rather than addressing the substantive question about strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 493,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "In 2022 and 2023, Linde listed “cultural challenges associated with integrating employees from the acquired company into the existing organization” as one of many risks in the acquisition‑integration section (see 2022 p. 12 and 2023 p. 12). By 2024, the filing added a distinct bullet that foreign acquisitions and joint ventures “involve unique risks … including those related to integration of operations across different cultures and languages” (2024 p. 12), explicitly framing cultural and language issues as a cross‑border risk. This evolution signals a more focused, risk‑aware strategy that treats cultural integration as a key lever for managing cross‑border acquisition risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies specific page references (p. 12 for 2022, 2023, and 2024) and accurately quotes language from the filings regarding cultural challenges in acquisition integration. The quantitative elements (years 2022-2024, page numbers) are accurate. However, there are significant gaps in completeness and reasoning quality compared to the ground truth. The LLM answer focuses narrowly on the explicit textual evolution (from 'cultural challenges associated with integrating employees' to 'unique risks including those related to integration of operations across different cultures and languages') but misses the deeper strategic evolution described in the ground truth. Specifically: (1) The ground truth identifies a 2023 expansion linking cultural challenges to 'broader context of global regulatory and compliance risks,' which the LLM answer does not mention. (2) The ground truth notes a 2024 shift toward framing cultural challenges in terms of 'strategic risk management and financial outcomes' and 'potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel' - the LLM answer does not capture this financial/outcome-focused reframing. (3) The LLM answer's conclusion about 'treating cultural integration as a key lever for managing cross-border acquisition risks' is somewhat generic and doesn't fully capture the progression from operational concerns to strategic financial risk management that the ground truth emphasizes. The LLM answer is partially correct in identifying the evolution but provides an incomplete analysis of how the company's strategic framing changed across the three-year period, particularly missing the 2023 regulatory/compliance linkage and the 2024 financial outcomes focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 487,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1.494 billion in 2022 to $491 million in 2024** – a decline of roughly **$1.0 billion**. This sharp reduction indicates that the company has either scaled back its derivative positions or achieved more efficient netting, reflecting tighter derivative‑exposure management and lower collateral‑cost exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial figures and the overall trend, but has a significant omission. CORRECT ELEMENTS: (1) Starting value of $1.494 billion in 2022 is accurate (matches $1,494 million in ground truth); (2) Ending value of $491 million in 2024 is correct; (3) The calculated decline of roughly $1.0 billion is accurate ($1,494M - $491M = $1,003M); (4) The interpretation about derivative exposure management and collateral-cost efficiency is sound and semantically equivalent to the ground truth. CRITICAL OMISSION: The LLM answer completely skips the 2023 intermediate data point ($800 million), which is explicitly mentioned in the ground truth as part of the 'consistent decline' narrative. This intermediate year is important for establishing the trend pattern and demonstrating the year-over-year progression. The ground truth emphasizes this as a 'three-year period' with consistent decline, while the LLM only presents a two-year comparison (2022 to 2024). QUANTITATIVE ACCURACY: The numbers provided are correct, and the calculation is accurate. However, the omission of 2023 data represents incomplete synthesis of the multi-hop information. QUALITATIVE ACCURACY: The reasoning about derivative exposure management and netting efficiency is sound and matches the ground truth's interpretation. The language about 'tighter derivative-exposure management' and 'lower collateral-cost exposure' effectively conveys the same meaning as the ground truth's 'strategic reduction in derivative exposure or improved offsetting mechanisms.' MULTI-HOP REASONING: The answer successfully synthesizes the relationship between collateral amounts and derivative exposure management, but fails to fully capture the complete temporal pattern across all three years requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 488,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "AVGO’s 2022 10‑K (page 10) described the Security Insights Platform as a mainframe‑centric tool that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps on an ongoing and ad‑hoc basis” and that its data can be fed into in‑house SIEM tools. The 2024 filing (page 10) repeats the same wording – the platform still focuses on continuous risk assessment, ad‑hoc remediation, and integration with internal SIEM systems – and it remains positioned as part of the mainframe software portfolio that supports AVGO’s broader cybersecurity strategy of providing a trusted environment for customers and employees. No new integration with external tools or expanded remediation processes is noted between 2022 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that fundamentally contradict the ground truth. (1) CORRECTNESS ISSUES: The LLM claims 'No new integration with external tools or expanded remediation processes is noted between 2022 and 2024,' which directly contradicts the ground truth showing clear evolution. The ground truth explicitly documents that by 2023, the platform was 'more explicitly tied to AVGO's broader cybersecurity portfolio' and by 2024 was 'contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps.' The LLM's assertion that the 2024 filing 'repeats the same wording' as 2022 is factually incorrect based on the ground truth. (2) QUANTITATIVE ACCURACY: The LLM correctly identifies page references (page 10) and years (2022, 2024), earning partial credit here. However, the core factual claims about what those pages contain are wrong. (3) MULTI-HOP REASONING FAILURE: The question asks about evolution from 2022 to 2024, requiring synthesis across three years. The ground truth shows a clear progression: standalone tool (2022) → explicitly tied to broader portfolio (2023) → integrated strategic component (2024). The LLM completely misses this evolution and incorrectly concludes there was no meaningful change. (4) SEMANTIC EQUIVALENCE FAILURE: The LLM's conclusion that the platform remained essentially unchanged contradicts the ground truth's documented shift 'from a standalone risk assessment tool toward a more integrated and strategically aligned component.' This is not a wording difference but a fundamental factual disagreement. (5) MISSING CONTEXT: The LLM fails to address the 2023 positioning entirely and misses the strategic contextualization within the expanded mainframe software suite (Cybersecurity, AIOps, DevOps) that the ground truth emphasizes as key to understanding the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 513,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "From 2022 through 2024, Simon’s Unsecured Notes – 32B remained unchanged: a face value of **$750,000** and an interest rate of **3.38 %** maturing in 2027. The unchanged terms show the company’s preference for a stable, low‑rate, long‑term debt mix that preserves predictable cash‑flow obligations and limits refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR - MAJOR QUANTITATIVE INACCURACY: The LLM states the face value as $750,000 when the ground truth clearly indicates $750,000,000 (750 million dollars). This is a 1,000x understatement of the debt amount - an enormous factual error that fundamentally misrepresents SPG's debt exposure. The interest rate of 3.38% and maturity date of 2027 are correct. The LLM correctly identifies that the terms remained unchanged from 2022-2024 and provides reasonable qualitative analysis about stable debt strategy and predictable cash flows. However, the face value error is so severe that it undermines the entire answer's credibility and usefulness. The LLM also provides less comprehensive analysis than the ground truth - it doesn't explicitly mention the June 15, 2027 maturity date specificity, and doesn't fully elaborate on the strategic implications (e.g., 'no early redemption or restructuring despite market shifts'). The reasoning about stable debt management is sound but cannot overcome the fundamental quantitative error. This is a case where one critical number error (off by a factor of 1,000) makes the answer substantially incorrect despite getting other elements right.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 336,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "CMCSA’s 10‑K filings from 2022, 2023 and 2024 all describe Lumen as a competitor that has been building fiber infrastructure and offering higher‑speed broadband services across many of CMCSA’s markets, with no change in that strategy over the period (page_7, 2022; page_7, 2023; page_7, 2024). The documents do not provide any new information on Lumen’s bundling of services, and bundling is only discussed for other carriers such as AT&T and Verizon (page_9, 2024). Thus, the competitive threat from Lumen has remained largely driven by fiber expansion rather than evolving bundling strategies.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in reasoning and interpretation despite some correct factual elements. CORRECT ELEMENTS: (1) The LLM correctly identifies that Lumen was mentioned as a fiber-building competitor across 2022-2024 in CMCSA's 10-K filings; (2) The page references appear plausible; (3) The identification of AT&T and Verizon as bundling-focused competitors is reasonable. CRITICAL ERRORS: (1) The LLM directly contradicts the ground truth by claiming 'no change in that strategy over the period' and that the threat 'remained largely driven by fiber expansion rather than evolving bundling strategies.' The ground truth explicitly states there was 'a clear escalation in competitive pressure' and 'a consistent and possibly intensifying competitive threat.' (2) The LLM dismisses bundling as not discussed for Lumen, but the ground truth indicates bundling was part of Lumen's competitive strategy in 2023-2024 ('more competitive service packages' and 'bundled offerings as a core competitive strategy'). (3) The LLM fails to capture the evolution/escalation dimension that is central to the question - the ground truth emphasizes progression from 2022 (noted as part of a group) to 2023 (explicitly called out for deeper deployment) to 2024 (continued focus). The LLM's conclusion that there was 'no change' directly contradicts this temporal evolution. MULTI-HOP REASONING: The LLM failed to synthesize the temporal dimension across the three years, instead treating all years as equivalent. The question specifically asks 'how has...evolved' requiring comparative analysis across time periods, which the LLM did not perform. SEMANTIC ISSUES: The LLM's interpretation that bundling was not part of Lumen's strategy appears to be a misreading of the source material, as the ground truth clearly indicates bundling was part of the competitive threat narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 509,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "Target’s branded payment‑card penetration fell steadily: 20.5 % in 2022, 19.8 % in 2023, and 18.6 % in 2024 (RedCard/Target Circle Card penetration【page 27 of 2023 10‑K】,【page 29 of 2024 10‑K】). This downward trend suggests the loyalty‑driven payment strategy is losing traction—its share of total purchases is shrinking, indicating the discount incentive may be less compelling or that competing payment options are gaining ground, and that Target may need to adjust the program to maintain card usage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN 2024 FIGURE: The LLM states the 2024 penetration rate as 18.6%, but the ground truth shows 17.8%. This is a significant factual error of 0.8 percentage points on a metric that is central to the question. The 2022 (20.5%) and 2023 (19.8%) figures are correct. QUANTITATIVE ACCURACY: The error in the 2024 figure is material and cannot be overlooked, especially since the question specifically asks about the evolution 'through 2024.' The LLM correctly identifies the downward trend direction but with an incorrect endpoint. QUALITATIVE ACCURACY: The reasoning about the trend is sound—the LLM correctly interprets the declining penetration as suggesting weakening effectiveness of the loyalty strategy and mentions competing payment options and need for program adjustment. The multi-hop synthesis is appropriate, connecting the numerical trend to strategic implications. ENTITY ACCURACY: Target and RedCard/Target Circle Card are correctly identified. The filing references (2023 10-K page 27, 2024 10-K page 29) appear reasonable though cannot be independently verified. COMPLETENESS: The answer addresses both parts of the question—the evolution of penetration rates and what the trend suggests about strategy effectiveness. However, the factual error undermines the completeness of accurate information. The semantic interpretation of the trend is appropriate and matches the ground truth's conclusion about weakening effectiveness. The error appears to be a data transcription or calculation mistake rather than a conceptual misunderstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 430,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "Chevron’s presence in the Republic of Congo moved from ownership of non‑operated assets to divestiture. In the 2022 10‑K, the company reported a 31.5 % non‑operated working interest in the offshore Haute Mer permit area and a 15.75 % interest in the Republic of Congo portion of the Lianzi block【page_31】. By the 2024 10‑K, Chevron announced that it would sell those interests in January 2025, effectively ending its ownership and signaling a strategic shift away from non‑operated assets in the Republic of Congo toward higher‑return projects elsewhere【page_43】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key asset ownership percentages (31.5% in Haute Mer, 15.75% in Lianzi) and accurately characterizes the strategic shift from ownership to divestiture. The timing of the sale announcement (January 2025) is correctly noted. The general narrative of moving away from non-operated assets is accurate. WEAKNESSES: (1) The LLM answer is incomplete regarding the 2023 investment data - the ground truth specifically mentions approximately $0.7 billion invested in offshore development and natural gas projects across Africa including the Republic of Congo in 2023, which the LLM completely omits. This is a significant gap in addressing the 'investment levels' component of the multi-part question. (2) The LLM answer lacks the contextual framing that the Republic of Congo was listed as a key operational country in 2022, which would better establish the baseline for understanding the evolution. (3) The answer focuses primarily on the 2022-2024 divestiture narrative but fails to adequately capture the 2023 investment phase that represents the middle point of the evolution requested. (4) The characterization of assets as 'non-operated' is accurate but the answer doesn't fully explain the strategic significance of this transition. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple 10-K filings (2022, 2024) but fails to incorporate the 2023 data point, which is critical for showing the full evolution across the three-year period. The question explicitly asks about evolution 'from 2022 through 2024,' requiring all three years to be addressed. QUANTITATIVE VERIFICATION: The percentages (31.5%, 15.75%) are correct. The timing reference to January 2025 sale announcement is accurate. However, the missing $0.7 billion investment figure from 2023 represents a material omission of quantitative data. OVERALL ASSESSMENT: The answer captures the endpoint of the evolution (divestiture) accurately but misses the middle chapter (2023 investment) that would demonstrate the full arc of engagement evolution. This makes the answer partially correct but incomplete for a question specifically asking about evolution across a three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 592,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "From 2022 to 2024, NextEra’s Level‑3 gas‑option exposure swung from a modest net asset position ($170 m assets, $8 m liabilities) to a large net liability ($‑854 m assets, $9 m liabilities) in 2023, and then rebounded to a strong net asset ($951 m assets, $24 m liabilities) in 2024.  The implied volatilities for these options fell from 20 % (assets) / 233 % (liabilities) in 2022–23 to 15 % / 150 % in 2024, signalling a shift to lower expected gas‑price volatility and a more conservative, favorable risk stance in the gas market.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across nearly all quantitative metrics and contains fabricated data that directly contradicts the ground truth. Specific issues: (1) ASSET/LIABILITY VALUES: Ground truth shows 2022: $356M assets/$347M liabilities; 2023: $100M assets/$97M liabilities; 2024: $100M assets/$102M liabilities. LLM claims 2022: $170M assets/$8M liabilities (wrong), 2023: -$854M assets/$9M liabilities (completely fabricated), 2024: $951M assets/$24M liabilities (completely fabricated). These numbers are not merely different—they are orders of magnitude off and internally inconsistent. (2) IMPLIED VOLATILITY: Ground truth shows 2022: 36%, 2023: 50%, 2024: 52%. LLM claims 2022-23: 20%/233% (assets/liabilities) and 2024: 15%/150%—these percentages are either nonsensical (233% and 150% are implausibly high for implied volatility) or completely fabricated. The ground truth shows a clear upward trend in volatility (36%→50%→52%), while LLM claims a downward trend (20%→15%). (3) NARRATIVE ACCURACY: Ground truth describes 'sharp reduction in exposure from 2022 to 2023, followed by stabilization' with 'volatility expectations increased and then slightly moderated.' LLM's narrative of 'swung from modest net asset to large net liability to strong net asset' with 'falling volatilities' is contradictory to ground truth on both exposure trajectory and volatility direction. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trend across all metrics. The answer appears to contain entirely fabricated data rather than misinterpretation of actual filing data. This represents a complete failure to answer the question accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 459,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "Nike has continued to list FlyEase among its core technologies in the product‑research and development section of each filing.  In the 2022, 2023 and 2024 10‑K reports, the phrase “FlyEase” appears in the same sentence that enumerates Nike’s key technologies (NKE_10k_2022.pdf page 6; NKE_10k_2023.pdf page 6; NKE_10k_2024.pdf page 6).  The unchanged mention shows that FlyEase remains a recognized component of Nike’s broader innovation portfolio, but its prominence has not shifted toward a flagship role, underscoring its function as a supporting technology within the company’s overall strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and interpretive errors that contradict the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies that FlyEase appears in the product research and development sections of 2022, 2023, and 2024 10-K filings; (2) The page references (page 6 for each year) appear consistent with typical filing structure; (3) The basic fact that FlyEase is listed among core technologies is accurate. CRITICAL ERRORS: (1) The LLM fundamentally misinterprets the progression - it claims 'prominence has not shifted' and describes FlyEase as merely a 'supporting technology,' directly contradicting the ground truth which explicitly states FlyEase evolved from 'newly introduced concept to foundational element' and was 'fully embedded' by 2024; (2) The LLM fails to recognize the expansion narrative - the ground truth emphasizes deliberate scaling from 2022 to 2023 and full integration by 2024, while the LLM suggests stagnation ('unchanged mention'); (3) The LLM's conclusion that FlyEase has not achieved 'flagship role' contradicts the ground truth's characterization of it as a 'core technology' and 'foundational element' by 2024; (4) The LLM misses the key insight about strategic evolution - the ground truth shows progression from portfolio listing to established long-term design strategy, while the LLM suggests static positioning. MULTI-HOP REASONING FAILURE: The question asks about evolution and what it indicates about innovation strategy. The ground truth synthesizes three years of data to show strategic progression. The LLM acknowledges the three-year span but fails to synthesize meaningful change, instead concluding there is no meaningful evolution. This represents a fundamental failure in multi-hop reasoning and interpretation of the filing data across time periods. The LLM's answer is internally consistent but factually contradicts the ground truth's characterization of FlyEase's strategic importance trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 533,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "From 2022 through 2024, the Unsecured Notes – 35A remained unchanged: a 2.65 % interest rate, $750,000 face amount, $19,875 annual debt service, and a maturity of July 15 2030 (page 50 for 2022/2023, page 51 for 2024). This stability indicates that Simon has chosen to retain a low‑cost, long‑dated debt instrument, reflecting a long‑term strategy that prioritizes predictable, low‑interest financing over frequent refinancing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: the 2.65% interest rate, $750,000 face amount, $19,875 annual debt service, and July 15, 2030 maturity date are all accurately stated and match the ground truth across all three years (2022-2024). The answer correctly identifies that these obligations remained unchanged throughout the period, which is the core factual finding. The LLM also provides appropriate page references (50 for 2022/2023, 51 for 2024) that add credibility. The reasoning about SPG's (Simon Property Group) long-term debt strategy is sound and semantically equivalent to the ground truth: both conclude that the consistency reflects a stable approach prioritizing low-cost, long-dated financing without refinancing. The LLM's characterization of this as 'a long-term strategy that prioritizes predictable, low-interest financing over frequent refinancing' is a reasonable interpretation that aligns with the ground truth's conclusion about 'steady approach' and 'avoiding refinancing or restructuring.' Minor note: The LLM uses 'Simon' as shorthand for SPG, which is acceptable given the context. The answer fully addresses the multi-part question about how obligations evolved (they didn't) and what this reveals about strategy (stability and predictability). No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 386,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "Across 2022, 2023 and 2024 Texas Instruments repeatedly stated that its core business model is “focused on analog and embedded‑processing products” (MD&A, 2022‑p. 19; 2023‑p. 19; 2024‑p. 19).  Embedded‑processing revenue grew only modestly in 2023 (≈ +3 % vs 2022) but fell sharply in 2024 (≈ –25 % vs 2023), yet the company still highlighted the line as a key source of strong cash flow (segment tables, 2023‑p. 20; 2024‑p. 20).  This unwavering positioning shows that TI’s long‑term growth strategy is to use the embedded‑processing portfolio—supported by its manufacturing and technology advantages—to drive and sustain free‑cash‑flow‑per‑share growth through disciplined capital allocation and efficiency.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of TI's strategic positioning on embedded processing products across 2022-2024. STRENGTHS: (1) Correctly identifies the consistent messaging across all three years about embedded processing being central to the business model; (2) Provides specific page references (MD&A p. 19 for all years, segment tables p. 20 for 2023-2024) showing multi-hop synthesis across documents; (3) Accurately captures the strategic narrative linking embedded processing to free cash flow per share growth; (4) Correctly identifies the revenue trends (modest +3% growth in 2023, sharp ~25% decline in 2024); (5) Properly synthesizes that despite revenue declines, TI maintained strategic emphasis on the segment. MINOR WEAKNESSES: (1) The LLM answer provides more granular revenue performance data (specific percentages) than the ground truth, which is actually a strength but goes slightly beyond what was explicitly stated in the original answer; (2) The ground truth emphasizes the segment as 'high-margin and scalable' while the LLM focuses more on cash flow generation—both are correct but slightly different framings; (3) The LLM answer could have more explicitly stated that this positioning reveals TI's view of embedded processing as a stable, long-term growth driver (though this is implied). QUANTITATIVE VERIFICATION: The revenue figures cited (~+3% in 2023, ~-25% in 2024) appear reasonable for the period and are presented with appropriate caveats ('≈'). The page references are consistent across years. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and connects strategic positioning to capital allocation and free cash flow per share objectives. The logic is sound: consistent messaging + revenue volatility + maintained emphasis = long-term strategic commitment. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same core message as the ground truth—that TI views embedded processing as foundational to its long-term strategy—while adding specific revenue performance context that enriches rather than contradicts the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 575,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "Disney’s 2023 10‑K (page 7) shows that Marvel was promoted to a top‑level tile on Disney+, a move that followed its 2022 classification of Marvel trademarks as an indefinite‑lived intangible asset (page 112).  The 2024 10‑K still lists Marvel under the same category (page 114), confirming the brand’s continued status as a key intangible asset.  This shift illustrates Disney’s financial strategy of using high‑value IP to differentiate its streaming platform, drive subscriber acquisition and retention, and generate long‑term revenue from the Marvel franchise.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Marvel was classified as an indefinite-lived intangible asset in 2022 and 2024, and accurately notes the 2023 promotion to a top-level tile on Disney+. The page references (page 7 for 2023 10-K, pages 112 and 114) appear reasonable for these disclosures. The core financial strategy explanation—using high-value IP to differentiate streaming and drive subscriber growth—is sound and aligns with the ground truth.\n\nWEAKNESSES: (1) The LLM answer is significantly less comprehensive than the ground truth. It omits the Disney+ subscriber count of 123 million as of September 28, 2024, which is a key quantitative metric directly supporting the financial strategy narrative. (2) The answer fails to mention ESPN+ and its planned tile launch in early fiscal 2025, which the ground truth identifies as part of a broader strategic pattern of leveraging branded content across platforms. This is a material omission for understanding Disney's multi-platform strategy. (3) The answer lacks the temporal narrative arc that the ground truth provides—the progression from 'passive asset recognition' to 'active brand utilization'—which is central to answering how the strategy 'evolved.' (4) The answer doesn't explicitly address the connection between Marvel's UI prominence and subscriber retention/growth outcomes, instead stating this 'likely contributed' without the supporting data point of the 123M subscriber base.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022, 2023, and 2024 filings, but the synthesis is incomplete. It identifies the key transition points but misses the broader strategic context (ESPN+ tile launch) that would demonstrate Disney's systematic approach to platform differentiation.\n\nQUANTITATIVE GAPS: The omission of the 123 million Disney+ subscriber figure as of September 28, 2024 is a significant quantitative oversight, as this number directly validates the financial strategy's effectiveness and is explicitly mentioned in the ground truth as supporting evidence.\n\nSEMANTIC EQUIVALENCE: While the LLM's explanation of the financial strategy is semantically sound, it lacks the depth and supporting evidence of the ground truth, making it a partial rather than complete answer to the multi-part question about evolution and financial strategy implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 630,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "MetLife’s modified‑coinsurance agreement continued to cover roughly 59 % of its closed block through 2024 (the same 59 % reported for 2023)【229】【206】.  Unsecured reinsurance recoverable balances rose from $3.8 billion in 2022 to $4.4 billion in 2023 and then dipped slightly to $4.2 billion in 2024【227】【204】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM answer contains a significant discrepancy in the 2022 reinsurance recoverable balance. Ground truth states $3.6 billion for 2022, but the LLM reports $3.8 billion - a $200 million error. The 2023 ($4.4 billion) and 2024 ($4.2 billion) figures are correct. PERCENTAGE ACCURACY: The LLM states 59% for both 2023 and 2024, which matches ground truth. However, the LLM omits the 2022 percentage of 59.25%, which is a notable detail showing the evolution of the metric. The LLM's statement that 2024 remained at 59% (same as 2023) is correct but incomplete without noting the 2022 starting point of 59.25%. COMPLETENESS: The answer addresses the core question about evolution from 2022-2024 and covers both the percentage reinsured and reinsurance recoverable balances. However, it misses the specific 2022 percentage figure (59.25%), which is important for showing the full evolution. REASONING: The multi-hop synthesis is sound - the LLM correctly identifies the trend of relatively stable percentages with minor fluctuations in unsecured balances. The characterization of 'roughly 59%' is reasonable given the 59.25% to 59% movement. CRITICAL ERROR: The $3.8 billion vs. $3.6 billion discrepancy for 2022 is a material factual error that affects the accuracy of the trend analysis, even though the overall narrative direction is correct. The answer demonstrates good understanding of the question's multi-hop nature but fails on precise numerical accuracy for a key data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 417,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "CVS’s fair‑value holdings of residential mortgage‑backed securities fell from **$721 million at December 31, 2022 to $614 million at December 31, 2023** (page 149) and then dropped sharply to **$71 million in separate‑account holdings at December 31, 2024** (page 160). This 90 % decline over three years indicates a deliberate shift away from RMBS, reducing the company’s exposure to interest‑rate and credit risk and signaling a strategic repositioning toward other fixed‑income instruments that better align with its risk‑management and investment‑income objectives.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2022 baseline figure. The ground truth states CVS held $629 million in RMBS in 2022, but the LLM claims $721 million. This is a $92 million discrepancy (14.6% overstatement). The 2023 figure of $614 million is correct, and the 2024 figure of $71 million is correct. However, the calculated 90% decline is based on the incorrect 2022 starting point ($721M to $71M = 90.1%), whereas the actual decline from the correct baseline is 88.7% ($629M to $71M). MISSING CRITICAL INFORMATION: The ground truth specifically mentions unrealized losses ($10 million in 2022, $60 million in 2023), which are important indicators of risk exposure and market conditions. The LLM answer completely omits this key metric that directly addresses the question about risk exposure. REASONING QUALITY: The LLM's interpretation of the trend as a 'deliberate shift away from RMBS' and 'strategic repositioning' is reasonable and aligns with the ground truth's assessment of de-risking. The mention of interest-rate and credit risk is contextually appropriate. However, the reasoning is built on an incorrect numerical foundation. MULTI-HOP SYNTHESIS: The answer does attempt to synthesize data across three years and connect it to strategic implications, which is appropriate for the multi-hop nature of the question. The page citations (149, 160) suggest proper source documentation, though the 2022 number appears to be sourced incorrectly. OVERALL ASSESSMENT: While the qualitative interpretation and reasoning about strategic repositioning are sound, the fundamental quantitative error in the 2022 baseline figure undermines the credibility of the entire analysis. The omission of unrealized losses data represents incomplete addressing of the question's focus on risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 502,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "MetLife’s modified‑coinsurance agreement continued to cover 59 % of its closed block in each of the 2022, 2023 and 2024 filings.  The company consistently applied the deposit method to account for the agreement, recording deposit assets and liabilities (≈$1.9 B assets and $1.4 B liabilities in 2022, $5.1 B assets and $1.3 B liabilities in 2023, and $4.6 B assets and $1.2 B liabilities in 2024) and offsetting the deposit liability with a deposit recoverable.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: MetLife's modified coinsurance agreement covered approximately 59% of the closed block across 2022-2024, and the deposit method accounting treatment remained consistent with offsetting of deposit liabilities and recoverables. However, there are significant quantitative accuracy issues. The ground truth specifies that in 2022 the percentage was 59.25%, not simply 59%, which is a material precision difference that the LLM failed to capture. More critically, the LLM provides specific dollar amounts for deposit assets and liabilities ($1.9B/$1.4B in 2022, $5.1B/$1.3B in 2023, $4.6B/$1.2B in 2024) that are not mentioned in the ground truth answer. These numbers cannot be verified against the provided ground truth and appear to be either hallucinated or sourced from unstated filing data. The ground truth explicitly states the percentages were 59.25% (2022) and 59% (2023-2024), but the LLM rounds all years to 59%, losing the precision distinction. The qualitative reasoning is sound - the LLM correctly synthesizes the multi-hop information about the reinsurance percentage, accounting method, and offsetting treatment across three years. The answer appropriately addresses the question's focus on evolution and consistency. However, the introduction of unverified financial figures and the loss of precision on the 2022 percentage significantly undermines the answer's reliability. The semantic understanding of the deposit method and offset treatment is correct, but the quantitative presentation contains errors that would be problematic in a financial analysis context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 447,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "NextEra Energy’s net fair‑value of gas forward contracts rose from **$162 million** in 2022 to **$300 million** in 2023, then fell to **$250 million** in 2024 (assets – liabilities: 170 – 8 = 162 m; 377 – 77 = 300 m; 296 – 46 = 250 m). The sharp increase in 2023 indicates a more aggressive hedging or speculative stance amid volatile gas prices, while the modest decline in 2024 suggests the company is trimming its exposure to adopt a more balanced risk profile in natural‑gas markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with only minor discrepancies. QUANTITATIVE VERIFICATION: The 2023 and 2024 figures are exactly correct ($300M and $250M respectively). The 2022 figure shows a $2M variance ($162M in LLM vs $160M in ground truth), which is negligible and within acceptable rounding tolerance. The calculations shown (377-77=300, 296-46=250) are arithmetically correct. The 2022 calculation shown (170-8=162) appears to reference slightly different component values than the ground truth (191-31=160), but both arrive at approximately the same net exposure figure. COMPLETENESS: The answer addresses all three years (2022-2024) and provides the trend analysis requested. ENTITY ACCURACY: NextEra Energy is correctly identified, the metric (net fair-value of gas forward contracts) is appropriate, and all years are correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the 2023 peak as indicating aggressive positioning and the 2024 decline as suggesting rebalancing toward a more balanced risk profile. This interpretation aligns well with the ground truth's characterization of a 'more cautious stance or rebalancing.' The reasoning about volatile gas prices driving 2023 behavior adds reasonable context. MINOR ISSUES: The $2M variance in 2022 is immaterial but technically a discrepancy. The LLM's interpretation of 'speculative stance' is slightly more assertive than the ground truth's neutral 'increased forward contracting,' though both convey similar meaning. Overall, the answer successfully synthesizes multi-year data and provides appropriate risk positioning analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 452,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "Across 2022, 2023 and 2024, Broadcom continued to present industrial fiber optics as a core element of its industrial portfolio, using it in a wide range of applications from factory automation and renewable‑energy power‑distribution to medical equipment, defense/aerospace and automotive subsystems such as electric‑vehicle powertrains and advanced‑driver‑assistance systems.  The company consistently highlighted the integration of fiber optics with motion encoders and Ethernet ICs, underscoring its focus on delivering end‑to‑end industrial solutions that combine optical, motion‑sensing and networking technologies.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies AVGO/Broadcom as the company; (2) Accurately mentions the consistent positioning of Industrial Fiber Optics across 2022-2024; (3) Correctly identifies applications including factory automation, renewable energy, medical, defense/aerospace, and automotive/EV subsystems; (4) Correctly mentions integration with motion encoders and Ethernet ICs; (5) No quantitative errors in dates or numbers. CRITICAL WEAKNESSES: (1) The LLM answer fails to capture the EVOLUTION and TRAJECTORY of positioning from 2022 to 2024. The ground truth explicitly describes how the integration scope evolved - from 2022 (optocouplers, LED devices alongside fiber optics) to 2023 (sensors, microcontrollers added) to 2024 (Ethernet PHYs, switch ICs, camera microcontrollers). The LLM presents this as static/consistent rather than evolving. (2) Missing specific 2024 evolution details: The ground truth emphasizes that by 2024, fiber optics became 'explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems.' The LLM does not capture this shift toward networked and vision-based systems. (3) Missing the strategic narrative: The ground truth describes a 'strategic shift from standalone industrial components to more interconnected, intelligent systems.' The LLM describes consistent positioning rather than this strategic evolution. (4) The LLM answer reads as a general description of AVGO's industrial portfolio rather than a year-by-year evolution analysis. The question specifically asks 'how did...evolve' requiring temporal comparison, which the LLM largely omits. The answer is partially correct on facts but fundamentally misses the core requirement of the question: demonstrating the evolution and changing strategic positioning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 526,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "From FY 2022 through FY 2024 Nike’s redeemable preferred stock—fully issued to Sojitz America—continued to carry a cumulative dividend of **$0.10 per share payable each May 31** (Note 10, pages 79 2022‑2024; page 8 2024).  The company’s filings state that **no dividends on common stock may be declared or paid unless the preferred dividend is fully paid** and that **there have been no changes to the preferred‑stock structure** (no new issuances, no blank‑check preferred stock, and no alteration of redemption terms) across those years (pages 79 2023‑2024, page 5 2024).  Thus the dividend obligation remained constant and the preferred‑stock structure stayed stable, preserving the financial relationship with Sojitz America.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. Strengths: (1) Correctly identifies the dividend obligation at $0.10 per share annually, matching ground truth exactly. (2) Accurately states the payment date (May 31) which adds specificity beyond the ground truth. (3) Correctly identifies Sojitz America as the sole holder of the redeemable preferred stock. (4) Accurately conveys the structural stability across FY 2022-2024 with no changes to terms or ownership. (5) Properly synthesizes the multi-hop requirement that preferred dividends must be paid before common stock dividends. (6) Correctly notes no redemption has occurred despite the option existing. (7) Appropriately cites specific page references to SEC filings (Note 10, pages 79, 8, 5) which demonstrates source verification. Minor observations: (1) The LLM answer does not explicitly mention the $0.3 million total par value stated in the ground truth, though this is a minor omission that doesn't affect the core narrative about dividend obligations and structural stability. (2) The LLM's phrasing 'cumulative dividend' is slightly different from ground truth's 'consistent at $0.10 per share annually,' but both convey the same financial reality. (3) The LLM adds helpful detail about the May 31 payment date and explicitly notes 'no blank-check preferred stock' which provides additional context. The multi-hop reasoning is sound: the answer correctly synthesizes information about dividend obligations, stock structure stability, and the priority of preferred dividends across the three-year period. All quantitative values are accurate, and the qualitative assessment of the relationship's stability is well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 473,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 31B remained unchanged: a $750,000 face amount, 3.25 % interest rate, maturity of November 30 2026, and annual debt service of $24,375 (page_50 for 2022/2023, page_51 for 2024). This stability indicates SPG’s long‑term financing strategy is to preserve a predictable, low‑cost debt instrument with a fixed maturity, avoiding refinancing or new issuance for this note.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Verification of key facts: (1) Face amount of $750,000 - CORRECT; (2) Interest rate of 3.25% - CORRECT; (3) Maturity date of November 30, 2026 - CORRECT; (4) Stability across 2022-2024 - CORRECT; (5) Annual debt service calculation of $24,375 ($750,000 × 3.25% = $24,375) - CORRECT and demonstrates quantitative precision. The LLM successfully synthesized multi-hop information by: identifying the specific debt instrument across three years, confirming no changes occurred, and drawing appropriate conclusions about SPG's financing strategy. The answer correctly identifies that despite broader portfolio changes (retirement of certain notes, issuance of new instruments like Unsecured Notes - 41A), this specific obligation remained unchanged. The reasoning is sound and logically connects the stability of the instrument to SPG's conservative financing approach. Minor observation: The LLM includes page references (page_50, page_51) which adds specificity but wasn't in the ground truth answer - this is a value-add rather than an error. The wording differs slightly from ground truth (e.g., 'preserve a predictable, low-cost debt instrument' vs 'maintained a consistent long-term financing approach') but conveys semantically equivalent meaning. All factual content is accurate with no calculation errors or entity misidentifications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 392,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "From the 2023 10‑K, TI’s U.S. defined‑contribution plans held $940 million of TI common stock in 2022 and $873 million in 2023.  The 2024 10‑K shows the value fell further to $852 million.  The steady decline over three years reflects a modest drop in the company’s share price and/or employees selling or reducing their company‑stock holdings in retirement plans, indicating a shift toward diversification or risk‑management in their investment choices.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All three key financial figures are correct: $940M (2022), $873M (2023), $852M (2024). (2) Numbers are properly sourced from 2023 and 2024 10-Ks as stated. (3) The quantitative trend is accurately captured - consistent decline over three years. (4) The interpretation about employee behavior (selling/reducing holdings, diversification, risk management) is reasonable and supported by the data. (5) Format and presentation are clear and professional.\n\nWEAKNESSES: (1) The LLM answer attributes the decline primarily to 'modest drop in company share price and/or employees selling' but omits a key contextual detail from the ground truth: the freeze on new contributions into the TI common stock fund since 2016. This is an important explanatory factor that provides fuller context for understanding the trend. (2) The ground truth explicitly mentions 'strategic reduction in stock allocations by employees' as a potential factor, which the LLM captures as 'employees selling or reducing holdings,' but the freeze on new contributions is a distinct and material point that should have been included. (3) The phrase 'modest drop in company share price' is somewhat speculative without explicit confirmation in the answer.\n\nMULTI-HOP REASONING: The LLM correctly synthesized information across two different 10-K filings (2023 and 2024) to construct the three-year trend. The logic connecting the numbers to employee behavior is sound.\n\nCALCULATIONS: No calculations were required, but the year-over-year changes are implicit and correct ($940M→$873M = $67M decline; $873M→$852M = $21M decline).\n\nOVERALL: The answer is substantially correct on all quantitative measures and provides reasonable interpretation, but loses points for omitting the freeze on new contributions since 2016, which is a material contextual factor mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 507,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "From 2022 to 2024, Disney’s workforce grew from roughly 220,000 employees to about 233,000.  U.S. employees increased from ~166,000 to ~171,000, while international employees rose from ~54,000 to ~62,000, and the share of seasonal workers climbed from 7 % to 8 % 【page_5】【page_16】.  Across all three years, a large portion of staff—especially those in theme‑park, production, and other key areas—remained covered by collective‑bargaining agreements, and employees outside the U.S. continued to be represented by works councils, trade unions, or other employee associations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numerical values are correct - total workforce 220,000 to 233,000 (✓), U.S. employees 166,000 to 171,000 (✓), international employees 54,000 to 62,000 (✓), seasonal percentage 7% to 8% (✓). The use of approximation symbols (~) is appropriate given the source material format. COMPLETENESS: The answer addresses all major components of the multi-part question: (1) total employee growth, (2) U.S. vs. international distribution with specific numbers, (3) seasonal workforce percentages, and (4) collective bargaining/employee association representation. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across multiple years (2022-2024) and multiple data categories (headcount, geography, employment type, representation). The logical flow from quantitative trends to qualitative context about bargaining agreements is sound. ENTITY ACCURACY: Disney is correctly identified, years are accurate (2022-2024), and metrics are properly labeled. MINOR OBSERVATIONS: The LLM answer includes slightly more contextual detail about international employee representation (works councils, trade unions) compared to the ground truth, which adds relevant context without contradicting the original answer. The citation markers [page_5][page_16] indicate source documentation. The phrasing 'roughly,' 'about,' and '~' appropriately conveys the approximate nature of workforce statistics. No calculation errors detected. The answer maintains semantic equivalence with the ground truth while using slightly different wording that enhances clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 450,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "GD has consistently excluded non‑economic accounting changes from its ROIC calculations in 2022, 2023 and 2024 (the 10‑K filings all state that ROIC “excludes goodwill impairments and non‑economic accounting changes”). The unchanged treatment shows the company’s deliberate focus on core operating performance and a commitment to comparability across periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that GD consistently excluded non-economic accounting changes from ROIC calculations across all three years (2022, 2023, 2024); (2) Accurately captures the specific exclusions mentioned (goodwill impairments and non-economic accounting changes); (3) Properly synthesizes the multi-hop reasoning by connecting the consistent treatment across years to the company's strategic intent (focus on core operating performance and comparability); (4) No quantitative errors—all dates and metrics are correct; (5) Entity identification is accurate (GD, ROIC, fiscal years). Minor considerations: (1) The LLM answer includes a direct quote from the 10-K filings ('excludes goodwill impairments and non-economic accounting changes'), which adds credibility and specificity beyond the ground truth's more general phrasing; (2) The LLM's language about 'deliberate focus' and 'commitment to comparability' is semantically equivalent to the ground truth's emphasis on 'stable performance evaluation framework' and 'economic performance over accounting volatility'; (3) Both answers convey the same core insight—that consistency in treatment reveals intentional methodology. The LLM answer is slightly more concrete with the direct quote, which enhances rather than detracts from accuracy. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 392,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "In 2022 Linde’s 10‑K (pages 94‑98) focused on overall industrial‑gas sales and distribution methods and did not outline a distinct rare‑gas production strategy. By 2024 the 10‑K (page 4) states that Linde is “continuously developing a wide range of proprietary and patented applications and technologies to produce, store, distribute and increase usage of its gases,” explicitly highlighting rare gases such as krypton, neon and xenon. This evolution signals a strategic shift toward high‑margin rare‑gas markets, reinforcing Linde’s competitive advantage through its scale, integrated supply chain and technological leadership in the industrial‑gas industry.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The identification of rare gases (krypton, neon, xenon) is accurate; (2) The reference to 2024 10-K page 4 discussing proprietary technologies is plausible; (3) The general framing of competitive advantage through scale and technological leadership is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM claims the 2022 10-K (pages 94-98) did NOT outline a distinct rare-gas production strategy, but the ground truth explicitly states that in 2022 Linde listed rare gases as part of its portfolio. This is a direct contradiction and factual error; (2) The LLM misses the critical 2023 filing that reiterated rare gases as a core atmospheric gas offering - this is a significant omission in the multi-hop synthesis across three years; (3) The LLM fails to mention the explicit evolution to non-cryogenic air separation technologies (VPSA, membrane separation) that the ground truth identifies as a key strategic shift by 2024. This is a major omission of the technological differentiation narrative; (4) The LLM's characterization of the evolution as primarily about 'high-margin rare-gas markets' differs from the ground truth's emphasis on technological innovation and efficiency improvements. MULTI-HOP REASONING: The LLM attempts to synthesize across 2022-2024 but fails to properly connect the progression. It incorrectly suggests rare gases were NOT mentioned in 2022, when they were. It also misses the 2023 intermediate step entirely, breaking the three-year narrative chain. QUANTITATIVE ACCURACY: Page references (94-98 for 2022, page 4 for 2024) cannot be verified as correct or incorrect from the ground truth, but the substantive claims about what those pages contain are inaccurate. The answer lacks the specific technological innovations (VPSA, membrane separation) that would strengthen the quantitative/technical accuracy. OVERALL: While the answer captures some correct elements and provides a reasonable competitive advantage narrative, it contains a fundamental factual error about 2022 content, omits the 2023 filing entirely, and misses key technological differentiation details that are central to the ground truth answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 595,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "NEER’s share of net generating capacity that is locked into long‑term bilateral contracts grew from about 92 % in 2022 to 94 % in 2023 and remained at 94 % in 2024.  The steady rise and high coverage level show the company’s deliberate shift toward locking in revenue and hedging price risk, underscoring a risk‑management strategy that prioritizes revenue certainty in a volatile energy market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key quantitative data correct: 92% in 2022, 94% in 2023, and 94% in 2024. The multi-hop synthesis is sound, correctly identifying the trend (slight increase then stabilization) and connecting it to risk management strategy. The answer accurately conveys the core insight about revenue certainty and price risk hedging in a volatile market. However, there are minor omissions compared to the ground truth: (1) The LLM does not mention the use of 'non-qualifying hedges to protect expected revenues,' which is a specific risk management tool mentioned in the original answer; (2) The phrase 'steady rise' is slightly imprecise—the rise occurred from 2022 to 2023, then remained steady in 2024, not a continuous rise. The LLM's characterization of this as a 'deliberate shift' is appropriate and semantically equivalent to the ground truth's 'strategic emphasis.' The reasoning about locking in revenue and hedging price risk is sound and directly addresses the question about risk management strategy. Overall, the answer captures the essential facts and demonstrates correct multi-hop reasoning, with only minor contextual details missing that don't materially affect the core conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 351,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "AVGO’s 3.125% notes due January 2025 stayed at a constant $495 million of outstanding principal from FY 2022 through FY 2024 (FY 2022: $495 million【page_103】; FY 2023: $495 million【page_81】; FY 2024: $495 million【page_81】). This unchanged balance shows the company has neither issued additional principal nor repaid any of this debt, reflecting a strategy of keeping a stable, low‑interest long‑term financing position for the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All three fiscal year amounts are correctly stated as $495 million (FY 2022, FY 2023, FY 2024), matching the ground truth exactly. The consistency across all three years is accurately captured. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the outstanding principal balance across the three-year period, (2) the trend (unchanged/stable), and (3) interpretation of debt management strategy. ENTITY ACCURACY: Company (AVGO), debt instrument (3.125% notes due January 2025), and fiscal years (2022-2024) are all correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identified that the constant $495 million balance across three years indicates no retirement or refinancing activity. The interpretation that this reflects a stable financing strategy is logical and appropriate. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM's characterization of this as a 'low-interest long-term financing position' is a reasonable inference but slightly more interpretive than the ground truth's more neutral statement about 'maintaining a consistent liability profile.' The ground truth uses 'did not retire or refinance' while the LLM uses 'neither issued additional principal nor repaid any of this debt' - these are semantically equivalent. The inclusion of page references (page_103, page_81, page_81) adds credibility and transparency. Overall, the answer demonstrates accurate multi-hop synthesis across three fiscal years with correct financial data and sound reasoning about debt management implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 455,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "From 2022 through 2024, SPG’s Unsecured Notes – 37B remained unchanged, with a face amount of $700,000 and a maturity date of January 15 , 2032 in each filing (SPG_10k_2022.pdf p. 50; SPG_10k_2023.pdf p. 50; SPG_10k_2024.pdf p. 51). The consistency of both the face amount and the maturity date indicates that the company has not altered this long‑term debt instrument, maintaining a stable debt profile rather than refinancing or restructuring it. This reflects a conservative long‑term debt strategy focused on predictable cash‑flow obligations and minimizing refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - face amount of $700,000 is accurate for both 2022-2024, and the maturity date of January 15, 2032 (01/15/32) is correctly stated. The answer properly formats the date in both numeric and written forms, which is acceptable variation. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) evolution of face amount across 2022-2024, (2) maturity date consistency, (3) what this reveals about debt strategy. ENTITY ACCURACY: SPG is correctly identified, the instrument name 'Unsecured Notes - 37B' is accurate, and all fiscal years (2022, 2023, 2024) are correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings (2022, 2023, 2024) and correctly identifies the consistency pattern. The citations to specific pages (p. 50 for 2022/2023, p. 51 for 2024) demonstrate proper source tracking. STRATEGIC INTERPRETATION: The LLM provides sound reasoning about what the stability indicates - no refinancing, stable debt profile, conservative strategy focused on predictable cash flow and minimizing refinancing risk. This interpretation aligns with and slightly expands upon the ground truth's conclusion. MINOR CONSIDERATIONS: The LLM adds interpretive language about 'conservative long-term debt strategy' and 'predictable cash-flow obligations' which goes slightly beyond the ground truth's more neutral statement of 'consistent long-term debt strategy,' but this is a reasonable and accurate elaboration rather than an error. The answer is well-structured, properly sourced, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 460,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia facility has consistently been an **analog‑only** site across the three reporting years. The 2022, 2023, and 2024 property tables all list an “X” under the Analog column for Melaka and leave the Embedded Processing column blank, indicating no embedded‑processing activity at that location during 2022‑24.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka facility evolution across 2022-2024. STRENGTHS: (1) Correctly identifies the core fact that Melaka was analog-only across all three years with no embedded processing activity; (2) Accurately references the marking system ('X' for analog, blank for embedded processing) from the source documents; (3) Properly synthesizes information across three fiscal years to demonstrate consistency and stability; (4) Correctly identifies all entities (Texas Instruments, Melaka Malaysia, analog vs. embedded processing product lines); (5) Uses appropriate terminology ('analog-only site') that matches the ground truth characterization. MINOR CONSIDERATIONS: (1) The LLM uses 'X' notation while the ground truth mentions 'checkmark' - both refer to the same marking system indicating presence, so this is a semantic equivalence issue rather than an error; (2) The LLM answer is slightly more concise than the ground truth but captures all essential information without omission; (3) The phrasing 'leave the Embedded Processing column blank' is a clear and accurate way to convey the absence of activity. VERIFICATION: The core claim that Melaka remained exclusively analog-focused with no embedded processing expansion across 2022-2024 is fully supported and correctly stated. The multi-hop reasoning (synthesizing data across three years and two product categories) is sound and logically presented. No numerical errors, date errors, or entity misidentifications present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 432,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "Disney continued to list post‑production services from Industrial Light & Magic as part of the “Other revenue” within its Content Sales/Licensing segment in each of the fiscal 2022, 2023, and 2024 10‑Ks. The segment’s structure remained essentially unchanged, with ILM’s revenue consistently reported alongside music, stage‑play, and Skywalker Sound services. Thus, Disney’s reliance on ILM for post‑production services stayed stable over the three‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to capture the key evolution described in the ground truth. Specific issues: (1) STRUCTURAL MISCHARACTERIZATION: The LLM claims ILM was listed under 'Other revenue' within Content Sales/Licensing, but the ground truth indicates ILM was 'explicitly listed as part of the Content Sales/Licensing segment' - these are different characterizations of reporting structure. (2) MISSING EVOLUTION: The ground truth emphasizes a clear evolution from fiscal 2022 through 2024, with the segment's narrative shifting from post-production services focus to broader content licensing and distribution, and a 'strategic repositioning' within a 'DTC-first content model.' The LLM answer incorrectly claims the structure 'remained essentially unchanged' and that reliance 'stayed stable' - this directly contradicts the ground truth's core finding of contextual shifting and repositioning. (3) INCOMPLETE SYNTHESIS: The LLM mentions 'music, stage-play, and Skywalker Sound services' alongside ILM, but the ground truth specifically mentions 'National Geographic publishing' as part of the segment composition in fiscal 2022 - the LLM omits this detail. (4) MISSING CONTEXTUAL NUANCE: The ground truth describes a 'stable but contextually shifting reliance' and notes that ILM's role became 'increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.' The LLM completely misses this nuanced evolution and incorrectly characterizes the three-year period as showing no meaningful change. (5) MULTI-HOP REASONING FAILURE: The question asks how reliance 'evolved' - this requires identifying changes across the three-year period. The LLM fails to identify any evolution, which is the central requirement of the question. The answer demonstrates a fundamental misunderstanding of the filing data and the strategic repositioning that occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 520,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "MetLife’s equity‑method income from operating joint ventures fell from **$51 million in 2022 to $38 million in 2023**, then surged to **$175 million in 2024**. The sharp rebound in 2024 indicates that the company’s insurance‑underwriting joint ventures recovered and delivered substantially stronger profitability after a weaker year in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative metrics. Ground truth shows: 2022: $1,305M, 2023: $151M, 2024: $988M. LLM reports: 2022: $51M, 2023: $38M, 2024: $175M. Every single dollar amount is wrong by a factor of approximately 20-25x. The 2022 figure should be $1,305M but LLM states $51M (96% understatement). The 2023 figure should be $151M but LLM states $38M (75% understatement). The 2024 figure should be $988M but LLM states $175M (82% understatement). While the LLM correctly identifies the directional trend (decline in 2023, recovery in 2024) and appropriately characterizes it as volatility in joint venture performance, the magnitude of the numbers is catastrophically wrong. The reasoning about recovery and volatility is qualitatively sound, but the quantitative foundation is completely unreliable. This represents a critical failure in financial data accuracy - the numbers are off by orders of magnitude, making any analysis based on these figures misleading. The question specifically asks about evolution of equity method investment income, which requires precise numerical accuracy. The LLM failed to provide accurate financial data from the SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 337,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "General Dynamics produced 449 new Light Armored Vehicles (LAVs) for the Canadian Army in 2022, 399 in 2023, and 360 in 2024—a steady decline in new deliveries (see GD_10k_2022 page 10, GD_10k_2023 page 11, GD_10k_2024 page 9).  The downward trend reflects a shift in the Canadian order mix toward upgrades and modernization rather than new production, yet the LAV platform remains a strategically important export and modernization asset in General Dynamics’ land‑systems portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally inverted data that directly contradicts the ground truth. QUANTITATIVE ACCURACY FAILURE: The LLM states production was 449 units in 2022, 399 in 2023, and 360 in 2024 (declining trend). The ground truth shows the opposite: 360 units in 2022, 399 in 2023, and 449 in 2024 (increasing trend). Every single year's production figure is assigned to the wrong year. This is not a minor formatting error but a complete reversal of the data sequence. TREND ANALYSIS FAILURE: The LLM correctly identifies a 'steady decline' but this is the inverse of the actual 'consistent upward trend' documented in the ground truth. The LLM's interpretation of the trend as reflecting 'a shift toward upgrades and modernization' contradicts the ground truth's explanation that growth 'indicates that the LAV platform has become increasingly central to GD's defense offerings.' ENTITY AND REASONING ISSUES: While the LLM correctly identifies General Dynamics and the Canadian Army LAV program, the inverted chronological assignment of production volumes represents a fundamental failure in multi-hop data synthesis. The LLM appears to have reversed the year-to-year progression entirely. CONTEXTUAL RELEVANCE: The LLM's conclusion about strategic importance is partially reasonable but is built on inverted factual premises, making the overall assessment misleading. The question specifically asks about evolution 'from 2022 through 2024' - the LLM provides data in reverse chronological order relative to the actual progression. This is a severe factual error that undermines the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 446,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "CVS’s pension plan’s hedge‑fund limited‑partnership exposure rose steadily, increasing from $225 million in 2022 to $252 million in 2023 and to $280 million in 2024 (≈ 12 % growth each year)【page_174】【page_168】【page_167】.  The target allocation for hedge funds grew from 3 % in 2023 to 4 % in 2024【page_175】【page_169】, reflecting a deliberate shift toward greater alternative‑asset exposure to enhance expected returns and diversify beyond traditional fixed‑income holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are the foundation of this question. (1) WRONG BASELINE: LLM states 2022 value was $225 million, but ground truth shows $214 million - this is a $11 million error (5% discrepancy). (2) WRONG 2023 VALUE: LLM claims $252 million in 2023, but ground truth shows $225 million - this is a $27 million error (12% discrepancy). (3) WRONG 2024 VALUE: LLM states $280 million in 2024, but ground truth shows $252 million - this is a $28 million error (11% discrepancy). (4) INCORRECT GROWTH CALCULATION: LLM claims ~12% growth each year, but the actual growth rates are: 2022-2023: ($225-$214)/$214 = 5.1%, and 2023-2024: ($252-$225)/$225 = 12%. The LLM essentially shifted all values up by one year and added an extra $28 million to the 2024 figure. (5) ALLOCATION PERCENTAGES: While the LLM provides target allocation percentages (3% in 2023 to 4% in 2024), the ground truth answer does not mention these percentages, making it unclear if this is accurate or an addition. The qualitative reasoning about deliberate strategy and alternative asset allocation is sound and matches the ground truth's interpretation, but the quantitative foundation is fundamentally broken. The multi-hop synthesis attempted to connect allocation percentages to the dollar amounts, which shows reasoning effort, but the underlying numbers are wrong. This is a case where the semantic direction is correct (steady increase indicating deliberate strategy) but the specific financial data is substantially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 439,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "Sorriso has remained a core local brand within Colgate‑Palmolive’s Oral Care segment throughout 2022‑2024, as evidenced by its consistent listing among the company’s principal global and regional trademarks in each 10‑K (page 79 of 2022, 2023 and 2024). The brand continues to be integrated into the global Oral, Personal and Home Care product portfolio, with no reported divestiture or repositioning during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies Sorriso as a core local/regional brand within Colgate-Palmolive's Oral Care segment across 2022-2024; (2) Accurately notes consistent listing among principal global and regional trademarks across all three years; (3) Correctly states no divestiture or repositioning occurred; (4) Properly synthesizes multi-hop information across three fiscal years; (5) Appropriately cites page 79 of 10-Ks as source documentation. MINOR WEAKNESSES: (1) The LLM answer characterizes Sorriso as a 'core local brand' while the ground truth emphasizes it as a 'regional brand asset' - these are semantically similar but the ground truth's framing of 'regional market penetration and diversified consumer engagement' is slightly more nuanced; (2) The LLM answer is more concise and factual but lacks the ground truth's explicit discussion of Sorriso being 'positioned alongside major global brands like Colgate and Palmolive,' which provides important context about its portfolio positioning; (3) The ground truth emphasizes '3-year continuity' and 'stable role' more explicitly as a strategic insight. QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; page reference (79) is appropriately cited; no numerical errors present. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and properly connects the trademark listings to portfolio integration. The logic is sound and the conclusion about no repositioning is well-supported. The answer could have been slightly stronger by explicitly noting the strategic consistency and regional market focus mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 467,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "MetLife’s net investment income from operating joint ventures fell from $51 million in 2022 to $38 million in 2023, then surged to $175 million in 2024 (page 224). This sharp uptick in 2024 signals a deliberate shift toward greater equity‑method exposure in operating joint ventures, underscoring the company’s strategy to diversify earnings and capture growth opportunities in these partnerships (page 222).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors across multiple dimensions: (1) QUANTITATIVE ERRORS - All numbers are incorrect. Ground truth shows: 2022=$77M, 2023=$51M, 2024=$38M. LLM claims: 2022=$51M, 2023=$38M, 2024=$175M. The 2024 figure of $175M is completely fabricated and contradicts the ground truth of $38M. (2) METRIC CONFUSION - The LLM conflates 'net investment income from operating joint ventures' with 'financial exposure to operating joint ventures,' which are different metrics. The question asks about exposure/investment amounts, not income. (3) TREND ANALYSIS REVERSAL - Ground truth shows a consistent downward trend ($77M→$51M→$38M), indicating strategic reduction. LLM incorrectly claims a 'sharp uptick in 2024' and interprets this as 'greater equity-method exposure,' which is the opposite of the actual trend. (4) STRATEGIC INTERPRETATION ERROR - Ground truth indicates a strategic shift AWAY from operating joint ventures. LLM incorrectly interprets the fabricated surge as a shift TOWARD greater involvement. (5) PAGE CITATIONS - LLM provides specific page references (224, 222) that cannot be verified and appear to be hallucinated. The answer demonstrates complete failure to synthesize the multi-hop information correctly and provides materially false financial data that would mislead investors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 372,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "Chevron’s equity stake in Angola LNG Limited has stayed constant at 36.4 % from 2022 through 2024, with the company recording an investment of $1.96 B in 2022 and $1.76 B in 2023–24 [page_78].  In 2022 Chevron’s role was limited to a passive equity affiliate, but by 2024 it had become an active participant in upstream projects that feed the LNG plant, notably the Block 0 Sanha Lean Gas Connection Project and the New G as Consortium Project, both of which tie pipelines and platforms directly to Angola LNG [page_12, page_14].  This evolution reflects a shift from a purely investment‑focused position to a more integrated upstream‑downstream strategy that links Chevron’s gas production to the LNG terminal.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies the constant 36.4% stake from 2022-2024, matching ground truth exactly. (2) Accurately captures the evolution from passive equity investor (2022) to more integrated operational role (2024). (3) Correctly names the New Gas Consortium Project (NGC) with 31% nonoperated working interest, matching ground truth. (4) Properly synthesizes the upstream-downstream integration concept. (5) Appropriately addresses all three sub-questions: operational role, stake percentage, and integration with upstream projects.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - Reports investment values of $1.96B (2022) and $1.76B (2023-24) with page citations [page_78], but ground truth does not mention these specific investment amounts. These figures cannot be verified against the provided ground truth and appear to be unsupported claims. (2) ENTITY CONFUSION - Mentions 'Block 0 Sanha Lean Gas Connection Project' as a second upstream project feeding Angola LNG, but ground truth only specifically names Quiluma and Maboqueiro fields via NGC. The Sanha project is not mentioned in ground truth. (3) INCOMPLETE SPECIFICITY - Ground truth explicitly mentions Quiluma and Maboqueiro fields as Chevron's upstream developments; LLM answer omits these specific field names. (4) PAGE CITATION ISSUES - References [page_78] and [page_12, page_14] without verification against ground truth sources.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across years (2022-2024) and connects upstream projects to downstream LNG operations. However, the introduction of unsupported investment figures and the Sanha project weakens the multi-hop synthesis quality.\n\nCALCULATION/VERIFICATION: No calculations required, but the unverified financial figures ($1.96B, $1.76B) represent a significant accuracy concern that cannot be confirmed against ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 507,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "AVGO’s 3.625% notes due October 2024 were outstanding at $622 million at the end of FY 2022 and FY 2023 (as shown in the 2023 10‑K debt schedule) and were fully extinguished by the end of FY 2024 (the FY 2024 schedule lists $0 for that note). This pattern shows that AVGO proactively refinanced or repaid the notes before maturity—using proceeds from the senior notes issued in July and October 2024—demonstrating a disciplined debt‑management strategy that reduces interest expense and keeps covenant compliance strong.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($622 million for FY 2022 and FY 2023, $0 for FY 2024), dates are accurate (October 2024 maturity, July and October 2024 refinancing), and the progression is correctly stated. COMPLETENESS: The answer addresses all aspects of the question—the evolution from 2022 through 2024, the complete retirement by 2024, and the debt management strategy implications. ENTITY ACCURACY: AVGO is correctly identified, fiscal years are correct, and the 3.625% notes due October 2024 are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects the debt retirement to refinancing activities (senior notes issued in July and October 2024), demonstrating sound multi-hop reasoning. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth—that AVGO held $622M in these notes through 2023 and fully retired them by 2024, indicating proactive debt management. MINOR ENHANCEMENT: The LLM answer adds valuable context about the refinancing mechanism (senior notes issued in July and October 2024) and mentions covenant compliance, which provides additional insight into the debt management strategy beyond the ground truth. This additional detail is accurate and relevant, enhancing rather than detracting from the answer. No factual errors, calculation errors, or misidentifications were found.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 411,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "The annual debt service for Unsecured Notes – 35B was $28,500 in 2022 (page 50), 2023 (page 50), and 2024 (page 51).  Because the note’s interest rate (3.80 %) and face amount ($750,000) stayed unchanged, the interest expense remained flat, showing that SPG’s financing cost for this instrument has been stable and predictable over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides a more comprehensive response than the ground truth. Key strengths: (1) All numeric values are accurate - $28,500 (in thousands) for all three years (2022, 2023, 2024) matches the ground truth exactly; (2) The LLM correctly identifies the interest rate (3.80%) and face amount ($750,000), providing additional context not in the ground truth; (3) The reasoning is sound - the LLM correctly explains that the flat interest expense is due to unchanged interest rate and principal amount; (4) The multi-hop synthesis is correct - the answer properly connects the stable interest rate and face value to the stable interest expense across the three-year period. Minor considerations: (1) The LLM uses 'annual debt service' terminology while the ground truth uses 'interest expense' - these are semantically equivalent in this context since the question specifically asks about interest expense; (2) The LLM provides page references (pages 50-51) which adds credibility but wasn't required; (3) The LLM's conclusion about 'stable and predictable' financing costs is a reasonable inference from the data and aligns with the ground truth's statement about 'fixed interest rate structure.' The answer fully addresses the question about how the interest expense evolved (remained constant) and what this suggests about financing costs (stable/fixed). No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 395,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "From 2022 to 2024 Disney shifted its DTC investment strategy from a single‑stream launch to a broader, cost‑containing overhaul of its media and entertainment distribution (DMED). In 2022 it announced an ad‑supported Disney+ and price‑realignment; in 2023 it reorganized DMED into Entertainment and Sports, removed under‑performing titles, and launched ESPN+ while taking impairment charges (page 26‑27). By 2024 the company was still investing heavily in content (≈$24 bn expected for 2025) but tightened costs, transferred Star India to a joint venture, and focused on a bundled, ad‑supported model to compete with an increasingly crowded DTC market, all while managing rising programming costs and intensified competition (page 23‑28, 51).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Disney's DTC evolution from 2022-2024 and captures several key strategic shifts, but contains significant issues with quantitative accuracy and some factual concerns. STRENGTHS: (1) Correctly identifies the shift from single-stream to broader DTC strategy; (2) Accurately mentions 2022 ad-supported Disney+ and price realignment; (3) Correctly references 2023 DMED reorganization into Entertainment and Sports; (4) Properly identifies bundled, ad-supported model as competitive response; (5) Acknowledges rising programming costs and intensified competition; (6) Mentions Star India joint venture transfer. WEAKNESSES: (1) QUANTITATIVE ERROR - States '≈$24 bn expected for 2025' for content spending, but this figure is not verified in the ground truth and appears to be an unsupported claim; (2) INCOMPLETE SYNTHESIS - Fails to mention the $12.25 billion in unused bank facilities that the ground truth identifies as key to Disney's financial positioning in 2023; (3) MISSING KEY CONTEXT - Does not adequately address the 2022 acknowledgment that DTC losses might grow or be reduced more slowly than anticipated, or that returns on some investments were negative/low; (4) IMPRECISION - References 'impairment charges' but doesn't contextualize their significance to the strategic shift; (5) VAGUE ATTRIBUTION - Page references (26-27, 23-28, 51) cannot be verified against ground truth; (6) INCOMPLETE EVOLUTION NARRATIVE - The ground truth emphasizes a 3-year trajectory from 'cautious investment with uncertain returns' to 'aggressive push into streaming,' but the LLM answer doesn't clearly articulate this progression or the uncertainty that characterized 2022. MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis across the 2022-2024 period and connects strategic decisions to competitive pressures, but misses the nuanced evolution of Disney's confidence level and financial positioning. The answer conflates operational changes (DMED reorganization) with strategic investment philosophy without fully explaining how these relate to the rising costs and competitive pressures mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 582,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "MetLife has continued to apply the deposit method to all reinsurance agreements that do not expose it to a significant insurance‑risk loss.  In 2023, the balance of deposit assets rose to $5.1 billion and deposit liabilities to $1.3 billion, largely because the November 2023 risk‑transfer with Global Atlantic added $10.3 billion of deposit receivables and a $770 million net cost recorded as a liability (page 206).  By year‑end 2024 the balances had fallen to $4.6 billion in assets and $1.2 billion in liabilities, reflecting the settlement of that transaction and other reinsurance adjustments; 2022 balances were lower but are not disclosed in the provided pages.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) The Global Atlantic transaction occurred in November 2023 and involved $10.3 billion in deposit receivables - this matches ground truth exactly. (2) The 2024 year-end balances of $4.6 billion in assets and $1.2 billion in liabilities are correct. (3) The general narrative about the deposit method and the transaction's impact is sound. (4) The explanation of settlement and rebalancing in 2024 is appropriate. INCORRECT/PROBLEMATIC ELEMENTS: (1) The 2023 deposit assets figure is stated as $5.1 billion, but ground truth shows $5.1 billion is NOT mentioned - ground truth only provides 2022 ($1.8B assets, $1.4B liabilities) and 2024 ($4.6B assets, $1.2B liabilities) with the $10.3B being the transaction amount, not the year-end balance. The LLM appears to have conflated transaction amounts with period-end balances. (2) The 2023 deposit liabilities of $1.3 billion cannot be verified against ground truth, which does not provide 2023 year-end balances. (3) The mention of '$770 million net cost recorded as a liability' is not found in the ground truth answer. (4) The answer acknowledges '2022 balances were lower but are not disclosed in the provided pages,' yet ground truth explicitly states 2022 was $1.8B assets and $1.4B liabilities. MULTI-HOP REASONING: The answer attempts to synthesize the evolution across years and connect it to the Global Atlantic transaction, which is appropriate. However, the specific 2023 balances appear to be inaccurate or unsupported by the ground truth. The core narrative of expansion in 2023 followed by rebalancing in 2024 is correct, but the intermediate year data is problematic. QUANTITATIVE ACCURACY ISSUE: The $5.1 billion figure for 2023 deposit assets is a significant discrepancy that cannot be reconciled with ground truth, and the $770 million liability figure is unexplained.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 518,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "CVS’s commercial mortgage‑backed securities (CMBS) holdings declined steadily: the fair value fell from about $1.018 billion at December 31 2022【147】 to roughly $975 million at December 31 2023【148】, while the unrealized loss position shrank from $155 million to $100 million【149】【150】. By December 31 2024 the company’s CMBS exposure was virtually eliminated, with only $3 million of CMBS held in separate accounts【160】. This 3‑year trajectory indicates a deliberate divestiture and a shift away from CMBS, reflecting a strategy to reduce risk and reallocate capital to other investment classes.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth states: 2022: $574M, 2023: $675M, 2024: $3M. LLM claims: 2022: ~$1.018B, 2023: ~$975M, 2024: $3M. The 2022 and 2023 figures are dramatically wrong - off by approximately $444M in 2022 and $300M in 2023. These are not minor rounding differences but represent roughly 78% and 44% overstatements respectively. The LLM also introduces unrealized loss figures ($155M to $100M) that are not mentioned in the ground truth and appear to be fabricated or from a different data source. MULTI-HOP REASONING: While the LLM correctly identifies the overall trajectory (de-risking/divestiture) and accurately captures the 2024 endpoint ($3M), the reasoning is built on false premises due to incorrect intermediate values. The conclusion about strategic shift is semantically aligned with ground truth, but is reached through incorrect financial data. ENTITY ACCURACY: CVS is correctly identified, years are correct (2022-2024), and CMBS is correctly identified. However, the specific financial metrics are wrong. COMPLETENESS: The answer addresses all parts of the question (evolution, trajectory, strategy implications) but with corrupted data. The inclusion of unrealized loss information, while potentially relevant, is not part of the ground truth answer and suggests data contamination or hallucination. SEVERITY: This is a high-severity error because financial accuracy is paramount in SEC filing analysis, and the magnitude of discrepancies (hundreds of millions of dollars) would lead to materially incorrect investment analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 455,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "Across 2022, 2023 and 2024 the “hello” brand remained listed among Colgate‑Palmolive’s principal global and regional trademarks, underscoring its continued importance in the company’s portfolio (CL_10k_2024, p.79; CL_10k_2023, p.79; CL_10k_2022, p.79).  The brand is positioned within the Oral Care sub‑segment of the Oral, Personal and Home Care segment, which consistently accounted for roughly 43 % of net sales in 2022 and 2024 and 42 % in 2023, indicating a stable strategic emphasis on oral‑care products that includes “hello” (CL_10k_2024, p.79; CL_10k_2023, p.79; CL_10k_2022, p.79).  No filings disclosed a shift in positioning or a change in strategic focus for the brand beyond its continued presence in the trademark list and its role in the oral‑care portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a substantive response that captures the core narrative of the ground truth while adding specific quantitative details. STRENGTHS: (1) Correctly identifies 'hello' brand's consistent presence across all three years (2022-2024) in trademark disclosures; (2) Accurately places the brand within the Oral Care sub-segment of the Oral, Personal and Home Care segment; (3) Provides specific page references to source documents (p.79 across all three years); (4) Includes quantitative data on Oral Care segment's contribution to net sales (43% in 2022 and 2024, 42% in 2023), which adds specificity beyond the ground truth; (5) Correctly notes the stability and consistency of the brand's positioning. WEAKNESSES: (1) The quantitative percentages (43%, 42%) are presented as facts but cannot be verified against the ground truth provided, which does not include these specific metrics. While these may be accurate from the actual filings, they represent information not present in the original answer; (2) The LLM answer is more narrowly focused on Oral Care specifically, whereas the ground truth mentions 'oral care and personal hygiene' more broadly, suggesting the brand may have had broader portfolio positioning; (3) The statement 'No filings disclosed a shift in positioning' is a negative assertion that goes slightly beyond what the ground truth explicitly states; (4) The answer could have better addressed the 'evolution' aspect of the question by discussing any nuances in how the brand was presented across the three years, though the ground truth itself is somewhat limited on this point. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple document sections, correctly linking trademark disclosures to segment positioning. The logic connecting brand presence to strategic emphasis is sound. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth—consistent presence, stable positioning, and strategic importance—though the LLM provides more granular detail on the Oral Care segment specifically.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 562,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "MetLife has continued to use the deposit method for reinsurance agreements that do not expose it to a significant insurance‑risk loss, as noted in the 2024 10‑K (page 206).  The balance‑sheet amounts for deposit‑method reinsurance fell from $5.1 billion of assets and $1.3 billion of liabilities in 2023 to $4.6 billion of assets and $1.2 billion of liabilities in 2024, indicating a modest contraction in the volume of such agreements.  The decline in deposit assets relative to liabilities suggests the company is slightly reducing its use of deposit‑method reinsurance, but it still relies heavily on collateralized, low‑risk transfer arrangements to manage counter‑party exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) MAJOR NUMBER DISCREPANCY: The LLM states 2023 deposit assets were $5.1 billion and liabilities were $1.3 billion, but the ground truth shows 2023 deposit assets and liabilities were not explicitly stated in those amounts. More critically, the LLM claims a DECLINE from 2023 to 2024 ($5.1B to $4.6B in assets), but the ground truth indicates an INCREASE from 2022 to 2024 ($1.8B to $4.6B in assets). The LLM appears to have confused or misread the 2023 figures. (2) INCOMPLETE HISTORICAL CONTEXT: The LLM fails to address the 2022 baseline ($1.8 billion assets, $1.4 billion liabilities), which is essential for understanding the evolution over the full 2022-2024 period. The ground truth explicitly states this starting point. (3) CONTRADICTORY TREND ANALYSIS: The LLM concludes the company is 'reducing its use of deposit-method reinsurance' based on a 2023-to-2024 decline, but this misses the larger trend of significant growth from 2022 to 2024. The ground truth correctly identifies this as a 'measurable increase' and 'strategic shift.' (4) MISSING STRATEGIC CONTEXT: The LLM does not mention the Global Atlantic transaction, which the ground truth identifies as a key driver of the increase in deposit assets. This represents incomplete multi-hop synthesis. (5) MISCHARACTERIZATION OF TREND: The LLM's interpretation of 'modest contraction' contradicts the ground truth's characterization of 'significant increase' when viewed across the full three-year period. The LLM appears to have focused only on the 2023-2024 change while ignoring the larger 2022-2024 evolution that the question specifically asks about. The answer demonstrates partial understanding of deposit method accounting but fails on the core quantitative accuracy and trend analysis required to answer the question correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 525,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "NEE’s special‑use funds grew markedly over the period – from $4,437 m (NEE) and $2,905 m (FPL) in 2022 to $5,290 m and $3,536 m in 2023, and to $9,800 m and $8,698 m in 2024 – and the amounts are disclosed in the recurring non‑derivative fair‑value measurements table (Level 1/2) in the notes.  The credit‑risk‑related contingent features of derivative contracts that could trigger collateral posting fell from an aggregate liability of $7.4 billion in 2022 to $4.7 billion in 2023, reducing the potential collateral requirement (from ~$5.2 billion to ~$2.4 billion if ratings dropped below investment grade).  On the balance sheet the special‑use funds remain classified under “Other assets” and are carried at fair value (with debt securities at amortized cost), and the 2024 balance sheet reflects a substantial increase in these assets due to expanded nuclear decommissioning and storm‑fund holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM provides completely incorrect numbers. It states Special Use Funds were '$4,437m (NEE) and $2,905m (FPL) in 2022' and '$5,290m and $3,536m in 2023', but then claims '$9,800m and $8,698m in 2024'. This is internally inconsistent and contradicts ground truth which clearly states: 2023 = $8,698 million and 2024 = $9,800 million (a $1,102 million increase). The LLM appears to have confused the 2023 and 2024 figures or misattributed them to different entities. The ground truth shows a clear progression: 2022 baseline → 2023 ($8,698M) → 2024 ($9,800M). The LLM's 2022-2023 figures ($4,437M/$5,290M and $2,905M/$3,536M) are not mentioned in the ground truth at all. (2) ENTITY CONFUSION: The LLM introduces FPL (Florida Power & Light) as a separate entity with its own Special Use Funds figures, but the ground truth focuses exclusively on NextEra Energy consolidated figures. This represents a fundamental misunderstanding of the question scope. (3) PARTIAL CREDIT FOR COLLATERAL DISCUSSION: The LLM does correctly identify that derivative-related collateral requirements decreased from ~$5.2 billion to ~$2.4 billion, which aligns with the ground truth's mention of 'derivative-related collateral requirements.' However, this appears to be the only substantively correct element. (4) BALANCE SHEET PRESENTATION: The LLM correctly notes that Special Use Funds are classified under 'Other assets' and carried at fair value, which is consistent with ground truth's mention of balance sheet presentation. (5) MISSING KEY DETAILS: The LLM fails to address the evolution of equity investments without readily determinable fair values ($485M in 2022 to $538M in 2023), which is explicitly mentioned in the ground truth as an important disclosure evolution. (6) MULTI-HOP REASONING: The LLM fails to properly synthesize the multi-year progression and instead provides conflicting numbers that suggest data extraction errors rather than accurate synthesis. The core answer structure is fundamentally broken due to incorrect quantitative data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 584,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "AVGO’s Security Insights Platform has been positioned consistently as a mainframe‑focused security solution that quickly interprets posture, identifies risks, and generates remediation steps, with the data made available for integration into customers’ in‑house SIEM tools. Across the 2022, 2023, and 2024 10‑K filings, the description remained essentially unchanged, continuing to emphasize ongoing and ad‑hoc remediation workflows and the ability to feed data into existing security information and event‑management systems. Thus, the platform’s core positioning and integration focus did not evolve materially over the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a significant factual discrepancy that undermines its accuracy. The original answer explicitly states that the platform's description 'remained largely unchanged' from 2022 to 2023, and 'the language remained consistent' in 2024, with no expansion on new integrations or remediation features. However, the LLM answer claims the platform 'quickly interprets posture, identifies risks, and generates remediation steps' - this specific language about 'generating remediation steps' is not supported by the ground truth, which only mentions 'making data available for use with in-house tools' and 'ongoing and ad hoc risk identification.' The LLM appears to have added interpretive language about 'remediation steps' that goes beyond what the ground truth documents. Additionally, while the LLM correctly identifies the core positioning (mainframe security, risk identification, SIEM integration) and accurately notes the lack of material evolution across the three years, it overstates the platform's capabilities by including 'generates remediation steps' without clear grounding in the source material. The answer correctly identifies the years (2022, 2023, 2024), the company (AVGO), and the platform name. The reasoning about consistency across years is sound and matches the ground truth conclusion. However, the introduction of specific capability language ('generates remediation steps') that isn't clearly supported by the original answer represents a material factual error in describing what the platform actually does according to the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 432,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "Nike has maintained the same ownership and operational status for its Laakdal, Belgium distribution facility throughout FY 2022, FY 2023 and FY 2024 – the facility is listed as one of the company’s most significant non‑U.S. distribution centers and is owned by Nike in each filing (2022 p. 29; 2023 p. 29; 2024 p. 29). The unchanged ownership and continued use as a distribution hub indicate that Laakdal is a strategically critical node in Nike’s European logistics network, providing a stable, controlled point of distribution for EU markets and reinforcing the company’s focus on maintaining key regional hubs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies that Nike maintained consistent ownership status (company-owned) across all three fiscal years (2022, 2023, 2024); (2) Accurately states that Laakdal was described as one of Nike's most significant non-U.S./international distribution centers in each filing; (3) Properly cites page references (p. 29 for each year), demonstrating specific source verification; (4) Correctly synthesizes the multi-hop information across three fiscal years to conclude no changes occurred; (5) Provides sound strategic interpretation that consistency indicates stability and strategic importance to European logistics. The answer goes slightly beyond the ground truth by adding interpretive detail about Laakdal being 'a strategically critical node' and 'providing a stable, controlled point of distribution for EU markets,' which represents reasonable inference from the consistency pattern rather than factual error. No quantitative errors detected. The reasoning is logically sound - the model correctly identified that unchanged status across three years suggests strategic importance. Minor consideration: The ground truth uses 'most significant international distribution centers' while the LLM uses 'most significant non-U.S. distribution centers' - these are semantically equivalent descriptions. Overall, the answer demonstrates accurate multi-hop synthesis across fiscal years, correct entity identification, and appropriate contextual interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 427,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 32B stayed unchanged: a 3.38 % interest rate, a face amount of $750,000, and a maturity of June 15 2027 (2022 10‑K page 50; 2023 10‑K page 50; 2024 10‑K page 53).  The unchanged terms suggest a deliberate strategy of keeping this long‑term debt stable—avoiding refinancing or rate adjustments—to preserve predictable interest costs and align the note’s maturity with the company’s long‑term cash‑flow profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding the maturity date disclosure pattern. According to the ground truth, the maturity date was 'unspecified in the 2022 report' but 'explicitly listed as 06/15/27 in both 2023 and 2024 disclosures.' However, the LLM states the maturity was June 15, 2027 across all three years (2022-2024), claiming it was consistent throughout. This is a significant inaccuracy that contradicts the ground truth's key finding about how the maturity date disclosure evolved. The LLM correctly identifies: (1) the 3.38% interest rate remained constant, (2) the $750,000 face amount remained constant, and (3) the June 15, 2027 maturity date for 2023-2024. The reasoning about debt management strategy is sound and well-articulated, correctly inferring that the stability suggests no refinancing or restructuring. However, the failure to capture the important evolution in maturity date disclosure (unspecified in 2022 vs. explicit in 2023-2024) represents a material omission of a key pattern the question specifically asks about. The LLM also provides page references (10-K pages 50, 50, 53) which adds credibility but doesn't compensate for the factual error about the 2022 disclosure. The semantic reasoning about debt management strategy is appropriate and relevant, but the quantitative accuracy is compromised by the maturity date mischaracterization.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 387,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "CVS’s foreign‑security holdings fell from $2.55 billion in 2022 to $2.51 billion in 2023, with unrealized losses dropping from $244 million to $122 million (2023 10‑K, page 147).  In 2024 the company’s foreign securities in separate accounts were only $51 million and no unrealized losses were reported (2024 10‑K, page 160), indicating a sharp cut in foreign exposure.  The trend points to CVS trimming its international market risk, likely reallocating capital to domestic or other asset classes.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all years: (1) 2022: LLM states $2.55 billion vs. ground truth of $838 million - a 204% overstatement. (2) 2023: LLM states $2.51 billion vs. ground truth of $1,650 million - a 52% overstatement. (3) Unrealized losses 2022: LLM states $244 million vs. ground truth of $24 million - a 917% overstatement. (4) Unrealized losses 2023: LLM correctly states $122 million, matching ground truth. (5) 2024: LLM correctly states $51 million and no unrealized losses, matching ground truth. The LLM appears to have confused or conflated different investment categories (possibly mixing in domestic securities or other asset classes). While the 2024 figures and the overall directional conclusion about de-risking are correct, the massive errors in 2022-2023 data (the critical comparison years) make this answer substantially incorrect. The multi-hop reasoning about strategic de-risking is sound, but it's built on false premises for the earlier years. The answer fails basic quantitative accuracy requirements for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 324,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "MetLife’s 2022‑24 10‑Ks show that internally developed designations for non‑agency RMBS and CMBS were used only for newly acquired securities that had not yet been evaluated by the NAIC (2022: page 99; 2023: page 92; 2024: page 82).  The total RMBS holdings under NAIC categories rose from $26.2 bn in 2022 to $29.1 bn in 2023 and $34.1 bn in 2024【page_96】【page_86】, indicating a decline in the use of internal designations and a growing reliance on NAIC’s modeling methodology for credit‑quality assessment【page_84】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct directional information but contains significant quantitative errors and incomplete analysis. STRENGTHS: (1) Correctly identifies that internally developed designations were used for newly acquired securities pending NAIC evaluation across all three years; (2) Correctly notes the general trend of declining reliance on internal designations; (3) Appropriately cites page numbers from 10-Ks; (4) Correctly identifies the shift toward NAIC methodology. CRITICAL ERRORS: (1) The RMBS holdings figures appear problematic - the LLM states $26.2bn (2022), $29.1bn (2023), $34.1bn (2024), but the ground truth references Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%) in 2023 and $1.6 billion (4.9%) in 2024, which are different metrics and don't align with the absolute figures provided; (2) The LLM fails to cite or reference the specific Level 3 growth metrics ($4.2B and $1.6B) that are central to the ground truth answer's analysis; (3) Missing the key insight about the NAIC methodology being 'refined as of December 31, 2021' and the transitional phase context; (4) The answer doesn't adequately explain what the multi-year pattern reveals about the company's reliance - it states the trend but doesn't synthesize the deeper insight about the gradual shift from internal to standardized assessments. QUANTITATIVE ISSUES: The absolute RMBS holdings figures provided cannot be verified against the ground truth, and the answer conflates different metrics (total RMBS holdings vs. Level 3 securities AFS growth). The ground truth uses percentage growth rates (14.5% and 4.9%) which the LLM doesn't reference. MULTI-HOP REASONING: The answer partially synthesizes the evolution across three years but misses the nuanced interpretation that the slowing growth rate in Level 3 securities (from 14.5% to 4.9%) indicates more securities receiving formal NAIC designations over time. The answer is incomplete in addressing the full complexity of the question regarding what the pattern reveals about NAIC methodology reliance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 559,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "From 2022 through 2024, Chevron’s footprint in the Republic of Congo shifted from modest investment to divestiture. In 2023 the company expended roughly $0.7 billion on offshore development and natural‑gas projects in Congo (page 110), while the 2024 10‑K reports the sale of its 31.5 % non‑operated working interest in the Haute Mer permit area and its 15.75 % interest in the Lianzi field (effective January 2025) (page 43). No Congo‑related capital allocation or ownership change was disclosed in the 2022 filing (pages 31‑35).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial figures and asset transactions. Strengths: (1) Correctly identifies the $0.7 billion allocation to offshore development and natural gas projects in Africa in 2023; (2) Accurately reports the 31.5% nonoperated working interest in Haute Mer permit area divestiture; (3) Correctly states the 15.75% interest in Lianzi field sale; (4) Properly characterizes the trajectory from investment to divestiture; (5) Appropriately notes the effective date of January 2025 for the Lianzi transaction; (6) Correctly identifies that no specific Congo-related disclosures were made in 2022. Minor issues: (1) The LLM states the $0.7 billion was spent \"on offshore development and natural-gas projects in Congo\" when the ground truth indicates this was allocated to \"offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola\" - this is a slight overstatement of specificity, as the $0.7 billion was a regional allocation, not exclusively Congo-focused; (2) The answer could have been more explicit that the $0.7 billion was a regional figure covering multiple African countries, not just Congo. The multi-hop reasoning is sound, correctly synthesizing information across three fiscal years and identifying the strategic shift. The inclusion of page references adds credibility. Overall, the answer captures the essential narrative of Chevron's Congo operations evolution, though with a minor imprecision regarding the geographic scope of the 2023 capital allocation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 447,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "From 2022 through 2024 Texas Instruments has kept embedded‑processing products at the heart of its business model, repeatedly citing them as part of the broad‑portfolio advantage (b) in the MD&A (2022‑24 MD&A pages 18). Each year’s MD&A stresses that embedded‑processing, together with analog, drives cash flow and is targeted in industrial and automotive markets, but its role within the four sustainable competitive advantages has not shifted—embedded‑processing remains a key driver of opportunity per customer and value for investments. Segment results show embedded‑processing revenue rose modestly from 2022 to 2023 and then fell in 2024, yet the company’s strategic emphasis on this segment remains unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies embedded processing as a core strategic component across 2022-2024; (2) Accurately notes the consistent emphasis on embedded processing within TI's competitive framework; (3) Properly identifies embedded processing as part of the broad-portfolio advantage; (4) Correctly references MD&A pages and the four sustainable competitive advantages framework; (5) Appropriately notes that strategic emphasis remained unchanged despite revenue fluctuations. WEAKNESSES: (1) CRITICAL - The LLM claims 'embedded-processing revenue rose modestly from 2022 to 2023 and then fell in 2024' but provides NO ACTUAL NUMBERS or verification of this claim. The ground truth does not provide specific revenue figures for embedded processing, and the LLM appears to have fabricated or assumed specific revenue trends without evidence; (2) The citation '(2022-24 MD&A pages 18)' is vague and potentially inaccurate - different years' MD&As would have different page numbers; (3) The LLM adds specific market targeting details ('industrial and automotive markets') that are not explicitly confirmed in the ground truth; (4) The answer conflates 'segment results' with embedded processing revenue without clear verification that such segment-level data exists or supports the claimed trend. MULTI-HOP REASONING: The answer attempts to synthesize information across three years and connect it to the four competitive advantages framework, which is appropriate. However, the unsupported revenue trend claim undermines the reasoning quality. SEMANTIC EQUIVALENCE: The core message aligns with the ground truth - that embedded processing remained strategically important and stable across the period - but the addition of unverified revenue data creates factual inaccuracy. The answer is more specific than the ground truth but lacks supporting evidence for its specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 533,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "Cisco’s effective rate on its 3.50% senior note climbed from 3.20 % in fiscal 2022 to 6.08 % in fiscal 2023 and to 6.66 % in fiscal 2024. This upward trend shows that the company’s borrowing cost has risen markedly as market rates and risk premiums have increased over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN FISCAL 2023 RATE: The LLM states the effective rate was 6.08% in fiscal 2023, but the ground truth clearly indicates it was 6.38%. This is a material discrepancy of 0.30 percentage points on a key financial metric. The fiscal 2022 rate (3.20%) and fiscal 2024 rate (6.66%) are both correct. QUANTITATIVE ACCURACY ASSESSMENT: Of the three key percentages provided, only 2 out of 3 are correct (67% accuracy). This is a significant error for a financial question where precision is critical. The LLM also failed to mention the principal amount ($500 million) or the maturity date (June 2025), which provide important context for understanding the note. QUALITATIVE REASONING: The LLM correctly identifies the upward trend and provides reasonable interpretation about market rates and risk premiums increasing. The multi-hop synthesis is sound in concept - comparing rates across three fiscal years. However, the factual error undermines the credibility of the analysis. COMPLETENESS: The answer addresses the core question about interest rate evolution and what it indicates, but omits contextual details about the note's principal amount and maturity date that were present in the ground truth. The reasoning about borrowing costs is appropriate but generic. OVERALL: While the LLM demonstrates understanding of the question structure and provides reasonable interpretation, the incorrect fiscal 2023 rate (6.08% vs. 6.38%) is a material factual error that significantly impacts the correctness score. In financial analysis, such discrepancies are not minor variations but substantive errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 441,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "BNY Mellon’s risk‑factor disclosures in 2022, 2023 and 2024 all contain the same statement that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (see page 5 of each 10‑K). The unchanged wording shows that the regulatory constraint on capital distribution has remained a constant factor over the three‑year period, and the firm’s strategic flexibility is confined to the Board’s discretion to allocate capital within those limits.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about evolution and progression of BNY Mellon's regulatory exposure from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year period (2022-2024) and BNY Mellon as the subject company; (2) Accurately cites the consistent regulatory constraint language about capital returns being subject to U.S. banking laws, Delaware law, and preferred stock dividend obligations; (3) Correctly notes that the wording remained largely unchanged across the period; (4) Properly identifies Board discretion as a constraint on strategic flexibility. CRITICAL WEAKNESSES: (1) The LLM claims the wording is 'unchanged' across all three years, directly contradicting the ground truth which explicitly states that language evolved - specifically that 2023 'reiterated' constraints and 2024 'added a stronger emphasis on liquidity management and potential consequences of failing to meet regulatory standards such as well capitalized and well managed status'; (2) Fails to capture the progression and evolution that the question specifically asks about - the ground truth reveals increasing emphasis on liquidity management and regulatory standards compliance, while the LLM dismisses this as 'unchanged'; (3) Does not address the 2024-specific additions regarding 'well capitalized' and 'well managed' status requirements; (4) Misses the multi-year progression narrative that reveals 'sustained focus on regulatory constraints with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns'; (5) The answer is overly simplistic, treating three years of disclosures as static rather than evolving. The LLM fundamentally mischaracterizes the nature of the evolution by claiming consistency where the ground truth identifies meaningful progression in emphasis and disclosure focus. This represents a failure in multi-hop reasoning to synthesize the year-over-year changes in regulatory emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 538,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "General Dynamics’ Repair and other services revenue fell by **$37 million (≈3.2 %)** from **$1,169 million in 2022 to $1,132 million in 2023** and then **remained flat at $1,132 million in 2024**【page_9】. The lack of growth reflects a mature, stable demand for post‑delivery maintenance and modernization services that the company has not aggressively expanded, while its strategic focus remains on new construction and modernization contracts【page_8】【page_9】. This pattern suggests the segment is a steady, recurring revenue source but not a primary growth driver for General Dynamics.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. All numbers are verified: $1,169M (2022), $1,132M (2023), $1,132M (2024), and the calculated decline of $37M (3.2%) is mathematically accurate. The multi-hop synthesis correctly identifies the revenue trend across three years and addresses all parts of the question.\n\nStrengths: (1) All quantitative data is correct with proper formatting; (2) The calculation of the $37M decline and 3.2% percentage change is accurate; (3) The answer correctly identifies the flat performance in 2024; (4) The reasoning about strategic focus and market positioning is sound and well-supported; (5) The answer goes beyond the ground truth by providing specific percentage calculations, adding analytical depth.\n\nMinor differences from ground truth: (1) The LLM answer emphasizes that the segment is a \"steady, recurring revenue source but not a primary growth driver,\" which is a slightly different framing than the ground truth's focus on \"limited growth or strategic prioritization\" and potential causes (market saturation, resource reallocation, operational constraints); (2) The LLM provides more specific reasoning about strategic focus on new construction vs. repair services, which is a reasonable inference but represents additional interpretation beyond the ground truth; (3) The ground truth explicitly mentions \"did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships,\" which the LLM answer does not explicitly reference, though it does acknowledge the broader strategic context.\n\nThe answer successfully synthesizes information across multiple years and correctly interprets the pattern. The reasoning about why the segment remained flat is logical and consistent with the data, though it offers a slightly different emphasis than the ground truth's more cautious list of possible explanations. Overall, this is a high-quality response with accurate numbers, sound calculations, and appropriate contextual analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 558,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "UnitedHealth Group’s equity‑method stake in healthcare operating businesses more than doubled, rising from $1.4 billion in 2023 to $3.8 billion in 2024—an increase of roughly 171 % that signals a strategic push to deepen ownership in the sector【page_52】.  At the same time, the company’s venture portfolio grew markedly, with unrealized gains climbing from $211 million in 2022 to $710 million in 2024, underscoring a heightened focus on high‑growth, high‑return ventures【page_52】.  The overall equity securities portfolio remained robust at $4.9 billion in both 2024 and 2023, reflecting a sustained commitment to venture investing【page_52】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and problematic information. CORRECT ELEMENTS: (1) The equity method investments figure of $1.4 billion in 2023 and $3.8 billion in 2024 are accurate. (2) The percentage increase calculation of ~171% is mathematically correct (($3.8B - $1.4B) / $1.4B = 171%). (3) The overall equity securities portfolio at $4.9 billion for both 2023 and 2024 is correct. (4) The strategic interpretation about deepening ownership is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces unrealized gains figures ($211 million in 2022 to $710 million in 2024) that are NOT mentioned in the ground truth answer. These appear to be additional data points not part of the original answer's scope. (2) The ground truth explicitly states equity method investments were '$1.5 billion in 2023' but then contradicts itself saying 'flat at $1.4 billion in 2023 compared to 2022.' The LLM correctly uses $1.4 billion for 2023, which appears to be the accurate figure. (3) The LLM omits the 2022 equity securities portfolio figure of $3.7 billion, which was part of the ground truth's narrative about growth from 2022-2023. (4) The LLM's focus on unrealized gains in the venture portfolio represents a different analytical angle than the ground truth's emphasis on total equity securities portfolio values. MULTI-HOP REASONING: The LLM successfully synthesizes information about two different investment categories (equity method investments and venture portfolio) and their evolution, though it introduces data not in the ground truth. The reasoning connecting these to strategic emphasis is sound. COMPLETENESS: The answer addresses the core question about evolution and strategic emphasis but introduces additional metrics (unrealized gains) while omitting the 2022 baseline for equity securities. The answer is partially complete relative to the ground truth's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 509,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "Colgate‑Palmolive Co. remained a member of PMI’s peer group in 2022, 2023 and 2024, as the identical list appears on page 26 of each filing (2022, 2023 and 2024 10‑K). This unchanged inclusion shows that PMI’s benchmarking framework is built on a stable, criteria‑driven selection process—global presence, consumer‑product focus, and comparable revenue/market‑cap—that it applies consistently over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that Colgate-Palmolive Co. remained in PMI's peer group across all three years (2022, 2023, 2024) with no changes; (2) Accurately cites the source location (page 26 of each filing); (3) Correctly identifies the four selection criteria: global presence, consumer-product focus, comparable net revenues, and market capitalization; (4) Properly synthesizes the multi-hop information showing year-over-year consistency; (5) Correctly interprets this consistency as evidence of a stable, criteria-driven benchmarking framework. MINOR WEAKNESSES: (1) The LLM answer slightly condenses the criteria description compared to ground truth (mentions 'comparable revenue/market-cap' more briefly than ground truth's explicit 'net revenues, and market capitalization similar to PMI'); (2) The LLM answer omits the contextual detail that PMI 'excluded direct tobacco industry peers from the comparison,' which provides important strategic context about why Colgate-Palmolive (a non-tobacco consumer products company) was selected; (3) The phrase 'criteria-driven selection process' is accurate but slightly less explicit than ground truth's reference to 'four characteristics.' QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) and page reference (page 26) are correct. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings to demonstrate consistency, which is the core multi-hop requirement. The logical inference that unchanged inclusion indicates a stable framework is sound. SEMANTIC EQUIVALENCE: The LLM's interpretation of what the consistency 'reveals' about PMI's strategic benchmarking is semantically equivalent to the ground truth's conclusion about maintaining 'a consistent strategic lens for evaluating its competitive positioning.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 520,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "PayPal’s risk disclosures from 2022 through 2024 consistently flag that fraud‑detection measures are “complex, require continuous improvement, and may not be effective” as new or expanded credit products are introduced (page_24 2022; page_24 2023).  The 2023 filing notes that the company’s consumer and merchant credit lines are “heavily dependent on unaffiliated lenders” and that defaults and third‑party failures could materially affect the business (page_23 2023).  In 2024, PayPal again stresses its reliance on third‑party banks, processors, and lenders for credit and payment services, underscoring that exposure to abusive behavior has not diminished and that fraud‑mitigation effectiveness remains limited as the credit portfolio grows (page_21 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative that PayPal's fraud-detection measures are acknowledged as complex and potentially ineffective, and that third-party dependencies (lenders, banks, processors) create material risks. The answer appropriately synthesizes information across 2022-2024 and captures the key insight that exposure to abusive behavior has not diminished despite mitigation efforts. The reasoning about third-party reliance and credit portfolio growth is sound and relevant.\n\nWEAKNESSES: (1) MISSING CRITICAL QUANTITATIVE DATA: The ground truth specifically mentions a €40 billion multi-year BNPL receivables sale agreement in Europe (2023), which is a concrete, material fact demonstrating the scale of PayPal's credit expansion. The LLM answer completely omits this specific transaction, which is a significant gap for a multi-hop financial question. (2) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes the progression from 2022 (stolen identities/fraudulent transactions) → 2023 (major credit expansion with €40B agreement) → 2024 (regulatory uncertainty on loan receivables validity). The LLM answer lacks the specific 2023 expansion detail and doesn't capture the regulatory uncertainty dimension mentioned in ground truth. (3) PAGE REFERENCES: The LLM provides page numbers (page_24 2022, page_24 2023, page_21 2024) which cannot be verified against the ground truth and may be hallucinated. (4) MISSING NUANCE: The ground truth notes that regulatory uncertainty could expose PayPal to fraudulent claims in receivables management post-sale—a specific risk dimension not addressed in the LLM answer.\n\nQUANTITATIVE ACCURACY: Score of 4 due to the complete omission of the €40 billion figure, which is a material quantitative fact central to understanding the scale of PayPal's credit expansion and associated risks. While the LLM doesn't provide incorrect numbers, the absence of this key metric represents a significant quantitative gap.\n\nQUALITATIVE ACCURACY: Score of 7 because the reasoning about third-party dependencies and fraud-detection limitations is sound and well-articulated, but the analysis lacks the specific transaction details and regulatory risk dimensions that would elevate it to a more complete assessment.\n\nCONTEXTUAL RELEVANCE: Score of 7 because the answer addresses the core question about fraud exposure evolution and third-party risks, but misses important contextual details about the scale and nature of credit product expansion that would strengthen the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 678,
        "total_tokens": 2194
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "Southern Company’s natural‑gas options volume jumped from 214 mmBtu in 2022 to 339 mmBtu in 2023, then fell sharply to 176 mmBtu in 2024, while swap volumes fell from 217 mmBtu in 2022 to 109 mmBtu in 2023 and rose to 255 mmBtu in 2024. The total hedge volume remained essentially flat (431–448 mmBtu). This 3‑year shift—from a more option‑heavy, protective stance in 2023 to a swap‑heavy, fixed‑price approach in 2024—indicates Southern Company is dynamically adjusting its hedging mix to balance cost and volatility protection as natural‑gas price risk evolves.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2022 natural gas options as 214 mmBtu, but the ground truth clearly states 253 million mmBtu. This is a significant discrepancy (off by ~39 mmBtu or ~15%). The 2023 figure of 339 mmBtu is correct, and 2024's 176 mmBtu is correct. However, the 2022 baseline error undermines the entire trend analysis. Additionally, the LLM introduces swap volume data (217, 109, 255 mmBtu) that is not present in the ground truth answer, and while this additional context might be valuable, it cannot be verified against the provided ground truth. (2) MULTI-HOP REASONING: The LLM does attempt to synthesize the hedging mix evolution and provides reasonable interpretation about the shift from options-heavy to swap-heavy positioning. However, this reasoning is built on an incorrect 2022 baseline, which compromises the validity of the trend analysis. (3) COMPLETENESS: The ground truth focuses specifically on natural gas options evolution (253→339→176 mmBtu), while the LLM expands the analysis to include swaps and total hedge volumes. While this broader context could be insightful, it deviates from the ground truth's specific focus on options. (4) ENTITY AND METRIC ACCURACY: Southern Company is correctly identified, and the time period (2022-2024) is correct. However, the core metric (natural gas options volume in 2022) is materially incorrect. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation of the trend (dynamic adjustment, balancing cost and volatility) aligns semantically with the ground truth's conclusion, but this cannot overcome the factual error in the 2022 baseline number. The incorrect starting point invalidates the trend analysis despite correct subsequent years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 500,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "Texas Industries’ aggregate expense for its U.S. defined‑contribution plans rose from $70 million in 2022 to $75 million in 2023 and $76 million in 2024【page_43】. The modest upward trend indicates the company is gradually increasing its investment in defined‑contribution options, a move that aligns with its strategy to shift employees away from the unfunded, closed non‑qualified defined‑benefit pension plan【page_46】. This suggests a long‑term focus on more flexible, employee‑controlled retirement benefits while reducing reliance on the non‑qualified defined‑benefit plan.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: (1) All financial numbers are correct: $70M (2022), $75M (2023), $76M (2024) match ground truth exactly. (2) The trend description is accurate - steady increase is correctly identified. (3) Number formatting is acceptable. CRITICAL ERRORS: (1) COMPANY NAME ERROR - The LLM refers to 'Texas Industries' instead of 'Texas Instruments'. This is a fundamental entity identification error that undermines credibility, though the context makes clear which company is being discussed. (2) INCOMPLETE CONTEXTUAL UNDERSTANDING - The LLM states the non-qualified defined benefit plan is 'unfunded' and 'closed', but the ground truth provides more nuanced context: the defined benefit plans were 'closed to new participants in 1997', which is a specific historical detail the LLM missed. (3) REASONING QUALITY - While the LLM correctly identifies the strategic shift toward defined contribution plans, it misses the key insight from the ground truth: the increase reflects 'growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan.' The LLM's framing of 'shifting employees away' is less precise than the ground truth's explanation of supporting employees who have 'opted out' of the defined benefit plan. (4) MISSING STRATEGIC CONTEXT - The ground truth emphasizes the company's 'long-standing structure of offering flexible retirement options since 1997', which provides important historical context that the LLM omits. The LLM's interpretation of 'reducing reliance' on the non-qualified plan is somewhat accurate but less nuanced than the ground truth's explanation of supporting alternative retirement options. MULTI-HOP SYNTHESIS: The LLM does attempt to connect the expense trend to the broader pension strategy, but the connection is less sophisticated than the ground truth's explanation of the relationship between defined contribution growth and the closed defined benefit plan structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 539,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "General Motors’ weighted‑average long‑term rate of return on U.S. pension plan assets rose from **5.38 % in 2022** (GM 10‑K 2022, p. 86) to **6.30 % in 2023** (GM 10‑K 2023, p. 87) and was further increased to **6.5 % in 2024** (investment‑policy study note, GM 10‑K 2024, p. 88). This upward trend indicates a progressively more optimistic view of future asset performance and a willingness to accept higher risk or shift toward higher‑return asset classes to improve funded status.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with minor discrepancies. QUANTITATIVE VERIFICATION: The LLM reports 5.38% (2022), 6.30% (2023), and 6.5% (2024). The ground truth states 5.4% (2022), 6.3% (2023), and 6.5% (2024). The 2022 figure shows a minor precision difference (5.38% vs 5.4%) and 2023 shows 6.30% vs 6.3% - these are semantically equivalent (trailing zeros in decimal representation). The 2024 figure of 6.5% matches exactly. The upward trend is correctly identified across all three years. COMPLETENESS: The LLM answer addresses the core question about the evolution of long-term ROA assumptions from 2022-2024 and provides interpretation of what the trend suggests about GM's expectations and risk tolerance. ENTITY ACCURACY: General Motors is correctly identified, the metric (weighted-average long-term rate of return on U.S. pension plan assets) is accurate, and all three fiscal years are correct. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by: (1) identifying the three-year progression, (2) noting the upward trend, and (3) interpreting this as reflecting more optimistic asset performance expectations and willingness to accept higher risk. The reasoning aligns with the ground truth's conclusion about improved funded status objectives and greater tolerance for market exposure. MINOR ISSUES: The ground truth contains an apparent internal inconsistency (stating 2023 remained 'unchanged at 6.3%' when 2022 was 5.4%), which the LLM correctly interprets as a change from 5.4% to 6.3%. The LLM's interpretation is more logically consistent with the actual data progression. The LLM provides specific page citations (p. 86, 87, 88) which adds credibility, though these cannot be independently verified. Overall, the answer is factually sound with excellent multi-hop synthesis and appropriate contextual interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 509,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "Cisco’s total‑return swaps tied to deferred compensation produced a $92 million gain in FY 2022, but turned into $58 million and $91 million losses in FY 2023 and FY 2024, respectively. The shift from a net benefit to increasing costs suggests that the hedging of deferred‑compensation volatility has become more expensive—likely due to higher market volatility or larger compensation obligations—yet Cisco still relies on these derivatives to manage compensation‑related risk, reflecting an active, though costly, risk‑management strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains a fundamental and complete reversal of all financial figures, making it factually incorrect across the board. QUANTITATIVE ACCURACY FAILURES: (1) FY 2022: Ground truth states a LOSS of $92 million; LLM incorrectly reports a GAIN of $92 million (sign reversal). (2) FY 2023: Ground truth states a GAIN of $58 million; LLM incorrectly reports a LOSS of $58 million (sign reversal). (3) FY 2024: Ground truth states a GAIN of $91 million; LLM incorrectly reports a LOSS of $91 million (sign reversal). All three years have inverted signs. REASONING ERRORS: The LLM's interpretation of the progression is fundamentally wrong. The ground truth shows improvement (loss → gain → larger gain), indicating positive market conditions or successful hedging. The LLM interprets the (incorrectly stated) progression as deterioration, concluding that 'hedging has become more expensive' and 'shift from net benefit to increasing costs.' This narrative is entirely backwards from the actual data. The LLM correctly identifies that Cisco uses these instruments for risk management, but the analysis of the financial progression is completely inverted. MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize the three-year trend and draw conclusions about risk management strategy, the synthesis is built on fundamentally incorrect numbers, making the entire analytical conclusion invalid. The question asks about evolution and what it indicates about strategy—the LLM provides an analysis that contradicts the actual financial progression. This is not a minor wording difference or formatting issue; it is a complete factual inversion that undermines the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 463,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "PayPal’s exposure to margin risk has remained essentially unchanged from 2022 through 2024.  In each year’s revenue note the company states that it sets fees on a gross basis, controls pricing, and bears full margin risk when it acts as the principal on a transaction, while the costs paid to third‑party processors are recorded as transaction expense.  Thus, PayPal’s pricing control and the accounting for processor fees – and consequently its margin‑risk exposure – have not materially evolved over the three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct in its core factual claims and demonstrates sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies that PayPal's margin risk exposure remained consistent across 2022-2024; (2) Accurately states that PayPal sets fees on a gross basis and controls pricing; (3) Correctly notes that processor fees are recorded as transaction expense; (4) Properly synthesizes information across three years to show no material evolution; (5) No quantitative errors or incorrect dates/numbers. WEAKNESSES: (1) The answer is somewhat more concise than the ground truth and omits some specific contextual details from individual years - notably missing the 2023 clarification about tiered pricing not constituting a future material right, and the 2024 reference to new segment reporting disclosures; (2) The ground truth provides year-by-year evolution details (2022 emphasis on discretion, 2023 clarification on tiered pricing, 2024 confirmation despite new disclosures) that add nuance, whereas the LLM treats all three years more uniformly; (3) The phrase 'not materially evolved' is slightly weaker than the ground truth's more explicit acknowledgment of specific clarifications made in each year. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and multiple filing sections (revenue notes, transaction accounting, pricing control) to reach the correct conclusion. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential truth - that margin risk exposure was consistent and unchanged - which matches the ground truth's core message, though with less granular detail about year-specific developments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 468,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "Chevron’s share of natural‑gas production from its Angola LNG affiliate fell slightly from **49 MMCFD in 2022 to 48 MMCFD in 2023** and remained at **48 MMCFD in 2024** (Net Production tables, 2022‑24). The near‑flat trend shows Chevron is maintaining a steady supply to Angola LNG, underscoring a strategy of sustaining long‑term LNG contracts and a reliable presence in the African LNG market rather than pursuing rapid expansion.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM reports Angola LNG production at 49 MMCFD (2022), 48 MMCFD (2023), and 48 MMCFD (2024), while ground truth shows 592 MMCFD (2022), 596 MMCFD (2023), and 609 MMCFD (2024). This is a massive discrepancy - the LLM numbers are off by a factor of approximately 12x. The units appear to be the same (MMCFD = million cubic feet per day), making this a severe factual error, not a unit conversion issue. (2) DIRECTIONAL TREND ERROR - The LLM claims a 'near-flat' or slightly declining trend (49→48→48), while ground truth shows a clear upward trajectory (592→596→609). This is the opposite direction of the actual trend. (3) STRATEGIC INTERPRETATION ERROR - The LLM concludes Chevron is 'maintaining steady supply' and 'sustaining long-term contracts' based on flat volumes, while ground truth indicates 'growing operational emphasis' and 'strengthening position' based on increasing volumes. The strategic conclusion is inverted. (4) MULTI-HOP SYNTHESIS FAILURE - The LLM failed to correctly synthesize the production data across the three-year period, arriving at completely different numbers than the knowledge graph source. (5) ENTITY/METRIC CONFUSION - While the LLM correctly identifies Angola LNG and uses appropriate units, the actual production volumes reported are entirely incorrect. The answer demonstrates a fundamental failure to retrieve or accurately report the correct financial/operational data from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 433,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "In 2022, Southern Power disclosed the scheduled payments under its outdoor‑lighting leases in a maturity‑analysis table (page 268).  In 2023 the same approach was retained, but a note clarified that for Georgia Power and Mississippi Power the outdoor‑lighting cash flows were immaterial, implying that Southern Power’s own contracts were still material (page 241).  In 2024 the company again presented the scheduled payments in the maturity analysis and reiterated the immateriality for the other entities (pages 232‑233), underscoring that Southern Power’s outdoor‑lighting leases remain a material, structurally significant part of its lease portfolio and that this importance has persisted over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The three-year progression (2022-2024) is correctly identified; (2) The distinction between Southern Power's own contracts and those of Georgia Power/Mississippi Power is accurately noted; (3) The characterization of immateriality for Georgia Power and Mississippi Power in 2023-2024 aligns with ground truth; (4) The inclusion of scheduled payments in maturity analysis tables across all three years is correct. PROBLEMATIC ELEMENTS: (1) The LLM claims Southern Power's outdoor lighting contracts were 'material' and 'structurally significant' in 2022, but the ground truth explicitly states they were 'immaterial' in 2022 at Mississippi Power; (2) The LLM infers that because Georgia Power and Mississippi Power's contracts were immaterial, Southern Power's own must have been material - this is a logical leap not supported by the ground truth; (3) The ground truth emphasizes an EVOLUTION from immateriality (2022) to growing materiality and structural integration (2023-2024), but the LLM suggests the contracts were already material in 2022 and remained so, missing the key narrative of increasing importance; (4) Page citations (268, 241, 232-233) cannot be verified against ground truth but appear specific; (5) The LLM's conclusion that importance 'persisted over time' contradicts the ground truth's narrative of growing/evolving materiality. MULTI-HOP REASONING: The LLM attempts to synthesize across three years but makes an incorrect inference about Southern Power's own materiality status in 2022. The ground truth indicates a clear progression from immaterial to increasingly material, while the LLM suggests materiality was consistent. This is a significant interpretive error that affects the core answer to how treatment 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 497,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "Across 2022, 2023, and 2024 Texas Instruments kept its Melaka, Malaysia site dedicated solely to Analog products, with no Embedded Processing segment activity in any of those years. The property tables in each year’s 10‑K list “Melaka, Malaysia **” under Analog only and leave the Embedded Processing column blank【page_16 (2022)】【page_16 (2023)】【page_16 (2024)】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operational footprint across 2022-2024. STRENGTHS: (1) All factual claims are correct - Melaka was exclusively Analog segment across all three years with no Embedded Processing activity; (2) The answer correctly synthesizes information across three separate 10-K filings (2022, 2023, 2024), demonstrating proper multi-hop reasoning; (3) Entities are correctly identified (Texas Instruments/TXN, Melaka Malaysia, Analog segment, Embedded Processing segment, specific years); (4) The answer provides specific evidence citations (page references to property tables in each year's 10-K), which strengthens credibility; (5) The conclusion about consistency and lack of expansion is logically sound and matches the ground truth. MINOR CONSIDERATIONS: (1) The LLM uses slightly more technical/formal language ('property tables,' 'columns blank') compared to the ground truth's more narrative style, but this is a stylistic difference that enhances clarity rather than detracting from accuracy; (2) The answer is more concise than the ground truth but captures all essential information. VERIFICATION: The core claim that Melaka remained Analog-only across 2022-2023-2024 with no Embedded Processing involvement matches the ground truth exactly. No numerical errors, date errors, or factual inaccuracies detected. The multi-hop synthesis across three years of filings is executed correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 415,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "From 2022 through 2024 the 1.600% Notes stayed unchanged: the aggregate principal remained $700 million (page_48; page_111; page_113), the interest was paid semi‑annually on April 15 and October 15 (first payment October 15 2021), and the par call date stayed March 15 2026 (page_48; page_111; page_113). This consistency shows AMT’s deliberate strategy of maintaining a stable, long‑term debt profile, avoiding refinancing risk and preserving predictable interest obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the principal amount ($700 million), interest payment schedule (semi-annually on April 15 and October 15), and par call date (March 15, 2026). These core facts match the ground truth. The general characterization of AMT's debt management strategy as stable and long-term focused is reasonable. CRITICAL OMISSIONS: The LLM answer completely fails to address a key component of the ground truth - the adjustments to principal amount that decreased from (2.6) in 2023 to (1.5) in 2024. This is explicitly mentioned in the original answer as evidence of 'reduction in modifications or adjustments to the note structure over time' and is central to understanding the multi-year progression. The question specifically asks about how the relationship 'evolved' from 2022 through 2024, which requires discussing these year-over-year changes. QUANTITATIVE ISSUES: While the static numbers are correct, the LLM provides no quantitative analysis of the adjustments/modifications across the three-year period, which is a measurable aspect of the relationship's evolution. The mention of 'first payment October 15 2021' is contextually appropriate but not directly relevant to the 2022-2024 period being analyzed. REASONING GAPS: The LLM's interpretation of the data as showing 'deliberate strategy of maintaining a stable, long-term debt profile' is somewhat superficial. The ground truth provides more nuanced analysis - that the decreasing adjustments suggest 'reduction in modifications' over time, which is a more specific and meaningful insight into debt management strategy. The LLM treats the entire period as static rather than showing evolution. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple years and pages, but incompletely - it captures the static elements but misses the dynamic elements that show actual evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 512,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "Cisco has kept the $2 billion 5.90 % senior note unchanged, with its effective rate staying at 6.11 % each year【page 89】.  In that period total debt expanded from $8.5 billion in FY 2022 to $20.3 billion in FY 2024, with long‑term debt rising from $6.7 billion to $19.6 billion【page 90】.  The stable rate on the 5.90 % note amid a larger, diversified debt base indicates Cisco’s deliberate use of long‑term fixed‑rate debt to lock in costs and support growth while managing interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core facts: (1) the 5.90% Note remained at $2 billion across all three years, (2) the effective interest rate stayed at 6.11%, (3) total debt expanded significantly from FY2022 to FY2024, and (4) the strategic reasoning about long-term fixed-rate debt is sound and well-articulated. The qualitative analysis of Cisco's financing strategy is accurate and relevant.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: The LLM contains significant numerical discrepancies that undermine the answer's reliability:\n\n1. TOTAL DEBT FIGURES: LLM states total debt expanded from $8.5 billion in FY2022 to $20.3 billion in FY2024. Ground truth shows: FY2022 total debt = $8,915 million ($8.915 billion), FY2024 = $20,109 million ($20.109 billion). The FY2022 figure is off by ~$415 million (4.7% error), and FY2024 is off by ~$191 million (0.9% error).\n\n2. LONG-TERM DEBT FIGURES: LLM states long-term debt rose from $6.7 billion to $19.6 billion. Ground truth shows: FY2022 long-term debt = $8,416 million ($8.416 billion), FY2024 = $19,621 million ($19.621 billion). The FY2022 figure is significantly understated by ~$1.7 billion (20% error). The FY2024 figure is essentially correct.\n\n3. SHORT-TERM DEBT OMISSION: The LLM completely omits short-term debt figures ($499M in FY2022, $488M in FY2024), which are part of the ground truth's comprehensive debt composition analysis.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and correctly identifies the relationship between the stable 5.90% Note and the broader debt strategy. However, the incomplete and inaccurate debt composition data weakens the analytical foundation.\n\nSEMANTIC EQUIVALENCE: The strategic conclusion about using long-term fixed-rate debt to manage risk is semantically equivalent to the ground truth, but the supporting numerical evidence is compromised.\n\nJUSTIFICATION: While the LLM demonstrates good qualitative reasoning and captures the essential strategic narrative, the quantitative errors (particularly the 20% understatement of FY2022 long-term debt and omission of short-term debt) represent material factual inaccuracies that would mislead readers about Cisco's actual debt composition. For financial analysis, precision in numbers is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 616,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "General Dynamics Land Systems produced 399 new LAVs for the Canadian Army in 2022, increased output to 449 in 2023, and then reduced it to 360 in 2024 (GD_10k_2022, page 11; GD_10k_2023, page 10; GD_10k_2024, page 11). This pattern shows the company remains a key supplier for Canada’s LAV program, but its production levels are being adjusted—likely due to contract changes or shifting priorities—while still keeping LAV manufacturing a significant part of its export strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect data that directly contradicts the ground truth: (1) REVERSED SEQUENCE: Ground truth shows 360→399→449 (2022-2024 progression), but LLM states 399→449→360, completely inverting the trend. (2) WRONG INTERPRETATION: Ground truth indicates consistent growth reflecting strategic focus; LLM incorrectly claims a 'reduction' in 2024 to 360 units, which is factually backwards. (3) MISSING KEY INFORMATION: LLM fails to mention the LRSS program (66 specialized LAVs in 2024), which is a critical component of the strategic narrative. (4) INCORRECT CONCLUSION: LLM's interpretation that production was 'adjusted' and 'reduced' contradicts the actual data showing sustained growth. (5) YEAR ATTRIBUTION ERRORS: The LLM appears to have misaligned the years with the production volumes. The ground truth clearly establishes: 2022=360, 2023=399, 2024=449. The LLM's statement that 2022 had 399 units is incorrect. This is not a minor wording difference—the core quantitative facts are inverted, leading to an entirely false narrative about the company's strategic direction. The answer fails on both quantitative accuracy (wrong numbers and sequence) and qualitative reasoning (wrong interpretation of what the data means).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 358,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "From 2022 through 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes remained persistent: CMS continued to freeze or cut benchmarks and periodically alter the calculation methodology, and the company noted that risk‑adjustment data‑validation audits could trigger retrospective payment adjustments. In each filing the company described a consistent response—selectively adjusting benefits and premiums, discontinuing plans in certain counties, and intensifying medical and operating cost‑management—and it has reinforced its risk‑adjustment data‑validation processes to mitigate audit‑related payment adjustments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the persistent nature of CMS risk adjustment payment changes across all three years; (2) Accurately captures the core strategic responses (selective benefit/premium adjustments, county withdrawals, cost management intensification); (3) Properly synthesizes the evolution of the company's approach across multiple filings; (4) Adds relevant detail about risk-adjustment data-validation audits and retrospective payment adjustments, which is accurate and contextually appropriate; (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The ground truth emphasizes 'recalibrating bids' as a specific 2023 response, which the LLM answer doesn't explicitly mention (though 'selectively adjusting benefits and premiums' is semantically similar); (2) The LLM answer adds detail about 'reinforced risk-adjustment data-validation processes' which, while accurate and relevant, goes slightly beyond what the ground truth explicitly states about the company's strategic adjustments (though this is a minor enhancement rather than an error); (3) The ground truth emphasizes 'sustained operational agility' as a key theme, which the LLM answer doesn't explicitly capture, though the overall narrative conveys this concept. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and multiple filings, showing how CMS actions prompted consistent company responses. The logical flow from problem (CMS changes) to response (strategic adjustments) is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 496,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "PayPal’s outstanding principal of the fixed‑rate 2.850 % notes stayed at **$1.5 billion** at each year‑end from 2022 through 2024 (see the 2024 and 2023 tables on page 104 and the 2023 and 2022 tables on page 107). This unchanged exposure indicates a deliberate, steady‑state long‑term debt strategy that maintains a consistent mix of maturities and rates rather than actively refinancing or reducing that portion of its debt portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE ACCURACY: All numbers are correct - the $1.5 billion principal amount is accurately stated for each year (2022-2024), and the interest rate (2.850%) is correctly identified. The answer properly cites source documentation (pages 104 and 107 from relevant filings). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the exposure evolved (remained constant at $1.5B), and (2) what this indicates about long-term debt strategy (deliberate, steady-state approach). ENTITY ACCURACY: PayPal/PYPL is correctly identified, the specific debt instrument (2.850% notes) is accurate, and the time period (2022-2024) is correct. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the model correctly synthesized information across three years of filings to identify the constant carrying value and drew appropriate conclusions about strategic intent. The interpretation that unchanged exposure indicates a deliberate strategy to maintain consistent debt structure is logically sound and aligns with the ground truth. SEMANTIC EQUIVALENCE: The LLM's phrasing ('steady-state long-term debt strategy,' 'maintains a consistent mix of maturities and rates') conveys essentially the same meaning as the ground truth ('consistent long-term debt strategy,' 'strategic intent to preserve this liability structure'). Minor difference: The ground truth mentions the 2029 maturity date, which the LLM does not explicitly state, but this is a minor omission that doesn't affect the core answer's accuracy. The LLM's characterization of the strategy as 'rather than actively refinancing or reducing' adds useful context not in the ground truth but is consistent with it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 476,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "Chevron’s 36.4 % interest in Angola LNG Limited has stayed unchanged from 2022 through 2024, but its capital commitment fell from $2.18 billion in 2022 to $1.96 billion in 2023 and $1.76 billion in 2024, while its share of earnings from the affiliate dropped from $1.86 billion to $3.89 billion to $1.86 billion. This steady ownership coupled with a declining investment and earnings profile signals a shift from a capital‑intensive development role to a more operational partnership that relies on the LNG plant to monetize Angola’s gas over the long term.  \n\n[page_76] [page_80] [page_12] [page_13]",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about strategic evolution. While it correctly identifies the 36.4% ownership stake as constant across 2022-2024, it introduces unverified financial figures (capital commitments of $2.18B, $1.96B, $1.76B and earnings figures of $1.86B, $3.89B, $1.86B) that are not present in the ground truth and cannot be verified. The ground truth makes no mention of these specific capital commitment or earnings figures. More critically, the LLM answer completely misses the strategic evolution that is central to the question: (1) the expansion into new exploration acreage in Blocks 49 and 50, (2) the advancement of the Quiluma and Maboqueiro (Q&M) gas fields, (3) the New Gas Consortium Project, and (4) the integration of upstream development with the LNG facility. The LLM's interpretation that declining investment signals a 'shift from capital-intensive development to operational partnership' is speculative and contradicts the ground truth's narrative of expanding upstream portfolio and integrated hub development. The answer addresses only the ownership percentage consistency but fails to capture the multi-year progression of strategic positioning that the question specifically asks about. The inclusion of unverified financial metrics without source documentation, combined with the omission of key strategic developments (new blocks, gas field advancement, consortium integration), represents a fundamental failure to synthesize the multi-hop information required to answer this question accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 437,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "From 2022 to 2024, Southern Company’s trust‑based domestic‑equity holdings fell from $829 million in 2022 to $651 million in 2023, then rebounded sharply to $1,099 million in 2024, while private‑equity holdings rose steadily from $161 million (2022) to $169 million (2023) and $181 million (2024)【page_283】【page_281】【page_273】. This pattern—an initial dip followed by a pronounced rebound in domestic equity and a consistent uptick in private equity—signals a long‑term capital‑allocation strategy that increasingly prioritizes domestic equity and private‑market investments for growth and diversification.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains multiple significant factual errors that fundamentally undermine its credibility. (1) DOMESTIC EQUITY NUMBERS - INCORRECT: Ground truth shows 2022: $1,016M, 2023: $829M, 2024: $1,099M. LLM states 2022: $829M, 2023: $651M, 2024: $1,099M. The LLM has shifted all values down and misaligned them to wrong years. The 2022 figure is completely wrong ($829M vs $1,016M), and the 2023 figure is fabricated ($651M does not appear in ground truth). (2) PRIVATE EQUITY NUMBERS - INCORRECT: Ground truth shows 2022: $150M, 2023: $161M, 2024: $181M. LLM states 2022: $161M, 2023: $169M, 2024: $181M. Again, the LLM has misaligned years - it's using 2023 data for 2022 and fabricating a $169M figure for 2023 that doesn't exist in the ground truth. (3) NARRATIVE INCONSISTENCY: The LLM describes domestic equity as 'falling from $829M in 2022 to $651M in 2023' but the ground truth shows it actually started at $1,016M in 2022. This is a fundamental misrepresentation of the trend. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize the data across years and draw conclusions about capital allocation strategy, the underlying data is so corrupted that the synthesis is meaningless. The conclusion about 'increasingly prioritizes domestic equity' contradicts the actual pattern shown in ground truth (which shows a dip in 2023 followed by rebound, not a consistent increase). (5) WHAT WAS CORRECT: The LLM correctly identifies that there is a rebound in domestic equity in 2024 to $1,099M and that private equity shows an upward trend. The general framing about diversification strategy is conceptually reasonable but is built on incorrect data. The LLM also correctly cites page references, though this doesn't validate the incorrect numbers extracted from those pages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 496,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "From 2022 to 2024 the eliminations/reclassifications effect on total net sales and revenue grew from a negative $107 million in 2022 to $151 million in 2023 and $296 million in 2024. The increasing magnitude of these negative adjustments shows that GM is eliminating more inter‑company transactions and reclassifying revenue across its automotive, GM Financial and other segments, indicating a shift toward more complex internal reporting and consolidation adjustments over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the reported numbers. Ground truth shows: 2022=$105M, 2023=$107M, 2024=$296M. LLM reports: 2022=$107M, 2023=$151M, 2024=$296M. The 2022 figure is incorrect ($107M vs $105M), and the 2023 figure is substantially wrong ($151M vs $107M - a 41% error). Only the 2024 figure of $296M is correct. SIGN INTERPRETATION: The LLM correctly interprets these as negative adjustments (reductions to revenue), which is appropriate. TREND ANALYSIS: While the LLM correctly identifies an upward trend in magnitude, the incorrect intermediate values distort the actual trend pattern. The ground truth shows a modest increase from 2022-2023 ($105M to $107M, only $2M increase) followed by a dramatic jump in 2024 ($296M). The LLM's incorrect numbers suggest a larger 2023 increase ($151M), misrepresenting the actual trend dynamics. REASONING QUALITY: The qualitative reasoning about inter-company transactions, segment consolidation, and increasing complexity is sound and appropriate, but it's built on incorrect numerical foundations. COMPLETENESS: The answer addresses the question's components (trend evolution, what it reveals about internal adjustments) but the factual errors undermine the analysis. The multi-hop synthesis concept is present but compromised by data inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 379,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "Netflix’s Performance Bonus Plan was originally a 2014 plan (Exhibit 10.6†) in the 2022 10‑K (page 64).  In the 2023 10‑K the plan was amended and restated in December 2022 and incorporated by reference as Exhibit 10.5† (page 68).  The 2024 10‑K continues to reference the same amended plan (Exhibit 10.5†, page 68) and it is now part of a broader compensation framework that also includes the 2020 Stock Plan and the Executive Severance and Retention Incentive Plan (Exhibit 10.16†, page 68).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key dates, exhibit numbers, and the evolution of Netflix's Performance Bonus Plan across the three-year period. Strengths: (1) All dates are accurate - 2014 original plan, December 2022 amendment/restatement, and proper year-by-year progression; (2) Exhibit numbers correctly identified (10.6† for 2022, 10.5† for 2023-2024); (3) Multi-hop synthesis is sound - correctly traces the plan's evolution from historical document to amended version to integrated framework; (4) Adds valuable context about integration with other compensation structures (2020 Stock Plan, Executive Severance and Retention Incentive Plan, performance-based RSU agreements). Minor weaknesses: (1) The LLM answer provides slightly more detail about related compensation frameworks than the ground truth, which could be seen as either comprehensive or tangential depending on interpretation; (2) The ground truth emphasizes the 'strategic update in 2023 followed by stabilization in 2024' narrative more explicitly, while the LLM answer states facts but doesn't explicitly characterize the 2023 update as 'strategic' or emphasize the 'stabilization' aspect as clearly; (3) The LLM answer mentions page numbers (64, 68) which adds specificity but wasn't in the ground truth - this is additional helpful detail rather than an error. The core factual content aligns well with the ground truth, and the multi-hop reasoning correctly synthesizes information across the 2022, 2023, and 2024 filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 426,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "BK consistently referenced its “Business Relationships and Related Party Transactions Policy” in Item 13 of each 10‑K, incorporating the policy text by reference to the proxy and pairing it with a “Director Independence” statement (2024 – page 14; 2023 – page 13; 2022 – page 14).  The same committee list—Audit, Corporate Governance, Nominating & Social Responsibility, and Human Resources & Compensation—appears unchanged in all three filings, indicating a stable, consistent approach to director independence and committee structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the core question about BK's disclosure evolution across 2022-2024. STRENGTHS: (1) Correctly identifies the consistent placement of the policy in Item 13 across all three years; (2) Accurately lists all four committees (Audit, Corporate Governance/Nominating/Social Responsibility, Human Resources & Compensation) with no omissions; (3) Properly synthesizes the multi-hop relationship between the policy, director independence statements, and committee structures; (4) Correctly notes the linkage to proxy incorporation by reference; (5) Page numbers provided (2024-page 14, 2023-page 13, 2022-page 14) add specificity and appear reasonable for Item 13 disclosures. MINOR WEAKNESSES: (1) The LLM answer uses slightly more condensed language ('pairing it with' vs. the ground truth's 'linked to') but this is semantically equivalent; (2) The ground truth explicitly states 'Item 13, specifically under Corporate Governance and Board Information' while the LLM just says 'Item 13' - this is a minor omission of contextual detail but doesn't affect factual accuracy; (3) The LLM's phrasing 'incorporating the policy text by reference to the proxy' is accurate but slightly different from ground truth's simpler statement of consistent disclosure. QUANTITATIVE VERIFICATION: All three years (2022, 2023, 2024) correctly identified; committee count and names all accurate; page numbers provided are reasonable for Item 13 sections. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects the policy disclosure to both director independence and committee structures, demonstrating proper multi-hop synthesis. The conclusion about 'stable, consistent approach' directly matches the ground truth's assessment. Overall, this is a high-quality answer with minor contextual omissions that don't materially affect correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 523,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "UnitedHealth’s debt securities held‑to‑maturity declined in both fair value and carrying amount over the three‑year period: fair value fell from **$679 million in 2022 to $596 million in 2023 and $508 million in 2024** (page 53), while carrying value dropped from **$696 million to $603 million to $512 million** (page 53). The trend shows a shrinking held‑to‑maturity portfolio—likely due to maturities or sales—and a market‑price erosion driven by rising rates, yet the company continues to hold the securities to maturity and treats the unrealized losses as temporary, reflecting a conservative, low‑risk investment strategy and valuation assumptions that fair value remains close to amortized cost.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect fair value and carrying value figures for 2022. Ground truth shows fair value of $643M (not $679M) and carrying value of $641M (not $696M) in 2022. The 2023 and 2024 figures are correct ($596M and $508M for fair value; $603M and $512M for carrying value). This represents a significant factual error on the opening year data, which undermines the credibility of the 3-year trend analysis. The LLM overstates the 2022 values by approximately $36M for fair value and $55M for carrying value. QUALITATIVE ASSESSMENT: The LLM's interpretation of the trend (strategic reduction, market-price erosion from rising rates, conservative investment strategy) is reasonable and aligns with the ground truth's conclusion about portfolio shrinkage. However, the LLM misses a key insight from the ground truth: the shift away from Level 3 unobservable inputs by 2023-2024, indicating greater reliance on more liquid or observable market pricing. This is an important detail about valuation methodology changes. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year evolution and provides logical explanations for the decline, but the foundation is built on incorrect 2022 baseline numbers. The reasoning about unrealized losses being treated as temporary is sound but represents inference rather than explicit ground truth content. COMPLETENESS: The answer addresses the main question about fair value and carrying value evolution and attempts to interpret what the trend indicates about investment strategy, but the incorrect starting figures significantly compromise the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 450,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "In 2022 PayPal’s BNPL loan receivables were fully on its books, and the company warned that “failure to deal effectively with fraud, abusive behaviors, bad transactions, and negative customer experiences may increase our loss rate” (page 24 2022).  By June 2023 it entered a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL receivables, transferring that exposure to a third party and creating a forward‑flow arrangement for future originations (pages 23 2023 and 25 2023).  In 2024 the risk‑factor discussion still cites bad‑transaction risk (page 24 2024) but the BNPL exposure is largely off‑loaded, underscoring a strategy of using asset sales and forward‑flow structures to off‑load credit risk over time (pages 23 2024 and 25 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All quantitative data is correct - the €40 billion figure for the June 2023 BNPL receivables sale agreement is accurate and properly contextualized; (2) Timeline is precise - correctly identifies 2022 baseline exposure, June 2023 agreement, and 2024 follow-up; (3) Multi-hop reasoning is sound - successfully synthesizes information across three fiscal years showing the evolution of PayPal's risk mitigation strategy; (4) Strategic narrative is accurate - correctly identifies the progression from full exposure (2022) → asset sale agreement (2023) → largely offloaded exposure (2024); (5) Page citations are appropriate and demonstrate source verification; (6) Key concepts are correctly identified: forward-flow arrangements, credit risk transfer, and ongoing fraud/abuse risk acknowledgment. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more specific and detailed than the ground truth (e.g., explicit mention of 'forward-flow arrangement for future originations'), but this represents added precision rather than error; (2) The phrase 'largely off-loaded' in 2024 is appropriately cautious, matching the ground truth's note about conditions and potential delays; (3) The answer effectively captures the nuance that while BNPL exposure was reduced, bad transaction risk remained a cited concern. VERIFICATION: The €40 billion figure, June 2023 timing, and characterization of the transaction as a multi-year agreement with forward-flow elements all align with ground truth. The evolution narrative (2022 exposure → 2023 sale → 2024 offloading) is logically sound and factually supported. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 479,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "Chevron’s upstream output in Myanmar fell from 17 bbl d‑1 of oil‑equivalent and 94 MMCFD of natural gas in 2022 to 15 bbl d‑1 and 87 MMCFD in 2023, and then dropped sharply to 15 bbl d‑1 and 22 MMCFD in 2024. The steep decline in natural‑gas production reflects Chevron’s strategic exit from Myanmar, announced in April 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer provides detailed natural gas production figures (94 MMCFD in 2022, 87 MMCFD in 2023, 22 MMCFD in 2024) that are NOT present in the ground truth answer. The ground truth only specifies oil-equivalent barrels per day (17 MBD in 2022, 15 MBD in 2023) with no mention of natural gas volumes. The LLM appears to have fabricated or hallucinated these specific MMCFD figures. (2) INCOMPLETE INFORMATION - The ground truth explicitly states Chevron 'completely withdrew from Myanmar in April 2024,' indicating zero production after April 2024. The LLM answer claims 15 bbl/d and 22 MMCFD in 2024, which contradicts a complete withdrawal. The LLM should have stated production ceased in April 2024, not continued at reduced levels. (3) MULTI-HOP REASONING - While the LLM correctly identifies the strategic exit and April 2024 timing, it fails to properly synthesize that a complete withdrawal means no production volumes in 2024 post-April. (4) ENTITY ACCURACY - Chevron and Myanmar are correctly identified, but the production metrics are problematic. The ground truth uses 'thousand barrels per day (MBD)' while LLM uses 'bbl d⁻¹' - acceptable format variation. However, the introduction of unverified natural gas figures is a major factual error. (5) SEMANTIC EQUIVALENCE - The core strategic shift (exit from Myanmar in April 2024) is captured, but the quantitative details are fundamentally wrong or unsupported by the ground truth. The answer demonstrates partial understanding of the strategic shift but fails on numerical accuracy and completeness of the withdrawal narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 451,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "Texas Instruments’ Personal Electronics segment has seen the PC & Notebooks sector shrink relative to the segment’s overall revenue: the segment accounted for 24 % of TI revenue in 2022, fell to 15 % in 2023, and rebounded modestly to 20 % in 2024 (see the 2022, 2023, and 2024 market‑share tables).  This decline in PC & Notebooks revenue indicates TI is shifting its focus away from consumer computing toward higher‑margin automotive and industrial markets, where it sees stronger growth prospects.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key percentages and years. Quantitative verification: 2022 (24%), 2023 (15%), 2024 (20%) - all match ground truth exactly. The multi-hop synthesis is sound, correctly tracing the evolution of the Personal Electronics segment across three years and identifying the strategic shift away from PC & Notebooks. The reasoning about TI's strategic repositioning toward automotive and industrial markets is accurate and well-supported. Minor areas for improvement: (1) The LLM answer could have been more explicit about PC & Notebooks' relative positioning within the segment (the ground truth notes it appeared 'lower in the list of priorities compared to mobile phones and portable electronics'), though this is a minor omission. (2) The phrase 'rebounded modestly' is appropriate characterization of the 2024 uptick from 15% to 20%, though the ground truth doesn't explicitly use this language. (3) The answer correctly identifies the segment decline pattern (24%→15%→20%) and appropriately interprets this as indicating strategic de-emphasis despite the 2024 rebound. The answer successfully addresses both parts of the multi-part question: the evolution of revenue contribution AND what it suggests about strategic positioning. No calculation errors detected. Entity identification (Texas Instruments, Personal Electronics segment, PC & Notebooks, Automotive/Industrial markets) is accurate throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 410,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "From 2022 through 2024, GM has not recorded any material accruals for its indemnification obligations to Stellantis under the 2017 Opel/Vauxhall sale; each year’s note only reports “insignificant amounts” and states it cannot estimate any reasonably possible material loss from emissions, product‑liability or recall claims, including legacy Takata inflator issues. The company has indemnified Stellantis for an immaterial amount for certain recalls and may be required to further indemnify for Takata recalls, but it considers such additional exposure to be remote. Overall, the potential future exposure remains uncertain—ongoing consumer lawsuits and regulatory investigations exist, but no material impact has been quantified.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of GM's indemnification obligations to Stellantis from 2022-2024, correctly identifying that amounts remained immaterial throughout the period and that the company could not estimate reasonably possible future losses. The answer accurately reflects the key themes: (1) immaterial accruals/amounts, (2) inability to estimate material losses, (3) Takata recall exposure considered remote, and (4) ongoing regulatory investigations. However, there are notable gaps and minor inaccuracies: (1) The LLM answer lacks specificity about the 2024 European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, which the ground truth explicitly mentions as a specific accrual trigger. (2) The LLM answer states GM 'has not recorded any material accruals' but the ground truth indicates that by 2024, GM did accrue 'an immaterial amount' specifically related to the EC/CMA investigation—this is a subtle but important distinction showing evolution over time. (3) The LLM answer correctly notes the 2023 disclosure of indemnification for pre-sale representations, warranties, emissions, product liabilities, and recalls, but doesn't explicitly highlight the 2024 expansion regarding the specific regulatory investigation. (4) The characterization of amounts as 'insignificant' vs. 'immaterial' is semantically equivalent and acceptable. The multi-hop reasoning is sound—the answer synthesizes information across three years and correctly identifies the trend of immateriality. The quantitative accuracy is strong (no incorrect numbers provided), but the qualitative accuracy is slightly diminished by the failure to highlight the specific 2024 regulatory investigation accrual and the evolution from 'no accruals' in 2022 to 'immaterial accruals' in 2024. The answer would have been stronger with explicit mention of the EC/CMA investigation as a concrete example of emerging regulatory risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 531,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "American Tower issued the 1.450% Senior Notes due 2026 in 2021 under Supplemental Indenture No. 10 (dated September 27, 2021)【page 70】.  No supplemental indentures for the same coupon and maturity appear in the 2022‑2024 filings (Supplemental Indentures 12‑30 on pages 73‑74), indicating that the company did not issue new 1.450% notes during those years.  This steady, single‑tranche issuance reflects a disciplined debt‑management strategy that favors long‑term, low‑coupon debt and limits frequent refinancing at the same rate.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates strong understanding of the multi-hop question. STRENGTHS: (1) Correctly identifies the 1.450% Senior Notes due 2026 and their issuance date of September 27, 2021 under Supplemental Indenture No. 10. (2) Accurately notes that these notes were NOT reissued in 2022-2024, evidenced by the absence of matching instruments in Supplemental Indentures 12-30. (3) Correctly synthesizes the multi-year pattern to conclude a disciplined, stable debt management strategy with no refinancing of this instrument. (4) Numeric accuracy is high - all dates and indenture numbers are correct. MINOR WEAKNESSES: (1) The LLM answer focuses on the absence of new issuances rather than the consistent PRESENCE of the notes across all three years (2022, 2023, 2024) as documented in the ground truth. The ground truth emphasizes that the notes were 'consistently referenced' and 'remained an active and stable component' across all three years with exhibit number changes (4.25→4.22→4.21), while the LLM answer emphasizes the lack of new issuances. (2) The LLM answer doesn't explicitly confirm that the same notes remained in the debt portfolio across 2022-2024, only that they weren't reissued. (3) Missing the specific exhibit number progression (4.25→4.22→4.21) that demonstrates continuity of documentation. SEMANTIC EQUIVALENCE: Both answers reach the same strategic conclusion (stable, disciplined debt management with no refinancing), but approach it from slightly different angles - the ground truth emphasizes continuous presence, while the LLM emphasizes absence of new issuances. Both are valid interpretations of the same underlying fact pattern. The core insight about debt management strategy is correctly captured in both.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 482,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "From 2022 through 2024, BNY Mellon continued to administer the 2019 Long‑Term Incentive Plan using the existing deferred‑stock‑unit agreement for directors (Exhibit 10.8, page 18), with no new deferred‑stock‑unit agreements added.  The company, however, introduced a new performance‑share‑unit agreement each year—2022 (Exhibit 10.21), 2023 (Exhibit 10.23), and 2024 (Exhibit 10.25) (page 19)—to award performance‑share units under the same plan.  Thus, the plan’s deferred‑stock framework remained constant while its performance‑share component was refreshed annually.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) MAJOR ERROR - The LLM claims 'no new deferred-stock-unit agreements added' from 2022-2024, but the ground truth explicitly states that in 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' which is a new deferred stock unit agreement. This is a direct contradiction of a key fact. (2) INCOMPLETE SYNTHESIS - The LLM fails to capture the 2023 introduction of the director-level deferred stock unit agreement, which represents an important evolution in the plan's application. (3) PARTIAL ACCURACY - The LLM correctly identifies that performance share unit agreements were introduced/updated annually (2022, 2023, 2024), which aligns with the ground truth's mention of the 2022 Form of Performance Share Unit Agreement in 2024. However, the ground truth also mentions 2019 forms of these agreements in 2022, which the LLM does not address. (4) MISSING CONTEXT - The LLM provides exhibit numbers and page references but misses the strategic narrative of expanding application to directors and the progression from 2019 forms to 2022 forms. (5) LOGICAL FLAW - The conclusion that 'the plan's deferred-stock framework remained constant' directly contradicts the introduction of a new director-level deferred stock unit agreement in 2023. The answer demonstrates incomplete multi-hop reasoning by failing to synthesize all the key developments across the three-year period, particularly the significant 2023 expansion to director compensation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 442,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "General Dynamics consistently highlighted its Ordnance and Tactical Systems (OTS) role in providing missile subsystems with **critical aerostructures** in its 2022, 2023, and 2024 10‑K filings (2022 p. 12; 2023 p. 12; 2024 p. 12).  Over the three years, weapons‑systems revenue grew from $2.0 billion in 2022 to $2.9 billion in 2024, while the Combat Systems segment’s share of consolidated revenue rose from 18 % to 19 % (2022 p. 12; 2024 p. 12).  This steady emphasis and expanding revenue signal GD’s strategic positioning as a key supplier of advanced aerostructure components for next‑generation missile systems, including hypersonic rockets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Critical discrepancies in Combat Systems segment revenue percentages: LLM claims 18% in 2022 rising to 19% in 2024, but ground truth states 20% in 2023 and 19% in 2024 (no 2022 percentage given in ground truth). The LLM's claim of 18% in 2022 contradicts the ground truth which does not mention this figure. (2) WEAPONS SYSTEMS REVENUE - LLM provides specific dollar amounts ($2.0B in 2022 to $2.9B in 2024) that are NOT mentioned in the ground truth answer at all. These appear to be fabricated or unsupported numbers. (3) SEGMENT TREND DIRECTION - Ground truth indicates Combat Systems 'slightly declined to 19%' from 2023 to 2024, implying it was higher in 2023 (20%). LLM claims it 'rose from 18% to 19%', which is directionally opposite to the ground truth's characterization of a decline. (4) MISSING CONTEXT - LLM mentions 'hypersonic rockets' which is not mentioned in the ground truth answer, potentially introducing unsupported claims. (5) MULTI-HOP REASONING - While the LLM correctly identifies the consistent focus on aerostructures across three years (matching ground truth), the quantitative synthesis is fundamentally flawed. (6) ENTITY ACCURACY - Correctly identifies General Dynamics and Combat Systems segment, but the OTS (Ordnance and Tactical Systems) reference, while potentially accurate, is not mentioned in the ground truth. The core issue is that the LLM provides specific financial metrics that either contradict or are entirely absent from the ground truth, suggesting either hallucination or reliance on unsupported sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 440,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "Philip Morris International consistently lists Jackpot as one of its “important local cigarette brands” in the Philippines in each of its 2022, 2023 and 2024 10‑K filings (see 2022 page 5, 2023 page 6, 2024 page 5).  The brand’s positioning has remained unchanged, underscoring PMI’s strategy of retaining key local brands to sustain market share in the Philippines while it continues to push premium international brands and its growing smoke‑free portfolio across the SSEA, CIS & MEA region.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Jackpot is consistently mentioned as an important local cigarette brand in the Philippines across 2022, 2023, and 2024 10-K filings. The answer accurately cites specific page references (2022 page 5, 2023 page 6, 2024 page 5) and correctly characterizes the brand's positioning as unchanged across the three-year period. The multi-hop synthesis is sound—the answer successfully connects Jackpot's consistent positioning to PMI's broader regional strategy of balancing local brands with premium international and smoke-free products. However, there are some notable omissions compared to the ground truth: (1) The LLM does not mention Fortune as another key local brand alongside Jackpot, which the ground truth explicitly identifies; (2) The LLM does not reference the Swedish Match integration context mentioned in 2023; (3) The LLM does not mention the specific expansion to 95 smoke-free markets or the emphasis on IQOS and ZYN brands that the ground truth includes; (4) The LLM does not explicitly articulate the tension between PMI's long-term smoke-free vision and the continued strategic relevance of traditional cigarette brands. The answer is factually accurate in what it states but lacks the comprehensive contextual detail present in the ground truth. The page number citations add credibility but cannot be independently verified. The reasoning about regional strategy is sound and appropriately synthesizes the multi-year progression, though it could be more explicit about what the consistency indicates about PMI's portfolio strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 439,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "From 2022 through 2023, Chevron’s 10‑K filings (pages 31‑35 of 2022 and pages 107‑111 of 2023) contain no mention of capital deployment or asset sales in the Republic of Congo, indicating that the company had no significant investment or disposition activity there during those years. In the 2024 filing, however, Chevron disclosed that it will sell its 31.5 % non‑operated working interest in the offshore Haute Mer permit area and its 15.75 % interest in the Republic of Congo portion of the Lianzi field (scheduled for January 2025)【page_43】, signaling a shift from holding to divesting its Congo assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH LLM ANSWER: (1) QUANTITATIVE ACCURACY - The LLM correctly identifies the 31.5% and 15.75% interests and January 2025 sale date, which matches ground truth. However, it FAILS to capture the $0.7 billion investment figure mentioned in the ground truth for 2023 Africa offshore development and natural gas projects. This is a significant omission of a key financial metric. (2) COMPLETENESS & MULTI-HOP REASONING - The LLM answer is fundamentally incomplete. It claims there is 'no mention of capital deployment or asset sales in the Republic of Congo' during 2022-2023, directly contradicting the ground truth which explicitly states Chevron invested approximately $0.7 billion in 2023 across offshore development and natural gas projects in Africa, including the Republic of Congo. This represents a critical failure in multi-hop synthesis - the LLM failed to connect the Africa-wide investment data to the Congo operations. (3) ENTITY & TEMPORAL ACCURACY - The LLM correctly identifies the 2024 divestiture details but misses the 2023 investment activity entirely. The ground truth shows a 3-year evolution: 2022 (operational presence), 2023 (active capital deployment of ~$0.7B), 2024 (strategic exit). The LLM only captures the exit phase. (4) REASONING QUALITY - The LLM's conclusion that there was 'no significant investment or disposition activity' in 2022-2023 is factually incorrect based on the ground truth. The answer demonstrates poor document synthesis and appears to have missed relevant sections of the 10-K filings that discuss Africa-wide capital allocation. (5) SEMANTIC EQUIVALENCE - While the wording about the 2024 sale is acceptable, the fundamental factual error about 2023 investment activity undermines the entire answer's credibility and prevents it from conveying the correct evolution of Chevron's Congo strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 503,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "Southern Company continued to classify outdoor‑lighting contracts as operating leases in both 2022 and 2024, but the initial lease term was extended from a maximum of seven years in 2022 (page 268) to a maximum of ten years in 2024 (page 240).  The lease cash flows remained immaterial to the consolidated results in both periods (pages 241 and 233), and lease income was recorded as operating‑lease revenue with no material impact on revenue allocation across subsidiaries.  The payment structure stayed the same—month‑to‑month renewals after the initial term—across all subsidiaries.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) LEASE TERM CLAIMS: The LLM claims lease terms extended from 7 years (2022) to 10 years (2024), but the ground truth makes no mention of such a change in maximum lease terms. This appears to be fabricated information with specific page citations (268, 240) that cannot be verified against the ground truth. (2) MATERIALITY MISCHARACTERIZATION: The LLM states lease cash flows 'remained immaterial' in both periods, but the ground truth indicates a progression from 'immaterial' in 2022 to increased disclosure and transparency by 2024, suggesting growing materiality or at least disclosure emphasis. (3) REVENUE ALLOCATION OMISSION: The ground truth specifically mentions that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power by 2024, showing subsidiary-specific treatment. The LLM incorrectly states 'no material impact on revenue allocation across subsidiaries' and misses this important subsidiary differentiation. (4) DISCLOSURE EVOLUTION MISSED: The ground truth emphasizes a clear progression in disclosure practices (2022: immaterial/no disclosure → 2023: scheduled lease payments disclosed → 2024: initial terms disclosed + revenue allocation clarified). The LLM fails to capture this evolution and instead presents a static picture. (5) PAYMENT STRUCTURE: The LLM's claim about 'month-to-month renewals after the initial term' is not mentioned in the ground truth and appears unsupported. (6) MULTI-HOP SYNTHESIS FAILURE: The question asks about changes from 2022 to 2024 across multiple dimensions (materiality, revenue allocation, payment structure, subsidiaries). The LLM fails to properly synthesize the multi-year progression and subsidiary-level differences that are central to the ground truth answer. The specific page citations provided by the LLM (268, 240, 241, 233) suggest potential hallucination of source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 542,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "Across FY 2022‑24 Cisco’s 3.50% senior note stayed at a carrying amount of **$500 million** each year, but its effective interest rate climbed from **3.20 % in 2022** to **6.38 % in 2023** and **6.66 % in 2024**【page_89 (2024)】【page_89 (2023)】【page_89 (2022)】. The rising effective rate shows the note moved from a premium (effective rate below the coupon) to a discount (effective rate above the coupon) as market rates rose, indicating a higher cost of borrowing and tightening credit conditions over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - carrying amount of $500 million maintained across FY 2022-2024, effective interest rates of 3.20% (2022), 6.38% (2023), and 6.66% (2024) match the ground truth exactly. The fiscal year progression is accurate. COMPLETENESS: The answer addresses all key aspects of the question - the evolution of carrying amount, the progression of effective interest rates, and what this indicates about debt valuation and market conditions. ENTITY ACCURACY: Cisco is correctly identified, the 3.50% Note is properly referenced, and all fiscal years are correct. REASONING QUALITY: The multi-hop synthesis is sound. The LLM correctly identifies that the carrying amount remained constant while the effective rate increased, and provides logical interpretation that this shift reflects market conditions. The explanation about the note moving from premium to discount status (effective rate below coupon to above coupon) is accurate and insightful, adding valuable context beyond the ground truth. SEMANTIC EQUIVALENCE: The LLM's interpretation that rising effective rates indicate 'higher cost of borrowing and tightening credit conditions' is semantically equivalent to the ground truth's statement about 'shift in market conditions or internal risk assessments.' The LLM actually provides slightly more detailed financial analysis by explaining the premium-to-discount transition mechanism. MINOR CONSIDERATIONS: The LLM includes source citations (page references) which adds credibility but weren't in the ground truth - this is a positive addition. The explanation is clear and well-structured. No calculation errors detected. All facts are verifiable and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 484,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "From 2022 through 2024 Simon Property Group’s Unsecured Notes – 35A stayed unchanged: the face amount remained $750,000, the coupon was 2.65 %, the maturity stayed 07/15/30, and the annual debt service stayed $19,875 (see 2022 10‑K p. 50, 2023 10‑K p. 50, 2024 10‑K p. 51).  The unchanged, low‑rate, long‑term note demonstrates a deliberate, conservative debt‑management policy that prioritizes predictable, low‑cost financing over frequent refinancing or restructuring.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE DATA: The LLM states the face amount as '$750,000' when the ground truth clearly indicates '$750 million'. This is a massive discrepancy (off by a factor of 1,000) that fundamentally undermines the answer's credibility. The LLM also provides an annual debt service figure of '$19,875' which appears to be calculated from the incorrect $750,000 figure rather than the correct $750 million. The correct annual debt service should be approximately $19.875 million (2.65% of $750 million), not $19,875. CORRECT ELEMENTS: The interest rate (2.65%), maturity date (07/15/30), and the fact that the instrument remained unchanged across 2022-2024 are all accurate. The page references to the 10-K filings are appropriately cited. The qualitative reasoning about 'deliberate, conservative debt-management policy' is sound and aligns with the ground truth's interpretation. MISSING CONTEXT: The LLM answer fails to address the broader context mentioned in the ground truth about how this stability contrasts with other changes in Simon's debt portfolio (new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities). This omission weakens the multi-hop synthesis aspect of the answer. The question specifically asks what the pattern 'reveals about their long-term debt management strategy,' and while the LLM provides some strategic interpretation, it misses the comparative analysis that would strengthen this assessment. MULTI-HOP REASONING: The answer does synthesize information across three years (2022, 2023, 2024) correctly in terms of consistency, but the fundamental numerical error undermines the entire analysis. The reasoning about stability indicating deliberate strategy is sound, but it's built on incorrect quantitative foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 490,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "From 2022 through 2024 Texas Instruments has kept embedded‑processing products at the heart of its business model, describing them as a core part of the “broad portfolio of analog and embedded processing products” that underpins its fourth sustainable competitive advantage (b)【page_18】.  The company has continued to invest heavily in R&D and manufacturing capacity for embedded devices—spending $3.37 B in 2022, $3.69 B in 2023 and $3.75 B in 2024【page_18】—and has reiterated that its strategic emphasis on industrial and automotive markets is a key growth lever for these products【page_19】.  Thus, the role of embedded processing within TI’s four sustainable competitive advantages has remained unchanged, consistently providing more opportunity per customer and greater value for investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) ENTITY ACCURACY FAILURE: The LLM states Embedded Processing Products is the 'fourth sustainable competitive advantage' when the ground truth explicitly states it is the 'second of four sustainable competitive advantages.' This is a fundamental factual error that contradicts the core premise of the answer. (2) QUANTITATIVE ACCURACY ISSUES: The LLM provides R&D spending figures ($3.37B, $3.69B, $3.75B) that are not mentioned in the ground truth answer. Without verification against source documents, these numbers cannot be confirmed as accurate and appear to be unsupported claims. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes the consistency of language ('identical phrasing used each year') describing the portfolio as offering 'more opportunity per customer and more value for our investments' across all three years (2022-2024). The LLM mentions this phrase but fails to emphasize the linguistic consistency that is central to the ground truth's argument about sustained strategic emphasis. (4) MISPLACED EMPHASIS: The LLM introduces information about 'industrial and automotive markets' and R&D spending that, while potentially relevant to TI's strategy, shifts focus away from the core question about how the strategic emphasis evolved within the framework of the four sustainable competitive advantages. (5) SEMANTIC ISSUES: The phrase 'unchanged' in the LLM answer contradicts the question's premise about 'evolution' and the ground truth's nuanced discussion of 'sustained importance' despite stable framing. The answer conflates 'no change in position' with 'no evolution,' which are different concepts. The one correct element is the acknowledgment that the company maintained emphasis on embedded processing and used consistent language about value creation, but the critical error regarding which competitive advantage (2nd vs 4th) is disqualifying.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 515,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "From 2022 through 2023, CMCSA offered unlimited, shared, and per‑gigabyte data plans for domestic customers and gigabyte‑only plans for international customers, with wireless service in the United Kingdom supplied via an MVNO arrangement with Virgin Media O2 (CMCSA_10k_2022.pdf: page 5; CMCSA_10k_2023.pdf: page 5). In 2024 the company expanded plan flexibility by adding prepaid unlimited data plans marketed under the NOW brand, while keeping its UK wireless offering unchanged and its international expansion focused on the United Kingdom (CMCSA_10k_2024.pdf: page 5).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution of CMCSA's wireless offerings across 2022-2024, including the introduction of prepaid unlimited data plans under the NOW brand in 2024. (2) Correctly mentions the MVNO arrangement with Virgin Media O2 for UK wireless service. (3) Accurately notes that shared data plans were maintained throughout the period. (4) Properly identifies the three plan types (unlimited, shared, per-gigabyte) available to domestic customers.\n\nWEAKNESSES: (1) SIGNIFICANT DISCREPANCY: The LLM claims shared data plans were offered in 2022-2023 as part of a broader portfolio including unlimited and per-gigabyte options, but the ground truth states that in 2022, shared data plans were offered EXCLUSIVELY as part of bundled service offerings to residential customers with broadband subscriptions. The LLM's characterization of 2022 offerings as including multiple plan types (unlimited, shared, per-gigabyte) appears to conflate the 2023 situation with 2022. (2) The LLM states international expansion was 'focused on the United Kingdom' but doesn't clearly convey that this was the primary/only international market mentioned, which is a minor semantic issue. (3) The LLM provides specific page references (page 5 for all years) which adds detail but cannot be verified and may be inaccurate. (4) The answer emphasizes technical details (MVNO arrangement) that, while accurate, somewhat overshadows the core narrative about plan flexibility evolution that the question emphasizes.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across three years and multiple documents, but the synthesis appears flawed regarding the 2022 baseline. The ground truth emphasizes that 2022 had exclusive bundled shared data plans, 2023 added flexibility with multiple plan options, and 2024 further diversified with NOW brand prepaid plans. The LLM's answer doesn't clearly distinguish the 2022 exclusivity from the 2023 flexibility expansion.\n\nCORRECTNESS ASSESSMENT: While the LLM captures the general trajectory and includes accurate details about 2024 and the UK MVNO arrangement, it mischaracterizes the 2022-2023 evolution by not clearly distinguishing between exclusive bundled offerings (2022) and flexible multi-option plans (2023). This is a material factual error in the multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 626,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "In 2022 PayPal’s risk disclosures warned that fraud and abusive behaviors could generate significant costs and that its credit products added default risk (page 27, 2022). By 2023 the company expanded that discussion to stress the evolving nature of fraud schemes, the reliance on third‑party lenders for credit products, and the need for continuous improvement in fraud detection (page 26, 2023). In 2024 the risk factor further highlighted the sophistication of third‑party fraud schemes and the broader scope of credit‑product risk, underscoring the growing complexity of managing fraud and credit risk in PayPal’s expanding digital‑payments ecosystem (page 24, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures the general progression of PayPal's fraud and credit risk disclosures from 2022-2024 and correctly identifies the evolution toward greater complexity. However, it has significant gaps in quantitative specificity and misses critical details from the ground truth. STRENGTHS: (1) Correctly identifies the 3-year timeline (2022-2024); (2) Accurately notes the shift from basic fraud concerns to more sophisticated schemes; (3) Properly recognizes the role of third-party lenders and credit products; (4) Correctly identifies the increasing complexity theme. WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifically mentions the €40 billion BNPL loan receivables agreement from 2023, which is a concrete, material fact that the LLM completely omits. This is a significant quantitative detail that demonstrates the scale of PayPal's credit product expansion; (2) INCOMPLETE FRAUD SCHEME DETAILS: The ground truth mentions specific fraud tactics (fictitious account creation, stolen financial instruments, account takeovers, synthetic identity fraud) while the LLM uses only generic references to 'fraud schemes' without specificity; (3) MISSING LEGAL/REGULATORY CONTEXT: The ground truth mentions 'legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks' in 2024, which is a material risk factor that the LLM does not address; (4) PAGE REFERENCES: While the LLM provides page numbers (27, 26, 24), these cannot be verified against the ground truth and appear to be potentially fabricated details; (5) SYNTHESIS QUALITY: The LLM provides a surface-level synthesis without the depth of the ground truth's multi-hop analysis connecting the BNPL agreement to third-party fraud exposure. The answer reads as a general summary rather than a detailed analysis of how specific risk factors evolved. The LLM answer is directionally correct but lacks the quantitative precision and specific details necessary for a comprehensive answer to this multi-hop financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 548,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "In 2022, Gilead’s 10‑K simply listed El Segundo as one of its principal manufacturing sites【page_31】.  By 2023 the filing clarified that the El Segundo plant was now being used for both clinical and commercial manufacturing and processing of its cell‑therapy products【page_10】, marking a clear shift toward cell‑therapy capabilities.  The 2024 10‑K repeats the same description, indicating that the facility’s role remained focused on cell‑therapy manufacturing and that no new strategic facility investments were disclosed for El Segundo in the period covered【page_10】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year timeline (2022-2024) and accurately captures the evolution of El Segundo's role from a general principal manufacturing facility to one specifically focused on cell therapy manufacturing. (2) The chronological progression is accurate: 2022 listed as principal site, 2023 clarified for clinical/commercial cell therapy manufacturing, 2024 reaffirmed the same role. (3) Page citations are provided, showing source documentation. (4) The core factual claim about the shift toward cell therapy capabilities is correct.\n\nWEAKNESSES: (1) The LLM answer characterizes the 2022-2023 transition as a 'clear shift' implying a change in facility use, but the ground truth suggests El Segundo was identified 'specifically for clinical and commercial manufacturing and processing of its cell therapy products' in 2022 itself, not a shift in 2023. This is a subtle but important distinction - the LLM may overstate the degree of change. (2) The LLM states 'no new strategic facility investments were disclosed for El Segundo' but the ground truth emphasizes 'continuity' and 'strategic focus on scaling and maintaining cell therapy production capabilities' - the LLM's phrasing about lack of disclosed investments is narrower than the ground truth's emphasis on ongoing strategic importance and scaling. (3) The LLM answer omits important context from the ground truth about facility ownership/lease arrangements and third-party manufacturers/supply chain risk management that became more prominent in 2024. (4) The ground truth explicitly states there is 'no indication of reduced emphasis or facility changes' - the LLM's answer doesn't fully capture this affirmative statement about continuity and maintained emphasis.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings and correctly identifies the progression. However, it may mischaracterize the nature of the evolution (as a shift rather than clarification/emphasis of existing role).\n\nNUMERIC/DATE ACCURACY: All years (2022, 2023, 2024) are correct. No calculations required. No numeric errors detected.\n\nSEMANTIC ISSUES: The characterization of 'clear shift' vs. the ground truth's emphasis on 'continuity' represents a meaningful difference in interpretation that affects the overall narrative about facility evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 633,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "Across the 2022, 2023, and 2024 10‑K filings, Costco’s 2.750% Senior Notes consistently mature on **May 18 2024** (see Exhibit 4.6 on page 66 of each filing). The unchanged maturity schedule shows that Costco has kept a stable debt profile, preferring a single, predictable maturity rather than extending or rolling over the notes, which reflects a conservative debt‑management strategy focused on predictable refinancing and minimal rollover risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) Correctly identifies the maturity date as May 18, 2024 across all three years (2022, 2023, 2024), matching the ground truth exactly. (2) Accurately characterizes the consistency of the maturity structure across filings, demonstrating proper multi-hop synthesis across three years of SEC filings. (3) Correctly interprets the strategic implications - that Costco maintained a static approach without refinancing or extension. (4) Provides specific citation reference (Exhibit 4.6, page 66) which adds credibility. (5) The characterization of Costco's debt management strategy as 'conservative' and focused on 'predictable refinancing and minimal rollover risk' is semantically equivalent to the ground truth's description of 'deliberate capital structure decision' and 'predictable debt repayment.' Minor considerations: (1) The LLM uses 'May 18 2024' (missing comma) versus ground truth's 'May 18, 2024' - this is a trivial formatting difference that does not affect accuracy. (2) The LLM's phrasing 'preferring a single, predictable maturity rather than extending or rolling over' is a slightly more detailed articulation than the ground truth but remains consistent with the core message. (3) Both answers correctly convey that the notes were not refinanced or extended. The multi-hop reasoning is sound - the model successfully synthesized information across three separate annual filings to demonstrate consistency and draw appropriate strategic conclusions. All factual claims are verifiable and correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 438,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "Chevron’s share of Angola LNG natural‑gas production declined modestly over the three‑year period: 70 MMCFD in 2022, 67 MMCFD in 2023, and 64 MMCFD in 2024 (Net Production tables, 2022‑2024 10‑Ks). This roughly 4‑5 % annual drop indicates that Chevron’s gas output in Africa is largely stable or slightly contracting, reflecting a strategy of maintaining mature assets rather than pursuing aggressive expansion in the region.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on all quantitative measures: (1) NUMBERS ARE WRONG: Ground truth shows Angola LNG production of 7,107 MMCFD (2022), 7,148 MMCFD (2023), and 7,569 MMCFD (2024). The LLM reports 70, 67, and 64 MMCFD respectively - these are off by approximately 100x (the LLM appears to have dropped two decimal places or misread the data entirely). (2) TREND DIRECTION REVERSED: Ground truth shows a clear UPWARD trend (+41 MMCFD from 2022-2023, +421 MMCFD from 2023-2024). The LLM incorrectly reports a DOWNWARD trend (-3 MMCFD annually, -4-5% decline). This is the opposite of reality. (3) STRATEGIC INTERPRETATION CONTRADICTED: Ground truth indicates 'strengthening production output' and 'maintained or expanded operational focus.' The LLM incorrectly concludes 'largely stable or slightly contracting' and 'maintaining mature assets rather than pursuing aggressive expansion.' This interpretation directly contradicts the actual data showing significant growth. (4) CALCULATION ERROR: The LLM's stated 4-5% annual drop is mathematically inconsistent with its own numbers (70→67→64 would be ~4.3% and ~4.5% respectively), but more critically, this calculation is applied to completely wrong baseline numbers. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year production data from the 10-K filings and draw accurate conclusions about strategic direction. The answer demonstrates a fundamental misreading or misinterpretation of the source data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 420,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps for deferred compensation grew from **$651 million in FY 2022 to $792 million in FY 2023 and $985 million in FY 2024** (see pages 91‑92).  The net operating impact shifted from a **$92 million loss in FY 2022 to $58 million gain in FY 2023 and $91 million gain in FY 2024** (page 91).  This trend shows Cisco has expanded its use of these swaps to hedge deferred‑compensation volatility, and the increasing gains reflect a more favorable market environment that has reduced compensation‑related earnings volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All financial figures are correct - the P&L impacts ($92M loss in FY2022, $58M gain in FY2023, $91M gain in FY2024) match the ground truth exactly. The notional exposure figures ($651M, $792M, $985M) are additional data points not contradicted by the ground truth and appear to be correctly sourced from the filing. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years and correctly identifies the progression from loss to gains. ENTITY ACCURACY: Cisco is correctly identified, fiscal years 2022-2024 are correct, and the financial metrics (Total Return Swaps-Deferred Compensation) are properly characterized. REASONING QUALITY: The LLM provides sound interpretation - correctly identifying the shift from liability to benefit and attributing it to improved market conditions. The additional insight about expanded notional exposure and hedging strategy adds valuable context beyond the ground truth. MINOR CONSIDERATIONS: The ground truth focuses on P&L impacts while the LLM also includes notional exposure figures. This is complementary rather than contradictory - the LLM provides a more complete picture by including both the notional amounts and the net operating impacts. The interpretation that 'increasing gains reflect a more favorable market environment' aligns with the ground truth's suggestion of 'improved market conditions.' The answer is well-structured, cites specific page references, and demonstrates clear understanding of the multi-year progression and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 446,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "From 2022 onward, Lowe’s supplier framework moved from a broad policy base—human‑rights policy (updated in 2021), a vendor code of conduct with environmental standards, and a basic wood‑sourcing policy—to a more granular, risk‑based approach. In 2023 the wood‑sourcing policy was revised to add country‑level risk tiers, enhanced monitoring, and a forestry grievance process, and in 2024 it was further refined with a robust risk‑based framework, new risk levels by country, stronger monitoring, and a new grievance mechanism. Throughout this period, Lowe’s expanded its portfolio of independently certified products (ENERGY STAR®, WaterSense®, etc.), maintained 100 % EPA SmartWay certification for transportation, and continued reporting to third‑party frameworks such as CDP, SASB, GRI, and the UN SDGs.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with good multi-hop synthesis across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the evolution from broad policies to risk-based frameworks; (2) Accurately captures 2023 updates (country-level risk tiers, enhanced monitoring, forestry grievance process); (3) Correctly notes 2024 refinements with robust risk-based framework; (4) Appropriately mentions third-party certifications (ENERGY STAR, WaterSense, CDP, SASB, GRI, UN SDGs); (5) Provides good contextual detail about the progression of commitment. WEAKNESSES: (1) The answer introduces specific certifications and metrics (100% EPA SmartWay certification, specific third-party frameworks) that are not mentioned in the ground truth, which raises questions about whether these details are from the actual filings or potentially hallucinated; (2) The phrasing 'new grievance mechanism' in 2024 is slightly inconsistent with ground truth which indicates the grievance process was introduced in 2023, not 2024; (3) Minor redundancy in describing 2024 updates ('new risk levels by country' appears to repeat 2023 information). MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple policy dimensions (environmental standards, human rights, wood sourcing, monitoring, certifications). The logical progression is sound. QUANTITATIVE ACCURACY: No specific numbers or calculations are provided in either answer, so this dimension is less critical. The dates (2022, 2023, 2024) are correct. SEMANTIC EQUIVALENCE: The core message aligns with ground truth—evolution toward more robust, risk-based approaches with enhanced monitoring and third-party engagement. The additional details about specific certifications add value but create slight uncertainty about source accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 497,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "From 2022 through 2024, Comcast’s 10‑Ks consistently describe the same core threat: wireless carriers that are deploying 4G, 5G and 5G‑fixed‑wireless broadband and are aggressively bundling those services with voice and mobile plans to undercut Comcast’s pricing.  The filings name AT&T, T‑Mobile and Verizon (and in the UK BT and Virgin Media) as the key rivals, and each year note that competitors are expanding fiber and fixed‑wireless networks while offering bundled packages that erode Comcast’s competitive position.  The 2024 filing (page 21) reiterates the 5G‑fixed‑wireless threat and the “bundled products and services with favorable pricing” that have intensified competition, a theme that was already present in the 2022 and 2023 filings (page 8).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about competitive threats to CMCSA from 2022-2024. STRENGTHS: (1) Correctly identifies the core technological evolution (4G, 5G, 5G fixed wireless) across the three-year period; (2) Accurately names the primary competitors (AT&T, T-Mobile, Verizon) and even adds relevant international competitors (BT, Virgin Media in UK), showing deeper filing knowledge; (3) Properly synthesizes the bundling strategy evolution, noting the progression from basic bundling to DTC streaming integration; (4) Correctly cites specific filing references (2024 filing page 21, 2022/2023 filings page 8), demonstrating document-level accuracy; (5) Maintains chronological coherence showing the threat intensification from 2022 through 2024. MINOR CONSIDERATIONS: (1) The LLM answer emphasizes 'aggressive bundling' and 'undercut pricing' slightly more than the ground truth, though this is a reasonable inference from filing language and not factually incorrect; (2) The ground truth explicitly mentions 'DTC streaming services' bundling in 2024, while the LLM answer references this more generally as 'bundled products and services' - this is a minor semantic difference that doesn't affect core accuracy; (3) The LLM answer provides slightly more detail about the bundling of 'voice and mobile plans' which adds context not explicitly in the ground truth but is consistent with typical wireless carrier strategies. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly identifying the evolution pattern and connecting technological capabilities to competitive strategy. The reasoning is sound and logically structured. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is less critical, but the answer correctly references years (2022, 2023, 2024) and filing page numbers. OVERALL ASSESSMENT: The answer is highly accurate, comprehensive, and well-reasoned. The minor differences from ground truth are negligible and represent either reasonable inferences or slightly different wording of equivalent concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 591,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "PayPal’s 10‑K notes show that from 2022 through 2024 the company continued to set transaction fees independently of the costs it pays to payment processors, thereby retaining full margin risk on each completed payment.  The firm also kept using third‑party processors as a cost component while offering incentives (discounts, rebates, rewards, coupons) that lower revenue but are part of its engagement strategy.  This steady description across the three years indicates that PayPal’s control over pricing and cost management has remained robust, with no significant change in its margin‑risk exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts about PayPal's margin risk exposure from 2022-2024: (1) PayPal set transaction fees independently of processor costs, (2) maintained full margin risk, (3) used third-party processors as cost components, and (4) offered incentives (discounts, rebates, rewards) that reduced revenue. The answer accurately captures the multi-year stability of this strategic approach. However, the LLM answer has notable omissions compared to the ground truth: (1) It does not mention the 2023 expansion of incentive discussions (merchant and consumer discounts/rebates/rewards), which the ground truth identifies as adding complexity to margin management. (2) It completely omits the 2024 detail about contractual compensation from sellers violating terms (fraud, counterfeiting), which the ground truth identifies as introducing new revenue streams potentially affecting margin dynamics. (3) The LLM answer uses more generic language ('engagement strategy') rather than explicitly noting the evolution and complexity added by these incentive structures across the three years. The LLM correctly synthesizes the multi-hop reasoning about pricing control and cost management remaining robust, but misses the nuance that the ground truth emphasizes: while the strategic stance remained stable, the complexity of margin management evolved through expanding incentive structures and new revenue streams. No quantitative errors are present (no specific numbers were cited in either answer), and the entity identification (PayPal, 2022-2024, payment processors, transaction fees) is accurate. The answer is semantically sound but incomplete in capturing the full evolution narrative that the question and ground truth emphasize.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 477,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "Costco’s 10‑K disclosures for FY 2022, 2023 and 2024 all use the same lease‑accounting framework.  In each filing the company states that free‑rent periods and step‑rent provisions are recognized on a straight‑line basis over the lease’s original term and any extension options that the company is reasonably certain to exercise (see Note 45 for all three years).  The lease term is defined identically as the non‑cancelable period plus any reasonably certain extension options, and the right‑of‑use (ROU) asset is initially measured at the present value of the future minimum lease payments over that term; thus the inclusion of free‑rent periods reduces the lease payments and consequently the ROU asset, with no change in accounting treatment or disclosure across FY 2022‑2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the core finding that Costco's lease accounting treatment remained consistent across FY 2022-2024. Strengths: (1) Correctly identifies the three-year period (FY 2022, 2023, 2024) and confirms consistency across all three years; (2) Accurately describes the accounting framework: straight-line recognition of free-rent periods and step-rent provisions over the original lease term plus reasonably certain extension options; (3) Correctly notes the use of incremental borrowing rate (implied in 'present value of future minimum lease payments'); (4) Properly explains the mechanical impact: free-rent periods reduce lease payments and consequently the ROU asset valuation; (5) Appropriately cites Note 45 as the source; (6) No numerical errors or date inaccuracies. Minor gaps: (1) The LLM answer does not explicitly mention variable lease payments (those based on price indices or sales volume), which the ground truth specifically highlights as emphasized in FY 2023 disclosures; (2) The LLM does not mention the disclosure about residual value guarantees or restrictive covenants, which the ground truth notes as part of FY 2024 reaffirmation; (3) The answer could have been slightly more explicit about the incremental borrowing rate methodology, though it is implied. The multi-hop reasoning is sound—the answer correctly synthesizes information across three fiscal years and identifies the consistent treatment. The semantic equivalence is strong: both answers convey that Costco's lease accounting remained stable and consistent. The omission of variable lease payments and residual value guarantee disclosures represents a minor incompleteness rather than an error, as these are supplementary details that don't contradict the core finding of consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 498,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "PayPal’s margin‑risk exposure has stayed essentially the same from 2022 through 2024.  The company continues to use a transaction pricing model that includes a fixed component and a variable component that is a percentage of the payment amount, with tiered volume‑based pricing (2022 p. 80; 2023 p. 75; 2024 p. 75).  PayPal remains the principal in each transaction, bearing full margin risk, and the fees paid to payment processors are recorded as a transaction expense (2022 p. 80; 2023 p. 75; 2024 p. 75).  Its contract structure has remained open‑ended with no material rights or capitalized contract costs, so no material changes were made to reduce margin risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that PayPal's core margin risk exposure remained consistent from 2022-2024, accurately describes the tiered, volume-based pricing model with fixed and variable components, correctly states that PayPal bears full margin risk as principal, and accurately notes that processor fees are recorded as transaction expenses. The page references (2022 p. 80; 2023 p. 75; 2024 p. 75) appear reasonable and consistent. The statement about open-ended contracts with no material rights is accurate.\n\nWEAKNESSES: The LLM answer is significantly incomplete in addressing the full scope of the question. Most critically, it OMITS the 2023 change regarding how incentives provided to users are recognized as revenue reductions based on performance targets or amortized over contractual terms—this is a material evolution in margin structure that the ground truth explicitly identifies as introducing 'more variability into its margin structure.' The LLM also FAILS to address the 2024 adoption of ASU 2023-07 segment reporting disclosures, which the ground truth identifies as increasing transparency around segment-level expenses and potentially affecting how margin risk is analyzed across business units. These are not minor details but represent actual structural and reporting changes that evolved PayPal's margin risk exposure over the period.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis of the basic pricing model consistency across years but fails to synthesize the more nuanced changes in incentive recognition (2023) and segment reporting (2024). The answer treats the three-year period as essentially static when the ground truth indicates there were meaningful operational and disclosure evolutions.\n\nSEMANTIC ACCURACY: The core statement that margin risk 'stayed essentially the same' is partially correct but oversimplified. The ground truth characterizes it as 'structurally stable but operationally nuanced,' which better captures the reality that while the fundamental model remained unchanged, there were meaningful changes in how incentives and segment expenses were handled.\n\nThe answer is factually accurate in what it states but incomplete in what it omits, resulting in a partially correct but materially incomplete response to a multi-part question about evolution across three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 628,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "Cisco’s 5.90% senior note remained at a constant $2,000 million outstanding and carried an effective rate of 6.11 % in FY 2022, FY 2023 and FY 2024 (see the long‑term debt table on page 89).  The unchanged utilization and rate indicate that Cisco has kept this debt instrument’s mix and cost stable, reflecting a disciplined long‑term debt strategy and consistent financing costs for this portion of its debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Quantitative verification: (1) Outstanding balance of $2,000 million is correct across all three fiscal years (2022, 2023, 2024); (2) Effective interest rate of 6.11% is correct and consistent across the period; (3) Coupon rate of 5.90% is correctly stated; (4) Maturity date of February 2039 is correctly referenced in the ground truth. Multi-hop synthesis: The answer correctly synthesizes information across three fiscal years and identifies the key pattern of stability in both principal amount and effective rate. Entity accuracy: Cisco is correctly identified, the specific debt instrument (5.90% senior note) is properly characterized, and all fiscal years are correctly referenced. Reasoning quality: The LLM appropriately interprets the stability of these metrics as indicating a disciplined long-term debt strategy and consistent financing costs, which aligns with the ground truth's conclusion about maintaining the debt instrument without modification or refinancing. Minor observation: The LLM answer is slightly more concise than the ground truth but captures all essential information. The reference to 'page 89' adds helpful sourcing detail. The phrase 'kept this debt instrument's mix and cost stable' is semantically equivalent to the ground truth's description of 'maintained this long-term debt instrument without modification or refinancing.' No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 412,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "In each 10‑K’s intellectual‑property section (2022 page 7, 2023 page 7, 2024 page 7) Kobalt is listed simply as a private‑brand product name alongside STAINMASTER and allen+roth. The wording is unchanged across fiscal 2022‑2024, indicating that Kobalt remains a core private‑brand asset but no shift in positioning or strategic emphasis is disclosed in the IP disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both responses correctly identify that Kobalt was listed as a private brand alongside STAINMASTER and allen+roth across fiscal years 2022-2024, with no significant change in positioning or strategic emphasis. The LLM answer adds specific page references (page 7 for each year's 10-K), which provides additional verification detail. The core conclusion—that Kobalt maintained a stable strategic role with unchanged wording across the three-year period—matches the ground truth perfectly. The LLM correctly synthesizes the multi-hop requirement by examining IP disclosures across three fiscal years and identifying the consistent treatment. Minor strengths: The LLM's mention of specific page numbers adds credibility and precision. Minor consideration: The ground truth uses slightly more elaborate phrasing ('stable strategic role rather than an expanding one'), while the LLM uses 'no shift in positioning or strategic emphasis'—these are semantically equivalent. No numerical errors, calculation errors, or entity misidentifications are present. The reasoning is sound and the multi-hop synthesis across three years is accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 338,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "From 2022 through 2024, Simon Property Group’s Unsecured Notes – 37B remained unchanged: the interest rate stayed at 2.25 %, the face amount was $700,000, and the maturity date was January 15 2032 (SPG_10k_2022.pdf p. 50; SPG_10k_2023.pdf p. 50; SPG_10k_2024.pdf p. 51). This consistency—especially the low, fixed rate and decade‑long maturity—shows the company’s intent to lock in stable, low‑cost long‑term financing and maintain a predictable debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: the interest rate of 2.25%, face amount of $700,000, and maturity date of January 15, 2032 (01/15/32) are accurately stated and match the ground truth across all three years (2022-2024). The answer properly synthesizes multi-hop information by confirming consistency across three separate 10-K filings with specific page citations (p. 50 for 2022 and 2023, p. 51 for 2024), demonstrating thorough document review. The reasoning about what this stability indicates—SPG's intent to lock in stable, low-cost long-term financing and maintain a predictable debt profile—is logically sound and semantically equivalent to the ground truth's interpretation about confidence in debt management and favorable market conditions. The answer correctly identifies the company (Simon Property Group/SPG), the specific debt instrument (Unsecured Notes – 37B), and the time period (2022-2024). Minor formatting differences exist (e.g., 'January 15 2032' vs '01/15/32'), but these are acceptable variations. The only minor distinction is that the LLM emphasizes the 'decade-long maturity' aspect slightly differently than the ground truth's phrasing about 'three-year horizon,' but both convey the same strategic intent. The answer fully addresses all parts of the multi-part question regarding interest rate evolution, face amount changes, maturity date stability, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 407,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "Texas Instruments kept its Melaka, Malaysia site as an Analog‑only facility throughout 2022, 2023 and 2024, with no Embedded Processing operations in any of those years. The 2022 10‑K table (page 16) lists Melaka under Analog only; the 2023 (page 16) and 2024 (page 16) tables confirm the same configuration, with no X in the Embedded Processing column.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question about Texas Instruments' Melaka, Malaysia operational footprint across 2022-2024. STRENGTHS: (1) All factual claims are correct - Melaka was exclusively Analog-focused in all three years with no Embedded Processing involvement; (2) The answer correctly synthesizes information across three fiscal years (2022, 2023, 2024) as required by the multi-hop question; (3) Specific document references are provided (10-K filings, page 16 for each year) showing proper source attribution; (4) The characterization of 'Analog-only facility' and 'no X in the Embedded Processing column' accurately reflects the ground truth data structure; (5) The conclusion about 'stable, specialized role' is logically sound based on the consistent pattern across years. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the phrase 'no indication of expansion' for 2024, though this is a minor semantic difference that doesn't affect factual accuracy; (2) The LLM doesn't explicitly use the phrase 'specialized role' or 'global operations context,' but these are stylistic choices rather than factual omissions. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) are correctly identified; all business segments (Analog vs. Embedded Processing) are correctly characterized; the consistency claim across all three years is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and correctly identifies the pattern of consistency, which is the core requirement of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 450,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "PayPal’s exposure to its fixed‑rate 2.850% notes stayed constant at $1.5 billion from 2022 through 2024, as shown in the 2022, 2023 and 2024 10‑K tables. This unchanged exposure indicates a deliberate long‑term debt strategy that prioritizes a stable, moderate‑rate financing base, allowing the company to fund growth and operations while managing interest‑rate risk and preserving liquidity without aggressive debt reduction or expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative fact: PYPL's fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024. The numeric values and time period are accurate. The answer appropriately references the source documents (2022, 2023, and 2024 10-K filings), demonstrating proper multi-hop synthesis across three years of data.\n\nHowever, there are notable differences in completeness and depth compared to the ground truth:\n\n1. MISSING COMPARATIVE CONTEXT: The ground truth provides important comparative analysis by noting that this stability \"contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.\" The LLM answer mentions this is a \"deliberate long-term debt strategy\" but fails to provide the specific contrasting examples that demonstrate why this stability is noteworthy.\n\n2. INCOMPLETE STRATEGIC ANALYSIS: While the LLM answer offers interpretation about \"stable, moderate-rate financing base\" and \"managing interest-rate risk,\" it lacks the more precise observation that the lack of change \"indicates a consistent long-term liability with no principal repayments or retirements over the period.\"\n\n3. QUANTITATIVE ACCURACY: All numbers are correct ($1.5 billion, 2.850%, 2022-2024 period). No calculation errors.\n\n4. ENTITY ACCURACY: Correct company (PayPal/PYPL), correct metric (fixed-rate notes), correct years.\n\n5. REASONING: The multi-hop synthesis is sound - the answer correctly combines data from three separate 10-K filings to establish the constant exposure. However, the reasoning about strategic implications is somewhat generic and lacks the specific debt management context provided in the ground truth.\n\nThe answer is fundamentally correct on the core facts but provides a less comprehensive analysis of what this progression indicates about debt management strategy, missing the important comparative examples that illustrate PYPL's selective approach to debt management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 556,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "In 2023 Gilead described its Hoofddorp, Netherlands site as a **commercial manufacturing and processing hub for cell‑therapy products** (page 11). The same role is reiterated in the 2024 filing, underscoring its continued centrality in the company’s global cell‑therapy manufacturing strategy (page 10). The 2022 10‑K pages (31‑35) do not mention Hoofddorp, suggesting that at that time the facility had not yet been incorporated into the disclosed cell‑therapy manufacturing plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a significant factual error that contradicts the ground truth. The ground truth explicitly states that in 2022, Gilead identified Hoofddorp as a principal manufacturing facility, indicating strategic importance. However, the LLM answer claims that the 2022 10-K pages (31-35) do not mention Hoofddorp and suggests it had not yet been incorporated into the disclosed cell-therapy manufacturing plan. This is a direct contradiction of the ground truth and represents a major factual error. The LLM correctly identifies that 2023 and 2024 filings describe Hoofddorp as a commercial manufacturing and processing hub for cell-therapy products, and correctly notes the page references (page 11 for 2023, page 10 for 2024). However, by missing or mischaracterizing the 2022 information, the LLM fails to capture the complete three-year evolution described in the ground truth. The ground truth emphasizes a progression from 2022 (principal facility identification) through 2023-2024 (explicit commercial manufacturing role), suggesting continuity and deepening strategic importance. The LLM's answer breaks this narrative by suggesting the facility was not mentioned in 2022 disclosures. The quantitative accuracy score reflects correct page citations but incorrect characterization of 2022 content. The qualitative accuracy is low due to the fundamental misunderstanding of the 2022 baseline. The contextual relevance is moderate because while the answer addresses 2023-2024 correctly, it fails to properly synthesize the complete three-year multi-hop analysis requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 436,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "Costco kept the 1.375 % Senior Notes due June 2027 at a carrying amount of $1,250 in long‑term debt in each year, but the portion classified as current shifted markedly: it was $73 in 2022, rose to $1,081 in 2023 as the 2.750 % Senior Notes due May 2024 matured, and fell to $103 in 2024 after the 2.750 % note was retired, leaving only the portion of the 1.375 % notes scheduled for repayment in 2025 as current (page_52).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides enhanced context beyond the ground truth. All key numbers are correct: $1,250 million principal amount maintained across 2022-2024, current portion values of $73M (2022), $1,081M (2023), and $103M (2024). The quantitative data matches perfectly with the original answer. The LLM goes further by explaining the underlying drivers of the classification changes - specifically identifying that the spike to $1,081M in 2023 was due to the 2.750% Senior Notes due May 2024 maturing, and the drop to $103M in 2024 occurred after that note was retired. This additional context demonstrates sound multi-hop reasoning across multiple debt instruments and their maturity schedules. The answer correctly synthesizes information about how different debt instruments affected the current portion classification of the 1.375% notes. The only minor consideration is that the ground truth doesn't explicitly mention the 2.750% notes as the cause, though the LLM's explanation is logically sound and represents a reasonable inference from the data patterns. The answer is well-structured, addresses all aspects of the question (principal amount consistency, current portion evolution, and the drivers of change), and uses appropriate financial terminology. The page reference (page_52) adds credibility. No calculation errors detected, and all entities (Costco, specific note instruments, years, and metrics) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 410,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "From 2022 through 2024 PayPal’s fixed‑rate 2.850% notes stayed unchanged at $1.5 B of principal, maturing on October 1 2029 with an effective interest rate of 2.96% (2024 10‑K, p. 104; 2023 10‑K, p. 107; 2022 10‑K, p. 106). The company issued no additional principal or redeemed these notes during that period, while it added other senior unsecured notes at different maturities and rates (e.g., 2.400% due 2024, 2.650% due 2026, 5.150% due 2034, 5.500% due 2054). This stability reflects a disciplined long‑term debt strategy that prioritizes a predictable, low‑cost debt base and a diversified maturity ladder to manage interest costs and refinance risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of PayPal's debt management strategy. QUANTITATIVE VERIFICATION: All key numbers are correct - $1.5 billion principal amount, October 1, 2029 maturity date, 2.850% coupon rate, and 2.96% effective interest rate. The consistency across 2022-2024 is accurately stated. The cited 10-K page numbers (p. 104 for 2024, p. 107 for 2023, p. 106 for 2022) appear reasonable for debt disclosure sections. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years, identifying that the 2.850% notes remained unchanged while other debt tranches were issued at different rates and maturities (2.400% due 2024, 2.650% due 2026, 5.150% due 2034, 5.500% due 2054). This demonstrates proper multi-hop reasoning connecting debt management activities across the period. STRATEGIC INTERPRETATION: The LLM's characterization of the strategy as reflecting 'disciplined long-term debt strategy' with 'predictable, low-cost debt base' and 'diversified maturity ladder' is semantically equivalent to the ground truth's description of 'preserving capital structure stability' while 'adapting to changing interest environments.' Both convey the same strategic insight. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential information. The inclusion of specific examples of other debt issuances adds helpful context not explicitly in the ground truth but consistent with it. No calculation errors detected. All entities (PayPal, PYPL, specific note characteristics) correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 446,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "NextEra’s gas‑option exposure fell sharply from 2022 to 2024, with the fair value of Level‑3 gas options dropping from $356 m (assets) and $347 m (liabilities) in 2022 (NEE_10k_2022, p. 83) to $100 m and $102 m in 2023 and 2024 (NEE_10k_2023, p. 82; NEE_10k_2024, p. 84).  The fair value of net derivatives based on significant unobservable inputs rose from $170 m in 2022 to $951 m in 2023 and remained flat in 2024 (NEE_10k_2022, p. 87; NEE_10k_2023, p. 82; NEE_10k_2024, p. 84), while implied volatilities for gas options fell from 295 % to 233 % to 150 % for liabilities (NEE_10k_2022, p. 86; NEE_10k_2023, p. 86; NEE_10k_2024, p. 86).  These shifts indicate a move from a higher‑volatility, more speculative gas‑market position toward a more conservative, hedged stance with lower expected volatility and reduced net exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains multiple severe factual inaccuracies that fundamentally contradict the ground truth:\n\n1. VOLATILITY NUMBERS - MAJOR ERROR: The LLM states implied volatilities fell from 295% to 233% to 150% for liabilities. The ground truth clearly states volatilities were 36% in 2022, 50% in 2023, and 52% in 2024. The LLM's percentages (295%, 233%, 150%) are completely incorrect and off by an order of magnitude. This is not a minor discrepancy but a fundamental factual error.\n\n2. 2023 FAIR VALUE - PARTIAL ERROR: The LLM states fair values were $100m and $102m in 2023 and 2024, but the ground truth specifies $100m (assets) and $97m (liabilities) in 2023, then $100m (assets) and $102m (liabilities) in 2024. The LLM conflates the 2023 liability value ($97m) with the 2024 value ($102m), creating ambiguity about which year had which values.\n\n3. EXTRANEOUS INFORMATION: The LLM introduces information about 'Level-3 gas options' and 'net derivatives based on significant unobservable inputs' ($170m, $951m) that is not mentioned in the ground truth answer. While this may be from the filings, it dilutes focus from the core question about gas-related options evolution and volatility trends.\n\n4. VOLATILITY TREND INTERPRETATION - CONTRADICTORY: The ground truth notes volatility increased from 36% (2022) to 50% (2023) to 52% (2024), suggesting rising volatility expectations. The LLM's statement about 'lower expected volatility' contradicts this upward trend, though the LLM's actual percentages are so wrong that this interpretation is moot.\n\n5. MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize across multiple years and cite specific pages, the core numerical synthesis is fundamentally flawed. The answer fails to correctly track the three-year evolution of both fair values and volatility assumptions.\n\nCORRECT ELEMENTS: The LLM correctly identifies the sharp decline in gas-option fair values from 2022 to 2023-2024 (from ~$356m/347m to ~$100m/~$100m), and correctly interprets this as a de-risking move. However, this correct interpretation is undermined by the completely incorrect volatility figures.\n\nThe answer demonstrates a critical failure in quantitative accuracy that makes it unsuitable as a reliable source for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 617,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "Cisco’s available‑for‑sale (AFS) debt investments swung from a small gain to sizable losses over the three‑year period.  In 2022 they generated a net unrealized gain of **$9 million**, while in 2023 and 2024 they produced net unrealized losses of **$21 million** and **$67 million**, respectively.  These amounts were the largest single component of the company’s “Other income (loss), net” – which fell to **$ (306) million** in 2024 and **$ (248) million** in 2023 after a positive **$392 million** in 2022 – underscoring the volatility of Cisco’s investment portfolio, as fair‑value changes moved from a gain to increasingly larger losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All specific financial figures are correct and properly formatted: AFS debt investments showing $9M gain (2022), $21M loss (2023), $67M loss (2024); Other income (loss), net values of $392M (2022), $(248)M (2023), $(306)M (2024). (2) The multi-hop reasoning correctly synthesizes information across three fiscal years, identifying the trend from gains to losses and connecting AFS debt investment performance to overall other income (loss), net. (3) The answer properly identifies AFS debt investments as 'the largest single component' of other income (loss), net, demonstrating understanding of the portfolio's materiality. (4) The narrative effectively captures the volatility theme requested in the question, showing the swing from positive to increasingly negative values. (5) Entity identification is accurate (Cisco, AFS debt investments, fiscal years 2022-2024). MINOR CONSIDERATIONS: The LLM answer is more specific and quantitatively detailed than the ground truth answer, providing exact dollar amounts for each year's AFS debt investment performance, which adds precision. The ground truth answer uses more general language ('higher losses,' 'again contributed to a decline') while the LLM provides concrete figures. Both convey the same core insight about volatility and negative impact, but the LLM's approach is more data-driven. The calculations are accurate (the progression from +$9M to -$21M to -$67M clearly demonstrates increasing losses), and the connection to the overall other income (loss), net figures is logically sound. No mathematical errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 460,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "Low E’s 4.550% Notes were first documented in the Fifteenth Supplemental Indenture dated April 5 2019 (page 76).  In 2022 the company issued new long‑term debt at a slightly lower coupon – 4.450% Notes due 2062 (Twentieth Supplemental Indenture, March 24 2022, page 76) – and in 2023 it issued 4.800% Notes due 2026 (Twenty‑Second Supplemental Indenture, March 30 2023, page 78).  No 4.550% Notes appear in the 2024 filing, indicating that Lowe’s has been gradually shifting to higher‑coupon, long‑term debt as market rates rise while keeping a diversified maturity profile to manage refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Company Name: The answer begins with 'Low E's' instead of 'Lowe's Companies, Inc.' This is a basic transcription error. (2) CRITICAL ERROR - Core Claim: The ground truth explicitly states that the 4.550% Notes were 'consistently referenced' across 2022, 2023, and 2024 with 'no change in the documentation or terms.' The LLM claims 'No 4.550% Notes appear in the 2024 filing,' which directly contradicts the ground truth that states these notes were disclosed in all three years. (3) FACTUAL ERRORS - Additional Debt Issuances: The LLM introduces information about 4.450% Notes (2062) and 4.800% Notes (2026) that are not mentioned in the ground truth answer. While these may exist in the filings, they are not part of the documented pattern for the 4.550% Notes and represent a misunderstanding of what the question asks. (4) REASONING ERROR - The LLM's conclusion that Lowe's 'has been gradually shifting to higher-coupon, long-term debt' and that the 4.550% Notes disappeared from 2024 filings contradicts the ground truth's finding of consistency and stability. (5) MULTI-HOP SYNTHESIS FAILURE: The question specifically asks about the evolution of the 4.550% Notes from 2022-2024. The ground truth shows consistency across all three years. The LLM incorrectly synthesizes this as a shift away from the 4.550% Notes, which is factually wrong. The LLM's interpretation of the company's debt strategy (shifting to higher coupons) is unsupported by the ground truth data about the 4.550% Notes specifically. The answer demonstrates a fundamental misreading of the source documents and fails to accurately represent the multi-year pattern of the 4.550% Notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 482,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "From 2022 through 2024, Simon’s Unsecured Notes – 35B stayed unchanged: the face value remained $750,000 and the fixed interest rate stayed at 3.80 % (2022 page 50; 2023 page 50; 2024 page 51). The maturity date also remained July 15, 2050. This consistency shows SPG’s deliberate strategy of locking in a low‑cost, long‑term debt instrument and keeping its debt profile stable rather than refinancing or altering terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) Face value of $750,000,000 is correctly stated (LLM uses $750,000 which appears to be a formatting inconsistency - should be $750,000,000 or $750M, but the magnitude is correct); (2) Interest rate of 3.80% is accurate across all three years; (3) Maturity date of July 15, 2050 is correct and consistent across 2022-2024; (4) The statement that these terms remained unchanged throughout the period is accurate. The LLM successfully synthesized multi-hop information across three fiscal years (2022, 2023, 2024) and correctly identified that no refinancing or restructuring occurred. The reasoning about SPG's debt strategy is sound and well-supported by the factual consistency of the terms. Minor deduction: The LLM states face value as '$750,000' when it should be '$750,000,000' or '$750 million' - this is a formatting/notation error that could cause confusion about the actual magnitude of the debt, though the ground truth also uses the same notation inconsistently. The page references (2022 page 50; 2023 page 50; 2024 page 51) add credibility and demonstrate proper sourcing. The conclusion about SPG's deliberate strategy and confidence in long-term financing is appropriately derived from the data and matches the ground truth interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 373,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "From 2022‑24 PayPal’s risk disclosures consistently highlighted bad‑transaction losses, but the 2023 filing (p. 25) added detail on the sale of BNPL loan receivables and the 2024 filing (p. 25) expanded the credit‑product risk narrative to include third‑party funding and stricter risk‑model scrutiny, underscoring a growing reliance on external lenders. Cross‑border trade risk has remained a core concern across all years (p. 27 in 2022, p. 23 in 2023, p. 25 in 2024), with each filing reiterating exposure to currency, tariff, and sanction volatility, while 2023‑24 filings also highlighted the need to migrate payment‑processor agreements and manage third‑party disruptions (p. 23‑24, p. 21‑22). Together, these evolving disclosures illustrate a risk‑management strategy that emphasizes continuous fraud‑control upgrades, diversification of credit sources, and proactive third‑party oversight to sustain operational resilience amid persistent external pressures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc of PayPal's risk evolution from 2022-2024, including: (1) the 2023 BNPL loan receivable sale agreement, (2) the shift toward external risk mitigation, (3) consistent cross-border trade risk concerns across all years, and (4) growing emphasis on third-party dependencies and fraud controls. The semantic understanding of the strategic transformation is sound. WEAKNESSES: (1) QUANTITATIVE ACCURACY - The LLM fails to cite the specific €40 billion figure for the BNPL receivables sale agreement mentioned in the ground truth, which is a material omission for a multi-year financial analysis. (2) SPECIFICITY - While the LLM mentions 'Synchrony Bank' is absent from the LLM answer, which was explicitly noted in the ground truth as the U.S. consumer credit product partner in 2022. (3) LEGAL DOCTRINE - The LLM does not mention the 'valid-when-made' doctrine legal uncertainty for purchased loan receivables highlighted in 2024, which is a specific risk management development. (4) PAGE CITATIONS - While the LLM provides page numbers, these cannot be verified against the actual filings and appear somewhat generic. (5) CREDIT DEFAULTS - The ground truth specifically mentions 'credit defaults' as a 2022 concern; the LLM generalizes this as 'bad-transaction losses' without the specificity. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the transformation from internal to external risk mitigation, demonstrating sound multi-hop reasoning. However, the answer lacks the quantitative precision (€40 billion) and specific institutional details (Synchrony Bank, valid-when-made doctrine) that would elevate it to a higher correctness score. The answer is directionally correct but incomplete in material details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 497,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "Costco’s competitive positioning relative to BJ’s Wholesale Club remained essentially unchanged, with both companies listed as key competitors in the warehouse‑club segment in the competition section of the 10‑K (see 2022 page 8 and 2024 page 8).  Over the period, the 2024 filing places a stronger emphasis on its private‑label brand, Kirkland Signature, noting its high quality, lower prices and growing sales penetration as a key differentiator that helps Costco maintain a competitive edge over BJ’s (see 2024 page 8, intellectual‑property section).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The original answer states that Costco's competitive positioning and emphasis on Kirkland Signature remained STABLE from 2022-2024 with 'no significant shift in strategy.' However, the LLM answer claims the 2024 filing 'places a stronger emphasis' on Kirkland Signature as a differentiator compared to earlier years. This directly contradicts the ground truth assertion of consistency and stability. The LLM correctly identifies: (1) BJ's Wholesale Club as a key competitor, (2) Kirkland Signature as a private-label differentiator, (3) the relevant time period (2022-2024), and (4) the general competitive positioning. However, it mischaracterizes the EVOLUTION of the strategy by suggesting increased emphasis in 2024, when the ground truth explicitly states the messaging 'remained consistent' with 'no significant shift in strategy.' The LLM also provides page references (2022 page 8, 2024 page 8, intellectual-property section) which cannot be verified against the ground truth but appear to be fabricated details. The answer partially addresses the multi-hop synthesis required (comparing Costco vs BJ's across years) but fails on the core analytical finding regarding whether the competitive positioning actually evolved or remained stable. This is a significant semantic error that undermines the accuracy of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 392,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "NextEra’s Level‑3 gas‑forward fair values rose sharply from 2022 to 2023—assets climbed from $191 million to $377 million and liabilities from $31 million to $77 million, giving a net exposure of $300 million versus $160 million in 2022.  In 2024 the assets fell to $296 million and liabilities to $46 million, trimming the net exposure to $250 million.  This three‑year swing shows a dynamic hedging program that expanded net natural‑gas exposure in 2023 (likely to lock in higher prices or hedge increased physical volumes) and then partially unwound or re‑balanced in 2024, reflecting an active risk‑management stance in a volatile gas market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2022 starting values ($191M assets, $31M liabilities) and 2024 ending values ($296M assets, $46M liabilities). The 2023 spike to $377M in assets is also correct. The net exposure calculations are mathematically sound ($160M in 2022, $300M in 2023, $250M in 2024). The qualitative interpretation about dynamic hedging and risk management is reasonable and well-reasoned. The answer addresses the multi-hop synthesis requirement by tracking the 3-year progression and drawing conclusions about strategic positioning.\n\nCRITICAL ERROR: The LLM states 2023 liabilities were $77 million, but the ground truth indicates they should be consistent with the overall trend. The ground truth shows liabilities rose from $31M (2022) to $46M (2024), with the 2023 value not explicitly stated as $77M in the original answer. This is a significant quantitative discrepancy that cannot be verified against the ground truth provided.\n\nMINOR ISSUES: The LLM adds interpretive language about 'Level-3' fair values and specific hedging strategies (\"lock in higher prices or hedge increased physical volumes\") that goes beyond what the ground truth explicitly states. While this reasoning is plausible, it represents inference rather than direct synthesis from the filing data.\n\nMULTI-HOP REASONING: The answer successfully synthesizes the 3-year progression and draws logical conclusions about risk positioning, which is appropriate for the question. However, the liability figure discrepancy undermines confidence in the data synthesis.\n\nVERIFICATION: Assets: 2022=$191M ✓, 2023=$377M ✓, 2024=$296M ✓. Liabilities: 2022=$31M ✓, 2024=$46M ✓, but 2023=$77M cannot be confirmed from ground truth (which doesn't explicitly state 2023 liability value). Net exposure calculations are correct given the stated figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 500,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "Lowe’s used a large forward‑interest‑rate‑swap program in 2022, with a notional amount of $2.56 billion (Note 9, page 62).  By the 2023 filing the program had been largely unwound, leaving only a $251 million fair‑value balance of forward swaps (page 54).  In the 2024 filing no forward‑swap balance is reported (page 54 shows a blank 2024 column), indicating the company had no forward swaps on its books.  This trajectory shows a shift from a broad hedging program to a more targeted or minimal use of forward swaps, likely reflecting lower interest‑rate volatility and a reduced need to hedge forecasted debt issuances.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key financial metrics and timeline. Strengths: (1) Correctly identifies the $2.56 billion notional amount for 2022 forward interest rate swaps; (2) Accurately cites the $251 million fair-value balance as of 2023; (3) Correctly notes the absence of forward swaps in 2024; (4) Properly synthesizes the multi-year progression showing unwind from 2022→2023→2024. The quantitative data is accurate and properly sourced with page references. The reasoning about the strategic shift from broad hedging to minimal use is sound and well-supported. Minor areas for improvement: (1) The ground truth emphasizes 'cash flow hedges' and impact on 'other comprehensive income and earnings' in 2022, which the LLM answer doesn't explicitly mention; (2) The ground truth notes the 2023 swaps were 'classified under other current assets,' a detail the LLM omits; (3) The LLM's interpretation about 'lower interest-rate volatility and reduced need to hedge forecasted debt issuances' is reasonable inference but goes slightly beyond what the ground truth explicitly states (which mentions 'stabilized interest rates or refinancing activities'). The answer successfully addresses all parts of the multi-part question: the evolution across three years, the specific values at each point, and the strategic implications. The multi-hop reasoning correctly synthesizes information across three fiscal years to show the trajectory. Overall, this is a high-quality answer with accurate numbers and sound reasoning, with only minor omissions of contextual details that don't materially affect the core answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 456,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "From 2022 through 2024, CMCSA steadily expanded its fiber‑to‑the‑premises offering—rolling out 2 Gbps downstream in 2022, deploying DOCSIS 4.0 for multigigabit speeds in 2023, and maintaining 10 Gbps residential and 100 Gbps business tiers in 2024 [page_7]—while Lumen continued to build fiber infrastructure into overlapping service areas, intensifying broadband competition [page_8]. This parallel expansion has pressured CMCSA to sustain or grow its fiber portfolio to preserve market share in those overlapping markets [page_8, page_7].",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific technical details about CMCSA's fiber expansion (2 Gbps in 2022, DOCSIS 4.0 in 2023, 10 Gbps/100 Gbps in 2024) and correctly identifies Lumen as a competing fiber-based infrastructure builder. However, there are significant issues: (1) The ground truth emphasizes Lumen's consistent presence as a key competitor across 2022-2024 with evolving competitive pressure, while the LLM answer focuses heavily on CMCSA's own technology deployments rather than the comparative competitive positioning evolution. (2) The LLM answer lacks verification of the specific technical specifications cited (2 Gbps, DOCSIS 4.0 deployment dates, 10 Gbps/100 Gbps tiers) - these appear to be specific claims that cannot be verified against the ground truth and may be hallucinated details. (3) The ground truth emphasizes how Lumen's fiber expansion 'intensified' competition and 'directly impacted CMCSA's market positioning and service strategies' across the three-year period, showing a progression of competitive pressure. The LLM answer mentions this but doesn't clearly articulate the evolution of competitive positioning from 2022→2023→2024. (4) The page citations [page_7], [page_8] are provided but cannot be verified and may be fabricated. (5) Multi-hop reasoning is partially sound - the answer does connect CMCSA's fiber expansion to Lumen's competitive threat - but it doesn't adequately synthesize how the competitive relationship evolved year-by-year. The answer reads more as a technical product roadmap than a competitive positioning analysis. The core insight about overlapping markets and competitive pressure is present but underdeveloped compared to the ground truth's emphasis on consistent competitive evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 475,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "PayPal’s 2024 filings show a deepening of its seamless‑checkout focus by embedding consumer‑credit products—PayPal Credit, PayPal Pay‑Later, and branded credit cards—directly into checkout flows across a broader set of markets (2024 page 6). The platform now supports payments in over 200 markets and 100 currencies, a marked expansion from the earlier 2022 disclosures (2024 page 11). Omnichannel merchant tools have also grown, with in‑person POS, Zettle, and card‑reader options fully integrated into the checkout experience, building on the 2022 foundation that already highlighted these solutions (2024 page 6; 2022 page 8).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the question's main themes but contains significant quantitative inaccuracies that undermine credibility. CRITICAL ERRORS: (1) Currency support claim is incorrect - LLM states 'over 200 markets and 100 currencies' in 2024, but ground truth indicates approximately 150 currencies by 2023 and no evidence of expansion to 200+ markets or currencies by 2024. The LLM appears to have conflated or inflated these numbers. (2) The LLM claims 2022 'already highlighted' omnichannel solutions like Zettle and card readers, but ground truth indicates these were emphasized more prominently in 2024 as part of the evolution, not as established 2022 features. CORRECT ELEMENTS: (1) Properly identifies BNPL integration into checkout experiences in 2024. (2) Correctly mentions PayPal Credit, PayPal Pay-Later, and branded credit cards. (3) Accurately references Zettle and Braintree as omnichannel solutions. (4) Correctly identifies the evolution from 2022 to 2024. MULTI-HOP REASONING: The LLM attempts to synthesize across years but makes a critical error in the temporal progression - it suggests 2022 already had mature omnichannel solutions when the ground truth indicates this was a 2024 development. The comparison between years is therefore flawed. MISSING ELEMENTS: The answer lacks the nuanced distinction that ground truth provides about the strategic shift from 'global scale and usability' (2022-2023) to 'enhanced financial services integration and comprehensive merchant enablement' (2024). The answer also doesn't clearly articulate the progression through 2023's emphasis on simplifying shopping experiences. The citation format (page numbers) appears fabricated and cannot be verified against actual filings. Overall, while the answer touches on correct themes, the quantitative inaccuracies regarding currency/market expansion and the temporal misplacement of omnichannel solutions significantly reduce its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 527,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "Target Debit Card (part of the RedCard program) penetration fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024** (RedCard penetration). The downward trend indicates a shrinking share of purchases made with the card, suggesting that its contribution to incremental sales is diminishing or plateauing over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provided incorrect penetration rates for 2023 and 2024. Ground truth shows: 2022: 20.5%, 2023: 18.6%, 2024: 17.8%. LLM stated: 2022: 20.5%, 2023: 19.8%, 2024: 18.6%. This represents a significant factual error - the 2023 figure is off by 1.2 percentage points (19.8% vs 18.6%), and the 2024 figure is off by 0.8 percentage points (18.6% vs 17.8%). These are not minor rounding differences but material misstatements of the data. QUALITATIVE ASSESSMENT: The LLM correctly identified the overall downward trend and appropriately characterized it as indicating diminishing contribution to incremental sales. The reasoning about a 'shrinking share of purchases' and 'plateauing' contribution is sound and semantically aligned with the ground truth's conclusion about 'diminishing role.' However, the LLM failed to mention the 5% discount value proposition or the internal linkage to increased sales that the ground truth emphasized. MULTI-HOP SYNTHESIS: The LLM successfully synthesized information about the RedCard program and its penetration rates across three years, demonstrating understanding of the multi-year trend analysis required. The connection between declining penetration and reduced sales impact is logically sound. COMPLETENESS: The answer addresses the evolution question and the implications for sales, but omits contextual details about the discount incentive and Target's internal expectations. The core question is substantially answered despite the numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 421,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "AMD’s policy on revenue recognition for development‑plus‑IP licensing agreements has not changed between 2022 and 2024.  In each year’s Notes (2022 p. 59‑60, 2023 p. 63, 2024 p. 63) AMD states that it evaluates whether the licensing component is distinct; if it is not, the arrangement is treated as a single performance obligation and revenue is recognized over time, whereas a distinct license is recognized at a point in time.  Standalone licensing arrangements are also recognized at a point in time, and no variable‑consideration estimates are associated with either type.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that AMD's revenue recognition policy remained consistent from 2022-2024, matching the ground truth assertion of 'maintained a consistent revenue recognition framework'; (2) Accurately describes the dual treatment: non-distinct licenses combined with development services recognized over time, distinct licenses recognized at point in time; (3) Properly notes that standalone licensing arrangements are recognized at point in time; (4) Provides specific page references (2022 p. 59-60, 2023 p. 63, 2024 p. 63) that demonstrate multi-hop synthesis across three years of filings; (5) Correctly states no variable consideration estimates are associated with either type. The answer is more concise than the ground truth but captures all essential information. Minor considerations: (1) The LLM answer doesn't explicitly mention 'when the customer can benefit from the IP' as a recognition trigger for distinct licenses, though this is a minor semantic detail; (2) The ground truth notes 'no explicit quantitative metrics being disclosed' while the LLM answer doesn't address this, but this is not a factual error, just a different emphasis. The LLM answer is actually more precise by providing specific page citations rather than general statements. All factual claims are accurate, the multi-hop reasoning across three years is sound, and the synthesis of information from multiple filing years is correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 412,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "FlyEase has remained a steady component of Nike’s innovation portfolio, consistently listed alongside flagship technologies such as Air, Zoom, Flyknit, and React in each year’s 10‑K. Across fiscal 2022, 2023 and 2024, the company’s filings show no shift in the strategic emphasis or positioning of FlyEase, indicating a continued, integrated role within its broader product‑innovation strategy【NKE_10k_2022.pdf page_6】【NKE_10k_2023.pdf page_6】【NKE_10k_2024.pdf page_6】.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim and directly contradicts the ground truth. CRITICAL ERRORS: (1) The LLM states FlyEase 'remained a steady component' with 'no shift in strategic emphasis or positioning' across the three years. This is factually wrong - the ground truth clearly documents a significant evolution: FlyEase moved from being 'newly introduced' in FY2022, to 'consistently named alongside established technologies' in FY2023, to being 'listed among mature technologies' in FY2024. This represents a clear progression from emerging to foundational status. (2) The LLM's characterization of FlyEase as consistently listed 'alongside flagship technologies such as Air, Zoom, Flyknit, and React' in each year is inaccurate. The ground truth indicates FlyEase's positioning relative to these technologies changed over time - it was initially separate/emerging, then integrated with established tech, then mature. (3) The LLM failed to capture the multi-hop synthesis required: tracking how FlyEase's strategic positioning evolved across three fiscal years and how its classification changed from 'novel concept' to 'foundational technology.' WHAT WAS CORRECT: The LLM correctly identified the three fiscal years (2022, 2023, 2024) and correctly cited Nike 10-K filings as sources. The quantitative accuracy score is higher because there are no specific numbers to verify, but the qualitative reasoning is severely flawed. The answer demonstrates a failure to synthesize the temporal evolution that is the core of the question. The LLM appears to have misread or misinterpreted the source documents, claiming consistency where the ground truth shows clear progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 464,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "Across 2022‑24 the aggregate principal amount of AMT’s 1.250% Notes has remained essentially flat at $517.7 million (the 2023 table on page 111 shows the same base amount, and the 2024 table on page 113 lists it again).  The only change is a modest reduction in the outstanding balance – a $1.9 million repayment in 2023 and a $0.4 million repayment in 2024 (page 113).  This pattern indicates a disciplined debt‑management strategy that keeps the debt level for this instrument stable while making incremental repayments, thereby preserving liquidity while gradually reducing exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM claims the principal amount 'remained essentially flat at $517.7 million' and that '2023 table shows the same base amount.' This is factually incorrect. The ground truth clearly shows: 2022: $609.1M → 2023: $551.9M → 2024: $517.7M. The LLM has confused the 2024 figure ($517.7M) with the 2023 figure, and incorrectly states the 2023 amount was the same as 2024. The actual decline from 2022-2023 was $57.2M ($609.1M - $551.9M), not the 'modest $1.9M repayment' claimed. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to properly synthesize the three-year trend. Instead of recognizing the consistent year-over-year decline pattern (2022→2023: -$57.2M; 2023→2024: -$34.2M), the LLM incorrectly characterized the debt as 'essentially flat' with only 'incremental repayments.' (3) REASONING ERROR: The LLM's conclusion about 'disciplined debt-management' and 'stable' debt levels contradicts the actual data showing significant principal reductions totaling $91.4M over the period. (4) ENTITY/METRIC ACCURACY: While AMT and the 1.250% Notes are correctly identified, the financial metrics are severely misrepresented. The ground truth interpretation of 'managed amortization or repurchase strategy' is correct and supported by the actual declining principal amounts, but the LLM's answer suggests the opposite (flat debt with minimal repayments). This is a fundamental misreading of the filing data that leads to an incorrect characterization of the company's debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 443,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2040 were carried at $1,000 million in each of FY 2022‑24 and classified as Level 2 debt securities, with fair value declining modestly from $870 million in FY 2023 to $851 million in FY 2024 (2024 10‑K, pp. 67‑72; 2023 10‑K, p. 67; 2022 10‑K, p. 78). The unchanged carrying amount and only a slight drop in fair value show the notes are held at amortized cost and not actively traded, underscoring a long‑term debt strategy focused on stable, low‑cost financing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) CARRYING AMOUNT ERROR: The LLM claims the notes were carried at $1,000 million in each of FY 2022-24, but the ground truth explicitly states FY 2022 was $1,066 million and FY 2023 was $851 million. Only FY 2024 at $1,000 million is correct. This is a critical error as it misrepresents the multi-year trajectory. (2) FAIR VALUE ERRORS: The LLM states fair value declined from $870 million in FY 2023 to $851 million in FY 2024. However, the ground truth shows FY 2023 fair value was $851 million (not $870M), and there is no FY 2024 fair value mentioned in the ground truth. The LLM appears to have confused or inverted these figures. (3) MISSING FY 2022 DATA: The LLM completely omits the FY 2022 fair value of $1,066 million, which is essential to understanding the multi-year trajectory. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution from FY 2022 through 2024, requiring synthesis of three years of data. The LLM only addresses FY 2023-24 and misrepresents FY 2022. (5) REASONING QUALITY: While the LLM's interpretation about amortized cost accounting and long-term debt strategy is reasonable, it is built on incorrect numerical foundations. The actual trajectory (FY 2022: $1,066M → FY 2023: $851M → FY 2024: $1,000M) shows more significant volatility than the LLM suggests. The LLM's characterization of 'unchanged carrying amount' is factually wrong. The answer demonstrates poor quantitative accuracy despite reasonable qualitative reasoning about debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 443,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "In 2022, Netflix added games to its library and launched a lower‑priced ad‑supported subscription, warning that if members did not value these new features the company could lose members (see 2022 Risk Factors, page 6). The 2023 filing repeated that expansion of games and the ad‑supported tier, again noting that failure to attract or retain members around these changes could hurt growth (2023 Risk Factors, page 6). By 2024 the company had added live‑programming to its portfolio, kept the ad‑supported tier, and continued to adjust pricing, with risk statements indicating that if these new services or price changes were not well received, member acquisition and retention could be adversely affected (2024 Risk Factors, page 6; “changes to pricing and plans,” 2024, page 4).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) TIMELINE INACCURACY - The LLM states Netflix 'launched a lower-priced ad-supported subscription' in 2022, but the ground truth clearly indicates the ad-supported tier was introduced in 2023, not 2022. This is a major factual error that contradicts the original answer. (2) GAMES TIMING - The LLM correctly identifies games as a 2022 introduction, which aligns with ground truth. (3) LIVE PROGRAMMING - Correctly identified as a 2024 addition. (4) RISK FACTORS ACCURACY - The LLM appropriately references risk statements across all three years and correctly captures the general theme that Netflix warned about member acquisition/retention risks tied to these changes. However, the specific claim about 2022 including the ad-supported tier is factually wrong. (5) MULTI-HOP SYNTHESIS - The answer attempts to synthesize information across three years but fails on a key factual point. The ground truth explicitly states the ad-supported tier was introduced in 2023, not 2022. The LLM's statement 'In 2022, Netflix added games to its library and launched a lower‑priced ad‑supported subscription' directly contradicts the ground truth which says games were 2022 but the ad-supported tier was 2023. (6) COMPLETENESS - The answer addresses all three years and mentions games, ad-supported tiers, and live programming, but the chronological misplacement of the ad-supported tier is a significant omission/error. (7) SEMANTIC ISSUES - While the general risk narrative is captured, the fundamental timeline error undermines the entire answer's credibility. The answer should have clearly separated 2022 (games only) from 2023 (ad-supported tier introduction).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 460,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "UnitedHealth’s venture exposure has risen steadily: equity‑security holdings grew from **$3.7 billion in 2022 to $4.9 billion in 2023 and remained at $4.9 billion in 2024**【page_48】【page_52】, while equity‑method investments in healthcare businesses more than doubled, climbing from **$1.4 billion in 2023 to $3.8 billion in 2024**【page_52】. This upward trend reflects a deliberate shift toward deeper integration and influence within the healthcare ecosystem, using venture capital to drive innovation and operational synergies.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding equity method investments in 2022. The ground truth states equity method investments were $1.3 billion in 2022, but the LLM answer omits this data point entirely and only mentions $1.4 billion in 2023 and $3.8 billion in 2024. This is a material omission that breaks the multi-hop synthesis required by the question, which specifically asks about the evolution 'from 2022 through 2024.' The LLM failed to capture the complete 3-year progression. CORRECT DATA: Equity securities figures are accurate ($3.7B→$4.9B→$4.9B). The 2023 and 2024 equity method investment figures ($1.4B and $3.8B) are correct. REASONING QUALITY: The qualitative interpretation about 'deeper integration and influence' and 'venture capital to drive innovation' is sound and aligns with the ground truth's characterization of 'deliberate strategic shift toward deeper engagement.' However, the incomplete data presentation undermines the analytical strength. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across multiple years and investment types, but the omission of the 2022 equity method investment figure ($1.3B) represents a failure to fully address the temporal evolution requested. The statement that equity method investments 'more than doubled' from 2023 to 2024 is mathematically correct (1.4B to 3.8B ≈ 2.7x) but misleading without the 2022 baseline. COMPLETENESS: The answer addresses the equity securities trend fully but incompletely addresses the equity method investments trend by missing the 2022 starting point.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 445,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "From FY 2022 through FY 2024 Nike’s relationship with Sojitz America remained unchanged: Sojitz America continued to be the sole owner of the company’s redeemable preferred stock, with a cumulative dividend of $0.10 per share payable annually on May 31 and no modifications to the preferred‑stock structure. The company also continues to rely on Sojitz America for import‑export financing services that support its global supply chain and international operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key quantitative facts: (1) Sojitz America as sole holder of redeemable preferred stock, (2) par value of $0.3 million (implied but not explicitly stated in LLM answer), (3) cumulative annual dividend of $0.10 per share, (4) dividend payment date of May 31, and (5) import-export financing services role. The numeric values are accurate and properly formatted.\n\nWEAKNESSES: The LLM answer fails to capture the critical 'evolution' dimension that is central to the question. The ground truth explicitly identifies a strategic shift from 'purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024.' The LLM answer states the relationship 'remained unchanged' and presents all information as static across the three-year period, missing the temporal evolution and the specific 2024 emphasis on Sojitz America's long-standing role (since 1972) in supporting international operations amid rising trade risks. The ground truth indicates Nike explicitly highlighted this strategic importance in FY 2024 as a response to global trade volatility, which is a meaningful evolution in how the relationship was characterized and leveraged.\n\nMULTI-HOP REASONING: The LLM answer demonstrates adequate synthesis of information about Sojitz America's dual roles (preferred stock holder and financing provider) but fails to synthesize the temporal dimension across the three fiscal years. It does not capture the shift in strategic emphasis or the contextual drivers (trade protectionism, supply chain volatility) that made the relationship more strategically important in 2024.\n\nCONCLUSION: While quantitatively accurate on specific facts, the answer is incomplete in addressing the 'evolution' aspect of the question, which is explicitly requested. The answer reads as a static description rather than a dynamic analysis of how the relationship evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 523,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "NVIDIA’s 3.50 % Notes Due 2050 were carried at $2,000 million at FY 2022 (Jan 30, 2022) 【page_82】, fell to $1,637 million at FY 2023 (Jan 29, 2023) 【page_67】, and further declined to $1,604 million at FY 2024 (Jan 28, 2024) 【page_67】. This gradual reduction shows that NVIDIA has been steadily repaying principal on its long‑term debt, reflecting a deliberate effort to keep its long‑term debt profile manageable while still maintaining a substantial, yet decreasing, debt load.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM reports FY2022 value as $2,000 million, but ground truth states $2,147 million (difference of $147M or 6.8%). The LLM reports FY2023 as $1,637 million, but ground truth states $1,604 million (difference of $33M or 2%). The LLM reports FY2024 as $1,604 million, but ground truth states $2,000 million (difference of $396M or 24.7% - this is a major error). (2) TREND ANALYSIS FAILURE - The LLM incorrectly characterizes the trend as a 'gradual reduction' across all three years (2022→2023→2024), when the actual trend shows: decrease from 2022 to 2023, then a SIGNIFICANT INCREASE from 2023 to 2024. This is a fundamental misinterpretation of the data pattern. (3) INTERPRETATION ERROR - The LLM concludes NVIDIA was 'steadily repaying principal on its long-term debt,' which is contradicted by the 2024 increase to $2,000M. The ground truth correctly identifies this as a 'temporary reduction in 2023 followed by strategic repositioning to increase long-term liabilities in 2024.' (4) MULTI-HOP SYNTHESIS - The LLM failed to properly synthesize the three-year evolution, missing the critical inflection point between FY2023 and FY2024. The answer demonstrates a pattern of declining values that doesn't match the actual data trajectory. The only partially correct element is the identification of the 3.50% Notes Due 2050 instrument itself.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 415,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "MetLife’s short‑term debt—primarily commercial paper—fell from $175 million in 2022 to $119 million in 2023, then surged to $465 million in 2024, reflecting a shift toward greater use of its commercial‑paper program backed by an unsecured revolving credit facility. Throughout this period the company continued to draw on a diversified mix of global funding sources—including preferred and common equity, long‑term debt, collateral financing, junior subordinated debt, PABs, credit and committed facilities, and a shelf registration statement—to preserve flexibility and keep the cost of capital low.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts ($175M in 2022, $119M in 2023, $465M in 2024) for commercial paper balances that cannot be verified against the ground truth. The ground truth explicitly states there were 'no major structural changes' and emphasizes consistent strategy across years, NOT a 'shift toward greater use' as the LLM claims. The LLM's narrative of a dramatic surge from $119M to $465M contradicts the ground truth's emphasis on stability and consistency. QUANTITATIVE ACCURACY FAILURE: The specific numbers provided ($175M, $119M, $465M) are presented as fact but lack verification in the provided ground truth, which does not cite these exact figures. This represents a potential hallucination of financial data. QUALITATIVE ACCURACY ISSUES: The LLM correctly identifies commercial paper, credit facilities, and diversified funding sources, but mischaracterizes the evolution as a 'shift' when the ground truth emphasizes consistency and stability. The LLM's framing of a 'surge' in 2024 contradicts the ground truth's message of 'stable reliance' and 'same core funding structure.' MULTI-HOP REASONING: While the LLM does synthesize information about funding sources across years, it does so incorrectly by imposing a narrative of change that the ground truth explicitly rejects. The ground truth emphasizes reiteration and consistency ('reiterated,' 'reaffirmed,' 'maintained the same core funding structure'), while the LLM emphasizes volatility and change. SEMANTIC EQUIVALENCE FAILURE: The answers convey fundamentally different messages—ground truth: stable strategy with consistent emphasis; LLM: evolving strategy with significant shifts in commercial paper usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 468,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "UnitedHealth’s service‑level guarantees remained immaterial throughout 2022‑2024, with the company reporting “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31, 2024, 2023 or 2022”【page 81 (2024)】.  In contrast, its financing of subsidiaries shifted markedly: short‑term notes payable fell from about $9.9 billion in 2023 to $2.0 billion in 2024 (down from $8.7 billion in 2022)【page 78 (2024)】【page 78 (2023)】【page 78 (2022)】, while long‑term notes payable to subsidiaries jumped to $14.4 billion in 2024 (none in 2023).  This evolution shows a deliberate move to reduce on‑demand short‑term liquidity obligations and extend maturities, thereby tightening liquidity commitments and keeping contractual risk exposure from service‑level guarantees low.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that service level guarantees were immaterial throughout 2022-2024, matching the ground truth. (2) The qualitative interpretation about shifting from short-term to long-term financing is sound and adds valuable insight. (3) The answer properly synthesizes information across multiple years and document sections. (4) The reasoning about liquidity strategy evolution is logical and well-articulated.\n\nCRITICAL ERRORS: (1) QUANTITATIVE DISCREPANCY - The LLM states short-term notes payable were '$8.7 billion in 2022' but the ground truth specifies '$8.1 billion in 2022'. This is a material factual error ($600M difference). (2) INCOMPLETE DATA - The ground truth explicitly states notes payable to subsidiaries were '$9.9 billion in 2023', which the LLM correctly cites. However, the LLM introduces 'long-term notes payable to subsidiaries jumped to $14.4 billion in 2024' - this figure does NOT appear in the ground truth answer and represents new information not verified against the source. The ground truth only mentions the $2.0 billion figure for 2024 without distinguishing between short-term and long-term components or mentioning a $14.4 billion long-term figure.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the relationship between service level guarantees (immaterial) and notes payable evolution (volatile), correctly identifying the inverse relationship. However, the introduction of unverified long-term debt figures undermines the reliability of this synthesis.\n\nNUMBER VERIFICATION: Ground truth shows $8.1B (2022), $9.9B (2023), $2.0B (2024). LLM shows $8.7B (2022) - INCORRECT, $9.9B (2023) - CORRECT, $2.0B (2024) - CORRECT, plus unverified $14.4B long-term (2024).\n\nThe answer demonstrates good qualitative reasoning and contextual understanding but contains a significant quantitative error in the 2022 figure and introduces unverified data for 2024 that cannot be confirmed against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 535,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "From 2022 to 2024, American Express remained the fourth‑largest global card network but faced mounting competition from Visa, Mastercard, UnionPay and digital‑wallet platforms, prompting a shift toward premium rewards and lounge services to differentiate. Regulatory scrutiny intensified—American Express became a Category III bank‑holding firm in 2024, new interchange‑fee caps and tighter oversight of network licensing and cobrand arrangements forced the company to exit EU and Australian licensing, tighten compliance, and pursue joint‑venture partnerships to mitigate regulatory risk. In response, the firm has bolstered its risk‑management framework, adjusted pricing, and engaged regulators on interchange policy while expanding alternative payment offerings to preserve its competitive edge.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key factual elements: (1) Amex as fourth-largest global card network, (2) Category III bank-holding firm designation in 2024, (3) regulatory scrutiny over interchange fees and network licensing, (4) exit from EU and Australian licensing businesses, (5) competitive pressures from Visa, Mastercard, UnionPay, and digital platforms. The timeline progression (2022-2024) is accurate. Numbers and dates are correct with no quantitative errors detected. WEAKNESSES: (1) The answer omits specific mention of alternative payment platforms like Alipay, PayPal, Venmo, and regional systems (National Payments Corporation of India) that were highlighted in the ground truth as part of the intensified competitive landscape. (2) The ground truth emphasizes a strategic 'trajectory' or 'evolution' showing transformation from 'market-driven competition to regulatory navigation'—the LLM captures this but less explicitly. (3) The ground truth notes Amex's 'independence and competitive edge have been increasingly shaped and constrained by regulatory forces'—the LLM mentions regulatory constraints but doesn't emphasize the loss of independence as clearly. (4) The LLM adds details about 'joint-venture partnerships' and 'risk-management framework adjustments' that aren't explicitly in the ground truth, though these are reasonable inferences. MULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and connects regulatory changes to strategic responses. The logic is sound: regulatory pressure → exit from certain markets → strategic adaptation. However, the ground truth provides more nuanced context about the shift in competitive dynamics (traditional networks vs. alternative platforms) that the LLM somewhat compresses. SEMANTIC EQUIVALENCE: The core message aligns—Amex faced increasing regulatory constraints that reshaped its strategy—but the ground truth provides richer detail on the competitive landscape evolution and the philosophical shift in Amex's strategic posture. The answer is substantially correct but lacks some contextual depth and specific competitive details from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1621,
        "completion_tokens": 584,
        "total_tokens": 2206
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "ConocoPhillips kept the same dividend‑equivalent structure for cash‑settled PSUs awarded for performance periods beginning in 2018 or later from 2022 through 2024—recipients receive an accrued reinvested dividend equivalent that is charged to compensation expense and paid only at settlement.  While the program grew in scale (more units granted and higher fair‑value settlements each year), the unchanged dividend‑equivalent treatment shows the company’s commitment to tying executive pay to company performance and shareholder returns rather than distributing cash dividends.  This consistency underscores a long‑term incentive alignment strategy that rewards executives for sustained value creation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key dividend equivalent structure for performance periods beginning in 2018 or later (accrued reinvested dividends paid at settlement) and accurately notes the consistency of this approach from 2022-2024. However, the answer has significant gaps in completeness and reasoning depth compared to the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the dividend equivalent treatment for 2018+ performance periods (accrued reinvested dividends paid at settlement)\n2. Accurately notes the consistency of this structure across 2022-2024\n3. Correctly characterizes the alignment strategy as tying pay to company performance\n4. Properly identifies cash-settled PSUs as the relevant instrument\n\nWEAKNESSES:\n1. INCOMPLETE EVOLUTION ANALYSIS: The ground truth emphasizes a critical evolution—comparing pre-2018 periods (no payments during performance period, began after conclusion) versus 2018+ periods (accrued reinvestment). The LLM answer only addresses the 2018+ structure and misses this comparative evolution entirely.\n2. MISSING VESTING FRAMEWORK: The ground truth mentions vesting tied to either five years or retirement eligibility, which the LLM answer omits.\n3. MISSING BALANCE SHEET CLASSIFICATION: The ground truth notes consistent classification as liabilities across all three years, which the LLM answer does not mention.\n4. VAGUE SCALE CLAIMS: The LLM states \"the program grew in scale (more units granted and higher fair-value settlements each year)\" but provides no specific numbers or evidence to support this claim, making it unverifiable.\n5. INCOMPLETE REASONING: The ground truth explains the strategic significance of the shift from deferred to accrued reinvestment as \"stronger long-term alignment by deferring rewards until performance outcomes are fully realized.\" The LLM answer provides a more generic explanation without this nuanced insight.\n6. MISSING DOWNSTREAM SEPARATION CONTEXT: The ground truth references the 2012 downstream separation as context for the PSU framework, which the LLM answer omits.\n\nMULTI-HOP SYNTHESIS: The LLM answer addresses only one dimension of the evolution (consistency of 2018+ structure) rather than synthesizing the full evolution across different performance period cohorts. This represents incomplete multi-hop reasoning.\n\nFACTUAL ACCURACY: The specific facts stated are accurate, but the answer is incomplete in addressing the full scope of the question about how the strategy \"evolved\" from 2022 to 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 671,
        "total_tokens": 2118
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "NextEra Energy’s Special Use Funds more than doubled from $7.3 billion in 2022 to $8.7 billion in 2023 and $9.8 billion in 2024 (page 64, page 88).  At the same time, potential derivative‑collateral requirements fell from $5.2 billion in 2022 to $2.4 billion in 2023, and the actual collateral posted dropped from $1.813 billion in cash and $2.806 billion in letters of credit in 2022 to $691 million in cash and $1.595 billion in letters of credit in 2023 (page 86).  This trend indicates that the company has strengthened its liquidity buffer, enabling it to meet derivative‑related collateral obligations with a larger internal asset base and reducing reliance on external credit facilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that undermine its credibility. (1) SPECIAL USE FUNDS: LLM claims $7.3B in 2022, but ground truth only provides 2023 ($8.698M) and 2024 ($9.8B) data. The 2022 figure of $7.3B cannot be verified against ground truth and appears to be fabricated. (2) COLLATERAL POSTED - CASH: LLM states $84M in 2022 and $691M in 2023, which matches ground truth. However, LLM also claims $1.813B in cash posted in 2022, which directly contradicts its own earlier statement of $84M. This is a major internal inconsistency. (3) LETTERS OF CREDIT: LLM introduces $2.806B in LOCs for 2022 and $1.595B for 2023, which are NOT mentioned in the ground truth answer. The ground truth only references cash collateral ($84M in 2022, $691M in 2023) and does not discuss letters of credit figures. (4) DERIVATIVE COLLATERAL REQUIREMENTS: LLM correctly states $5.2B (2022) and $2.4B (2023), matching ground truth. (5) MISSING CONTEXT: Ground truth mentions a $2.7B potential collateral requirement in event of credit downgrade, which LLM omits entirely. REASONING QUALITY: The LLM's conclusion about strengthened liquidity positioning is logically sound and aligns with ground truth interpretation. However, the reasoning is built on partially incorrect data. The synthesis of Special Use Funds growth with reduced collateral exposure is conceptually correct but marred by numerical inaccuracies. MULTI-HOP SYNTHESIS: The LLM attempts to connect three data points (Special Use Funds, collateral requirements, actual collateral posted) across multiple years, which is appropriate for the question. However, the execution is flawed due to data errors. The introduction of letters of credit data suggests the LLM may be conflating information from different sections or years without proper verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 504,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "The 1.600% Notes began 2022 with a $700 million balance and were not amortized that year (page 109). In 2023 AMT amortized $2.6 million, and in 2024 it amortized an additional $1.5 million, leaving a $695.9 million balance (page 111). This steady, modest repayment pattern shows a conservative debt‑management approach that keeps the balance low while preserving liquidity and avoiding large refinancing or early redemption.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth across multiple dimensions: (1) PRINCIPAL BALANCE ERROR: The ground truth clearly states the outstanding principal remained constant at $700.0 million across 2022-2024. The LLM incorrectly claims it began at $700 million in 2022 but ended at $695.9 million in 2024 - a $4.1 million reduction that did not occur. (2) AMORTIZATION TRAJECTORY ERROR: The ground truth indicates adjustments to principal decreased from (3.7) million in 2022 to (2.6) million in 2024, showing a declining pattern. The LLM claims amortization was $0 in 2022, $2.6 million in 2023, and $1.5 million in 2024 - these numbers are incorrect and don't match the ground truth's adjustment figures. The LLM appears to have confused or misinterpreted the adjustment data. (3) CALCULATION ERROR: The LLM's claim that $700M minus $2.6M minus $1.5M equals $695.9M is arithmetically correct ($695.9M), but this calculation is based on false premises about what actually happened to the principal. (4) INTERPRETATION ERROR: The ground truth emphasizes 'stable long-term debt strategy' with 'constant principal amount' and 'declining adjustments.' The LLM incorrectly characterizes this as 'steady, modest repayment' suggesting principal reduction, which is the opposite of what occurred. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the multi-year pattern from the filings. The core insight - that principal stayed flat while adjustments declined - was completely missed. The answer demonstrates a fundamental misreading of the source data rather than a minor wording difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 450,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "UnitedHealth Group’s 2022 10‑K warned that CMS had frozen or cut Medicare Advantage benchmarks and could change risk‑adjustment payment calculations, exposing the company to payment volatility (page 18). By 2023 the company reiterated that risk‑adjustment changes were a risk and began adjusting benefits and premiums selectively, withdrawing plans from certain counties, and tightening medical and operating cost controls to offset benchmark cuts (page 20). In 2024 the company maintained the same risk assessment and further intensified risk‑adjustment data validation and coding practices, along with expanded cost‑management initiatives, to mitigate the impact of future CMS payment changes (page 20).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the three-year period (2022-2024). STRENGTHS: (1) Correctly identifies the core regulatory challenge: CMS changes to risk adjustment payment methodologies and benchmark freezes/cuts across all three years. (2) Accurately captures UNH's strategic responses: selective benefit/premium adjustments, county exits, cost management intensification, and enhanced data validation/coding practices. (3) Properly sequences the evolution of responses from 2022 through 2024, showing escalating sophistication in mitigation strategies. (4) Correctly attributes information to appropriate years and filing documents. (5) No quantitative errors detected - all dates and year references are accurate. MINOR WEAKNESSES: (1) The LLM answer includes specific page references (page 18, page 20) which cannot be verified against the ground truth and may or may not be accurate to actual filings - this is a minor issue as it doesn't affect the substantive accuracy of the financial/strategic information. (2) The ground truth emphasizes the 'consistent theme' of evolving response to CMS recalibrations more explicitly, while the LLM answer focuses more on specific tactical actions. However, the LLM answer does capture this through its chronological progression. (3) The LLM answer could have been slightly more explicit about the 'ongoing' nature of adjustments required to maintain profitability and competitiveness, though this is implied. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate fiscal years and filing documents, correctly linking regulatory changes to company responses and showing how strategies evolved over time. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 535,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "Target’s employee discount remained a steady component of its benefits package through 2022‑2024, providing team members with a discount on all merchandise purchases as part of the “merchandise and other discounts” benefit (see the Compensation and Benefits sections in 2022 page 6, 2023 page 7, and 2024 page 7).  The unchanged scope and structure of the discount program signals Target’s ongoing commitment to employee financial well‑being by offering a tangible, cost‑saving benefit that helps staff manage everyday expenses.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and analytical errors that substantially misrepresent the ground truth. (1) MAJOR FACTUAL ERROR - SCOPE/STRUCTURE EVOLUTION: The LLM claims the discount program remained 'unchanged' in scope and structure from 2022-2024, directly contradicting the ground truth which documents a clear evolution in how Target framed and positioned these discounts within an expanding benefits ecosystem. The ground truth explicitly shows: 2022 (basic benefits suite with $15/hr minimum), 2023 (expanded to $15-$24/hr range with new benefits like sick pay and tuition-free education), and 2024 (reframed within equitable pay and belonging narrative with enhanced mental health services). The LLM completely missed this progression. (2) INCOMPLETE SYNTHESIS: The question specifically asks about 'evolution' and what the 'progression indicates about Target's strategy.' The LLM provides no analysis of how the benefits package evolved or what this reveals about strategic intent. The ground truth demonstrates Target's shift from basic compensation to a holistic financial wellness strategy - the LLM entirely misses this multi-hop synthesis. (3) MISSING CONTEXTUAL DETAILS: The LLM fails to mention the wage increases ($15 to $15-$24), the addition of new benefits (sick pay, tuition-free education, virtual healthcare, mental health services), or the strategic reframing around 'equitable pay and belonging.' These are central to understanding the evolution. (4) CITATION ACCURACY: While the LLM provides page references, it doesn't substantiate its claim of 'unchanged' structure with actual evidence from those pages. (5) ANALYTICAL WEAKNESS: The LLM's conclusion that the unchanged discount 'signals Target's ongoing commitment' is superficial and misses the deeper strategic narrative about holistic employee financial well-being that the ground truth emphasizes. The answer reads as a surface-level observation rather than the multi-year strategic analysis the question requires.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 541,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio was almost entirely short‑term in 2021 (99 % due within one year) and yielded a weighted average of roughly 2.1 % (page 121).  The 2022‑2024 figures are not disclosed in the supplied pages, but the 2021 snapshot suggests that the company has historically kept this portion of its investment portfolio highly liquid and low‑yielding.  This consistent short‑term, low‑yield profile indicates a conservative risk appetite and an asset‑allocation strategy that prioritizes liquidity and credit quality over higher returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the core question. Critical issues: (1) WRONG TIME PERIOD: The LLM discusses 2021 data when the question explicitly asks about 2022-2024 evolution. The ground truth provides specific 2022, 2023, and 2024 figures that the LLM claims are 'not disclosed.' (2) MISSING KEY DATA: The LLM completely fails to provide the required 2022-2024 yield and maturity distribution data. Ground truth shows: 2022 yields of 1.74% (within 1 year) and 2.42% (1-5 years); 2023 yields of 6.45% and 4.48%; 2024 yields of 5.86% and 2.03%. (3) INCORRECT HOLDINGS: The LLM mentions 2021 data with 99% short-term allocation, but the ground truth specifies $630 million in holdings for 2022 with different maturity distributions across the three-year period. (4) FAILED MULTI-HOP SYNTHESIS: The question requires synthesizing yield trends, maturity distribution changes, and strategic implications across three years. The LLM provides none of this synthesis and instead offers a generic characterization based on incomplete/wrong data. (5) CONTRADICTED CONCLUSION: The LLM concludes the company maintains a 'conservative risk appetite' with 'low-yield profile,' but the ground truth shows a dramatic shift to aggressive 6.45% yields in 2023, indicating dynamic risk appetite changes, not consistency. (6) INCOMPLETE ANSWER: The LLM does not address the 3-year pattern analysis or what it suggests about strategy evolution. The ground truth explicitly describes a shift from stable low-yield bonds (2022) to aggressive short-term investments (2023) to partial retreat (2024). The LLM's claim that data is 'not disclosed' is factually incorrect based on the ground truth knowledge graph.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 469,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell from **$1.49 billion in 2022** to **$800 million in 2023** and further to **$491 million in 2024** (the amounts are included in the “Other assets, including intangibles – net” line). This downward trend indicates that the company has reduced the collateral required for its derivative positions, reflecting tighter netting and margin practices and a more efficient management of its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $1.49 billion (2022) matches $1,494 million in ground truth (acceptable format variation), $800 million (2023) is exact, and $491 million (2024) is exact. The chronological sequence and year-to-year progression are accurate. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) identifies the specific collateral metric, (2) provides all three years of data, (3) explains the trend (downward), and (4) interprets what the trend suggests about derivative exposure management. ENTITY ACCURACY: Company (ExxonMobil/XOM), metric ('Other assets, including intangibles - net'), and all fiscal years (2022-2024) are correctly identified. REASONING QUALITY: The multi-hop synthesis is sound - the model correctly connected collateral amounts to derivative exposure management and interpreted the declining trend as indicating more efficient management practices. The explanation about 'tighter netting and margin practices' provides reasonable interpretation of the trend. SEMANTIC EQUIVALENCE: The LLM's interpretation ('reduced collateral required for derivative positions, reflecting tighter netting and margin practices') is semantically equivalent to and slightly more detailed than the ground truth's 'strategic reduction in derivative-related exposure or shift in risk management practices.' Minor note: The LLM provides slightly more specific interpretation (tighter netting/margin practices) compared to the ground truth's more general 'strategic reduction,' but this represents added value rather than error. No factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 463,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "AMT issued its 2.700% senior unsecured notes in March 2021 for $700 million with a fixed 2.700% coupon and a maturity of April 15 2031, and the terms have remained unchanged through 2024 (page 111, page 114, page 112). The company did not issue new 2.700% notes during 2022‑2024; instead, it raised new debt at higher rates—5.200%/5.450% in March 2024, 3.900%/4.100% in May 2024, and 5.000%/5.400% in November 2024—reflecting rising market rates (page 113). This pattern shows AMT’s strategy of locking in low rates early and using credit facilities to refinance, while later issuances adjusted to the tightening of market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MATURITY DATE ERROR: LLM states maturity of 'April 15 2031' but ground truth clearly shows 'January 15, 2031' - this is a critical factual error on a core term of the debt instrument. (2) MISINTERPRETATION OF QUESTION: The LLM fundamentally misunderstands what the question asks. The ground truth shows the 2.700% Notes were disclosed consistently across 2022-2024 with the same $700M principal and maturity date, with only a minor spread change (5.0 to 4.4). The LLM incorrectly claims 'the company did not issue new 2.700% notes during 2022-2024' and pivots to discussing entirely different debt issuances (5.200%, 3.900%, 5.000% notes), which are not the 2.700% Notes the question specifically asks about. (3) INCOMPLETE SYNTHESIS: The question asks specifically about how the 2.700% Notes evolved 2022-2024. The ground truth shows stability in principal ($700M) and maturity (January 15, 2031) with a spread reduction. The LLM fails to address this evolution and instead discusses unrelated debt instruments. (4) MISSING KEY DETAILS: The LLM omits the par call date (January 15, 2031) and the interest payment schedule (April and October) that are part of the ground truth. (5) STRATEGIC INTERPRETATION: While the LLM's interpretation about locking in low rates has some merit, it's based on discussing the wrong debt instruments and misses the actual insight from the ground truth - that AMT maintained stable long-term financing with the 2.700% Notes while the spread improved slightly by 2024. The answer demonstrates a fundamental misreading of the source documents and fails to directly address the specific 2.700% Notes evolution requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 476,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 rose modestly over the three‑year span: the carrying amount was $1,044 million at the end of 2022, $1,057 million at the end of 2023 (Jan 28 2024)【page 67】, and $1,250 million at the end of 2024 (Jan 28 2024)【page 72】. This incremental increase—about $193 million from 2023 to 2024—shows the company is adding long‑term debt at low rates to fund growth while keeping its debt profile stable and manageable.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the carrying values for 2023 ($1,057 million) and 2024 ($1,250 million), matching the ground truth. The calculation of the increase from 2023 to 2024 ($193 million) is accurate. The answer appropriately addresses the multi-hop question by tracking the debt evolution across three years and providing interpretation about debt strategy. The reasoning about stable debt management is sound and relevant.\n\nWEAKNESSES: Critical discrepancy in 2022 data - the LLM states $1,044 million for end of 2022, but the ground truth indicates $1.2 billion (or $1,200 million) for 2022. This is a significant $156 million error. The LLM appears to have confused the 2022 year-end value with the 2023 beginning-of-year value ($1,044 million). The ground truth explicitly states '2022, NVIDIA reported a fair value of $1.2 billion' while the LLM reports $1,044 million for 2022. This represents a fundamental factual error in the historical progression.\n\nADDITIONAL ISSUES: The LLM's interpretation that the company is 'adding long-term debt at low rates to fund growth' is somewhat speculative and not directly supported by the ground truth answer, which emphasizes 'strategic consistency' and 'stable approach' rather than active debt expansion. The ground truth notes the 2023 beginning value ($1.044 billion) separately from the ending value ($1.057 billion), suggesting these may be different measurement points, but the LLM conflates these.\n\nCALCULATION VERIFICATION: If 2022 was $1,200M and 2023 was $1,057M, that's actually a decrease of $143M, not the modest rise the LLM describes. The $193M increase from 2023 to 2024 is correct ($1,250M - $1,057M = $193M).\n\nMULTI-HOP REASONING: The answer attempts to synthesize across three years but fails on the 2022 baseline, undermining the entire progression narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 502,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances grew sharply in 2023, with deposit assets rising to **$5.1 billion** and deposit liabilities to **$1.3 billion** from roughly **$1.8 billion** and **$1.4 billion** in 2022 (the 2022 10‑K shows similar levels to 2021/2020). In 2024 the balances eased to **$4.6 billion** in assets and **$1.2 billion** in liabilities. The swing reflects a 2023 expansion of modified‑coinsurance and other deposit‑method agreements—particularly the Global Atlantic transaction—followed by a modest pullback in 2024 as MetLife rebalances its reinsurance mix toward more diversified or capital‑efficient structures【page_206】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR - The LLM states deposit assets were $5.1 billion in 2023, but the ground truth clearly indicates $5.1 billion was the 2024 figure. The LLM incorrectly places the peak in 2023 when it actually occurred in 2024. (2) INCORRECT 2024 FIGURE - The LLM claims 2024 deposit assets were $4.6 billion, but ground truth shows $5.1 billion in 2024 (the highest point in the trend). This is a fundamental misreading of the data. (3) DEPOSIT LIABILITIES ACCURACY - The LLM correctly identifies 2022 at $1.4 billion and 2024 at $1.2 billion, but the characterization of the trend is muddled by the year misalignment. Ground truth shows: 2022 ($1.4B) → 2023 ($1.3B) → 2024 ($1.2B), a consistent decline. The LLM's statement about 'easing' in 2024 contradicts the actual data showing 2024 as the peak year for assets. (4) MULTI-HOP REASONING FAILURE - The LLM correctly identifies the Global Atlantic transaction as a 2023 driver but then incorrectly concludes there was a 'pullback in 2024.' The ground truth indicates 2024 showed the HIGHEST deposit assets ($5.1B), not a pullback. This represents a fundamental misunderstanding of the temporal sequence and strategic implications. (5) STRATEGIC INTERPRETATION ERROR - The LLM's conclusion about 'rebalancing toward more diversified structures' in 2024 contradicts the actual trend showing increased deposit assets in 2024, not decreased. The ground truth indicates the trend reflects a strategic shift toward deposit-method structures, not away from them. The LLM demonstrates partial understanding of the Global Atlantic transaction's role but fundamentally misaligns the years and misinterprets the 2024 data direction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 466,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "UnitedHealth’s held‑to‑maturity debt securities declined in both fair value and carrying value over the three‑year period: fair value fell from $679 million in 2022 to $596 million in 2023 and to $508 million in 2024, while carrying value fell from $696 million to $603 million and then to $512 million【page_53】【page_55】. The small, persistent gap between fair value and carrying value (always a few million dollars) reflects unrealized losses that the company treats as temporary, consistent with its strategy of holding the securities to maturity and not realizing market‑valuation changes in earnings. This trend indicates a conservative, long‑term investment approach that accepts market‑price fluctuations as accounting adjustments rather than operational risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - fair value progression ($679M → $596M → $508M) and carrying value progression ($696M → $603M → $512M) match the ground truth exactly. The year-to-year changes are accurate (2022-2023: FV down $83M, CV down $93M; 2023-2024: FV down $88M, CV down $91M). ENTITY ACCURACY: Company (UnitedHealth/UNH), metric (Debt Securities - Held-to-Maturity), and time period (2022-2024) are all correctly identified. MULTI-HOP SYNTHESIS: The answer successfully synthesizes data across three fiscal years and correctly identifies the consistent downward trend in both metrics. REASONING QUALITY: The LLM provides enhanced analysis beyond the ground truth by explaining the gap between fair value and carrying value (unrealized losses treated as temporary), which demonstrates deeper understanding of accounting treatment for held-to-maturity securities. This interpretation is sound and adds valuable context about the company's investment strategy. SEMANTIC EQUIVALENCE: The core message matches the ground truth - a strategic reduction/repositioning indicated by declining values - though the LLM frames it as a 'conservative, long-term investment approach' rather than just 'strategic reduction or repositioning.' Both characterizations are semantically compatible and accurate. MINOR CONSIDERATIONS: The LLM includes citation markers (【page_53】【page_55】) which adds credibility but wasn't in the ground truth format. The explanation of unrealized losses and accounting treatment goes beyond the original answer but is factually sound and relevant. No calculation errors detected. The answer fully addresses all parts of the multi-part question regarding fair value, carrying value, and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 495,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "The Target Credit Card (Target Circle Card) penetration fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024**【page_27】. This steady decline indicates that fewer guests are using the card for purchases, suggesting the current credit‑card incentives are becoming less effective at generating incremental sales and may require a strategic refresh.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are precisely correct - 20.5% (2022), 19.8% (2023), 18.6% (2024) match ground truth exactly. (2) The downward trend is accurately identified and characterized as a 'steady decline.' (3) The entity identification is correct (Target Credit Card/Target Circle Card). (4) The answer correctly addresses the evolution question with proper year-by-year progression. WEAKNESSES: (1) The interpretation diverges from ground truth in tone and nuance. The LLM states the decline 'suggests the current credit-card incentives are becoming less effective at generating incremental sales and may require a strategic refresh,' which is more definitive than the ground truth's more balanced assessment. (2) The ground truth explicitly notes that 'Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value' - this important caveat about ongoing strategic value is completely absent from the LLM answer. (3) The LLM's conclusion about needing a 'strategic refresh' is an inference not explicitly supported by the ground truth, which presents the trend more neutrally as indicating 'weakening engagement or shifting consumer preferences' while acknowledging 'ongoing strategic value.' (4) The ground truth mentions 'card-linked discounts and loyalty benefits' as context for Target's strategy, which the LLM omits. MULTI-HOP REASONING: The answer correctly synthesizes the penetration rate data across three years and connects it to strategic implications, but the interpretation is somewhat one-sided compared to the balanced ground truth assessment. The quantitative accuracy is perfect, but the qualitative interpretation lacks the nuance present in the original answer regarding the continued strategic value despite the decline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 506,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "Nike owned a distribution center in Laakdal, Belgium in FY 2022, and the 10‑K for FY 2023 and FY 2024 again list Laakdal as an owned facility (see the “Properties” section of each filing).  The footprint—an owned, key European hub—remained unchanged across the three years, underscoring Nike’s strategy of maintaining owned logistics infrastructure in Europe to secure supply‑chain control and resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The LLM correctly identifies that Nike owned the Laakdal, Belgium distribution facility across FY 2022, 2023, and 2024, with no changes in ownership status. The characterization of it as a 'key European hub' and 'owned facility' matches the ground truth's description of it as 'one of the most significant international distribution centers.' (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required in this question, and the LLM appropriately avoids introducing unsupported figures. The temporal references (FY 2022, 2023, 2024) are all correct. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years to demonstrate consistency in ownership and operational role. It correctly identifies the pattern of stability and draws a logical inference about strategic intent (maintaining owned logistics infrastructure for supply-chain control and resilience). (4) ENTITY ACCURACY: Nike is correctly identified, Laakdal, Belgium is correctly located, and the facility type (distribution center) is accurate. The reference to the 'Properties' section of 10-K filings is appropriate and demonstrates proper sourcing. (5) SEMANTIC EQUIVALENCE: The LLM's conclusion about 'maintaining owned logistics infrastructure in Europe to secure supply-chain control and resilience' is semantically equivalent to the ground truth's 'stable strategic focus on maintaining direct control over key logistics nodes in Europe.' Minor differences: The LLM provides slightly more explicit strategic reasoning (supply-chain control and resilience) compared to the ground truth's more general 'stable strategic focus,' but this represents appropriate elaboration rather than deviation. The answer is comprehensive, well-sourced, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 517,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "Lumentum remains listed as a competitor in NVIDIA’s 10‑K filings each year (2022: page 9; 2023: page 15; 2024: page 9).  NVIDIA’s supply‑chain strategy shifted from a concentrated Asia‑Pacific focus in 2022 to a more diversified, redundancy‑focused network in 2023 (page 8) and 2024 (page 10), while its IP‑protection posture strengthened through expanded patent filings, licensing, and export‑control compliance (page 15 and page 10).  These moves have tightened the competitive environment for Lumentum, limiting its ability to match NVIDIA’s performance, pricing, and market access, especially under tightening export‑control regimes (page 10, 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIABLE PAGE CITATIONS: The LLM provides specific page numbers (2022: page 9; 2023: page 15; 2024: page 9) that cannot be verified against the ground truth knowledge graph. These citations appear fabricated or hallucinated, which is a serious accuracy concern. (2) UNSUPPORTED CLAIMS: The LLM makes several assertions not present in the ground truth: (a) 'supply-chain strategy shifted from concentrated Asia-Pacific focus in 2022 to diversified, redundancy-focused network in 2023/2024' - the ground truth mentions manufacturing partnerships (TSMC, Samsung) but does NOT characterize a shift from Asia-Pacific concentration; (b) 'tightened competitive environment for Lumentum, limiting its ability to match NVIDIA's performance, pricing, and market access' - this is interpretive analysis NOT supported by the ground truth, which states Lumentum 'maintained its relevance'; (c) 'export-control regimes' limiting Lumentum - not mentioned in ground truth. (3) PARTIAL ALIGNMENT: The LLM correctly identifies: (a) Lumentum listed as competitor across 2022-2024; (b) NVIDIA's IP protection expansion; (c) Supply chain resilience efforts. However, the ground truth emphasizes that despite NVIDIA's strategic advances, Lumentum 'remained a persistent competitive force' and 'maintained its relevance,' whereas the LLM suggests Lumentum's competitive position has weakened. (4) REASONING QUALITY: The multi-hop synthesis is attempted but flawed - the LLM connects supply chain/IP strategies to Lumentum's competitive position, but this connection is speculative rather than grounded in the source material. The ground truth presents a more nuanced view: NVIDIA strengthened its position while Lumentum persisted. (5) SEMANTIC DIVERGENCE: Ground truth emphasizes 'consistent mention' and 'persistent competitive force' suggesting stability; LLM emphasizes constraint and limitation, suggesting decline. These are contradictory interpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 529,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "Netflix’s 10‑K filings from 2022 through 2024 all contain the same risk paragraph that its ability to deliver content “depends on obtaining various rights from third parties…if studios, content providers or other rights holders refuse to license…our business could be adversely affected” (2022 page 11; 2023 page 4; 2024 page 4).  The 2024 filing adds a regulatory section noting new content quotas, levies, investment obligations and ownership‑restriction rules that could tighten licensing terms (2024 page 4).  Together, these documents show that Netflix still relies heavily on licensed titles but is simultaneously expanding original‑content production to hedge against rising competition and a more restrictive regulatory environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across Netflix's 2022-2024 10-K filings. STRENGTHS: (1) Correctly identifies the consistent risk paragraph language across all three years regarding third-party licensing dependencies; (2) Accurately notes the 2024 addition of regulatory constraints (content quotas, levies, investment obligations, ownership restrictions); (3) Properly synthesizes the evolution from licensing risk focus to regulatory/competitive pressures; (4) Correctly identifies Netflix's strategic response of expanding original content production; (5) Page references are specific and verifiable (2022 page 11; 2023 page 4; 2024 page 4). MINOR GAPS: (1) The LLM answer is more concise than the ground truth and doesn't explicitly detail the 2023 discussion of 'variability of license terms' or the emphasis on 'maintaining a compelling mix of content to support membership growth'—though this is a minor omission of contextual detail rather than factual error; (2) The answer could have elaborated slightly more on the 'progression' or 'evolution' narrative to match the ground truth's framing of strategic shift; (3) No quantitative metrics provided (though the question doesn't explicitly require them). QUANTITATIVE VERIFICATION: No specific dollar amounts, percentages, or calculations are present in either answer, so quantitative accuracy is assessed on date/year correctness and page references, which are accurate. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and two distinct themes (licensing risk + regulatory impact) to reach a coherent conclusion about Netflix's strategic pivot. The logic connecting increased competition/regulation to original content expansion is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth—that Netflix's reliance on rights holders persists but is being mitigated through original content production in response to competitive and regulatory pressures. The wording differs but the meaning aligns well.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 566,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "In the 2022 10‑K, Southern Company presented scheduled lease payments under outdoor‑lighting contracts in a maturity‑analysis table (2024‑2028) and classified the revenue as lease income‑operating leases, treating the amounts as material【page_270】. By the 2024 10‑K the company still disclosed the payments in a similar table (2025‑2029) but added a note that the undiscounted cash flows for Georgia Power and Mississippi Power were immaterial, while Southern Company’s amounts remained material; the revenue classification as lease income‑operating leases was unchanged, and the maturity analysis continued to show the present‑value discount and operating lease obligations【page_233】【page_241】【page_232】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. Key issues: (1) MATERIALITY REVERSAL: The LLM claims 2022 treated outdoor lighting payments as 'material' and included them in maturity tables, while the ground truth explicitly states they were 'considered immaterial' in 2022. This is a critical factual inversion. (2) EVOLUTION MISCHARACTERIZATION: The ground truth describes a progression from immaterial/undisclosed (2022) → beginning inclusion in maturity analyses (2023) → explicit inclusion with formalized disclosure (2024). The LLM presents a static picture where payments were already in maturity tables in 2022 and remained there in 2024, missing the key evolution. (3) COMPANY-SPECIFIC DETAILS: The LLM introduces company-specific materiality distinctions (Georgia Power and Mississippi Power immaterial vs. Southern Company material in 2024) that are not mentioned in the ground truth, which focuses on Mississippi Power specifically in 2022. (4) REVENUE CLASSIFICATION: While the LLM correctly identifies 'lease income-operating leases' classification, this detail is not emphasized in the ground truth's focus on the evolution of disclosure and materiality treatment. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM fails to synthesize the three-year progression showing increasing formalization and transparency. Instead, it presents a static comparison between 2022 and 2024 that misrepresents the 2022 baseline. The answer demonstrates a fundamental misunderstanding of how the treatment evolved from immaterial/undisclosed to increasingly visible and formalized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 443,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "The 5.000% notes due April 2030 had an outstanding principal balance of **$606 million** in FY 2022 (page 101 of the 2022 10‑K), FY 2023 (page 81 of the 2023 10‑K), and FY 2024 (page 81 of the 2024 10‑K). The unchanged balance over three years shows that AVGO has neither issued additional principal nor repaid any portion of this note, reflecting a conservative debt‑management strategy that maintains a stable long‑term debt load.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data. According to the ground truth, AVGO's 5.000% notes due April 2030 had an outstanding principal balance of $1,086 million in FY 2022, NOT $606 million as the LLM states. The LLM incorrectly claims the balance was $606 million in FY 2022, when it actually decreased FROM $1,086 million in FY 2022 TO $606 million in FY 2023. This is a major factual error that completely misrepresents the debt evolution. The LLM's conclusion that the balance was 'unchanged over three years' is incorrect - there was a significant $480 million reduction from FY 2022 to FY 2023. The LLM's characterization of the strategy as 'conservative debt-management' that 'maintains a stable long-term debt load' is also misleading, as it fails to recognize the deliberate debt reduction that occurred in 2023. The LLM appears to have confused or misread the FY 2022 figure, possibly conflating it with the FY 2023/2024 figure. While the LLM correctly identifies that the balance remained at $606 million from FY 2023 to FY 2024, this represents only partial correctness of the three-year progression. The multi-hop reasoning is flawed because it fails to synthesize the actual year-over-year changes in the debt balance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 357,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "General Motors’ weighted‑average long‑term rate of return on U.S. pension plan assets was 6.3 % in 2022 and remained unchanged at 6.3 % in 2023, but rose to 6.5 % in 2024 (2024 10‑K, page 88; 2023 10‑K, page 87; 2022 10‑K, page 88). The 2024 increase reflects a strategic shift toward higher‑return, higher‑risk asset classes—such as private equity, real estate, and alternative investments—to improve funded status amid favorable market conditions, while the unchanged 2023 assumption indicates a period of stability before the adjustment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error in the 2022 figure. According to the ground truth, GM's weighted-average long-term rate of return on U.S. pension plan assets was 5.4% in 2022, NOT 6.3% as stated in the LLM answer. The LLM incorrectly reports 6.3% for 2022, which is actually the 2023 figure. This is a major quantitative accuracy failure. The correct progression should be: 2022: 5.4% → 2023: 6.3% → 2024: 6.5%, showing a 1.1 percentage point increase over two years. The LLM's stated progression (6.3% → 6.3% → 6.5%) misses the initial 2022 baseline entirely and therefore fails to capture the true 3-year trend. While the LLM correctly identifies 2023 and 2024 figures (6.3% and 6.5% respectively), the 2022 error is disqualifying for a multi-hop question specifically asking about evolution 'from 2022 through 2024.' The qualitative reasoning about strategic shifts toward higher-return assets is reasonable and contextually appropriate, but it is built on incorrect foundational data. The LLM also provides specific page citations (which cannot be verified here but appear plausible), but this does not compensate for the core factual error. The answer fails the primary requirement of quantitative accuracy for a financial question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 360,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "American Tower’s 2.700% Senior Notes due 2031 were issued in 2021 and reported in the 2022 10‑K as part of a supplemental indenture (Exhibit 4.20, page 70).  The notes are absent from the 2023 and 2024 filings, where a new 4.625% Senior Notes due 2031 is disclosed instead (Exhibit 4.27, page 73), indicating that the older debt was likely retired or refinanced.  This pattern shows the company’s active management of its debt maturity profile—replacing lower‑coupon, older debt with newer long‑term notes to keep a diversified, cost‑effective financing mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Entity Identification: The LLM claims the 2.700% Senior Notes due 2031 are 'absent from the 2023 and 2024 filings' and were 'likely retired or refinanced.' This is directly contradicted by the ground truth, which explicitly states the notes were consistently referenced across all three filings (2022, 2023, and 2024) with the same Supplemental Indenture No. 8. (2) CRITICAL ERROR - Multi-hop Reasoning: The LLM incorrectly synthesized information by claiming a 4.625% Senior Notes due 2031 replaced the 2.700% notes. The ground truth indicates the 2.700% notes remained a consistent core component of the capital structure across all three years. (3) QUANTITATIVE ACCURACY: While the LLM correctly identifies the 2.700% coupon rate and 2031 maturity date, it incorrectly introduces a 4.625% note as a replacement, which is not supported by the ground truth. The reference to Supplemental Indenture No. 8 dated March 29, 2021 is correct, but the LLM's interpretation of its treatment is wrong. (4) STRATEGIC INTERPRETATION ERROR: The ground truth indicates a 'stable long-term financing strategy' with 'steady approach' and 'confidence in financing terms.' The LLM incorrectly characterizes this as 'active management' involving retirement/refinancing, which misrepresents the company's actual strategy. (5) DOCUMENT CITATION: The LLM provides specific exhibit numbers and page references that cannot be verified against the ground truth, and the claim about absence from 2023-2024 filings is demonstrably false based on the ground truth statement that these documents consistently referenced the notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 468,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "From 2022 to 2024 PayPal’s filings increasingly flagged that abusive behaviors—particularly fraud and synthetic‑identity schemes—were rising as the company broadened its credit‑product portfolio and cross‑border trade, with 2023 and 2024 risk‑factor sections explicitly warning that cross‑border transactions could be hit by higher fraud and regulatory costs (see 2023 pages 23‑27 and 2024 pages 23‑25). In response, PayPal has strengthened fraud‑detection and credit‑risk models, diversified its reliance on third‑party lenders and payment processors, sold large portions of its BNPL receivables to reduce credit exposure, and enhanced compliance and merchant‑monitoring controls to mitigate these risks (see 2023 page 24 and 2024 pages 22‑24).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PayPal's evolving approach to abusive behaviors across 2022-2024, correctly identifying the key strategic actions (BNPL receivables sale, fraud detection improvements, third-party management). However, there are notable issues with quantitative specificity and citation accuracy:\n\nSTRENGTHS:\n- Correctly identifies the three-year trajectory of risk evolution (2022 identification → 2023 offloading → 2024 reinforcement)\n- Accurately mentions the BNPL receivables sale as a key mitigation strategy\n- Properly synthesizes multi-hop information about credit products and cross-border transactions\n- Correctly identifies fraud, synthetic-identity schemes, and third-party dependencies as core concerns\n- Semantic equivalence is strong: 'sold large portions of BNPL receivables' matches ground truth's €40 billion sale\n\nWEAKNESSES:\n- CRITICAL: The LLM provides specific page citations (2023 pages 23-27, 2024 pages 23-25, etc.) that cannot be verified against the ground truth. These appear to be hallucinated references, which is problematic for a financial document evaluation task\n- Missing the specific €40 billion figure from the ground truth, which is a concrete quantitative detail that should have been included\n- The phrase 'diversified its reliance on third-party lenders' is somewhat awkward and less precise than the ground truth's description of 'ongoing reliance' as an introduced risk\n- Does not explicitly mention the 'multi-year agreement' structure of the BNPL sale\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across three years and connects credit products, cross-border transactions, and strategic responses. The logical flow (risk identification → portfolio offloading → enhanced controls) matches the ground truth's narrative structure.\n\nQUANTITATIVE ACCURACY:\nThe answer lacks the specific €40 billion figure that appears in the ground truth. While the general concept of 'large portions' is correct, the absence of this concrete number reduces quantitative precision. The page citations, while specific, appear unreliable.\n\nOVERALL ASSESSMENT:\nThe answer captures the essential narrative and strategic evolution correctly but falls short on quantitative specificity and introduces potentially unreliable citations. The core facts about PayPal's approach are sound, but the execution lacks the precision expected for financial document analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 653,
        "total_tokens": 2162
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "UNP’s pension plan allocation to Collective Trust and Other Funds fell from **$622 million at NAV in 2022** (page 58) to **$382 million in 2023** (page 57) and slightly further to **$370 million in 2024** (page 54). This downward trend indicates the company is reducing exposure to these funds, likely reallocating capital toward other asset classes—such as venture capital, real estate, or debt—to align with a more diversified, risk‑adjusted investment strategy for long‑term employee benefits.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the primary numbers being evaluated. (1) 2022 VALUE DISCREPANCY: The LLM states '$622 million at NAV in 2022' but the ground truth clearly indicates '$756 million in 2022'. This is a $134 million error (17.7% variance) on a key data point. (2) 2024 VALUE DISCREPANCY: The LLM claims '$370 million in 2024' but the ground truth explicitly states 'no updated dollar value is provided' for 2024. The LLM fabricated a specific number that does not exist in the source material. (3) 2023 VALUE: The LLM correctly identifies '$382 million in 2023', which matches the ground truth. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize the trend across three years, it does so with incorrect data points for 2022 and 2024. The reasoning about de-risking and rebalancing is logically sound, but it's built on false premises. (5) STRATEGIC INTERPRETATION: The LLM's interpretation about diversification toward venture capital, real estate, or debt is speculative and not supported by the ground truth, which focuses on NAV-based valuation transparency. The ground truth emphasizes 'transparency and accurate reporting' rather than specific reallocation strategies. (6) MISSING CONTEXT: The LLM fails to acknowledge the ground truth's emphasis on NAV-based valuation methodology as a strategic focus. OVERALL ASSESSMENT: The answer demonstrates reasonable qualitative reasoning about pension de-risking trends, but the quantitative foundation is severely compromised by incorrect 2022 and fabricated 2024 figures. This makes the answer fundamentally unreliable despite some correct elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 460,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "Pfizer did not grant or have any Breakthrough Performance Awards (BPAs) in 2022, 2023, or 2024.  The 2024 10‑K (page 98) and the 2023 10‑K (page 97) both state that no BPAs were granted or outstanding as of December 31 of those years, and the 2022 10‑K table for BPAs (page 100) shows no grant activity, implying none were issued.  Across all three years the valuation and accounting treatment remained the same: BPAs are valued at intrinsic value using the closing price of common stock at grant date and amortized on a straight‑line basis over the probable vesting term into operating expenses, with periodic adjustments for changes in stock price, shares likely to be earned, and the probability of meeting performance criteria (see pages 98, 96, 100).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical factual points: (1) QUANTITATIVE ERRORS: The ground truth explicitly states that in 2022, Pfizer issued 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. The LLM claims 'no BPAs were granted or outstanding' in 2022, which directly contradicts these specific numerical values. (2) TEMPORAL EVOLUTION MISSED: The ground truth describes a clear evolution: 2022 had active issuance and outstanding awards, 2023 had none, and 2024 introduced a formalized valuation methodology. The LLM incorrectly claims no activity across all three years, completely missing the 2022 grant activity and the 2024 methodology formalization. (3) ACCOUNTING TREATMENT: While the LLM correctly identifies the intrinsic value method and straight-line amortization framework, it fails to recognize that this formalized methodology was specifically detailed in 2024 as a new development, not a consistent treatment across all years. (4) MULTI-HOP SYNTHESIS FAILURE: The question requires synthesizing information across three years to show evolution. The LLM failed to identify the key distinction that 2022 had actual grant activity (1,165 thousand awards), 2023 had none, and 2024 had a new valuation framework. This represents a complete failure of multi-hop reasoning. (5) CITATION ISSUES: The LLM cites specific page numbers but the underlying facts contradict the ground truth data, suggesting either misreading of source documents or hallucinated citations. The answer is internally inconsistent with documented SEC filing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 465,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: it was $1.49 billion at 12‑31‑2022, dropped to $800 million at 12‑31‑2023, and further declined to $491 million at 12‑31‑2024 (page 102; page 99). This downward trend indicates that the company’s derivative exposure or the initial‑margin requirement for its investments, advances and long‑term receivables has been reduced—likely reflecting lower trading volumes or more efficient hedging that lessens the need for collateral.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three collateral amounts are correct: $1,494 million (formatted as $1.49 billion - acceptable format variation), $800 million, and $491 million at the respective year-ends (12-31-2022, 12-31-2023, 12-31-2024). The downward trend is accurately captured. (2) ENTITY ACCURACY: ExxonMobil (XOM) correctly identified, fiscal years properly specified, and the metric (collateral under master netting arrangements related to Investments, advances and long-term receivables) is accurately referenced. (3) MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and correctly interprets what the declining collateral suggests about derivative exposure and margin requirements. The reasoning that lower collateral indicates reduced derivative exposure or more efficient hedging is sound and matches the ground truth interpretation. (4) COMPLETENESS: The answer addresses all parts of the question - the specific collateral amounts across all three years, the trend direction, and the implications for derivative exposure and margin requirements. (5) MINOR ENHANCEMENTS: The LLM answer adds helpful context by citing page numbers and providing slightly more detailed interpretation (mentioning 'lower trading volumes or more efficient hedging'), which enhances rather than detracts from accuracy. The semantic meaning is fully equivalent to the ground truth, with only stylistic differences in presentation (e.g., 'fell sharply' vs. 'fluctuated significantly' - both accurately describe the downward trend). No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 457,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "Broadcom’s 2022 10‑K listed fiber‑optic components only as part of its general “Fiber Optic Components” line for Ethernet networking, storage and telecom markets (page 11). By 2023 the company had explicitly added “industrial fiber optics” to its industrial portfolio, pairing it with optocouplers, sensors and Ethernet ICs and describing use in factory automation, renewable‑energy, automotive electronics and other industrial sectors (page 7). The 2024 filing repeats that positioning but broadens the application scope to include power‑generation, medical systems, defense, aerospace and vehicle subsystems, underscoring a deliberate shift to embed fiber‑optic technology as a core enabler across a wide range of industrial markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) CONTRADICTORY TIMELINE: The LLM claims 2022 had only general 'Fiber Optic Components' for networking/telecom, but the ground truth explicitly states 2022 positioned Industrial Fiber Optics across industrial automation, power systems, medical equipment, defense, aerospace, and automotive. The LLM incorrectly suggests Industrial Fiber Optics was 'explicitly added' in 2023, when it was already present in 2022. (2) REVERSED EVOLUTION: The LLM describes a broadening from 2023 to 2024 (adding power-generation, medical, defense, aerospace), but the ground truth shows these applications were already mentioned in 2022, with 2023-2024 showing more structured/streamlined presentation rather than expanded scope. (3) MISSING KEY INSIGHT: The ground truth emphasizes the evolution toward 'structured, application-specific clarity in product communication' and 'streamlined presentation,' but the LLM frames it as scope expansion. (4) INCOMPLETE SYNTHESIS: The LLM fails to capture that the strategic focus remained consistent across all three years—the change was in presentation format (table structure, streamlining) not in application scope. (5) PAGE REFERENCES: The LLM cites specific pages (11, 7, etc.) which cannot be verified and may be inaccurate. The core narrative is fundamentally inverted—the LLM describes an expansion when the ground truth describes consistent positioning with evolving presentation clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 421,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "PayPal’s exposure to margin risk has remained essentially unchanged from 2022 through 2024.  In each year’s 10‑K, the company states that it sets its own transaction fees and bears full margin risk as the principal in every payment, even while paying third‑party processors for services that are recorded as transaction expense ([page_80], [page_78], [page_77]).  Thus, PayPal’s control over pricing and its margin‑risk exposure have not materially evolved over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL CORRECTNESS: The answer correctly identifies that PayPal's margin risk exposure remained stable from 2022-2024, accurately capturing the core finding that the company maintained full margin risk, pricing discretion, and principal status throughout the period. The statement that fees to third-party processors are recorded as transaction expense is factually correct and matches the ground truth. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required for this question, and the answer appropriately avoids introducing unsupported figures. The temporal references (2022, 2023, 2024) are all correct. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings, correctly identifying the consistent pattern of PayPal's margin risk profile and its relationship to third-party processor costs. The logical connection between pricing control, margin risk, and transaction expense treatment is sound. (4) ENTITY ACCURACY: PayPal is correctly identified, and the financial metrics (margin risk, transaction fees, pricing discretion) are properly characterized. (5) COMPLETENESS: The answer addresses all components of the multi-part question: evolution of margin risk exposure, control over transaction pricing, and use of third-party processors across the three-year period. The citation references to specific pages ([page_80], [page_78], [page_77]) add credibility, though these cannot be independently verified in this evaluation. (6) SEMANTIC EQUIVALENCE: The LLM's phrasing 'essentially unchanged' and 'not materially evolved' conveys the same meaning as the ground truth's 'stable margin risk profile, with no material changes.' Minor deduction (1 point) only because the answer is slightly more concise than the ground truth and could have included marginally more detail about the explicit statements made in each year, though this is not a material deficiency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 552,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "Pfizer sold Meridian in 2021 for $51 million cash and a $167 million loss, and since then has only maintained a post‑sale relationship through interim transition service agreements (TSAs) and a three‑year manufacturing supply agreement (MSA) with a two‑year extension, which were not material to its 2023 or 2024 results (2023 10‑K, p. 71). The shift from ownership to a limited service arrangement signals a strategic divestiture of a non‑core medical‑technology business, underscoring Pfizer’s long‑term focus on its core pharmaceutical and vaccine portfolio rather than on peripheral medical‑technology assets (2023 10‑K, p. 71).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct financial figures ($51 million sale price, $167 million loss) and accurate contractual details (three-year MSA with two-year extension option). The timeline is correct (2021 sale, post-sale relationship through 2023-2024). However, there are notable gaps in completeness and qualitative reasoning: (1) The LLM answer does not explicitly address the 2022 status (discontinued operations presentation), which was a key part of the evolution narrative in the ground truth. (2) The LLM mentions TSAs (transition service agreements) which are reasonable inferences but not explicitly confirmed in the ground truth answer. (3) The LLM answer correctly identifies the strategic shift from ownership to contract-based relationship and the focus on core pharmaceutical/vaccine portfolio, matching the ground truth's conclusion about refocusing on core therapeutic areas. (4) The 2024 glossary reference to 'Meridian Medical Technologies, Inc.' mentioned in the ground truth is absent from the LLM answer, representing a minor omission in documenting the full evolution. (5) The LLM's characterization of the relationship as 'limited service arrangement' and 'non-core medical-technology business' aligns well with the ground truth's assessment. The answer successfully synthesizes the multi-hop information (financial impact, contractual arrangements, strategic positioning) but could have been more comprehensive in documenting the year-by-year progression, particularly the 2022 discontinued operations status. The reasoning about strategic refocusing is sound and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 449,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "From 2022 to 2024, PMI’s competitive positioning has become increasingly constrained by product‑regulation that limits differentiation and adult‑consumer communication for RRPs/SFPs. In 2022 the company warned that new rules could commoditize its products and impede conversion to RRPs, citing advertising, packaging and ingredient restrictions (page 13). By 2023 the focus shifted to SFP‑specific challenges—advertising and corporate‑communication restrictions that blunt brand differentiation and limit truthful information to adult consumers (pages 18–20). In 2024 PMI continues to face the same regulatory hurdles, with ongoing legal challenges over product classification, advertising, distribution and communication that further constrain differentiation and adult‑consumer messaging for RRPs/SFPs (pages 18–21).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year period (2022-2024) and the core regulatory constraint theme. (2) It accurately captures the evolution from RRPs to SFPs terminology. (3) It correctly identifies the key regulatory challenges: advertising, packaging, ingredient restrictions, and communication limitations. (4) The multi-hop synthesis across years is attempted and shows understanding of the progression. (5) Page references are provided, suggesting source documentation. WEAKNESSES: (1) CRITICAL FACTUAL DISCREPANCY: The LLM states that in 2023 'the focus shifted to SFP-specific challenges,' but the ground truth indicates that 2023 still used 'RRPs' language and only 2024 replaced 'RRPs' with 'SFPs.' This is a material error in the temporal evolution of terminology. (2) The LLM introduces specific regulatory mechanisms (advertising, packaging, ingredient restrictions) that are not explicitly mentioned in the ground truth answer, which focuses more on the general constraint on differentiation and consumer communication. While these may be accurate from the filings, they represent added detail not in the ground truth. (3) The ground truth emphasizes that regulation 'disproportionately impacted the commercialization of RRPs relative to competitors' in 2023—a competitive positioning insight that the LLM answer does not capture. (4) The ground truth notes the regulatory burden 'possibly intensified' over time, but the LLM's language ('same regulatory hurdles,' 'continues to face') suggests persistence rather than intensification. (5) The LLM mentions 'legal challenges over product classification' which is not present in the ground truth answer. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this score reflects the accuracy of dates and temporal sequencing. The 2022-2024 timeframe is correct, but the 2023 terminology error (RRPs vs SFPs) is a factual mistake. QUALITATIVE ACCURACY: The reasoning about regulatory constraint is sound, but the misplacement of the RRP-to-SFP terminology shift undermines the quality of the multi-hop synthesis. The answer shows understanding of the general trend but misses the precise evolution described in the ground truth. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about competitive positioning evolution and regulatory impact, though it adds details not in the ground truth and misses the disproportionate impact on commercialization relative to competitors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 670,
        "total_tokens": 2132
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "ExxonMobil’s collateral under master netting arrangements related to Notes and accounts receivable – net fell from **$1,494 million in 2022** (page 102) to **$800 million in 2023** (page 102) and further to **$491 million in 2024** (page 109), a cumulative drop of roughly **$1.0 billion**. The declining collateral requirement indicates the company is reducing its exposure to initial‑margin collateral, likely through more efficient netting and lower derivative exposure. This trend reflects a tightening of its derivative risk‑management practices and stronger counterparty risk controls.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three key figures are correct - $1,494 million (2022), $800 million (2023), and $491 million (2024). The calculated cumulative decline of $1.0 billion is accurate ($1,494M - $491M = $1,003M ≈ $1.0B). Page references provided (102, 102, 109) add credibility. ENTITY ACCURACY: Company (ExxonMobil/XOM), metric (collateral under master netting arrangements related to Notes and accounts receivable - net), and years (2022-2024) are all correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes the three-year trend and connects it to derivative risk management practices. The interpretation that declining collateral reflects reduced derivative exposure and more efficient netting is logically sound and aligns with the ground truth's assessment of strategic risk mitigation. SEMANTIC EQUIVALENCE: The LLM's explanation of 'tightening of derivative risk-management practices and stronger counterparty risk controls' is semantically equivalent to the ground truth's 'strategic reduction in derivative exposure or shift in risk management practices.' Both convey the same insight about proactive risk mitigation. MINOR CONSIDERATIONS: The LLM provides slightly more specific interpretation (initial-margin collateral, netting efficiency) compared to the ground truth's more general statement about 'lower margin requirements.' This additional detail is accurate and enhances the answer without introducing errors. The answer fully addresses the question's two components: (1) how exposure changed (with specific numbers), and (2) what the trend suggests about risk management practices (with sound reasoning).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 470,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "Duke Energy’s TSR‑based performance‑award model used a three‑year historical volatility estimate that changed as follows:  \n\n- **2022** – 26.9 % (page 214)  \n- **2023** – 28.6 % (page 206)  \n- **2024** – 18.7 % (page 215)  \n\nThe model’s volatility assumption rose modestly from 2022 to 2023, then dropped sharply in 2024. This downward swing indicates that Duke Energy now views the market as less volatile relative to its predefined peer group, reflecting a more conservative or stable perception of market risk over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three volatility percentages are correct - 26.9% (2022), 28.6% (2023), and 18.7% (2024) - matching the ground truth exactly. Page citations are provided (214, 206, 215), adding credibility. (2) COMPLETENESS: The answer addresses all parts of the multi-hop question: the evolution of volatility assumptions across the three-year period, the trend pattern, and interpretation of what this suggests about market risk perception. (3) ENTITY ACCURACY: Duke Energy is correctly identified, the TSR-based performance award model is properly named, and the peer group context is maintained throughout. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the pattern (increase 2022→2023, then sharp decrease 2023→2024), calculates the directional changes, and provides logical interpretation that the 2024 drop suggests lower perceived market volatility and more stable risk perception. The characterization of the 2024 shift as reflecting 'a more conservative or stable perception of market risk' is semantically equivalent to the ground truth's 'improved market stability or strategic changes affecting its risk profile.' (5) MINOR DIFFERENCES: The LLM uses slightly different phrasing ('now views the market as less volatile relative to its predefined peer group') compared to ground truth ('shift in how the company's stock is behaving relative to its peers'), but both convey the same essential meaning. The LLM's interpretation is slightly more concise but equally valid. No calculation errors detected. All facts are accurate and properly synthesized across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 468,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "Broadcom’s 3.125 % notes due January 2025 stayed at a principal of $495 million and an effective interest rate of 3.23 % in 2023 and 2024 (the same balance reported in 2022), indicating no repayment or refinancing of that instrument during the period. The company’s short‑term debt profile remained low, with a current portion of long‑term debt of $1,245 million in 2024 versus $1,563 million in 2023 and no commercial paper outstanding, showing that it uses new senior notes and term loans to refinance other obligations while keeping short‑term debt exposure minimal.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $495 million principal amount for the 3.125% notes is accurate across the years mentioned. (2) The identification of the note transitioning to current portion of long-term debt in 2024 is correct. (3) The general characterization of Broadcom's refinancing strategy using senior notes and term loans is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM introduces an 'effective interest rate of 3.23%' which is not mentioned in the ground truth and appears to be unsupported information. (2) The LLM provides specific current portion of long-term debt figures ($1,245M in 2024 vs $1,563M in 2023) that are not in the ground truth answer, making it difficult to verify their accuracy without additional sources. (3) The statement about 'no commercial paper outstanding' is additional detail not in the ground truth. (4) The LLM answer conflates 2023 and 2024 data ('in 2023 and 2024') when the ground truth clearly distinguishes that the $495M remained stable in 2022 and 2023, with the transition occurring in 2024. MULTI-HOP REASONING: The LLM attempts to synthesize information about short-term debt management and refinancing strategy, which is appropriate to the question. However, the introduction of unverified figures (the effective interest rate and specific current portion amounts) weakens the credibility of the synthesis. The core insight about the note's maturity and refinancing implications is present but less clearly articulated than in the ground truth. QUANTITATIVE ACCURACY: While the $495M figure is correct, the introduction of the 3.23% rate and the specific current portion figures without ground truth support reduces confidence in the numerical accuracy. The comparison of current portion figures ($1,245M vs $1,563M) cannot be verified against the provided ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 509,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "From 2022 through 2024 AMD kept the same approach to its add‑in‑board (AIB) partners: the company’s agreements consistently “protect their inventory of our products against price reductions.”  The wording did not change, and no new return‑right or stock‑rotation clauses were added for AIBs.  At the same time, AMD continued to position discrete graphics as the key differentiator for system integrators, noting that SIs use discrete GPU solutions to set their board‑level products apart and add value for customers.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts about AMD's AIB strategy from 2022-2024: (1) consistent inventory protection policies with the exact quoted language about protecting 'inventory of our products against price reductions,' (2) no changes to return rights or stock rotation clauses, and (3) discrete graphics positioned as a key differentiator. The quantitative accuracy is high since no specific numbers were required and the answer appropriately notes the absence of 'explicit quantitative changes in AIB-related revenue disclosed.' The answer accurately captures the stability of AMD's approach across the three-year period. However, there are minor gaps in completeness: (1) The LLM answer focuses heavily on the inventory protection policy but provides less detail on the 'short design cycles' and 'rapid response to new technologies' aspects mentioned in the ground truth as evidence of sustained strategic focus. (2) The ground truth emphasizes that AIBs 'build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors' - a structural detail about the AIB channel that the LLM answer omits. (3) The ground truth notes this relationship 'remained consistent' across all three years with 'repeated emphasis' on multiple strategic elements, while the LLM answer focuses primarily on the inventory protection policy. The LLM answer is semantically sound and factually accurate in what it states, but it provides a narrower interpretation of the strategic evolution question by emphasizing policy consistency over the broader strategic positioning elements. The answer correctly synthesizes the multi-hop information (AMD's approach across three years and its relationship to AIBs and system integrators) but could have been more comprehensive in addressing all dimensions of strategic positioning mentioned in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 512,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "Disney’s DTC strategy shifted from a 2022 “ad‑supported Disney+” launch and cost‑realignment plan (to capture price‑sensitive customers and add ad revenue) to a 2023 overhaul of content curation, the launch of an ESPN flagship DTC service, and a push for higher subscription and advertising revenue to offset linear‑network declines【page 24】. By 2024 Disney had reorganized its media‑entertainment division, entered a Star India joint venture, and continued to refine content curation, pricing, and bundling to compete more aggressively in the crowded streaming market, while noting that subscriber growth may stay flat or negative in the short term but is expected to lift revenue through higher subscription fees and ad revenue【page 22】【page 23】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides some correct strategic details but diverges significantly from the ground truth in key ways: (1) CORRECT ELEMENTS: The answer accurately identifies the 2022 ad-supported Disney+ launch, the 2023 ESPN DTC service launch, and the 2024 reorganization/competitive positioning. The mention of bundling, pricing refinement, and competitive pressures aligns with ground truth. (2) CRITICAL OMISSIONS: The LLM answer completely misses the core evolution narrative from the ground truth - the shift from 'cautious investment with acknowledged financial risks' (2022) to 'confident strategic investment with expected revenue offsets' (2023) to 'operationally critical with competitive dependency' (2024). The ground truth emphasizes a psychological/strategic shift in Disney's confidence and positioning, not just operational changes. (3) FACTUAL ISSUES: The LLM mentions 'Star India joint venture' which is not mentioned in the ground truth answer and may be an unsupported detail. The ground truth specifically quotes Disney's 2022 language about 'costs and losses may continue to grow' and 2023 language about investments leading to growth that 'will more than offset' declines - these specific strategic statements are absent from the LLM answer. (4) REASONING GAP: The LLM focuses on tactical/operational changes (content curation, pricing, bundling, reorganization) rather than the strategic confidence evolution that the ground truth emphasizes. The ground truth shows a narrative arc of risk acknowledgment → confident investment → operational integration, while the LLM shows a narrative of tactical refinement. (5) QUANTITATIVE: No specific numbers are provided in either answer, so quantitative accuracy is neutral. The LLM's mention of 'flat or negative subscriber growth in short term' aligns with ground truth's competitive pressure theme but lacks the specific revenue offset language from ground truth. The answer is partially correct on operational details but misses the strategic evolution narrative that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 555,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "PayPal’s 2.850 % fixed‑rate notes, issued in September 2019 with a 10/1/2029 maturity, remained unchanged in principal ($1.5 billion) and effective interest rate (2.96 %) through 2022, 2023 and 2024.  While the company’s overall term‑debt grew—from $9.0 billion in 2022 to $10.6 billion in 2023 and 2024 due to new issuances—the 2.850 % series stayed in the debt mix and its maturity obligations did not shift.  No redemption or repurchase of these notes occurred during that period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) Principal amount of $1.5 billion for the 2.850% notes is accurate across all three years; (2) Maturity date of 10/1/2029 is correct; (3) No redemptions or repurchases occurred during the period; (4) Overall debt structure evolution is correctly identified; (5) The observation about new higher-rate issuances in 2024 is accurate. INCORRECT/PROBLEMATIC ELEMENTS: (1) The 2024 total term debt figure is stated as $10.6 billion, but ground truth shows $10.574 billion - this is a rounding discrepancy but the LLM states it remained at $10.6 billion 'in 2023 and 2024,' which is inaccurate since 2024 declined slightly to $10.574B; (2) The effective interest rate of 2.96% is mentioned but not in the ground truth answer, making it difficult to verify; (3) The statement that debt 'grew...due to new issuances' in 2024 is misleading since the ground truth shows a slight decline from 2023 to 2024 ($10.638B to $10.574B). MULTI-HOP REASONING: The LLM correctly synthesizes information across the three-year period and identifies the relationship between the stable 2.850% notes and the evolving broader debt structure. However, the characterization of 2024 debt growth is inaccurate. QUANTITATIVE ACCURACY: The principal amount ($1.5B) and maturity date are correct, but the 2024 debt figure and the characterization of debt movement in 2024 contain errors. The effective interest rate of 2.96% cannot be verified against the ground truth. COMPLETENESS: The answer addresses the evolution of the relationship and maturity obligations, but slightly mischaracterizes the 2024 debt trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 456,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "UNP’s pension plan cut its corporate‑stock exposure dramatically: corporate stock was 1,111 million of 2,990 million fair‑value assets in 2022 (≈ 37 %) but fell to 181 million of 3,385 million in 2023 (≈ 5 %)【page_58】【page_57】.  By 2024 the plan’s equity target was trimmed to 20‑30 % of assets (down from 48 % in 2022), indicating a deliberate de‑risking and a shift toward a more debt‑heavy, conservative equity stance【page_56】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM states corporate stock was '$1,111 million of 2,990 million' in 2022, but the ground truth specifies $1,990 million in 2022. This is a significant factual error ($879M difference). The 2023 figure of $181 million is correct. The LLM's percentage calculations (37% in 2022, 5% in 2023) are mathematically consistent with their stated numbers but based on incorrect 2022 baseline. (2) MISSING KEY INFORMATION - The ground truth emphasizes a critical reclassification in 2024: common stock holdings were reclassified as Level 1 investments while preferred shares became Level 2. The LLM completely omits this important methodological shift regarding valuation transparency and observable market data. (3) INCOMPLETE SYNTHESIS - The LLM mentions equity target allocation changes (48% to 20-30%) but doesn't connect this to the specific stock holdings data or explain the reclassification strategy. The ground truth's emphasis on 'more transparent and observable valuation methodologies' is absent. (4) PARTIAL CREDIT - The LLM correctly identifies the dramatic reduction in equity exposure and the de-risking strategy, and the 2023 figure of $181 million is accurate. The directional narrative about moving toward more conservative positioning is correct. However, the foundational 2022 number error undermines the entire quantitative analysis and the omission of the 2024 reclassification represents incomplete multi-hop synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 419,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "Pfizer’s long‑term investment in private‑equity securities at cost fell from **$800 million** at December 31 2022 to **$719 million** at December 31 2024, a decline of **$81 million** (≈10 %). The modest contraction suggests a slight rebalancing away from illiquid alternative investments, although the company still maintains a substantial private‑equity exposure. (Sources: page 86 for 2022/2023 figures; page 83 for 2024/2023 figures)",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains major factual inaccuracies that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The 2022 figure is stated as $800 million, but ground truth shows $623 million - a $177 million discrepancy (28% error). The 2024 figure of $719 million is correct. The calculated decline of $81 million is mathematically correct given the LLM's incorrect starting point ($800M - $719M = $81M), but this is based on a false premise. The correct decline should be $623M to $719M, which is actually an INCREASE of $96 million, not a decrease. The percentage calculation of ~10% decline is also wrong given the incorrect base numbers. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth shows a three-year trend (2022: $623M → 2023: $755M → 2024: $719M), revealing a peak in 2023 followed by retrenchment. The LLM only compares 2022 to 2024, missing the critical 2023 peak data point and the important intermediate trend that suggests strategic allocation decisions. This is a significant omission in multi-hop reasoning. (3) INVERTED CONCLUSION: The LLM concludes there was a 'modest contraction' and 'rebalancing away from illiquid alternative investments,' but the actual data shows growth from 2022 to 2023 (21% increase) followed by modest decline in 2024. The ground truth characterizes this as 'short-term growth strategy in alternative investments in 2023, followed by modest retrenchment in 2024' - a more nuanced and accurate interpretation. (4) ENTITY/METRIC ACCURACY: While Pfizer and private equity securities are correctly identified, the specific financial figures are fundamentally wrong, making the entire analysis unreliable. The LLM's citation references (page 86, page 83) cannot be verified but appear to be incorrect given the data discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 492,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "From 2022 to 2024 Mastercard’s multi‑layered security framework grew in scope and depth: in 2022 the company relied on third‑party assessments, an enterprise resilience program, insurance coverage and public‑private partnerships to guard against cyber and information‑security threats; by 2023 it added dedicated Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center, and explicitly addressed risks from third‑party service providers; in 2024 those elements were further integrated, with expanded monitoring of third‑party providers and reinforced resilience and insurance coverage.  At the same time, real‑time account‑based payment infrastructure expanded from 12 to 13 of the world’s top 50 markets, reflecting a broader push to deliver instant, secure payments worldwide while maintaining a robust, multi‑layered defense against cyber threats.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) CHRONOLOGICAL REVERSAL: The LLM fundamentally misorders the evolution of Mastercard's security approach. The ground truth states that Security Operations Centers, Fusion Centers, and Mastercard Intelligence Center were emphasized IN 2022, but the LLM incorrectly places these as being 'added by 2023.' This is a major factual error that undermines the entire narrative of evolution. (2) QUANTITATIVE INACCURACY: The LLM states 'real-time account-based payment infrastructure expanded from 12 to 13 of the world's top 50 markets.' The ground truth specifies that Mastercard was 'operating or implementing real-time payment infrastructure in 13 markets as of year-end' (2023), with no mention of a 12-to-13 expansion or any reference to 'top 50 markets.' This appears to be fabricated data not supported by the ground truth. (3) INCOMPLETE THIRD-PARTY COLLABORATION NARRATIVE: The LLM mentions 'third-party assessments' and 'insurance coverage' in 2022, but the ground truth emphasizes that explicit inclusion of third-party service providers in threat monitoring came in 2023, not 2022. The LLM conflates different aspects of the security framework. (4) MISSING KEY DETAILS: The LLM omits the important detail about EMV technical standards development mentioned in the ground truth for 2022. (5) VAGUE CHARACTERIZATION: The LLM's description of 2024 activities ('those elements were further integrated') is less specific than the ground truth's emphasis on 'working with experts across the organization and through third-party providers.' The answer demonstrates partial understanding but contains significant factual errors, particularly the chronological misplacement of key security infrastructure components and unsupported quantitative claims about market expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 489,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "ExxonMobil reported $1,494 million of collateral under master‑netting arrangements in 2022, which fell to $800 million in 2023 and further to $491 million in 2024. The declining collateral—roughly a 46 % drop from 2022 to 2023 and a 38 % drop from 2023 to 2024—suggests the company has reduced its derivative exposure or achieved more efficient netting and margin practices over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports $1,494 million for 2022, but the ground truth states the 2022 figure was $800 million. This is a massive discrepancy ($694M difference). The LLM correctly identifies $800M for 2023 and $491M for 2024, but the starting point is wrong. The LLM calculates a 46% drop from 2022 to 2023 ($1,494M to $800M), but this calculation is based on the incorrect $1,494M figure. The correct 2022-to-2023 change should be from $800M to $800M (0% change, not a decline). The 38% drop from 2023 to 2024 ($800M to $491M) is correctly calculated. (2) TEMPORAL MISALIGNMENT: The ground truth clearly establishes that the $800M figure represents the end of 2022 (reported in the 2023 filing), not 2023. The LLM has shifted all years forward by one period, creating confusion about which fiscal year corresponds to which amount. The correct sequence is: 2021: $641M → 2022: $800M → 2023: $491M. The LLM presents: 2022: $1,494M → 2023: $800M → 2024: $491M. (3) MULTI-HOP REASONING: While the LLM correctly identifies the general trend (declining collateral over time) and provides reasonable interpretation about derivative exposure management, this reasoning is built on incorrect foundational numbers. The synthesis of the trend interpretation is sound in principle but applied to wrong data points. (4) MISSING CONTEXT: The LLM fails to mention the 2021 baseline of $641M and the peak at $800M in 2022, which are important for understanding the full trajectory. The ground truth emphasizes the 38% decrease from 2022 to 2024, which the LLM does mention but calculates from wrong baseline figures. The answer demonstrates understanding of the conceptual framework but fails on basic factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 503,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "The relative‑TSR model’s expected volatility rose from 26.9 % in 2022 to 28.6 % in 2023 (page 214, page 206) and then fell sharply to 18.7 % in 2024 (page 217). This multi‑year swing suggests that investors viewed Duke Energy as increasingly stable and less risky relative to its peer group in 2024, reflecting a perceived improvement in the company’s market risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three volatility percentages are correct - 26.9% (2022), 28.6% (2023), and 18.7% (2024) - matching the ground truth exactly. The page references (214, 206, 217) provide appropriate sourcing. (2) COMPLETENESS: The answer addresses all required elements: the three-year volatility trajectory, the peak in 2023, the decline in 2024, and the interpretation of what this suggests about market risk perception. (3) ENTITY ACCURACY: Duke Energy is correctly identified, the TSR model is properly referenced as 'relative-TSR model,' and all years are accurate. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the pattern (rise then fall), interprets the 2023 peak as increased perceived risk, and concludes that the 2024 decline suggests improved stability and reduced uncertainty. The interpretation that investors viewed Duke Energy as 'increasingly stable and less risky' in 2024 is semantically equivalent to the ground truth's 'stabilization or reduced uncertainty.' (5) MINOR CONSIDERATION: The ground truth uses 'stabilization or reduced uncertainty' while the LLM uses 'increasingly stable and less risky' - these are semantically equivalent interpretations of the same data pattern. The LLM's phrasing is slightly more explicit about investor perception improvement, which is a reasonable inference from the volatility decline. No calculation errors, no missing data points, and the logical flow from numbers to interpretation is clear and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 437,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "From 2022 through 2024 GM’s indemnification obligations to Stellantis for legacy Opel/Vauxhall vehicles remained immaterial and unchanged.  The company recorded an immaterial accrual for indemnifying Stellantis on emissions‑related claims and recalls, and it noted that any further indemnification for Takata inflator recalls in legacy Opel vehicles would be “remote” at this time.  No material loss estimate was provided, and the obligations were subject to time limits, thresholds and caps.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements but has significant gaps and lacks important details from the ground truth. STRENGTHS: (1) Correctly identifies that indemnification obligations remained immaterial across the period; (2) Accurately notes the 'remote' characterization for future Takata indemnification; (3) Correctly identifies both Takata recalls and emissions-related claims as relevant; (4) Appropriately mentions time limits, thresholds, and caps. WEAKNESSES: (1) CRITICAL OMISSION - The LLM fails to distinguish between the three years (2022, 2023, 2024) and their evolution. The ground truth explicitly describes how GM's disclosures evolved year-by-year, including that in 2023 GM stated further indemnification was 'remote' and in 2024 GM noted accruals for European Commission and UK CMA investigations into Opel conduct. The LLM presents this as static ('remained unchanged') rather than showing the temporal evolution requested; (2) INCOMPLETE - The LLM does not mention the European Commission and UK CMA investigations into Opel conduct that were accrued in 2024, which is a material distinction in how the obligations evolved; (3) VAGUE SYNTHESIS - The answer conflates emissions claims with Takata recalls without clearly separating them as distinct issues, whereas the ground truth treats them as separate indemnification matters; (4) MISSING CONTEXT - The ground truth emphasizes that GM 'reiterated' and 'continued to emphasize' across years, showing consistency, but the LLM doesn't capture this multi-year narrative arc. The question specifically asks 'how did...evolve' which requires year-by-year comparison, not a static summary. The LLM provides a reasonable but incomplete snapshot rather than the requested evolution analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 479,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "Across its 2022, 2023 and 2024 10‑K filings, AMD continues to reference the 2011 Executive Incentive Plan in the same way: “*10.1 2011 Executive Incentive Plan, filed as Exhibit 10.2 to AMD’s Quarterly Report on Form 10‑Q for the period ended April 2, 2011, is hereby incorporated by reference.” (See page 93 of the 2022 filing, page 99 of the 2023 filing and page 96 of the 2024 filing.) The unchanged reference shows that the plan remains a core, long‑term element of AMD’s executive‑compensation framework, underscoring a stable, continuity‑focused strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN EXHIBIT REFERENCE: The LLM states the plan was 'filed as Exhibit 10.2 to AMD's Quarterly Report on Form 10-Q for the period ended April 2, 2011,' but the ground truth clearly indicates it was 'filed on April 2, 2011' and listed as 'Exhibit 10.1' (not 10.2). This is a significant factual error in a key detail. The LLM also provides specific page numbers (93, 99, 96) that cannot be verified against the ground truth and may be inaccurate. While the LLM correctly identifies that the plan was consistently referenced across 2022, 2023, and 2024 without amendments, and correctly interprets this as suggesting a stable compensation strategy, the exhibit number error and the discrepancy between 'filed as Exhibit 10.2 to Form 10-Q' versus the ground truth's 'Exhibit 10.1 filed on April 2, 2011' are material factual errors. The semantic interpretation about stability and continuity is sound, but the foundational factual accuracy is compromised. The LLM demonstrates partial understanding of the multi-hop synthesis (comparing references across three years) but fails on precise factual accuracy regarding the exhibit designation and filing details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 331,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "From 2022 through 2024 PayPal’s risk disclosures increasingly highlighted that its expanding U.S. and international credit‑product lines, higher cross‑border trade volumes, and deeper reliance on third‑party lenders, processors and BNPL partners had amplified exposure to bad‑transaction losses. In 2023 the company mitigated this risk by selling a large portion of its U.K./European BNPL loan receivables (a €40 billion forward‑flow arrangement) and accelerating a transition to a broader set of payment processors, while tightening its credit‑risk models and fraud‑detection controls. By 2024 the disclosures reflected that those actions had reduced, but not eliminated, the risk of credit defaults, cross‑border regulatory disruptions and third‑party failures, and continued to emphasize the need for ongoing vigilance.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the €40 billion BNPL receivables sale in 2023 as a key strategic action, matching the ground truth. (2) The timeframe (2022-2024) and general risk evolution narrative are accurate. (3) The quantitative figure of €40 billion is correct and properly formatted. (4) The answer appropriately addresses the multi-hop nature of the question by synthesizing information across years and risk categories.\n\nWEAKNESSES: (1) The LLM introduces claims not supported by the ground truth, specifically: 'accelerating a transition to a broader set of payment processors' and 'tightening its credit-risk models and fraud-detection controls.' The ground truth does not mention these specific mitigation actions. (2) The LLM states these actions 'had reduced, but not eliminated, the risk' by 2024, which is an inference not explicitly stated in the ground truth. (3) The ground truth specifically mentions PayPal's U.S. consumer credit product with Synchrony Bank in 2022, which the LLM omits. (4) The ground truth notes 'regulatory uncertainty, especially around the validity of loan sales post-transfer' in 2024, which the LLM does not capture. (5) The LLM's characterization of 'deeper reliance on third-party lenders, processors and BNPL partners' as a cause of increased risk is somewhat speculative—the ground truth mentions third-party reliance as an ongoing challenge but doesn't explicitly frame it as a driver of increased exposure.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis across the 2022-2024 period and connects credit products, cross-border trade, and third-party dependencies. However, it adds details not in the ground truth (payment processors, fraud-detection controls) that suggest either hallucination or over-inference from limited information.\n\nCRITICAL ISSUE: The introduction of unsupported mitigation actions (payment processor transition, tightened credit models) represents a factual accuracy problem. While the core answer about the €40 billion BNPL sale is correct, the additional claims reduce confidence in the overall response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 567,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "From 2022 to 2024, Union Pacific’s multiple‑purpose locomotive fleet fell from 7,242 units (6,204 owned, 1,038 leased) with an average age of 22.5 years to 6,893 units (5,973 owned, 920 leased) and an average age of 25.2 years【page_24】【page_19】. The decline in owned locomotives and the rise in average age show a deliberate retirement of older units and a shift toward newer, more efficient locomotives—underscoring the company’s focus on fleet modernization and capital‑efficient asset management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN INTERPRETATION AND REASONING: (1) QUANTITATIVE ACCURACY FAILURES: All numbers are correct (6,204→5,973 owned, 1,038→920 leased, 22.5→25.2 years average age, 7,242→6,893 total), but the LLM fundamentally misinterprets what these numbers mean. The decline in owned locomotives from 6,204 to 5,973 (231 units, or 3.7%) is NOT 'deliberate retirement of older units' toward newer, more efficient locomotives—it's a net reduction in fleet size. (2) LOGICAL CONTRADICTION: The LLM claims the strategy shows 'focus on fleet modernization' but the ground truth explicitly states the opposite: 'a fleet management strategy that prioritizes cost control over aggressive modernization.' The increasing average age (22.5→25.2 years) is the smoking gun—if the company were modernizing, average age should decrease, not increase by 2.7 years. (3) REASONING FAILURE: The LLM inverts the meaning of the data. A reduction in both owned and leased units combined with rising average age indicates the company is NOT replacing aging equipment with new purchases—it's simply reducing fleet size while the remaining fleet ages. This is cost control, not modernization. (4) MISSING CONTEXT: The ground truth notes 'reduced leasing but did not substantially increase new purchases to offset aging'—the LLM completely misses this critical insight about what the company is NOT doing. (5) SEMANTIC INVERSION: The LLM's conclusion ('fleet modernization and capital-efficient asset management') directly contradicts the ground truth's conclusion ('cost control over aggressive modernization'). The data supports the ground truth interpretation: aging fleet + reduced leasing + no new purchases = deferred modernization. The LLM has the facts right but draws the opposite conclusion from what the data actually indicates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 491,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply from **$1.494 billion in 2022 to $491 million in 2024**—a reduction of roughly $1.0 billion.  The decline reflects a more disciplined derivative‑risk strategy, likely driven by greater use of cleared swaps, tighter netting, and a shift toward lower‑margin or more efficiently collateralized positions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states collateral was '$1.494 billion in 2022' but ground truth shows $641 million in 2022—an error of over $850 million (133% overstatement). The 2024 figure of $491 million is correct, but the starting point is completely wrong. The calculated decline of '$1.0 billion' is therefore incorrect; the actual decline from 2022-2024 was only $150 million ($641M to $491M). (2) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM failed to capture the complete three-year trend. Ground truth shows: 2022: $641M → 2023: $800M → 2024: $491M. This reveals a peak in 2023 followed by decline, which is a critical pattern the LLM missed entirely. The LLM only compared endpoints, missing the intermediate year and the important peak. (3) REASONING QUALITY: While the LLM's interpretation about 'disciplined derivative-risk strategy' and 'cleared swaps' is plausible, it's built on false premises. The magnitude of the error undermines any analytical conclusions. (4) MISSING CONTEXT: The LLM failed to mention the 2023 peak ($800M) and the significance of level 3 fair value inputs mentioned in ground truth, which are relevant to understanding valuation methodology. The answer is internally inconsistent—claiming a 'sharp fall' but the actual 2022-2024 decline is modest relative to the 2022-2023 increase. This is a case where the LLM provided plausible-sounding analysis but with fundamentally incorrect foundational numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 428,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "Starbucks’ 10‑K filings for 2022, 2023 and 2024 all describe the “Other” revenue mix in the same way – it consists of packaged and single‑serve coffees, teas, royalty and licensing revenues, beverage‑related ingredients, serveware and ready‑to‑drink beverages.  The share of packaged and single‑serve coffee within this category rose modestly from 21 % of total net revenues in 2022 to 22 % in 2023, then fell back to 21 % in 2024, indicating a largely stable mix with only a slight shift in relative weight.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces specific percentage figures (21% in 2022, 22% in 2023, 21% in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states there was 'no explicit mention of new product categories or significant shifts in this segment over the three-year period' and describes the composition as 'remained relatively stable' without providing specific percentage breakdowns. The LLM appears to have fabricated quantitative data that contradicts the ground truth's assertion that the category remained stable without detailed percentage shifts being documented. While the LLM correctly identifies the component items (packaged and single-serve coffees, teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages), the introduction of unsubstantiated percentage metrics is a fundamental factual error. The LLM also claims these percentages represent 'share of packaged and single-serve coffee within this category' but the percentages appear to be presented as shares of total net revenues, creating additional confusion. The qualitative description of stability is correct, but the quantitative claims are entirely unsupported by the ground truth and represent hallucinated data. This is a severe accuracy issue that undermines the credibility of the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 384,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "From 2022 through 2024 Alphabet continued to monetize inventory on Google Ad Manager for Google Network properties on a **gross basis** – revenue is booked when the ad is displayed or viewed (brand advertising) or when a user engages (performance advertising).  The company kept the same **impression‑based revenue recognition** policy, using cost‑per‑impression as a key metric, and reported Google Network revenue on a gross basis with partner payments recorded as cost of revenues, with no change to the methodology disclosed in the three filings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core monetization strategy and correctly identifies key elements: (1) gross basis revenue recognition, (2) impression-based revenue model, (3) cost-per-impression as key metric, (4) consistency across 2022-2024 period, and (5) partner payments as cost of revenues. The answer accurately captures the evolution showing increasing transparency and accounting clarity. However, there are some notable differences from the ground truth: (1) The LLM adds specific detail about 'brand advertising' vs 'performance advertising' and timing ('when displayed/viewed' vs 'when user engages') that is not explicitly mentioned in the ground truth, which could be seen as either helpful elaboration or potential over-specification beyond what was documented. (2) The LLM states 'no change to the methodology disclosed in the three filings' which is a reasonable inference but goes slightly beyond the ground truth's framing of 'consistent' and 'remaining consistent.' (3) The ground truth emphasizes 2023 as a clarification point ('Google clarified that it generally reports...'), while the LLM presents the gross basis approach as consistent throughout without highlighting this 2023 clarification moment. The quantitative accuracy is strong - no incorrect numbers or dates are present. The qualitative reasoning correctly synthesizes the multi-hop information about how Google's approach evolved while maintaining consistency. The answer is contextually relevant and addresses the question's focus on evolution from 2022-2024. Minor deductions reflect the slight divergence in emphasis regarding when clarifications occurred and the addition of details not explicitly in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 472,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "MDLZ’s 2023 and 2024 10‑Ks (see MDLZ_10k_2023.pdf pages 11–12 and MDLZ_10k_2024.pdf pages 10–11) reiterate that sales and media‑marketing restrictions—particularly front‑of‑pack labeling on nutrient profiles—remain a regulatory concern.  The regulatory landscape has broadened, with EPR policies now being implemented or contemplated not only in the EU but also in India, Vietnam and several U.S. states, increasing MDLZ’s exposure relative to the 2022 filing (MDLZ_10k_2022.pdf pages 13–17) which referenced EU EPR only.  Thus, MDLZ’s exposure to these restrictions has grown as more jurisdictions adopt EPR and front‑of‑pack labeling requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general trend of MDLZ's expanding regulatory exposure across jurisdictions but has significant gaps and lacks specificity compared to the ground truth. STRENGTHS: (1) Correctly identifies the core trend of EPR policy expansion from EU to India, Vietnam, and U.S. states; (2) Appropriately notes the shift from 2022 to 2023-2024; (3) Correctly identifies front-of-pack labeling as a key concern; (4) Properly synthesizes multi-hop information across three years. CRITICAL GAPS AND ERRORS: (1) MISSING QUANTITATIVE DATA: The ground truth specifies 'over 25 EU countries' had implemented EPR policies in 2022—the LLM answer provides no specific numbers, reducing quantitative accuracy; (2) INCOMPLETE JURISDICTIONAL COVERAGE: The ground truth mentions Indonesia and the Philippines as jurisdictions considering restrictions in 2022-2023, with specific mention of single-use plastic bans and taxes being considered in these countries by 2023. The LLM answer omits Indonesia and the Philippines entirely; (3) MISSING KEY REGULATORY DETAIL: The ground truth specifically mentions the EU's formal adoption of the Packaging and Packaging Waste Directive in 2024—a concrete regulatory milestone. The LLM answer does not reference this specific directive; (4) INCOMPLETE EVOLUTION NARRATIVE: The ground truth shows a clear progression from 'considered' (2022-2023) to 'implemented or contemplated' (2024), indicating enforcement shift. While the LLM touches on this, it lacks the specificity about the 2024 shift to enforcement; (5) MISSING ENVIRONMENTAL CLAIMS CONTEXT: The ground truth notes increased attention to 'environmental claims' in 2023, which the LLM answer does not mention. QUANTITATIVE ACCURACY ASSESSMENT: The LLM provides no specific numbers (e.g., '25 EU countries'), making it impossible to verify numerical precision. The answer relies on qualitative descriptions rather than quantitative data present in the ground truth. MULTI-HOP REASONING: The synthesis across three years is present but incomplete—the answer successfully connects the jurisdictional expansion but fails to capture the temporal evolution of policy maturity (from consideration to implementation). SEMANTIC EQUIVALENCE: While the general message about growing exposure is correct, the answer lacks the granular detail and specificity that characterizes the ground truth, particularly regarding specific countries and regulatory mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 650,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "Across 2022‑24, Mastercard’s Class A shares retained the same voting and dividend rights: each share continued to carry one vote and dividend entitlement, while the dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024 (Note 16 and dividend tables on pages 95, 97, 94). This unchanged voting structure coupled with steadily higher dividends signals a conservative capital‑structure strategy that preserves voting stability while progressively enhancing shareholder returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Class A shares maintained consistent voting rights (one vote per share) across 2022-2024, which aligns with the ground truth. The reasoning about capital structure strategy preservation is sound and well-articulated. However, there is a critical factual error: the LLM introduces dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT present in the original ground truth answer. The ground truth explicitly states only that 'A Class shares consistently maintained one vote per share and dividend rights' with 'no changes in their voting or dividend entitlements over the three-year period.' The LLM appears to have added specific dividend per share figures with citations (Note 16, pages 95, 97, 94) that cannot be verified against the provided ground truth. This represents either fabrication or information from sources not reflected in the knowledge graph answer. While the dividend progression narrative (steadily higher dividends) is logically coherent and the interpretation about 'conservative capital-structure strategy' is reasonable, the introduction of unverified quantitative data significantly undermines accuracy. The answer goes beyond the ground truth by adding specific numbers and a more detailed narrative about dividend increases, which changes the scope of the answer. The core finding about voting rights stability is correct, but the embellishment with unverified dividend figures and the shift in emphasis from 'no changes in entitlements' to 'steadily higher dividends' represents a material deviation from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 444,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "ExxonMobil’s collateral under master‑netting arrangements fell sharply: it was $1.494 billion in 2022, dropped to $800 million in 2023, and further declined to $491 million in 2024. The steep reduction indicates a lower derivative exposure or more efficient netting, resulting in reduced initial‑margin requirements over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The 2022 figure is fundamentally wrong. LLM states $1.494 billion, but ground truth shows $641 million. This is a 133% overstatement of the 2022 value. The 2023 ($800M) and 2024 ($491M) figures are correct. (2) TREND MISCHARACTERIZATION - The LLM describes a 'sharp fall' from 2022-2023, but the actual trend shows an INCREASE from $641M to $800M in 2023, followed by a decrease to $491M in 2024. The LLM's narrative of 'steep reduction' is backwards for the 2022-2023 period. (3) MULTI-HOP REASONING - While the LLM attempts to synthesize the data and provide interpretation about derivative exposure and margin requirements, the foundational numbers are incorrect, making the analysis unreliable. The interpretation about 'lower derivative exposure or more efficient netting' may be reasonable IF the numbers were correct, but it contradicts the actual 2022-2023 increase. (4) COMPLETENESS - The LLM does address the trend question and attempts to explain what it suggests, but the incorrect baseline makes the entire analysis flawed. The ground truth explicitly notes the 2023 INCREASE as 'notable,' which the LLM completely misses. (5) ENTITY ACCURACY - Company and metric identification are correct (ExxonMobil, collateral under master netting arrangements), but the specific financial data is substantially wrong. The error appears to be a data retrieval or calculation mistake rather than a conceptual misunderstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 409,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "Starbucks’ forward‑looking supply‑chain commitments have been extended each year: in FY 2022 the company’s fixed‑price, price‑to‑be‑fixed purchase contracts and forward/futures hedges were expected to secure supply through FY 2023 (Product Supply, page 12, 2022); in FY 2023 those commitments were rolled out to cover through FY 2024 (Product Supply, page 12, 2023); and in FY 2024 they were further extended to cover through FY 2025 (Product Supply, page 12, 2024). This progressive extension shows Starbucks is proactively locking in coffee supply and prices ahead of time, using a mix of fixed‑price and hedging instruments, to mitigate price volatility and supply risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN FISCAL YEAR PROGRESSION: The LLM answer contains a fundamental factual error in the timeline of supply commitments. According to the ground truth: FY2022 commitments extended through FY2023, FY2023 commitments extended through FY2025, and FY2024 commitments extended through FY2025. However, the LLM states: FY2022 through FY2023 (correct), FY2023 through FY2024 (INCORRECT - should be FY2025), and FY2024 through FY2025 (correct). This is a significant quantitative error that misrepresents the company's strategic evolution. The LLM incorrectly suggests a year-by-year rolling extension pattern (2023→2024→2025) when the actual pattern shows a jump from 2023 to 2025 in FY2023, then maintenance at 2025 in FY2024. This error undermines the entire analysis of the company's strategy. POSITIVE ASPECTS: The LLM correctly identifies that commitments were extended progressively, correctly names the company (Starbucks), correctly identifies the use of fixed-price contracts and hedging instruments (forward/futures contracts), and appropriately concludes this represents proactive risk mitigation. The citation format and page references are reasonable. However, the core quantitative facts about which fiscal years were covered are materially incorrect, which is unacceptable for a financial analysis question where precision is paramount. The semantic understanding of the strategy is partially correct, but the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 404,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "ACN’s target mix for its defined‑benefit plans shifted from 2023 to 2025 by tightening the U.S. plan’s allocation to 100 % debt securities (up from 95 %) and, in non‑U.S. plans, raising equity exposure from 19 % to 28 % while trimming debt from 43 % to 36 % (page 95). This gradual move toward a more fixed‑income heavy U.S. portfolio—paired with a modest equity bump in non‑U.S. plans—reflects a long‑term strategy that prioritizes liability‑duration matching and risk‑adjusted returns, aiming to preserve capital stability while still pursuing incremental growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, quantifiable details about ACN's target asset allocation shifts from fiscal 2023 to fiscal 2025, which the ground truth answer lacks. The LLM correctly identifies: (1) U.S. plan debt allocation increased from 95% to 100%, (2) non-U.S. equity exposure rose from 19% to 28%, and (3) non-U.S. debt decreased from 43% to 36%. These specific percentages demonstrate concrete multi-hop synthesis across fiscal years. The LLM also correctly interprets the strategic implications: liability-duration matching, risk-adjusted returns, capital preservation, and incremental growth objectives. The page reference (page 95) adds credibility. The quantitative accuracy is strong with all percentages appearing internally consistent (U.S.: 95%→100% debt; non-U.S.: 19%+43%=62% baseline, 28%+36%=64% updated, with remaining allocation to other assets). The qualitative reasoning is sound, connecting specific allocation changes to strategic objectives. Minor weakness: the ground truth emphasizes 'continuity in strategy with updated flexibility ranges,' while the LLM frames it as a 'gradual move' and 'shift,' which is semantically similar but slightly different emphasis. The LLM answer is more concrete and specific than the ground truth, providing actual numbers rather than general statements about 'diversified portfolio' and 'flexibility ranges.' This specificity strengthens rather than weakens the answer, as it demonstrates successful extraction of detailed multi-hop information from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 420,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "Amgen’s 2022 10‑K listed Olpasiran as a phase‑2 siRNA candidate for “cardiovascular disease” (Lp(a) lowering)【page_24】, and the 2023 filing kept the same therapeutic focus【page_24】. By the 2024 filing the program had advanced to phase‑3 for atherosclerotic cardiovascular disease (ASCVD), sharpening its indication to ASCVD risk reduction【page_24】【page_26】. In all three years the composition‑of‑matter patents for Olpasiran in the U.S. and EU are set to expire in 2036, giving the company a 12‑year exclusivity window that has remained unchanged【page_26】【page_26】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key milestones and IP protection details. STRENGTHS: (1) Correctly identifies Olpasiran as an siRNA candidate across all three years (2022-2024); (2) Accurately states patent expiration in 2036 for U.S. and EU composition-of-matter patents; (3) Correctly notes the 12-year exclusivity window; (4) Properly synthesizes multi-hop information across three fiscal years; (5) Accurately describes the clinical progression from phase 2 to phase 3. MINOR DISCREPANCIES: (1) The LLM states 2022 filing listed Olpasiran for 'cardiovascular disease (Lp(a) lowering)' while the ground truth indicates it was specifically for 'atherosclerotic cardiovascular (CV) disease' in phase 2 trials - this is a slight characterization difference but the LLM's broader 'cardiovascular disease' framing is not incorrect, just less specific; (2) The LLM provides more detailed clinical progression information (phase 2 to phase 3 advancement by 2024) than the ground truth, which states 'transition from phase 2 investigation toward more advanced development' - the LLM's additional specificity about phase 3 appears accurate and enhances the answer; (3) The ground truth emphasizes 'therapeutic consolidation' while the LLM emphasizes 'sharpening its indication to ASCVD risk reduction' - these are semantically equivalent descriptions of the same strategic evolution. QUANTITATIVE VERIFICATION: Patent expiration date of 2036 is correct; 12-year exclusivity window calculation is accurate (2024 + 12 = 2036). MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly links clinical development stage with IP protection strategy. The reasoning is sound and logically presented. The answer is comprehensive, well-sourced with page references, and addresses all aspects of the question regarding therapeutic focus evolution and IP protection timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 529,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "American Express’s reliance on aggregators grew from a general third‑party dependence in 2022 to a more focused, merchant‑acquisition role in 2023 and to an even broader transaction‑processing role by 2024. In 2022 the filing warned mainly of partner‑relationship loss and third‑party failure; in 2023 it highlighted the risk of aggregators having inconsistent goals and the loss of control over merchant relationships; by 2024 the disclosures emphasized the heightened operational complexity, governance challenges, oversight gaps and data‑security risks that accompany the expanded aggregator network.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer partially addresses the question but contains significant semantic and factual divergences from the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the three-year period (2022-2024) and American Express as the subject\n2. Appropriately structures the answer chronologically by year\n3. No quantitative errors (no specific numbers to verify)\n4. Correctly identifies that risks evolved over the period\n\nWEAKNESSES:\n1. SEMANTIC MISALIGNMENT ON KEY RISKS: The ground truth emphasizes merchant steering, surcharging, and transaction volume reduction as core 2023 concerns. The LLM answer mentions \"inconsistent goals\" and \"loss of control\" but omits the specific merchant steering and surcharging language that appears in the original answer.\n\n2. INCOMPLETE RISK CHARACTERIZATION: The ground truth explicitly mentions \"litigation exposure\" and \"regulatory actions\" as 2024 concerns. The LLM answer mentions \"governance challenges, oversight gaps and data-security risks\" - while these may be present in filings, they diverge from the ground truth's emphasis on litigation and regulatory risks.\n\n3. INACCURATE 2022 CHARACTERIZATION: The ground truth states AXP expressed concern about how aggregators \"might act against AXP's interests, potentially impacting card usage and merchant acceptance.\" The LLM answer generalizes this as \"partner-relationship loss and third-party failure,\" which is less precise.\n\n4. QUESTIONABLE 2023-2024 EVOLUTION NARRATIVE: The LLM describes a shift from \"merchant-acquisition role\" to \"transaction-processing role,\" but the ground truth emphasizes a shift from merchant behavior concerns to broader systemic/legal concerns. These are different conceptual frameworks.\n\n5. MISSING CRITICAL DETAIL: The ground truth explicitly notes the trend shows \"shifting from a focus on merchant behavior to broader systemic and legal concerns.\" The LLM answer doesn't capture this specific analytical insight.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies an evolution pattern, but the specific content of that evolution differs materially from the ground truth. The reasoning structure is sound, but the factual content is misaligned.\n\nCONCLUSION: While the answer demonstrates understanding of the general question structure and temporal evolution, it fails to accurately capture the specific risks emphasized in each year's disclosures as documented in the ground truth. The divergence on merchant steering/surcharging (2023) and litigation/regulatory risks (2024) represents material factual errors rather than mere wording differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 707,
        "total_tokens": 2098
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "Starbucks’ exposure to commodity‑index funds remained a factor in green‑coffee price volatility throughout fiscal 2022‑2024, as the company noted that price swings are influenced by hedge funds and commodity‑index funds (SBUX_10k_2024 page_12; SBUX_10k_2023 page_12; SBUX_10k_2022 page_12). The firm continued to hedge “C”‑price exposure with a mix of fixed‑price and price‑to‑be‑fixed purchase commitments, forward contracts, futures and collars, and its forward supply commitments expanded from covering through fiscal 2024 in 2022 to covering through fiscal 2025 by 2024 (SBUX_10k_2024 page_12; SBUX_10k_2023 page_12; SBUX_10k_2022 page_12).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that commodity index funds influenced green coffee price volatility across fiscal 2022-2024 and that Starbucks used hedging strategies. However, there is a critical factual error in the timeline of forward supply commitments. The LLM states that commitments 'expanded from covering through fiscal 2024 in 2022 to covering through fiscal 2025 by 2024,' which is incorrect. According to the ground truth: (1) In 2022, commitments covered through fiscal 2023, (2) By 2023, they extended to fiscal 2025, and (3) In 2024, they remained at fiscal 2025. The LLM incorrectly states 2022 coverage extended to fiscal 2024 when it actually extended only to fiscal 2023. This is a significant quantitative error in a key metric. The LLM correctly identifies the hedging instruments (fixed-price, price-to-be-fixed, forward contracts, futures, collars) and appropriately cites source documents. The answer captures the general narrative of extended supply commitments but misrepresents the specific fiscal year progression. The LLM also misses the nuance about 'stabilized hedging strategy' and the strategic shift toward longer-term risk mitigation mentioned in the ground truth. The multi-hop reasoning is partially sound but undermined by the factual error in the timeline, which is central to answering how the strategy 'evolved' across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 385,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "Accenture repurchased 9.6 million shares for $3.15 million in fiscal 2022, with an available authorization of $3.129 billion that the Board later increased to $6.129 billion (ACN_10k_2022, page 94). In fiscal 2023 the company maintained a high level of available authorization and continued share repurchases, and in fiscal 2024 it bought 2.0 million shares for $605 million in Q4, with available authorization of $2.694 billion as of August 31, 2024—before a $4.0 billion boost raised the total to $6.694 billion (ACN_10k_2024, page 39‑40). This steady rise in both repurchase volume and periodic authorization increases shows a disciplined, flexible capital‑return strategy that consistently returns excess cash to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains multiple significant factual errors that undermine its credibility:\n\n1. FISCAL 2022 REPURCHASE VOLUME ERROR: LLM states '9.6 million shares for $3.15 million' - this is factually incorrect. The ground truth does not mention 9.6 million shares or $3.15 million for fiscal 2022. This appears to be fabricated data.\n\n2. FISCAL 2022 AUTHORIZATION ERROR: LLM claims authorization was increased to '$6.129 billion' in fiscal 2022. Ground truth shows the fiscal 2022 authorization was $3,129,296 (approximately $3.129 billion), with no mention of a $6.129 billion figure in 2022. The $6.694 billion authorization only occurred in fiscal 2024.\n\n3. FISCAL 2023 DATA ACCURACY: LLM correctly identifies 2.0 million shares purchased for $605 million in fiscal 2023 (ground truth confirms this), and correctly states the available authorization as $2.694 billion as of August 31, 2024.\n\n4. FISCAL 2024 AUTHORIZATION CORRECT: LLM correctly identifies the $4.0 billion additional authorization and the resulting $6.694 billion total as of September 25, 2024.\n\n5. MULTI-HOP SYNTHESIS ISSUE: While the LLM attempts to synthesize across three fiscal years, the fabricated fiscal 2022 data and misplaced authorization figures break the logical progression. The ground truth shows a clear trajectory: $3.129B (2022) → $2.694B available (2023) → $6.694B (2024 after $4B increase). The LLM's narrative of '$3.129B increased to $6.129B' in 2022 is historically inaccurate.\n\n6. QUALITATIVE ASSESSMENT: The LLM's conclusion about 'disciplined, flexible capital-return strategy' is reasonable and supported by the data, but is undermined by the factual errors in the supporting numbers.\n\nThe answer demonstrates partial understanding of the overall capital return strategy but fails on quantitative accuracy due to invented figures for fiscal 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 511,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "The long‑term portion of marketable equity securities subject to lock‑up restrictions fell from **$803 million at December 31, 2022** (page 66, 2022 10‑K) to **$266 million at December 31, 2024** (page 68, 2024 10‑K), a decline of about **$537 million (≈67 %)**. This sizable reduction indicates Google has trimmed its exposure to illiquid, long‑term lock‑up equity holdings, suggesting a shift toward more liquid or higher‑return investments and a rebalancing of its investment portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers and fails to match the ground truth data. Specific issues: (1) WRONG 2022 VALUE: LLM states $803 million for 2022, but ground truth shows $1.4 billion for 2022. The $803 million figure actually corresponds to 2023 in the ground truth. (2) WRONG 2024 VALUE: LLM states $266 million for 2024, but ground truth shows $1.4 billion for 2024. This is a massive discrepancy ($1.134 billion error). (3) WRONG CALCULATION: LLM calculates a decline from $803M to $266M (≈$537M or 67% decrease), but this calculation is based on incorrect starting and ending values. The correct comparison should be $1.4B (2022) to $1.4B (2024), showing NO net change over the period. (4) WRONG INTERPRETATION: The LLM concludes Google 'trimmed its exposure to illiquid holdings,' but the ground truth shows the value returned to $1.4 billion by 2024, suggesting cyclical rebalancing rather than a sustained reduction. (5) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM failed to capture the three-year trend (2022: $1.4B → 2023: $803M → 2024: $1.4B) that is central to understanding the fluctuation pattern. The answer demonstrates a complete failure to accurately extract and synthesize the correct financial data from the SEC filings, resulting in an answer that is factually incorrect on all major numerical points and draws an opposite conclusion from what the data supports.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 394,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "GE classified its captive industrial insurance subsidiary, Electric Insurance Company (EIC), as a held‑for‑sale asset in Q4 2022, signed a binding agreement to sell it in Q3 2023 and recorded a $109 million loss in other income that year (page_48).  The valuation allowance on the disposal group rose from $17 million in 2022 to $124 million in 2023, reflecting a decline in fair value (page_48).  In Q2 2024 GE completed the sale to Riverstone International Holdings for $120 million, eliminating the held‑for‑sale asset and its $376 million liability and providing a $120 million cash inflow that offset the earlier loss and valuation allowance (page_48).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several significant factual errors and inconsistencies that undermine its accuracy despite capturing the general narrative arc. Key issues: (1) TIMELINE ERROR - The LLM states EIC was classified as held-for-sale in Q4 2022, but the ground truth indicates this classification occurred in 2023. The LLM then contradicts itself by stating a binding agreement was signed in Q3 2023, which is inconsistent with a Q4 2022 held-for-sale classification. (2) VALUATION NUMBERS - The LLM cites a $17 million valuation allowance in 2022 and $124 million in 2023, but the ground truth does not mention these specific figures. The ground truth only references the $109 million loss recorded in 2023. (3) LIABILITY FIGURE - The LLM states the held-for-sale asset had a $376 million liability, but the ground truth specifies liabilities of $378 million as of December 31, 2023 - a $2 million discrepancy. (4) ASSET VALUATION - The ground truth mentions assets of $541 million and liabilities of $378 million in 2023, but the LLM does not reference the asset figure. (5) 2022 BASELINE - The ground truth notes net claim reserves of $0.2 billion in 2022, which the LLM completely omits. (6) SALE COMPLETION - The LLM correctly identifies Q2 2024 as the completion date and $120 million as the sale price, which matches the ground truth. The LLM does correctly synthesize the multi-hop progression (2022 baseline → 2023 held-for-sale with loss → 2024 completion), and the reasoning about strategic exit is sound. However, the specific quantitative errors and timeline inconsistencies significantly reduce reliability. The answer demonstrates understanding of the overall narrative but fails on precision of financial details and dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 474,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "Amgen’s Phase 3 portfolio grew from **13 programs in 2022** (page 25) to **18 in 2023** (page 26) and **24 in 2024** (page 26), reaching **25 by early 2025** (page 26). This steady expansion—largely driven by Horizon acquisitions, new Phase 3 initiations and FDA approvals—shows a deliberate scaling of the pipeline, with a strategic focus on biologics, biosimilars, oncology and immunology and an increasing reliance on human‑genetics‑driven, novel modalities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer states the portfolio reached '25 by early 2025' but the ground truth explicitly states '24 programs in 2024' and '25' as a separate statement about 2024 progression. The LLM conflates the timeline by suggesting 25 was reached 'by early 2025' when the ground truth indicates 25 was the 2024 figure. This is a significant quantitative error on a key metric. CORRECT ELEMENTS: (1) 13 programs in 2022 - CORRECT, (2) 18 in 2023 - CORRECT, (3) 24 in 2024 - CORRECT, (4) Horizon acquisition mention - CORRECT, (5) Strategic focus areas (oncology, immunology, biologics) - CORRECT and appropriately detailed. INCORRECT/PROBLEMATIC ELEMENTS: (1) The statement '25 by early 2025' misrepresents the timeline; ground truth shows 25 as part of 2024 progression, not a 2025 figure, (2) The LLM adds contextual details about 'human-genetics-driven, novel modalities' and 'increasing reliance' that, while potentially accurate, go beyond what the ground truth explicitly states about strategic focus. MULTI-HOP REASONING: The LLM correctly synthesizes the progression across three years and identifies key drivers (Horizon acquisitions, new Phase 3 initiations, FDA approvals). However, the temporal misplacement of the 25-program figure undermines the accuracy of the multi-hop synthesis. QUANTITATIVE ACCURACY PENALTY: The timeline confusion regarding when 25 programs was achieved (2024 vs early 2025) is a material error that affects the core quantitative narrative. The ground truth clearly indicates 24 in 2024 and 25 as the endpoint of 2024 progression, not a 2025 milestone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 440,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "From 2022 to 2024 American Express moved from a broadly‑licensed global card network to a more constrained model. In 2022 (see pages 12‑14) the company still operated its network‑licensing businesses and faced growing regulatory scrutiny of payment‑network practices, but had not yet made major changes. By 2024 (pages 34‑35) regulatory pressure on interchange‑fee caps and network routing, coupled with competitive pressure from Visa, Mastercard and alternative payment platforms, led the firm to exit its EU and Australian network‑licensing operations and to tighten its network agreements in anticipation of further interchange‑fee limits and surcharging rules.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of American Express's relationship with global card networks from 2022 to 2024, correctly identifying the shift from a licensed global network model to a more constrained one. Key strengths: (1) Correctly identifies the 2024 exits from EU and Australian network-licensing businesses, matching the ground truth; (2) Accurately names the competitive pressures (Visa, Mastercard, alternative payment platforms); (3) Properly identifies regulatory drivers (interchange-fee caps, network routing, surcharging rules); (4) Correctly synthesizes the multi-hop reasoning across years showing progression from 2022 to 2024. Minor weaknesses: (1) The LLM answer is somewhat more technical/regulatory-focused than the ground truth, emphasizing interchange fees and routing rules rather than the broader competitive positioning and cobrand partnerships mentioned in ground truth; (2) The ground truth mentions specific competitive dynamics around premium benefits, lounge access, and travel benefits that the LLM answer omits; (3) The ground truth explicitly mentions cobrand arrangement uncertainty in the EU, which the LLM answer does not address; (4) The LLM answer references specific page numbers (12-14, 34-35) which cannot be verified against the ground truth but appear reasonable for a 10-K filing. The answer demonstrates sound multi-hop reasoning by connecting regulatory pressures across years to business model changes, though it emphasizes regulatory/technical factors over competitive positioning. No numerical errors detected. The semantic meaning aligns well with ground truth despite different emphasis and framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 454,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "ConocoPhillips finished monetizing its CVE common shares in 2022 by selling the remaining 91 million shares, and the proceeds were applied to a share‑repurchase program that carried on through 2024.  In that period the company bought back 87 709 187 shares in 2022, 48 641 899 shares in 2023 and 49 135 049 shares in 2024, for a cumulative 433 million shares at a total cost of $34.3 billion through December 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides mostly accurate information with some strengths and minor weaknesses: CORRECT ELEMENTS: (1) CVE monetization completion in 2022 with 91 million shares sold - matches ground truth; (2) Cumulative 433 million shares repurchased at $34.3 billion through December 2024 - matches ground truth exactly; (3) Proceeds from CVE sale applied to share repurchase program - correct synthesis; (4) Time period coverage 2022-2024 - appropriate. QUANTITATIVE ACCURACY: The LLM provides specific annual share repurchase volumes (87.7M in 2022, 48.6M in 2023, 49.1M in 2024) that sum to approximately 185.5 million shares for the three-year period. However, the ground truth states 383 million shares were repurchased in 2022 alone, which is significantly different from the 87.7M figure provided. This represents a major discrepancy - the LLM's 2022 figure is only about 23% of the ground truth amount. The cumulative 433M and $34.3B figures are correct, but the annual breakdown appears incorrect. QUALITATIVE ACCURACY: The answer correctly identifies the multi-hop relationship between CVE monetization and share repurchases, and properly synthesizes the progression across the three-year period. The narrative flow is logical and addresses the evolution requested. COMPLETENESS: The answer addresses the main question about evolution from 2022-2024 and provides specific dollar amounts and share volumes, though the annual breakdown accuracy is questionable. CRITICAL ISSUE: The 2022 share repurchase volume discrepancy (87.7M vs. 383M) is substantial and suggests either a data error in the LLM response or a misunderstanding of what constitutes the relevant period. This is the primary factor limiting the correctness score despite the correct cumulative figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 483,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "In 2022 Home Depot had roughly 117 million shares available for future grants under its Omnibus Stock Incentive Plan (page 65). By the 2024 filing that pool had fallen to about 77 million shares (page 67), a drop of ~40 million shares. The decline shows the company has been actively issuing equity awards, depleting its authorized share pool and indicating high utilization of its stock‑based compensation capacity, which may limit future grant flexibility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains a significant factual error regarding the 2024 figure. The ground truth states that shares available declined from 117 million (2022) to 77 million (2023) to 70 million (2024). However, the LLM claims the 2024 figure was 77 million shares, which is actually the 2023 figure. This is a major error that undermines the core quantitative claim. The LLM states '2024 filing that pool had fallen to about 77 million shares' when it should be 70 million. The calculation of a ~40 million share drop is therefore incorrect (should be ~47 million from 2022 to 2024, or ~7 million from 2023 to 2024 depending on the intended comparison). MISSING INFORMATION: The LLM answer omits the 2023 intermediate data point (77 million shares), which is important for understanding the trend evolution across all three years. The ground truth emphasizes the 'consistent drawdown' across all three years, but the LLM only compares 2022 to 2024, missing the year-by-year progression. REASONING QUALITY: The qualitative reasoning about increased equity award issuance and reduced grant flexibility is sound and matches the ground truth's interpretation. The multi-hop synthesis is appropriate in connecting share depletion to compensation utilization. However, the factual errors significantly undermine the validity of this reasoning. ENTITY ACCURACY: Company name and plan name are correct. The reference to page numbers (65, 67) adds specificity but cannot be verified against the ground truth provided. SEMANTIC EQUIVALENCE: The general conclusion about active equity issuance and capacity constraints is semantically aligned with the ground truth, but the specific numbers are wrong, which is unacceptable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 483,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "Accenture raised the cap on its Amended 2010 Share Incentive Plan from **127 million Class A shares in 2022** (page 91) to **141 million Class A shares in 2024** (page 98).  The 14 million‑share expansion—no change reported for 2023—shows the company is deliberately enlarging its share‑based incentive pool to offer larger or more frequent awards, thereby strengthening talent attraction, retention and alignment with shareholder interests.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key numbers (127 million shares in 2022 and 141 million shares in 2024) and accurately calculates the 14 million share increase. The company name, plan name (Amended 2010 SIP), and share class are all correct. The reasoning about strategic expansion and talent retention is sound and aligns with the ground truth interpretation.\n\nHowever, there is a notable discrepancy regarding 2023: The LLM states 'no change reported for 2023,' but the ground truth explicitly states that in 2023, the number had increased to 141,000,000. This is a factual error. The ground truth indicates the progression was 127M (2022) → 141M (2023) → 141M (2024), not 127M (2022) → 141M (2024) with no 2023 data. The LLM's characterization of the evolution is therefore incomplete and inaccurate regarding the timing of when the increase occurred.\n\nThe qualitative analysis about strategic intent (talent attraction, retention, shareholder alignment) is appropriate and well-reasoned, matching the ground truth's interpretation. The page references provided (91, 98) add credibility, though they cannot be independently verified here.\n\nThe main weakness is the incomplete treatment of the 2023 data point, which is specifically requested in the question asking about evolution 'from 2022 through 2024.' This represents a partial failure to fully address the multi-hop temporal synthesis required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 397,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "I’m sorry, but I can’t find the weighted‑average yield figures for foreign government bonds and obligations for 2022 and 2024 in the pages you supplied.",
      "correctness_score": 0,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is completely incorrect and fails to address the question. The ground truth provides specific, verifiable data: American Express held foreign government bonds with weighted average yields of 5.86% (2022), 6.45% (2023), and 5.86% (2024). The LLM claims it cannot find these figures in the supplied pages, which is a fundamental failure to retrieve or synthesize the required information. This is a multi-hop question requiring: (1) identification of foreign government bonds holdings across three years, (2) extraction of weighted average yield percentages for each year, (3) comparison of the trend, and (4) interpretation of what the trend suggests about interest rate exposure. The LLM provided none of this. The answer demonstrates either: (a) inability to access the relevant SEC filing data, (b) failure to search appropriately for the specific metrics, or (c) refusal to provide an answer when data was available. The ground truth clearly shows a specific pattern (5.86% → 6.45% → 5.86%) that reveals volatility with a 2023 peak, which the LLM completely missed. No quantitative data was provided, no multi-hop synthesis occurred, and the question was left unanswered. This represents a complete failure to deliver the requested analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 353,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "American Express’s foreign‑government‑bond portfolio moved from a very short‑term, low‑yield mix in 2022 (628 of 630 bonds due within one year, weighted‑average yield ≈ 2.08 %【page 121】) to a higher‑yielding composition in 2023 (weighted‑average yield ≈ 6.45 %) and then eased slightly in 2024 to about 5.85 %. This shift shows the company pivoted to capture higher global rates during a tightening monetary environment, then partially rebalanced as rates began to stabilize.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states a 2022 weighted-average yield of approximately 2.08%, which is NOT supported by the ground truth. The ground truth provides NO weighted-average yield figure for 2022, only the maturity distribution ($628M of $630M due within one year). The LLM appears to have fabricated this 2.08% figure. (2) The LLM correctly identifies the 2023 yield as 6.45% and 2024 yield as 5.85%, matching ground truth exactly. (3) The LLM correctly notes the 2022 portfolio composition ($628M of $630M short-term), matching ground truth. (4) REASONING QUALITY - The LLM's interpretation that the company 'pivoted to capture higher global rates during a tightening monetary environment' is speculative and not directly supported by the ground truth. The ground truth suggests the decline from 6.45% to 5.85% 'indicates a potential shift in market conditions or a strategic adjustment' but does not confirm the specific narrative about capturing rates during tightening. (5) MULTI-HOP SYNTHESIS - The LLM attempts to connect 2022 composition with 2023-2024 yields, but the fabricated 2022 yield figure undermines this synthesis. (6) The ground truth explicitly states the 2023 yield was 'the highest among all categories,' providing important context the LLM omits. (7) MAJOR ISSUE: The citation reference [page 121] appears to be an attempt to provide source attribution but the 2.08% figure contradicts the ground truth entirely. This represents a fundamental factual error that cannot be overlooked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 425,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "In 2022 the 10‑K listed the 7% debentures together with common stock (“Common Stock, $.01 Par Value 7% Debentures due 2029”) in a single line of the Section 12(b) table【COP_10k_2022.pdf page_1】.  By 2023 the filing split the securities into two distinct rows—one for common stock and a separate row for the debentures with its own trading symbol (CUSIP‑718507BK1)【COP_10k_2023.pdf page_1】—and the 2024 filing continued that format, presenting the debentures as a separate entry【COP_10k_2024.pdf page_1】.  This evolution shows ConocoPhillips’ deliberate move toward clearer, more distinct disclosure of its debt instrument, enhancing transparency and aligning with regulatory expectations for investor information.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about COP's 7% Debentures disclosure evolution across 2022-2024. STRENGTHS: (1) Correctly identifies the 2022 presentation as combined with common stock in a single line; (2) Accurately describes the 2023 split into two distinct rows with separate CUSIP (718507BK1); (3) Properly notes the 2024 continuation of the separated format; (4) Correctly identifies the company as ConocoPhillips (COP); (5) Accurately synthesizes the multi-year progression showing movement toward clearer disclosure. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct. The CUSIP number 718507BK1 matches the ground truth. The 7% interest rate is correctly stated. No calculation errors present. QUALITATIVE ACCURACY: The reasoning about the evolution from combined to separated disclosure is sound and logically presented. The interpretation that this represents a deliberate move toward transparency aligns with the ground truth's conclusion about 'growing emphasis on clarity and specificity.' The multi-hop synthesis across three years of filings is correctly executed. MINOR CONSIDERATIONS: The LLM answer uses slightly different phrasing than ground truth (e.g., 'deliberate move toward clearer, more distinct disclosure' vs. 'growing emphasis on clarity and specificity') but these are semantically equivalent. The LLM provides slightly more interpretive detail about 'aligning with regulatory expectations' which, while reasonable inference, goes marginally beyond the ground truth but does not contradict it. The answer fully addresses all aspects of the question: the presentation evolution, the multi-year progression, and what it indicates about the company's reporting approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 483,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00 % Notes Due 2031 was $1,044 million at year‑end 2022, remained unchanged at $1,044 million at year‑end 2023, and rose modestly to $1,057 million at year‑end 2024 (2024 10‑K note, page 67; 2022 10‑K note, page 78). The incremental $13 million increase over two years reflects a disciplined, conservative debt‑management approach that keeps long‑term debt stable while adding new debt only as needed to support growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERRORS: The LLM answer contains significantly incorrect financial figures that contradict the ground truth. Ground truth shows: 2022: $1.2B, 2023: $1.057B, 2024: $1.25B. LLM reports: 2022: $1.044B, 2023: $1.044B, 2024: $1.057B. These are material discrepancies - the LLM's 2022 figure is off by ~$156M (13% error), 2023 is off by ~$13M, and 2024 is off by ~$193M (15% error). The LLM also mischaracterizes the trend: ground truth shows an increase from 2022 to 2024 ($1.2B → $1.25B), while LLM shows minimal change ($1.044B → $1.057B, only $13M increase). The LLM's claim that amounts 'remained unchanged' at $1.044M in 2023 contradicts ground truth showing $1.057B. The LLM provides specific page citations (page 67, page 78) which cannot be verified but appear to be fabricated details. The reasoning about 'disciplined, conservative debt-management' is somewhat reasonable but is built on fundamentally incorrect numbers. The multi-hop synthesis fails because the underlying data is wrong. The question asks about evolution and strategy implications - the LLM's answer suggests stability when ground truth shows meaningful fluctuation. This is a case where the LLM appears to have hallucinated specific numbers rather than accurately extracting them from source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 362,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "Disney has kept Marvel as a core brand in its streaming strategy, with the 2023 10‑K describing Marvel as a top‑level tile on Disney+ (page 7).  The company’s balance‑sheet treatment has remained unchanged, with Marvel trademarks counted among its $1,792 million of indefinite‑lived intangible assets in both 2022 (page 110) and 2024 (page 114).  Thus, Disney’s positioning of Marvel has stayed consistent—prominent in Disney+ branding and protected as a key intangible asset—throughout the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Marvel's strategic positioning in Disney+ as a top-level tile in 2023 and its consistent treatment as an indefinite-lived intangible asset across 2022 and 2024. The reasoning about Marvel's dual role (streaming branding + balance sheet asset) is sound and addresses the multi-hop nature of the question. However, there is a significant quantitative error: the LLM cites '$1,792 million of indefinite-lived intangible assets' as the total, but this appears to be either incorrect or misleading. The ground truth does not specify this exact figure, and the LLM provides a specific dollar amount without clear verification. Additionally, the LLM answer lacks the contextual detail that Marvel was listed 'alongside ESPN and Pixar' as mentioned in the ground truth, which provides important context about Marvel's peer positioning among Disney's key brands. The answer also doesn't explicitly confirm that Marvel's inclusion in intangible assets was 'reaffirmed' in 2024 with the same emphasis as 2022. The core narrative is correct—Marvel remained consistently positioned across the three-year period—but the quantitative specificity and some contextual details are either missing or potentially inaccurate. The answer is well-structured and addresses the main question effectively, but the unverified dollar figure and missing comparative context reduce overall accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 390,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "American Express has continued to recognize discount revenue at the time of each Card‑Member transaction, with network‑rate fees negotiated on a case‑by‑case basis with third‑party merchant acquirers and recorded as discount revenue (2022: page 104; 2023: page 103).  The 2024 filing does not alter this accounting treatment but underscores a heightened focus on expanding merchant coverage worldwide through partnerships with third‑party acquirers, aggregators and processors (2024: page 93).  Thus, while discount‑revenue recognition and fee‑negotiation practices remain unchanged, the company’s merchant‑coverage expansion strategy has intensified over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that discount revenue is recognized at transaction time with negotiated network rate fees from third-party acquirers, which matches the ground truth. (2) Page citations (2022: page 104; 2023: page 103; 2024: page 93) provide specific sourcing. (3) The statement about 2024's focus on merchant coverage expansion through third-party acquirers, aggregators, and processors aligns with ground truth. (4) The core accounting treatment description is accurate.\n\nWEAKNESSES: (1) INCOMPLETE EVOLUTION NARRATIVE: The LLM states that 'discount-revenue recognition and fee-negotiation practices remain unchanged' from 2022-2024, but the ground truth indicates a significant evolution. Specifically, the ground truth notes that by 2023, American Express 'introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners.' The LLM completely omits this important development of processed revenue as a distinct revenue stream. (2) MISSING PROCESSED REVENUE COMPONENT: The ground truth explicitly distinguishes between discount revenue and processed revenue (royalties and fees from network partnerships), which emerged in 2023. The LLM fails to capture this structural evolution in revenue recognition. (3) INCOMPLETE CHARACTERIZATION OF CHANGE: By stating practices 'remain unchanged,' the LLM misses the strategic shift toward 'deeper collaboration with third-party acquirers' and the introduction of new revenue streams that the ground truth emphasizes. (4) OVERSIMPLIFICATION: The LLM presents the evolution as primarily a merchant coverage expansion strategy, when the ground truth indicates a more nuanced evolution including new revenue recognition categories and partnership models.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to identify and properly characterize the key structural changes in revenue composition. The reasoning is partially sound but incomplete—it correctly identifies continuity in discount revenue treatment but misses the introduction of processed revenue as a new component.\n\nFACTUAL ACCURACY: The specific statements made are accurate (discount revenue recognition, network rate fees, merchant coverage expansion), but the answer is incomplete in addressing the full evolution of the revenue structure. The claim that practices 'remain unchanged' is misleading given the introduction of processed revenue in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 669,
        "total_tokens": 2174
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "In the 2022 10‑K (p. 34) Amgen only noted that a subset of its products are used with drug‑delivery or companion diagnostic devices that carry regulatory and manufacturing risks and that third‑party collaborations could affect device development. By the 2023 filing (pp. 52‑54) the disclosure was expanded to detail the regulatory oversight of those devices, the requirement to monitor user complaints and adverse events, and the possibility of post‑marketing studies, inspections, warning letters or product withdrawal if device safety issues arise. The 2024 filing (pp. 50‑54) reiterated these points but added greater emphasis on the interdependence of device and drug approvals, the potential for device‑related safety reviews to delay or prevent product approvals, and the impact of post‑marketing requirements on clinical‑trial timelines and market availability.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Amgen's regulatory risk disclosures across 2022-2024, with generally accurate characterization of the progression. STRENGTHS: (1) Correctly identifies the three-year timeline (2022, 2023, 2024) and the evolution from general to more specific disclosures; (2) Accurately captures the shift from basic acknowledgment of device risks to detailed post-marketing and safety compliance concerns; (3) Properly synthesizes multi-hop information showing how disclosures became more detailed and specific over time; (4) Correctly identifies key concepts like post-marketing studies, inspections, warning letters, and product withdrawal; (5) Page references (2022 p.34, 2023 pp.52-54, 2024 pp.50-54) are specific and verifiable. WEAKNESSES: (1) The LLM answer does not explicitly mention LUMAKRAS or the Complete Response Letter from FDA, which are specifically highlighted in the ground truth as concrete examples of the regulatory scrutiny evolution; (2) The ground truth emphasizes surrogate endpoints and confirmatory studies more explicitly, while the LLM answer focuses more on device interdependence and approval delays; (3) The LLM answer mentions 'third-party collaborations' affecting device development in 2022, which is not explicitly mentioned in the ground truth; (4) The ground truth's framing of 'transformation' from general dependencies to specific post-marketing challenges is captured but less explicitly articulated in the LLM response. QUANTITATIVE ACCURACY: Page numbers and year references are correct and specific. No calculations required. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information across three years showing progression, though it misses some specific regulatory examples (LUMAKRAS, CRL) that would strengthen the answer. CONTEXTUAL RELEVANCE: The answer directly addresses all three components of the question (clinical trial dependencies, post-marketing requirements, device-related safety reviews) and shows appropriate understanding of regulatory context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 559,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "ConocoPhillips expanded its HSE audit scope from a business‑unit‑only focus in 2022 to auditing both business units and staff groups by 2024 (page 18, 2024). The program added a formal improvement‑tracking mechanism that requires improvement actions to be tracked to completion (page 18, 2024). Governance reporting has remained consistent, with audit progress reported to the Executive Leadership Team and the Board of Directors (page 18, 2024).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant gaps and misrepresentations compared to the ground truth. CRITICAL ISSUES: (1) FACTUAL ERROR - The LLM claims the scope expanded 'from a business-unit-only focus in 2022 to auditing both business units and staff groups by 2024,' but the ground truth explicitly states that in 2022, ConocoPhillips was ALREADY conducting audits on 'business units and staff groups.' This is a fundamental mischaracterization of the evolution. (2) INCOMPLETE SYNTHESIS - The LLM completely omits the 2023 data point, which is essential to understanding the evolution across the three-year period. The ground truth emphasizes the progression from 2022 (conformance focus) → 2023 (expanded context with Life Saving Rules, Process Safety Fundamentals, stop work policy) → 2024 (Corporate HSE audits with standardization). (3) MISSING KEY DETAILS - The LLM fails to capture: (a) the shift from 'localized conformance checks' to 'integrated safety systems' to 'corporate-level standardization'; (b) the introduction of Life Saving Rules, Process Safety Fundamentals, and stop work policy in 2023; (c) the explicit terminology change to 'Corporate HSE audits' in 2024 suggesting centralization; (d) the broader human capital management framework context. (4) OVERSIMPLIFICATION - The LLM presents the evolution as merely adding staff groups to scope and formalizing tracking, when the ground truth shows a more nuanced strategic shift toward greater cohesion and institutionalization. (5) PARTIAL CREDIT - The LLM correctly identifies: governance reporting to ELT and Board (accurate), improvement action tracking to completion (accurate), and that governance structure remained consistent (accurate). However, these correct elements are insufficient to offset the major factual error about scope expansion and the complete omission of the 2023 evolution. The answer demonstrates weak multi-hop reasoning by failing to synthesize information across all three years and mischaracterizing the baseline conditions in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 546,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "Accenture’s 2022 10‑K explicitly warned that cloud‑ and AI‑driven services were changing how the firm earns revenue and that it must “introduce new pricing or commercial models that reflect the value of these technological developments” or risk revenue shortfalls (pages 18‑22).  The 2023 and 2024 filings echo this point, noting that failure to adapt pricing to rapid technology changes could materially affect client demand and results (page 21).  Across all three years the same risks recur: client spending delays and revenue loss if pricing lags, regulatory compliance costs for AI and data handling, and cybersecurity threats that could undermine the delivery of new AI‑enabled services (pages 23‑24).",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues that prevent it from being considered substantially correct: (1) FACTUAL ERRORS: The LLM introduces risks NOT mentioned in the ground truth - specifically 'regulatory compliance costs for AI and data handling' and 'cybersecurity threats' are presented as consistent risks across all three years, but the original answer makes no mention of these. The ground truth identifies only ONE consistent risk: failure to introduce pricing models quickly enough and insufficient client adoption rates leading to revenue shortfalls and competitive disadvantages. (2) INCOMPLETE SYNTHESIS: The LLM fails to capture the evolution narrative that is central to the question. The ground truth shows a clear progression: 2022 (general acknowledgment of need), 2023 (focus on innovation and strategic investments with delays in client spending), 2024 (dependence on successful deployment with significant AI investments). The LLM answer collapses this evolution into a generic statement that 'all three years echo this point' without demonstrating how the approach actually evolved. (3) PAGE REFERENCES: The LLM provides specific page numbers (18-22, 21, 23-24) that cannot be verified against the ground truth and appear to be fabricated details, which is a serious accuracy concern. (4) MISSING CONTEXT: The LLM omits important details about the 2023 focus on 'delays in client spending due to evaluation of new technologies' and the 2024 emphasis on 'significant investments already being made in AI-based services.' (5) SEMANTIC ISSUES: While the core idea about pricing models is present, the introduction of unsubstantiated risks (regulatory compliance, cybersecurity) fundamentally misrepresents what Accenture actually highlighted as consistent concerns. The answer is partially correct on the main pricing model evolution but significantly incorrect on the risks component.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 515,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "GE’s AerCap senior‑note holdings rose from $900 million at year‑end 2022 to $944 million in 2023 and $982 million in 2024 [page_70]. In 2023 GE sold its remaining AerCap equity shares, leaving only the senior note as its AerCap exposure [page_73]. This progression reflects a deliberate shift from equity to debt exposure, indicating GE is pursuing a more income‑focused, lower‑risk investment strategy in AerCap.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM claims holdings rose from $900M (2022) to $944M (2023) to $982M (2024), showing an INCREASE. The ground truth states holdings DECREASED from $993M (end of 2021, reported in 2022) to $944M (end of 2023, reported in 2024). The LLM's numbers are directionally opposite to reality - it describes an upward trend when the actual trend was downward. The specific values cited ($900M, $982M) do not match the ground truth figures ($993M, $944M). (2) TEMPORAL CONFUSION: The LLM appears to conflate different reporting periods and years, presenting a 2024 figure ($982M) that contradicts the ground truth's 2023 ending value ($944M). (3) STRATEGIC INTERPRETATION ERROR: While the LLM correctly identifies that GE sold equity shares and retained the senior note (which aligns with the shift from equity to debt), this contextual detail does not compensate for the incorrect quantitative foundation. The interpretation of 'income-focused, lower-risk strategy' may be reasonable, but it's built on false numerical premises. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the multi-year progression of holdings. The ground truth shows a consistent decline suggesting portfolio reduction, while the LLM describes an increase suggesting portfolio growth - these are opposite conclusions. The answer demonstrates a fundamental misreading or misrepresentation of the underlying data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 419,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "Amgen kept Bemarituzumab in the same development stage throughout 2022‑2024: it remained a Phase 3 program for gastro‑esophageal junction (GEJ) adenocarcinoma, with Phase 2 for other solid tumors and Phase 1 for NSCLC (2022 page 25; 2023 page 24; 2024 page 24).  The composition‑of‑matter patents issued in the U.S. and Europe continue to be estimated to expire in 2029, with no change in the IP timeline (2022 page 26; 2023 page 26; 2024 page 26).",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterprets the question's intent. (1) CRITICAL ERROR - Clinical Phase Progression: The LLM claims Bemarituzumab 'remained a Phase 3 program' throughout 2022-2024 with 'Phase 2 for other solid tumors and Phase 1 for NSCLC.' This directly contradicts the ground truth, which indicates the drug evolved from Phase 3 for GEJ adenocarcinoma in 2022 to a broader investigational scope by 2024 including 'gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC.' The LLM's claim of Phase 1 for NSCLC is not supported by the ground truth and appears to be fabricated. (2) PATENT EXPIRATION - Partially Correct: The LLM correctly identifies the 2029 patent expiration date for U.S. and European patents, which matches the ground truth. However, the LLM states there was 'no change in the IP timeline,' which is technically accurate but misses the key point that the ground truth emphasizes 2023 as when 'Amgen disclosed intellectual property details' - suggesting this was new or clarified information in 2023. (3) MULTI-HOP REASONING FAILURE: The LLM fundamentally misunderstands the question's focus on 'evolution' from 2022-2024. The ground truth shows a clear progression: 2022 (Phase 3 for GEJ), 2023 (IP disclosure), 2024 (expanded scope). The LLM incorrectly claims stasis ('remained...throughout') rather than evolution. (4) MISSING CONTEXT: The LLM provides page citations (which cannot be verified) but fails to capture the qualitative shift from 'clinical development focus to broader therapeutic positioning and IP strategy' mentioned in the ground truth. The answer is overly narrow and mechanistic, missing the strategic evolution that is central to the question. (5) QUANTITATIVE ACCURACY: The 2029 date is correct, but the clinical phase descriptions are inaccurate and unsupported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 507,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "From 2022 to 2024 American Express has shifted from a broad acknowledgment of fintech competition to a risk‑based, technology‑centric stance.  In the 2022 10‑K (pp. 12‑13) the company noted the rapid rise of alternative payment mechanisms—payment facilitators, digital wallets, buy‑now‑pay‑later, etc.—and the need for “speed of innovation and investment in systems, technologies and product and service offerings.”  By the 2024 10‑K (pp. 29‑31) it explicitly frames fintech disruption as a material risk, citing merchant discount‑rate erosion from merchants building their own payment solutions and listing concrete technology priorities (AI/ML, tokenization, real‑time settlement, open banking) that must be pursued to preserve card volumes and merchant acceptance.  This evolution signals a long‑term strategy of proactive, sustained technology investment and partnership development to counter the competitive threat posed by fintech.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of American Express's strategic evolution from 2022-2024 and correctly identifies the core narrative: a shift from defensive acknowledgment to proactive technology investment. Strengths: (1) Correctly identifies the three-year progression (2022→2023→2024), (2) Accurately names specific alternative payment mechanisms (digital wallets, buy-now-pay-later, payment facilitators, open banking), (3) Properly identifies concrete 2024 technology priorities (AI/ML, tokenization, real-time settlement, open banking), (4) Correctly characterizes the strategic shift toward proactive investment, (5) Appropriately cites page numbers (pp. 12-13 for 2022, pp. 29-31 for 2024) showing document-specific grounding. Minor weaknesses: (1) The answer omits the explicit 2023 expansion of the threat list to include open banking and payment facilitators as a distinct intermediate step—it jumps from 2022 to 2024 without fully capturing the 2023 evolution, (2) The ground truth emphasizes a shift from 'defensive acknowledgment' to 'dependency posture' (framing alternatives as necessary to integrate), while the LLM frames it more as 'risk-based, technology-centric stance'—semantically similar but not precisely capturing the 'dependency' framing, (3) The LLM mentions 'merchant discount-rate erosion' as a specific competitive pressure, which is accurate but not explicitly mentioned in the ground truth summary. The multi-hop reasoning is sound: the answer correctly synthesizes information across three years and identifies the strategic inflection point. Quantitative accuracy is high (dates, page numbers, technology terms all correct). The semantic meaning aligns well with ground truth despite some wording differences. The answer would benefit from explicitly acknowledging the 2023 intermediate step and the 'dependency' framing more directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 510,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "The weighted‑average grant‑date fair value of cash‑settled PSUs rose from **$91.58 million in 2022 to $112.50 million in 2023** and then fell modestly to **$110.39 million in 2024** (2024 “Granted” row). The sharp jump in 2023 reflects a higher expected cost—likely due to stronger stock‑price assumptions or more ambitious performance targets—while the slight decline in 2024 indicates a modest recalibration of the program. Overall, the trend shows ConocoPhillips maintaining a competitive, high‑value long‑term incentive plan while fine‑tuning it to align with market conditions and performance expectations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) UNIT MISINTERPRETATION: The LLM incorrectly stated values in 'millions' ($91.58 million, $112.50 million, $110.39 million) when the ground truth shows these are per-unit fair values in dollars ($91.58, $112.50). This is a fundamental error—weighted-average grant date fair values for PSUs are expressed as dollar amounts per unit, not in millions. (2) INCOMPLETE DATA: The LLM provided a 2024 value of $110.39 million (incorrectly stated as millions) which does not match the ground truth's 2024 value of $112.50. The ground truth explicitly states the value increased from $91.58 in 2022 to $112.50 in 2024. The LLM appears to have introduced a third data point ($110.39) that contradicts the ground truth trajectory. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the three-year trend. The ground truth shows a consistent upward trend (2022: $91.58 → 2024: $112.50), but the LLM introduced an intermediate 2023 value and a decline to 2024, which does not align with the ground truth. (4) REASONING QUALITY: While the LLM's qualitative interpretation about strategic shifts and market conditions is reasonable, it is built on incorrect quantitative foundations. The explanation of 'sharp jump in 2023' and 'slight decline in 2024' contradicts the ground truth's simpler upward trend narrative. (5) ENTITY ACCURACY: Company (ConocoPhillips) and metric type (cash-settled PSUs, weighted-average grant date fair value) are correctly identified, but the numerical values and their units are fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 430,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "From 2022 through 2024 PayPal’s 10‑K filings consistently warned that its expanding credit‑product line and reliance on third‑party lenders had increased exposure to abusive behaviors and fraud.  The company noted that fraud‑detection measures are complex and may not fully prevent new schemes, and that its proprietary credit‑risk models can mis‑predict default risk, while the risk of regulatory fines and partner‑bank interruptions has grown.  This steady‑state of heightened risk suggests that PayPal’s risk‑management effectiveness has not yet kept pace with the growth of its credit and payment‑service offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core theme of PayPal's evolving exposure to abusive behaviors and fraud from 2022-2024, and accurately captures the general progression showing heightened risk concerns. The answer appropriately synthesizes the multi-hop concept that PayPal's risk management has not kept pace with business growth. The reasoning about third-party reliance and regulatory uncertainties is sound and relevant.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer completely omits the specific €40 billion multi-year agreement to sell BNPL receivables mentioned in the ground truth for 2023. This is a concrete, material fact that demonstrates PayPal's strategic response to credit/fraud risks. The absence of this specific figure is a significant omission for a financial question.\n\nWEAKNESSES - COMPLETENESS: The LLM answer mentions 'valid-when-made doctrine' is NOT explicitly referenced, though the ground truth specifically notes this regulatory uncertainty's impact on U.S. credit products in 2024. The answer also doesn't clearly distinguish between the 2023 strategic shift (€40B receivables sale) and the 2024 regulatory concerns, missing important temporal nuance.\n\nWEAKNESSES - ENTITY/METRIC ACCURACY: The answer references 'partner-bank interruptions' as a risk, which is not explicitly mentioned in the ground truth. While this may be a reasonable inference, it introduces information not grounded in the source material.\n\nMULTI-HOP REASONING: The answer demonstrates adequate multi-hop synthesis by connecting credit products, third-party reliance, and regulatory factors across the three-year period. However, it misses the specific strategic mitigation action (the €40B receivables sale agreement) that is central to understanding PayPal's actual risk management response.\n\nOVERALL ASSESSMENT: The answer captures the general narrative correctly but lacks the specific quantitative details and strategic actions that distinguish a complete answer. The omission of the €40 billion figure is particularly problematic for a financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 563,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "Cyramza’s therapeutic positioning has stayed essentially the same from 2022 through 2024, continuing to be sold as monotherapy or in combination for second‑line gastric, NSCLC, colorectal, and hepatocellular carcinoma and first‑line EGFR‑mutated NSCLC (2022/2024 product lists)【page_5】【page_5】.  Its intellectual‑property profile has also remained stable, with compound patents set to expire 2026 (U.S.), 2028 (Europe), 2026 (Japan) and data‑protection ending 2026 (U.S.), 2024 (Europe), 2023 (Japan) (2023/2024 IP tables)【page_11】【page_12】.  The persistence of a broad indication slate coupled with robust, long‑term patent and data protection indicates Lilly’s long‑term oncology strategy of building a multi‑indication portfolio that relies on strong IP to secure revenue streams while pursuing biomarker‑driven expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Cyramza's therapeutic positioning across multiple cancer types (gastric, NSCLC, colorectal, hepatocellular carcinoma) and notes the stability of indications from 2022-2024. The qualitative reasoning about Eli Lilly's strategy (multi-indication portfolio with strong IP protection) is sound and well-articulated. The answer appropriately addresses the evolution question by noting persistence rather than change.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: The LLM provides patent expiration dates that CONTRADICT the ground truth:\n- LLM states: U.S. 2026, Europe 2028, Japan 2026\n- Ground truth states: U.S. 2026, Japan 2026 (Europe not mentioned in ground truth)\n- The Europe 2028 date appears to be fabricated or from unreliable sources\n\nData protection dates also show discrepancies:\n- LLM states: U.S. 2026, Europe 2024, Japan 2023\n- Ground truth states: Japan 2023 (confirmed), but doesn't specify U.S. or Europe dates\n- The LLM's U.S. 2026 and Europe 2024 dates cannot be verified against ground truth\n\nMINOR ISSUES: The LLM adds detail about \"first-line EGFR-mutated NSCLC\" which is not mentioned in the ground truth summary, though this may be accurate from source documents. The ground truth notes \"no new indications added\" in 2024, which the LLM doesn't explicitly address.\n\nMULTI-HOP REASONING: The synthesis connecting IP protection to long-term strategy is logical and well-reasoned, though the LLM's interpretation about \"biomarker-driven expansion\" goes slightly beyond what the ground truth explicitly states about \"preparing next-generation oncology products.\"\n\nOVERALL: The answer demonstrates good qualitative understanding but contains unverified/potentially incorrect patent and data protection dates that undermine quantitative reliability. The core narrative about therapeutic positioning stability is correct, but the specific IP timeline claims are problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 528,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "From 2022‑2024 PMI kept the 3.875% Notes due 2042 on its balance sheet while actively issuing and refinancing other debt to manage liquidity and interest costs.  In 2022 the company issued 2.375% and 2.500% Notes due 2022, 2.625% Notes due 2023, and 2.875% Notes due 2024; in 2023 it added 2.750% Notes due 2025, 3.375% Notes due 2025, 4.375% Notes due 2041, 4.500% Notes due 2042, and the 3.875% Notes due 2042; and in 2024 it continued to issue 2.875% and 3.250% Notes due 2024, 2.750% Notes due 2025, 3.375% Notes due 2025, 4.375% Notes due 2041, 4.500% Notes due 2042, and the 3.875% Notes due 2042.  This pattern shows a strategy of maintaining a long‑term, fixed‑rate instrument while using shorter‑term or higher‑coupon notes to refinance maturing debt and optimize the debt mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent Philip Morris's capital structure strategy. CRITICAL ERRORS: (1) The LLM introduces numerous debt instruments (2.375%, 2.500%, 2.625%, 2.875% Notes due 2022-2024, 2.750%, 3.375%, 4.375%, 4.500% Notes) that are NOT mentioned in the ground truth answer. These appear to be fabricated or confused with other companies' debt instruments. (2) The ground truth specifically identifies 4.125% Notes due 2043 and 4.875% Notes due 2043 as present in 2022 but retired by 2024 - the LLM completely omits these critical instruments. (3) The ground truth mentions 4.250% Notes due 2044 in 2023 - the LLM does not reference this. (4) The LLM incorrectly lists the 3.875% Notes due 2042 as being 'added' in 2023 and 'continued' in 2024, when the ground truth establishes it was present across ALL three years (2022, 2023, 2024) as a stable component. REASONING ISSUES: The LLM's multi-hop synthesis is fundamentally flawed. It fails to identify the key strategic pattern: the retirement of the 4.125% and 4.875% Notes due 2043 (and 4.250% Notes due 2044), which is central to understanding the capital structure evolution. Instead, it invents a narrative about short-term refinancing with instruments that don't appear in the ground truth. The conclusion about 'shorter-term or higher-coupon notes' contradicts the ground truth's finding that longer-dated notes were retired. COMPLETENESS: The answer fails to address the core evolution pattern - the shift from having multiple long-dated tranches (2043, 2044) to stabilizing around the 2042 maturity. This is a fundamental misunderstanding of the question's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 460,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "PayPal’s 2022 risk‑factor disclosures underscored a growing exposure to abusive behavior, especially as its credit‑product portfolio and reliance on third‑party lenders and processors expanded (pages 24–25).  In 2023 the company reduced that exposure by selling a large portion of its U.K. and European buy‑now‑pay‑later loan receivables and initiating a forward‑flow sale of future originations (page 23).  In 2024 it further mitigated risk by diversifying its reliance on a small number of third‑party payment processors and migrating its U.S. arrangements to new processors as part of a wind‑down transition (page 21).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the €40 billion BNPL loan receivable sale in 2023, matching the ground truth. (2) Correctly identifies 2022 as the year PayPal highlighted growing risks from abusive behaviors in credit products. (3) Accurately notes the forward-flow sale of future originations in 2023. (4) Correctly identifies 2024 mitigation efforts related to third-party payment processor diversification and U.S. migration. (5) Page references suggest document-specific sourcing.\n\nWEAKNESSES: (1) SIGNIFICANT OMISSION: The LLM answer completely fails to mention the 2024 emphasis on 'ongoing efforts to improve detection mechanisms and reduce fraud at scale' that is explicitly stated in the ground truth. This is a material omission of a key 2024 action. (2) The LLM shifts focus from the ground truth's emphasis on fraud detection/prevention infrastructure improvements in 2024 to processor diversification instead. While processor diversification is mentioned in ground truth as part of third-party risk management, the LLM de-emphasizes the fraud detection improvements. (3) The LLM answer doesn't explicitly address the synthetic identities, stolen financial instruments, and fraudulent transactions mentioned in the 2022 ground truth as specific abusive behavior types. (4) The narrative flow differs: ground truth emphasizes a progression from 'identifying the problem (2022) → offloading risk (2023) → enhancing fraud prevention (2024)' while LLM emphasizes 'exposure reduction (2023) → processor diversification (2024)'. (5) The LLM answer is somewhat narrower in scope, focusing more on asset sales and processor changes rather than the broader fraud detection and prevention infrastructure improvements.\n\nQUANTITATIVE ACCURACY: The €40 billion figure is correct. No calculation errors detected. Dates (2022, 2023, 2024) are all correct.\n\nMULTI-HOP REASONING: The LLM does synthesize information across three years and identifies strategic actions, but incompletely. It successfully connects the 2023 asset sale to risk mitigation and the 2024 processor changes to third-party risk management, but misses the critical 2024 fraud detection improvements that are central to the ground truth's narrative.\n\nSEMANTIC EQUIVALENCE: While the LLM uses different language, the core issue is not wording but rather incomplete coverage of the ground truth answer. The omission of 2024 fraud detection/prevention efforts is a factual gap, not a semantic difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 661,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "AMD’s 10‑K filings for 2022 (page 37), 2023 (page 39) and 2024 (page 41) all list the risk of “loss or modification of exemptions for taxes and tariffs” as a political‑legal‑economic risk.  The wording and emphasis have not changed over the three years, indicating that the exposure has persisted rather than diminished.  This steady, unchanged mention signals that regulatory uncertainty in AMD’s global operations remains high—and may be intensifying amid shifting trade policies, sanctions and geopolitical tensions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CORE FACTUAL ERROR: The LLM claims 'The wording and emphasis have not changed over the three years,' directly contradicting the ground truth which explicitly states AMD 'emphasized this risk more strongly' in 2023 and 'elevated the risk further' in 2024 with 'explicit linking' to geopolitical conflicts. This is a fundamental mischaracterization of the evolution described in the original answer. (2) PAGE NUMBER VERIFICATION: The LLM provides specific page numbers (37, 39, 41) but these cannot be verified against the ground truth, which does not cite specific pages. The page numbers may be fabricated or incorrect. (3) MULTI-HOP REASONING FAILURE: The question asks about how the exposure 'evolved' and what the 'trend' suggests. The ground truth identifies a clear progression: 2022 (noted as risk) → 2023 (emphasized more strongly) → 2024 (elevated further with explicit geopolitical linkage). The LLM completely misses this progression, instead claiming the risk remained 'steady' and 'unchanged.' This is a critical failure in multi-hop synthesis. (4) SEMANTIC CONTRADICTION: The LLM's conclusion that 'regulatory uncertainty...remains high—and may be intensifying' contradicts its own claim that wording 'has not changed.' If the risk truly remained unchanged, the LLM cannot logically conclude it is 'intensifying.' The ground truth clearly shows intensification through changing emphasis and explicit linkage to geopolitical factors. (5) MISSING KEY DETAILS: The LLM fails to capture the ground truth's important details about the 2024 elevation explicitly linking the risk to 'ongoing geopolitical conflicts' and indicating 'heightened concern over potential regulatory changes.' These are material distinctions that show evolution, not stasis. The answer demonstrates poor comprehension of the source material and provides an analysis that is factually opposite to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 535,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "Cisco reported a $92 million loss from total‑return swaps tied to deferred compensation in FY 2022, a $58 million gain in FY 2023, and a $91 million gain in FY 2024 (all figures in millions, from the “Operating expenses and other” column of the derivatives‑not‑designated‑as‑hedges table – pages 91 and 92). This shift from a negative to a positive impact shows that Cisco’s use of these swaps has become more effective at offsetting compensation‑expense volatility, indicating an active hedging strategy to manage deferred‑compensation exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All three financial figures are correct - FY 2022 loss of $92 million, FY 2023 gain of $58 million, and FY 2024 gain of $91 million. The numbers match the ground truth exactly with proper formatting. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) the evolution of gains/losses across the three fiscal years, (2) the progression trend (shift from loss to gains), and (3) interpretation of what this indicates about the company's exposure/strategy. ENTITY ACCURACY: Correctly identifies Cisco, the specific derivative instrument (total return swaps tied to deferred compensation), and all three fiscal years (2022, 2023, 2024). REASONING QUALITY: The LLM correctly synthesizes the multi-hop information by: (a) presenting the chronological progression, (b) identifying the reversal pattern (loss to gains), and (c) interpreting the strategic implications. The interpretation that this 'shows that Cisco's use of these swaps has become more effective at offsetting compensation-expense volatility' is a reasonable inference from the data pattern. MINOR DIFFERENCES: The LLM provides additional context (citing specific source pages 91-92 and the 'Operating expenses and other' column) which adds credibility but wasn't in the ground truth. The LLM's interpretation emphasizes 'active hedging strategy' while the ground truth uses more neutral language about 'improved market conditions or strategic shift' - both are valid interpretations of the same data pattern. The LLM's answer is slightly more specific in its strategic characterization but remains consistent with the underlying facts. No calculation errors detected. All semantic meanings align with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 487,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "From fiscal 2022 to 2024 Disney shifted its DTC strategy from a single ad‑supported Disney+ launch and cost‑realignment plan to a multi‑service, reorganized media‑and‑entertainment model that added ESPN+ and a Star India joint‑venture while tightening content curation and removing under‑performing titles.  This evolution has driven a steep rise in content and marketing spend—projected at roughly $24 billion in 2025—alongside goodwill and intangible‑asset impairments and a series of debt‑rating downgrades that raise borrowing costs.  The trajectory shows that scaling streaming services demands large upfront investment, aggressive subscriber and ad‑revenue targets, and intense price‑sensitive competition, all of which amplify financial risk and pressure on profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Disney's DTC evolution and financial risks, but contains significant quantitative accuracy issues and some unsupported claims. STRENGTHS: (1) Correctly identifies the strategic pivot from 2022-2024 toward multi-service DTC model; (2) Accurately captures the shift toward more aggressive investment despite financial pressures; (3) Properly identifies key risk factors (rising costs, competition, pricing constraints, profitability uncertainty); (4) Correctly mentions goodwill/intangible asset impairments and debt-rating downgrades as financial consequences; (5) Good synthesis of multi-hop reasoning about scaling challenges. WEAKNESSES: (1) The $24 billion 2025 content/marketing spend projection is not verified in the ground truth and appears to be an unsupported specific number that may be inaccurate or out of context; (2) Claims about 'ad-supported Disney+ launch' and 'Star India joint-venture' are mentioned but not substantiated in the ground truth provided; (3) References to 'removing under-performing titles' and 'content curation' are not explicitly mentioned in the original answer; (4) The answer provides more operational detail than the ground truth but some of these details lack verification. MULTI-HOP REASONING: The answer does synthesize information across fiscal years 2022-2024 and connects strategic decisions to financial consequences, which is sound. However, the introduction of specific numbers and initiatives not in the ground truth weakens confidence. The core narrative about investment escalation despite rising risks is correct, but the supporting details are partially speculative. The answer is more detailed than the ground truth but introduces unverified quantitative claims that reduce reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 486,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "PayPal’s exposure to margin risk has remained essentially unchanged through 2022‑2024.  In each year’s revenue note (2022 page 78, 2023 page 77, 2024 page 76) the company states it has full discretion in setting transaction fees, independent of the costs it incurs from payment processors, and therefore bears full margin risk.  The fees paid to payment processors are consistently recorded as transaction expense, with no material change in the nature of that exposure over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. Strengths: (1) Correctly identifies that PayPal's margin risk exposure remained stable/unchanged across 2022-2024, matching the ground truth's core finding; (2) Accurately states PayPal has full discretion in setting transaction fees independent of processor costs, which is the key factual claim; (3) Correctly notes that processor fees are recorded as transaction expense with no material changes; (4) Provides specific page references (2022 page 78, 2023 page 77, 2024 page 76) that demonstrate multi-hop synthesis across three years of filings; (5) Properly identifies the accounting treatment consistency across years. Minor considerations: (1) The LLM answer is more concise than the ground truth and doesn't explicitly mention ASU 2023-07 adoption in 2024, though this is a minor omission since the answer correctly states there were no structural changes despite the new reporting standard; (2) The ground truth emphasizes 'no indication of structural changes' while the LLM says 'no material change in the nature of that exposure,' which are semantically equivalent; (3) The LLM doesn't explicitly use the phrase 'full margin risk' in the opening sentence as clearly as the ground truth, though it does reference this concept. Overall, the answer demonstrates sound multi-hop reasoning by synthesizing information across three years of filings, correctly identifies the key financial and accounting relationships, and provides accurate page citations. The core finding—that margin risk exposure remained stable with consistent fee-setting discretion and transaction expense treatment—is correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 456,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "Honeywell’s Aerospace risk factor in each filing (2022 page 31, 2023 page 31, 2024 page 31) consistently warned that downturns in air‑travel demand could delay or cancel new aircraft orders.  The unchanged wording shows that the cancellation risk has remained a persistent concern, even as the company’s financials improved—net sales rose from $5.996 bn in 2022 to $6.425 bn in 2024 and segment profit grew from $1.555 bn to $1.522 bn—indicating a gradual recovery and increasing stability in the commercial aviation sector.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and incomplete analysis. QUANTITATIVE ISSUES: (1) The financial numbers provided are problematic - the LLM states segment profit 'grew from $1.555 bn to $1.522 bn' but this is actually a DECLINE of $33M, not growth. The LLM's own numbers contradict its claim of 'increasing stability.' (2) The net sales figure of $5.996 bn for 2022 and $6.425 bn for 2024 cannot be verified against the ground truth and appear to be Aerospace segment-specific numbers, but the characterization of growth is correct directionally. QUALITATIVE ISSUES: (1) The LLM answer fails to capture the evolution of risk language across the three years. The ground truth shows a clear progression: 2022 (COVID-19 pandemic effects) → 2023 (broader macroeconomic/geopolitical risks) → 2024 (new entrants and competitive shifts). The LLM dismisses this as 'unchanged wording,' which is factually incorrect and misses the key insight about how the nature of the risk evolved. (2) The LLM provides no analysis of the shift from pandemic-specific concerns to structural market changes, which is central to understanding the sector's recovery trajectory. (3) The conclusion that 'unchanged wording shows persistent concern' contradicts the ground truth's finding that the wording actually CHANGED significantly across years. REASONING ERRORS: The LLM's logic is flawed - it uses declining segment profit ($1.555bn to $1.522bn) as evidence of 'increasing stability,' which is contradictory. The answer also fails to synthesize the multi-hop information about how risk characterization evolved alongside financial performance. COMPLETENESS: The answer addresses the basic question of whether cancellation risk persisted, but completely misses the evolution aspect and the implications about sector recovery dynamics that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 504,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "From 2022 to 2024 PMI’s risk disclosures show a progressive tightening of regulatory constraints that increasingly curtail product differentiation and adult‑consumer communication for both its Reduced‑Risk Products (RRPs) and Smoke‑Free Products (SFPs). In 2022 the company warned that advertising bans, packaging rules and product‑classification challenges could commoditize its offerings and impede conversion to RRPs (see pages 13‑17). By 2023 and 2024 the risk language expanded to include SFPs, citing stricter advertising restrictions, corporate‑communication limits and scientific‑substantiation requirements that further erode branding and truthful information access (see pages 18‑22 and 17‑21), underscoring an intensifying regulatory environment that threatens PMI’s competitive positioning.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc from 2022-2024 showing intensifying regulatory constraints on PMI's product differentiation and adult consumer communication. It accurately captures the progression from RRPs to SFPs and the shift in regulatory focus. The semantic meaning aligns well with the ground truth regarding regulatory pressure, competitive positioning threats, and the evolution of PMI's risk disclosures. The answer appropriately emphasizes the multi-year trend and regulatory asymmetries.\n\nWEAKNESSES: (1) QUANTITATIVE ISSUES: The LLM provides page number citations (pages 13-17, 18-22, 17-21) that cannot be verified against the ground truth and appear to be fabricated or hallucinated references. These specific page numbers are not mentioned in the original answer and represent unsubstantiated claims about source locations. (2) SPECIFICITY: The LLM answer lacks the nuanced detail present in the ground truth regarding how the language 'evolved' - the ground truth specifically notes the 2023 emphasis on 'disproportionate impact relative to competitors' and 'digital media spreading misleading information,' which the LLM answer does not capture. (3) TERMINOLOGY: The LLM uses 'risk disclosures' as the framing mechanism, which is reasonable but differs from the ground truth's focus on how the company 'emphasized' and 'highlighted' regulatory impacts in its filings. (4) COMPLETENESS: While the LLM captures the main regulatory constraints (advertising bans, packaging rules, classification challenges, substantiation requirements), it doesn't fully articulate the ground truth's emphasis on the 'strategic shift in product focus' or the specific concern about 'unfair competition and regulatory asymmetries' as distinctly as the original.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and two product categories (RRPs and SFPs), demonstrating sound multi-hop reasoning. The progression from 2022 through 2024 is logically presented.\n\nNUMERIC/DATE ACCURACY: All years (2022, 2023, 2024) are correct. No specific financial metrics or percentages are provided in either answer, so quantitative comparison is limited. However, the fabricated page citations represent a significant accuracy concern.\n\nJUSTIFICATION: The answer is substantially correct in its core narrative and reasoning but loses points for unverifiable page citations and missing some of the nuanced evolution details present in the ground truth. The semantic alignment is strong, but the specific details about how regulatory language evolved year-to-year are incompletely captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 702,
        "total_tokens": 2244
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "PayPal’s margin‑risk exposure has remained essentially unchanged from 2022 through 2024.  In each year the company continues to act as the principal in payment transactions, setting a volume‑based tiered fee schedule (2022 p. 80; 2023 p. 75; 2024 p. 77) and bearing full margin risk while treating processor fees as transaction expense.  Incentives—discounts, rebates, rewards and coupons—have persisted as a revenue‑reduction factor (2022 p. 80; 2024 p. 77) but have not materially altered the pricing model or the company’s exposure to margin risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies several key facts: (1) PayPal bears full margin risk across all three years, (2) the company acts as principal in transactions, (3) processor fees are treated as transaction expense, and (4) incentives are recognized as revenue reduction. The page citations (2022 p. 80; 2023 p. 75; 2024 p. 77) appear reasonable for 10-K filings. However, there are significant issues with completeness and reasoning: (1) The LLM states margin risk exposure 'remained essentially unchanged' but the ground truth emphasizes 'increasing detail around incentives and transaction pricing' and 'more nuanced disclosure,' suggesting evolution in disclosure rather than static exposure. (2) The LLM omits the 2023 data entirely from its analysis, failing to address the full three-year period comprehensively. The ground truth explicitly notes that 2023 'added details about incentives provided to merchants and consumers' and details about 'amortized over the contractual term,' which the LLM does not mention. (3) The LLM's characterization that incentives 'have not materially altered the pricing model' contradicts the ground truth's emphasis on 'dynamic pricing and cost structures' as mechanisms for managing margin risk. (4) The LLM misses the nuance that the independence of fees charged to customers from processor costs (highlighted in 2024 per ground truth) represents an important evolution in how the company manages margin risk. The answer is partially correct on core facts but fails to capture the evolution and increasing sophistication in disclosure across the three-year period, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 450,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "AMD’s approach to AIB manufacturers stayed essentially the same from 2022 through 2024: it continues to supply component‑level graphics and chipset products while its agreements protect AIB inventory from price cuts (2022 page_11; 2023 page_11; 2024 page_11). The company also kept selling directly to some system integrators and reiterated that SIs use discrete graphics solutions to differentiate and add value to their products (2022 page_11; 2023 page_11; 2024 page_11). No substantive changes in inventory‑protection policy or the role of discrete graphics for SIs were noted across the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant qualitative errors that fundamentally misrepresent AMD's strategy evolution. While the answer correctly identifies that inventory protection policies existed across 2022-2024 and that discrete graphics solutions were emphasized for SIs, it makes a critical error in its core conclusion. The LLM states 'No substantive changes in inventory-protection policy or the role of discrete graphics for SIs were noted across the three years,' which directly contradicts the ground truth. The ground truth explicitly identifies a 'subtle shift in language' and 'deepening of the value proposition' by 2024, with AMD placing 'more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies.' The LLM completely misses this evolution. Additionally, the LLM fails to capture the nuanced distinction that by 2024, AMD shifted toward 'more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings,' representing a meaningful evolution in the relationship dynamic. The answer is overly simplistic in claiming consistency when the ground truth identifies clear strategic evolution. The page references (page_11 for all years) are correctly cited, and the basic facts about inventory protection and discrete graphics are accurate, but the failure to identify the strategic evolution represents a fundamental misunderstanding of the multi-hop synthesis required by the question. The answer reads as if the LLM did not fully analyze the temporal changes across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 436,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "Disney has consistently limited derivative counterparties to those with an A‑ or better rating and has avoided balances with below‑investment‑grade institutions (2022 filing, pages 109‑113).  In fiscal 2024 the company added a collateral trigger—requiring collateral when a counterparty’s rating falls below A‑ or when aggregate exposures exceed contractual limits—while keeping a 10 % concentration threshold; the company’s actual concentration was zero in fiscal 2023 and rose to 24 % of cash and cash equivalents in fiscal 2024 (pages 120 and 119).  No collateral requirement is noted in the 2022 filing, and the concentration threshold was not explicitly disclosed but implied to be 10 % across the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Disney's credit risk management evolution but contains some issues with precision and clarity. STRENGTHS: (1) Correctly identifies the A- or better counterparty rating requirement as consistent across the period; (2) Accurately reports the 24% concentration figure for fiscal 2024; (3) Correctly notes the shift from zero concentration in an earlier year to 24% in fiscal 2024; (4) Properly identifies the collateral trigger mechanism tied to A- ratings and contractual limits; (5) Appropriately synthesizes multi-hop information across fiscal years. WEAKNESSES AND CONCERNS: (1) The statement 'In fiscal 2024 the company added a collateral trigger' is problematic—the ground truth indicates collateral requirements existed as policy through the period, not newly added in 2024. The LLM may have conflated policy disclosure with policy implementation; (2) The claim 'No collateral requirement is noted in the 2022 filing' contradicts the ground truth which states Disney 'requiring collateral if credit ratings fell below A-' as a consistent policy from 2022 onward; (3) The 10% concentration threshold claim lacks clear grounding in the ground truth, which doesn't explicitly state this threshold; (4) The statement about 'zero in fiscal 2023' is not mentioned in the ground truth (which only references fiscal 2022 having no concentration); (5) Page citations (109-113, 120, 119) cannot be verified against the ground truth provided. QUANTITATIVE ACCURACY: The 24% figure and A- rating threshold are correct. The zero concentration baseline and fiscal 2024 24% figure are accurate. However, the temporal attribution (fiscal 2023 vs fiscal 2022) may be incorrect. QUALITATIVE ACCURACY: The multi-hop synthesis is generally sound—connecting counterparty ratings, collateral requirements, and concentration metrics—but the characterization of 'added' collateral triggers in 2024 misrepresents the evolution. CONTEXTUAL RELEVANCE: The answer appropriately addresses all three dimensions of the question (ratings, collateral, concentration) and correctly identifies this as a shift in liquidity strategy despite credit risk controls.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 584,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "PayPal’s exposure to the 2029‑maturing Fixed‑rate 2.850% notes remained unchanged at $1.5 billion in 2022, 2023, and 2024 (the notes table lists $1,500 million for the 2029 maturity in each year)【page_107】【page_104】【page_108】. This steady exposure indicates a deliberate, disciplined long‑term debt strategy that prioritizes predictable maturity and interest‑rate profiles, rather than frequent refinancing or restructuring.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Quantitative accuracy is strong - the LLM correctly identifies the $1,500 million ($1.5 billion) principal amount for the 2029 notes across all three years (2022, 2023, 2024), with proper format variation acceptance. (2) The core factual claim that exposure remained unchanged is correct. (3) Entity identification is accurate (PYPL/PayPal, correct fiscal years, correct debt instrument). WEAKNESSES: (1) INCOMPLETE MULTI-HOP SYNTHESIS - The original answer provides critical context about PYPL's broader debt management strategy by noting that despite issuing NEW debt in 2023 and 2024 (including higher-interest notes like 5.150% and 5.500% in 2024), the company maintained the 2029 notes. The LLM answer completely omits this comparative analysis, which is essential to understanding the 'multi-year pattern' and 'long-term debt management strategy' aspects of the question. (2) WEAKER REASONING - The LLM's explanation that this indicates 'disciplined long-term debt strategy' and 'predictable maturity and interest-rate profiles' is generic and doesn't explain WHY the company chose to retain this specific instrument while issuing higher-rate debt elsewhere. The original answer's suggestion about 'preserving favorable interest terms' provides more substantive strategic insight. (3) MISSING STRATEGIC CONTEXT - The question explicitly asks what the pattern 'suggests about the company's long-term debt management strategy.' The original answer addresses this by noting the strategic decision to retain favorable terms despite new issuances. The LLM answer provides only surface-level observation without this deeper strategic analysis. (4) CITATION QUALITY - While the LLM provides page references, it doesn't synthesize information across multiple sections to build the fuller strategic picture that the original answer provides. The answer reads as a simple data lookup rather than multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 520,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "Honeywell’s 2022 risk‑factor disclosure flagged raw‑material demand and supply risk as a key concern for its Performance Materials and Technologies segment, noting that 63 % of the supply base was under contract (page 32, 2022). The 2023 disclosure was unchanged, but contract coverage rose slightly to 64 % (page 30, 2023). The 2024 risk‑factor text is identical, again highlighting raw‑material demand and supply risk, and no significant change in contract coverage is reported (page 32, 2024). This consistency—coupled with only a marginal increase in contract coverage—indicates that the segment remains materially exposed to commodity price volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported quantitative claims that are not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific contract coverage percentages (63% in 2022, 64% in 2023, no change in 2024) with page references, but these specific metrics do not appear in the ground truth answer. These appear to be fabricated or hallucinated data points. The ground truth makes no mention of contract coverage percentages at all. (2) SEGMENT NAMING INCONSISTENCY: The LLM correctly identifies the 2022-2023 segment as 'Performance Materials and Technologies' but fails to note the 2024 rebranding to 'Energy and Sustainability Solutions' that the ground truth explicitly mentions. This is a material omission. (3) INCOMPLETE SYNTHESIS: The LLM answer focuses narrowly on contract coverage metrics and misses the broader evolution described in the ground truth: the shift in emphasis from product commoditization and illegal imports (2022) to oil/natural gas price volatility (2023) to production capacity and downtime minimization (2024). (4) REASONING QUALITY: While the LLM's conclusion about sustained commodity vulnerability is directionally correct, it is based on unsupported numerical claims rather than the actual risk factor evolution documented in the ground truth. The multi-hop synthesis across three years is incomplete and relies on invented data rather than actual filing disclosures. (5) MISSING CONTEXT: The answer omits important contextual details about how the risk framing evolved and what strategic repositioning occurred, which the ground truth identifies as significant. The LLM answer is more concise but at the cost of accuracy and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 474,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "PMI’s peer group list remained unchanged from 2022 through 2024, with Imperial Brands PLC consistently included (see the 2022 peer‑group list on page 21 and the identical 2023‑ and 2024‑year lists on page 26). This stability shows that PMI benchmarks its performance against a fixed set of large, globally‑present consumer‑product firms—including major tobacco peers—rather than shifting its peer set as its portfolio evolves. The approach underscores PMI’s strategy of measuring progress against a broad, comparable cohort that reflects both its core tobacco business and its expanding smoke‑free and other consumer‑product lines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies Imperial Brands PLC as consistently included in PM's peer group across 2022-2024; (2) Accurately states the peer group remained unchanged/stable across all three years; (3) Provides specific page references (page 21 for 2022, page 26 for 2023-2024) that add credibility; (4) Correctly interprets the strategic implication—that PM maintains a stable benchmarking approach; (5) Appropriately contextualizes the peer group composition within PM's broader portfolio strategy including smoke-free products. MINOR CONSIDERATIONS: (1) The LLM uses 'PMI' while the question uses 'PM'—these are equivalent (Philip Morris International), so this is not an error but a minor terminology variation; (2) The LLM provides slightly more detail about PM's portfolio evolution (smoke-free products) than the ground truth, which is contextually relevant and adds value without contradicting the original answer; (3) Both answers convey the same core finding: consistency in peer group composition reflects strategic stability in benchmarking. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no calculations required; page references appear reasonable for SEC filings. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and connects peer group composition to strategic benchmarking intent. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while providing additional supporting detail about the rationale for the stable peer group approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 447,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "PayPal’s exposure to its fixed‑rate 2.850% notes stayed flat at **$1.5 billion** each year: $1.5 billion in 2022 (page 108), $1.5 billion in 2023 (page 107), and $1.5 billion in 2024 (page 104). This unchanged balance shows the company is deliberately maintaining a consistent long‑term debt mix, using fixed‑rate debt to lock in interest costs and preserve a stable capital structure rather than expanding or contracting that particular note series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All dollar amounts are correct ($1.5 billion for each year 2022-2024), and the progression is accurately stated as unchanged/flat. The specific page references (108, 107, 104) add credibility though cannot be independently verified here. ENTITY ACCURACY: Correctly identifies PayPal/PYPL and the specific debt instrument (fixed-rate 2.850% notes). MULTI-HOP REASONING: Successfully synthesizes information across three fiscal years to identify the pattern of stability and draws appropriate conclusions about debt management strategy. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth - that the $1.5 billion balance remained constant across all three years with no repayments or refinancing. The LLM's interpretation that this reflects 'deliberate maintenance' of a 'consistent long-term debt mix' and use of fixed-rate debt to 'lock in interest costs' is logically sound and semantically equivalent to the ground truth's assessment of 'consistent long-term liability position' and 'leveraging the low fixed rate as part of a broader capital structure strategy.' MINOR DIFFERENCES: The LLM provides slightly more specific strategic interpretation (locking in interest costs, preserving stable capital structure) compared to the ground truth's more cautious language ('possibly prioritizing other debt maturities'). Both interpretations are reasonable given the data. The LLM answer is complete, accurate, and appropriately addresses all aspects of the multi-part question regarding evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 452,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "ConocoPhillips’ HSE audit program has consistently covered all business units and staff groups, with improvement actions tracked to completion and progress reported to the Executive Leadership Team and Board of Directors (page_18, 2022; page_18, 2023; page_18, 2024). The 2024 10‑K explicitly labels the program as “corporate HSE audits,” underscoring a formalized corporate‑level governance integration that builds on the 2023 framework (page_18, 2024). Overall, the audit scope, conformance tracking, and governance reporting have remained stable, with the 2024 filing reinforcing the corporate‑level oversight language.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key facts about ConocoPhillips' HSE audit program across 2022-2024, including consistent coverage of business units/staff groups, tracking of improvement actions, and reporting to ELT and Board. The page references (page_18) are appropriately cited. However, the answer has significant weaknesses in capturing the evolution narrative that the ground truth emphasizes: (1) The LLM characterizes the evolution as 'stable' with 'remained stable' language, which contradicts the ground truth's clear narrative of evolution showing 'a shift from localized conformance checks toward a more integrated, governance-driven audit model.' (2) The LLM misses the explicit 2023 development of linking audit outcomes to 'annual objectives, targets, and deadlines' - a key intermediate step in the evolution. (3) The LLM fails to adequately characterize the 2024 shift toward 'centralized oversight' and the significance of the move from distributed audits to 'corporate level' audits as representing a meaningful structural change. (4) The answer lacks the interpretive synthesis that the ground truth provides about what this evolution means (shift from localized to integrated governance-driven model). The LLM's statement that things 'remained stable' with 2024 'reinforcing' prior frameworks understates the actual evolution described in the ground truth. While individual facts are largely correct, the reasoning about how the program evolved and what that evolution signifies is incomplete and somewhat contradictory to the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 432,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "Across 2022, 2023, and 2024 AMD continued to treat the 2011 Executive Incentive Plan as the core governance framework for executive pay.  In each year’s 10‑K the plan is incorporated by reference in the proxy statement’s Executive Compensation section (2022 – page 93; 2023 – page 101; 2024 – page 98), underscoring its persistent role as the foundational document even as the company added newer plans and amendments to its broader compensation disclosures.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides specific page numbers (2022 – page 93; 2023 – page 101; 2024 – page 98) that cannot be verified against the ground truth and appear to be fabricated. The ground truth does not mention these specific page numbers, and the LLM's citation of exact pages without source verification is a serious factual error. (2) EXHIBIT REFERENCE DISCREPANCY: The ground truth explicitly states the plan was listed as *10.1* in the 10-K filings for all three years (2022, 2023, 2024). The LLM answer omits this critical exhibit designation entirely, instead vaguely referencing 'incorporated by reference in the proxy statement's Executive Compensation section.' This is a material omission of a key factual detail from the original answer. (3) DOCUMENT CONFUSION: The ground truth specifies the plan appears in the 10-K filing as exhibit 10.1, while the LLM shifts focus to 'proxy statement's Executive Compensation section' without clarifying whether this is the same reference or a different disclosure location. This creates ambiguity about whether the LLM is discussing the same governance document citations. (4) QUALITATIVE REASONING: While the LLM correctly identifies the core concept (2011 plan as foundational framework across three years with continuity), it fails to provide the specific exhibit designation that anchors the ground truth answer. The reasoning about 'newer plans and amendments' is present but less detailed than the ground truth's mention of specific companion plans (AMD Executive Severance Plan, AMD Deferred Income Account Plan). (5) COMPLETENESS: The LLM addresses the three-year evolution and continuity theme but loses precision on the specific governance documentation references that define how AMD formally disclosed this continuity. The fabricated page numbers are particularly problematic as they suggest false specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 517,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "From 2022 through 2024 GM’s indemnification obligations to Stellantis for legacy Opel/Vauxhall vehicles have not materially changed – the company continues to indemnify Stellantis for losses that may arise from inaccuracies in representations and warranties, emissions‑related claims, product liabilities and recalls, and it still views any additional indemnification for Takata‑inflator recalls as remote.  Because GM remains unable to estimate a reasonably possible material loss and the obligations are still subject to time limits, thresholds and caps, the progression indicates that its post‑sale liability exposure remains significant and uncertain, but is bounded by contractual limits.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that contradict the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - The LLM claims obligations \"have not materially changed\" from 2022-2024, directly contradicting the ground truth which explicitly states the \"geographic and legal scope of exposure expanded\" with new jurisdictions (Austria) and regulatory investigations added.\n   - The LLM fails to mention the European Commission and UK CMA regulatory investigations that occurred by 2024, which are explicitly documented in the ground truth as a key development.\n   - The LLM omits the geographic expansion to Austria as a jurisdiction by 2024.\n   - The LLM does not acknowledge the progression from 2022 (no specific accrual) → 2023 (lawsuits in Germany, UK, Netherlands; Takata recalls) → 2024 (Austria added; regulatory investigations; immaterial accrual recorded).\n\n2. INCOMPLETE SYNTHESIS:\n   - The question asks how obligations \"evolved\" from 2022-2024, requiring a temporal progression analysis. The LLM provides a static description rather than tracking the evolution across years.\n   - The ground truth explicitly documents year-by-year changes; the LLM collapses this into a single statement that obligations \"have not materially changed.\"\n   - The LLM mentions Takata inflators but fails to connect this to the 2023 timeline and the immaterial accrual recorded.\n\n3. MISCHARACTERIZATION OF EXPOSURE:\n   - The LLM states exposure \"remains significant and uncertain, but is bounded by contractual limits\" - while contractual limits are mentioned in ground truth, the LLM misses that the key insight is the INCREASING COMPLEXITY AND PERSISTENCE of actions, not just bounded uncertainty.\n   - The ground truth emphasizes \"growing complexity and persistence of post-sale liabilities\" as the key indicator; the LLM focuses on contractual bounds instead.\n\n4. MISSING CRITICAL DETAILS:\n   - No mention of specific accruals (immaterial accrual in 2024)\n   - No mention of Germany, UK, Netherlands, or Austria jurisdictions\n   - No mention of regulatory investigations by European Commission and UK CMA\n   - No acknowledgment of the recall activities tied to Takata inflators in legacy Opel vehicles\n\n5. QUANTITATIVE ACCURACY:\n   - While the LLM correctly notes amounts are immaterial/remote, it fails to document the progression of accruals and the addition of new regulatory actions that changed the exposure profile.\n\nThe LLM answer fundamentally misses the core finding: that while individual items remain immaterial, the PATTERN of escalating legal and regulatory actions across multiple jurisdictions indicates growing post-sale liability complexity. The answer reads as a generic statement about indemnification rather than a specific analysis of how GM's Opel/Vauxhall exposure evolved from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 754,
        "total_tokens": 2229
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "In 2022, bamlanivimab generated roughly $2.0 billion of Lilly’s revenue, with AbCellera receiving tiered royalties in the mid‑teens to mid‑twenties on those sales【page_68】. By 2023 the antibody’s sales fell to zero, eliminating both revenue and royalty obligations, and the product remained absent in 2024【page_68】. This trajectory shows that bamlanivimab was a short‑lived pandemic‑era revenue driver rather than a long‑term strategic asset for Lilly【page_71】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline. Quantitative verification: (1) 2022 revenue of ~$2.0 billion matches ground truth's $2,008.9 million (acceptable rounding); (2) royalty tier range of mid-teens to mid-twenties is correctly stated; (3) 2023 drop to zero revenue is accurate; (4) 2024 absence from portfolio is confirmed. Multi-hop reasoning is sound: the answer correctly synthesizes information about both revenue contribution AND royalty obligations across the three-year period, showing how they evolved together. Entity identification is accurate (Eli Lilly, AbCellera, bamlanivimab, COVID-19 antibodies category). The conclusion about strategic importance (pandemic-era revenue driver vs. long-term asset) aligns with ground truth. Minor weaknesses: (1) The answer could have been slightly more explicit about the specific dollar amount ($2,008.9M vs. 'roughly $2.0 billion'), though the rounding is reasonable and acceptable; (2) The phrase 'eliminating both revenue and royalty obligations' in 2023 is slightly imprecise—while revenue dropped to zero, the ground truth doesn't explicitly state that royalty obligations were eliminated (though this is a reasonable inference). The answer is well-structured, directly addresses all parts of the multi-part question, and provides appropriate context about the product's strategic trajectory. Page citations are included, enhancing credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 409,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "From 2022 through 2024, PMI’s filings consistently list Jackpot as a local cigarette brand in the Philippines (2022 10‑K, page 5; 2023 10‑K, page 6; 2024 10‑K, page 5) with no change in its positioning or product mix. This steady inclusion over three years shows that PMI continues to prioritize local brands in key markets, reinforcing its strategy to sustain market share and meet local consumer preferences.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Jackpot as a local cigarette brand in the Philippines mentioned across 2022-2024 10-K filings. The page number citations (2022 10-K page 5, 2023 10-K page 6, 2024 10-K page 5) appear reasonable and specific. The core factual claim that Jackpot was consistently listed across all three years aligns with the ground truth. WEAKNESSES: (1) The LLM answer is significantly less comprehensive than the ground truth. It fails to mention Fortune as another key local brand in the Philippines that was referenced alongside Jackpot in 2022, missing important context about PMI's portfolio strategy. (2) The answer lacks the nuanced evolution narrative present in the ground truth - specifically, the 2023 emphasis on local brands' role in 'complementing international brands' and the 2024 context of PMI's 'broader strategic pivot toward smoke-free products.' (3) The LLM states there was 'no change in its positioning or product mix,' which is overly simplistic and misses the strategic context that while Jackpot remained listed, it existed within an evolving corporate strategy toward smoke-free products. (4) The answer doesn't adequately address the 'dual strategy' aspect highlighted in the ground truth - the tension between maintaining local cigarette brands while transitioning to smoke-free products. (5) The phrase 'with no change in its positioning' is somewhat misleading because the strategic context around the brand clearly evolved, even if the brand itself remained listed. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years of filings but fails to synthesize the broader strategic context that evolved during this period. The reasoning is linear rather than capturing the nuanced trajectory described in the ground truth. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension is neutral. The page citations in the LLM answer cannot be verified without access to actual filings but appear plausible. OVERALL ASSESSMENT: The LLM provides a partially correct but incomplete answer that captures the basic fact (Jackpot's consistent presence) but misses important contextual details about the evolution of PMI's strategy and the role of local brands within a broader corporate transformation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 620,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "From 2022 to 2024, PayPal’s exposure to bad transactions shifted as the company moved to off‑load its BNPL risk while still facing credit‑product default risk and fraud. In 2023, PayPal announced a multi‑year sale of up to €40 bn of U.K. and European BNPL loan receivables, which began in October 2023, thereby removing the majority of future BNPL exposure; however, the 2023 filing still warned that the sale of future receivables was condition‑dependent and that credit‑product defaults and fraud losses remained significant. By 2024, the BNPL receivables sale was complete, but the 10‑K continued to highlight ongoing credit‑product default risk and the persistent threat of fraud and third‑party processing disruptions that could impact operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PayPal's BNPL risk evolution from 2022-2024 with mostly accurate information. STRENGTHS: (1) Correctly identifies the €40 billion BNPL receivables sale in 2023 (June per ground truth, October per LLM - minor timing discrepancy); (2) Accurately captures the shift from managing growing credit/BNPL exposure to offloading risk through the sale; (3) Correctly notes the condition-dependent nature of the sale and ongoing fraud/default risks; (4) Properly synthesizes multi-hop information across 2022-2024 period; (5) Appropriately emphasizes persistent fraud and third-party processing risks despite the sale. WEAKNESSES: (1) States the sale 'began in October 2023' when ground truth indicates the agreement was entered in June 2023 (timing of execution vs. agreement is ambiguous, but LLM's phrasing could be misleading); (2) Claims 'the BNPL receivables sale was complete' by 2024, but ground truth indicates it was a 'multi-year agreement' with execution risks and conditions - the LLM overstates completion status; (3) Omits some nuance from ground truth regarding synthetic identities and stolen financial instruments as specific fraud vectors in 2022; (4) Less detailed on the 2022 baseline risks compared to ground truth. QUANTITATIVE ACCURACY: The €40 billion figure is correct; dates are approximately correct but with minor ambiguity on sale timing. QUALITATIVE ACCURACY: Multi-hop reasoning is sound - correctly connects the 2023 sale to risk reduction while maintaining awareness of persistent threats. The synthesis across years is logical and well-structured. CONTEXTUAL RELEVANCE: Directly addresses all major elements of the question including the sale, fraud risks, and third-party processing concerns. The answer is appropriately focused on the evolution of exposure rather than static risk assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1582,
        "completion_tokens": 506,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "In 2022, Honeywell’s Safety & Productivity Solutions segment was identified as vulnerable to retail‑market swings, with the risk factor noting that such volatility could erode market share, pricing and margins (page 32).  In 2024 the newly‑realigned Industrial Automation segment reported net sales of $6.425 bn and segment profit of $1.522 bn – a 2 % rise from 2023 but a 4 % decline from 2022 – indicating that retail‑market volatility continues to weigh on profitability (page 28).  The 2023 risk‑factor disclosures still list retail‑market fluctuations as a material risk to Safety & Productivity Solutions, underscoring that Honeywell’s industrial portfolio remains sensitive to retail demand volatility across multiple segments (page 30).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the three-year progression of retail market volatility risk across Honeywell's segments (2022 Safety & Productivity Solutions, 2023 risk reiteration, 2024 Industrial Automation). It accurately captures the core narrative that retail market fluctuations remained a persistent concern across the company's portfolio reorganization. The qualitative reasoning about sensitivity to retail demand volatility is sound and well-articulated.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The LLM introduces specific financial metrics (2024 Industrial Automation net sales of $6.425bn, segment profit of $1.522bn, 2% rise from 2023, 4% decline from 2022) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be either fabricated or sourced from documents not reflected in the knowledge graph. This is a critical error as it adds unverified quantitative claims.\n\nMULTI-HOP REASONING: The LLM attempts to strengthen the answer by adding financial performance data to support the risk narrative. However, the ground truth answer does NOT include these specific financial metrics - it focuses purely on risk factor disclosures and their evolution. The LLM conflates risk exposure with actual financial performance, which is a logical leap not supported by the original answer.\n\nCOMPLETENESS: The LLM addresses all three years (2022, 2023, 2024) and all three segments mentioned in the question. However, it adds information not in the ground truth rather than synthesizing what was actually provided.\n\nPAGE REFERENCES: The LLM cites specific pages (32, 28, 30) which cannot be verified against the ground truth answer provided. This adds specificity but introduces unverifiable claims.\n\nOVERALL ASSESSMENT: The answer captures the correct narrative arc and demonstrates sound qualitative reasoning about Honeywell's persistent sensitivity to retail volatility. However, the introduction of unverified financial metrics and calculations significantly undermines credibility. The core insight is correct, but the execution includes fabricated or unverifiable quantitative details that violate the strict standard for numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 598,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "From 2022 through 2024 the Incyte collaboration kept the same financial framework: milestone payments of $260 million (for 2021) and $210 million (for 2020) were capitalized as intangible assets and amortized to cost of sales, with no new milestone payments recorded in 2023 or 2024 【page_72】.  Royalty terms stayed unchanged, with Incyte receiving tiered double‑digit royalties up to 20 % on worldwide net sales and an additional low‑teens royalty on COVID‑19 sales that exceed a threshold 【page_72】.  The strategic focus remained on expanding Olumiant’s market reach, and its contribution to LLY’s revenue grew, with net product revenue rising from $830.5 million in 2022 to $957.4 million in 2024 【page_72】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially undermine its accuracy:\n\n1. CRITICAL ERRORS IN MILESTONE PAYMENTS:\n   - Ground truth states: $260.0 million capitalized in 2022 for regulatory approvals, with up to $200.0 million in contingent payments\n   - LLM states: \"$260 million (for 2021) and $210 million (for 2020)\" - This is factually incorrect. The LLM misattributes the years and introduces a $210 million figure not mentioned in the ground truth. The ground truth clearly indicates $260.0 million was the capitalized amount in 2022, not historical payments from 2020-2021.\n   - The LLM also fails to mention the $200.0 million in contingent/additional milestone payments that Incyte was eligible for\n\n2. INCOMPLETE CONTINGENT PAYMENT DISCLOSURE:\n   - Ground truth explicitly mentions: \"Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones)\"\n   - LLM completely omits this important financial obligation, representing a significant gap in the financial structure discussion\n\n3. ROYALTY STRUCTURE ACCURACY:\n   - LLM correctly identifies tiered royalties up to 20% and additional low-teens royalty on COVID-19 sales\n   - However, the LLM describes these as \"double-digit royalties\" which is imprecise terminology compared to ground truth's \"tiered, with rates up to 20%\"\n   - The threshold description is accurate but less detailed than ground truth\n\n4. REVENUE FIGURES:\n   - LLM provides: $830.5 million (2022) to $957.4 million (2024)\n   - These numbers appear to be from the filing but are not verified against ground truth, which does not provide specific Olumiant revenue figures for comparison\n   - The revenue growth narrative is appropriate but lacks the strategic context provided in ground truth\n\n5. EVOLUTION NARRATIVE:\n   - Ground truth emphasizes the evolution from 2022 (capitalized milestones) → 2023 (ongoing revenue recognition, maturity) → 2024 (strategic expansion)\n   - LLM states \"no new milestone payments recorded in 2023 or 2024\" which aligns with ground truth's narrative of maturity, but misses the strategic evolution emphasis\n   - LLM fails to capture the shift from milestone-focused (2022) to revenue recognition-focused (2023-2024) framing\n\n6. STRATEGIC POSITIONING:\n   - Ground truth mentions: \"EUA use and inclusion of follow-on compounds, suggesting long-term commitment and therapeutic expansion\"\n   - LLM only vaguely references \"expanding Olumiant's market reach\" without the specific strategic details about EUA or follow-on compounds\n\n7. MULTI-HOP SYNTHESIS:\n   - The LLM fails to properly synthesize the evolution across years. It presents a static view rather than showing how the financial structure and strategic focus evolved\n   - Ground truth clearly shows progression: capitalized milestones (2022) → revenue recognition maturity (2023) → strategic expansion (2024)\n   - LLM presents these as simultaneous rather than evolutionary\n\nThe most damaging error is the misattribution of milestone payment years ($260M for 2021, $210M for 2020) which contradicts the ground truth's clear statement that $260.0 million was capitalized in 2022. This represents a fundamental factual error that undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 872,
        "total_tokens": 2393
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "Altria’s relationship with UST has remained structurally unchanged, with UST continuing as a wholly‑owned subsidiary through USSTC (page 4).  The intangible‑asset book for UST’s trademarks has stayed substantial and largely unchanged—indefinite‑lived MST and snus trademarks were valued at $8.8 B and cigar trademarks at $2.6 B as of 2021, with no impairment charges reported through 2024 (page 66).  Altria has kept UST’s moist‑smokeless tobacco products in its smoke‑free transition portfolio, positioning them as a core offering in its Vision to move adult smokers toward less‑harmful products (page 5, page 4).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides partially correct information but contains a significant factual error and incomplete temporal analysis. STRENGTHS: (1) Correctly identifies UST as wholly-owned subsidiary through USSTC across the period; (2) Correctly cites $8.8B for MST and snus trademarks; (3) Correctly mentions $2.6B cigar trademarks; (4) Appropriately notes no impairment charges; (5) Correctly identifies smoke-free transition positioning. CRITICAL ERRORS: (1) MAJOR DATE ERROR - The LLM states trademark values were 'as of 2021' when the ground truth specifies these were 2022 values. This is a significant factual error that undermines the temporal analysis requested in the question. (2) INCOMPLETE TEMPORAL EVOLUTION - The question specifically asks about evolution FROM 2022 TO 2024. The LLM fails to provide a 3-year trajectory analysis. It states values 'stayed substantial and largely unchanged' but doesn't demonstrate how they evolved year-to-year or what changed between 2022-2024. (3) MISSING STRATEGIC EVOLUTION CONTEXT - The ground truth emphasizes a strategic shift toward oral nicotine pouches (Helix) and e-vapor (NJOY) as complementary to UST's traditional MST business. The LLM mentions smoke-free positioning but doesn't capture the strategic diversification narrative or the evolution of Altria's broader portfolio strategy around UST. (4) INCOMPLETE SYNTHESIS - The question asks about 'integration into Altria's broader smoke-free transition strategy' - the LLM mentions this briefly but doesn't synthesize how UST's role evolved relative to newer alternatives. QUANTITATIVE ISSUES: The date attribution error (2021 vs 2022) is a material factual mistake that affects the credibility of the temporal analysis. The numbers themselves ($8.8B, $2.6B) are correct, but the dating is wrong. REASONING: The multi-hop synthesis is incomplete - the answer doesn't adequately connect the three-year evolution of financial exposure, ownership structure, and strategic positioning as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 540,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "Cisco’s 3.50% senior note’s effective rate jumped from 3.20 % in FY 2022 to 6.38 % in FY 2023 and 6.66 % in FY 2024, reflecting a steep rise in market borrowing costs as rates climbed and capital markets tightened [page_90, page_89].  The higher effective rates indicate that Cisco’s fixed‑rate exposure became more expensive, prompting the company to hedge the note with a $0.5 billion interest‑rate swap to offset the impact on earnings [page_89].  Overall, the trend shows that Cisco’s borrowing costs increased markedly over the period, mirroring broader tightening in the capital markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All core numeric values are correct - the effective interest rates of 3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024) match the ground truth exactly. (2) The fiscal year progression is accurate. (3) The overall trend interpretation is sound - correctly identifies the upward trajectory and links it to capital market tightening. (4) The semantic meaning aligns with the ground truth regarding borrowing cost increases. WEAKNESSES: (1) The LLM introduces information about a $0.5 billion interest-rate swap that is NOT present in the ground truth answer. While this detail may be factually accurate from the source documents, it goes beyond what was established in the original answer and represents an addition not verified against the ground truth. (2) The statement about 'fixed-rate exposure became more expensive' is somewhat misleading - the 3.50% coupon rate itself didn't change; rather, the effective rate increased, which typically reflects market valuation changes or swap adjustments, not the fixed coupon becoming more expensive. (3) The explanation lacks clarity on WHY the effective rate diverged from the coupon rate (3.50% vs 3.20% in FY2022, and the subsequent increases). The ground truth doesn't explain this either, but the LLM's explanation about hedging with swaps, while potentially accurate, introduces complexity not addressed in the original answer. MULTI-HOP REASONING: The answer correctly synthesizes the three-year trend and connects it to broader capital market conditions, which is appropriate for the question. However, the introduction of the swap detail suggests the LLM may have synthesized information beyond what was in the ground truth knowledge graph. CALCULATION VERIFICATION: No calculations required; all percentages are stated correctly. The progression from 3.20% to 6.38% to 6.66% is accurately presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 506,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from **$16,000 million at December 31 2022** (2022 10‑K, page 58) to **$15,000 million at December 31 2023** (2023 10‑K, page 56) and further to **$13,000 million at December 31 2024** (2024 10‑K, page 57).  The steady decline shows a deliberate debt‑reduction strategy—Amazon is paying down or refinancing portions of the 2017 Notes to lower interest expense and strengthen its balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with all three key financial figures correct: $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024). The format variation ($16,000 million vs $16.0 billion) is acceptable and equivalent. The dates and document references are appropriately cited. The reasoning about deliberate debt reduction strategy is sound and logically supported by the declining balance trajectory. However, the answer has two notable limitations: (1) It does not include the broader context provided in the ground truth about Amazon's total long-term debt reduction from $67.2 billion (2022) to $52.6 billion (2024), which would strengthen the multi-hop synthesis and demonstrate how the 2017 Notes reduction fits into the company's overall debt management strategy; (2) The explanation of debt reduction rationale (paying down/refinancing to lower interest expense) is reasonable but somewhat generic and doesn't explicitly connect to the specific $3.0 billion reduction over the two-year period or calculate the reduction rate. The core answer is factually correct and addresses the main question about the evolution and strategy, but lacks the comprehensive multi-hop synthesis that would elevate it to a 9-10 score. The answer successfully identifies the trend and its strategic implications, making it a solid 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 379,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "The 5.000% notes due April 2030 were issued in April 2020 with a principal amount of $606 million and an effective interest rate of 5.18 % (see the debt schedule table on page 81).  The outstanding principal balance remained at $606 million and the effective rate stayed at 5.18 % from fiscal 2022 through fiscal 2024, indicating that AVGO has kept this long‑term debt stable without refinancing or repayment and is managing it as a predictable, low‑cost financing tool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. QUANTITATIVE VERIFICATION: All numbers are correct - $606 million principal balance, 5.18% effective interest rate, April 2030 maturity date, and April 2020 issuance date. The LLM correctly identifies that these figures remained constant across fiscal 2022-2024. COMPLETENESS: The answer addresses the core question about how the principal balance and interest rate evolved (remained static) across the three-year period. It also provides the requested interpretation of what this indicates about debt management strategy. ENTITY ACCURACY: AVGO is correctly identified, fiscal years 2022-2024 are properly referenced, and the specific debt instrument (5.000% notes due April 2030) is accurately described. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years to demonstrate the static nature of this debt position and correctly interprets this as a deliberate strategy of maintaining stable, predictable long-term financing without refinancing or early repayment. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer includes additional context (April 2020 issuance date, reference to page 81 debt schedule) that, while not in the ground truth, is factually accurate and enhances the answer. The LLM's characterization of the debt as a 'low-cost financing tool' is a reasonable interpretation of the static management approach, though the ground truth uses slightly different language ('static approach'). Both convey the same essential meaning. The answer is well-structured, provides clear evidence of the three-year progression, and offers sound reasoning about the company's debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 475,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "Netflix formalized its Performance Bonus Plan in the 2022 10‑K as Exhibit 10.5† (Def 14A, file 001‑35727, 10.1, April 28 2014) (page_65). The plan was amended and restated in December 2022, disclosed in the 2023 10‑K (Exhibit 10.5†, 8‑K, file 001‑35727, 10.1, December 9 2022) (page_69). By the 2024 10‑K, the restated plan was fully integrated into the company’s executive‑compensation framework, appearing as Exhibit 10.5† and referenced in the executive‑compensation section, underscoring its formal inclusion in executive agreements (page_71).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy in addressing the core question about Netflix's Performance Bonus Plan evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the key timeline events: 2022 foundational reference, December 9, 2022 amendment and restatement via 8-K filing, and 2024 integration into broader compensation framework. (2) Accurately cites specific exhibit numbers (Exhibit 10.5†) and filing references (file 001-35727). (3) Properly synthesizes the multi-hop information showing progression from foundational role → formal amendment/restatement → full integration into executive compensation architecture. (4) Correctly identifies related compensation documents (Executive Officer Severance Plan, Performance-Based Restricted Stock Unit Award Agreement) that demonstrate integration. (5) Date accuracy is correct (December 9, 2022 for 8-K filing). MINOR WEAKNESSES: (1) The inclusion of specific page numbers (65, 69, 71) and exhibit citations with parenthetical references adds granular detail that, while potentially accurate, creates slight formatting awkwardness and may not be essential to answering the core question. (2) The answer could have been slightly clearer in distinguishing between the 2022 10-K reference and the December 2022 8-K filing as separate events. (3) The phrase 'Def 14A, file 001-35727, 10.1, April 28 2014' appears somewhat disconnected and could confuse the timeline (2014 date seems historical context rather than part of the 2022-2024 evolution). MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple filing types (10-K, 8-K, Def 14A), correctly showing how the plan evolved from foundational status to formal amendment to integrated framework. The semantic meaning aligns well with the ground truth answer's narrative arc. QUANTITATIVE ELEMENTS: All dates are accurate; no calculations required; exhibit numbers and file references appear correct. Overall, this is a solid answer that captures the essential evolution of the Performance Bonus Plan with appropriate supporting documentation references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 570,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "In the 2022 Form 10‑K, AIG disclosed a specific modeled loss estimate of **$1.3 billion** for a five‑ton bomb attack (net of TRIPRA and reinsurance recoveries) and described its terrorism exposure strategy as scenario‑based modeling, TRIPRA coverage, limited private reinsurance and government‑sponsored terrorism pools (2022 p. 169). By the 2024 filing, the company reiterated the same framework—scenario‑based modeling, TRIPRA, targeted reinsurance purchases and reliance on government‑sponsored pools (2024 p. 88)—but did not publish a new loss estimate, and its reinsurance recoverable assets for 2024 were $38 billion, indicating a shift in overall reinsurance strategy while maintaining the same terrorism‑risk mitigation approach (2024 p. 90). Thus, from 2022 to 2024 AIG’s terrorism exposure management remained largely consistent in terms of reinsurance protections and risk‑mitigation tactics, with the only notable change being the absence of a new modeled loss estimate in the 2024 report.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual errors and omissions that undermine its accuracy:\n\n1. QUANTITATIVE ERRORS:\n   - The LLM states reinsurance recoverable assets for 2024 were $38 billion, but the ground truth specifies $20.1 billion in collateral to support reinsurance recoverable assets. This is a major discrepancy ($38B vs $20.1B).\n   - The $1.3 billion loss estimate is correctly cited from 2022.\n\n2. MISSING KEY INFORMATION:\n   - The LLM fails to mention the specific 2024 retention points: $200 million for Japan and $125 million for the rest of the world. These are concrete, quantifiable risk mitigation details that directly answer the question about how management evolved.\n   - The LLM does not mention the global property per risk covers for non-critical and critical catastrophe events outside North America, which represents a specific evolution in reinsurance strategy.\n   - The 2023 information about routine monitoring and targeted reinsurance purchases is completely absent from the LLM answer.\n\n3. INCOMPLETE MULTI-HOP SYNTHESIS:\n   - The question asks specifically about evolution from 2022 to 2024 across three dimensions: modeled loss estimates, reinsurance protections, and risk mitigation strategies.\n   - The LLM addresses modeled loss estimates (correctly noting the $1.3B figure and absence of new 2024 estimate) but fails to adequately address the evolution in reinsurance protections and risk mitigation strategies with specific 2024 details.\n   - The ground truth shows a \"strategic deepening\" with specific attachment points and collateral holdings, but the LLM misses these concrete details.\n\n4. REASONING QUALITY:\n   - The LLM's conclusion that management \"remained largely consistent\" is partially supported but incomplete. While the framework remained consistent, the specific reinsurance protections and risk mitigation mechanisms evolved significantly (retention points, global property covers, collateral holdings).\n   - The LLM correctly identifies that no new modeled loss estimate was published in 2024, but this is presented as the \"only notable change,\" which understates the actual evolution in reinsurance strategy.\n\n5. CONTEXTUAL ISSUES:\n   - The LLM provides page references (2022 p. 169, 2024 p. 88, 2024 p. 90) which adds credibility but doesn't compensate for the missing substantive details.\n   - The answer is relevant to the question but incomplete in addressing the specific evolution requested.\n\nThe core issue is that the LLM answer provides a partial, somewhat accurate overview but misses critical quantitative details ($200M/$125M retention points, $20.1B collateral) and fails to fully synthesize the evolution across all three requested dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 728,
        "total_tokens": 2216
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "UnitedHealth’s venture portfolio expanded markedly between 2022 and 2024. In 2022 the company held about $3.5 billion in equity securities and $1.3 billion in equity‑method investments in healthcare operating businesses (page 54). By 2023 the equity‑security balance rose to $4.9 billion while equity‑method holdings edged up to $1.4 billion (page 52). In 2024 the equity‑security balance remained flat at $4.9 billion, but equity‑method investments surged to $3.8 billion, reflecting a strategic shift toward deeper equity‑method exposure in the healthcare sector (page 52).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data points are correct: 2022 equity securities ($3.5B), 2022 equity method investments ($1.3B), 2023 equity securities ($4.9B), 2023 equity method investments ($1.4B), 2024 equity securities ($4.9B), and 2024 equity method investments ($3.8B). The multi-hop synthesis is sound, correctly tracking the evolution across three years and two investment categories. The LLM properly identifies the strategic pivot toward equity method investments in 2024 (tripling from $1.4B to $3.8B) while equity securities remained flat, which aligns with the ground truth's characterization of a shift toward 'deeper involvement in operating businesses.' The reasoning about strategic intent is well-articulated and matches the ground truth's interpretation. Minor strengths: the answer includes page references (54, 52) which adds credibility, and the phrasing 'strategic shift toward deeper equity-method exposure' effectively captures the operational engagement emphasis noted in the ground truth. The only negligible difference is that the LLM uses 'equity-method' (hyphenated) while ground truth uses 'equity method' (unhyphenated), but this is purely stylistic and does not affect accuracy. The answer fully addresses all components of the multi-part question regarding the evolution of venture investment strategy from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 390,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "Altria’s 2022 10‑K lists both 1.000% Notes due 2023 and 1.700% Notes due 2025 (MO25) (page 1, 2022). In the 2023 and 2024 10‑Ks the 1.700% Notes remain listed while the 1.000% Notes are no longer present (page 1, 2023; page 1, 2024), indicating that the short‑term debt was retired or matured. This steady presence of the 1.700% 2025 Notes and the elimination of the 2023 notes shows a deliberate shift to a longer‑term, lower‑interest debt profile, underscoring a strategy of maintaining a stable capital structure and reducing refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Altria's debt management strategy across the three-year period. STRENGTHS: (1) All numeric values are correct - accurately identifies the 1.000% Notes due 2023, 1.700% Notes due 2025, and correctly notes their presence/absence across 2022-2024 filings. (2) Multi-hop synthesis is sound - properly traces the evolution of the capital structure across three fiscal years and correctly identifies the maturation/retirement of the 2023 Notes. (3) Entity identification is accurate - correctly names Altria and its debt instruments with proper notation (MO25). (4) The reasoning about debt management strategy is logical and well-supported: the answer correctly infers that the elimination of short-term 2023 debt while maintaining the 2025 Notes indicates a deliberate shift toward longer-term, lower-interest debt and reduced refinancing risk. (5) The answer goes slightly beyond the ground truth by explicitly characterizing this as a 'shift to a longer-term, lower-interest debt profile,' which is a reasonable inference supported by the facts presented. MINOR CONSIDERATIONS: The ground truth uses slightly more cautious language ('suggests Altria maintained this liability') while the LLM uses more assertive language about deliberate strategy ('deliberate shift'), but this represents enhanced analytical insight rather than factual error. The LLM also provides slightly more strategic interpretation than the ground truth, which adds value without contradicting the facts. All dates, percentages, and debt instrument identifications are factually correct and properly formatted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 454,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock rose steadily: it was $51.354 million at December 31 2022, climbed to $60.429 million at December 31 2023, and further increased to $71.431 million at December 31 2024【page_71】【page_68】. This upward trend shows the company is consistently using excess cash to repurchase shares, indicating a capital‑allocation strategy that prioritizes shareholder returns and likely aims to support earnings per share and share price.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. The ground truth shows treasury stock values as NEGATIVE numbers (in parentheses): $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024. These negative values represent treasury stock as a contra-equity account (standard accounting treatment). The LLM incorrectly reports: (1) $51.354 million for 2022 instead of $(36,658) million - this is off by approximately $88 billion and has the wrong sign; (2) $60.429 million for 2023 - while the absolute value matches the ground truth, it's missing the negative sign that indicates treasury stock; (3) $71.431 million for 2024 - again, correct absolute value but missing the critical negative sign. The LLM also misidentifies the 2022 figure entirely ($51.354M vs $36,658M). While the LLM correctly identifies the upward trend in absolute values and provides reasonable interpretation about capital allocation strategy and shareholder returns, the quantitative foundation is severely flawed. The negative signs are not merely formatting preferences - they are economically significant, indicating these are contra-equity accounts reducing shareholders' equity. The reasoning about stock repurchases and capital allocation is qualitatively sound, but it's built on incorrect numerical data. This represents a major factual error that undermines the credibility of the entire answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 404,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "Cisco’s total‑return swaps used to hedge deferred‑compensation exposure swung from a $92 million loss in FY 2022 to a $58 million gain in FY 2023, and then to a $91 million gain in FY 2024 (see the “Total return swaps‑deferred compensation” line on page 91).  This trajectory shows a reversal of the negative exposure and a strengthening of the hedging position, with the notional amount of the swaps rising from $651 million in 2022 to $792 million in 2023 and $985 million in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: the loss of $92M in FY 2022, gain of $58M in FY 2023, and gain of $91M in FY 2024 are all accurately stated. The LLM additionally provides notional amounts ($651M in 2022, $792M in 2023, $985M in 2024) that enhance the answer beyond the ground truth, demonstrating deeper synthesis of the filing data. The multi-hop reasoning is sound: the answer correctly identifies the reversal from loss to gain and the strengthening of the hedging position over the three-year period. The semantic meaning matches the ground truth perfectly - both convey that Cisco's exposure shifted from negative to positive and strengthened over time. The LLM answer goes further by explaining that these are total-return swaps used to hedge deferred-compensation exposure and provides a specific filing reference (page 91), which adds credibility and context without contradicting the ground truth. The only minor distinction is that the LLM provides additional contextual information (notional amounts and filing reference) that wasn't in the ground truth, but this represents value-added analysis rather than any factual error. All numbers, dates, and financial metrics are precisely correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 353,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "From 2022 through 2024 Netflix’s reliance on third‑party rights holders remained a core risk, with the company warning that refusal or withdrawal of licenses could harm its service and raise costs (page 11).  The 2023 and 2024 filings show that competition for exclusive content has intensified, driving up programming costs and prompting a greater focus on securing original productions to reduce licensing exposure (page 6 2023; page 6 2024).  At the same time, regulatory scrutiny has grown, with new content‑quotas, levies, investment obligations and ownership‑right restrictions in several markets limiting the availability of licensed titles (page 4 2023; page 4 2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the core evolution of Netflix's dependency on rights holders intensifying over the period; (2) Accurately captures the three main risk dimensions: licensing/refusal risks, competition for exclusive content driving costs up, and regulatory pressures (content quotas, levies, investment obligations); (3) Properly synthesizes multi-hop information showing the progression from 2022 concerns about content providers launching competing services, through 2023-2024 intensification of regulatory scrutiny; (4) Correctly notes Netflix's strategic response of focusing on original productions to reduce licensing exposure; (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The answer references specific page numbers (page 11, page 6, page 4) which cannot be verified against the ground truth and may or may not be accurate to actual filings - this is a minor issue as the substantive content is correct; (2) The answer is slightly more concise than the ground truth, omitting some contextual detail about IP disputes potentially leading to content unavailability or service disruptions mentioned in 2023; (3) Does not explicitly frame this as a '3-year progression' or 'strategic challenge' as clearly as the ground truth, though the progression is clearly implied. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple risk categories (licensing, competition, regulatory), showing how these factors evolved and interconnected. The logic connecting rising competition to higher costs to increased focus on original content is sound. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth with appropriate wording variations. The characterization of risks and their evolution matches the original answer's intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 526,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "UnitedHealth Group’s parent company noted that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material as of December 31 2024, 2023 or 2022” (Schedule I, Commitments and Contingencies, page 81).  The absence of material changes over the three‑year span indicates that the company’s service‑delivery guarantees to its subsidiaries have remained stable and have not grown significantly.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is significantly incomplete and misses critical quantitative information from the ground truth. Strengths: (1) Correctly identifies that service level guarantees were immaterial across all three years (2022-2024), which matches the ground truth statement. (2) Properly cites the source (Schedule I, Commitments and Contingencies). (3) Correctly identifies the company as UnitedHealth Group's parent company. Weaknesses: (1) MAJOR OMISSION - The LLM completely fails to address the second critical component of the ground truth: the significant fluctuations in parent company's notes payable to subsidiaries ($8.1B in 2022 → $9.9B in 2023 → $2.0B in 2024). This is a substantial quantitative trend that directly answers the question about how financial obligations evolved. (2) The LLM's conclusion that service-delivery guarantees 'have remained stable and have not grown significantly' is only partially correct—it addresses the immateriality of charges but ignores the material changes in the internal financing structure (notes payable), which is explicitly mentioned in the ground truth as 'notable variation.' (3) The answer fails to synthesize the multi-hop relationship between service level guarantees and the internal financing mechanisms supporting them. (4) The LLM does not address what the 3-year trend suggests about stability, as requested in the question—the ground truth indicates the trend suggests 'shifting liquidity strategies or operational adjustments,' which is absent from the LLM response. The LLM answer addresses only about 40% of the complete answer, focusing narrowly on the immateriality of charges while completely omitting the significant financial obligation fluctuations that are central to understanding the evolution and stability of the company's service delivery commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 496,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "Altria’s long‑duration fixed‑income portfolio has trended toward a more conservative mix of credit quality.  In the 2022 filing (the most recent figure available for that year is the 2021 allocation) the pension plan held roughly 16 % of its fixed‑income holdings in below‑investment‑grade securities (≈ 11 % of total plan assets) and the post‑retirement plan about 8 % of its fixed‑income holdings (≈ 3 % of total plan assets)【page_91】.  By 2023 the pension allocation fell to ~11 % of fixed‑income holdings (≈ 9 % of total assets) and the post‑retirement allocation rose slightly to ~9 % of fixed‑income holdings (≈ 4 % of total assets)【page_86】, and in 2024 it further declined to ~8 % of fixed‑income holdings for the pension plan (≈ 7 % of total assets) and remained at ~8 % for the post‑retirement plan (≈ 3 % of total assets)【page_90】.  This downward trend in below‑investment‑grade exposure signals a cautious risk appetite, with Altria trimming lower‑rated debt to better safeguard its long‑term obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces 2024 data that was explicitly NOT disclosed in the ground truth. The original answer clearly states 'In 2024, specific percentages for below investment grade allocations were not disclosed,' yet the LLM provides specific 2024 figures (8% of fixed-income holdings for pension plan ≈ 7% of total assets, and 8% for postretirement plan ≈ 3% of total assets). This is a major factual error that contradicts the source material. Additionally, the LLM's opening statement about '2021 allocation' in the 2022 filing is confusing and potentially inaccurate - the ground truth clearly references 2022 data as the starting point. The 2022 and 2023 figures provided by the LLM match the ground truth (pension: 16%→11%, postretirement: 8%→9%), but the fabrication of 2024 data is a serious breach of accuracy. The reasoning about 'cautious risk appetite' and 'trimming lower-rated debt' is sound in principle, but it's based on false data for 2024. The LLM correctly identifies the multi-hop nature of the question and attempts to synthesize across years and plan types, but the introduction of unsupported 2024 figures undermines the entire analysis. The citation markers suggest the LLM is referencing specific pages, but the 2024 data appears to be hallucinated rather than extracted from actual filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 376,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "Mastercard’s settlement‑exposure calculation has not changed from 2022 through 2024; it still uses the average daily payment volume of the prior three months multiplied by an estimated number of days of exposure, then subtracts risk‑mitigation arrangements (see Notes 22 in 2022, 2023, and 2024 filings).  The method has simply produced larger numbers as volumes and risk‑mitigation needs grew (gross exposure rose from $64.9 bn in 2022 to $78.4 bn in 2024, with net exposure moving from $55.7 bn to $64.9 bn).  This steady methodology signals a disciplined, resilient risk‑management framework that remains unchanged even as regulatory scrutiny and litigation pressures intensify.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core methodology (average daily payment volume × estimated days of exposure) and confirms it remained consistent across 2022-2024. The answer appropriately references Note 22 across all three years and correctly characterizes the risk management framework as unchanged despite regulatory and litigation pressures. However, there are significant quantitative accuracy issues: (1) The gross exposure figures provided ($64.9bn in 2022 to $78.4bn in 2024) cannot be verified against the ground truth, which does not provide these specific numbers. (2) The net exposure figures ($55.7bn to $64.9bn) similarly lack verification in the ground truth. (3) The LLM appears to have introduced specific financial metrics that may or may not be accurate but are not confirmed by the original answer. The qualitative reasoning is sound—the answer correctly synthesizes that methodology consistency indicates robust risk management despite external pressures, and it properly identifies the regulatory investigations (FTC, DOJ, European Commission) and litigation risks mentioned in the ground truth. The answer is well-structured and addresses the multi-hop nature of the question by connecting methodology consistency to risk management implications. The main weakness is the introduction of unverified numerical data that, while plausible, cannot be confirmed as accurate. The answer would score higher if these specific dollar amounts were either verified or omitted in favor of the confirmed methodological consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 426,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "Cisco’s 5.90% senior note has been issued at a constant principal of $2,000 million and an effective interest rate of 6.11 % in FY 2022, FY 2023, and FY 2024 (see the long‑term debt tables on page 89 for each year). The unchanged utilization and effective rate show that Cisco has kept this fixed‑rate instrument on a stable maturity and cost profile, reflecting a disciplined long‑term debt strategy that prioritizes predictable interest expense and hedges against rate volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the $2,000 million principal balance is accurately stated, the 5.90% coupon rate is correct, and the 6.11% effective interest rate matches the ground truth exactly. The fiscal year range (2022-2024) is correctly identified. ENTITY ACCURACY: Cisco is correctly identified, the 5.90% Note is properly referenced, and all financial metrics are accurately named. COMPLETENESS: The answer addresses both parts of the multi-part question - how the utilization and effective interest rate evolved (showing they remained constant), and what this indicates about debt management strategy. MULTI-HOP REASONING: The synthesis is sound - the model correctly identifies that constant principal and rate across three years indicates strategic retention rather than refinancing, and properly connects this to predictable interest obligations and rate hedging. SEMANTIC EQUIVALENCE: The LLM's interpretation that this reflects 'disciplined long-term debt strategy' and 'hedges against rate volatility' is semantically equivalent to the ground truth's characterization of 'strategic intent to maintain predictable interest obligations.' The reference to 'page 89' adds helpful specificity without contradicting the ground truth. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing ('fixed-rate instrument on a stable maturity and cost profile' vs. 'preserved this high-yield long-term debt instrument as a fixed component') but conveys the same strategic meaning. The answer is comprehensive, accurate, and demonstrates proper multi-hop synthesis across the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 471,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "AVGO’s 3.125 % notes due January 2025 stayed at a principal balance of **$495 million** at the end of FY 2023 and FY 2024 (no change from the prior year)【page_81】.  The balance was unchanged from FY 2022 as well, indicating that the company has neither repaid nor issued additional amounts of this note over the three‑year period.  This steady balance reflects a deliberate strategy of keeping a stable, low‑interest debt level for long‑term financing rather than actively refinancing or paying down the instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE ACCURACY: All numbers are correct - the $495 million principal balance is accurately stated for all three fiscal years (2022, 2023, 2024), and the characterization of 'no change' is factually correct. The percentage rate (3.125%) and maturity date (January 2025) are also accurate. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of the balance across the three-year period, (2) the specific amounts for each year, and (3) what this trend indicates about debt management strategy. ENTITY ACCURACY: AVGO is correctly identified, the specific debt instrument (3.125% notes due January 2025) is correctly specified, and all fiscal years are correctly referenced. REASONING: The multi-hop synthesis is sound - the model correctly identified that the unchanged balance across three years indicates no early repayments or refinancing, and drew a logical conclusion about the company's deliberate strategy. The interpretation that this reflects 'a deliberate strategy of keeping a stable, low-interest debt level' is a reasonable inference from the data, though slightly more interpretive than the ground truth's more neutral statement about 'consistent approach.' SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly more detailed interpretation of the strategic implications. The phrase 'neither repaid nor issued additional amounts' is semantically equivalent to 'did not make any early repayments or refinancing adjustments.' Minor note: The LLM's characterization of this as a 'low-interest debt level' is reasonable given the 3.125% rate context, though the ground truth simply called it 'fixed-rate debt.' Overall, this is a comprehensive, accurate answer with sound multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 503,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "From 2022 through 2023, CMCSA’s shared‑data wireless plans were only available within bundled broadband packages, with customers able to add multiple lines and choose device options. In 2024 the company added prepaid unlimited data plans under the NOW brand, giving customers the option to purchase wireless service separately from broadband bundles while still offering shared‑data and per‑GB plans, thereby expanding flexibility and choice.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of CMCSA's shared data plan offerings from 2022-2024 with generally accurate information. Strengths: (1) Correctly identifies the timeline (2022-2024), (2) Accurately notes the introduction of prepaid unlimited data plans under the NOW brand in 2024, (3) Properly identifies the bundling strategy with broadband services, (4) Correctly conveys the expansion of customer flexibility and choice. Weaknesses: (1) The statement that shared data plans were 'only available within bundled broadband packages' in 2022-2023 is slightly overstated - the ground truth indicates they were offered 'as part of bundled service offerings' but doesn't explicitly state they were exclusively bundled, (2) Missing some nuance about the 2023 positioning where the company 'emphasized bundling with broadband, reinforcing integration across services' - the LLM treats 2022-2023 as essentially the same, (3) The phrase 'while still offering shared-data and per-GB plans' in the 2024 description could be clearer about whether these remain bundled-only or gained additional flexibility. Quantitative accuracy is high (no numerical errors, dates correct). Qualitative accuracy is good but misses some of the strategic nuance about the progression and emphasis on integration. The answer successfully synthesizes multi-hop information across three years and multiple service offerings, demonstrating sound reasoning about the bundling strategy evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 407,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes remained a persistent issue from 2022 through 2024, as CMS continued to reduce or freeze benchmarks and alter the calculation methodology—creating ongoing funding pressures【page_25】【page_20】. In each year the company responded by selectively adjusting member benefits and premiums, pulling out of certain county markets, and intensifying medical and operating cost management to offset the reduced payments【page_25】【page_20】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) UnitedHealth Group faced persistent Medicare Advantage risk adjustment payment changes from 2022-2024, (2) CMS reduced or froze benchmarks and altered methodology, (3) the company responded with selective benefit/premium adjustments and cost management. The answer accurately captures the multi-hop synthesis across three years and the reactive posture of the company. However, there are notable differences from the ground truth: (1) The LLM adds a specific strategic response ('pulling out of certain county markets') that is not mentioned in the original answer, which could be accurate but represents information beyond what was verified in the ground truth. (2) The LLM answer is more concise and omits some nuance from the original, specifically the characterization that 'these adjustments were ongoing rather than one-time fixes' and the explicit statement that 'UnitedHealth did not find a full resolution.' (3) The original answer emphasizes the 'reactive posture' and continuous adaptation more explicitly, while the LLM answer is more factual/descriptive. The citation references (page_25, page_20) suggest the LLM is grounding claims in source material, which is appropriate. No quantitative errors are present (no specific numbers were claimed). The reasoning is sound regarding the three-year evolution and strategic responses. The answer is contextually relevant and addresses the question's core requirements about exposure evolution and strategic adjustments, though it could have been more explicit about the lack of full resolution and the reactive nature of the company's approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 453,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "Mastercard’s 2022 10‑K (page 11) described a multi‑layered security program that relied on third‑party assessments and benchmarking, integrated real‑time account‑based payments into new flows, and operated real‑time infrastructure in 12 markets. By 2023, the 10‑K (page 11) confirmed the same framework but had expanded real‑time coverage to 13 markets, and the 2024 10‑K (page 11) further emphasized collaboration with issuers, acquirers, merchants, governments and industry associations—alongside public‑private partnerships—to develop technical standards and respond to threats, while continuing to build, implement and operate real‑time clearing and settlement platforms across those 13 markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key metrics and evolution across years. Strengths: (1) All numeric values are accurate - correctly identifies 12 markets in 2022, expansion to 13 markets by 2023, and continuation through 2024. (2) Properly synthesizes multi-hop information across three fiscal years (2022, 2023, 2024). (3) Accurately captures the evolution of third-party collaboration, mentioning issuers, acquirers, merchants, governments, and industry associations. (4) Correctly identifies real-time payments infrastructure expansion and integration of value-added services. (5) Appropriately cites page 11 of respective 10-Ks as source. Weaknesses: (1) The LLM answer does not explicitly mention the China joint venture for domestic transaction processing that appears in the ground truth for 2024, which represents a specific geographic expansion example. (2) The phrase 'integrated real-time account-based payments into new flows' in the 2022 description is somewhat vague compared to the ground truth's mention of 'fraud scoring and tokenization' as specific value-added services integrated by 2023. (3) Minor semantic difference: the LLM says 'continuing to build, implement and operate' for 2024 while ground truth emphasizes 'further solidified' and 'deeper integration of security into new markets and services.' These are not contradictory but the LLM misses the emphasis on deepening security integration. Overall, the answer correctly addresses the multi-layered security approach evolution, third-party collaboration expansion, real-time service integration, and geographic expansion across the three-year period, with only minor omissions of specific examples (China JV) that don't fundamentally undermine the core answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 486,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "Amazon’s 1.500 % Note due 2030 remained on its balance sheet unchanged from 2022 through 2024 (2022 10‑K, page 72; 2024 10‑K, page 72). During the same period the company issued a series of higher‑coupon notes—4.700 % due 2024, 4.600 % due 2025, 4.550 % due 2027, 4.650 % due 2029, and 4.700 % due 2032—showing a strategy of refinancing short‑term maturities with higher‑yield debt while preserving the lower‑cost long‑term debt (2024 10‑K, page 72). This reflects a long‑term debt‑management approach that balances cost and maturity, prioritizing liquidity and flexibility over aggressive refinancing of older, lower‑rate debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about Amazon's financing strategy evolution related to the 1.500% Note due 2030 from 2022-2024.\n\nSTRENGTHS:\n1. Correctly identifies that the 1.500% Note due 2030 remained on the balance sheet across all three years\n2. Accurately cites page 72 of the 2024 10-K as a source\n3. Correctly identifies multiple higher-coupon notes issued during the period (4.700% due 2024, 4.600% due 2025, 4.550% due 2027, 4.650% due 2029, 4.700% due 2032)\n4. Provides reasonable interpretation that the strategy reflects balancing cost and maturity\n\nCRITICAL WEAKNESSES:\n1. INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth reveals a critical evolution in Amazon's financing strategy involving NEW credit agreements (Term Loan Agreement in 2023, 364-Day Revolving Credit Agreement in 2024). The LLM answer completely omits these important developments, which are central to understanding the \"evolution\" of the financing strategy.\n\n2. MISSING EXHIBIT REFERENCES: The ground truth specifically references Exhibits 4.5, 4.6, 10.8, and 10.9 across different years. The LLM answer provides no exhibit citations and misses the structural evolution of how these instruments were disclosed.\n\n3. INCOMPLETE ANSWER TO QUESTION: The question asks specifically about how the strategy \"evolved\" from 2022-2024. The ground truth shows a clear progression: (2022) long-term fixed obligations → (2023) addition of short/medium-term liquidity instruments → (2024) layered approach with flexible credit facilities. The LLM answer only discusses the issuance of higher-coupon notes and doesn't capture this temporal evolution or the shift toward liquidity flexibility.\n\n4. MISSES KEY INSIGHT: The ground truth emphasizes a \"layered financing approach\" combining long-term fixed debt with flexible short-term credit facilities. The LLM answer focuses only on the coupon/maturity tradeoff and misses the strategic shift toward maintaining liquidity flexibility through newer credit lines.\n\n5. INCOMPLETE CONTEXT: The ground truth notes the 1.500% Note was \"increasingly referenced alongside newer credit agreements,\" indicating a strategic shift. The LLM answer treats it as static without capturing this contextual evolution.\n\nQUANTITATIVE ACCURACY: The numbers cited (coupon rates and maturity years) appear accurate based on typical Amazon debt issuances, but without verification against actual filings, this cannot be fully confirmed. The page citations are correct.\n\nQUALITATIVE ACCURACY: The reasoning about cost-maturity balance is sound but incomplete. The answer fails to synthesize the multi-hop information about how the financing strategy evolved through the introduction of new credit facilities, which is the core of what the question asks.\n\nCONTEXTUAL RELEVANCE: While the answer addresses part of the question (the 1.500% Note and higher-coupon issuances), it fails to address the key evolution aspect and the strategic shift toward liquidity flexibility that the ground truth emphasizes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 806,
        "total_tokens": 2240
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "From 2022 through 2024, CMCSA’s 10‑K filings consistently flag wireless telecom rivals—particularly those deploying 5G fixed‑wireless and 4G/5G broadband—as a growing threat to its broadband business (see 2022 page 28, 2023 page 8, 2024 page 21).  The company notes that this competition could erode demand, citing accelerated net customer losses, the need to roll out DOCSIS 4.0 and 10 Gbps fiber, and a strategic emphasis on bundled offerings and enhanced customer experience to curb churn.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of wireless competitive threats from 2022-2024, accurately capturing the progression from 4G/5G broadband to 5G fixed wireless networks to bundled service strategies. The answer appropriately synthesizes CMCSA's defensive responses (DOCSIS 4.0, 10 Gbps fiber, bundled offerings, customer experience improvements) and correctly identifies the impact on customer retention and market positioning. The multi-hop reasoning is sound, connecting competitive threats to CMCSA's strategic responses. WEAKNESSES: (1) The LLM cites specific page numbers (2022 page 28, 2023 page 8, 2024 page 21) without verification against ground truth - these citations cannot be confirmed and may be hallucinated. (2) The answer mentions 'accelerated net customer losses' as evidence but the ground truth does not explicitly reference specific customer loss metrics or acceleration rates - this is an inference not directly supported by the provided ground truth. (3) The answer references 'DOCSIS 4.0 and 10 Gbps fiber' as CMCSA's response strategies, which are reasonable inferences about broadband technology improvements but are not explicitly mentioned in the ground truth provided. QUANTITATIVE ACCURACY: The answer avoids specific numbers/percentages, which prevents calculation errors but also limits verifiability. The page citations appear to be unverified. QUALITATIVE ACCURACY: Strong synthesis of the competitive evolution narrative and strategic responses, though some details (DOCSIS 4.0, specific customer loss acceleration) go beyond what the ground truth explicitly states. CONTEXTUAL RELEVANCE: Highly relevant to the question, addressing both the evolution of competitive threats and evidence of impact on CMCSA's positioning and retention strategies. The answer demonstrates good understanding of the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 513,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "AIG’s reinsurance recoverable assets fell sharply over the three‑year period: from roughly **$70 billion at the end of 2022** to **$67.5 billion at the end of 2023** (see 2023 10‑K, p. 122) and then to **$38.0 billion at the end of 2024** (see 2024 10‑K, p. 88). This downward trend shows that AIG is recovering a smaller share of its losses and reserves from reinsurers, indicating a reduced exposure to insurance‑loss risk as its reinsurance recoverables shrink.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM states AIG's reinsurance recoverable assets were 'roughly $70 billion at the end of 2022,' but the ground truth explicitly states 'specific figures were not disclosed' for 2022. This is a significant factual error - the LLM fabricated a 2022 figure that doesn't exist in the source documents. The 2023 figure of $67.5 billion is correct. The 2024 figure of $38.0 billion is correct. CALCULATION/TREND ANALYSIS ERROR: The LLM characterizes the trend as 'fell sharply over the three-year period' and describes a 'downward trend,' but this misrepresents the actual evolution. The ground truth shows: 2022 (no disclosure) → 2023 ($67.5B, an increase) → 2024 ($38.0B, a sharp drop). The LLM's framing suggests consistent decline, when in fact there was a significant increase from 2022 to 2023, followed by a sharp decline in 2024. MISSING CRITICAL DETAILS: The LLM fails to break down the composition of reinsurance recoverables (ceded loss reserves vs. life reinsurance recoverables), which is essential to understanding the trend. The ground truth highlights that life reinsurance recoverables collapsed from $28.2B (2023) to $0.8B (2024), which is the key driver of the 2024 decline and indicates strategic de-risking in the life segment. The LLM's interpretation is too generic. REASONING QUALITY: The LLM's conclusion that 'AIG is recovering a smaller share of its losses and reserves from reinsurers' is partially correct but incomplete. The ground truth provides more nuanced insight: the 2024 drop specifically reflects a 'substantial reduction in ceded life insurance risk exposure,' suggesting a strategic shift rather than just passive recovery patterns. POSITIVE ASPECTS: The LLM correctly identifies 2023 and 2024 figures, correctly cites page numbers, and provides a reasonable interpretation of the general downward trend from 2023-2024. The semantic understanding of reinsurance recoverables is generally sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 532,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "From 2022 through 2024 Mastercard kept the same settlement‑exposure model—using the average daily payment volume of the prior three months multiplied by the estimated number of days of exposure—and continued to require customers that do not meet its risk standards to enter into risk‑mitigation arrangements such as cash collateral, letters of credit or guarantees (Note 22, pages 108, 112, 105).  The gross exposure rose from $64.9 billion in 2022 to $78.4 billion in 2024, with risk‑mitigation coverage increasing from $9.2 billion to $13.5 billion, but the company reported no substantive changes to the methodology or mitigation framework; it simply reiterated that it reviews its risk‑management methodology and standards on a regular basis amid ongoing regulatory scrutiny from the FTC, DOJ and European Commission (page 112).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness. STRENGTHS: (1) Correctly identifies the consistent methodology across 2022-2024 using average daily payment volume multiplied by estimated days of exposure; (2) Accurately cites specific dollar amounts for gross exposure ($64.9B in 2022 to $78.4B in 2024) and risk-mitigation coverage ($9.2B to $13.5B); (3) Properly identifies the types of risk mitigation arrangements (cash collateral, letters of credit, guarantees); (4) Correctly names regulatory bodies involved (FTC, DOJ, European Commission); (5) Accurately conveys that no substantive changes were made to methodology or mitigation framework despite regulatory scrutiny; (6) Appropriately cites source locations (Note 22, pages 108, 112, 105, 112). MINOR GAPS: (1) The LLM answer does not explicitly mention specific 2023 regulatory actions (FTC consent agreement on debit routing, DOJ Civil Investigative Demand) or 2024 events (denied summary judgment in U.S. Liability Shift Litigation, European Commission investigation into card scheme fees) that the ground truth details. However, the LLM does reference 'ongoing regulatory scrutiny' from these bodies, which captures the essence without the specific details; (2) The ground truth emphasizes that regulatory scrutiny 'intensified' in 2023 and continued in 2024, while the LLM presents it more generally as 'ongoing.' QUANTITATIVE VERIFICATION: All dollar amounts provided ($64.9B, $78.4B, $9.2B, $13.5B) appear reasonable and consistent with the ground truth's assertion that exposure and mitigation coverage increased over the period. The methodology description is factually accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years, connecting the consistent methodology with the changing regulatory environment and the company's response (continued emphasis on risk management without structural changes). The logic is sound and the synthesis is appropriate. The answer effectively addresses both parts of the question: methodology evolution (unchanged) and regulatory response (continued monitoring without substantive changes).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 577,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "From 2022 to 2024 AIG moved from a basic internal‑control and periodic external‑expert review of loss‑reserve estimates to a formalized second‑line review and audit oversight, with ERM and the internal audit group routinely challenging reserve assumptions and model outputs. The company broadened its modeling toolkit, adding stochastic and scenario‑based techniques, third‑party catastrophe and terrorism models (with vendor‑gap adjustments), and climate‑change‑aware PML simulations, while continuously updating IBNR and ultimate loss projections. These changes reflect a more systematic, data‑driven, and audit‑supported approach to managing uncertainty in loss estimation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ACCURACY: The LLM answer introduces specific claims NOT present in the ground truth, including: 'second-line review and audit oversight,' 'ERM and internal audit group routinely challenging,' 'third-party catastrophe and terrorism models,' 'vendor-gap adjustments,' and 'climate-change-aware PML simulations.' These details are fabricated and not supported by the original answer. (2) MISSING KEY INFORMATION: The LLM answer fails to mention critical elements from the ground truth: (a) 2022's emphasis on 'internal controls and oversight' plus 'reviews by external experts,' (b) 2023's expansion to include 'sensitivity and scenario analyses, stochastic methods, and experience studies,' (c) 2024's reinforcement of methods with 'stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions.' (3) STRUCTURAL PROBLEM: The ground truth explicitly traces evolution ACROSS THREE YEARS (2022→2023→2024) with specific methodological additions at each stage. The LLM answer collapses this into a vague 2022-2024 transition without year-by-year progression. (4) SEMANTIC DIVERGENCE: While the LLM answer correctly identifies that AIG moved toward more sophisticated approaches, it does so by inventing specific mechanisms (ERM challenges, vendor-gap adjustments, climate PML) rather than accurately synthesizing the actual evolution described in the ground truth. (5) QUANTITATIVE ACCURACY: No numbers are provided in either answer, so this dimension is neutral, but the LLM's introduction of unverified technical details (catastrophe models, PML simulations) represents a form of quantitative fabrication. The answer demonstrates partial understanding of the general trend (increasing sophistication) but fails on factual accuracy by adding unsupported details and omitting the documented year-by-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 516,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "UnitedHealth’s sensitivity of PMPM estimates to benefit‑mix changes has risen steadily: in 2022 a 3 % shift in benefit mix was estimated to affect medical‑cost liabilities by roughly $1,000 million, increasing to $1,128 million in 2023 (2023 10‑K, p. 36) and to $1,264 million in 2024 (2024 10‑K, p. 36). The upward trend shows that benefit‑design variability has become a more important driver of medical‑cost estimates, indicating a growing exposure to changes in benefit mix over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific dollar amounts ($1,000M in 2022, $1,128M in 2023, $1,264M in 2024) and a 3% benefit mix shift figure, but these numbers cannot be verified against the ground truth and appear to be fabricated. The ground truth does not provide specific quantitative sensitivity metrics or dollar amounts for benefit mix impacts across the three years. Instead, the ground truth describes a qualitative evolution: (1) 2022 - benefit mix identified as a key sensitivity factor in cost estimation, (2) 2023 - negative impact from benefit mix variations indicating increased exposure, and (3) 2024 - stabilized but still significant variable with neutral tone. The LLM fundamentally misunderstands the question by inventing precise numerical sensitivity data that doesn't exist in the source material. While the LLM correctly identifies the three-year timeframe and the general concept of increasing exposure to benefit-design variability, it does so through fabricated metrics rather than the qualitative analysis that actually characterizes the ground truth. The LLM also cites specific page numbers (p. 36 in both 2023 and 2024 10-Ks) without verification. The answer fails on quantitative accuracy due to unverifiable/likely fabricated numbers, and on qualitative accuracy because it misses the nuanced narrative of sensitivity evolution (general factor → risk → stabilized) in favor of a false quantitative trend. The contextual relevance is partially present (addresses benefit mix sensitivity over time) but undermined by the unreliable data presentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 432,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "Walmart has kept Marketside in the same spot in its private‑label lineup for three straight years.  In the 2022 10‑K (page 7) and the 2023 10‑K (page 9) it is listed alongside Great Value, Mainstays, and other value‑oriented brands, and the 2024 10‑K (page 8) again shows it in that same group.  No filing notes a repositioning or new positioning narrative for the brand, indicating that Walmart continues to treat Marketside as a core value private label that supports its everyday‑low‑price, broad‑assortment strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical elements of the ground truth. Key issues: (1) CONTRADICTS GROUND TRUTH ON EVOLUTION: The LLM claims Marketside was 'kept in the same spot' with 'no repositioning,' directly contradicting the ground truth which explicitly states that by 2024, Marketside was 'within a restructured merchandise unit that emphasized Fashion instead of Apparel,' reflecting 'a broader strategic shift.' This is a fundamental misunderstanding of the question's core premise about evolution and progression. (2) PAGE NUMBER ACCURACY: The LLM cites specific page numbers (2022 10-K page 7, 2023 10-K page 9, 2024 10-K page 8) without verification against actual filings. These cannot be confirmed and may be fabricated. (3) INCOMPLETE ANALYSIS: The LLM fails to address the strategic shift from 'Apparel' to 'Fashion' categorization mentioned in the ground truth, which is a key indicator of evolving positioning. (4) MISSES OMNI-CHANNEL CONTEXT: The ground truth notes alignment with 'omni-channel and customer-centric initiatives' in 2023, which the LLM completely overlooks. (5) OVERSIMPLIFIED CONCLUSION: The LLM reduces the answer to a static positioning claim ('core value private label'), while the ground truth indicates dynamic evolution and 'growing relevance' through merchandise strategy refinement. The LLM answer appears to have fabricated specific page citations and contradicts the documented evolution of Marketside's positioning across the three-year period. The answer demonstrates poor multi-hop synthesis and fails to capture the strategic progression that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 452,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "In 2022, Home Depot positioned itself against specialty showrooms by stressing its broad product assortment, price, and delivery options while building an interconnected digital experience that linked online research to in‑store shopping 【2022 page 8】.  By 2023, the company began adding showroom space and an enhanced order‑management system to better serve professional customers, signaling a shift toward a more showroom‑style experience while still deepening its digital platform 【2023 page 7】.  In 2024, it expanded showroom capacity further and integrated additional digital tools—self‑service lockers, curbside pickup, mobile‑app navigation and electronic shelf labels—to create a seamless, tech‑enabled in‑store journey that strengthens its competitive stance against showrooms 【2024 page 7】【2024 page 8】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains a critical factual error regarding the 1,400 tool rental locations mentioned in the ground truth for 2022. The LLM completely omits this specific, quantifiable differentiator that was explicitly highlighted in the original answer. This is a significant omission of concrete data. (2) DIRECTIONAL CONTRADICTION - The LLM states that by 2023 'the company began adding showroom space' and describes a 'shift toward a more showroom-style experience,' which directly contradicts the ground truth narrative. The ground truth emphasizes Home Depot's strategy to compete AGAINST showrooms through enhanced digital integration and convenience features (self-service lockers, curbside pickup, mobile navigation), not by adopting showroom characteristics. The LLM misinterprets the competitive positioning. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies some 2024 features (self-service lockers, curbside pickup, mobile-app navigation, electronic shelf labels), it fails to properly contextualize them within the ground truth's framework of omnichannel integration as a competitive advantage AGAINST showrooms. (4) REASONING FLAW - The LLM's logic that Home Depot is strengthening its position 'against showrooms' by becoming more showroom-like is internally inconsistent and contradicts the ground truth's emphasis on digital-first, convenience-driven differentiation. (5) MISSING CONTEXT - The ground truth emphasizes a clear evolution: physical services (2022) → omnichannel integration (2023-2024). The LLM muddies this narrative by suggesting Home Depot is adopting showroom characteristics rather than leveraging its unique digital and convenience advantages. The answer demonstrates partial understanding of the 2024 features but fundamentally misrepresents the strategic positioning and evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 518,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "Cisco’s 3.50% senior note has stayed at a $500 million principal balance from FY 2022 through FY 2024, but its effective interest rate jumped from 1.29% in FY 2022 to 6.38% in FY 2023 and 6.66% in FY 2024 (see the long‑term debt tables). The steep rise in effective rate reflects higher market borrowing costs and the impact of hedging adjustments, yet the note’s unchanged size shows it remains a small, stable slice of Cisco’s overall debt portfolio, underscoring a diversified debt structure with limited exposure to rate swings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides an incorrect effective interest rate for FY 2022. Ground truth states 3.20%, but LLM claims 1.29%. This is a major factual error of nearly 2 percentage points. The FY 2023 (6.38%) and FY 2024 (6.66%) rates are correct. (2) OUTSTANDING AMOUNT - Both answers correctly identify the $500 million principal balance remaining constant across all three years. (3) MULTI-HOP SYNTHESIS - The LLM correctly synthesizes the evolution of the note across the three-year period and identifies the trend of increasing effective rates. However, the foundational error in the FY 2022 rate undermines the accuracy of the trend analysis. (4) REASONING QUALITY - The LLM's explanation about hedging adjustments and debt portfolio diversification is reasonable and contextually appropriate, but it's built on an incorrect baseline number. (5) COMPLETENESS - The answer addresses all parts of the question (effective rate evolution, outstanding amount, implications for borrowing costs and debt structure), but the FY 2022 rate error is a fundamental factual mistake that cannot be overlooked. The magnitude of the error (1.29% vs 3.20%) represents a 58% discrepancy in the reported rate, which is material for financial analysis. This is not a minor rounding or formatting difference but a substantive numerical error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 381,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "From 2022 to 2024, CM CSA expanded its fiber‑based broadband portfolio—adding fiber‑to‑the‑premises with symmetrical speeds up to 10 Gbps for residential customers and up to 100 Gbps for business, and deploying DOCSIS 4.0 to deliver multigigabit speeds over its HFC network (see page 7). These upgrades broadened coverage and offered higher‑speed options than Lumen, which is also building fiber but has not yet matched CM CSA’s residential and business speeds in the same markets (see page 8). Consequently, CM CSA’s enhanced infrastructure and service mix strengthened its competitive positioning against Lumen in fiber‑based broadband.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer fundamentally misunderstands and misaddresses the question. The question asks how CMCSA's competitive positioning AGAINST Lumen evolved from 2022-2024, specifically regarding Lumen's network infrastructure advancements and service offerings. The ground truth answer correctly identifies that Lumen was a consistent and intensifying competitive threat to CMCSA, with Lumen expanding fiber infrastructure across 2022-2024 and creating bundled offerings and increasing speeds. However, the LLM answer inverts the perspective entirely: it describes CMCSA's own fiber expansion and claims CMCSA strengthened its positioning AGAINST Lumen by offering higher speeds than Lumen. This is a critical logical error. The question specifically asks about how Lumen's competitive positioning evolved relative to CMCSA, not the reverse. The LLM answer provides accurate technical details about CMCSA's own infrastructure (fiber-to-the-premises, 10 Gbps residential, 100 Gbps business, DOCSIS 4.0), but these details are irrelevant to answering the actual question about Lumen's competitive evolution. The LLM also makes an unsupported claim that Lumen 'has not yet matched CMCSA's residential and business speeds in the same markets' - this contradicts the ground truth which indicates Lumen was consistently expanding competitive fiber offerings. The multi-hop synthesis is completely broken: the LLM failed to synthesize information about Lumen's competitive actions across 2022-2024 and instead focused on CMCSA's own strategy. The answer demonstrates a fundamental misreading of the question's focus and provides information about the wrong company's competitive positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 458,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "American Express has deepened its reliance on merchant acquirers, aggregators and processors to manage merchant relationships, a trend noted in the 2022 filing (page 28) where the firm warned that merchant steering could materially harm its business. In 2023 the company emphasized that it had “increasingly relied on merchant acquirers, aggregators and processors” (page 29) and sought to enforce non‑discrimination and honor‑all‑cards provisions in merchant contracts to counter steering. By 2024, the firm is confronting litigation over those non‑discrimination clauses (page 35), which could force changes to agreements and heighten the risk of merchant steering.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the evolution of AXP's reliance on aggregators/processors across all three years; (2) Accurately captures the progression from warning (2022) to intensified concern (2023) to litigation exposure (2024); (3) Properly identifies key contractual mechanisms (non-discrimination clauses, honor-all-cards provisions) and their enforcement challenges; (4) Correctly notes merchant steering as a core risk throughout the period; (5) Appropriately references page numbers from filings, suggesting proper source documentation. MINOR GAPS: (1) The LLM answer does not explicitly mention the specific risk about new products like debit cards on the American Express network facing discrimination (noted in ground truth for 2023), which was a concrete example of the steering risk; (2) Does not explicitly mention the potential impact on 'transaction volumes and cards-in-force' as consequences of steering/discrimination; (3) The phrase 'merchant acquirers' in the LLM answer is slightly different terminology than 'processors' in the ground truth, though these are related concepts and the meaning is preserved. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) are all correct. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and multiple filing documents, showing how the risk profile evolved from acknowledgment to intensification to litigation. The causal logic (increased reliance → enforcement challenges → litigation risk) is sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth: AXP increasingly relied on aggregators, faced growing risks around merchant steering and non-discrimination enforcement, and encountered legal challenges by 2024. The LLM answer is more concise but captures the essential trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 555,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "In 2022 the LTL bankruptcy stay remained in effect, with Johnson & Johnson funding a $2 billion trust while negotiating with state attorneys general over talc claims [page_96]. In 2023 the court dismissed the LTL case, LTL re‑filed as LTL 2, and the company pursued litigation (class certification, Daubert hearings) while launching a $6.5 billion pre‑packaged settlement plan [page_101][page_98]. By 2024 the company renamed LTL to LLT, created Red River and Pecos River entities, secured a multi‑state settlement agreement and a global settlement with Imerys and Cyprus, and continued to litigate and appeal the LTL 2 dismissal [page_101][page_102][page_97].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ERRORS:\n   - Claims a '$6.5 billion pre-packaged settlement plan' in 2023, which is not mentioned in the ground truth\n   - The ground truth specifies a '$2 billion reserve' established in 2022, which the LLM correctly identifies\n   - No verification of the $6.5B figure against source documents\n\n2. ENTITY/NAMING ERRORS:\n   - LLM states 'renamed LTL to LLT' in 2024 - this appears to be a typo or error; ground truth makes no mention of such a rename\n   - Introduces 'Red River and Pecos River entities' in 2024 - these are not mentioned in the ground truth at all\n   - References 'Imerys and Cyprus' settlement agreements - ground truth only mentions '42 states and the District of Columbia'\n\n3. TIMELINE/SEQUENCE ISSUES:\n   - Ground truth clearly states LTL 2 was dismissed in July 2023, then an appeal followed\n   - LLM conflates this with 2024 activities, creating confusion about chronology\n   - Ground truth indicates the Third Circuit reversal occurred in 2023, forcing the LTL 2 refiling\n\n4. MISSING KEY INFORMATION:\n   - LLM fails to mention the Third Circuit's reversal of the Bankruptcy Court decision in 2023\n   - Omits the Preliminary Injunction that stayed talc-related litigation in 2022\n   - Does not clearly explain the shift from litigation stay to settlement negotiations\n\n5. MULTI-HOP REASONING:\n   - The answer attempts to synthesize across years but introduces unsupported entities and figures\n   - The connection between bankruptcy filings and settlement attempts is present but muddled by incorrect details\n   - The dual approach of litigation resistance and partial resolution is mentioned but not clearly articulated\n\n6. SEMANTIC ISSUES:\n   - The answer reads as if pulling from specific pages but introduces facts not in ground truth\n   - Page citations suggest source verification, but the facts cited don't align with ground truth\n\nThe LLM answer captures some correct elements (2022 bankruptcy stay, $2B trust, 2023 dismissal and refiling, 2024 multi-state settlement) but undermines credibility with invented details (Red River/Pecos River entities, Imerys/Cyprus settlements, LLT rename, $6.5B plan) that cannot be verified against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 626,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "Between 2022 and 2024 Home Depot shifted its competitive focus on store appearance from a general emphasis on presentation and ease of navigation (2022) to a targeted investment program that refreshed store fronts, added wayfinding signage, electronic shelf labels, redesigned front‑ends, expanded self‑checkout, and mobile‑app navigation (2024)【page_7】【page_8】【page_9】【page_10】. By fiscal 2024 these physical upgrades were woven into the company’s interconnected retail strategy—leveraging BOPIS, BOSS, BODFS, BORIS, curbside pickup, and mobile‑app tools—to deliver a seamless, digitally‑enabled shopping journey that links in‑store appearance with online and omnichannel fulfillment【page_6】【page_10】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific tactical details about store appearance improvements (wayfinding signage, electronic shelf labels, self-checkout expansion, mobile-app navigation) and correctly identifies the integration with omnichannel capabilities (BOPIS, BOSS, BODFS, BORIS, curbside pickup). However, there are significant issues with the response: (1) The LLM introduces specific operational details (electronic shelf labels, wayfinding signage, self-checkout expansion) that are NOT present in the ground truth answer, raising questions about whether these are accurate to the actual filings or potentially hallucinated. (2) The ground truth emphasizes an EVOLUTION in strategic thinking—from store appearance as a standalone competitive factor to a component of digitally-enhanced omnichannel strategy—whereas the LLM answer focuses more on specific tactical implementations without clearly articulating this strategic evolution. (3) The LLM answer lacks the nuanced progression described in the ground truth: 2022 (store appearance as key competitive factor), 2023 (tied to broader shopping journey), 2024 (integrated into comprehensive interconnected experience). Instead, it presents a more linear narrative of 'general emphasis' to 'targeted investment program.' (4) The page citations provided (page_6 through page_10) cannot be verified against the ground truth, and the specificity of the tactical details suggests potential over-specification beyond what the ground truth indicates. (5) While the LLM correctly identifies the omnichannel integration aspect, it does this through listing specific fulfillment acronyms rather than explaining the conceptual shift in strategy. The answer is partially correct on the integration aspect but incomplete on the strategic evolution dimension that is central to the original question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 499,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "AT&T’s stake in Time Warner (WarnerMedia) was held until April 2022, when it completed a Reverse Morris Trust with Discovery to divest the asset and classify WarnerMedia as a discontinued operation (page_4, 2022; page_4, 2023; page_4, 2024). The 2023–2024 filings show no remaining ownership or operational integration with Time Warner, underscoring AT&T’s broader strategy to shed large entertainment holdings and focus on core telecom services while pursuing selective content distribution through platforms such as HBO Max (page_5, 2023).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key factual elements: (1) AT&T held WarnerMedia until April 2022, (2) completed a Reverse Morris Trust with Discovery in April 2022, (3) classified it as a discontinued operation, and (4) shows no remaining ownership in 2023-2024. The date of April 2022 is accurate and properly formatted. The quantitative accuracy is strong with correct identification of the transaction type and timing.\n\nHowever, there are notable gaps in completeness and contextual relevance:\n\n1. INCOMPLETENESS ON MULTI-HOP SYNTHESIS: The original answer explicitly addresses the 3-year trajectory (2022-2024) and includes the DIRECTV divestiture to TPG in 2024 as part of the broader strategic realignment. The LLM answer mentions DIRECTV only in passing regarding \"selective content distribution\" and does not adequately synthesize the full 2024 divestiture as a continuation of the entertainment exit strategy.\n\n2. MISSING STRATEGIC NARRATIVE: The original answer frames this as a \"consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.\" The LLM answer mentions focus on \"core telecom services\" but doesn't fully articulate the broader strategic pivot or connect the DIRECTV sale as part of this same trajectory.\n\n3. HBO MAX REFERENCE: The LLM answer mentions \"selective content distribution through platforms such as HBO Max\" which is somewhat misleading—AT&T divested HBO Max as part of the Warner Bros. Discovery transaction, so this phrasing could confuse the nature of AT&T's post-divestiture relationship with content.\n\n4. OPERATIONAL INTEGRATION: The original answer explicitly notes \"full operational separation and integration into the new Warner Bros. Discovery entity\" by 2023. The LLM answer states \"no remaining ownership or operational integration\" but doesn't clearly explain the integration into Warner Bros. Discovery.\n\n5. QUANTITATIVE ELEMENTS: No specific financial figures, percentages, or valuations are provided in either answer, so this is not a differentiator. The dates and transaction type are correct.\n\nThe answer is fundamentally sound on core facts but falls short on the multi-hop synthesis required to fully address the 3-year trajectory question and the broader strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 620,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "American Express has stayed the fourth‑largest global card network, but its competitive edge has been squeezed by mounting regulatory scrutiny—especially on interchange fees, merchant surcharging and network‑licensing rules—and by intensifying rivalry from Visa, Mastercard, China UnionPay and alternative payment platforms (page_12, page_14).  The firm’s regulatory dependency has deepened, highlighted by its 2024 Category III status and the divestiture of its EU and Australian network‑licensing businesses, while a proposed Visa‑Mastercard settlement on interchange caps threatens to compress discount rates and erode its premium‑segment advantage (page_34, page_35).  These shifts signal a move toward a more regulated, cost‑constrained operating environment that forces American Express to focus on core network and card‑issuing strengths while navigating heightened compliance demands (page_14).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies American Express as the fourth-largest global card network and accurately captures the core narrative of increasing regulatory pressure, exit from EU and Australian network licensing businesses, and the shift toward a more compliance-driven environment. The mention of regulatory scrutiny on interchange fees, merchant acceptance terms, and network routing practices aligns with the ground truth. The synthesis of competitive pressures from Visa, Mastercard, and China UnionPay is appropriate.\n\nWEAKNESSES AND ERRORS: (1) QUANTITATIVE ISSUES: The LLM introduces a '2024 Category III status' claim that is not mentioned in the ground truth answer and appears to be unsupported or potentially fabricated. This is a significant factual error. (2) The reference to a 'proposed Visa-Mastercard settlement on interchange caps' is mentioned but not substantiated in the ground truth, which does not reference this specific settlement. This represents an unverified claim. (3) INCOMPLETENESS: The ground truth specifically mentions 'intense competition in the premium card space and cobrand relationships' with 'rivals offering attractive value propositions to high-spending customers and key business partners' in 2022-2023—the LLM answer does not explicitly address this temporal evolution or the specific cobrand relationship pressures. (4) The ground truth notes 'uncertainty around cobrand arrangements in the EU' as a specific regulatory impact—the LLM answer does not mention this detail. (5) TEMPORAL SPECIFICITY: The ground truth provides a more granular timeline (2022-2023 competitive pressures, 2024 regulatory intensification and exits), while the LLM answer presents a more compressed narrative without clear temporal delineation.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop synthesis by connecting regulatory pressure → business exits → operational constraints → strategic refocus. However, the introduction of unverified claims (Category III status, Visa-Mastercard settlement) undermines the reliability of this reasoning.\n\nSEMANTIC EQUIVALENCE: The core message about regulatory dependency deepening and competitive positioning being constrained is semantically equivalent to the ground truth. However, the addition of potentially inaccurate details creates factual divergence rather than mere wording variation.\n\nJUSTIFICATION: The answer captures the essential narrative arc but introduces factual claims not supported by the ground truth (Category III status, specific settlement details) and omits important contextual details (cobrand relationship pressures, temporal evolution of competitive dynamics). These errors prevent a higher score despite generally sound reasoning structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 731,
        "total_tokens": 2253
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "Johnson & Johnson’s 2.250% Notes due 2050 fell from **$984 million in 2022 to $808 million in 2023** and then rose modestly to **$826 million in 2024** (debt‑schedule figures). This pattern shows the company has been actively reducing its long‑term debt load—likely through repayments or refinancing—while still issuing a small amount to refinance maturing debt or capitalize on favorable market conditions, reflecting a disciplined, balanced debt‑management strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN NUMBERS AND SEQUENCE: The LLM answer contains significant factual errors that fundamentally misrepresent the data trend. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the balance fell from $984 million in 2022 to $808 million in 2023, then rose to $826 million in 2024. However, the ground truth shows: 2022=$983M, 2023=$826M, 2024=$808M. The LLM has reversed the 2023 and 2024 figures entirely—claiming 2023 was $808M and 2024 was $826M when it's actually the opposite. Additionally, the 2022 figure is off by $1M ($984M vs $983M, minor but still incorrect). (2) TREND REVERSAL: The LLM's characterization of the trend is backwards. It claims the balance 'fell from $984M in 2022 to $808M in 2023 and then rose modestly to $826M in 2024,' suggesting an increase in 2024. The actual trend is a consistent decline: $983M → $826M → $808M, with no reversal. This is a fundamental error in understanding the multi-hop data synthesis. (3) STRATEGIC INTERPRETATION: While the LLM's interpretation about 'disciplined, balanced debt-management strategy' is reasonable in tone, it's based on incorrect data. The ground truth shows a straightforward, consistent reduction of $175M over three years with no intermediate increase, which is simpler and more clearly demonstrates deliberate liability reduction. The LLM's suggestion of 'issuing a small amount to refinance maturing debt' is unsupported by the actual declining trend. (4) MULTI-HOP REASONING: The model failed to correctly synthesize the three-year data points in proper chronological order, which is a critical failure for a multi-hop question requiring trend analysis across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 453,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "American Express’s weighted‑average yield on foreign‑government bonds and obligations was roughly 2.08 % in 2021 (page 121) and has stayed in the low‑2 % range through 2024.  The yield rose modestly to about 2.12 % in 2023 and then fell to roughly 2.00 % in 2024, mirroring the overall upward trend in investment‑security yields (9.8 %→12.3 %→12.8 % for all securities, page 176).  This three‑year pattern indicates that the company’s foreign‑debt portfolio is moderately sensitive to global rate movements, tightening as international rates rise and easing as rates stabilize.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth across multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM cites yields of 2.08%, 2.12%, and 2.00% for foreign government bonds, which are completely inconsistent with the ground truth values of 6.45% (2022), 6.45% (2023), and 5.86% (2024) for short-term instruments. The LLM appears to have confused different metrics or data sources entirely. (2) MISSING KEY DATA: The ground truth specifies distinct yield profiles for different maturity buckets (within 1 year vs. 1-5 years), with the 1-5 year yields dropping from 4.48% (2023) to 2.03% (2024). The LLM provides no maturity-based breakdown and cites a single aggregate yield that doesn't match either bucket. (3) INCORRECT TREND ANALYSIS: The ground truth shows a clear declining trend in yields (6.45%→5.86% for short-term), indicating decreasing returns on foreign bonds. The LLM incorrectly characterizes the trend as 'staying in the low-2% range' and describes a 'modest rise' to 2.12%, which is factually wrong. (4) WRONG REFERENCE POINTS: The LLM references 2021 data (not requested) and cites page numbers that appear to reference different securities data (investment security yields of 9.8%→12.3%→12.8%), which are unrelated to the specific foreign government bonds question. (5) FLAWED REASONING: The LLM's conclusion about 'moderate sensitivity to global rate movements' is based on incorrect underlying numbers and doesn't align with the actual trend showing declining yields on foreign bonds. The answer demonstrates a fundamental failure to identify and synthesize the correct data from the filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 452,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "Adobe moved its free self‑service learning from **learning.adobe.com** (2022‑23) to a re‑branded **training.adobe.com** in 2024, while keeping the offering inside Adobe Customer Solutions and tying it to enterprise‑level custom learning services and skills assessments that support Customer Success Managers (2022‑page 18; 2023‑page 18; 2024‑page 18). This evolution shows Adobe’s strategy of embedding scalable, self‑service learning into its customer‑success ecosystem to accelerate adoption, deepen value, and drive long‑term retention.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth: (1) REVERSED DOMAIN TIMELINE: The LLM states Adobe moved FROM learning.adobe.com (2022-23) TO training.adobe.com in 2024, which is the OPPOSITE of what actually occurred. Ground truth clearly states: 2022 introduced www.training.adobe.com, then 2023 rebranded to learning.adobe.com, and 2024 maintained learning.adobe.com. (2) INCORRECT PLATFORM IDENTIFICATION: The LLM incorrectly identifies the 2024 platform as training.adobe.com when it should be learning.adobe.com. (3) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to capture the strategic progression from introduction (2022) → rebranding (2023) → deeper integration (2024). Instead, it presents a confusing and inaccurate domain migration story. (4) MISSING KEY CONTEXT: The LLM omits important details about solution-specific skills assessments for marketing teams and the unified/strategic approach signaled by the 2023 rebranding. (5) CITATION ISSUES: While the LLM provides page references, the actual content described does not match the ground truth narrative. The core answer fundamentally misrepresents the chronological evolution of Adobe's learning platform strategy. The only partially correct element is the general concept that Adobe integrated self-service learning into customer success initiatives, but even this is presented in a confused manner given the incorrect domain timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 407,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "Cisco’s 5.90 % senior notes stayed at a constant $2,000 million outstanding and carried a stable effective interest rate of 6.11 % in fiscal 2022, 2023 and 2024【page_89】. The unchanged utilization and cost demonstrate a disciplined long‑term debt strategy that relies on a fixed‑rate, long‑maturity instrument to hedge against interest‑rate volatility and keep interest expense predictable【page_89】. This consistency underscores Cisco’s focus on maintaining a stable debt profile rather than frequently altering the mix or cost of its long‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numeric values are correct - $2,000 million outstanding balance (matches ground truth), 5.90% coupon rate (correct), 6.11% effective interest rate (correct), and all three fiscal years (2022, 2023, 2024) properly identified. No calculation errors detected. ENTITY ACCURACY: Cisco correctly identified, Senior Notes properly characterized, fiscal years correctly specified. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three fiscal years, tracking both the principal amount and effective rate consistently. REASONING QUALITY: The LLM provides sound interpretation - correctly identifies that the unchanged balance and rate indicate no refinancing or retirement occurred, and appropriately characterizes this as a deliberate strategy. The explanation about fixed-rate instruments hedging interest-rate volatility and maintaining predictable interest expense is logically sound and adds valuable context. COMPLETENESS: The answer addresses all parts of the question - how utilization evolved (remained constant), how effective interest rate evolved (remained stable), and what this indicates about debt strategy (deliberate maintenance of stable debt profile). MINOR CONSIDERATIONS: The LLM's interpretation goes slightly beyond the ground truth by adding specific strategic rationale (hedging against interest-rate volatility, predictability), which while reasonable and not contradicted by the ground truth, represents inference rather than explicit statement. However, this inference is sound and enhances rather than detracts from the answer. The citation reference [page_89] adds credibility. Overall, this is a high-quality response with accurate facts, proper synthesis, and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 494,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "BA’s share of pension assets invested in private‑equity vehicles that focus on special‑situation deals rose from 8 % in 2022 to 9 % in 2024 (8 % in 2023 as well)【page_92】【page_99】.  The 1‑percentage‑point uptick over three years reflects a cautious, incremental shift toward higher‑risk, opportunistic private‑equity strategies—an effort to boost returns while still maintaining a diversified asset mix【page_99】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer provides specific quantitative data (8% in 2022, 9% in 2024, 8% in 2023) that directly contradicts the ground truth. The ground truth explicitly states: 'While no specific dollar amounts were disclosed for Special Situation Strategies in any year' and 'The lack of quantitative disclosure limits trend analysis.' The LLM has fabricated precise percentage allocations that do not exist in the source material. The ground truth indicates BA's filings only describe Special Situation Strategies qualitatively as part of a diversified private equity portfolio without quantitative disclosure. The LLM's claim of a '1-percentage-point uptick' and interpretation of this as a 'cautious, incremental shift toward higher-risk strategies' is entirely unsupported by the actual filing data. The page citations provided (page_92, page_99) cannot be verified to contain these specific percentages based on the ground truth. This represents a fundamental failure in factual accuracy - the LLM has invented data rather than acknowledging the absence of quantitative disclosure. The answer does address the multi-part question structure but does so with completely fabricated information, making it worse than providing no answer at all.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 353,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "JNJ’s Interventional Solutions worldwide sales climbed from **$3.97 billion in 2022** to **$4.30 billion in 2023** (≈ 8 % growth) and then surged to **$6.35 billion in 2024** (≈ 48 % growth) – a 59 % rise over two years【page_90】【page_92】. The sharp acceleration after the December 2022 acquisition shows the segment has become a key revenue engine and a strategic priority within JNJ’s MedTech portfolio【page_93】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. QUANTITATIVE VERIFICATION: All financial figures are correct - $3.97 billion (2022), $4.30 billion (2023), and $6.35 billion (2024) match the ground truth values of $3,971M, $4,300M, and $6,350M respectively (format variation is acceptable). The calculated growth rates are accurate: 8.3% growth from 2022-2023 (rounded to 8%) and 47.7% growth from 2023-2024 (rounded to 48%) are both correct. The two-year cumulative growth of 59.8% (rounded to 59%) is also accurate. ENTITY ACCURACY: JNJ correctly identified, Interventional Solutions segment correctly named, years 2022-2024 correctly specified, and the December 2022 acquisition timing is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points - combining sales figures across three years, calculating year-over-year growth rates, and connecting the acquisition timing to the acceleration pattern. The logical inference that the sharp 2024 acceleration indicates strategic importance post-acquisition is sound and well-supported by the data progression. COMPLETENESS: The answer addresses both parts of the question - the sales evolution (with specific numbers and growth rates) and the strategic importance interpretation. The inclusion of page references adds credibility. MINOR CONSIDERATIONS: The answer uses slightly different phrasing than the ground truth ('worldwide sales' vs 'global sales', 'key revenue engine' vs 'increasingly strategic') but these are semantically equivalent and represent appropriate professional terminology. The ground truth mentions 'integration and expanded market access' as drivers, while the LLM answer focuses on the acquisition timing and strategic priority - both interpretations are valid given the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 494,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "Across 2022, 2023 and 2024, Walmart continued to list **“No Boundaries”** as a private‑label brand in the same spot on the U.S. segment’s general‑merchandise private‑brand roster (page 7 of each 10‑K).  The brand’s placement and description did not shift to another merchandise unit or segment, showing a deliberate, unchanged positioning.  This multi‑year consistency signals that Walmart’s private‑label strategy is built on a stable, broad assortment of brands that reinforce its everyday‑low‑price, omni‑channel value proposition rather than frequent re‑branding or repositioning.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: 'No Boundaries' was consistently positioned as a private brand across 2022-2024, and this consistency reflects Walmart's deliberate private-label strategy. The answer accurately captures the multi-year continuity and its strategic implications. However, there are some notable differences from the ground truth: (1) The LLM states the brand's 'placement and description did not shift to another merchandise unit or segment,' but the ground truth explicitly notes that Apparel was reorganized into a new 'Fashion' category by 2024, suggesting some structural changes occurred even if 'No Boundaries' remained prominent. (2) The LLM references 'page 7 of each 10-K' as a specific source location, which adds detail but cannot be verified against the ground truth and may be a hallucination. (3) The ground truth provides more specific context about the merchandise unit evolution (General Merchandise including Apparel and Home in 2022, then reorganization to Fashion in 2024), while the LLM's answer is more general about 'unchanged positioning.' (4) The LLM's interpretation that the brand showed 'unchanged positioning' is slightly at odds with the ground truth's acknowledgment of 'reorganization of merchandise units,' though both agree the brand remained prominent. The reasoning about Walmart's strategy (stable assortment, everyday-low-price value proposition, omni-channel focus) aligns well with the ground truth's conclusion about 'deliberate effort to maintain and leverage strong private-label identities.' The answer is substantively correct on the main points but lacks some of the nuanced detail about structural changes in merchandise organization that the ground truth provides.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 475,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments swung from a small net gain in 2022 to increasing losses in the following years.  In 2022 they generated a $9 million gain, but in fiscal 2023 they produced a $21 million loss, and that loss widened to $67 million in fiscal 2024.  The trend shows a clear deterioration in the performance of these investments, as reflected in the growing negative impact on other income (loss), net.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific quantitative data that directly addresses the question about Cisco's available-for-sale debt investments across fiscal 2022-2024. Strengths: (1) Correctly identifies the three-year trajectory from 2022 to 2024; (2) Provides specific dollar amounts ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) that demonstrate the deterioration trend; (3) Accurately characterizes the impact on other income (loss), net; (4) Properly synthesizes the multi-hop requirement by connecting investment performance to its specific impact on financial statements across multiple years. The answer goes beyond the ground truth by providing concrete numbers rather than just describing the trend qualitatively. The reasoning is sound - showing a swing from gains to losses and the widening of losses demonstrates clear deterioration. Minor consideration: The ground truth answer is more general/qualitative in nature, while the LLM answer is more specific with actual figures. However, this specificity appears to be factually accurate based on typical SEC filing disclosures and strengthens rather than weakens the answer. The semantic equivalence is strong - both convey that these investments had a negative trajectory from 2022 to 2024, with increasing negative impacts on other income. No calculation errors detected, and all entities (Cisco, available-for-sale debt investments, other income/loss, fiscal years) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 404,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "American Express has continued to rely on third‑party merchant acquirers to extend coverage across all merchant tiers—small and mid‑size merchants typically sign open‑ended agreements, while large merchants enter fixed‑term contracts (2022–2023 filings, page 103–104).  The 2024 risk‑factor discussion explicitly highlights the growing strategic role of these acquirers, aggregators and processors in driving global merchant coverage and transaction growth, underscoring their importance in expanding acceptance for small, mid‑size and large merchants (page 93).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the evolution but has significant gaps and lacks the depth of the ground truth. STRENGTHS: (1) Correctly identifies third-party merchant acquirers as strategically important across 2022-2024; (2) Accurately notes the distinction between small/mid-sized merchants (open-ended agreements) and large merchants (fixed-term contracts); (3) Correctly references the 2024 risk-factor discussion highlighting growing strategic dependency; (4) Appropriately mentions aggregators and processors alongside acquirers. WEAKNESSES: (1) MISSING CRITICAL CONTENT: The answer omits the 2023 financial structure discussion about negotiated network rate fees and discount revenue recording, which is a key element of the ground truth showing financial integration; (2) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes a shift from 'supplementary' to 'essential' for growth, but the LLM answer doesn't capture this strategic evolution as clearly; (3) VAGUE CITATIONS: References to 'page 103-104' and 'page 93' are provided but cannot be verified and may be hallucinated page numbers; (4) MISSING PROGRAM NAMES: The ground truth specifically mentions OptBlue and GNS programs, which the LLM answer omits; (5) INCOMPLETE SYNTHESIS: The answer doesn't fully synthesize how the relationship evolved year-by-year (2022 → 2023 → 2024), instead presenting a more static view. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiator, but the LLM's page citations are unverifiable and potentially inaccurate. MULTI-HOP REASONING: The LLM demonstrates basic multi-hop reasoning by connecting third-party acquirers to merchant coverage expansion across merchant tiers, but fails to synthesize the full evolution across the three-year period with the financial and strategic nuances present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 510,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "Johnson & Johnson’s multi‑year initiative, first disclosed in the 2022 10‑K, has continued unchanged through 2023 and 2024, concentrating on integrating, simplifying and standardizing processes and systems across HR, IT, procurement, supply chain and finance to expand its financial shared‑service capabilities and standardize financial systems. The company has reiterated that the effort is not a response to any control deficiency but is intended to align and streamline its financial control environment (2022, p. 115; 2023, p. 118; 2024, p. 119).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core facts correctly: (1) Johnson & Johnson's multi-year initiative spanning 2022-2024, (2) the five functional areas (HR, IT, procurement, supply chain, finance), (3) the goal of expanding financial shared-service capabilities and standardizing systems, and (4) the key assertion that this is proactive, not responsive to control deficiencies. The page number citations (2022 p. 115; 2023 p. 118; 2024 p. 119) add specificity and credibility. However, the LLM answer is notably more concise than the ground truth and omits some nuanced details: (1) it doesn't explicitly mention that the company 'reiterated' or 'maintained' the narrative across years, which emphasizes consistency; (2) it doesn't capture the phrase about 'not prompted by any material changes or weaknesses in internal control over financial reporting' from 2024; (3) it characterizes the initiative as 'continued unchanged' which is slightly different from the ground truth's emphasis on 'consistent, multi-year approach' with evolving emphasis on 'aligning and streamlining the design and operation of its financial control environment.' The answer demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and correctly identifying the evolution (or consistency) of the initiative. No quantitative errors are present. The semantic meaning aligns well with the ground truth despite the brevity. The answer is contextually relevant and directly addresses the question about how the initiative evolved from 2022-2024, though it could have emphasized the evolution aspect more explicitly rather than stating it 'continued unchanged.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 455,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "From 2022 to 2024, American Express has shifted from a largely defensive acknowledgment of competition to an active, technology‑driven strategy.  In 2022 (pp. 12‑13) the company highlighted the threat of digital wallets, open‑banking and real‑time settlement as emerging risks, while 2024 filings (pp. 29‑31) detail new investments in tokenization, real‑time settlement, and open‑banking integration, and note that merchant discount‑rate erosion and the rise of tech‑based payment platforms are intensifying competitive pressure.  This evolution shows a move from simply recognizing alternative payment mechanisms to strategically adapting through technology upgrades, partnerships, and regulatory compliance to preserve its market position.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates a solid understanding of American Express's strategic evolution from 2022 to 2024 regarding alternative payment mechanisms, with generally accurate characterization of the company's shift from defensive acknowledgment to active technological adaptation. STRENGTHS: (1) Correctly identifies the core narrative arc - from recognizing threats to strategic adoption of technologies; (2) Accurately names specific technologies (digital wallets, open banking, real-time settlement, tokenization); (3) Appropriately characterizes the competitive pressures (merchant discount-rate erosion, tech-based payment platforms); (4) Correctly identifies the strategic response elements (investments, partnerships, regulatory compliance); (5) Semantic equivalence is strong - the answer conveys the same fundamental transformation described in the ground truth. WEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUE - The LLM provides specific page references (pp. 12-13 for 2022, pp. 29-31 for 2024) that cannot be verified against the ground truth and may be fabricated or inaccurate. This is a significant concern as it suggests potential hallucination of specific filing locations; (2) The answer mentions 'tokenization' as a 2024 investment, which is not explicitly mentioned in the ground truth's list of strategic focuses (open banking, digital identification, real-time settlement); (3) Missing explicit mention of 'payment aggregators' as a competitive threat, which was specifically noted in the ground truth; (4) The phrase 'dynamic and rapid growth' from 2022 is not directly quoted or referenced in the LLM answer, though the concept is captured; (5) The ground truth emphasizes a transformation from viewing mechanisms as 'external threats' to 'essential components of technological roadmap' - the LLM captures this but with slightly different framing ('defensive acknowledgment' to 'active strategy'). MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period and correctly identifies the evolution in American Express's positioning. The logic connecting competitive pressure to strategic adaptation is sound. OVERALL ASSESSMENT: The answer is substantially correct in its core narrative and demonstrates good understanding of the question's multi-hop nature, but the unverifiable page citations and minor omissions/additions reduce confidence in complete accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 644,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "In 2022, Frame.io was presented as a cloud‑native collaboration platform tightly coupled to Premiere Pro and After Effects, with camera‑to‑cloud uploads for on‑set review 【page_12】. By 2023 and 2024 the description stayed the same but added integration with Adobe Express, Firefly Services and GenStudio and broadened support to still images, design files, PDFs and other Creative Cloud apps 【page_12】【page_12】, showing Adobe’s intent to embed real‑time collaboration and AI‑driven workflows across its entire Creative Cloud ecosystem.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth progression. Key issues: (1) INCORRECT 2022 POSITIONING: The LLM claims Frame.io was presented as 'cloud-native collaboration platform tightly coupled to Premiere Pro and After Effects' with 'camera-to-cloud uploads for on-set review' in 2022. The ground truth states Frame.io was merely 'listed among Adobe's trademarks' in 2022, indicating strategic importance but NOT describing it as already integrated with specific products or having these capabilities. This is a major factual error. (2) MISSING 2023 DETAILS: The ground truth explicitly describes 2023 as when Frame.io was positioned as a 'cloud-native creative collaboration platform' with specific integrations (Premiere Pro, After Effects) and capabilities (real-time upload, review, approval, frame-accurate commenting). The LLM conflates this 2023 positioning with 2022, creating a false timeline. (3) INCOMPLETE 2024 EXPANSION: The ground truth specifies Frame.io expanded into 'casting, location scouting, and marketing campaign management' in 2024, and integrated with 'Photoshop, Lightroom, and Workfront.' The LLM mentions 'Adobe Express, Firefly Services and GenStudio' instead, which are different products not mentioned in the ground truth. The LLM also mentions 'still images, design files, PDFs' which are not in the ground truth's specific 2024 expansion details. (4) STRATEGIC INTERPRETATION: The ground truth emphasizes Frame.io becoming 'a central hub for multi-app, cross-functional workflows at scale' with 'end-to-end creative collaboration.' The LLM's interpretation about 'embedding real-time collaboration and AI-driven workflows' is somewhat aligned but misses the specific workflow expansion areas (casting, location scouting, marketing). (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the year-by-year evolution, incorrectly dating capabilities to 2022 that belong to 2023, and substituting different product integrations for 2024. The answer demonstrates poor temporal accuracy and entity identification across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 571,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "Amazon’s 2017 Notes balance fell from **$16.0 billion at December 31 2022** (page 58) to **$15.0 billion at December 31 2023** (page 58) and further to **$13.0 billion at December 31 2024** (page 57). This steady decline shows Amazon is actively repaying older, higher‑rate debt, thereby reducing its overall interest burden and keeping its debt‑maturity profile balanced.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. (1) QUANTITATIVE ACCURACY: All three key financial figures are correct - $16.0 billion (Dec 31, 2022), $15.0 billion (Dec 31, 2023), and $13.0 billion (Dec 31, 2024). The progression and year-over-year changes are accurate. Page references are provided, adding credibility. (2) COMPLETENESS: The answer addresses all parts of the multi-part question - it tracks the evolution across all three years and provides interpretation of the debt management strategy. (3) ENTITY ACCURACY: Amazon and the 2017 Notes are correctly identified, and all dates are accurate. (4) REASONING: The multi-hop synthesis is sound - the model correctly identified the pattern (consistent decline) and drew a logical conclusion about deliberate debt reduction strategy. The interpretation that Amazon is 'actively repaying older, higher-rate debt' and 'reducing overall interest burden' is reasonable inference from the data pattern, though slightly more interpretive than the ground truth's simpler statement of 'deliberate debt management strategy to gradually pay down this liability.' (5) SEMANTIC EQUIVALENCE: The core message matches the ground truth - steady decline indicating intentional debt reduction. The LLM provides slightly more detailed interpretation about interest burden and maturity profile management, which is contextually relevant and accurate reasoning. Minor difference: Ground truth uses simpler language ('gradually pay down'), while LLM adds specific strategic rationale (interest burden, maturity profile). Both are correct interpretations of the same underlying data pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 448,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "Boeing’s 2022, 2023, and 2024 10‑K filings all list “upgrades and conversions” as a core offering of its Global Services segment (see 2022 page 3; 2023 pages 3‑4; 2024 pages 3‑4). The unchanged emphasis over three years signals a deliberate strategy to sustain and extend the life of its commercial and defense platforms, positioning upgrades and conversions as a key driver of recurring service revenue and long‑term customer relationships.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies 'upgrades and conversions' as a consistent core offering across all three years (2022-2024) in Boeing's Global Services segment; (2) Accurately captures the strategic implication of unchanged emphasis over three years; (3) Properly synthesizes the multi-hop requirement by connecting the 3-year trajectory to strategic focus on sustaining aerospace platforms; (4) Correctly identifies the connection to lifecycle management and service-based revenue streams; (5) Provides specific page references (2022 page 3; 2023 pages 3-4; 2024 pages 3-4) that add credibility. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth, omitting some contextual details like the explicit mention of 'supply chain management and maintenance' as companion services in 2022, though this is a minor omission; (2) The ground truth explicitly states 'unchanged emphasis' while the LLM uses 'unchanged emphasis' as well, so this is consistent; (3) The LLM answer emphasizes 'commercial and defense platforms' while the ground truth mentions 'defense and commercial needs' - semantically equivalent but slightly different framing. QUANTITATIVE ACCURACY: No numerical calculations or specific dollar amounts are required for this question, so this dimension is less critical. The years (2022, 2023, 2024) are all correct. QUALITATIVE ACCURACY: The reasoning is sound - the model correctly identifies that consistent presence across three years indicates deliberate strategy, and properly connects this to lifecycle management and service revenue. The multi-hop synthesis (connecting year-to-year consistency to strategic implications) is executed correctly. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution and trajectory, and appropriately interprets what the 3-year consistency suggests about strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 533,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "Johnson & Johnson’s pension strategy did not change materially between 2022 and 2024 – the company continued to apply the Retirement Value formula to **all eligible U.S. non‑union employees regardless of hire date** effective January 1, 2026, a change first announced in January 2021. The 2022‑2024 10‑K filings reiterate this transition and clarify that it does not affect benefits accrued under the Final Average Pay formula for service before that date, and the company has repeatedly communicated the 2026 implementation to employees in its annual reports【page_77】【page_73】. No additional eligibility adjustments or formula revisions were disclosed for 2022‑2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) All key dates are accurate - January 2021 announcement, 2026 implementation date, and the 2022-2024 timeframe are all correct. (2) The core factual claim is accurate: JNJ consistently communicated the Retirement Value formula implementation for all U.S. non-union employees effective January 1, 2026 across all three years. (3) The answer correctly identifies that employees hired after 2014 were already under the Retirement Value formula. (4) The statement that Final Average Pay formula still applies to pre-2015 hires for service before 2026 is accurate. (5) The multi-hop synthesis is sound - the answer correctly synthesizes information across 2022-2024 filings to show consistency in messaging. (6) The claim that no material changes occurred is supported by the ground truth. MINOR WEAKNESSES: (1) The LLM answer states the formula applies to 'all eligible U.S. non-union employees regardless of hire date' effective 2026, which is technically correct but could be slightly clearer that this represents a change from the prior system where pre-2015 hires had different treatment. The ground truth emphasizes that eligibility criteria 'remained unchanged' across the three years, meaning the announcement itself didn't change, not that the formula applies equally to all hires currently. (2) The answer could have been more explicit about the 2023 clarification regarding employees hired after 2014 already being under the formula, though this is mentioned. (3) The citation references (page_77, page_73) are included but cannot be verified against the ground truth provided. QUANTITATIVE ACCURACY: All dates and numeric references are correct (January 2021, 2026, 2022-2024 period). No calculations are required for this question. QUALITATIVE ACCURACY: The reasoning correctly synthesizes the evolution (or lack thereof) of the pension strategy across three years, properly identifying that consistency rather than change was the key characteristic. The multi-hop reasoning connecting announcement date, eligibility criteria, and implementation timeline is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 581,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "AVGO’s 5.000% notes due April 2030 had an outstanding principal balance of **$606 million** at the end of FY 2022, and the balance remained unchanged at **$606 million** at the end of FY 2023 and FY 2024 (see debt schedule, page 81).  \nThis steady balance shows that the company has neither issued additional principal nor repaid any of the existing notes, indicating a deliberate strategy of keeping this long‑term debt instrument stable while focusing on other financing activities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the balance was $606 million at the end of FY 2022, but the ground truth clearly shows it was $1,086 million in FY 2022. This is a $480 million discrepancy - a 44% error in the starting value. The LLM correctly identifies $606 million for FY 2023 and FY 2024, but misses the critical $480 million reduction that occurred between FY 2022 and FY 2023. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The question explicitly asks how the balance 'evolved from fiscal year 2022 through 2024.' The ground truth shows a three-year progression: $1,086M (2022) → $606M (2023) → $606M (2024). The LLM only captures the last two years and misses the significant debt reduction event. (3) REASONING FAILURE: The LLM's interpretation that 'the company has neither issued additional principal nor repaid any of the existing notes' is incorrect for the full period. While technically true for 2023-2024, it ignores the substantial $480 million repayment that occurred in 2022-2023. This leads to an incorrect characterization of the debt management strategy. The ground truth correctly identifies this as 'a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy,' which the LLM fails to recognize. (4) The LLM's conclusion about 'keeping this long-term debt instrument stable' only applies to the 2023-2024 period and misses the more significant strategic action of the prior year's reduction. The answer demonstrates a critical failure to synthesize the complete multi-year progression required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 468,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "AT&T had folded Time Warner Inc. into its WarnerMedia segment after the 2018 acquisition, a fact highlighted in the 2022 10‑K (“From 2018 through April 2022, we acquired … Time Warner Inc., which comprised a substantial portion of our previous WarnerMedia segment”【page_4】).  In April 2022 the company completed a Reverse Morris Trust transaction with Discovery, Inc., separating and divesting its stake in WarnerMedia and restructuring its media operations (“In April 2022, we completed the separation of our WarnerMedia business in a Reverse Morris Trust transaction (WarnerMedia/Discovery Transaction)”【page_4】).  By 2024 the WarnerMedia segment was no longer part of AT&T’s reporting segments, reflecting the full divestiture of its media assets and a renewed focus on telecommunications (the 2024 10‑K still references the WarnerMedia segment but treats it as a discontinued operation【page_6】).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AT&T's strategic evolution regarding Time Warner/WarnerMedia from 2022-2024, with mostly accurate facts and dates. STRENGTHS: (1) Correctly identifies the 2018 Time Warner acquisition and its integration into WarnerMedia segment; (2) Accurately dates the April 2022 Reverse Morris Trust transaction with Discovery as the key divestiture event; (3) Properly notes the shift away from media/entertainment back to telecommunications focus; (4) Correctly identifies that WarnerMedia was treated as discontinued operations by 2024. WEAKNESSES: (1) The statement 'the 2024 10-K still references the WarnerMedia segment but treats it as a discontinued operation' is somewhat ambiguous - if WarnerMedia was fully divested in April 2022, it should not appear as an active segment in 2024 filings, only as historical/discontinued operations. This creates minor confusion about the timeline; (2) The answer could be more explicit about the complete exit from entertainment content creation space that occurred in April 2022, not gradually through 2024; (3) Missing explicit mention of DIRECTV divestiture in 2024 that the ground truth highlights as 'the last major asset tied to the entertainment strategy.' QUANTITATIVE ACCURACY: All dates are correct (2018 acquisition, April 2022 transaction, 2024 reporting). No numerical errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents, connecting the acquisition, separation transaction, and eventual reporting treatment. However, the temporal framing could be clearer - the major divestiture occurred in April 2022, not gradually through 2024. SEMANTIC EQUIVALENCE: The core narrative matches the ground truth regarding strategic pivot and divestiture, though with slightly different emphasis on timing and completeness of the exit.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 510,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "AIG’s approach to international terrorism exposure stayed essentially the same from 2022 through 2024.  The company continued to use a third‑party vendor model to estimate losses from a range of terrorism scenarios, adjusting for model gaps and monitoring concentration, and it relied on TRIPRA for U.S. coverage plus limited private reinsurance and targeted reinsurance purchases for selected lines.  No new attachment‑point structure for international terrorism exposure was disclosed, and the largest concentration remained in New York City with no material change to geographic attachment points.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) CORE CLAIM ERROR: The LLM states AIG's approach 'stayed essentially the same from 2022 through 2024,' directly contradicting the ground truth which explicitly describes an 'evolution' and 'strategic shift from reactive modeling to proactive geographic risk segmentation.' (2) MISSING KEY QUANTITATIVE DATA: The ground truth provides specific, verifiable numbers that the LLM completely omits: $1.3 billion loss estimate for 2022 five-ton bomb scenario, $200 million attachment point for Japan (2024), and $125 million attachment point for rest of world (2024). These are concrete facts that demonstrate the evolution the LLM denies occurred. (3) FACTUAL INACCURACY ON ATTACHMENT POINTS: The LLM claims 'No new attachment-point structure for international terrorism exposure was disclosed,' which directly contradicts the ground truth's documentation of specific 2024 attachment points ($200M Japan, $125M rest of world). This is a material factual error. (4) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-hop progression across three years (2022→2023→2024) that the question explicitly asks for. It provides no differentiation between years and misses the documented evolution in scenario modeling sophistication and geographic risk segmentation. (5) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes a 'progression' showing 'increasing sophistication' and 'refined geographic attachment points,' while the LLM characterizes this as 'no material change.' This represents a fundamental misunderstanding of the filing data. (6) PARTIAL CREDIT FOR METHODOLOGY: The LLM correctly identifies some general methodologies (third-party vendor models, TRIPRA, reinsurance purchases) but uses these correct elements to support an incorrect overall conclusion about stasis rather than evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 519,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "Emerson’s pipe‑working tools line shifted from a largely manual mix in 2022—pipe wrenches, cutters, threading/roll‑grooving equipment, mechanical crimping systems and closed‑circuit television inspection tools (see 2022 10‑K, page 9)—to a more electrified, high‑tech offering by 2024 that adds battery‑hydraulic tools for press connections and sewer‑inspection cameras (2023/2024 10‑K, page 73). This evolution shows the company is repositioning itself as a modern professional‑tools provider, expanding its portfolio to meet the growing demand for battery‑powered, digital‑enabled solutions and reinforcing its competitive stance in the market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop information about Emerson's product portfolio evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the core progression from manual/traditional tools (pipe wrenches, cutters, threading equipment, mechanical crimping, CCTV inspection) in 2022 to electrified/battery-powered solutions (battery-hydraulic tools for press connections, sewer inspection cameras) by 2023-2024. (2) Accurately captures the strategic shift toward modernization and digital integration. (3) Properly synthesizes information across multiple years and filing documents. (4) Correctly identifies Emerson (EMR) and the professional tools market context. (5) The characterization of tools as 'manual mix' vs 'electrified, high-tech offering' aligns well with the ground truth's description of 'traditional' vs 'battery-powered and diagnostic technologies.' MINOR CONSIDERATIONS: (1) The LLM mentions 'closed-circuit television inspection tools' in 2022, while the ground truth lists 'drain cleaners' as a 2022 tool—these are not contradictory but represent slightly different emphasis. The LLM's inclusion of CCTV tools in 2022 is reasonable given the progression described. (2) The LLM provides specific page references (2022 10-K page 9, 2023/2024 10-K page 73) which adds credibility but cannot be verified against the ground truth. (3) The answer is slightly more detailed and specific than the ground truth while maintaining semantic equivalence. The multi-hop reasoning is sound: comparing 2022 baseline → 2023 transition → 2024 positioning, and drawing conclusions about strategic repositioning. No calculation errors or factual contradictions with the ground truth are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 479,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "Costco’s lease accounting has not changed from 2022 through 2024.  In each year the company states that free‑rent periods (and step‑rent provisions) are recognized on a straight‑line basis over the original lease term and any extension options that the company is reasonably certain to exercise.  The right‑of‑use (ROU) asset is still initially measured at the present value of the discounted minimum lease payments over the lease term, which includes the zero‑payment free‑rent period and therefore lowers the ROU asset balance.  The disclosure language and the impact on ROU valuation remain the same across the three filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The core issue: The LLM claims 'Costco's lease accounting has not changed from 2022 through 2024' and that 'The disclosure language and the impact on ROU valuation remain the same across the three filings.' This is INCORRECT according to the ground truth, which explicitly states there WAS an evolution: the 2022 filing included detailed disclosure of the discounting process and ARO treatment that was NOT repeated in 2023 and 2024 filings. The ground truth describes this as 'a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics' and notes 'the depth and specificity of disclosure around ROU asset valuation decreased over time.' The LLM completely missed this key evolution in disclosure practices. Quantitative accuracy is relatively high (8/10) because the LLM correctly identifies the straight-line recognition methodology, the inclusion of extension options, and the present value/discounting mechanism for ROU assets. However, qualitative accuracy is very low (2/10) because the LLM failed to identify the critical distinction between 2022 and 2023-2024 regarding disclosure depth and specificity. The LLM's statement that disclosure 'remain[s] the same' directly contradicts the ground truth's finding of decreased disclosure depth. The answer addresses the right topics (free-rent periods, step-rent provisions, ROU asset valuation) but reaches the wrong conclusion about whether evolution occurred. This is a multi-hop question requiring synthesis across three years of filings, and the LLM failed to identify the temporal evolution that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 470,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "Microsoft’s 2.000 % notes have been issued in successive years with progressively later maturities, each time documented by a supplemental indenture that adds to the original May 18, 2009 base indenture.  \n• In the 2022 10‑K the Tenth Supplemental Indenture (Exhibit 4.13) documents 2.000 % notes due 2020.  \n• In the 2023 10‑K the Eleventh Supplemental Indenture (Exhibit 4.14) documents 2.000 % notes due 2023.  \n• In the 2024 10‑K a new supplemental indenture (Exhibit 4.15) extends the 2.000 % notes to a 2024 maturity, again referencing the base indenture.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth:\n\n1. MATURITY DATES - MAJOR ERROR: The LLM claims the 2.000% Notes had different maturities across years (2020 in 2022, 2023 in 2023, 2024 in 2024), suggesting multiple issuances with progressively later maturities. The ground truth clearly states these were the SAME note with a 2023 maturity referenced consistently across all three years (2022, 2023, and 2024). This is a fundamental misunderstanding of the debt instrument.\n\n2. SUPPLEMENTAL INDENTURE IDENTIFICATION - MAJOR ERROR: The LLM incorrectly identifies the indentures:\n   - Claims 2022 10-K shows Tenth Supplemental Indenture (Exhibit 4.13) with 2020 maturity - INCORRECT\n   - Claims 2023 10-K shows Eleventh Supplemental Indenture (Exhibit 4.14) with 2023 maturity - PARTIALLY CORRECT (right indenture and maturity, but wrong exhibit number)\n   - Claims 2024 10-K shows a new supplemental indenture (Exhibit 4.15) extending to 2024 - INCORRECT (ground truth indicates the 2023 maturity notes were still referenced in 2024 exhibits, not extended to 2024)\n\n3. CORE NARRATIVE ERROR: The LLM presents a narrative of \"successive years with progressively later maturities\" and \"new supplemental indentures\" each year. The ground truth explicitly states \"no structural changes\" and \"consistent debt instrument with no modifications across the three years.\"\n\n4. EXHIBIT NUMBERS: The specific exhibit numbers cited (4.13, 4.14, 4.15) cannot be verified against ground truth and appear to be fabricated or incorrectly recalled.\n\n5. BASE INDENTURE: The LLM correctly identifies May 18, 2009 as the base indenture date, which aligns with the ground truth's reference to the Eleventh Supplemental Indenture framework.\n\nThe answer demonstrates a fundamental misinterpretation of the question and the underlying debt structure. Rather than showing evolution with new issuances, the ground truth shows stability and consistency of a single debt instrument across three years. The LLM's multi-hop reasoning failed to correctly synthesize the information across the three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 578,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "Amazon has consistently recognized revenue from third‑party seller services when the services are rendered—generally at the point of product delivery to a carrier or customer. The revenue is composed of commissions plus any related fulfillment and shipping fees. The 2022, 2023, and 2024 10‑Ks all describe the same timing and composition, indicating no change in the policy over that period.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core revenue recognition timing (upon delivery to carrier or customer) and composition (commissions plus fulfillment/shipping fees), which aligns with the ground truth. However, there are significant issues with completeness and synthesis:\n\n(1) WHAT WAS CORRECT: The LLM accurately captures that Amazon recognizes revenue when services are rendered at point of delivery, and that revenue comprises commissions and fulfillment/shipping fees. The statement about consistency across years is factually supported.\n\n(2) WHAT WAS INCORRECT/INCOMPLETE: The ground truth explicitly states that in 2022, Amazon disclosed revenue sources as \"fixed fees, a percentage of sales, per-unit activity fees, and interest.\" The LLM answer omits these specific 2022 details entirely, instead claiming the policy was identical across all three years. This represents a failure to capture the evolution in disclosure specificity mentioned in the ground truth. The ground truth notes \"increasing clarity in disclosures over time,\" but the LLM states \"no change in the policy over that period\" - conflating policy consistency with disclosure evolution.\n\n(3) MULTI-HOP REASONING ASSESSMENT: The question asks about evolution \"particularly in terms of timing and composition.\" The ground truth shows evolution in HOW MUCH DETAIL was disclosed about composition (2022 listed multiple fee types; 2023 specified commissions and fulfillment/shipping fees). The LLM fails to synthesize this disclosure evolution, instead presenting a flat narrative of consistency.\n\n(4) ENTITY AND TEMPORAL ACCURACY: All years (2022, 2023, 2024) and the company (Amazon) are correctly identified. No quantitative errors in numbers or dates.\n\n(5) SEMANTIC ISSUES: The LLM's claim of \"no change in the policy\" is misleading. While the underlying revenue recognition principle may be consistent, the ground truth explicitly documents increasing clarity and specificity in disclosures - which is a meaningful evolution that the LLM misses. This represents a qualitative reasoning error rather than a factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 569,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "AT&T’s 10‑K filings for 2022, 2023 and 2024 all continue to list a guaranty of Southwestern Bell Telephone Co.’s obligations (see the 2023 10‑K Item 4, page 103; the 2022 10‑K Item 4, pages 133‑137; and the 2024 10‑K Item 4, pages 96‑100). This persistence shows that AT&T deliberately retains long‑term liability commitments to legacy telecom entities, a conservative strategy that preserves service continuity and regulatory compliance while hedging future financial exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that AT&T's guaranty of Southwestern Bell Telephone Co.'s obligations persists across 2022, 2023, and 2024 filings, matching the ground truth. The answer appropriately cites specific document locations (Item 4 with page numbers), demonstrating multi-hop synthesis across three years of filings. The reasoning about AT&T's 'deliberate' and 'conservative strategy' for managing legacy telecom liabilities aligns with the ground truth's characterization of an 'unchanging commitment' and 'stable strategy.' However, there are minor differences: (1) The LLM adds interpretive language about 'preserving service continuity and regulatory compliance while hedging future financial exposure' that goes slightly beyond what the ground truth explicitly states—the ground truth focuses on the fact of unchanged commitments without speculating on motivations beyond liability management. (2) The LLM's phrasing 'deliberately retains long-term liability commitments' is semantically equivalent to the ground truth's 'deliberate and stable strategy' but frames it slightly differently. (3) The specific page citations in the LLM answer (2023 10-K Item 4, page 103; 2022 10-K Item 4, pages 133-137; 2024 10-K Item 4, pages 96-100) cannot be verified against the ground truth but appear reasonable and specific. The core multi-hop reasoning is sound: the LLM correctly synthesizes information across three years to demonstrate consistency. The answer appropriately addresses the question about long-term liability management strategy. Minor deduction for adding interpretive elements beyond what the ground truth explicitly supports, though these are reasonable inferences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 466,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "Johnson & Johnson’s outstanding 2.250% Notes due 2050 grew from $808 million in 2022 to $826 million in 2023 and then to $983 million in 2024 【page_71】【page_67】. This incremental rise reflects a deliberate expansion of low‑interest long‑term debt, underscoring the company’s strategy of steadily adding inexpensive borrowing to support its capital structure and growth while keeping overall debt costs stable.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reversed the entire progression of the debt instrument. Ground truth shows: 2022=$983M → 2023=$826M → 2024=$808M (declining trend). LLM claims: 2022=$808M → 2023=$826M → 2024=$983M (rising trend). Every single year's figure is either wrong or in wrong position. (2) DIRECTIONAL MISINTERPRETATION: The LLM describes this as 'incremental rise' and 'steady adding' of debt, when the actual data shows a consistent DECLINE of $175M over two years ($983M to $808M). This is a 180-degree mischaracterization of the company's debt strategy. (3) STRATEGIC INTERPRETATION ERROR: The LLM concludes the company is 'steadily adding inexpensive borrowing,' when the ground truth indicates 'gradual decline' and 'cautious approach to managing long-dated liabilities.' These are opposite strategic conclusions. (4) PARTIAL CREDIT: The LLM correctly identifies the instrument (2.250% Notes due 2050) and mentions the fixed effective rate concept, but these correct elements are overwhelmed by the fundamental numerical and analytical errors. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year progression across the three-year period, which is the core requirement of this multi-hop question. The answer demonstrates a complete inversion of the actual data trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 398,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "Costco’s 1.375% Senior Notes due June 2027 stayed at a carrying value of $1,250 million in 2022, 2023 and 2024 (page_52 2022; page_52 2023; page_52 2024).  The company’s total long‑term debt fell from $6,590 million in 2022 to $5,919 million in 2024, largely because it repaid the 2.750% Senior Notes due May 2024 and reduced other debt (page_52 2024).  This reflects a disciplined capital‑management strategy that prioritizes paying down higher‑interest debt while preserving a stable, low‑interest long‑term debt base to support growth and maintain financial flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key numbers and dates. Quantitative verification: (1) 1.375% Senior Notes correctly stated at $1,250 million for all three years (2022, 2023, 2024); (2) Total long-term debt figures accurate: $6,590M (2022) to $5,919M (2024); (3) The intermediate 2023 figure of $6,484M mentioned in ground truth is not explicitly stated in LLM answer, though the overall trend is captured. The LLM correctly identifies the decline from $6,590M to $5,919M and attributes it to repayment of the 2.750% Senior Notes due May 2024 and other debt reduction. Multi-hop reasoning is sound: the answer synthesizes information across three years and correctly connects the stable 1.375% notes with declining overall debt to characterize capital management strategy. The interpretation that Costco prioritized paying down higher-interest debt while preserving low-interest obligations is logically sound and aligns with the ground truth's characterization of 'selective capital management strategy.' Minor weakness: the LLM does not explicitly mention the intermediate 2023 debt level ($6,484M), which represents a step in the three-year evolution. The characterization of the strategy as 'disciplined' and focused on 'financial flexibility' is semantically equivalent to the ground truth's 'selective capital management strategy.' The answer appropriately addresses the question's multi-part structure regarding debt evolution and capital management implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 420,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "Mastercard’s real‑time payments infrastructure expanded from 12 markets in 2022 to 13 markets by the end of 2023 (page 11).  Simultaneously, its multi‑layered security program evolved from basic controls to a comprehensive architecture that now includes an enterprise resilience program, Security Operations Centers, Fusion Centers, the Mastercard Intelligence Center, and the development of technical standards such as EMV and tokenization (page 12).  This parallel evolution shows that Mastercard is strategically embedding robust risk‑management and security capabilities into its global expansion, ensuring resilient and secure payment processing as its network scales worldwide.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM states real-time payments infrastructure expanded 'from 12 markets in 2022 to 13 markets by the end of 2023.' However, the ground truth indicates that 12 markets was the figure as of December 31, 2021 (not 2022), and 13 markets was the 2023 figure. The LLM conflates the baseline year. Additionally, the ground truth notes that by 2024, Mastercard shifted to describing deployment in 'several countries around the world' rather than specific numbers, which the LLM completely omits. This is a critical temporal/factual error. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to address the 2024 evolution mentioned in the ground truth, which is essential to answering a question about 2022-2024 development. The answer only covers 2022-2023. (3) UNSUPPORTED CLAIMS: The LLM introduces specific security infrastructure elements (Security Operations Centers, Fusion Centers, Mastercard Intelligence Center, EMV, tokenization) that are NOT mentioned in the ground truth answer. While these may exist in Mastercard filings, they are not part of the verified knowledge graph answer and represent potential hallucination or unsourced information. (4) MISSING NUANCE: The ground truth explicitly notes 'the filings do not explicitly state that security measures directly enabled infrastructure expansion,' which is an important caveat the LLM omits. The LLM makes a stronger causal claim ('strategically embedding robust risk-management...ensuring resilient and secure payment processing') without this qualification. (5) CORRECT ELEMENTS: The LLM correctly identifies the parallel evolution concept and the general strategic intent, and correctly names Mastercard. However, these correct elements are overshadowed by the quantitative and temporal errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 490,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "Microsoft issued the 4.000% Notes due 2021 in 2011 as part of the Third Supplemental Indenture (page 104). Across fiscal years 2022, 2023, and 2024 no new debt instruments related to that maturity were issued, as the supplemental indentures filed in those years (exhibits 4.15, 4.16, 4.17, 4.18 on page 106) list notes with different maturities and coupon rates but not the 4.000% Notes due 2021. This pattern reflects a disciplined long‑term debt strategy that keeps the maturity profile stable and focuses on refinancing rather than adding new debt at that specific tranche.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that contradict the ground truth. Key issues: (1) INCORRECT CLAIM ABOUT ISSUANCE: The LLM states Microsoft 'issued the 4.000% Notes due 2021 in 2011' - this is not supported by the ground truth, which only references the notes as part of existing debt structure across 2022-2024. (2) MISIDENTIFIED EXHIBITS: The LLM cites exhibits 4.15, 4.16, 4.17, 4.18 on page 106 as containing different maturity notes, but the ground truth specifically states the Third Supplemental Indenture was listed as Exhibit 4.6 in 2022 and 2023. The exhibit numbers cited by the LLM appear to be incorrect or from a different context. (3) FUNDAMENTAL MISUNDERSTANDING: The ground truth indicates the 4.000% Notes due 2021 were CONSISTENTLY REFERENCED across all three years (2022, 2023, 2024) as part of ongoing disclosure, even post-maturity. The LLM incorrectly concludes that 'no new debt instruments related to that maturity were issued' and that the notes don't appear in later supplemental indentures - this directly contradicts the ground truth's statement that the same instrument was 'again referenced' in 2023 and continued to be disclosed in 2024. (4) INCORRECT REASONING: The LLM's conclusion about 'refinancing rather than adding new debt' misses the actual pattern: consistent disclosure of the same instrument across years, suggesting delayed settlement or rollover, not refinancing of different tranches. (5) MISSING KEY INSIGHT: The LLM fails to capture the ground truth's main finding - that Microsoft maintained transparent disclosure of the 4.000% Notes even after their maturity date (2021), which is past by 2022-2024. The answer demonstrates a fundamental misreading of the filing data and incorrect synthesis of multi-hop information across the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 499,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "Amazon’s repeated mention of the 1.500% Note due 2030 in its 10‑K filings shows that the company treats this mid‑term, moderate‑coupon debt as a core, stable element of its long‑term capital structure (page_73, page_75, page_76). By keeping the note alongside higher‑rate, longer‑maturity notes (e.g., 3.6% due 2032) and lower‑rate, shorter‑maturity notes (e.g., 0.4% due 2023), Amazon spreads interest‑rate risk and preserves a predictable debt profile that matches its long‑term funding needs. This consistency signals a deliberate strategy of diversification and risk management rather than frequent refinancing of that particular instrument.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the strategic concept (diversification, risk management, stable capital structure) and correctly identifies the 1.500% Note due 2030 as a core element. However, there are significant quantitative accuracy issues: (1) The LLM cites a '3.6% due 2032' note, but the ground truth references a '4.700% Note due 2032' - this is a material error in the specific debt instrument comparison. (2) The LLM mentions a '0.4% due 2023' note, which is not mentioned in the ground truth and appears to be fabricated or misremembered. (3) The ground truth specifically references the '4.700% Note due 2024' as a key comparison point in 2023, which the LLM omits. The LLM's reasoning about layered maturity profiles and risk mitigation is sound and aligns with the ground truth's core message. However, the incorrect debt instrument rates and missing specific comparisons across the 2022-2024 period weaken the multi-hop synthesis. The answer captures the essence of Amazon's strategy but fails on precise factual details that are critical for evaluating debt instrument comparisons. The qualitative reasoning is strong, but quantitative errors in citing specific debt instruments significantly undermine credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 351,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "From 2022 through 2023, AT&T held a 41.3 % equity stake in SKY Mexico and accounted for the investment under the equity method, recording equity in net income and distributions【94】【66 2023】. In June 2024 the company sold that stake, ending the equity‑method treatment and removing the investment from its balance sheet【66 2024】. This three‑year trajectory—culminating in the divestiture of SKY Mexico—mirrors earlier exits such as Vrio and signals AT&T’s broader strategy to streamline its international pay‑TV portfolio【93】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key facts: (1) 41.3% ownership stake in SKY Mexico - CORRECT; (2) equity method accounting treatment in 2022-2023 - CORRECT; (3) June 2024 sale/exit - CORRECT; (4) reference to Vrio exit as parallel divestiture - CORRECT. Quantitative accuracy is high with all percentages, dates, and financial metrics accurately stated. The multi-hop reasoning is sound, correctly synthesizing AT&T's three-year trajectory from ownership through equity method accounting to complete exit. The answer appropriately connects this to broader divestiture strategy in international pay-TV markets. Minor areas for improvement: (1) The original answer provides slightly more granular detail about 2022 explicitly stating 'continued ownership stake following the sale of Vrio,' which the LLM answer references but doesn't emphasize the temporal sequencing as clearly; (2) The original answer emphasizes the 'phased approach' more explicitly, while the LLM uses 'three-year trajectory' which is semantically similar but slightly less precise about the deliberate staging; (3) The LLM answer could have been more explicit about the 2022 baseline before discussing 2023-2024 progression, though the information is present. The answer correctly addresses all parts of the multi-part question: ownership stake evolution (41.3% maintained through 2023, exited 2024), accounting treatment (equity method through 2023), and strategic implications (international pay-TV divestiture strategy). No calculation errors or factual inaccuracies detected. The citation format suggests proper source attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 453,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path strategy, as described in the 2023 10‑K, “de‑risks the qualified plan via regular monitoring through liability‑driven investing and the glide path approach, where the glide path defines the target allocation for the ‘Return‑Seeking’ portion of the portfolio (i.e., growth assets) based on the funded ratio and level of interest rates. Under this approach, the allocation to growth assets is reduced and the allocation to liability‑hedging assets is increased as the plan’s funded ratio increases in accordance with the defined glide path”【page_310】.  Accordingly, the target equity allocation fell from 15 % in 2022 (based on the 2021 funded status) to an intermediate level in 2023 and to 9 % in 2024 (based on the 2023 funded status), with fixed‑maturity securities rising from 75 % to 80 % and other investments modestly increasing【page_310】【page_252】.  This progression demonstrates a deliberate de‑risking strategy: as the plan’s funded status improves, AIG systematically reduces exposure to growth assets and increases liability‑hedging assets to manage risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AIG's glide path de-risking strategy and provides specific quantitative details that align with the ground truth. STRENGTHS: (1) Correctly identifies the core mechanism of the glide path approach - reducing growth assets and increasing liability-hedging assets as funded ratio improves; (2) Provides specific equity allocation percentages (15% in 2022, 9% in 2024) that demonstrate the de-risking progression; (3) Notes fixed-maturity securities rising from 75% to 80%, showing the shift to liability-hedging assets; (4) Correctly attributes allocations to specific funded status dates (2021 for 2022 allocation, 2023 for 2024 allocation); (5) Includes direct quote from 10-K explaining the glide path mechanism; (6) Demonstrates sound multi-hop reasoning by synthesizing information across multiple pages and years. MINOR WEAKNESSES: (1) The answer states the 2024 allocation was 'based on the 2023 funded status' but the ground truth indicates 2024's target allocation for 2025 should be based on December 31, 2024 funded status - this is a slight temporal mismatch in the most recent year; (2) Does not explicitly mention the 2025 target allocation that would complete the three-year progression (2022, 2023, 2024 allocations), though this is a minor omission; (3) The intermediate level for 2023 is mentioned but not quantified with a specific percentage. QUANTITATIVE VERIFICATION: The equity allocation progression (15% → 9%) and fixed-maturity increase (75% → 80%) appear consistent with typical de-risking patterns and are presented with appropriate precision. The answer correctly synthesizes the relationship between funded status improvements and allocation shifts. Overall, the answer captures the essential evolution of AIG's de-risking strategy with accurate supporting details, though it could be slightly more precise about the 2024-2025 transition and the 2023 intermediate allocation level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 529,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "Mastercard’s credit‑risk mitigation for settlement exposure grew steadily: the company’s risk‑mitigation arrangements increased from $9.2 bn in 2022 to $12.2 bn in 2023 and to $13.5 bn in 2024, while net settlement exposure rose from $55.7 bn to $64.9 bn (page_110, page_105). In parallel, Mastercard expanded its use of cash collateral, letters of credit and guarantees—alongside regular reviews of risk standards—to meet the heightened scrutiny of the FTC, DOJ and European Commission and the escalating class‑action litigation (page_111, page_110). This evolution demonstrates the company’s proactive, adaptable risk‑management approach, scaling its credit‑risk buffers in line with regulatory and litigation pressures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED NUMBERS: The LLM provides specific dollar amounts ($9.2bn, $12.2bn, $13.5bn for risk-mitigation arrangements; $55.7bn, $64.9bn for net settlement exposure) with page citations, but these numbers cannot be verified against the ground truth knowledge graph. The ground truth makes NO mention of these specific quantitative figures. This is a major red flag - the LLM appears to have fabricated or hallucinated precise financial data. (2) INCOMPLETE ANSWER TO CORE QUESTION: The original answer addresses the evolution of credit risk mitigation strategies across the three-year period by discussing how Mastercard's FRAMEWORK remained consistent while the CONTEXT changed due to regulatory and litigation pressures (FTC consent agreement 2023, DOJ investigation 2023, U.S. Liability Shift Litigation and EC investigation 2024). The LLM answer focuses almost entirely on quantitative growth in risk-mitigation arrangements but largely ignores the qualitative evolution of strategy in response to specific regulatory events. (3) MISSING KEY CONTEXTUAL DETAILS: The ground truth emphasizes that despite escalating external pressures, Mastercard maintained low settlement failure losses, demonstrating effective core strategies. The LLM mentions 'proactive, adaptable risk-management approach' but doesn't substantiate this with the actual evidence of consistent effectiveness. (4) REGULATORY TIMELINE: While the LLM mentions FTC, DOJ, and European Commission scrutiny, it doesn't clearly map these to specific years (FTC 2023, DOJ 2023, EC 2024) as the ground truth does. (5) METHODOLOGY EVOLUTION: The ground truth notes that Mastercard 'refined its risk management methodology' in 2024 - the LLM doesn't address this methodological evolution. POSITIVE ASPECTS: The LLM correctly identifies the types of risk mitigation tools (cash collateral, letters of credit, guarantees), correctly names the regulatory bodies involved, and attempts to show a progression over time. However, the unverified quantitative claims and incomplete qualitative analysis significantly undermine the answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 570,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "The share pool for future grants under Home Depot’s Omnibus Stock Incentive Plan fell from roughly 117 million shares in 2022 (the 2005 Plan’s available pool) to about 77 million shares in 2024 (page 66). This decline signals a tightening of the equity‑compensation program, likely aimed at curbing dilution and aligning awards more closely with performance or cash‑based incentives (page 67, page 66).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) INCOMPLETE DATA: The LLM answer only provides two data points (117M in 2022 and 77M in 2024) when the ground truth specifies THREE years of data: 117M (2022), 77M (2023), and 70M (2024). The question explicitly asks about evolution from 2022 to 2024, requiring all three years. (2) MISSING 2024 DATA: The LLM states '77 million shares in 2024' but ground truth shows 70M shares in 2024 (as of Feb 2, 2025). This is a factual error - the LLM conflates the 2023 figure with 2024. (3) INCOMPLETE TREND ANALYSIS: The ground truth identifies a consistent three-year decline (117M→77M→70M), showing progressive reduction. The LLM only captures the first decline and misses the continued reduction in 2024. (4) INTERPRETATION DIVERGENCE: The LLM interprets the trend as 'curbing dilution and aligning awards more closely with performance or cash-based incentives,' which contradicts the ground truth's interpretation that it signals 'increased reliance on equity incentives.' These are opposite conclusions about strategy. The ground truth suggests active issuance of stock-based compensation, while the LLM suggests a shift away from equity. (5) POSITIVE ASPECTS: The LLM correctly identifies the 2005 Plan, correctly states the 117M figure for 2022, and correctly identifies the general trend of decline. The writing is clear and the page references suggest proper sourcing. However, the missing 2024 data point and the incorrect interpretation of what the trend means are significant errors that undermine the answer's accuracy and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 429,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "Broadcom issued the 3.625% notes due October 2024 in 2022 with a principal of $622 million.  The obligation remained unchanged through fiscal year 2023 – $622 million was still outstanding as of October 29 2023【page 81】 – and was fully retired by fiscal year 2024, leaving a $0 balance as of November 3 2024【page 81】.  This pattern shows a deliberate debt‑management approach: Broadcom keeps the instrument on the books until close to maturity and then repays it, thereby reducing long‑term debt exposure and preserving financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Broadcom's debt management strategy for the 3.625% notes. QUANTITATIVE VERIFICATION: All numerical values are correct - $622 million obligation in FY2022 and FY2023, $0 balance in FY2024. The dates are accurate (October 2024 maturity, October 29, 2023 and November 3, 2024 fiscal year-end dates). MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three fiscal years, tracking the progression of the obligation from $622M → $622M → $0. ENTITY ACCURACY: Broadcom (AVGO) correctly identified, instrument properly described as 3.625% notes due October 2024, fiscal years correctly referenced. REASONING QUALITY: The interpretation of the progression as a deliberate debt management strategy is sound and well-articulated. The explanation that Broadcom 'keeps the instrument on the books until close to maturity and then repays it' accurately reflects the timeline and demonstrates understanding of the strategic intent. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while adding slightly more context about the strategic rationale (reducing long-term debt exposure, preserving financial flexibility). MINOR CONSIDERATIONS: The LLM answer includes specific page references (page 81) which adds credibility but wasn't in the ground truth - this is a positive addition. The phrasing 'fully retired' is semantically equivalent to 'full repayment or restructuring.' The answer is complete, addressing all aspects of the question including the evolution across years and what it indicates about debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 455,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "AT&T’s relationship with Time Warner Inc. began in 2021 when the company announced a plan to merge its WarnerMedia (Time Warner) segment with Discovery, a transaction that was expected to close in Q2 2022 (2023 10‑K, page 2).  The merger was completed in April 2022 via a Reverse Morris Trust, separating WarnerMedia as a discontinued operation and ending AT&T’s ownership of the Time Warner assets (2022 10‑K, page 4).  By the 2024 10‑K, AT&T no longer references WarnerMedia, indicating a full divestiture and a strategic pivot from entertainment to a core focus on telecommunications infrastructure and services (2024 10‑K, page 5).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility: (1) CRITICAL DATE ERROR: The LLM states the WarnerMedia-Discovery merger was 'announced in 2021' and 'expected to close in Q2 2022' with completion 'in April 2022.' The ground truth indicates the separation was completed in 2023, not 2022. This is a major chronological error affecting the entire timeline. (2) INCOMPLETE COVERAGE: The LLM completely omits the 2024 DIRECTV divestiture to TPG, which is explicitly mentioned in the ground truth as the 'final exit strategy' and 'full retreat from media investments.' This is a critical omission for a question asking about evolution 'through 2024.' (3) MISSING CONTEXT: The LLM fails to address the 2022 baseline (when T 'still held Time Warner Inc.'), making it impossible to show the evolution from 2022-2024 as requested. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the strategic pivot from entertainment to telecommunications, it fails to synthesize the complete multi-hop progression across all three years (2022, 2023, 2024) as required by the question. (5) PARTIAL CREDIT: The LLM correctly identifies the Reverse Morris Trust transaction with Discovery and the strategic pivot away from entertainment, but the timing error and omission of the DIRECTV exit significantly undermine the answer's accuracy. The answer addresses only 2 of 3 required years and misses the final and most recent strategic action.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 404,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "In 2022 Emerson’s pipe cutters were sold as part of the Tools & Home Products segment, described as pipe‑working tools that included diagnostic systems but no battery‑powered integration (page_9). By 2023 the company repositioned the line to the Safety & Productivity segment, adding battery‑hydraulic tools for press connections and diagnostic systems (page_73). In 2024 that positioning deepened further, now featuring battery‑hydraulic tools for cutting and crimping electrical cable and expanded diagnostic equipment, underscoring a stronger focus on battery‑powered technologies across Safety & Productivity (page_73).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) SEGMENT CLASSIFICATION ERROR: The LLM claims Pipe Cutters were in 'Tools & Home Products segment' in 2022, but the ground truth indicates they were part of the Safety & Productivity segment throughout the period. The LLM also incorrectly states a repositioning occurred in 2023 from Tools & Home Products to Safety & Productivity, which contradicts the ground truth's consistent placement in Safety & Productivity. (2) PRODUCT EVOLUTION MISCHARACTERIZATION: The LLM describes 2022 Pipe Cutters as having 'diagnostic systems but no battery-powered integration,' which contradicts the ground truth stating they were 'standalone tools' in 2022 with no diagnostic integration mentioned. (3) PRODUCT SCOPE ERROR: The LLM introduces 'electrical cable cutting and crimping' in 2024, which is not mentioned in the ground truth and appears to be an incorrect extrapolation. The ground truth specifically mentions 'sewer inspection cameras' as the diagnostic system integration, not electrical cable tools. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution across years - it misidentified the segment classification and incorrectly characterized the 2022 baseline. (5) PAGE REFERENCES: While the LLM provides page citations, these cannot be verified against the ground truth knowledge graph, and the content described does not align with the ground truth narrative. The core narrative of progression from standalone tools (2022) → battery hydraulic integration (2023) → smart integrated ecosystem with diagnostic systems (2024) is fundamentally misrepresented in the LLM answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 467,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "Johnson & Johnson’s 2022, 2023 and 2024 10‑Ks all describe the same multi‑year, enterprise‑wide initiative: “to integrate, simplify and standardize processes and systems for human resources, information technology, procurement, supply chain and finance, thereby expanding its financial shared‑service capabilities and standardizing financial systems” (2022 10‑K, page 118; 2023 10‑K, page 118; 2024 10‑K, page 119).  The wording and scope have remained unchanged, indicating a sustained commitment to aligning and streamlining the financial control environment.  This consistent emphasis reveals that J&J’s strategic focus is on standardizing financial processes to improve efficiency, strengthen controls and ensure uniform reporting across the enterprise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about J&J's financial shared services initiative evolution from 2022-2024. STRENGTHS: (1) Correctly identifies the consistent, multi-year enterprise-wide initiative across all three years (2022, 2023, 2024); (2) Accurately cites specific page numbers from 10-Ks (page 118 for 2022 and 2023, page 119 for 2024), which can be verified; (3) Provides the exact initiative description with proper scope (human resources, information technology, procurement, supply chain, and finance); (4) Correctly synthesizes the multi-hop information showing consistency across years; (5) Accurately interprets the strategic implications - standardization, efficiency, control strengthening, and uniform reporting; (6) Properly notes that wording and scope remained unchanged, indicating sustained commitment. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, which provides additional context about the 2022 framing (not in response to internal control deficiencies) and the 2023 affirmation of commitment; (2) The ground truth emphasizes this as a 'long-term strategic commitment to process optimization and financial systems modernization,' while the LLM focuses more on the practical outcomes (efficiency, controls, reporting); (3) The LLM doesn't explicitly mention the proactive nature emphasized in 2022 or the specific 2023 reiteration language. However, these are minor omissions of contextual nuance rather than factual errors. The core answer is semantically equivalent and factually sound. All quantitative elements (years, page numbers, initiative scope) are accurate. The reasoning correctly synthesizes information across three years of filings to demonstrate strategic consistency.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 494,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "Costco continued to list the Executive Health Plan as Exhibit 10.1* by reference in each of its 10‑K filings for FY 2022, FY 2023 and FY 2024, with identical filing details (Form 10‑K, period ended 9/2/2012, filing date 10/19/2012)【page 66 (2022)】【page 66 (2023)】【page 66 (2024)}. The unchanged filing status shows that the plan has not been amended or re‑filed in recent years, indicating a stable, long‑term executive benefit strategy that Costco maintains consistently over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) All key dates are correct - Period Ended 9/2/2012 and Filing Date 10/19/2012 match the ground truth exactly. (2) All fiscal years covered (2022, 2023, 2024) are correctly identified. (3) The exhibit reference (Exhibit 10.1*) is accurate. (4) The core finding is correct: the plan was consistently disclosed with identical filing details across all three years. (5) The multi-hop reasoning is sound - the answer correctly synthesizes information across three fiscal years and draws the appropriate conclusion about stability in executive benefit strategy. (6) The interpretation that unchanged filing status indicates no material amendments is logically sound and matches the ground truth's conclusion. (7) Page references are provided (though not verified against actual documents, they appear reasonable). MINOR CONSIDERATIONS: (1) The LLM uses slightly different phrasing ('by reference' vs. the ground truth's parenthetical notation) but this is semantically equivalent and actually more precise. (2) The LLM explicitly states 'Form 10-K' which adds helpful context not explicitly in the ground truth but is factually correct. (3) Both answers reach identical conclusions about the stability and consistency of Costco's executive benefit strategy. The answer demonstrates strong multi-hop synthesis across three years of filings and correctly identifies the strategic implication of the unchanged disclosure pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 416,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "From 2022 through 2024 Mastercard’s Class A shares retained the same dividend and voting structure—one vote per share and dividend rights (page_16).  The declared dividend per share climbed from $2.04 in 2022 (page_95) to $2.37 in 2023 (page_100) and $2.74 in 2024 (page_94).  This consistency shows the company’s commitment to a stable, shareholder‑friendly governance framework that preserves equal voting power and predictable dividend entitlements for its primary shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that MA's Class A shares maintained consistent dividend and voting rights (one vote per share) across 2022-2024, matching the ground truth on the core governance finding. The reasoning about stable shareholder governance strategy is sound and well-articulated. However, there is a significant factual error: the LLM introduces dividend per share amounts ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that are NOT part of the original question or ground truth answer. The original answer explicitly focuses on the RIGHTS associated with A Class Shares (voting rights and dividend rights as a category), not the actual dividend amounts paid. By introducing specific dividend payment amounts, the LLM conflates two different concepts: (1) the structural rights attached to the share class (which remained constant), and (2) the actual dividend payments made (which varied). This represents a material deviation from the ground truth, which makes no mention of specific dividend per share amounts. The LLM also cites specific page numbers that cannot be verified against the ground truth. The multi-hop reasoning is partially sound—the model correctly synthesizes that consistency in rights reveals governance strategy—but the introduction of unverified dividend payment data undermines the accuracy of the response. The answer would have been stronger by staying focused on the rights themselves rather than adding dividend payment information that wasn't part of the original question or answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 421,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "Broadcom’s Security Insights Platform has maintained the same core offering across FY 2022, FY 2023 and FY 2024. In each 10‑K (pages 10–12 of the 2022, 2023 and 2024 filings) the platform is described as “quickly interpreting and assessing mainframe security posture, identifying risks and developing remediation steps on an ongoing and ad‑hoc basis” with the data “available for use with in‑house tools for security information and event management.” No new integration or risk‑identification features were added in the later years; the description and capabilities remained essentially unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies all three fiscal years (2022, 2023, 2024) with no date errors. (2) Accurately captures the core platform description including the specific capabilities: 'quickly interpreting and assessing mainframe security posture, identifying risks and developing remediation steps on an ongoing and ad-hoc basis' and integration with 'in-house tools for security information and event management.' (3) Properly synthesizes the multi-hop information across three years, correctly concluding that the platform remained stable with no new features added. (4) Provides specific page references (pages 10-12) which adds credibility. (5) The semantic meaning matches the ground truth perfectly - both convey that the platform maintained consistent functionality across the three-year period. Minor observation: The LLM answer is slightly more detailed and specific than the ground truth (includes exact quote and page numbers), but this adds value rather than detracting. The conclusion that the platform represents 'a mature and well-defined offering' is implicit in the LLM's statement that capabilities 'remained essentially unchanged,' which is semantically equivalent. No quantitative errors, no entity misidentification, and the multi-hop reasoning correctly synthesizes information across all three fiscal years as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 390,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "From 2022 through 2024, AIG has continued to assess loss‑reserve adequacy with a blend of stochastic and deterministic modeling, sensitivity and scenario analyses, and experience‑study reviews.  The 2022 and 2023 filings explicitly state that internal controls and oversight of the reserve‑setting process are reinforced by reviews from external experts, whereas the 2024 filing repeats the same modeling and internal‑control framework but does not explicitly mention external‑expert validation, implying the role remains but is not highlighted.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core methodologies (stochastic and deterministic modeling, sensitivity and scenario analyses, experience-study reviews) used consistently across 2022-2024, which aligns with the ground truth. The answer also accurately notes the role of internal controls and external expert reviews in 2022-2023. However, there are significant qualitative accuracy issues: (1) The LLM states that the 2024 filing 'does not explicitly mention external-expert validation,' which contradicts the ground truth that 2024 shows 'continued reliance on external experts.' This is a material mischaracterization of the evolution. (2) The LLM fails to capture the key evolution described in the ground truth: the progression from basic uncertainty management in 2022, to expanded risk management with formalized actuarial reviews in 2023, to a 'maturing and increasingly proactive approach' with ERM second-line reviews and enhanced monitoring in 2024. The LLM presents the framework as largely static rather than evolving. (3) The LLM misses important 2024 enhancements mentioned in the ground truth: ERM second-line reviews, enhanced budget and expense assumption monitoring, and the characterization of this as a 'multi-tiered risk oversight' approach. (4) The phrase 'implying the role remains but is not highlighted' in the LLM answer is speculative and contradicts the ground truth's assertion of 'continued reliance.' The answer is partially correct on methodologies but significantly incomplete on the evolution narrative and misrepresents the 2024 position on external expert involvement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 441,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "Emerson’s 2022 and 2023 10‑K segment descriptions list electrical distribution equipment as part of the Discrete Automation segment【page_73】.  By 2024, the company re‑classified that product line into its Industrial Solutions segment, where the 2024 10‑K describes Industrial Solutions as “providing … electrical distribution equipment”【page_76】.  This shift signals Emerson’s intent to embed discrete‑automation components within its broader industrial‑solutions portfolio, underscoring a strategic emphasis on expanding discrete‑automation capabilities through integrated industrial solutions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that in 2022, Electrical Distribution Equipment was part of Industrial Solutions, and by 2023 it was reorganized into the Discrete Automation segment where it remained in 2024. The LLM answer reverses this trajectory, claiming that in 2022-2023 the equipment was in Discrete Automation, and then by 2024 it was reclassified into Industrial Solutions. This is the opposite of what actually occurred. The LLM's conclusion about 'embedding discrete-automation components within broader industrial-solutions portfolio' is therefore backwards from the actual strategic shift. The ground truth reveals a movement FROM general industrial positioning TO discrete automation focus, while the LLM describes a movement in the opposite direction. Additionally, the LLM fails to capture the nuanced evolution described in the ground truth regarding how the equipment was grouped with different product categories across the three years (fluid control/materials joining in 2022, solenoid valves/programmable automation in 2023, electric linear motion/programmable control in 2024), which demonstrates the deepening integration into discrete automation. The LLM's answer is internally inconsistent with the actual filing data and misrepresents Emerson's strategic direction. This is a critical factual error that undermines the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 403,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "Johnson & Johnson announced in 2021 that, effective Jan 1 2026, all eligible U.S. non‑union employees would be covered by the Retirement Value formula, replacing the Final Average Pay formula for new hires and gradually phasing it out for existing employees (page 77, page 73). Over 2022‑2024 the company is shifting its pension structure toward a fully Retirement Value‑based plan, a multi‑year transition that reflects a long‑term strategy to modernize benefits, align them with current compensation patterns, and manage pension liabilities more sustainably (page 76).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key entities (Johnson & Johnson, U.S. non-union employees, Retirement Value formula, Final Average Pay formula) and the effective date (January 1, 2026). The answer appropriately synthesizes the multi-year transition concept and captures the strategic intent around cost predictability and benefit modernization. The reasoning about long-term workforce strategy is sound and semantically aligned with the ground truth.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL DATE ERROR: The LLM states the announcement was made in 2021, but the ground truth indicates the company 'reiterated' this change in 2022, with no mention of a 2021 announcement. This is a factual inaccuracy regarding the timeline. (2) INCOMPLETE CHARACTERIZATION: The LLM describes the transition as 'gradually phasing it out for existing employees,' but the ground truth explicitly states the policy applies to 'all eligible employees regardless of hire date' with 'Final Average Pay formula benefits accrued before 2026' being preserved. This is a subtle but important distinction—the change is not a gradual phase-out but rather a formula change effective a specific date while preserving prior accruals. (3) MISSING CONSISTENCY EMPHASIS: The ground truth emphasizes that 2022, 2023, and 2024 disclosures maintained 'the same structural description' with 'no reversal or delay,' highlighting consistency as a key indicator of strategic commitment. The LLM mentions the multi-year period but doesn't emphasize this consistency across all three years as evidence of deliberate strategy. (4) VAGUE SOURCING: The LLM cites 'page 77, page 73, page 76' but these page references cannot be verified against the ground truth, which doesn't provide specific page citations.\n\nMULTI-HOP REASONING: The LLM does synthesize information across the 2022-2024 period and connects it to workforce strategy, but the synthesis is less precise than the ground truth regarding what the consistency of messaging reveals about strategic intent.\n\nOVERALL ASSESSMENT: The answer captures the general narrative and strategic implications correctly but contains a factual error about the announcement date and mischaracterizes the nature of the phase-out. These are material errors that affect the accuracy of the historical timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 618,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "The 10‑K tables list Downy as a major brand in the Fabric & Home Care segment for 2022, 2023 and 2024, but they do not disclose the brand’s exact share of the segment’s net sales.  The fact that Downy remains consistently highlighted among the segment’s flagship brands suggests its contribution has stayed steady over the three‑year period, underscoring the brand’s ongoing strategic importance to P&G’s portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and fails to address the core question. CRITICAL ERRORS: (1) The LLM claims that 10-K tables 'do not disclose the brand's exact share of the segment's net sales,' but the ground truth explicitly provides specific percentages: Downy contributed 35% in 2022 and 36% in both 2023 and 2024. These are factual data points that should have been extracted from the filings. (2) The LLM provides NO quantitative data whatsoever, when the question specifically asks 'how did the percentage contribution...evolve' - this requires numerical comparison across years. (3) The LLM's reasoning is vague and speculative ('the fact that Downy remains consistently highlighted...suggests its contribution has stayed steady') rather than based on actual disclosed percentages. (4) The LLM fails the multi-hop synthesis requirement by not connecting the specific percentage figures to the segment's growth context mentioned in the ground truth. The ground truth clearly states the segment 'grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024,' showing a 1 percentage point increase from 2022 to 2023-2024. The LLM's conclusion about 'steady' contribution is partially correct in spirit but lacks the supporting numerical evidence that should have been provided. The answer demonstrates a failure to extract and synthesize available quantitative data from SEC filings, which is the core requirement for this type of financial analysis question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 411,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "Capital One’s senior and subordinated notes rose from $27,219 million in 2022 (Table 8.2) to $31,248 million in 2023 (Table 8.2), then fell modestly to $30,696 million in 2024 (Table 9.2). The 2023 jump reflects a deliberate use of long‑term debt to fund growth or refinance, while the slight decline in 2024 indicates a modest tightening of leverage and a focus on managing interest‑rate risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a 2024 figure of $30,696 million, which contradicts the ground truth value of $31,248 million. This is a significant discrepancy of $552 million (1.8% error). The ground truth explicitly states the 2024 carrying value was $31,248 million, matching 2023. The LLM's claim of a 'modest decline' to $30,696 million is factually incorrect. (2) TREND ANALYSIS - The ground truth indicates a peak in 2023 at $31,248 million that remained flat through 2024 (both $31,248M), not a decline as the LLM suggests. The LLM mischaracterizes the 2023-2024 trend. (3) STRATEGIC INTERPRETATION - The LLM's interpretation of a 'modest tightening of leverage' in 2024 is unsupported by the actual data, which shows no decline. The ground truth correctly identifies an upward trend from 2022-2024 with values of $27,219M → $31,248M (2023) → $31,248M (2024). (4) MULTI-HOP SYNTHESIS - While the LLM correctly identifies the 2022 and 2023 figures, the incorrect 2024 figure breaks the multi-hop synthesis across the three-year period. The reasoning about debt strategy is partially sound but built on incorrect data. (5) POSITIVE ASPECTS - The LLM correctly cites Capital One (COF), correctly identifies the 2022 starting point ($27,219M), and correctly identifies the 2023 peak ($31,248M). The general framework of analyzing debt financing strategy is appropriate. However, the fundamental error in the 2024 figure is a critical failure that undermines the entire answer's reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 423,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "In 2022 AT&T still owned a 41.3 % stake in SKY Mexico and accounted for it under the equity method (2022 10‑K, page 93). The stake remained unchanged in 2023, still treated under the equity method. In 2024 AT&T sold its 41.3 % interest, ending the equity‑method accounting and exiting the investment (2024 10‑K, page 66). This three‑year path underscores AT&T’s broader strategy of divesting non‑core Latin American pay‑TV assets to streamline its portfolio and focus on core operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about T's (AT&T's) strategic positioning in SKY Mexico from 2022-2024. STRENGTHS: (1) All numeric values are correct: 41.3% ownership stake is accurately cited throughout the 3-year period; (2) Dates are precise: 2022, 2023, and 2024 are correctly sequenced, with the June 2024 exit timing implied through the 2024 10-K reference; (3) Accounting treatment is correctly identified: equity method accounting in 2022-2023, transitioning to exit in 2024; (4) Multi-hop synthesis is sound: the answer correctly traces the evolution across three years and connects it to AT&T's broader divestiture strategy; (5) Entity identification is accurate: SKY Mexico is correctly identified as a Latin American pay-TV asset; (6) Strategic interpretation aligns with ground truth: the answer correctly characterizes this as part of AT&T's strategy to divest non-core international assets and focus on core operations. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the explicit mention that SKY Mexico was listed alongside DIRECTV and Gigapower as key equity method investments in 2023—however, this is a minor contextual detail that doesn't affect the core answer's accuracy; (2) The phrase 'ending the equity-method accounting' is semantically equivalent to the ground truth's description of the exit; (3) Page references (page 93 for 2022, page 66 for 2024) add credibility and specificity. The answer successfully captures the 3-year trajectory and its implications for AT&T's Latin American strategy without any factual errors or calculation mistakes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 462,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "BNY Mellon’s 10‑K risk‑factor disclosures about capital‑return limits were essentially unchanged from 2022 through 2024.  Each year reiterated that the ability to return capital is subject to board discretion and may be constrained by U.S. banking laws, capital‑planning rules, Delaware law, and the requirement to pay dividends on preferred stock, and that failure to meet regulatory standards—including well‑capitalized status and capital‑adequacy/liquidity rules—could restrict activities.  No new regulatory or dividend‑policy language was added beyond this consistent framing.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical elements of the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies that capital returns are subject to board discretion, U.S. banking laws, capital-planning rules, Delaware law, and preferred dividend requirements across all three years. (2) The LLM correctly notes that regulatory standards like well-capitalized status and capital-adequacy/liquidity rules could restrict activities. (3) No quantitative errors in dates or numbers (2022-2024 period is correct). CRITICAL ERRORS AND OMISSIONS: (1) The LLM claims 'no new regulatory or dividend-policy language was added beyond this consistent framing,' which directly contradicts the ground truth. The ground truth explicitly states that by 2023, 'the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation.' (2) The LLM completely misses the 2024 evolution: the ground truth indicates that by 2024, disclosures included 'additional emphasis on the Parent company's reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning.' (3) The LLM fails to capture the evolution trend described in the ground truth: 'The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.' The LLM incorrectly characterizes the disclosures as 'essentially unchanged,' when the ground truth shows meaningful evolution in contextual complexity. MULTI-HOP REASONING: The question asks about evolution from 2022 to 2024 'particularly in relation to regulatory requirements, dividend policies, and capital adequacy.' The LLM addresses regulatory requirements and capital adequacy but fails to synthesize the evolution across years and misses the contextual additions (ESG pressures, strategic initiatives, subsidiary dividend reliance) that represent the actual evolution. The LLM's conclusion that nothing changed is fundamentally at odds with the ground truth's characterization of increasing contextual complexity. This represents a failure in multi-hop synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 595,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "3M’s 2022, 2023 and 2024 10‑K tables all list “Structural adhesives and tapes” as a core product of the Safety & Industrial segment (page 107 for 2022, page 110 for 2023 and 2024).  The description and bundling with tapes and other industrial specialty items—such as abrasives, automotive‑repair solutions, electrical products and construction materials—remained unchanged, showing that adhesives are positioned as a foundational, cross‑functional component that enhances the value of a broad range of industrial solutions.  This consistency underscores the strategic importance of adhesives in providing structural bonding that underpins many of 3M’s industrial offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses when compared to the ground truth. STRENGTHS: (1) Correctly identifies Structural Adhesives as a core product in the Safety & Industrial segment across 2022-2024; (2) Appropriately cites page numbers (107 for 2022, 110 for 2023 and 2024); (3) Correctly notes the bundling with tapes and other industrial products; (4) Accurately identifies the foundational, cross-functional role of adhesives. CRITICAL WEAKNESSES: (1) The LLM claims 'the description and bundling with tapes and other industrial specialty items...remained unchanged' - this directly contradicts the ground truth, which explicitly states an EVOLUTION from 2022 through 2024, with shifts in positioning and emphasis; (2) The ground truth describes a clear progression: 2022 emphasized metalworking and OEM electrical markets; 2023 showed expanded emphasis on packaging and closure systems; 2024 shifted toward specialized industrial applications and construction/maintenance materials. The LLM completely misses this temporal evolution; (3) The ground truth emphasizes that the positioning 'evolved' and shows a 'shift toward more specialized industrial applications' - the LLM incorrectly characterizes this as 'unchanged'; (4) The LLM fails to capture the nuanced strategic insight about reinforcement as a 'foundational component in complex industrial systems' versus earlier positioning. MULTI-HOP REASONING: The question explicitly asks about evolution 'from 2022 through 2024' - this requires synthesizing year-over-year changes. The LLM fails this multi-hop requirement by asserting consistency rather than documenting the documented evolution. The answer is factually incomplete and misrepresents the nature of the strategic positioning changes across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 492,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "From 2022 through 2024 Eli Lilly kept Cyramza’s core therapeutic portfolio unchanged – it continued to be marketed for advanced or metastatic gastric cancer, metastatic NSCLC, metastatic colorectal cancer, hepatocellular carcinoma, and first‑line metastatic NSCLC with EGFR mutations [page_7, page_5].  The company’s IP strategy remained focused on the same compound patents in the U.S., major European countries and Japan (expiring 2026, 2028 and 2026, respectively) and data‑protection exclusivities (U.S. 2026, Europe 2024, Japan 2023) [page_11, page_12], with the 2024 filing confirming that these protections are still in place while approaching their expiry dates.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Cyramza's therapeutic indications (gastric, NSCLC, colorectal, hepatocellular carcinoma) and demonstrates understanding that these remained consistent from 2022-2024. The answer appropriately addresses the IP protection aspect and correctly identifies the three key geographic markets (U.S., Europe, Japan). The qualitative reasoning about lifecycle management and preparing for market competition is sound.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: The LLM provides specific patent expiration dates that contradict the ground truth:\n- LLM states: U.S. patents expire 2026, European patents 2028, Japan patents 2026\n- Ground truth indicates: U.S. biologics data protection 2026, European data protection 2024, Japan data protection 2023\nThe LLM conflates compound patents with data protection exclusivities and provides incorrect European patent expiration date (2028 vs. 2024 for data protection). This is a significant factual error on specific dates.\n\nPARTIAL ISSUES: While the LLM correctly identifies data protection expirations (U.S. 2026, Europe 2024, Japan 2023), it also introduces unverified patent expiration dates (2026, 2028, 2026) that appear to be fabricated or confused with other IP protections. The ground truth focuses on data protection timelines, not compound patent expirations.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2024 period and connects therapeutic indications to IP strategy. However, the synthesis is undermined by the incorrect patent dates.\n\nCOMPLETENESS: The answer addresses both parts of the question (therapeutic indications and IP protections) and covers the geographic scope requested. The evolution narrative is present but somewhat muted compared to ground truth's emphasis on lifecycle management preparation.\n\nSCORING JUSTIFICATION: The core narrative is correct (unchanged indications, IP protection focus), but the specific numeric dates for patents are problematic. The quantitative accuracy score is low (4) due to the patent expiration date errors. The qualitative accuracy is higher (7) because the reasoning framework is sound despite the numeric errors. The correctness score of 6 reflects that while the main thesis is correct, the specific factual claims about patent dates are unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 626,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "Capital One’s fixed unsecured senior debt rose from **$19,975 million at a 2.91 % weighted‑average rate in 2022** (COF_10k_2022, page 188) to **$27,168 million at 4.45 % in 2023** (COF_10k_2023, page 178), then fell slightly to **$26,930 million at 4.84 % in 2024** (COF_10k_2024, page 188). The upward swing in the weighted‑average rate and the large 2023 issuance indicate the company is refinancing older debt with higher‑rate, longer‑term notes, while the modest 2024 decline in carrying value suggests partial repayments or refinancing of the most expensive tranches. This multi‑year pattern signals a strategy of extending maturities at increasingly higher rates to maintain liquidity, accepting higher financing costs as market rates climb.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. QUANTITATIVE VERIFICATION: All key numbers are correct - 2022 carrying value of $19,975 million (matches ground truth), 2022 weighted-average rate of 2.91% (matches), 2024 carrying value of $26,930 million (matches), and 2024 weighted-average rate of 4.84% (matches). The intermediate 2023 figures ($27,168 million at 4.45%) are provided with appropriate source citations. The overall trend from $19,975M to $26,930M represents a 34.9% increase, correctly characterized as an upward trajectory. MULTI-HOP SYNTHESIS: The answer successfully synthesizes data across three fiscal years (2022, 2023, 2024) and correctly identifies the dual evolution: (1) carrying value increase, and (2) weighted-average interest rate increase. The model appropriately notes the 2023 peak followed by 2024 decline, showing nuanced understanding of the multi-year pattern. REASONING QUALITY: The interpretation is sound - the company issued more fixed-rate debt at higher rates, reflecting market conditions and capital structure decisions. The explanation about refinancing older debt with higher-rate notes and extending maturities is logical and consistent with the data. The conclusion about accepting higher financing costs as market rates climb aligns with the observed 2.91% to 4.84% rate increase. COMPLETENESS: The answer addresses all aspects of the question: (1) carrying value evolution, (2) weighted-average interest rate evolution, (3) multi-year trend analysis, and (4) strategic implications. MINOR CONSIDERATIONS: The LLM provides more granular detail (including 2023 intermediate data) than the ground truth answer, which is additive rather than contradictory. The source citations (page numbers) add credibility. The semantic meaning is fully equivalent to the ground truth, with slightly more detailed explanation of the strategic rationale. No calculation errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 530,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "Cisco’s notional exposure to total‑return swaps tied to deferred compensation grew from **$651 million in FY 2022 to $730 million in FY 2023 and to $985 million in FY 2024** (page 92 for 2022; page 91 for 2023‑24).  The fair‑value impact on operating results was a **$92 million loss in FY 2022, a $58 million gain in FY 2023, and a $91 million gain in FY 2024** (page 91).  This pattern shows that the instrument’s value fluctuates markedly from year to year, with volatility increasing as the exposure expands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All financial figures match the ground truth exactly: (1) Loss of $92 million in FY 2022 - CORRECT, (2) Gain of $58 million in FY 2023 - CORRECT, (3) Gain of $91 million in FY 2024 - CORRECT. The LLM also provides additional notional exposure values ($651M, $730M, $985M) that enhance the answer without contradicting the ground truth. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three fiscal years and identifies the pattern of volatility (loss to gains). ENTITY ACCURACY: Correctly identifies Cisco, Total Return Swaps, Deferred Compensation, and fiscal years 2022-2024. REASONING QUALITY: The LLM goes beyond the ground truth by providing notional exposure amounts and explicitly connecting the expanding notional exposure to increasing volatility, which is a logical and insightful extension. The characterization of the pattern as 'volatile' and 'fluctuating markedly' aligns with the ground truth's description of 'volatile financial impact' and 'swinging from loss to gains.' PAGE CITATIONS: The LLM provides specific page references (pages 92, 91) which adds credibility, though these cannot be independently verified against the ground truth. MINOR CONSIDERATION: The ground truth focuses on gains/losses while the LLM adds notional exposure context, but this is additive rather than contradictory. The core answer about the three-year pattern of losses and gains is identical and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 418,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "From 2022 to 2024 Home Depot moved from a limited focus on store appearance to a full‑scale refresh program—wayfinding signage, electronic shelf labels, curb‑side pickup, self‑service lockers and mobile‑app navigation—reporting higher customer‑satisfaction scores and that roughly 50 % of U.S. online orders were fulfilled through a store, which has strengthened its competitive position against multichannel and online rivals [page_9, page_10].",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and conceptual issues when compared to the ground truth. MAJOR PROBLEMS: (1) The LLM provides specific tactical details (wayfinding signage, electronic shelf labels, curbside pickup, self-service lockers) that are NOT mentioned in the ground truth, which focuses on strategic positioning and integration with digital capabilities rather than specific store renovation features. (2) The LLM cites a specific metric ('roughly 50% of U.S. online orders were fulfilled through a store') with page references, but this quantitative claim cannot be verified against the ground truth and appears to be fabricated or hallucinated. (3) The LLM fundamentally mischaracterizes the evolution: it describes a 'limited focus' in 2022 that evolved into a 'full-scale refresh program,' but the ground truth indicates store appearance was ALREADY a key component in 2022, with the evolution being about integration with digital/omnichannel capabilities, not about the introduction of store appearance itself. (4) The LLM fails to capture the critical multi-hop synthesis that the ground truth emphasizes: the strategic pivot from standalone in-store experience to a hybrid omnichannel model. Instead, it focuses on tactical store improvements and fulfillment metrics. WHAT WAS CORRECT: The LLM correctly identifies that store appearance remained important across the period and that this relates to competitive positioning against online retailers. However, the specific mechanisms and strategic framing are substantially different from the ground truth. The answer reads more like a retail operations summary than a strategic positioning analysis. The page references suggest citation of specific documents, but the content doesn't align with the knowledge graph ground truth, raising concerns about accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 498,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "NVIDIA’s 3.50% Notes Due 2050 carried $1.637 billion at the end of fiscal 2022 (Jan 29 2023) (page_67), fell slightly to $1.604 billion at the end of fiscal 2023 (Jan 28 2024) (page_67), and rose to $2.000 billion at the end of fiscal 2024 (Jan 28 2024) (page_72). This modest dip followed by a notable increase reflects NVIDIA’s active management of its long‑term debt mix and maturity profile, indicating a stable yet strategically adjusted long‑term debt position.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the carrying values reported. Ground truth shows: FY2022: $2,147M, FY2023: $1,637M, FY2024: $2,000M. LLM reports: FY2022: $1,637B (which equals $1,637M - this is actually the FY2023 value), FY2023: $1,604B (incorrect - no such value in ground truth), FY2024: $2,000B (correct). The LLM has misaligned the fiscal year data, attributing the FY2023 value to FY2022, and introduced an entirely fabricated intermediate value of $1,604B for FY2023. The fiscal year end dates provided (Jan 29 2023 for FY2022, Jan 28 2024 for FY2023 and FY2024) are also problematic - the LLM lists the same date (Jan 28 2024) for both FY2023 and FY2024, which is internally inconsistent. MULTI-HOP SYNTHESIS FAILURE: The answer fails to correctly synthesize the three-year progression. The ground truth shows a clear pattern: decrease from $2,147M to $1,637M (FY2022-2023), then recovery to $2,000M (FY2024). The LLM's narrative about 'modest dip followed by notable increase' is qualitatively reasonable but is built on incorrect numbers. ENTITY AND METRIC ACCURACY: The instrument identification (3.50% Notes Due 2050) is correct, and NVIDIA is correctly identified. However, the carrying values - the core quantitative metrics - are substantially wrong. The LLM appears to have confused or misread the fiscal year alignment of the data. REASONING QUALITY: While the interpretive commentary about 'active management' and 'strategic adjustment' is reasonable in tone, it is based on false premises due to the incorrect numbers. This makes the reasoning fundamentally unsound despite appearing logical on its surface.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 460,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "From 2022 through 2024, 3M’s Scotchgard exposure was limited to a single consolidated putative class action in Michigan against Wolverine.  The case, pending in 2022, was settled in June 2023 for an immaterial amount, leaving only 3M and Wolverine as defendants.  No new Scotchgard lawsuits, additional defendants, or geographic expansion of litigation emerged in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is substantially incorrect and contradicts the ground truth on multiple critical dimensions: (1) SETTLEMENT FACTS: The LLM correctly identifies the Michigan/Wolverine settlement in June 2023 as immaterial, but completely omits the 2022 Baker class action settlement in New York involving 3M, Saint-Gobain, and Honeywell for $65 million. This is a major factual omission. (2) GEOGRAPHIC EXPANSION: The ground truth explicitly states litigation expanded geographically to Alabama and Georgia by 2024 with multiple new cases. The LLM claims 'No new Scotchgard lawsuits...or geographic expansion of litigation emerged in 2024,' which directly contradicts the ground truth. This is a fundamental error. (3) DEFENDANTS AND COMPLEXITY: The ground truth indicates the number of defendants increased significantly, with DuPont, Chemours, and carpet manufacturers like Mohawk Industries appearing alongside 3M. The LLM claims 'only 3M and Wolverine as defendants' and states no additional defendants emerged, which is factually incorrect. (4) CASE EXPANSION: The ground truth mentions multiple new cases brought by municipal water utilities, individual landowners, and carpet manufacturers. The LLM claims the litigation was limited to 'a single consolidated putative class action in Michigan,' which is demonstrably false. (5) MULTI-HOP REASONING: The LLM failed to synthesize information across the 2022-2024 period, missing the evolution and expansion of the legal landscape that is central to the question. The answer presents a static, incomplete picture rather than tracking the evolution requested. The LLM's conclusion that litigation remained limited and unchanged is contradicted by the ground truth's clear documentation of expansion, geographic spread, and increasing complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 488,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "From 2022 to 2024 the AbCellera collaboration kept a mid‑teens to mid‑twenties royalty on worldwide net sales of bamlanivimab and bebtelovimab, with no change to the royalty structure. Milestone payments were not material or disclosed in the 2023 and 2024 filings, and no milestone payments were recorded in those years. Net product revenue fell sharply, with $2.02 billion recognized in 2022 and zero revenue in 2023 and 2024 as sales ceased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop financial question about LLY's AbCellera collaboration. STRENGTHS: (1) All quantitative data is correct - $2.02 billion in 2022 revenue, zero revenue in 2023-2024, and the mid-teens to mid-twenties royalty structure are all accurate. (2) The answer correctly identifies the product names (bamlanivimab and bebtelovimab), which adds specificity beyond the ground truth. (3) Multi-hop synthesis is sound - the answer properly connects financial terms (royalty structure), milestone payments (none in 2023-2024), and net product revenue across the three-year period. (4) The narrative of declining commercial trajectory is clearly conveyed. (5) The statement about royalty structure remaining consistent is accurate. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different phrasing ('milestone payments were not material or disclosed') compared to ground truth's more direct statement about 'no new milestone payments,' but this is semantically equivalent and actually more precise about disclosure practices. (2) The answer is slightly more concise than the ground truth but captures all essential information. (3) The LLM provides product names which adds helpful context not in the original answer. VERIFICATION: All numbers check out ($2.02B in 2022, $0 in 2023-2024), the royalty percentages are correct (mid-teens to mid-twenties), and the timeline is accurate. The answer successfully synthesizes information across multiple years and financial dimensions as required by the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 438,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "Procter & Gamble has kept Dawn dish soap listed as one of the “major brands” in its Fabric & Home Care segment, which grew from 35 % of net sales (31 % of net earnings) in 2022 to 36 % of net sales (34 % of net earnings) in 2024 (PG 10‑K 2022, p. 19; PG 10‑K 2024, p. 18). The brand’s unchanged status amid the segment’s incremental share and earnings growth shows that Dawn remains a core, high‑volume driver of the home‑care portfolio, underscoring its strategic importance as a key product in P&G’s daily‑use category strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct segment percentages (35% to 36% net sales, 31% to 34% earnings) and proper identification of the time period (2022-2024). The answer correctly identifies Dawn as a major brand within Fabric & Home Care and accurately characterizes its strategic importance. However, there are notable gaps in completeness: (1) The answer only explicitly compares 2022 and 2024 data, omitting the 2023 intermediate year that the ground truth specifically mentions (36% net sales, 34% earnings in 2023), which is a material omission for a question asking about evolution 'from 2022 to 2024.' (2) The ground truth emphasizes the consistency across all three years as the key insight, while the LLM answer focuses primarily on the 2022-2024 comparison and growth trajectory. (3) The LLM's characterization of the segment's growth as 'incremental' is reasonable but slightly understates the consistency theme that the ground truth emphasizes. The reasoning about Dawn's strategic importance is sound and well-supported, and the semantic meaning aligns with the ground truth's conclusion about sustained strategic importance. The answer would have been stronger with explicit mention of 2023 data to demonstrate the full three-year consistency pattern that reveals the true nature of the strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 378,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024, while long‑term debt rose from $47.8 B in 2022 to $49.3 B in 2023 and declined to $45.0 B in 2024, so the combined short‑term plus long‑term debt fell from $48.7 B to $45.6 B over the three years. The floating‑unsecured senior debt dropped sharply from $1.6 B in 2022 to $349 M in 2023 and to zero in 2024, indicating a deliberate shift away from floating‑rate exposure toward fixed‑rate debt. This mix change, coupled with a rise in the weighted‑average interest rate on unsecured senior debt from 4.45% in 2022 to 4.84% in 2024, reflects a strategy to lock in rates and reduce interest‑rate variability amid a higher‑rate environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) TOTAL DEBT NUMBERS: LLM states combined short-term + long-term debt fell from $48.7B to $45.6B, but ground truth shows it increased from $43.086B in 2022 to $48.715B in 2023, then declined to $45.551B in 2024. The LLM's 2022 starting figure of $48.7B is incorrect (should be $43.086B). (2) SHORT-TERM BORROWINGS: LLM claims $883M in 2022, $538M in 2023, $562M in 2024. Ground truth does not provide these specific short-term figures separately, but the combined totals suggest these breakdowns may be inaccurate. (3) LONG-TERM DEBT: LLM states $47.8B (2022), $49.3B (2023), $45.0B (2024). These appear to be approximations but are close enough to the combined figures. (4) FLOATING UNSECURED SENIOR DEBT: LLM states $1.6B in 2022, but ground truth clearly shows $1.709B in 2022. This is a material discrepancy. The 2023 ($349M) and 2024 (zero) figures are correct. (5) WEIGHTED-AVERAGE INTEREST RATE ERROR: LLM states the rate rose from 4.45% in 2022 to 4.84% in 2024, but ground truth shows it was 2.91% in 2022, 4.45% in 2023, and 4.84% in 2024. The LLM completely omitted the 2.91% 2022 baseline and incorrectly attributed 4.45% to 2022 instead of 2023. This is a fundamental error in the multi-hop synthesis. (6) MULTI-HOP REASONING: While the LLM correctly identifies the strategic shift from floating to fixed-rate debt and the overall trend direction, the foundational numbers are wrong, undermining the entire analysis. The reasoning about interest rate strategy is sound but built on incorrect data. (7) COMPLETENESS: The answer addresses the main components of the question but with significant numerical inaccuracies that distort the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 460,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "Cisco’s 5.90% senior note stayed a $2 billion fixed‑rate instrument with an effective rate of 6.11 % and remained classified as long‑term debt in FY 2022, FY 2023 and FY 2024.  However, its share of total debt fell as Cisco issued new senior notes in 2024—total debt rose from $8.9 billion in FY 2022 to $20.1 billion in FY 2024—so the 5.90% note accounted for roughly 22 % of debt in 2022 and only about 10 % in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts about Cisco's 5.90% Note but contains significant quantitative errors that undermine accuracy. CORRECT ELEMENTS: (1) Principal amount of $2 billion maintained across all three years—correct; (2) Effective interest rate of 6.11% unchanged—correct; (3) Long-term debt classification throughout period—correct; (4) Note remained a fixed-rate instrument—correct; (5) Overall debt increased significantly—correct directionally; (6) New senior notes issued in 2024—correct; (7) Note's proportion of total debt decreased—correct directionally. QUANTITATIVE ERRORS: (1) Total long-term debt FY 2022: LLM states $8.9 billion, but ground truth is $8,416 million ($8.416 billion)—error of ~$484 million or 5.7% overstatement; (2) Total long-term debt FY 2024: LLM states $20.1 billion, but ground truth is $19,621 million ($19.621 billion)—error of ~$479 million or 2.4% overstatement; (3) Percentage calculations: LLM calculates ~22% for 2022 ($2B/$8.9B = 22.5%) and ~10% for 2024 ($2B/$20.1B = 9.95%), which are mathematically consistent with the LLM's stated debt figures but inconsistent with ground truth figures. Using ground truth numbers: 2022 would be $2,000M/$8,416M = 23.8%, and 2024 would be $2,000M/$19,621M = 10.2%—the LLM's percentages are directionally correct but slightly off due to the debt figure errors. MULTI-HOP REASONING: The LLM successfully synthesizes information across three fiscal years, correctly identifying the stable nature of the 5.90% Note while contextualizing it within the broader debt portfolio expansion. The reasoning about debt composition evolution is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential narrative that the note remained stable while its relative importance in the debt portfolio diminished. The wording differs from ground truth but captures the key insights. The primary weakness is the quantitative inaccuracy in absolute debt figures, which propagates through the percentage calculations, though the directional conclusions remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 551,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "NVIDIA’s 1.55% Notes Due 2028 carried $1.099 million on the balance sheet in FY 2022 and FY 2023, rising modestly to $1.115 million in FY 2024 (page 82, page 67).  The effective interest rate on the notes stayed essentially unchanged at about 1.64% in FY 2023 and FY 2024 (page 72).  This flat balance and stable, low cost indicate a disciplined long‑term debt strategy that prioritizes low‑cost financing and minimal refinancing activity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that make it largely incorrect:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - LLM states carrying value was '$1.099 million' in FY 2022 and 2023, rising to '$1.115 million' in FY 2024\n   - Ground truth shows: $1,200 million (2022) → $1,099 million (2023) → $1,250 million (2024)\n   - The LLM has the decimal point in the wrong place by a factor of 1,000 (stating millions when the actual values are in hundreds of millions)\n   - FY 2024 value is completely wrong: LLM says $1.115M vs. actual $1,250M (off by ~$135M or 10.8%)\n   - The trend analysis is inverted: LLM shows flat/modest increase, but actual data shows decrease then significant increase\n\n2. MISSING KEY DATA:\n   - LLM fails to report the FY 2022 carrying value ($1,200M), which is critical for showing the 3-year evolution\n   - LLM omits the significant 2023 decrease ($1,200M to $1,099M), which is a material change\n   - LLM misses the substantial 2024 increase ($1,099M to $1,250M), which contradicts the 'flat balance' characterization\n\n3. EFFECTIVE INTEREST RATE ISSUES:\n   - LLM states rate 'stayed essentially unchanged at about 1.64% in FY 2023 and FY 2024'\n   - Ground truth indicates the rate increased from an implied rate in 2022 to 1.64% in 2024\n   - LLM fails to capture the evolution/increase in the effective interest rate over the period\n\n4. REASONING AND INTERPRETATION ERRORS:\n   - LLM's conclusion about 'flat balance and stable, low cost' is contradicted by the actual data showing material fluctuations\n   - The characterization of 'minimal refinancing activity' is unsupported by the significant carrying value changes\n   - LLM fails to recognize the strategic reacquisition/maintenance pattern described in ground truth\n\n5. MULTI-HOP SYNTHESIS:\n   - The answer fails to properly synthesize the 3-year trend across FY 2022-2024\n   - Does not connect the carrying value changes with the interest rate evolution\n   - Misses the strategic implications of the observed pattern\n\nThe LLM answer is fundamentally unreliable due to magnitude errors in the primary financial figures and incomplete/inaccurate trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 589,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "Google has kept Pixel device sales within the “devices” component of its Google Subscriptions, Platforms, and Devices revenue category from 2022 through 2024 (2022 10‑K pages 6‑8, 2023 10‑K page 33, 2024 10‑K page 59).  During the same period the company amplified its hardware‑innovation spend, as shown by a jump in purchases of property and equipment—from $32.3 bn in 2023 to $52.5 bn in 2024 (2024 10‑K page 57)—and by the continued launch of newer Pixel models and complementary devices such as Nest and Chromecast.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides accurate quantitative data and correctly identifies the revenue categorization of Pixel devices across the 2022-2024 period. The property and equipment figures ($32.3B in 2023 to $52.5B in 2024) appear reasonable and are cited with specific page references. The answer correctly notes that Pixel devices remained in the 'devices' segment of the Subscriptions, Platforms, and Devices revenue stream throughout the period.\n\nSTRENGTHS:\n1. Correctly identifies the consistent revenue categorization of Pixel devices from 2022-2024\n2. Provides specific quantitative evidence of increased hardware investment (property and equipment spending)\n3. Mentions complementary devices (Nest, Chromecast) showing ecosystem integration\n4. Includes proper citations to 10-K filings with page numbers\n5. Addresses both revenue categorization and investment in hardware innovation as requested\n\nWEAKNESSES:\n1. The answer is more focused on demonstrating increased investment spending rather than explaining the strategic evolution or transformation described in the ground truth\n2. Does not explicitly characterize the progression as moving from 'hardware investment focus to a mature, strategically embedded product line'\n3. Missing discussion of how Pixel devices were positioned relative to AI and cloud capabilities integration\n4. The answer is somewhat more transactional (listing facts) versus interpretive (explaining strategic evolution)\n5. Does not capture the nuance that 2023 marked a shift to 'explicit categorization' as a distinct segment, suggesting a strategic elevation\n\nQUANTITATIVE VERIFICATION:\nThe property and equipment figures ($32.3B in 2023 to $52.5B in 2024) cannot be independently verified from the provided context, but the magnitude and direction of change are plausible for a major tech company's capital expenditure trajectory during this period. The citation format and page references appear credible.\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across three years and connects revenue categorization with investment spending, demonstrating multi-hop reasoning. However, it could have better synthesized the strategic implications of these facts.\n\nSEMANTIC ALIGNMENT:\nWhile the LLM answer is factually accurate regarding the categorization and investment data, it captures only part of the ground truth's narrative about strategic evolution and transformation. The ground truth emphasizes a qualitative shift in strategic positioning, while the LLM answer focuses more on quantitative evidence of that shift.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 688,
        "total_tokens": 2049
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "BNY Mellon’s 10‑K Item 14 from 2022, 2023 and 2024 all contain the identical wording: “The information required by this Item is included in the Proxy in the following section: ‘Item 3 – Ratification of KPMG LLP,’ which is incorporated herein by reference. KPMG LLP’s PCAOB firm identification number is 185.” (page_14, 2022; page_14, 2023; page_14, 2024) The unchanged presentation across three consecutive filings signals that the audit engagement with KPMG has remained continuous and stable, with no changes in the principal accountant relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) All numeric values are correct - PCAOB firm identification number 185 is accurately cited; (2) All years are correctly identified (2022, 2023, 2024); (3) The exact quotation of the disclosure language is provided with proper page references, demonstrating thorough documentation; (4) The multi-hop synthesis is sound - the model correctly identified the consistency pattern across three years and drew the appropriate conclusion about audit relationship stability; (5) The reasoning is logically sound - unchanged presentation across consecutive filings correctly signals continuity and stability; (6) Entity identification is perfect - BNY Mellon and KPMG LLP are correctly named and their relationship properly characterized. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail (specific page numbers, exact quotations) compared to the ground truth, which is actually a strength rather than a weakness as it enhances verifiability; (2) Both answers convey identical semantic meaning regarding the consistency and stability of the audit relationship; (3) The conclusion that there were 'no changes in the principal accountant relationship' is correctly supported by the evidence of identical wording across all three years. The answer fully addresses the multi-part question about how disclosure evolved (answer: it didn't change) and what this reveals about audit relationship stability (answer: it indicates stability and continuity). No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 434,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "From 2022 to 2024 Lilly’s private‑alternative‑investment holdings fell from $8.87 billion (56.6 % of total defined‑benefit and retiree assets) to $8.61 billion (52.9 %) and then to $8.21 billion (50.6 %)【page 99】【page 100】【page 99】. The modest decline in both dollar amount and share of the portfolio suggests the company is slowly trimming its illiquid exposure—likely to improve liquidity or risk balance—while still maintaining a substantial long‑term commitment to private alternatives for higher returns.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM reports private alternative investments of $8.87B (2022), $8.61B (2023), and $8.21B (2024), but the ground truth shows $10,542.5M (2022), $10,335.2M (2023), and $10,051.0M (2024). Converting ground truth to billions: $10.5425B, $10.3352B, and $10.051B respectively. The LLM's numbers are approximately $1.6-1.8 billion LOWER than the actual figures - a massive discrepancy of roughly 17-18%. (2) DIRECTIONAL ANALYSIS ERROR: While the LLM correctly identifies a declining trend, the magnitude and context are wrong. The ground truth shows a decline from $10,542.5M to $10,051.0M (a $491.5M or 4.7% decrease), whereas the LLM shows a decline from $8.87B to $8.21B (a $660M or 7.4% decrease). The LLM's percentage allocations (56.6%, 52.9%, 50.6%) also appear inconsistent with the actual data. (3) MULTI-HOP SYNTHESIS: The LLM failed to correctly extract and synthesize the multi-year allocation data across the three fiscal years. The reasoning about 'slowly trimming illiquid exposure' may be directionally sound, but it's based on incorrect underlying numbers. (4) ENTITY AND METRIC ACCURACY: While the company (LLY/Lilly) is correctly identified, the specific financial metric values are fundamentally wrong. The ground truth explicitly states the allocation amounts in millions, and the LLM's conversion to billions with different values represents a critical data extraction failure. This is not a minor rounding or formatting difference - it's a substantial factual error that undermines the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 459,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "In 2022, Tampax was listed under the “Feminine Care” sub‑category of the Baby, Feminine & Family Care segment, grouped with adult incontinence and general feminine care (PG_10k_2022, p. 19). By 2023, P&G re‑classified that sub‑category as “Menstrual Care,” reflecting a sharper focus on menstrual products, while Tampax Bounty remained a key brand alongside Always and Always Discreet (PG_10k_2023, p. 18). The classification and brand emphasis stayed the same in 2024, with Tampax Bounty still highlighted as a major brand in the Menstrual Care sub‑category (PG_10k_2024, p. 19).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer completely omits the specific sales contribution percentages that are central to the ground truth: 25% in 2022, 24% in 2023, and 24% in 2024. These are factual data points that should have been included. (2) ENTITY ACCURACY - The LLM incorrectly references 'Tampax Bounty' as a brand name. The ground truth identifies 'Tampax' as the product, and mentions 'Always' and 'Always Discreet' as related brands, but 'Tampax Bounty' appears to be a conflation or error. This is a significant factual mistake. (3) INCOMPLETE SYNTHESIS - The ground truth explicitly states that in 2024, 'Baby Care' was removed from the segment entirely, signaling a strategic shift away from infant products. The LLM answer completely misses this important structural change and strategic implication. (4) CATEGORY NAMING - The LLM states that in 2023 'Menstrual Care' replaced 'Feminine Care,' but the ground truth indicates both terms were used (Tampax remained in Feminine Care but Menstrual Care became the explicit sub-category designation). The LLM's wording suggests a cleaner transition than actually occurred. (5) WHAT WAS CORRECT - The LLM correctly identified: the 2022 positioning under Feminine Care within Baby, Feminine & Family Care; the 2023 reclassification to Menstrual Care; the 2024 continuation of Menstrual Care classification; and the general strategic emphasis on feminine hygiene products. (6) MISSING CONTEXT - The LLM failed to capture the segment's sales contribution percentages and the removal of Baby Care in 2024, both of which are essential to understanding the strategic evolution. The answer reads as partially correct but with significant omissions and one apparent factual error regarding brand naming.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 485,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "Capital One continued to value its net derivative assets and liabilities with discounted‑cash‑flow models throughout 2022‑2024, but the key unobservable inputs shifted. In 2022 the discounting was based on swap rates (1‑2 % range, weighted 2 %); in 2023 the model switched to default rates (53‑163 % range, weighted 4 %); and in 2024 it returned to swap rates (4 % range, weighted 4 %). Correspondingly, the fair‑value balance rose from $19 million in 2022 to $58 million in 2023 and $69 million in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - 2022 fair value: LLM claims swap rates of 1-2% (weighted 2%), but ground truth states the specific valuation technique was NOT disclosed for 2022\n   - 2023 default rates: LLM correctly identifies 53-163% range, but ground truth shows swap rates were 3-5% in 2023, not default rates as the primary metric\n   - 2024 fair value: LLM states $69 million, but ground truth clearly states it remained at $58 million (same as 2023)\n   - Swap rate ranges: LLM claims 1-2% in 2022 and 4% in 2024, but ground truth indicates 3-5% for 2023-2024\n\n2. CONCEPTUAL MISUNDERSTANDING:\n   - LLM incorrectly characterizes the evolution as a \"switch\" between default rates and swap rates as primary inputs, when ground truth shows both were used as unobservable inputs in the DCF models\n   - LLM misrepresents 2022 as having disclosed swap rate methodology, when ground truth explicitly states the specific valuation technique was not disclosed in 2022\n   - The characterization of 2023 as \"switching to default rates\" is misleading; default rates and swap rates were both unobservable inputs in the DCF models\n\n3. MULTI-HOP REASONING FAILURE:\n   - Failed to correctly synthesize the progression showing increased transparency starting in 2023\n   - Incorrectly portrayed the evolution as alternating between metrics rather than showing consistent DCF methodology with increasingly disclosed unobservable inputs\n\n4. MISSING KEY INSIGHT:\n   - Ground truth emphasizes a shift toward \"more transparent and methodologically consistent valuation practices starting in 2023\" - the LLM completely misses this critical contextual finding\n\nThe only correct element is the 2023 fair value of $58 million and the 2022 fair value of $19 million. The 2024 fair value is definitively wrong ($69M vs. $58M), and the characterization of valuation methodology evolution is fundamentally incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 545,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio swung from a small gain in fiscal 2022 to progressively larger losses in the next two years – a net gain of $9 million in 2022, a net loss of $21 million in 2023, and a net loss of $67 million in 2024. This reversal shows the portfolio’s fair‑value performance deteriorated, making it a growing drag on the company’s other‑income (loss) metric and indicating higher market or credit risk over time.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific numerical values ($9M gain in 2022, $21M loss in 2023, $67M loss in 2024) that are NOT supported by the ground truth. The ground truth explicitly states that 'no specific performance metrics were provided for that year' (fiscal 2022), yet the LLM confidently asserts a $9 million gain. This is a fundamental factual error. The ground truth indicates that fiscal 2023 and 2024 showed 'higher losses' and 'significant' negative impacts, but does not provide the specific dollar amounts the LLM cites. The LLM appears to have fabricated precise numbers without evidence from the source material. While the LLM's directional analysis (losses increasing over time, negative impact on other income) aligns with the ground truth's conclusion about 'growing financial risk,' the specific quantitative claims are unsupported and therefore incorrect. The LLM also fails to acknowledge the key distinction in the ground truth: that 2022 had no disclosed performance metrics, making it fundamentally different from 2023-2024. The reasoning about deteriorating fair-value performance and increasing market/credit risk is qualitatively sound, but this cannot compensate for the fabricated numbers. The answer demonstrates a pattern of hallucination rather than faithful synthesis of available information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 374,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "In FY 2022 Starbucks’ 10‑K noted that its purchase commitments and inventory would provide an adequate green‑coffee supply through FY 2023 (page 12, 2022).  In FY 2023 the projection was extended to FY 2024 (page 12, 2023), and in FY 2024 it was further extended to FY 2025 (page 12, 2024).  This one‑year‑ahead roll‑forward shows a forward‑looking sourcing strategy that relies on fixed‑price and price‑to‑be‑fixed contracts, hedging, and farmer‑support centers to secure supply and mitigate price and supply risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a significant factual error in the fiscal 2023 projection. According to the ground truth, in FY 2023 Starbucks extended its supply adequacy projection to FY 2025, NOT FY 2024 as the LLM states. This is a fundamental error that undermines the entire multi-hop analysis. The correct progression should be: FY 2022→FY 2023 adequacy, FY 2023→FY 2025 adequacy, FY 2024→FY 2025 adequacy (or similar forward extension). The LLM's statement 'In FY 2023 the projection was extended to FY 2024' directly contradicts the ground truth which explicitly states the FY 2023 projection extended to FY 2025. This is not a minor wording difference but a factual misstatement of a key data point. QUANTITATIVE ACCURACY: The year-by-year progression is incorrectly stated, making the quantitative assessment of the multi-year trend inaccurate. The LLM correctly identifies the general pattern of forward-looking projections but gets the specific years wrong. QUALITATIVE ACCURACY: While the LLM provides reasonable context about sourcing strategy (fixed-price contracts, hedging, farmer-support centers), this contextual information appears to be added interpretation rather than directly derived from the ground truth answer. The ground truth focuses on 'strengthening sourcing strategy,' 'longer-term purchase commitments,' and 'supply chain resilience,' while the LLM adds specific mechanisms not mentioned in the original answer. MULTI-HOP REASONING: The synthesis across three fiscal years is attempted but fundamentally flawed due to the FY 2023 error. The characterization as a 'one-year-ahead roll-forward' is reasonable but doesn't capture the actual extension pattern described in the ground truth. MISSING ELEMENTS: The LLM does not adequately emphasize the key insight from the ground truth about 'enhancing supply chain resilience and reducing delivery risk with coffee producers' as the strategic outcome of this progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 534,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "NVIDIA’s carrying amount of the 2.00% Notes Due 2031 rose modestly from **$1,044 million** as of January 29 2023 (FY 2023) to **$1,057 million** as of January 28 2024 (FY 2024)【page_67】. The 2022 amount is not disclosed in the provided pages, but the small uptick indicates a steady, low‑growth debt strategy—using long‑term notes to fund growth while keeping leverage largely unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that directly contradict the ground truth. (1) NUMBERS INCORRECT: Ground truth shows FY2022: $1,200M, FY2023: $1,044M, FY2024: $1,250M. The LLM claims FY2023 was $1,044M (correct) but FY2024 was only $1,057M (INCORRECT - should be $1,250M). This is a $193M discrepancy for the final year. (2) INCOMPLETE DATA: The LLM states '2022 amount is not disclosed' when ground truth clearly shows $1,200M for FY2022. The LLM failed to synthesize the complete three-year trend. (3) CALCULATION/TREND ERROR: The LLM describes a 'small uptick' of $13M ($1,044M to $1,057M), but the actual trend shows a significant increase of $206M from FY2023 to FY2024 ($1,044M to $1,250M). This fundamentally mischaracterizes the debt strategy. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution from 2022-2024, requiring synthesis of three data points. The LLM only addresses two years and gets the FY2024 number wrong, failing the core multi-hop requirement. (5) STRATEGIC INTERPRETATION FLAWED: The LLM's conclusion about 'steady, low-growth debt strategy' is contradicted by the actual $206M increase in FY2024, which represents a 19.7% jump from FY2023. The ground truth interpretation of 'dynamic approach' with 'consistent presence' is more accurate than the LLM's 'steady, low-growth' characterization. The LLM answer demonstrates incomplete data gathering and significant quantitative errors that undermine the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 416,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "From 2022 to 2024 3M shifted Fall Protection Solutions from a broad “Respiratory, hearing, eye and fall protection solutions” category within the Safety and Industrial segment to a more focused position in the newly created Industrial Specialties division (which houses the Personal Safety division).  This re‑categorization moves fall‑protection gear into a dedicated personal‑safety product line, giving it clearer emphasis relative to other industrial‑safety offerings such as respiratory and hearing protection.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Fall Protection Solutions were moved to a 'newly created Industrial Specialties division' with a 'Personal Safety division' structure. The ground truth indicates Fall Protection Solutions remained within the Safety and Industrial segment throughout 2022-2024, with no mention of a new divisional structure or reorganization into Industrial Specialties. (2) CONTRADICTORY FRAMING - The ground truth describes a 'subtle shift' in positioning and grouping within the same segment, while the LLM describes a major re-categorization into a different division entirely. These are fundamentally different narratives. (3) UNSUPPORTED CLAIMS - The LLM's assertion about 'newly created Industrial Specialties division' and the specific structural reorganization is not supported by the ground truth, which shows consistent positioning within Safety and Industrial segment. (4) PARTIAL ACCURACY - The LLM correctly identifies that the positioning evolved and that there was some shift in emphasis/grouping, but the nature and scope of that shift is dramatically overstated and incorrectly characterized. (5) MULTI-HOP REASONING FAILURE - The model failed to correctly synthesize the actual evolution described in the filings, instead inventing a divisional reorganization that did not occur. The ground truth's more nuanced description of revised grouping and alignment with broader industrial safety systems is replaced with a false narrative of divisional restructuring.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 436,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "Bamlanivimab generated **$2.009 billion in 2022** (the only year it was sold under an EUA), but sales **fell to $0 in 2023 and remained $0 in 2024**【page_68】.  This sharp drop shows that Lilly has largely exited the COVID‑19 antibody market, reducing its reliance on that portfolio over time.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Quantitative verification: The 2022 revenue figure of $2.009 billion matches the ground truth of $2.01 billion (minor rounding difference is acceptable and expected). The 2023 and 2024 figures of $0 are correct. The revenue trajectory (2022: $2.01B → 2023: $0 → 2024: $0) is accurately captured. Multi-hop reasoning: The answer correctly synthesizes the revenue evolution across three years and draws the appropriate conclusion about Eli Lilly's declining reliance on the COVID-19 antibody portfolio. Entity accuracy: Eli Lilly, bamlanivimab, and the COVID-19 antibody portfolio are all correctly identified. The mention of EUA (Emergency Use Authorization) adds helpful context about why sales occurred only in 2022. Semantic equivalence: The LLM's characterization of the trend as a 'sharp drop' and 'largely exited the COVID-19 antibody market' conveys the same meaning as the ground truth's 'rapid decline' and 'waned demand.' The answer directly addresses both parts of the question: (1) how revenue evolved and (2) what this indicates about reliance. Minor note: The citation reference [page_68] is included but cannot be verified in this evaluation context; however, it demonstrates source attribution. Overall, this is a comprehensive, accurate answer with sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 373,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "Starbucks’ 2022 10‑K (page 12) warned that coffee price volatility is affected by hedge funds and commodity index funds and that its fixed‑price and hedging commitments cover supply through fiscal 2023. The 2023 10‑K (page 12) repeats that exposure and extends the coverage to fiscal 2024, while the 2024 10‑K (page 12) again cites the same exposure but now extends purchase commitments—using forward contracts, futures and collars—to secure green coffee through fiscal 2025. This progressive extension of hedging and fixed‑price commitments shows a deliberate risk‑management strategy aimed at locking in prices and ensuring a stable supply against index‑fund‑driven volatility for an increasingly longer horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the three-year progression (fiscal 2022, 2023, 2024) with accurate supply visibility extensions: fiscal 2023 coverage in 2022 → fiscal 2024 in 2023 → fiscal 2025 in 2024. (2) Accurately cites the consistent acknowledgment of commodity index fund exposure across all three years. (3) Correctly identifies the specific hedging instruments used: forward contracts, futures contracts, and collars. (4) Properly synthesizes the multi-hop reasoning showing how Starbucks' risk management strategy evolved through progressive extension of supply commitments. (5) Accurately conveys the core insight that this represents deliberate risk management to lock in prices against index-fund-driven volatility. (6) Page references (page 12 for all three years) are consistent with typical 10-K disclosure locations. MINOR CONSIDERATIONS: (1) The LLM answer mentions 'hedge funds' in addition to 'commodity index funds' when citing the 2022 10-K, while the ground truth focuses specifically on 'commodity index funds.' However, this is a minor addition that doesn't contradict the ground truth and may reflect actual filing language. (2) The LLM answer uses slightly different phrasing ('locking in prices' vs 'securing supply visibility') but conveys semantically equivalent meaning. (3) Both answers correctly identify the progression of supply chain resilience improvements. QUANTITATIVE VERIFICATION: All dates and fiscal year references are accurate. The progression of supply commitments (2023 → 2024 → 2025) matches ground truth exactly. No calculations are required for this question, and no numerical discrepancies exist. MULTI-HOP REASONING: The LLM successfully synthesizes information across three separate 10-K filings and correctly identifies the causal relationship between commodity index fund exposure and Starbucks' evolving hedging strategy. The answer properly connects the dots between financial market activity and operational risk management decisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 561,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "In 2022, Google’s 10‑K (page 31) identified Google Ad Manager as a core component of the Google Network, monetizing impressions on partner sites and measuring revenue by cost‑per‑impression.  The 2023 10‑K (page 58) reports that extending the useful life of servers and network equipment from 4–5 to 6 years cut depreciation by $3.9 B and raised 2023 net income by $3.0 B, thereby improving the margin on ad‑inventory and bolstering long‑term profitability.  By 2024, the 10‑K (pages 56‑60) still lists Ad Manager within the Google Network with no change to the model, and the one‑time depreciation benefit supports the continued reliance on impression‑based monetization as the business expands into new formats and devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis across the 2022-2024 period. QUANTITATIVE VERIFICATION: All key numbers are correct - the $3.9 billion depreciation reduction and $3.0 billion net income increase for 2023 match the ground truth exactly. The server useful life extension from 4 to 6 years and network equipment from 5 to 6 years are accurately stated. ENTITY ACCURACY: Google Ad Manager is correctly identified as the core monetization mechanism; Google Network properties are properly referenced; all fiscal years (2022, 2023, 2024) are correctly applied. MULTI-HOP REASONING: The answer successfully synthesizes information across three years, connecting: (1) 2022 baseline of impression-based monetization via Ad Manager, (2) 2023 infrastructure depreciation adjustment and its financial impact, and (3) 2024 continuation of the Ad Manager model. The causal link between depreciation schedule changes and long-term profitability optimization is clearly established. MINOR OBSERVATIONS: The LLM answer includes specific page references (31, 58, 56-60) which adds credibility but cannot be independently verified from the ground truth. The phrase 'one-time depreciation benefit' is semantically accurate and appropriately contextualizes the 2023 adjustment. The conclusion about 'expansion into new formats and devices' is a reasonable inference but goes slightly beyond what the ground truth explicitly states, though it doesn't contradict it. COMPLETENESS: The answer addresses all components of the multi-part question: evolution from 2022-2024, the 2023 depreciation adjustment, and implications for long-term profitability. The semantic equivalence is strong - both answers convey the same core narrative of infrastructure optimization supporting advertising revenue growth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 497,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "BK continued to issue a new Performance Share Unit Agreement each year from 2022 through 2024 under its 2019 Long‑Term Incentive Plan (2022 Form of Performance Share Unit Agreement – Exhibit 10.25 in the 2022 10‑K; 2023 Form of Performance Share Unit Agreement – Exhibit 10.20 in the 2023 10‑K; 2024 Form of Performance Share Unit Agreement – Exhibit 10.25 in the 2024 10‑K). This steady, year‑over‑year issuance underscores the company’s sustained focus on tying executive pay to long‑term performance and aligning incentives with shareholder value.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. Key issues: (1) EXHIBIT NUMBERS INCORRECT: The LLM cites Exhibit 10.25 for both 2022 and 2024, and Exhibit 10.20 for 2023, but the ground truth specifies Exhibit 10.45 (2021 agreement in 2022), Exhibit 10.14 (2019 plan re-filed in 2023), and Exhibit 10.18 (2022 agreement in 2024). These are material factual errors in document references. (2) AGREEMENT FORMS MISIDENTIFIED: The LLM claims BK issued a '2023 Form of Performance Share Unit Agreement' in 2023, but the ground truth indicates BK re-filed the 2019 Long-Term Incentive Plan itself in 2023, not a new agreement form. This is a fundamental mischaracterization of what occurred. (3) EVOLUTION PATTERN MISREPRESENTED: The LLM describes a 'steady, year-over-year issuance' of new agreements, but the ground truth shows a more nuanced pattern: 2021 agreements referenced in 2022, foundational plan re-filed in 2023, then 2022 agreements in 2024. This is not a simple annual issuance pattern. (4) MISSING STRATEGIC CONTEXT: The LLM fails to capture the ground truth's key insight about 'maintaining the core of the 2019 plan while iteratively refining incentive mechanisms' and the significance of the 2023 re-filing as a recommitment to foundational structure. (5) REASONING QUALITY: While the LLM's conclusion about 'tying executive pay to long-term performance' is reasonable, it's based on incorrect factual premises and misses the actual strategic evolution described in the ground truth. The answer demonstrates a fundamental failure to accurately synthesize the multi-hop information about how the company's approach evolved across these three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 466,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "In 2023, 3M’s Safety and Industrial segment described its electrical portfolio as “Electrical products and materials for construction and maintenance, power distribution and electrical original equipment manufacturers (OEMs)” (page 107). The same wording appears unchanged in the 2024 filing (page 110), and the 2022 10‑K used an identical, though slightly less detailed, phrasing. The lack of change in specificity or product categorization over these three years signals that 3M has maintained a steady focus on supplying electrical OEMs in construction, maintenance and power‑distribution markets rather than shifting its product mix.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CORE FACTUAL ERROR: The LLM claims the language was 'identical' and 'unchanged' across 2022-2024, stating there was 'lack of change in specificity.' This directly contradicts the ground truth, which documents a clear evolution: 2022 used 'construction and maintenance, power distribution and electrical OEMs'; 2023 refined to 'electrical original equipment manufacturers (OEMs)' with increased precision; 2024 evolved to 'power distribution and electrical original equipment manufacturers (OEMs).' The ground truth explicitly states this represents 'a growing strategic emphasis' with 'increasing specificity,' while the LLM concludes the opposite—that 3M 'maintained a steady focus' with no shift. (2) MULTI-HOP REASONING FAILURE: The question asks about evolution across three years and what it suggests about strategic focus. The LLM failed to synthesize the year-over-year changes documented in the filings. Instead of tracking the progression from less specific to more specific language, the LLM incorrectly asserts consistency. (3) INTERPRETATION ERROR: The LLM mischaracterizes the significance of the changes. The ground truth identifies meaningful refinements in language precision (adding 'original equipment manufacturers' in full form, adding 'power distribution' back in 2024), while the LLM dismisses these as 'identical' or 'slightly less detailed.' (4) CONCLUSION INVERSION: The LLM's conclusion that there is 'no shift' in product mix directly opposes the ground truth's finding of 'growing strategic emphasis' and 'increasing specificity.' This is a fundamental misreading of the evidence. The LLM does correctly identify the company (3M/MMM), the segment (Safety and Industrial), and the general product categories, but the core analytical finding is inverted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 508,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "Capital One’s fixed unsecured senior debt stayed at **$27,168 million** with a weighted‑average rate of **4.45 %** in both 2022 and 2023, but in 2024 the carrying value fell to **$26,930 million** while the weighted‑average rate rose to **4.84 %** as the maturity range shifted from 2024‑2034 to 2025‑2035【page 186 (2022)】【page 186 (2023)】【page 188 (2024)】. This modest decline in principal coupled with a slight rate increase reflects a rollover strategy that keeps debt levels stable while gradually moving to newer issues at marginally higher rates, indicating a cautious, forward‑looking long‑term financing approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that directly contradict the ground truth across all three years. (1) 2022 DATA: LLM states $27,168M at 4.45%, but ground truth shows $19,975M at 2.91% - this is a $7.2 billion overstatement and 1.54% rate error. (2) 2023 DATA: LLM correctly states $27,168M at 4.45%, matching ground truth. (3) 2024 DATA: LLM correctly states $26,930M at 4.84%, matching ground truth. The LLM appears to have confused 2022 and 2023 values, treating 2022 as if it had 2023's figures. This is a critical multi-hop synthesis failure - the model failed to correctly extract and sequence the three-year progression. (4) MULTI-HOP REASONING: The LLM's interpretation of the data as showing 'stable debt levels' is incorrect given the actual 35% increase from 2022 to 2023 ($19,975M to $27,168M). The ground truth correctly identifies this as a 'strategic shift toward securing more long-term fixed-rate financing,' which the LLM misses entirely due to the data error. (5) QUANTITATIVE ACCURACY: Two of three years contain major errors (2022 completely wrong, 2023-2024 correct). The 2022 error is not a minor formatting issue but a fundamental misstatement of $7.2 billion. (6) REASONING QUALITY: Even where numbers are correct (2023-2024), the LLM's characterization of the strategy as 'cautious' and 'stable' contradicts the actual pattern of aggressive debt accumulation followed by modest reduction. The ground truth's interpretation of 'locking in capital at increasingly higher costs' is more accurate to the actual financial strategy. The answer demonstrates partial knowledge of 2023-2024 but fails catastrophically on 2022 and the overall strategic narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 470,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "NVIDIA has consistently classified its 3.50 % Notes Due 2040 as Level 2 fair‑value liabilities and carried them at original issuance value net of discount and issuance costs (FY 2022: $870 m, FY 2023: $851 m, FY 2024: $1,000 m)【page_78】【page_67】【page_72】. The slight dip in 2023 followed by a $150 m increase in 2024 reflects the issuance of additional 2040 notes while the effective interest rate remained steady at 3.54 % and the expected remaining term stayed at 15.2 years【page_72】. This progression shows NVIDIA’s long‑term debt strategy of expanding its long‑dated, fixed‑rate debt to secure favorable rates and fund growth while maintaining a balanced maturity profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM reports FY 2022 value as $870M, but ground truth states $1,066M (196M discrepancy). FY 2023 matches at $851M. FY 2024 matches at $1,000M. The LLM claims a '$150M increase in 2024' but this is mathematically incorrect: $851M to $1,000M = $149M increase, not $150M (minor rounding acceptable, but combined with other errors is problematic). (2) CONCEPTUAL MISALIGNMENT - Ground truth emphasizes a shift from 'fair value' reporting ($1,066M in FY2022, $851M in FY2023) to 'carrying amount' reporting ($1,000M in FY2024), suggesting an accounting methodology change. The LLM instead claims consistent 'Level 2 fair-value liabilities' treatment across all three years, which contradicts the ground truth's core insight about the evolution in accounting treatment. (3) MISSING KEY INSIGHT - Ground truth highlights that the company 'no longer reported a fair value but instead listed a carrying amount' in FY2024, indicating a significant shift in debt accounting approach. The LLM misses this critical distinction entirely. (4) ADDITIONAL CLAIMS NOT VERIFIED - The LLM introduces specific details (effective interest rate 3.54%, expected remaining term 15.2 years, 'issuance of additional 2040 notes') that are not present in the ground truth and cannot be verified. While these may be accurate, they represent unsupported additions. (5) REASONING QUALITY - The LLM's explanation of 'expanding its long-dated, fixed-rate debt' is reasonable but is built on incorrect foundational numbers and misses the actual accounting evolution that the ground truth emphasizes. The multi-hop synthesis fails because it doesn't correctly identify the shift from fair value to carrying amount treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 476,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "Amazon’s 2017 Notes outstanding balance fell from **$16.0 billion** at December 31 2022 (page 56, 2022 10‑K) to **$15.0 billion** at December 31 2023 (page 57, 2023 10‑K) and further to **$13.0 billion** at December 31 2024 (page 57, 2024 10‑K). This steady decline shows a deliberate repayment plan, indicating Amazon is actively reducing its long‑term debt exposure and interest burden for this issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $16.0 billion (2022), $15.0 billion (2023), and $13.0 billion (2024). The year-over-year reductions are accurate ($1.0 billion decline 2022-2023, $2.0 billion decline 2023-2024). The dates (December 31 for each year) are correct. (2) COMPLETENESS: The answer fully addresses both parts of the multi-part question - it traces the evolution of the outstanding balance across all three years and provides interpretation of the debt management strategy. (3) ENTITY ACCURACY: Amazon is correctly identified, the 2017 Notes are properly referenced, and all fiscal years are accurate. (4) REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly extracted data from three separate 10-K filings (2022, 2023, 2024) and synthesized them into a coherent narrative showing the reduction trajectory. The interpretation that this represents 'a deliberate repayment plan' and 'active reduction of long-term debt exposure' is logically sound and semantically equivalent to the ground truth's 'deliberate debt management strategy to gradually retire this issuance.' (5) MINOR ENHANCEMENT: The LLM answer adds slightly more analytical depth by mentioning 'interest burden reduction,' which is a reasonable inference from the debt reduction pattern and adds value without contradicting the ground truth. The inclusion of specific page references (pages 56-57) demonstrates source documentation, though this wasn't required. Overall, the answer is factually accurate, complete, well-reasoned, and appropriately contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 454,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "Apple’s 10‑Ks for 2022, 2023 and 2024 all list “Floating Rate Notes due 2019” in the description of securities (Exhibit 4.4)【page_54】, indicating that the company still holds short‑term, variable‑rate debt.  Because floating‑rate notes reset with market rates, this ongoing exposure means Apple’s interest expense will rise as rates climb, making the company more sensitive to a tightening rate environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Apple's 2022, 2023, and 2024 filings reference Floating Rate Notes due 2019 and accurately explains the interest rate sensitivity mechanism (floating rates reset with market rates, causing interest expense to rise in a tightening environment). However, there are significant issues with completeness and reasoning: (1) The LLM answer lacks critical context from the ground truth - it does not explain that these notes were due in 2019 yet still appeared in 2022-2024 filings, which is the key insight suggesting rollover obligations or continuing disclosure obligations. (2) The ground truth emphasizes that the persistence of these notes across three consecutive years despite their 2019 maturity date indicates 'ongoing exposure' through 'outstanding obligations or ongoing disclosure obligations,' suggesting Apple may have had refinancing or rollover arrangements. The LLM answer misses this nuance by simply stating Apple 'still holds' the debt without addressing the temporal anomaly. (3) The ground truth mentions 'liquidity planning and capital structure flexibility' implications, which the LLM answer omits entirely. (4) The LLM answer's characterization of these as 'short-term, variable-rate debt' is somewhat misleading given they were due in 2019 and the filings are from 2022-2024 - the ground truth better captures the complexity of why they appear in later filings. (5) The interest rate sensitivity explanation is correct and well-articulated in both answers. The LLM answer provides accurate but incomplete analysis, missing the deeper multi-hop reasoning about why these notes persist in disclosures years after their maturity date.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 462,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "Google’s 2022 10‑K framed the Pixel line as part of a long‑term hardware strategy, noting the launch of Pixel 5a 5G and Pixel 6 and a commitment to invest in devices for the future【page_7】. By 2023 and 2024, Pixel sales are explicitly reported as part of the devices revenue segment【page_33】【page_59】, indicating the product line has moved from early‑stage launches to a mature, though still modest, revenue contributor. This shift shows Google treats hardware—particularly Pixel—as a strategic, AI‑integrated complement to its core advertising and cloud businesses, maintaining a cautious yet persistent presence in the hardware market rather than positioning it as a primary growth engine.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across 2022-2024 filings. STRENGTHS: (1) Correctly identifies the 2022 positioning as long-term investment with specific device mentions (Pixel 5a 5G, Pixel 6); (2) Accurately notes the transition to explicit revenue reporting in 2023-2024 under 'devices' segment; (3) Properly synthesizes the progression from investment phase to revenue-generating category; (4) Correctly interprets this as indicating increased product maturity and strategic confidence. MINOR WEAKNESSES: (1) The phrase 'modest revenue contributor' is interpretive and not explicitly stated in ground truth, though reasonable inference; (2) The characterization of hardware as 'cautious yet persistent' and 'not a primary growth engine' adds analytical framing beyond the ground truth's more neutral observation about 'stable and strategic' positioning; (3) Ground truth emphasizes the transition itself as the key indicator, while LLM adds interpretive layers about Google's strategic intent that, while reasonable, go slightly beyond what the filings explicitly state. QUANTITATIVE ACCURACY: No specific numbers provided in either answer (appropriate given the question's qualitative nature), and dates/years are all correct. MULTI-HOP REASONING: Excellent synthesis across three fiscal years showing clear progression. The logic connecting investment language → revenue categorization → product maturity is sound and matches ground truth reasoning. SEMANTIC EQUIVALENCE: The core message aligns well - Pixel evolved from investment focus to revenue contributor, signaling strategic importance. The LLM's additional context about AI integration and positioning relative to advertising/cloud businesses adds relevant context without contradicting ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 497,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "Schwab has steadily increased the amount of client securities it uses as collateral for margin lending and securities‑lending activities.  In 2021 the fair value of client securities available to be pledged rose to $120.3 billion from $84.0 billion in 2020, and the amount pledged for margin‑lending, short‑sales, and securities‑lending grew to $31.4 billion from $23.0 billion.  The 2024 disclosures continue this trend, showing that Schwab is further expanding its use of client collateral to support liquidity and financing while remaining compliant with regulatory requirements【page_108】.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question. Critical issues: (1) WRONG TIME PERIOD: The LLM cites 2020-2021 data ($84.0B, $120.3B, $23.0B, $31.4B) when the question explicitly asks about 2022-2024 evolution. The ground truth specifies no dollar values were provided in 2022, expanded disclosure in 2023, and specific activities in 2024 - none of which are mentioned in the LLM answer. (2) MISSING KEY INFORMATION: The LLM completely omits the 2022-2024 progression that is central to the question. It does not address: the lack of specific dollar values in 2022, the formalized collateral management process in 2023, or the specific 2024 activities (pledging for OCC option contracts, cash collateral in securities lending). (3) INCOMPLETE SYNTHESIS: The question asks about evolution 'from 2022 through 2024' - the LLM provides only 2020-2021 data and a vague reference to '2024 disclosures' without substantive detail. (4) MISALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes a qualitative evolution in disclosure and strategic approach across three specific years; the LLM provides quantitative data from the wrong years entirely. (5) CALCULATION/VERIFICATION: The numbers cited ($84.0B, $120.3B, $23.0B, $31.4B) cannot be verified against the ground truth as they refer to a different time period. The answer demonstrates a fundamental failure to address the specific 2022-2024 timeframe requested and provides data from an entirely different period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 416,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "GE’s 10‑K disclosures show that the company’s approach to long‑term‑care premium‑rate increases has been consistent from 2022 through 2024: in each filing it states that it “often collaborates” with the primary insurers that issued the underlying policies to file proposed rate‑increase actions under reinsurance contractual terms (see 2022 page 51‑53, 2023 page 20‑22, 2024 page 20‑22).  However, the sensitivity tables for the potential impact of a 25 % adverse change in the success rate of those filings have fluctuated—$400 million in 2022, $200 million in 2023, and $300 million in 2024—reflecting adjustments in the expected frequency or magnitude of rate‑increase filings and the company’s conservative reserve assumptions.  This progression indicates that GE’s run‑off risk‑management strategy remains focused on monitoring and adjusting assumptions about premium‑rate actions while maintaining a collaborative relationship with primary insurers to manage reinsurance exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a partially correct response with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies that GE maintained consistent collaboration with primary insurers across 2022-2024; (2) Accurately notes the collaborative framework under reinsurance contractual terms; (3) Appropriately emphasizes the focus on monitoring and adjusting assumptions about premium-rate actions; (4) Correctly identifies the multi-year progression as a key analytical element. WEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUE - The sensitivity table figures ($400M in 2022, $200M in 2023, $300M in 2024) are presented as fact but cannot be verified against the ground truth, which does not mention these specific dollar amounts. This is a critical error as these numbers are presented with high specificity and page references that suggest they are from actual filings, but the ground truth does not corroborate them. (2) The LLM answer introduces specific page references (2022 page 51-53, 2023 page 20-22, 2024 page 20-22) that are not mentioned in the ground truth and cannot be verified. (3) The answer focuses heavily on sensitivity analysis and reserve assumptions, which is a valid analytical angle but diverges from the ground truth's emphasis on the evolution from indirect role (2022) to formalized collaboration (2023) to reinforced framework with experience-based expectations (2024). (4) The ground truth emphasizes a strategic SHIFT toward 'proactive risk management and tighter integration,' while the LLM answer characterizes the approach as 'consistent' - this represents a meaningful difference in interpretation of the evolution. (5) The LLM answer does not capture the ground truth's nuance about GE's role evolving from 'indirect' to 'active participation' to 'reinforced collaborative framework with recent experience integration.' MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and identifies the relationship between collaboration practices and risk management strategy, but the specific quantitative claims about sensitivity tables are unverified and potentially inaccurate. The reasoning about reserve assumptions is sound but represents a different analytical lens than the ground truth's focus on the evolution of collaboration structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 617,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "CVS’s residential mortgage‑backed‑security (RMBS) exposure stayed essentially flat over the three‑year period: the fair‑value of RMBS that support its experience‑rated products was $614 million in both 2022 and 2023, while the amortized cost rose modestly from $845 million to $862 million (page 147 & 150). In 2024 the company’s separate‑accounts RMBS fair value grew from $51 million to $71 million (page 160). Across 2022‑24 the company maintained a low unrealized‑loss position ($60 million in 2022‑23) and invested only in high‑quality, agency‑guaranteed RMBS (AA/AAA), underscoring a conservative, low‑risk stance in structured credit.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth across all key metrics. (1) CRITICAL QUANTITATIVE ERRORS: The LLM states RMBS fair value was '$614 million in both 2022 and 2023' when the ground truth clearly shows $721 million in 2022 and $614 million in 2023 - a significant $107 million discrepancy for 2022. The LLM also claims 2024 RMBS grew 'from $51 million to $71 million' when the ground truth shows it simply increased TO $71 million in 2024 (no prior $51M baseline stated). The LLM's statement that amortized cost 'rose modestly from $845 million to $862 million' cannot be verified against the ground truth which focuses on fair values. (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the 3-year trend. The ground truth shows a clear pattern: $721M (2022) → $614M (2023) → $71M (2024), representing a substantial reduction in 2023 followed by further reduction in 2024. The LLM mischaracterizes this as 'essentially flat' which is factually incorrect - there was a $107M decline from 2022-2023 and a $543M decline from 2023-2024. (3) INTERPRETATION ERROR: The LLM's conclusion that the company 'maintained a low unrealized-loss position' and 'conservative stance' contradicts the ground truth's characterization of 'cautious reduction in RMBS holdings in 2023 amid rising unrealized losses.' The LLM's framing suggests stability when the ground truth indicates active risk reduction. (4) MISSING CONTEXT: The LLM provides page references and discusses separate accounts and amortized costs, but these details appear to obscure rather than clarify the core trend, and the fundamental 2022 figure is wrong. The answer demonstrates poor multi-hop reasoning by failing to correctly track values across the three-year period and misinterpreting the strategic implications of the actual trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 505,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "COF’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt grew from $47.8 billion in 2022 to $49.3 billion in 2023 and declined to $44.9 billion in 2024【page 186】【page 188】. Consequently, the combined short‑term borrowings and long‑term debt increased slightly from $48.7 billion in 2022 to $49.9 billion in 2023, before falling to $45.6 billion in 2024, indicating a deliberate deleveraging effort and a shift toward lower‑cost, short‑term funding to strengthen liquidity and reduce interest expense.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental quantitative errors that severely undermine its credibility. (1) MAJOR NUMBER DISCREPANCIES: The LLM reports total combined debt of $48.7B (2022), $49.9B (2023), and $45.6B (2024), but the ground truth states $43.086B, $49.856B, and $45.551B respectively. The 2022 figure is off by approximately $5.6 billion (13% error), which is a massive discrepancy. The LLM's breakdown of short-term borrowings ($883M, $538M, $562M) and long-term debt ($47.8B, $49.3B, $44.9B) do not reconcile to the stated totals and contradict the ground truth figures. (2) MISSING CRITICAL INFORMATION: The LLM completely omits the weighted-average interest rate progression (2.76% → 4.48% → 4.84%), which is explicitly mentioned in the ground truth as a key indicator of rising borrowing costs. This is a significant omission that fails to fully address the question about debt management strategy. (3) MISSING FLOATING DEBT ANALYSIS: The ground truth highlights the strategic reduction of floating unsecured senior debt from $1,709M (2022) to $349M (2023) to $0 (2024), which is a crucial insight into the company's shift away from variable-rate instruments. The LLM completely fails to mention this important strategic element. (4) FLAWED REASONING: The LLM's conclusion about 'shift toward lower-cost, short-term funding' is contradicted by the rising interest rates documented in the ground truth and the elimination of floating debt. The reasoning does not align with the actual financial data. (5) CALCULATION VERIFICATION: The LLM's combined totals ($48.7B + $49.9B + $45.6B) do not match the stated component figures, suggesting internal inconsistency. The ground truth totals ($43.086B, $49.856B, $45.551B) are internally consistent with the multi-hop synthesis required. The answer demonstrates partial understanding of the general trend (increase then decrease) but fails on quantitative accuracy, completeness of analysis, and strategic insight.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 538,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "NVIDIA’s long‑term liability for the 3.50% Notes Due 2050 was **$1.637 billion in FY 2022, unchanged at $1.637 billion in FY 2023, and fell to $1.604 billion in FY 2024**【page_78】【page_67】, indicating a modest reduction in long‑term debt and a deliberate effort to keep leverage low while potentially refinancing at lower rates.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) FY 2022 VALUE ERROR: LLM states $1.637 billion for FY 2022, but ground truth shows $2,147 million ($2.147 billion). This is a massive discrepancy of $510 million or 23.8% understatement. (2) FY 2023 VALUE ERROR: LLM correctly states $1.637 billion, matching ground truth. (3) FY 2024 VALUE: LLM correctly states $1.604 billion, matching ground truth. (4) TREND MISCHARACTERIZATION: The LLM claims the value was 'unchanged at $1.637 billion in FY 2023' when comparing FY 2022 to FY 2023, but this is false. The actual trend shows a SIGNIFICANT DECLINE from $2,147M (FY 2022) to $1,637M (FY 2023), a reduction of $510 million. The LLM's characterization of this as 'modest reduction' in FY 2024 alone misses the major reduction that occurred between FY 2022-2023. (5) REASONING QUALITY: While the LLM's interpretation about 'deliberate effort to keep leverage low' is reasonable, it is based on incorrect starting data, making the analysis fundamentally flawed. The actual trend shows a much more aggressive debt reduction strategy than the LLM suggests. (6) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year progression, presenting an inaccurate picture of the company's capital structure evolution. The ground truth shows a 25.3% reduction over three years ($2,147M to $1,604M), with the bulk occurring in the first year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 409,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "Apple issued the 0.45% Notes due 2016 in 2013, which matured in 2016. By the 2022, 2023, and 2024 10‑Ks the notes were no longer outstanding but remained listed in the Description of Securities exhibit 4.1, showing that Apple continues to disclose all long‑term debt issuances—even after they have matured—to maintain a complete historical record of its debt obligations. [page_54] [page_53] [page_54]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Strengths: (1) All numeric values and dates are correct - the 0.45% interest rate, 2016 maturity date, 2013 issuance date, and the three fiscal years (2022, 2023, 2024) are all accurate. (2) The multi-hop reasoning is sound - the answer correctly synthesizes that the notes matured in 2016 but continued to appear in 10-K filings through 2024, demonstrating the pattern across all three years requested. (3) Entity identification is precise - correctly identifies Apple, the specific debt instrument (0.45% Notes due 2016), and the relevant exhibit (Description of Securities exhibit 4.1). (4) The interpretation of the pattern is semantically equivalent to the ground truth: both convey that Apple maintains legacy debt disclosures post-maturity for transparency and historical record purposes. The LLM answer is slightly more specific by mentioning the exhibit location (4.1) and explicitly stating the notes were 'no longer outstanding,' which adds helpful detail. Minor consideration: The ground truth uses phrases like 'continued to reference' and 'legacy debt disclosures,' while the LLM uses 'remains listed' and 'complete historical record' - these are semantically equivalent and both accurately capture Apple's disclosure strategy. The citation references [page_54], [page_53], [page_54] are appropriately included. No calculation errors, no missing information, and the answer fully addresses the question about how the disclosure evolved and what it indicates about Apple's strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 431,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "Capital One’s net derivative assets (liabilities) fair‑value grew from **$5 million** at 12‑31‑2022 to **$58 million** at 12‑31‑2023 and **$69 million** at 12‑31‑2024 (Table 16.3, 2023; Table 17.2, 2024).  Across all three years the valuation relied on discounted‑cash‑flow models with **swap rates** as the sole significant unobservable input, ranging 3‑5 % in 2022–2023 and 4 % in 2024 (weighted average 4 %).  The steady swap‑rate assumptions and the expanding balance indicate that the firm’s exposure to interest‑rate derivatives has increased while its modeling assumptions remain conservative and stable, reflecting a consistent hedging and risk‑measurement approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) WRONG 2022 VALUE: LLM states $5 million for 2022, but ground truth shows $31 million - a 84% error. (2) WRONG 2024 VALUE: LLM states $69 million for 2024, but ground truth shows $58 million - a 19% overstatement. (3) WRONG RISK INPUT EVOLUTION: LLM claims 'swap rates' was the sole significant unobservable input across all three years (2022-2024), but ground truth clearly indicates a SHIFT in risk drivers: 'default' was the significant input in 2023 (weighted average 4%), while 'swap rates' became the significant input only in 2024 (weighted average 4%). This is a critical mischaracterization of the multi-year progression. (4) MISSING KEY INSIGHT: LLM completely misses the core finding that the significant unobservable input SHIFTED from 'default' to 'swap rates' between 2023 and 2024, which is the central point of the question about how risk inputs evolved. (5) INCOMPLETE CONTEXT: LLM fails to mention the net unrealized loss of $20 million in 2022 or the reduction in realized losses from $43 million in 2022 to stable values in 2023-2024, which are important indicators of risk management evolution. (6) FLAWED REASONING: The conclusion that 'swap rates' remained constant across all years contradicts the ground truth showing a shift in which input was 'significant' between years. The multi-hop synthesis is fundamentally broken - the LLM failed to correctly identify and synthesize the temporal evolution of risk inputs across the three-year period. The answer demonstrates a pattern of numerical inaccuracy and misses the essential narrative about shifting risk drivers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 469,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "NVIDIA’s 1.55% Notes Due 2028 were not reported in the 2022 filing, but the debt schedule in the 2023 10‑K shows a $1,099 million balance at year‑end 2023, which increased to $1,115 million at year‑end 2024 (page 67). The modest, steady rise indicates a deliberate, incremental expansion of long‑term debt to fund growth while maintaining a conservative leverage profile and keeping interest costs manageable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth across all three years. (1) 2022: Ground truth shows $1.2 billion; LLM claims the notes 'were not reported in the 2022 filing' - this is incorrect. (2) 2023: Ground truth shows $1.1 billion; LLM reports $1,099 million ($1.099 billion) - while numerically close, this is a minor understatement. (3) 2024: Ground truth shows $1.25 billion; LLM reports $1,115 million ($1.115 billion) - this is significantly understated by $135 million or ~10.8%. The progression narrative is also fundamentally wrong: the LLM describes a 'modest, steady rise' from 2023 to 2024 ($1.099B to $1.115B = +$16M increase), but the actual data shows a substantial increase from $1.1B to $1.25B (+$150M). The LLM's characterization of the trend as 'incremental expansion' contradicts the actual 2024 jump. The LLM also fails to capture the correct 2022 baseline, missing the full three-year evolution. The reasoning about 'conservative leverage profile' and 'manageable interest costs' is speculative and not grounded in the actual financial progression shown in the ground truth. The multi-hop synthesis across three fiscal years is incomplete and inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 346,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "GE’s 2022 10‑K disclosed trailing legal liabilities from the 2015 Alstom acquisition and shareholder suits over past financial reporting, with reserves set but uncertain (pages 69‑71). The 2023 filing reiterated the same exposure, noting ongoing cash outflows and that reserves may be insufficient (pages 34‑35). In 2024, GE again highlighted these legacy matters and shareholder litigation, stressing that reserves are still necessary and that actual losses could exceed estimates, underscoring the persistence and continued financial risk of these contingent liabilities (pages 31‑32).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core elements of the question: (1) GE's trailing legal liabilities from the 2015 Alstom acquisition, (2) shareholder lawsuits tied to historical financial reporting, (3) the 3-year progression from 2022-2024, and (4) the persistence of these contingent liabilities. The answer accurately captures the key narrative that these liabilities remained unresolved and potentially exceeded reserves across all three years. The semantic meaning aligns well with the ground truth regarding the persistence and financial impact of these matters.\n\nWEAKNESSES: (1) QUANTITATIVE SPECIFICITY: The LLM answer cites specific page numbers (69-71, 34-35, 31-32) but provides no actual dollar amounts, reserve figures, or quantitative metrics from the filings. The ground truth discusses the liabilities as a persistent burden but the LLM provides no numerical context to substantiate the financial impact claims. (2) DETAIL LEVEL: The ground truth mentions specific types of claims (anti-competitive conduct, corruption) and emphasizes reputational risks more explicitly. The LLM answer is more generic in describing the legal matters. (3) RESERVE DISCUSSION: While the LLM mentions reserves may be insufficient, it doesn't elaborate on the nature or magnitude of these reserves or how they changed year-over-year. (4) EXITED BUSINESSES: The ground truth mentions 'contingent liabilities from exited businesses' as part of the 2024 exposure, which the LLM answer omits.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the progression showing persistence rather than resolution. The logic connecting Alstom acquisition legacy matters to ongoing shareholder litigation is sound.\n\nFACTUAL VERIFICATION: All entities (GE, Alstom, 2015 acquisition, 2022-2024 years) are correctly identified. The characterization of these as 'trailing legal liabilities' and 'contingent liabilities' is accurate. No factual errors detected, but significant quantitative gaps exist.\n\nJUSTIFICATION: The answer is directionally correct and addresses the multi-hop nature of the question adequately, but lacks the financial specificity and comprehensive detail that would make it a strong answer. The page citations suggest research was done, but no actual figures are provided to substantiate claims about financial impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 639,
        "total_tokens": 2150
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "CVS’s pension plan grew its hedge‑fund limited‑partnership exposure from **$225 million in 2022 to $280 million in 2024**—an increase of about $55 million【page 174】【page 167】.  The jump, coupled with a target allocation of roughly 4 % to hedge funds in 2024【page 169】, signals a deliberate shift toward higher‑return alternative assets to boost expected plan returns and diversify risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) WRONG 2022 FIGURE: LLM states $225 million in 2022, but ground truth shows $214 million in 2022. This is a $11 million error on the starting value. (2) WRONG 2024 FIGURE: LLM states $280 million in 2024, but ground truth shows $252 million in 2024. This is a $28 million error on the ending value—a 11% overstatement. (3) WRONG CALCULATION: LLM calculates the increase as $55 million ($280M - $225M), but the correct increase from 2022 to 2024 should be $38 million ($252M - $214M). The LLM's calculation is mathematically consistent with its incorrect numbers, but both the inputs and output are wrong. (4) MISSING DATA POINT: The ground truth shows a three-year progression ($214M → $225M → $252M), demonstrating a consistent upward trend year-over-year. The LLM only provides 2022 and 2024 endpoints, missing the intermediate 2023 data point ($225 million) which is important for understanding the evolution. (5) QUALITATIVE REASONING: While the LLM's interpretation about strategic intent (higher-return alternative assets, risk diversification) is reasonable and aligns with the ground truth's conclusion about 'strategic decision to maintain and gradually expand,' this cannot compensate for the fundamental numerical errors. The 4% target allocation mentioned is not contradicted by ground truth but adds context not explicitly in the original answer. MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize information across multiple pages (174, 167, 169) and connect the investment amounts to strategic intent, which shows appropriate multi-hop reasoning structure. However, the execution fails due to incorrect data extraction. The semantic intent about pension fund strategy evolution is directionally correct but built on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 512,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "Colgate‑Palmolive’s Africa/Eurasia segment earned **$228 million in operating profit in 2022**【page_117】. In 2023, restructuring charges allocated to the region were about **5 % of the $32 million total Global Productivity Initiative charges—roughly $1.6 million pretax**【page_86】, indicating a modest restructuring effort. In 2024, depreciation and amortization spending for Africa/Eurasia was **$8 million, slightly lower than the $9 million in 2023 and 2022**【page_117】, reflecting a focus on maintaining existing assets rather than large‑scale investment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) OPERATING PROFIT ERROR: LLM states $228 million for 2022, but ground truth is $203 million—a $25 million discrepancy (12% error). This is a critical factual error on a core metric. (2) RESTRUCTURING CHARGES ERROR: LLM claims 5% of $32 million = $1.6 million, but ground truth states 10% of expected charges = $20-24 million. This is a massive understatement (off by ~12-15x). The LLM's calculation is internally consistent (5% × $32M = $1.6M) but the underlying percentages and base amounts are wrong. (3) DEPRECIATION/AMORTIZATION: LLM correctly states $8 million in 2024 and $9 million in prior years, matching ground truth. This is the only correct metric. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information across three years, the foundational numbers are incorrect, making the overall narrative unreliable. The conclusion about 'modest restructuring effort' contradicts the ground truth's characterization of a more substantial $20-24 million allocation. (5) COMPLETENESS: The answer addresses all three time periods requested but with wrong data. The semantic framing about 'maintaining existing assets' is reasonable but built on incorrect financial premises. The answer demonstrates an attempt at multi-hop synthesis but fails on quantitative accuracy, which is critical for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 403,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "In 2022, AIG’s 10‑K reported a $1.3 billion modeled loss for a five‑ton bomb attack net of TRIPRA and reinsurance recoveries, with attachment points of $200 million for Japan and $100 million for the rest of the world (pages 168‑169). By 2024, the company cut the Japan attachment point to $150 million (while the rest‑of‑world attachment point rose to $125 million) and its reinsurance recoverable assets fell from $67.5 billion in 2023 to $38 billion in 2024 (pages 122 and 90), with no new terrorism loss estimate disclosed beyond the 2021 figure. The 2024 filing notes that international terrorism exposure remains scenario‑modeled and that targeted reinsurance purchases are maintained.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility:\n\n1. ATTACHMENT POINT ERRORS (Critical): The LLM claims Japan attachment point was $200M in 2022 and was 'cut to $150 million' by 2024, while rest-of-world was $100M rising to $125M. The ground truth states AIG 'retained core attachment points of $200 million in Japan and $125 million elsewhere' throughout the period. The LLM's claim of a reduction from $200M to $150M in Japan is factually incorrect and contradicts the ground truth's statement of consistent $200M attachment in Japan.\n\n2. REST-OF-WORLD ATTACHMENT POINT: The LLM states $100M in 2022 rising to $125M in 2024. The ground truth indicates $125M was maintained throughout. The LLM's claim of a $100M starting point appears incorrect.\n\n3. REINSURANCE RECOVERABLE ASSETS: The LLM states assets 'fell from $67.5 billion in 2023 to $38 billion in 2024.' The ground truth only confirms $38.0 billion in 2024 with $29.1 billion in ceded loss reserves. The claim about a $67.5 billion figure in 2023 cannot be verified against the ground truth and appears to be an unsupported assertion.\n\n4. MODELED LOSS ESTIMATE: The LLM correctly identifies the $1.3 billion net loss figure for 2022 and correctly notes no new terrorism loss estimate was disclosed beyond 2021. This is accurate.\n\n5. QUALITATIVE ELEMENTS: The LLM correctly captures that international terrorism exposure remains scenario-modeled and targeted reinsurance purchases are maintained, matching the ground truth's characterization.\n\n6. MULTI-HOP SYNTHESIS: The answer attempts to synthesize information across years but does so with inaccurate attachment point figures, which is a core component of the question about 'evolution' of protections.\n\nThe answer demonstrates partial understanding of the topic but contains material factual errors regarding attachment points and unsupported claims about 2023 reinsurance recoverable assets that significantly detract from its reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 541,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "NVIDIA’s 2.00% Notes Due 2031 liability has stayed roughly flat—$1.20 B in 2022, $1.04 B in 2023, and $1.25 B in 2024—showing a deliberate effort to keep long‑term debt at a stable level. The modest dip in 2023 likely reflects a partial repayment or discount amortization, while the rebound in 2024 indicates a new issuance or rollover to maintain the maturity profile and match cash‑flow needs. Overall, the trend signals disciplined maturity management and a focus on balancing refinancing with liquidity preservation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures: $1.20B (2022), $1.04B (2023), and $1.25B (2024). All numbers match the ground truth exactly, with appropriate formatting variations ($1.20B vs $1.2 billion). The multi-hop synthesis is sound—the answer correctly identifies the three-year trend and interprets the liability movements. The reasoning about the 2023 dip (partial repayment or discount amortization) and 2024 rebound (new issuance or rollover) aligns with the ground truth's interpretation. The LLM appropriately characterizes the overall pattern as 'relatively stable' and 'disciplined maturity management.' However, there are minor differences in emphasis: (1) The LLM introduces 'new issuance or rollover' as a possible explanation for the 2024 increase, which is slightly more speculative than the ground truth's simpler statement that NVIDIA 'maintained its long-term capital structure.' (2) The LLM's phrase 'match cash-flow needs' is a reasonable inference but not explicitly stated in the ground truth. (3) The ground truth emphasizes the strategic intent to 'preserve stable long-term liabilities' and support 'R&D and operational investments,' while the LLM focuses more on 'maturity management' and 'liquidity preservation'—both valid interpretations but with slightly different emphasis. The answer is comprehensive, addresses the multi-part question about debt management strategy, and provides sound reasoning. The minor interpretive differences do not constitute factual errors but represent slightly different analytical angles on the same underlying data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 443,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 were issued in 2014 as part of a global notes offering and matured in 2017.  In each of the 2022, 2023, and 2024 Form 10‑Ks, Apple still lists the 1.05 % Notes due 2017 in its “Description of Securities” (Exhibit 4.4) (2022 10‑K p. 54; 2023 10‑K p. 54; 2024 10‑K p. 54), showing that the company continues to disclose all past debt issuances even after maturity.  This practice demonstrates Apple’s long‑term visibility and continuity in its debt structure, providing investors with a complete historical record of its obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) Correctly identifies the 1.05% Notes due 2017 as the specific instrument in question; (2) Accurately states the notes matured in 2017 (consistent with ground truth that notes were 'issued well before this period'); (3) Correctly verifies the notes appear in all three years (2022, 2023, 2024) in the Description of Securities/Exhibit 4.4; (4) Provides specific page references (p. 54 for all three years) showing diligent verification; (5) Correctly interprets the persistence of these notes post-maturity as a disclosure practice showing historical record-keeping; (6) The reasoning about 'long-term visibility and continuity' aligns with ground truth's conclusion about 'stable and transparent debt management strategy.' MINOR DIFFERENCES: (1) The LLM adds detail about the 2014 issuance date and 'global notes offering' which, while plausible and consistent with Apple's debt practices, is not explicitly confirmed in the ground truth provided; (2) The LLM's explanation focuses more on 'complete historical record' disclosure practice, while ground truth mentions possibilities of 'rollover, refinancing, or retention...under the same indenture framework'—these are complementary interpretations rather than contradictory; (3) Ground truth uses more cautious language ('may have been rolled over') while LLM is more definitive about disclosure practices. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three years (2022, 2023, 2024) and connects the maturity date (2017) to the filing years, demonstrating proper multi-hop reasoning. CALCULATION/VERIFICATION: No calculations required; date references are accurate. The answer successfully addresses how the notes 'evolved' (remained consistent) and what this reveals about debt structure continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 502,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "Under the 2019 IDA agreement, Schwab could migrate up to $10 billion of IDA balances each year and did so in 2021 and 2022.  In 2023 the 2019 agreement was replaced by a new 2023 IDA agreement that eliminated the 80 % fixed‑rate requirement, set new minimum and maximum balance limits (through September 10 2025: minimum above the total of then‑outstanding unmatured fixed‑rate obligations with a $30 billion cap; after that: minimum $60 billion and a $90 billion cap) and made migration contingent on capital and binding limits, and Schwab did not move balances that year.  The same 2023 agreement continued in 2024, with Schwab again not migrating balances, the sweep term extended to July 1 2034, and the same minimum/maximum balance requirements and capital‑dependent migration ability remaining in effect.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about the IDA agreements and their evolution, but contains a critical factual error that undermines accuracy. CORRECT ELEMENTS: (1) The 2019 IDA agreement allowed up to $10 billion annual migration - correct; (2) The 2023 agreement replaced the 2019 agreement - correct; (3) The 2023 agreement eliminated the 80% fixed-rate requirement - correct; (4) Schwab did not migrate balances in 2023 and 2024 - correct; (5) New minimum/maximum balance thresholds were established - correct; (6) Migration became contingent on capital and binding limits - correct; (7) The sweep term was extended to July 1, 2034 - correct. CRITICAL ERROR: The LLM states Schwab 'did so in 2021 and 2022' regarding the $10 billion migration under the 2019 agreement. The ground truth specifies that Schwab had 'already moved $10.1 billion by year-end' 2022, but does not confirm migrations in both 2021 and 2022. The LLM's claim about 2021 migration cannot be verified from the ground truth and appears to be an unsupported assertion. QUANTITATIVE ISSUES: The specific balance thresholds provided ($30 billion cap through September 10, 2025; minimum $60 billion and $90 billion cap thereafter) are detailed but cannot be verified against the ground truth, which only mentions 'new minimum and maximum balance thresholds' without specifying exact figures. This represents either additional accurate detail or potential hallucination. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years (2022-2024) and correctly identifies the strategic shift from active migration to constrained off-balance sheet management, matching the ground truth's characterization. However, the unsupported claim about 2021 migration and the unverified specific threshold numbers create accuracy concerns. The answer is more detailed than the ground truth but introduces elements that cannot be confirmed, reducing confidence in overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 531,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "From 2022 to 2024 GE’s exposure to Bank BPH’s borrower litigation grew in estimated loss from $1.359 billion in 2022 to $2.669 billion in 2023, then eased slightly to $2.461 billion in 2024. Capital support shifted from a $530 million cash contribution in 2022 to a $1.797 billion non‑cash inter‑company loan forgiveness in 2023, with no additional cash injections in 2024. The mortgage portfolio’s carrying value fell from roughly $1.799 billion at the end of 2021 (and still present in 2022) to zero by the end of 2023 and remained zero in 2024, reflecting a settlement program and valuation allowance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall trajectory of GE's Bank BPH exposure but contains a significant factual error regarding the mortgage portfolio timeline. CORRECT ELEMENTS: (1) Estimated losses progression: $1.359B (2022) → $2.669B (2023) → $2.461B (2024) - all correct; (2) Capital contributions: $530M cash in 2022 and $1.797B non-cash intercompany loan forgiveness in 2023 - both correct; (3) No additional contributions in 2024 - correct; (4) Overall narrative of worsening through 2023 then stabilization in 2024 - correct. CRITICAL ERROR: The LLM states the mortgage portfolio carrying value 'fell from roughly $1.799 billion at the end of 2021 (and still present in 2022) to zero by the end of 2023 and remained zero in 2024.' The ground truth indicates the carrying value dropped to zero by the end of 2024, not 2023. This is a material factual error in the timeline of the valuation write-down. MISSING CONTEXT: The LLM does not mention the $1.014 billion charge recorded in Q2 2023 as part of the settlement program, which is a key detail in understanding the strategic handling of the litigation. The LLM also doesn't explicitly state that the portfolio reached zero by end of 2024 (it says 'remained zero in 2024' which is ambiguous about when it first reached zero). MULTI-HOP REASONING: The answer successfully synthesizes information across three years and multiple financial metrics (estimated losses, capital contributions, portfolio values), demonstrating adequate multi-hop reasoning. The narrative flow is logical and shows understanding of the evolution. QUANTITATIVE ACCURACY PENALTY: The mortgage portfolio timeline error (2023 vs 2024) is a significant factual mistake that reduces quantitative accuracy despite most numbers being correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 480,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "CVS’s commercial‑mortgage‑backed‑security (CMBS) holdings fell sharply from a fair value of **$1.68 billion in 2022 to $0.68 billion in 2023** (page 149‑150), while unrealized losses stayed flat at **$100 million**. In 2024 the fair value of CMBS in its separate‑account portfolio dropped to **$3 million** from $6 million in 2023, with no unrealized losses reported (page 160). The steady unrealized‑loss level and the declining fair value indicate a conservative risk‑management strategy that focuses on holding CMBS to maturity and limiting exposure to market‑price volatility rather than actively trading or realizing losses.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect financial figures that contradict the ground truth across all years. (1) 2022 CMBS Fair Value: LLM states $1.68 billion, but ground truth is $574 million - a 193% overstatement. (2) 2023 CMBS Fair Value: LLM states $0.68 billion ($680 million), but ground truth is $675 million - this is close but still slightly off. (3) 2023 Unrealized Losses: LLM correctly states $100 million, matching ground truth. (4) 2024 CMBS Fair Value: LLM states $3 million from $6 million in 2023, but ground truth shows $3 million in 2024 with no prior year comparison provided in the original answer. The claim of $6 million in 2023 contradicts the stated $675 million fair value for 2023. (5) 2024 Unrealized Losses: LLM states 'no unrealized losses reported,' but ground truth does not explicitly state this - it only provides the 2024 fair value of $3 million. The LLM's interpretation of the 2024 unrealized loss position is unsupported. REASONING ERRORS: The LLM's interpretation of the trend is fundamentally flawed. The ground truth clearly indicates a 'strategic shift in 2024 to de-risk the portfolio' in response to elevated unrealized losses in 2023. The LLM instead characterizes the strategy as 'holding CMBS to maturity and limiting exposure to market-price volatility,' which misses the dramatic 99.6% reduction in fair value from 2023 to 2024 ($675M to $3M) - this is clearly active de-risking, not passive holding to maturity. MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the three-year trend. The correct narrative shows: 2022 ($574M fair value, $12M losses) → 2023 ($675M fair value, $100M losses - sharp increase in losses) → 2024 ($3M fair value - dramatic reduction). This pattern clearly indicates reactive de-risking in response to 2023 losses, not a conservative buy-and-hold strategy. The LLM's characterization is semantically opposite to the actual risk management strategy evidenced by the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 536,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "Walmart’s private‑label lineup has remained essentially unchanged from FY 2022 through FY 2024, with Marketside consistently listed among its private brands (2022: page 7; 2023: page 7; 2024: page 7). The steady inclusion of Marketside across three consecutive filings signals a sustained emphasis on private‑label grocery offerings, underscoring the company’s strategy to grow margin‑generating grocery brands and deepen customer loyalty.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Marketside was consistently featured across FY 2022-2024, which aligns with the ground truth. The page references (page 7 for each year) provide specific sourcing. The core factual claim about continuity is accurate. WEAKNESSES: (1) The LLM answer significantly undersells the strategic evolution described in the ground truth. It states the lineup 'remained essentially unchanged,' which contradicts the ground truth's emphasis on 'strategic expansion and modernization' through introduction of new brands like 'bettergoods.' (2) The answer fails to capture the dual strategy explicitly mentioned in ground truth: maintaining legacy brands while innovating. The LLM focuses only on continuity, missing the 'introduction of new private brands' element that is central to understanding the 3-year progression. (3) The LLM provides a narrower interpretation of the strategy (margin growth and customer loyalty) without addressing the broader strategic shift toward modernization and meeting evolving consumer preferences. (4) The answer lacks the nuanced understanding that the progression indicates both preservation AND innovation, not just steady-state maintenance. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years but fails to fully synthesize the complete strategic picture that includes both continuity AND change. The reasoning is partially sound but incomplete. SEMANTIC EQUIVALENCE: While the LLM's statement about Marketside's consistent presence is factually correct, it misses the essential narrative of the ground truth regarding strategic evolution and brand portfolio modernization. The answer is too reductive for a question specifically asking about 'evolution' and what the 'progression indicates.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 487,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "From 2022 through 2024, Lowe’s tightened its supplier‑monitoring framework by building on its human‑rights, conflict‑minerals, Vendor Code of Conduct and wood‑sourcing policies and then adding a country‑specific risk‑based approach, enhanced monitoring tools and a new forestry grievance process in 2023 and 2024.  The company also expanded supplier engagement—encouraging CDP emissions reporting and pursuing 100 % SmartWay certification—while investing $550 million (2022), $300 million (2023) and $400 million (2024) in energy‑efficiency and renewable‑energy upgrades, including rooftop solar at 174 store and distribution‑center sites, to cut scope‑3 emissions and strengthen supply‑chain sustainability.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding investment amounts. Ground truth states 'multi-year investments exceeding $550 million by 2022 and over $400 million through 2023.' The LLM breaks this down as '$550 million (2022), $300 million (2023) and $400 million (2024)' - this is incorrect. The ground truth does not mention a $300 million figure for 2023 or a separate $400 million for 2024. The LLM appears to have fabricated year-by-year breakdowns that don't match the source data. The ground truth indicates cumulative/multi-year figures, not annual allocations. QUALITATIVE STRENGTHS: The LLM correctly identifies the evolution of policies (human rights, conflict minerals, Vendor Code of Conduct, wood sourcing), the 2023 introduction of country-specific risk levels and forestry grievance process, and the 2024 strengthening of risk-based approaches. The mention of CDP emissions reporting, SmartWay certification, and rooftop solar installations adds relevant context about supplier engagement and operational sustainability. MULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and connects policy enhancements to investment commitments, though the investment figures are materially incorrect. COMPLETENESS: The answer addresses policy evolution and investments but misrepresents the investment data structure. The ground truth's emphasis on 'multi-year investments' is fundamentally different from the LLM's year-by-year breakdown. This is a major factual error that undermines the credibility of the quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 447,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "Apple disclosed the 2.40% Notes due 2023 in its 2022 Form 10‑K (page 58) as part of the global notes. The same note appears unchanged in the 2023 Form 10‑K (page 56) and again in the 2024 Form 10‑K (page 56). The consistent, unchanged listing over three years shows that Apple is maintaining a stable, long‑term debt structure with minimal changes to its interest‑rate exposure, reflecting a disciplined and predictable debt‑management strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several significant issues that prevent it from being considered substantially correct: (1) FACTUAL ERRORS: The LLM provides specific page numbers (page 58 for 2022, page 56 for 2023 and 2024) that cannot be verified against the ground truth and appear to be hallucinated details. The ground truth does not cite specific page numbers, suggesting the LLM fabricated these citations. (2) QUANTITATIVE ACCURACY ISSUES: While the core debt instrument (2.40% Notes due 2023) is correctly identified, the LLM adds unverifiable specificity about page locations that undermines credibility. (3) SEMANTIC DIVERGENCE: The LLM's interpretation differs from the ground truth in important ways. The ground truth emphasizes 'sustained transparency' and 'deliberate approach to managing and disclosing legacy debt obligations,' focusing on disclosure strategy evolution. The LLM instead claims the notes appeared 'unchanged' and interprets this as reflecting 'minimal changes to its interest-rate exposure' and a 'stable, long-term debt structure' - a different analytical framing that may mischaracterize the situation. The ground truth notes the notes were 'set to mature within that year' (2024), making the continued disclosure noteworthy; the LLM doesn't adequately emphasize this maturity context. (4) MULTI-HOP REASONING: Both answers attempt to synthesize the 3-year pattern, but the LLM's conclusion about 'minimal changes' and 'stable, long-term debt structure' seems to miss the point that these are maturing notes (due 2023), not a stable long-term structure. The ground truth better captures that the disclosure pattern reflects management of 'legacy debt obligations.' (5) COMPLETENESS: The LLM addresses the basic question but misses the nuance about the notes approaching and reaching maturity, which is central to understanding the disclosure strategy. The answer is partially correct in identifying the consistent disclosure pattern but incorrect in its interpretation of what this pattern signifies about debt management strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 553,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "GE’s AerCap senior‑note holdings grew steadily: $900 million at 12/31/2022, $944 million at 12/31/2023, and $982 million at 12/31/2024 (see the fair‑value table on page 70).  The incremental build‑up—$44 million in 2023 and $38 million in 2024—shows a deliberate strategy of accumulating high‑quality, long‑term debt securities to generate stable income and diversify its investment‑securities portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect starting value for 2022. Ground truth states $976 million at 12/31/2022, but LLM claims $900 million. This is a $76 million discrepancy (7.8% error). The 2023 ($944M) and 2024 ($982M) figures are correct. CALCULATION ERRORS: The LLM calculates incremental increases of $44M (2023) and $38M (2024), which are arithmetically correct based on their stated numbers ($900M→$944M→$982M), but these calculations are based on the wrong 2022 baseline. The correct progression shows a DECREASE from 2022-2023 ($976M→$944M, a $32M decline), then an INCREASE from 2023-2024 ($944M→$982M, a $38M increase). REASONING QUALITY: The LLM's interpretation of the data as showing 'steady growth' and 'deliberate accumulation strategy' is fundamentally incorrect given the actual 2022-2023 decline. The ground truth correctly identifies this as a 'dynamic approach' with 'fluctuation' rather than steady growth. The LLM's narrative about 'incremental build-up' mischaracterizes the actual pattern. COMPLETENESS: The LLM does address the evolution question and attempts to discuss investment strategy, but the incorrect baseline data undermines the entire analysis. The ground truth provides more nuanced context about 'slight overall stability' and mentions broader portfolio changes, which the LLM omits. ENTITY ACCURACY: Correctly identifies AerCap senior notes and years 2022-2024. The reference to 'page 70' adds specificity but cannot be verified. SEMANTIC EQUIVALENCE: The LLM's characterization of strategy (accumulating high-quality debt for stable income) may be reasonable, but it's based on a false premise of steady growth rather than the actual fluctuating pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 469,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "AIG’s glide‑path policy—outlined in the 2023 and 2024 10‑Ks (page 250)—sets the target mix of growth versus liability‑hedging assets based on the plan’s funded ratio and prevailing interest rates, automatically reducing growth exposure as the ratio improves.  The target equity allocation fell from 15 % in the 2022 plan (funded status at 12/31/2021, page 308) to 9 % in the 2024 plan (funded status at 12/31/2023, page 252) and remains at 9 % for 2025 (page 184), while fixed‑maturity securities rose from 75 % to 80 % and other investments increased from 10 % to 11 %.  This shift demonstrates a deliberate de‑risking of the U.S. pension portfolio in response to an improving funded status.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AIG's glide path approach and provides specific, verifiable quantitative details that align with the ground truth. STRENGTHS: (1) Correctly identifies the glide path mechanism as being based on funded status and interest rates; (2) Provides specific target allocation percentages (equity 15% in 2022 declining to 9% in 2024-2025, fixed-maturity securities rising from 75% to 80%, other investments from 10% to 11%); (3) Correctly maps the temporal relationship between funded status dates and target allocations (2022 plan based on 12/31/2021 status, 2024 plan based on 12/31/2023 status); (4) Accurately characterizes the de-risking strategy and liability-driven investing principles; (5) Includes specific page references to source documents. MINOR WEAKNESSES: (1) The ground truth emphasizes that the glide path 'progressively reduced' allocations across all three years (2022, 2023, 2024), but the LLM answer only provides explicit data points for 2022 and 2024/2025, omitting the 2023 intermediate step; (2) The ground truth mentions that the 2023 target allocation for 2024 was set according to 12/31/2022 funded status, which is not explicitly addressed in the LLM answer; (3) The LLM answer could have been more explicit about the three-year progression pattern. QUANTITATIVE VERIFICATION: The equity allocation decline from 15% to 9% and the corresponding increases in fixed-maturity securities (75% to 80%) and other investments (10% to 11%) appear reasonable and internally consistent (15% + 75% + 10% = 100%; 9% + 80% + 11% = 100%). The answer correctly identifies the temporal mapping between funded status dates and target allocations. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents to demonstrate the evolution of the glide path approach and its relationship to improving funded status. The connection between improving funded ratios and de-risking is clearly articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 538,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "Texas Instruments has kept “analog and embedded processing” as the core of its business model in every MD&A from 2022 through 2024 (2022 page 18; 2023 page 18; 2024 page 18), underscoring that embedded‑processing products remain a pillar of its competitive advantage.  The segment results show the line’s continued contribution to operating profit—up 3 % in 2023 versus 2022 and still a sizable share of 2024 revenue (though down 25 % versus 2023) (2023 page 20; 2024 page 20)—which, together with the company’s stated focus on free‑cash‑flow‑per‑share growth, signals that embedded processing is a stable, long‑term engine for generating cash for shareholders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic narrative—that Texas Instruments consistently emphasized 'analog and embedded processing' as foundational to its business model across 2022-2024. The answer appropriately cites page references (page 18 for MD&A sections, page 20 for segment results) and correctly identifies the multi-year consistency theme. The reasoning that embedded processing is a 'stable, long-term engine' aligns with the ground truth's conclusion about it being a 'foundational pillar' in TI's cash flow strategy.\n\nWEAKNESSES: (1) QUANTITATIVE ISSUES: The LLM provides specific percentage changes (3% operating profit increase in 2023 vs 2022; 25% revenue decline in 2024 vs 2023) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided ground truth and represent potential factual errors or unsupported claims. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes specific qualitative statements from each year ('more opportunity per customer and more value for our investments' from 2023; supply chain control, customer reach, diversified returns from 2024). The LLM answer omits these specific strategic narratives that demonstrate the evolution of emphasis. (3) MISSING CONTEXT: The ground truth explicitly notes that embedded processing is 'one of two key product lines (alongside analog)' that anchor 'four sustainable competitive advantages'—a structural detail the LLM conflates by treating 'analog and embedded processing' as a single combined unit rather than two distinct but complementary pillars.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three years and connects strategic emphasis to cash flow generation. However, the introduction of unsupported percentage figures (3% and 25%) undermines confidence in the quantitative synthesis. The connection between strategic emphasis and free cash flow per share growth is stated but less explicitly developed than in the ground truth.\n\nSEMANTIC EQUIVALENCE: The core message—that embedded processing is strategically consistent and foundational—is preserved. However, the specific evolution of strategic emphasis across the three years is less detailed in the LLM answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 601,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "From fiscal 2022 through 2024, Lowe’s IP strategy consistently protected its private‑brand names—including Kobalt, STAINMASTER and allen+roth—by maintaining registered and unregistered trademarks (2022 page 7; 2024 page 7). Over the same period the company amplified its emphasis on private brands, positioning them as high‑value offerings alongside national brands in its product mix (2023 page 6; 2024 page 6). Concurrently, Lowe’s integrated this IP focus with digital transformation, leveraging omnichannel and digital tools—such as online inspiration, design and project‑management platforms—to promote and sell private‑brand products across e‑commerce and in‑store channels (2023 page 5; 2024 page 5).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and inaccuracies compared to the ground truth. CORRECT ELEMENTS: (1) The three core private brands (Kobalt, STAINMASTER, allen+roth) are correctly identified across all years; (2) The general theme of digital transformation integration is present; (3) The mention of omnichannel and digital tools is appropriate. SIGNIFICANT GAPS AND ERRORS: (1) The LLM completely omits the critical evolution detail that RONA and Reno Depot were listed in fiscal 2022 but removed by fiscal 2023—this is a key part of the 'evolution' the question asks about; (2) The LLM states the company 'amplified its emphasis on private brands' but provides no evidence from the ground truth that this amplification occurred—the ground truth indicates a 'streamlining' or 'simplification' of disclosure, not amplification; (3) The LLM references specific page numbers (2022 page 7, 2024 page 7, 2023 page 6, 2024 page 6, 2023 page 5, 2024 page 5) but these cannot be verified against the ground truth and appear to be fabricated citations; (4) The ground truth explicitly notes the removal of RONA and Reno Depot as reflecting 'a simplification or refocusing of brand emphasis,' but the LLM misses this entirely; (5) The LLM's characterization of the strategy as 'amplified emphasis' contradicts the ground truth's characterization of 'streamlined disclosure' and 'simplification.' MULTI-HOP REASONING: The LLM attempts to synthesize across three fiscal years and connect IP strategy with digital transformation, but fails to capture the key evolution (brand portfolio reduction) that distinguishes the three-year period. The reasoning about digital integration is present but incomplete—the ground truth notes this as a 'new language' introduced in fiscal 2024, suggesting a more recent shift than the LLM implies. QUANTITATIVE ACCURACY: No specific numbers or calculations are provided by either answer, so this is neutral, but the LLM's page citations appear unreliable. The answer would score higher if it had accurately captured the brand portfolio reduction from 5 brands (2022) to 3 brands (2023-2024).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 577,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "IBM’s 10‑K filings from 2022 through 2024 consistently list “client relationships and trust” as a core competitive differentiator, with the wording unchanged across the three years (2022 p. 3; 2023 p. 3; 2024 p. 3). This steady emphasis signals that IBM views trust and long‑term client relationships as essential to its hybrid‑cloud and AI strategy, reinforcing its positioning as a trusted partner in a highly competitive market.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer fails to address the core requirement of the question: demonstrating how IBM's emphasis on client relationships and trust EVOLVED from 2022 to 2024. Instead, it claims the wording was 'unchanged across the three years,' which directly contradicts the ground truth that shows clear evolution in how this differentiator was framed and contextualized. Specific failures: (1) The LLM states the emphasis remained static with identical wording across years, but the ground truth shows substantive evolution—2022 focused on hybrid cloud/AI platform integration, 2023 expanded to ecosystem partnerships (AWS, Microsoft, SAP), and 2024 added cybersecurity partners (Palo Alto Networks). (2) The LLM completely misses the multi-hop synthesis required: connecting trust to strategic partnerships, ecosystem development, and security integration over time. (3) The LLM fails to identify the strategic implications of this evolution—the shift from technical capabilities alone to a secure partner ecosystem approach. (4) While the page citations (p. 3 for each year) may be accurate, the LLM's interpretation of what those pages contain is fundamentally wrong. The answer demonstrates no understanding of the 3-year trajectory or what it indicates about IBM's strategic positioning in hybrid cloud and AI markets. The LLM essentially provides a static snapshot rather than the dynamic evolution analysis the question explicitly requests. This is a critical failure in multi-hop reasoning and contextual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 419,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "By 2023, Gilead’s El Segundo, California site was described as handling both clinical and commercial manufacturing and processing of cell‑therapy products, a role that continued unchanged into 2024 [page_11]. In contrast, the 2022 10‑K did not list the El Segundo facility as a commercial manufacturing site—only as a clinical manufacturing location—indicating that its commercial production responsibilities were added between 2022 and 2023 [page_31].",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the El Segundo facility's role 'remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities' and that it was 'described as being utilized for clinical and commercial manufacturing and processing of cell therapy products' in 2022. However, the LLM answer claims the opposite: that 'the 2022 10-K did not list the El Segundo facility as a commercial manufacturing site—only as a clinical manufacturing location—indicating that its commercial production responsibilities were added between 2022 and 2023.' This is a direct contradiction of the ground truth assertion that the facility had both clinical AND commercial responsibilities in 2022. The LLM's core claim about evolution (commercial responsibilities being added between 2022-2023) is factually incorrect according to the knowledge graph. The LLM correctly identifies that by 2023-2024 the facility handled both clinical and commercial manufacturing, but incorrectly characterizes this as a change from 2022 when it was actually consistent throughout. The citation references [page_11] and [page_31] cannot be verified but the factual claim contradicts established ground truth. The answer does address the question's timeframe (2022-2024) and the facility name/location correctly, but the core narrative about evolution is fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 415,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "From 2022 to 2024, Lowe’s did not issue new 4.550% Notes; the only 4.550% Notes were issued in 2019 under the Fifteenth Supplemental Indenture and mature in 2049 (page_76). The 2022 supplemental indentures issued 4.250% and 4.450% Notes (page_76), the 2023 supplemental indentures issued 4.800% Notes (page_77), and the 2024 supplemental indentures did not add any 4.550% Notes (page_77), underscoring a conservative long‑term debt strategy that prioritizes rate lock‑in and predictable cash‑flow management.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some correct information but diverges significantly from the ground truth in its interpretation and focus. CORRECT ELEMENTS: (1) The 4.550% Notes were issued in 2019 under the Fifteenth Supplemental Indenture and mature April 5, 2049 - this is accurate. (2) The LLM correctly identifies that no new 4.550% Notes were issued in 2022-2024. (3) The reference to other notes issued in 2022 (4.250%, 4.450%) and 2023 (4.800%) appears factually accurate based on the page citations. CRITICAL ISSUES: (1) MISALIGNMENT WITH QUESTION: The question specifically asks about the 4.550% Notes' evolution from 2022-2024, but the LLM shifts focus to OTHER notes issued during this period. The ground truth correctly identifies that the 4.550% Notes remained CONSISTENTLY REFERENCED across all three years (2022, 2023, 2024) as part of the long-term debt structure. (2) INTERPRETATION ERROR: The LLM concludes 'Lowe's did not issue new 4.550% Notes' which is technically true but misses the key insight - the ground truth emphasizes the CONSISTENT INCLUSION and STABILITY of this instrument across filings, indicating strategic long-duration debt management. (3) STRATEGIC ANALYSIS MISMATCH: The ground truth focuses on what the multi-year pattern INDICATES (commitment to extended maturities, avoiding refinancing risks), while the LLM pivots to discussing OTHER instruments and characterizes the strategy differently ('rate lock-in and predictable cash-flow management' for the OTHER notes, not the 4.550% Notes). (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution and what the pattern indicates about long-term debt strategy. The LLM provides information about OTHER debt instruments but fails to properly synthesize the significance of the 4.550% Notes' consistent presence across the three-year period. The answer addresses a different aspect of Lowe's debt strategy rather than directly answering the specific question about the 4.550% Notes' evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 542,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "From 2022 through 2024, 3M’s Scotchgard litigation moved from a pending Michigan class action to a settled, immaterial‑cost agreement. The company settled the case in June 2023, paying an immaterial amount and reporting only ongoing immaterial liabilities in its 2024 filing 【124†L1-L4】【124†L5-L7】【100†L1-L3】. This trend shows that while PFAS litigation remains a legal exposure, the financial impact of Scotchgard‑related claims has been limited and has not materially affected 3M’s financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM claims a June 2023 settlement with 'immaterial amount' but the ground truth explicitly states a $65 million settlement in 2022 alongside Saint-Gobain and Honeywell, and another $65 million settlement in New York being finalized in 2024. The LLM completely omits these material dollar amounts. (2) INCOMPLETE SYNTHESIS: The LLM fails to capture the multi-hop evolution across 2022-2024. Ground truth shows: 2022 - $65M settlement in Michigan; 2023 - approximately 68 AFFF suits outside MDL, Illinois case, Canadian class action, non-material Michigan settlement; 2024 - Alabama/Georgia litigation expansion, $65M New York settlement finalized, 2026 trial dates set. The LLM only mentions a single 2023 settlement and ignores the 2024 expansion entirely. (3) ENTITY/TIMELINE ERRORS: The LLM incorrectly characterizes the litigation as moving to 'settled, immaterial-cost agreement' when the ground truth shows escalating litigation with material settlements ($65M in 2022, $65M in 2024) and expanding geographic scope. (4) CONTRADICTORY CONCLUSION: The LLM concludes 'financial impact...has been limited and has not materially affected 3M's financial statements,' which directly contradicts the ground truth's finding that the trend 'reveals a growing financial burden...with increasing geographic spread and case complexity, suggesting...liabilities and legal costs...are escalating over time.' (5) MISSING KEY FACTS: The LLM omits all references to: Wolverine's disposal practices, AFFF suits, Illinois and Canadian litigation, Alabama/Georgia expansion, municipal water utilities, property owners, carpet manufacturers, and 2026 trial dates. The answer demonstrates a fundamental misunderstanding of the litigation's scope and financial materiality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 511,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "From 2022 through 2024, Gilead’s Foster City, California site has remained a core R&D and clinical‑trial manufacturing hub. In 2022 it was used for process‑chemistry research and API/drug‑product manufacturing for clinical studies; by 2023 it continued those functions while also expanding cell‑therapy manufacturing and tighter integration with global operations【page_12 (2023)】; in 2024 the facility’s focus remains on process chemistry, analytical method development, formulation/device development, and API/drug‑product manufacturing for clinical trials, reinforcing its strategic alignment with Gilead’s worldwide operations【page_12 (2024)】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM claims that in 2022, Foster City was used for 'process-chemistry research and API/drug-product manufacturing for clinical studies,' but the ground truth explicitly states that in 2022, Foster City was 'primarily described as housing administrative, manufacturing, and R&D activities' with NO specific mention of process chemistry or clinical manufacturing focus. This is a fundamental mischaracterization of the 2022 baseline. (2) MISSING KEY TRANSITION - The ground truth emphasizes a TRANSITION from 2022 (general admin/manufacturing/R&D) to 2023-2024 (specific focus on process chemistry, analytical methods, formulation, device development, clinical manufacturing). The LLM incorrectly suggests continuity of process chemistry work from 2022 onward, missing the strategic shift that occurred. (3) UNSUPPORTED CLAIM - The LLM states that by 2023 the facility 'expanded cell-therapy manufacturing,' but this detail does NOT appear in the ground truth answer and appears to be fabricated or misattributed. (4) INCOMPLETE STRATEGIC CONTEXT - The ground truth emphasizes the strategic consolidation pattern (Foster City for early-stage/clinical, other locations for commercial-scale), which the LLM mentions only vaguely as 'tighter integration with global operations' without capturing the specific geographic division of labor. (5) CITATION ISSUES - The LLM provides page citations (page_12 2023/2024) that cannot be verified against the ground truth and may be hallucinated. The ground truth does not reference specific page numbers. WHAT WAS CORRECT: The LLM correctly identifies Foster City as remaining a core R&D and clinical-trial manufacturing hub, and correctly lists the 2023-2024 functions (process chemistry, analytical methods, formulation, device development, API/drug-product manufacturing). However, these correct elements are undermined by the false claim about 2022 continuity and the missing strategic transition narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 539,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "From 2022 to 2024, AIG shifted its loss‑reserve oversight from a business‑unit‑centric model that relied on periodic external expert reviews (2022 pages 165‑167) to a more centralized framework in which ERM’s second‑line review and the Internal Audit Group routinely challenge pricing and reserving models, embedding reserve modeling in a formal model‑risk‑management and validation process (2024 page 86). Modeling approaches evolved from stochastic/deterministic risk‑selection and pricing models with periodic reserve challenges (2023 page 119) to a structured escalation and actuarial reserve review process that is now routinely audited internally, reducing the need for separately cited external reviews.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution from 2022-2024, capturing the shift toward more centralized, formalized oversight. (2) Correctly names key entities (ERM, Internal Audit Group, model-risk-management framework). (3) Accurately references the progression from periodic external reviews to integrated internal challenge processes. (4) Page citations (2022 pages 165-167, 2023 page 119, 2024 page 86) appear plausible and specific. (5) Correctly identifies the shift from business-unit-centric to enterprise-wide governance.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM states that evolution led to 'reducing the need for separately cited external reviews' in 2024, which contradicts the ground truth that shows external expert reviews remained a consistent and integrated component through 2024. The ground truth explicitly states AIG's approach remained 'consistently anchored in internal controls and external expert reviews' with integration into ERM framework, not replacement of external reviews. (2) The LLM characterizes the 2024 evolution as moving away from external reviews, when the ground truth shows external reviews were enhanced and better integrated into the ERM framework. (3) Missing explicit mention of sensitivity and scenario analyses as distinct methodological enhancements in 2023. (4) The characterization of 2023 modeling as 'stochastic/deterministic risk-selection and pricing models' is narrower than the ground truth's broader reference to 'sensitivity and scenario analyses, stochastic methods, and experience studies.' (5) The answer implies external reviews became less important over time, when they actually became more formally integrated.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the progression in oversight mechanisms. However, it misinterprets the relationship between internal and external review mechanisms, suggesting substitution rather than integration.\n\nNUMERIC/FACTUAL VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy focuses on dates and structural claims. The 2022-2024 timeframe is correct. Page references cannot be independently verified but appear reasonable.\n\nSEMANTIC ACCURACY: The core semantic error is the characterization of external reviews as becoming less necessary, which fundamentally misrepresents the evolution described in the ground truth. The ground truth emphasizes integration and enhancement of external reviews within ERM, not their reduction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 681,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "Texas Instruments’ Melaka, Malaysia facility is listed only under the Analog column and not under Embedded Processing in the 2022, 2023 and 2024 10‑Ks (2022 page 16, 2023 page 16, 2024 page 16).  The footprint has therefore remained unchanged over the three‑year period, with no expansion into embedded‑processing manufacturing.  This steady state indicates TI continues to prioritize analog production in Melaka, maintaining a consistent focus on analog rather than embedded processing in that region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Strengths: (1) Correctly identifies that Melaka, Malaysia operations were listed exclusively under Analog in all three years (2022, 2023, 2024), with specific page references (page 16) provided for verification; (2) Accurately states no expansion into Embedded Processing occurred during the period; (3) Properly synthesizes the multi-hop information across three years to conclude the footprint remained unchanged; (4) Correctly interprets what this stability indicates about TI's manufacturing strategy in the region. The reasoning is sound - the absence of Melaka from Embedded Processing columns across all three 10-Ks, combined with consistent presence in Analog columns, logically supports the conclusion of stable, specialized Analog-focused operations. Minor consideration: The answer could have been marginally enhanced by explicitly stating the 3-year consistency (2022→2023→2024 progression) more emphatically, though this is a very minor point as the answer does address the 3-year evolution question adequately. The semantic meaning matches the ground truth perfectly - both convey that Melaka maintained exclusive Analog focus with no Embedded Processing expansion. No numerical errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 367,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "In fiscal 2022 Lowe’s had $2.56 billion of forward‑interest‑rate‑swap notional exposure (page 62).  In fiscal 2023 the company continued to use forward swaps to hedge forecasted debt issuances – the swaps were still in place as of February 3 2023 (page 46) and had a fair value of $251 million (page 54).  By fiscal 2024 the company maintained forward‑rate‑swap contracts for forecasted debt issuances (page 46), showing a consistent, proactive hedging strategy to mitigate benchmark‑rate risk on future debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a $2.56 billion notional exposure for fiscal 2022, which is not mentioned in the ground truth and appears to be fabricated or misattributed. The ground truth does not provide this specific number. (2) CRITICAL FACTUAL CONTRADICTION: The ground truth explicitly states that 'By fiscal 2024, however, the company no longer held forward interest rate swaps' - this is a clear, definitive statement. The LLM answer contradicts this by claiming 'By fiscal 2024 the company maintained forward-rate-swap contracts for forecasted debt issuances.' This is a fundamental error that misrepresents the company's actual hedging position. (3) INCOMPLETE ANALYSIS: The LLM correctly identifies the $251 million fair value for fiscal 2023, which matches the ground truth. However, it fails to capture the strategic shift that is central to the question - the transition from hedging forecasted debt issuances to managing existing debt through fixed-to-floating swaps. (4) REASONING FLAW: The LLM concludes the company maintained a 'consistent, proactive hedging strategy' when the ground truth indicates a strategic shift away from forward swaps entirely by fiscal 2024. This represents a failure in multi-hop synthesis and understanding of the company's evolving risk management approach. (5) MISSING CONTEXT: The LLM does not mention the shift to fixed-to-floating interest rate swaps as fair value hedges on existing debt, which is a crucial element of understanding the strategic evolution. The answer presents an incomplete and partially contradictory narrative that misses the core insight about the company's changing hedging strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 479,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "IBM’s 2022 10‑K lists the 6.50% Debentures due 2028 as “Exhibit 2 to Form 8‑K, filed on January 8 1998” (page 19). The same wording appears unchanged in the 2023 and 2024 10‑Ks (page 19). The unchanging reference to the 1998 filing shows the debt was issued in 1998 and has remained structurally unchanged, with IBM continuing to rely on the original 8‑K documentation—evidence of a stable, long‑term debt structure that has not been amended or re‑issued.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. STRENGTHS: (1) All numeric values are correct—the 6.50% rate, the 2028 maturity date, the January 8, 1998 filing date, and page 19 references are all accurate. (2) The multi-hop synthesis is sound: the answer correctly identifies that IBM referenced the same exhibit across all three years (2022, 2023, 2024) and correctly interprets what this consistency reveals about the debt instrument's stability. (3) The reasoning is logical and well-articulated: the unchanging reference to the 1998 8-K filing is correctly interpreted as evidence of structural stability and lack of material amendments. (4) The answer directly addresses both parts of the question: how the disclosure evolved (it didn't—remained consistent) and what the consistency reveals (stable, long-standing structure with no amendments). (5) Entity identification is correct throughout (IBM, the specific debenture, the form types and dates). MINOR CONSIDERATIONS: The LLM answer includes a parenthetical note about page 19 appearing in all three filings, which adds helpful specificity beyond the ground truth but doesn't contradict it. The phrasing 'The unchanging reference...shows the debt was issued in 1998' is a reasonable inference from the 1998 filing date, though the ground truth is slightly more cautious in its language. Overall, the answer demonstrates strong comprehension of multi-hop financial document analysis and correctly synthesizes information across three years of filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 418,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "Reflective signage has been listed as a product within 3M’s Transportation and Electronics segment in both the 2023 and 2024 10‑K filings, with no change in its description or placement (see 2023 product list on page 107 and the 2024 list on page 110). Because the same product appears in the segment’s portfolio for all three years, it indicates that 3M treats reflective signage as a stable, core offering that remains strategically important to the Transportation and Electronics business.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about positioning evolution across three years. Specific issues: (1) POSITIONING DATA MISSING: The ground truth provides detailed positioning information (5th in 2022, 4th in 2023, 4th in 2024), but the LLM claims 'no change in its description or placement' between 2023 and 2024 only, completely omitting 2022 data and the actual positional shifts. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The question explicitly asks about evolution 'across 2022, 2023, and 2024' - the LLM only addresses 2023 and 2024, missing the critical 2022 baseline and the movement from 5th to 4th position. (3) INCORRECT CHARACTERIZATION: The LLM states there was 'no change in placement' between 2023-2024, which is technically true for those two years, but this misses the strategic narrative of the 2022→2023 promotion from 5th to 4th position. (4) MISSING CONTEXTUAL DETAILS: The ground truth identifies specific products that Reflective Signage was positioned relative to (advanced ceramics, attachment tapes, light management films, sound and temperature management), which provides meaningful context about its strategic tier. The LLM provides only page references without substantive positioning analysis. (5) WEAK CONCLUSION: While the LLM correctly concludes that reflective signage is 'strategically important,' it fails to capture the nuanced finding that the 2023 promotion and maintenance in 2024 suggests 'a slight early boost in prominence' - a key insight about strategic evolution. The answer reads as a surface-level acknowledgment rather than a thorough analysis of positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 456,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "Gilead has consistently used its Hoofddorp, Netherlands facility for commercial manufacturing and processing of cell‑therapy products from 2022 through 2024, with the same role described in each year’s 10‑K. The facility’s function has remained unchanged, underscoring its ongoing strategic importance as a core commercial production site within Gilead’s manufacturing footprint. (GILD_10k_2022, page 11; GILD_10k_2023, page 12; GILD_10k_2024, page 12)",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a significant factual error that contradicts the ground truth. The ground truth explicitly describes an evolution in the facility's role from 2022-2024: (1) 2022 - identified as 'one of its principal manufacturing facilities' with operational role, (2) 2023 - 'explicitly described as being utilized for commercial manufacturing and processing of cell therapy products', and (3) 2024 - 'retained its designation as a key facility for commercial cell therapy manufacturing.' The LLM claims the facility's function 'has remained unchanged' across all three years, which is factually incorrect. The ground truth indicates a progression toward increasing emphasis on cell therapy specifically, not a static role. The LLM's statement that the facility was used for 'commercial manufacturing and processing of cell-therapy products from 2022 through 2024' misrepresents the 2022 baseline, which did not explicitly identify cell therapy as the primary function. The numeric/date references (2022, 2023, 2024) are correct, and the facility name and company are accurate. However, the core semantic meaning of the answer is wrong - it fails to capture the strategic evolution and increasing importance of the facility for cell therapy manufacturing that the ground truth emphasizes. The LLM also provides specific page citations that cannot be verified but appear plausible. The answer demonstrates incomplete multi-hop reasoning by failing to synthesize the year-over-year changes in how the facility was described and its strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 429,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "The equity‑compensation tables for each year show that the 2003 Director Compensation Plan has **zero shares remaining for future issuance**: the 2022 table (page 63) lists only the 2009 LTIP, 2014 ESPP and 2018 Director Plan; the 2023 table (page 61) lists the 2009 LTIP, 2014 ESPP and 2018 Director Plan; and the 2024 table (page 59) lists the 2024 LTIP, 2014 ESPP and 2018 Director Plan—none of which include the 2003 plan (see notes (c) on each page). This steady absence indicates that Texas Instruments has fully exhausted the 2003 plan and no longer relies on it for future director compensation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical factual points. Ground truth shows specific share counts for the 2003 Director Compensation Plan: 1,843,134 shares (2022), 1,786,785 shares (2023), and 1,745,284 shares (2024). The LLM claims the plan has 'zero shares remaining' and states it was 'fully exhausted,' which directly contradicts the documented share availability data. The LLM also incorrectly claims the 2003 plan does not appear in the equity compensation tables for any of the three years, when the ground truth explicitly documents its presence with specific share counts in each year's filing. The LLM's reasoning about the plan being absent from tables and exhausted is logically sound IF the premise were true, but the premise is factually wrong. The LLM failed to identify the actual declining trend (1,843,134 → 1,786,785 → 1,745,284) that demonstrates active ongoing use of the plan. The answer demonstrates a complete failure in multi-hop synthesis—it should have extracted share availability data across three years and identified the consistent year-over-year decline. Instead, it made an unsupported assertion about zero shares and plan exhaustion. This is a critical factual error that completely misrepresents Texas Instruments' use of the 2003 Director Compensation Plan.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 366,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "IBM’s 0.950% Notes due 2025 were incorporated by reference in the 2023 10‑K, indicating a relatively modest disclosure level [page_20]. By the 2024 10‑K, the notes were listed as a registered security on the NYSE and disclosed in the securities list, reflecting a shift toward greater market transparency [page_1]. This progression signals IBM’s broader capital‑market strategy of diversifying its debt mix while actively enhancing investor engagement through more open, timely disclosures of its debt instruments.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 0.950% Notes due 2025 as the instrument in question. (2) The LLM accurately captures the progression from 2023 to 2024, noting incorporation by reference in 2023 and NYSE listing with market transparency in 2024. (3) The conclusion about enhanced investor engagement and market transparency aligns with the ground truth's core finding. (4) The mention of the NYSE listing and trading symbol concept is directionally correct.\n\nWEAKNESSES: (1) The LLM omits the 2022 baseline entirely, which is a critical part of the three-year evolution (2022→2023→2024). The ground truth explicitly discusses 2022 as the starting point where the notes were referenced as part of a broader debt list. (2) The LLM does not mention the May 22, 2017 Form 8-K filing (Exhibit 4.1) that was consistently referenced across years—this is an important detail showing continuity of the defining instrument. (3) The LLM does not explicitly mention the trading symbol 'IBM25B' that appears in the ground truth for 2024, though it references NYSE listing. (4) The LLM's characterization of 2023 as 'relatively modest disclosure level' is somewhat vague compared to the ground truth's description of the notes being listed 'alongside newer instruments, suggesting increased prominence.' (5) The LLM adds interpretation about 'diversifying its debt mix' which, while plausible, is not explicitly supported by the ground truth and represents inference beyond the stated facts.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across two years (2023-2024) but fails to complete the full three-year synthesis required by the question. The reasoning about capital market strategy and investor engagement is sound but incomplete without the 2022 baseline.\n\nNUMERIC/DATE ACCURACY: All dates mentioned (2023, 2024) are correct. The percentage (0.950%) is correct. No calculation errors detected.\n\nSEMANTIC EQUIVALENCE: The core message about progression toward greater transparency is preserved, but the incompleteness of the temporal analysis (missing 2022) represents a material gap in answering the question as posed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 578,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "MetLife’s deposit‑method reinsurance balances expanded sharply after 2022: deposit assets grew from $1.8 billion in 2022 (the same level reported for 2021) to $5.1 billion in 2023 and then fell to $4.6 billion in 2024, while deposit liabilities moved from $1.4 billion in 2022 to $1.3 billion in 2023 and $1.2 billion in 2024【page_216】【page_206】. The November 2023 Global Atlantic transaction created $10.3 billion of deposit receivables and transferred $9.5 billion of assets to the reinsurer, a move that leveraged the deposit method for a large, asset‑backed reinsurance deal and allowed MetLife to record significant recoverables and offset deposit liabilities, thereby reducing capital exposure【page_206】. This shift illustrates MetLife’s strategic use of the deposit method to manage risk and optimize capital while expanding its reinsurance portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics and dates. Quantitative verification: (1) Deposit assets: $1.8B (2022) → $5.1B (2023) → $4.6B (2024) - all correct; (2) Deposit liabilities: $1.4B (2022) → $1.3B (2023) → $1.2B (2024) - all correct; (3) Global Atlantic transaction: $10.3 billion in deposit receivables correctly stated. The LLM provides additional context about the $9.5 billion asset transfer, which adds detail beyond the ground truth but does not contradict it. Multi-hop reasoning is sound: the answer correctly synthesizes the evolution of deposit method accounting across three years and connects this to the 2023 Global Atlantic transaction as a strategic inflection point. The characterization of the transaction as 'asset-backed reinsurance' and its role in 'reducing capital exposure' aligns with the ground truth's description of 'more aggressive use of the deposit method to manage risk exposure.' Minor strengths: the answer includes helpful context about the November 2023 timing and explains the mechanism (recording recoverables and offsetting liabilities). No significant errors detected. The only minor limitation is that the answer adds interpretive details (e.g., '$9.5 billion of assets transferred') that, while plausible and consistent with the $10.3B figure, are not explicitly confirmed in the ground truth statement, though this represents elaboration rather than contradiction.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 409,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "3M’s Safety and Industrial segment has continued to list fall‑protection solutions as a core product line in its 2022, 2023 and 2024 10‑K disclosures【page_108】【page_107】【page_110】.  Over the same period, net sales in the segment fell from $11.6 bn in 2022 to $10.96 bn in 2024, yet operating income more than doubled from $1.14 bn to $2.49 bn【page_111】【page_108】, indicating that the company is maintaining and strengthening its focus on workplace‑safety products—especially fall protection—to drive profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about fall protection solutions' evolution in MMM's Safety and Industrial segment from 2022-2024, correctly identifying that fall protection remained a consistent product line across all three years. The qualitative assessment of strategic focus on workplace safety is sound and well-reasoned. However, there are significant quantitative accuracy issues that substantially impact the overall score: (1) The net sales figures appear incorrect or unverified - the LLM states net sales fell from $11.6bn in 2022 to $10.96bn in 2024, but these specific numbers are not confirmed in the ground truth and lack proper verification. (2) The operating income figures ($1.14bn in 2022 to $2.49bn in 2024) are also unverified and represent a claimed doubling that seems inconsistent with the declining revenue trend - this calculation/claim needs verification. (3) The LLM provides specific page references (page_108, page_107, page_110, page_111) but these cannot be independently verified against the ground truth. The ground truth focuses on the consistency of product portfolio language across years (respiratory, hearing, eye and fall protection solutions) rather than financial performance metrics. The LLM answer goes beyond the ground truth by introducing financial data that, while potentially relevant to the question's second part about 'focus on workplace safety solutions,' introduces unverified numbers that could be factually incorrect. The semantic content about fall protection remaining a core component is correct, but the quantitative claims significantly weaken the answer's reliability. The multi-hop reasoning connecting product portfolio consistency to strategic focus is sound, but the financial metrics used to support this reasoning are questionable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 491,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "Altria has kept UST LLC as a wholly‑owned subsidiary of the Group, with its operating arm, U.S. Smokeless Tobacco Company LLC (USSTC), unchanged from 2022 through 2024【page 4】【page 5】【page 60】.  The 2024 filing still reports USSTC as the leading producer of moist smokeless tobacco (MST) and snus within the “oral tobacco products” segment, the same structure noted in 2023 and 2022【page 66】.  This continuity signals Altria’s sustained commitment to a dedicated smokeless‑tobacco business as a core pillar of its transition‑to‑smoke‑free strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies UST LLC as a wholly-owned subsidiary and accurately names USSTC (U.S. Smokeless Tobacco Company LLC) as the operating arm. The statement about MST and snus products in the oral tobacco segment is factually accurate across 2022-2024. The characterization of continuity in structure is correct.\n\nWEAKNESSES - CRITICAL GAPS: (1) The LLM completely omits the $8.8 billion trademark valuation mentioned in the ground truth for 2022, which is a significant quantitative fact. (2) The LLM fails to capture the evolution/progression aspect of the question - it emphasizes 'continuity' and 'unchanged' structure rather than describing how Altria's strategic positioning evolved from 2022 to 2024. (3) The ground truth explicitly mentions Altria's 'Moving Beyond Smoking' initiative and strategic pivot toward reduced-risk tobacco offerings in 2024, which the LLM does not address. (4) The LLM misses the distinction between how Altria emphasized UST's role differently across years (2022 focus on trademarks/amortization, 2023 reaffirmation of subsidiary status, 2024 integration as core operating company under strategic initiative).\n\nMULTI-HOP REASONING: The LLM provides a horizontal synthesis (same structure across years) rather than a vertical/temporal synthesis (how the strategic positioning evolved). The question specifically asks 'how has...evolved' and 'what does this progression reveal' - requiring analysis of change over time and strategic implications. The LLM's answer is more about consistency than evolution.\n\nSEMANTIC MISMATCH: While the LLM's facts about organizational structure are correct, it fundamentally misinterprets the question's focus on strategic evolution and positioning. The ground truth emphasizes increasing alignment with reduced-risk strategy; the LLM emphasizes structural continuity.\n\nQUANTITATIVE: The missing $8.8 billion figure is a material omission, though other structural facts are accurate.\n\nQUALITATIVE: The reasoning about 'sustained commitment' is sound but incomplete - it doesn't capture the strategic pivot or the evolution of how Altria positioned UST across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 583,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "Tesla’s continual inclusion of SolarCity’s 5.45% Solar Bonds, Series 2015/C92‑15 in the 2022, 2023 and 2024 10‑K exhibits shows that the bonds remain outstanding and are still a core part of its debt mix.  The repeated reference signals a strategy of relying on long‑term, fixed‑rate debt—rather than short‑term borrowing or equity—to finance its solar projects, underscoring a commitment to stable, predictable capital for its solar portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the bond series (5.45% Solar Bonds, Series 2015/C92-15), the years referenced (2022, 2023, 2024), and accurately conveys that these bonds remain outstanding and are part of Tesla's debt structure. The quantitative elements are accurate with no calculation errors or incorrect numbers/dates. The answer appropriately synthesizes the multi-hop information about Tesla's financing strategy across three consecutive filings. However, the LLM answer is somewhat less comprehensive than the ground truth in several ways: (1) It omits the specific reference to the 'One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015,' which the ground truth identifies as a key legal/financial linkage; (2) It provides less detail about the strategic implications, such as Tesla's 'confidence in the bond's performance' or its 'alignment with Tesla's broader clean energy business model'; (3) The ground truth emphasizes 'securitized solar debt as a core funding source,' while the LLM focuses more generally on 'long-term, fixed-rate debt.' The LLM's interpretation that the bonds represent a strategy of relying on long-term fixed-rate debt rather than short-term borrowing or equity is logically sound and semantically equivalent to the ground truth's emphasis on 'sustained reliance on structured solar financing mechanisms.' The answer demonstrates correct multi-hop reasoning by connecting the repeated references across three years to a broader strategic pattern. Minor omissions of specific legal details and slightly less nuanced strategic analysis prevent a higher score, but the core factual content and reasoning are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 456,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "IBM’s 10‑K risk‑factor disclosures for debt securities consistently cite “governmental and stock‑exchange regulations” as a risk factor in 2022 (page 22), 2023 (page 11), and 2024 (page 11), with no change in wording, while the equity‑security risk factor remains unchanged, focusing on market volatility. This steady language across three years signals a conservative, transparent capital‑market risk‑management strategy that treats regulatory risk as a persistent, largely uncontrollable factor affecting debt securities.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The identification of stock exchange regulations as a consistent risk factor across 2022-2024 is accurate; (2) The characterization of regulatory risk as persistent and largely uncontrollable aligns with ground truth; (3) The focus on debt securities is appropriate. SIGNIFICANT ISSUES: (1) The LLM claims 'no change in wording' across three years, but the ground truth explicitly states IBM 'expanded on this risk' by 2024, linking it to 'broader market liquidity conditions and customer credit risks' - this represents a material evolution that the LLM missed; (2) The LLM states the equity-security risk factor 'remains unchanged, focusing on market volatility,' but the ground truth does not support this claim about equity securities specifically; (3) The LLM provides specific page numbers (22, 11, 11) without verification against actual filings - these cannot be confirmed as accurate; (4) The LLM's conclusion that there is 'no change in wording' directly contradicts the ground truth's finding of an 'expansion' and 'more integrated view' by 2024. MULTI-HOP REASONING: The LLM failed to synthesize the three-year progression correctly. The ground truth reveals a clear evolution: 2022 (basic risk acknowledgment) → 2023 (reiteration with emphasis on regulatory environment) → 2024 (expansion linking to market liquidity and credit risks). The LLM collapsed this into a static 'no change' narrative. SEMANTIC ISSUES: While the LLM correctly identifies regulatory risk as persistent, it misses the key insight that IBM's risk management strategy evolved to integrate regulatory dynamics with broader financial risk factors. The answer is partially correct on surface-level facts but fundamentally misses the multi-year progression that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 503,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "Across 2022‑2024 the Safety & Industrial segment kept “electrical products and materials for construction and maintenance, power distribution and electrical OEMs” as a core offering (see page 107).  Net sales for that segment fell from $11.6 B in 2022 to $10.96 B in 2023 and held at $10.96 B in 2024 (page 108, 111), while operating income jumped from $1.14 B to $2.32 B and then $2.49 B (page 108, 111).  The 2024 creation of an Industrial Specialties division that bundles these electrical and other industrial specialty products (page 110) signals a deliberate shift toward higher‑margin industrial‑market solutions, underscoring 3M’s strategic repositioning to capture growth in construction‑ and maintenance‑related electrical markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that electrical products remained a core offering across all three years. (2) Financial figures appear reasonable and are presented with proper context (segment net sales and operating income trends). (3) The LLM correctly notes the creation of an Industrial Specialties division in 2024. (4) The multi-hop synthesis across years is attempted with financial data supporting the narrative.\n\nWEAKNESSES: (1) CRITICAL - The LLM answer fundamentally misses the ground truth's key finding about the EVOLUTION of product descriptions across years. The ground truth emphasizes that in 2022, closure systems/masking/packaging were listed alongside electrical products, while in 2023 industrial abrasives and autobody repair were added, and by 2024 the emphasis shifted to 'industrial specialty products' with electrical offerings becoming less prominent in the description. The LLM treats this as static ('kept...as a core offering') rather than showing the actual evolution. (2) The LLM answer focuses heavily on financial metrics (sales and operating income) which, while interesting, are NOT part of the ground truth answer and may distract from the actual question about how the FOCUS evolved. (3) The ground truth explicitly discusses how product descriptions changed year-to-year (what was emphasized, what was added, what was rephrased), but the LLM answer doesn't capture these nuanced shifts in strategic positioning language. (4) The LLM mentions 'Industrial Specialties division' creation in 2024 but doesn't explain how this relates to the specific evolution of electrical product positioning that the ground truth emphasizes. (5) The LLM answer lacks discussion of the 2023 additions (industrial abrasives, autobody repair) that the ground truth identifies as key to understanding the strategic evolution.\n\nQUANTITATIVE ASSESSMENT: The financial numbers provided ($11.6B, $10.96B, $1.14B, $2.32B, $2.49B) cannot be verified against the ground truth, which contains no financial data. However, these numbers appear internally consistent and plausible. The page references (107, 108, 110, 111) suggest proper sourcing.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize across years but does so primarily through financial metrics rather than the product portfolio evolution that the question and ground truth emphasize. The connection between financial performance and strategic positioning is asserted but not deeply explored.\n\nSEMANTIC ALIGNMENT: The LLM answer addresses a different aspect of the question than the ground truth. While both discuss MMM's electrical products focus, the ground truth emphasizes the EVOLUTION of product descriptions and strategic emphasis, while the LLM emphasizes financial performance and divisional reorganization. This represents a partial answer to the question about how the focus 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 761,
        "total_tokens": 2286
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "In 2022, Gilead’s Oceanside, California site was used for commercial retroviral‑vector production and for the clinical manufacturing and process development of biologics candidates (page 11, 2022).  In 2023 the facility’s focus shifted to the clinical and commercial manufacturing and processing of cell‑therapy products (page 12, 2023).  By 2024 the site had returned to its original role, again concentrating on commercial retroviral‑vector manufacturing and biologics process development (page 10, 2024).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CORRECTNESS ISSUES: The ground truth clearly states that in 2022, the Oceanside facility was referenced as part of general R&D operations, NOT for commercial retroviral vector production. The LLM incorrectly claims commercial retroviral-vector production occurred in 2022. The ground truth indicates a progression FROM general R&D (2022) TO clinical manufacturing/process development (2023) TO commercial retroviral vector manufacturing (2024). The LLM reverses this progression, claiming the facility 'returned to its original role' in 2024, which contradicts the ground truth's characterization of 2024 as a new specialized function. (2) ENTITY/TIMELINE ERRORS: The LLM introduces cell-therapy products in 2023, which is not mentioned in the ground truth at all. This appears to be fabricated information. The ground truth makes no mention of cell-therapy products being manufactured at Oceanside. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the three-year progression. It mischaracterizes the 2022 baseline (claiming commercial production when ground truth says general R&D), misidentifies 2023 activities (adding cell-therapy when ground truth says clinical manufacturing/process development), and misinterprets 2024 as a 'return' rather than a new strategic emphasis. (4) SEMANTIC MEANING: The fundamental narrative is inverted - the ground truth describes an evolution toward specialization and scale-up, while the LLM describes a cycle that returns to an earlier state. These are contradictory interpretations. The LLM answer is largely incorrect on the core facts of the facility's evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 466,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "AIG’s glide‑path strategy has steadily reduced the equity (Return‑Seeking) target.  In 2022 the plan’s target allocation for equity securities was 15 % (2021 Form 10‑K, page 310).  By 2024 the target had fallen to 9 % equity (2023 Form 10‑K, page 252).  The 2023 target is not disclosed, but the actual 2023 allocation was 8 % equity, indicating a continued glide toward a more conservative, liability‑hedged mix as the plan’s funded ratio improved.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the ground truth and provides incorrect information. Key issues: (1) MISALIGNMENT WITH GROUND TRUTH: The original answer explains that AIG's glide path approach evolved in how target allocations were SET (based on different funded status dates), not in the actual percentage values themselves. The LLM incorrectly claims the equity target fell from 15% to 9%, suggesting a directional change in strategy, when the ground truth indicates the approach remained consistent in strategy but evolved in timing/methodology. (2) QUANTITATIVE ERRORS: The LLM provides specific percentages (15% in 2022, 9% in 2024, 8% actual in 2023) that cannot be verified against the ground truth provided. The ground truth does not specify these exact percentages, making these claims unsubstantiated. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution of the glide path approach across three years (2022, 2023, 2024) with target allocations for each. The LLM only addresses two years clearly and misses the core insight that the glide path remained strategically consistent while the timing of allocation adjustments evolved based on funded status measurements. (4) SEMANTIC MISINTERPRETATION: The LLM interprets 'glide path evolution' as a reduction in equity allocation percentages, when the ground truth indicates evolution in the forward-looking methodology (allocations set for future years based on current funded status). (5) MISSING KEY CONTEXT: The LLM fails to explain that 2022 allocations were based on 2021 funded status, 2023 allocations were set for 2024 based on 2023 funded status, and 2024 allocations were set for 2025 based on 2024 funded status—this dynamic, forward-looking adjustment is the core of the answer. The LLM's narrative about 'steady reduction' and 'glide toward more conservative mix' contradicts the ground truth's emphasis on consistent strategy with evolving implementation timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 529,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "ACN kept its U.S. plans 100 % debt‑heavy throughout, but for non‑U.S. plans the target mix shifted from fiscal 2023 to fiscal 2025: debt fell from 48 % to 36 %, equity rose from 27 % to 28 %, cash increased from 4 % to 7 %, insurance contracts jumped from 11 % to 21 % and “other” dropped from 10 % to 8 % (see pages 88 and 95). This modest re‑balancing toward higher‑return, higher‑risk assets—especially the larger insurance‑contract allocation—indicates a cautious but slightly more aggressive long‑term risk tolerance, aiming to enhance returns while still maintaining a debt‑dominant core.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth in multiple critical ways: (1) FACTUAL MISMATCH: The ground truth discusses ACN's target asset allocation strategy evolution and planning horizon extension (fiscal 2023→2024 vs fiscal 2024→2025), emphasizing flexibility, risk-adjusted returns, and a shift toward more strategic (less reactive) positioning. The LLM answer instead provides specific percentage allocations for U.S. vs non-U.S. plans with detailed breakdowns (debt 48%→36%, equity 27%→28%, etc.). These are completely different narratives. (2) QUANTITATIVE ACCURACY FAILURE: The LLM provides specific percentages (48%, 36%, 27%, 28%, 4%, 7%, 11%, 21%, 10%, 8%) that cannot be verified against the ground truth, which contains no such specific allocation percentages. The ground truth emphasizes qualitative strategic shifts (planning horizon extension, flexibility language, measured approach) rather than quantitative asset mix changes. (3) ENTITY/METRIC CONFUSION: The LLM distinguishes between U.S. and non-U.S. plans with specific allocations, but the ground truth makes no such distinction and focuses instead on target allocation planning methodology and time horizons. (4) REASONING DISCONNECT: The ground truth's key insight is about increased confidence in long-term outlook evidenced by extending planning from 1-year to 2-year horizons. The LLM's reasoning about 'cautious but slightly more aggressive' risk tolerance based on asset mix rebalancing is a different analytical framework entirely. (5) MISSING CORE ANSWER: The LLM completely fails to address the actual evolution described in ground truth—the shift from one-year to two-year planning horizons and what this suggests about strategic confidence. Instead, it provides asset allocation percentages that appear to be either fabricated or from a different section of the filing than what the ground truth references. The citation to 'pages 88 and 95' cannot be verified against the ground truth provided. This represents a fundamental failure to synthesize the correct information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 558,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "Tesla’s 5.45% Solar Bonds, Series 2015/C25‑15 were issued in 2015 and have remained unchanged in the company’s debt portfolio, with the same supplemental indenture appearing in each year’s 10‑K exhibit list (2022: page 100; 2023: page 98; 2024: page 97). No new issuance or restructuring of that bond series is disclosed in those filings, indicating that Tesla continues to rely on the original long‑term debt to finance its solar projects. This consistency across three years shows a conservative, long‑term solar‑financing strategy that prioritizes predictable, stable debt terms over frequent refinancing or new bond issues.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that substantially diverge from the ground truth. Key issues: (1) INCORRECT ISSUANCE DATE: The LLM claims the bonds were 'issued in 2015,' but the ground truth indicates these are SolarCity-originated bonds acquired through Tesla's acquisition of SolarCity (which occurred in 2016). The bond series designation '2015/C25-15' refers to the original SolarCity issuance structure, not Tesla's issuance date. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth explicitly documents an evolution showing: 2022 referenced multiple series (C5-15, C10-15, C20-15, C25-15), 2023 added newer structures (C28-15, C33-15), and 2024 maintained C25-15. The LLM completely misses this expansion pattern and the introduction of newer bond series, which is central to understanding Tesla's evolving solar financing strategy. (3) MISCHARACTERIZATION OF STRATEGY: The LLM describes a 'conservative, long-term' strategy with 'no new issuance or restructuring,' but the ground truth reveals an active expansion of the financing framework with new bond series being added. This is a fundamental misinterpretation of the strategic pattern. (4) PAGE NUMBER CLAIMS: While the LLM provides specific page numbers (100, 98, 97), these cannot be verified against the ground truth and appear to be fabricated details. (5) MISSING CONTEXT: The LLM fails to address the SolarCity acquisition context and the strategic significance of maintaining and expanding this structured financing approach. The answer demonstrates surface-level consistency observation but fails to capture the actual evolution and expansion of Tesla's solar financing strategy across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 469,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "From 2022 to 2024 AIG’s approach to international terrorism exposure stayed largely the same: it continued to use a third‑party vendor model for scenario‑based loss estimates, with the 2022 filing disclosing a $1.3 billion estimate for a five‑ton bomb attack (10‑K 2022, p. 169). The 2023 filing repeated that modeling framework and the same mix of mitigation tools—TRIPRA for U.S. coverage, targeted private reinsurance for selected lines, and participation in government‑sponsored terrorism pools abroad—without issuing a new numeric estimate (10‑K 2023, p. 121). By 2024 AIG maintained the same core strategy, relying on scenario‑based modeling, TRIPRA, targeted reinsurance, and international terrorism pools, again without updating the loss estimate (10‑K 2024, p. 86).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the $1.3 billion loss estimate for the five-ton bomb attack in New York City from 2022, matching the ground truth exactly. (2) The LLM accurately captured the core mitigation tools (TRIPRA, reinsurance, government-sponsored pools) used across all three years. (3) The general characterization of the approach as 'scenario-based modeling' is correct. (4) The observation that 2023 and 2024 did not issue new numeric estimates is reasonable. CRITICAL WEAKNESSES: (1) The LLM completely missed the $38.0 billion reinsurance recoverable assets figure mentioned in the ground truth for 2024—a significant quantitative omission that represents a major evolution in risk transfer mechanisms. (2) The LLM failed to capture the 2023 shift toward 'active management and monitoring of exposure concentrations' with emphasis on 'disciplined reinsurance purchases'—this represents a qualitative evolution that the ground truth explicitly highlights. (3) The LLM missed the 2024 enhancement of 'global property per risk covers' and the specific retention of 'core attachment points for Japan at $200 million'—these are concrete examples of how the strategy evolved in 2024. (4) The LLM's characterization of the evolution as 'largely the same' contradicts the ground truth's narrative of meaningful evolution in reinsurance structure, global coverage specificity, and risk transfer scaling. MULTI-HOP REASONING: The LLM failed to synthesize the full picture of evolution across the three-year period. While it correctly identified continuities, it missed the key inflection points and enhancements that distinguish 2023-2024 from 2022. The answer reads as a static description rather than a dynamic evolution narrative. QUANTITATIVE GAPS: Missing the $38.0 billion figure is a significant omission that undermines the answer's completeness on risk transfer mechanisms. The answer provides only 1 of at least 3 key quantitative data points (the $1.3B estimate, the $200M Japan attachment point, and the $38.0B reinsurance recoverable assets).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 556,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "Honeywell’s 10‑K filings for 2022, 2023 and 2024 all list the same risk for its Safety and Productivity Solutions segment: adverse industry economic conditions that could erode market share, selling prices and margins. The exposure remained consistently highlighted each year, indicating no change in the company’s view of the threat. The specific risks repeatedly cited as driving margin pressure were reduced investments in process automation, safety monitoring and plant‑capacity‑utilization initiatives, retail‑market fluctuations, a slowdown in demand for safety products, competitive pressure from new entrants and technologies that commoditize products, and the broader adverse industry economic environment.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core theme that Honeywell's Safety and Productivity Solutions segment faced consistent adverse industry economic conditions from 2022-2024, with proper year-by-year coverage. The answer accurately captures several key risks: reduced investments in process automation, retail market fluctuations, commoditization from new entrants, and margin compression. The temporal framing (2022, 2023, 2024) is correct, and the conclusion about persistent vulnerability is sound. WEAKNESSES: (1) The LLM introduces 'safety monitoring and plant-capacity-utilization initiatives' as specific risks, which are NOT mentioned in the ground truth answer. This represents potential fabrication or conflation of details not supported by the source material. (2) The LLM states 'no change in the company's view of the threat' which contradicts the ground truth's more nuanced observation that risks were 'reiterated' with 'additional mention' of adverse industry economic conditions in 2023, suggesting some evolution rather than static repetition. (3) The LLM fails to explicitly mention the segment restructuring (Industrial Automation as the renamed entity) that the ground truth emphasizes as important context for understanding the 2024 period. (4) The phrase 'slowdown in demand for safety products' is mentioned by the LLM but not explicitly in the ground truth answer. MULTI-HOP REASONING: The LLM demonstrates adequate synthesis across three years and correctly identifies the persistent pattern, but misses the structural reorganization element that provides important context for the evolution. The reasoning is generally sound but incomplete in capturing the full narrative arc. FACTUAL ACCURACY: No specific numbers or calculations are involved in this question, so quantitative accuracy is high where applicable. However, the introduction of unsupported specific risks reduces overall factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 524,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "In 2022 Pfizer granted Breakthrough Performance Awards (BPAs) and valued them at intrinsic value using the closing price of its common stock, amortizing the resulting expense straight‑line over the probable vesting term into cost of sales, selling, informational and administrative or R&D expenses (page 99). By 2023 and 2024 the company reported that no BPAs were granted or outstanding (page 97) and continued to apply the same intrinsic‑value valuation and straight‑line expense recognition methodology, adjusting the expense each period for changes in stock price and the likelihood of meeting performance criteria (page 96).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of BPA treatment but has significant gaps in quantitative specificity. CORRECT ELEMENTS: (1) The answer correctly identifies that BPAs were granted in 2022 using intrinsic value methodology; (2) Correctly states no BPAs were granted or outstanding in 2023-2024; (3) Accurately describes the valuation methodology (intrinsic value, straight-line amortization); (4) Correctly notes adjustments for stock price changes and performance criteria. CRITICAL OMISSIONS: (1) The ground truth specifies 1,165 thousand BPAs granted in 2022 with a weighted average intrinsic value of $38.73 per share - the LLM answer completely omits these specific quantitative metrics; (2) The ground truth states 859 thousand BPAs remained nonvested at end of 2022 - this detail is missing; (3) The LLM answer lacks the specific numerical data that demonstrates the scale and progression of the program. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly traces the evolution from 2022 (active grants) through 2023-2024 (wind-down and methodology focus). However, the answer reads more like a general description of accounting treatment rather than a detailed evolution analysis. SEMANTIC ISSUES: The answer is somewhat vague about the 'shift' or 'evolution' - it doesn't clearly articulate the dramatic change from 1,165 thousand grants in 2022 to zero in 2023-2024. The page references provided appear reasonable but cannot be verified. The answer would score higher if it included the specific grant quantities and per-share valuations that are central to understanding how the program evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 449,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "Accenture’s share‑buyback program has expanded dramatically.  In fiscal 2022 the company repurchased 12.18 million shares for $4.11 million and, after adding $3 million in new authority, had an aggregate available authorization of $6.13 million【page_94】.  By fiscal 2024 it had repurchased shares worth $4.5 billion and its total outstanding repurchase authority had risen to $6.694 billion after a $4,000 million increase【page_39】.  This trajectory – from modest repurchases and a small authorized pool to a multi‑billion‑dollar buy‑back program and a large, flexible authorization – signals Accenture’s commitment to an increasingly aggressive capital‑return strategy that prioritizes shareholder value.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains severe quantitative inaccuracies that fundamentally undermine its credibility. (1) MAJOR NUMBER ERRORS: The LLM states fiscal 2022 repurchased shares were worth '$4.11 million' and had '$6.13 million' in authorization - these are off by orders of magnitude (should be billions). The ground truth shows $3,129,296,000 (~$3.1 billion) in fiscal 2022 authorization, not $6.13 million. (2) CALCULATION ERRORS: The LLM claims 'after adding $3 million in new authority' - this is nonsensical given the scale of actual repurchase programs. The ground truth indicates $4,000 million in new authority by fiscal 2024, not $3 million. (3) PARTIAL CORRECTNESS: The LLM correctly identifies the final fiscal 2024 total of $6.694 billion and the $4,000 million increase, but these correct numbers are contradicted by the earlier incorrect figures. (4) MULTI-HOP SYNTHESIS FAILURE: While the LLM attempts to show evolution across fiscal years, the intermediate data points are wildly inaccurate, breaking the logical chain of reasoning. The ground truth shows: FY2022 authorization ~$3.1B → FY2023 partial spending → FY2024 remaining $2.694B + $4B new = $6.694B total. The LLM's progression is internally inconsistent and factually wrong. (5) QUALITATIVE ASSESSMENT: The conclusion about 'increasingly aggressive capital-return strategy' is reasonable in tone, but is built on false premises and incorrect numbers. The semantic intent about commitment to shareholder returns is present but undermined by factual errors. The answer demonstrates a fundamental misunderstanding or misreporting of the financial magnitudes involved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 452,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "Pfizer sold Meridian in 2021 for about $51 million and recorded a $167 million loss (Meridian‑On December 31, 2021, Discontinued operations‑net of tax)【page_75】.  After the divestiture the company entered into interim TSAs and a three‑year MSA (with a two‑year extension) to continue providing services; the TSAs were completed by Dec 31 2023 and the MSA remained in effect, but amounts recorded under either arrangement in 2022 and 2023 were not material to operations【page_75】【page_74】.  The 2024 Form 10‑K pages provided contain no new mention of Meridian, indicating that the post‑divestiture relationship has remained limited to the existing MSA and TSAs with no material financial impact or new strategic alignment beyond a service‑level agreement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and dates. Key strengths: (1) Correctly identifies the December 31, 2021 sale date for $51 million with $167 million loss net of tax - these match the ground truth exactly. (2) Accurately describes the post-divestiture relationship including TSAs (Transition Service Agreements) and MSA (Master Service Agreement), with correct timeline (TSAs completed by Dec 31, 2023, MSA with two-year extension remaining). (3) Properly notes that amounts recorded were not material to operations in 2022-2023. (4) Correctly identifies that 2024 Form 10-K contains no new mention of Meridian. (5) Multi-hop reasoning is sound - synthesizes information across multiple years and filing types to show the evolution from divestiture through post-sale service arrangements to eventual disengagement.\n\nMinor areas for improvement: (1) The LLM answer provides more operational detail about TSAs and MSAs than the ground truth, which focuses on the progression from discontinued operations → divestiture → definitional reference only. While this additional detail is accurate and relevant, it slightly shifts emphasis from the 'complete strategic disengagement' narrative in the ground truth. (2) The ground truth emphasizes the 2024 status as 'mere definitional reference' in glossary terms, while the LLM focuses on the MSA remaining in effect - both are accurate but represent different framings of the post-divestiture relationship. (3) The LLM could have been more explicit about the transition from 'discontinued operations' classification in 2022 to full divestiture completion.\n\nQuantitative verification: All numbers are correct ($51M sale price, $167M loss, Dec 31 2021 date, Dec 31 2023 TSA completion). No calculation errors detected. The answer successfully synthesizes multi-hop information across 2021-2024 periods and multiple agreement types.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 520,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "The Amended 2010 Share Incentive Plan’s authorized pool was **127 million Class A shares in FY 2022 and FY 2023** (page 91 of the 2022 10‑K and 2023 10‑K). It rose to **141 million shares in FY 2024** (page 98 of the 2024 10‑K). The steady pool in 2022‑23 followed by a 14 % expansion in 2024 signals Accenture’s intent to keep a sizable equity‑compensation reserve, underscoring a long‑term strategy that prioritizes share‑based awards for talent attraction, retention, and alignment with shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding FY 2022 and FY 2023 share counts. According to the ground truth, FY 2022 had 127 million shares authorized, but FY 2023 increased to 141 million shares. The LLM incorrectly states that both FY 2022 and FY 2023 had 127 million shares, then claims a rise to 141 million in FY 2024. This is backwards from the actual progression. The correct evolution is: FY 2022 (127M) → FY 2023 (141M) → FY 2024 (141M), not 127M → 127M → 141M as the LLM states. This represents a significant misreading of the data across multiple fiscal years. The LLM's characterization of a '14% expansion in 2024' is also incorrect—the expansion occurred between 2022 and 2023 (10.2% increase), while 2024 maintained the 2023 level with no change. The multi-hop synthesis failed because the LLM did not correctly track the year-by-year progression across the three-year period. While the LLM correctly identifies the company (Accenture plc), the metric (Amended 2010 SIP Class A shares), and provides reasonable strategic interpretation about talent retention and equity compensation strategy, the core numerical facts are materially wrong. The reasoning about long-term strategy is qualitatively sound but is built on incorrect data points, undermining the entire answer's credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 378,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "Tesla consistently disclosed the 4.70% Solar Bonds, Series 2015/C52‑10 in each filing, with the same supplemental indenture (Exhibit 4.49) appearing on page 102 of the 2022, 2023, and 2024 10‑Ks and no changes to its terms or status. This unchanged disclosure indicates that the company continues to hold the bond as a long‑term financing instrument and has no immediate plans to refinance or retire it. The pattern suggests a strategic priority of maintaining a stable debt structure and leveraging solar bonds as part of its diversified financing strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER INCONSISTENCY: The LLM claims Exhibit 4.49 appears in all three years (2022, 2023, 2024), but the ground truth explicitly states the exhibit numbers changed: Exhibit 4.49 (2022), Exhibit 4.42 (2023), Exhibit 4.40 (2024). This is a significant factual error that contradicts the core finding. (2) PAGE NUMBER CLAIM: The LLM states the exhibit appears on page 102 of all three 10-Ks, but this specific page number is not mentioned in the ground truth and appears to be an unsupported assertion. (3) INCOMPLETE MULTI-HOP SYNTHESIS: While the ground truth carefully tracks the changing exhibit numbers across years while noting the underlying document (Seventieth Supplemental Indenture with June 16, 2015 filing date) remained the same, the LLM conflates these two distinct pieces of information. The exhibit numbers changing is material information that the LLM missed. (4) REASONING QUALITY: The LLM's interpretation about 'no immediate plans to refinance or retire' and 'long-term financing instrument' goes beyond what can be inferred from the ground truth, which focuses on consistent re-disclosure without material modification. (5) WHAT WAS CORRECT: The LLM correctly identified the bond series name (4.70% Solar Bonds, Series 2015/C52-10), correctly noted consistent disclosure across three years, and correctly inferred stable financial commitment. However, the factual errors about exhibit numbers are fundamental to answering a question specifically about how disclosures 'changed or remain consistent.' The changing exhibit numbers represent a form of change that the LLM failed to capture.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 450,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "Adobe’s free, self‑service learning catalog has remained a core element of its Digital Learning Services portfolio from 2022 through 2024.  In 2023 the 10‑K described it as “a large number of free online self‑service learning options on learning.adobe.com” that complement fee‑based training (page 18, 2023).  By 2024 the same offering was re‑branded to “training.adobe.com” and highlighted as a foundational part of Adobe Customer Solutions’ broader learning‑and‑enablement services, underscoring its role in accelerating customer adoption and reducing support costs (page 18, 2024).  The 2022 filing (page 18, 2022) used the same language, showing a consistent positioning that evolved only in the platform’s name and its explicit emphasis as a key driver of customer adoption.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual inversion that contradicts the ground truth. The ground truth clearly states that in 2022, Adobe's offering was hosted on 'www.training.adobe.com' and by 2023 it moved to 'learning.adobe.com'. However, the LLM answer reverses this timeline, claiming the 2024 offering was 're-branded to training.adobe.com' from learning.adobe.com. This is backwards. The LLM states '2023 the 10-K described it as...on learning.adobe.com' and 'By 2024 the same offering was re-branded to training.adobe.com' - this directly contradicts the ground truth which shows training.adobe.com in 2022 and learning.adobe.com in 2023-2024. Additionally, the LLM introduces unsupported claims about 'reducing support costs' and 'Adobe Customer Solutions' that are not mentioned in the ground truth. The LLM also cites specific page numbers (page 18 for all three years) without verification against actual filings. While the LLM correctly identifies the offering as part of Digital Learning Services and acknowledges its role in customer adoption, the platform name timeline is fundamentally inverted, which is a critical factual error for a question specifically asking about evolution over time. The answer demonstrates partial understanding of the general concept but fails on the specific chronological details that are central to answering 'how did it evolve.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 391,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "AIG’s glide‑path strategy has become more conservative as the plan’s funded status improved. In 2022 the target allocation for the Return‑Seeking portion (equity securities) was 15 % of the U.S. qualified plan assets【page_310】. By the 2024 measurement the target had fallen to 9 %—the same level that will be used in 2025—reflecting the glide‑path rule that reduces growth‑asset allocation and increases liability‑hedging assets when the plan’s funded ratio rises【page_252】【page_184】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides specific, quantifiable information about AIG's glide path evolution that goes beyond the ground truth answer. Strengths: (1) Correctly identifies the specific percentages for Return-Seeking allocation: 15% in 2022 and 9% in 2024/2025, demonstrating concrete data synthesis across multiple years. (2) Accurately captures the core mechanism: the glide path reduces growth-asset allocation as funded ratio improves. (3) Properly identifies the relationship between funded status improvement and de-risking strategy. (4) Correctly cites relevant page numbers suggesting proper source documentation. (5) The directional logic is sound—showing a decrease from 15% to 9% reflects increasing conservatism as funded status improved. Minor considerations: (1) The ground truth explicitly states 'specific percentages for the Return-Seeking portion are not listed in the provided excerpts,' yet the LLM provides specific percentages (15% and 9%). This creates a discrepancy—either the LLM found data the ground truth says wasn't available, or the LLM may have hallucinated these numbers. However, the percentages appear reasonable and internally consistent with the narrative. (2) The ground truth emphasizes the annual recalibration process (2022 allocation based on 2021 funded status, 2024 allocation based on 2023 funded status, etc.), while the LLM focuses more on the outcome percentages rather than the timing mechanism. (3) The LLM answer is more concrete and actionable than the ground truth, which acknowledges missing specific data. The quantitative accuracy is high if the 15% and 9% figures are correct from the source documents. The qualitative reasoning about the glide path mechanism and its relationship to funded status is sound and well-explained.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 483,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "Honeywell’s risk‑factor disclosures for the Performance Materials and Technologies segment consistently flag raw‑material demand and supply risk each year.  In 2022 (page 30) the bullet lists “raw material demand and supply” as a key risk; the 2023 filing (page 32) repeats the same language and adds that 64 % of the segment’s raw‑material supply base was under contract as of December 31, 2023; and the 2024 filing (page 30) again cites the same risk without a new contract‑coverage figure.  The unchanged emphasis across 2022‑2024 indicates that Honeywell remains materially exposed to commodity‑price volatility, as fluctuations in raw‑material demand and supply can still materially affect its operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides some accurate details but significantly diverges from the ground truth in key ways: (1) QUANTITATIVE ACCURACY: The LLM correctly cites the 64% contract coverage figure for 2023, which is verifiable. However, it provides page numbers (30, 32, 30) that cannot be verified against the ground truth and may be inaccurate. (2) COMPLETENESS & MULTI-HOP REASONING: The ground truth describes a clear 3-year evolution with specific contextual changes: 2022 framed around COVID-19 pandemic impacts and supply chain disruptions; 2023 emphasized chemical/refining/semiconductor plant utilization rates; 2024 added emphasis on oil and natural gas price volatility affecting customer investment. The LLM answer characterizes the risk as 'unchanged emphasis across 2022-2024,' which directly contradicts the ground truth's narrative of an 'intensifying' risk profile with evolving contextual factors. (3) ENTITY & SEMANTIC ACCURACY: Both correctly identify Honeywell and the Performance Materials and Technologies segment. However, the LLM misses critical nuances: it states the risk was 'repeated' with 'unchanged emphasis,' while the ground truth shows the risk evolved in character and context each year. (4) REASONING QUALITY: The LLM's conclusion that 'unchanged emphasis...indicates...Honeywell remains materially exposed' is logically sound but based on an incomplete analysis. The ground truth suggests the vulnerability is not merely sustained but 'intensifying' due to changing market conditions (energy volatility). The LLM fails to capture this progression. (5) MISSING CONTEXT: The LLM omits the specific contextual drivers mentioned in ground truth (COVID-19 impacts in 2022, plant utilization rates in 2023, energy price volatility in 2024), which are essential to answering how the exposure 'evolved.' The answer reads as static rather than dynamic. Overall, while some facts are correct, the fundamental characterization of the trend is incorrect, and critical contextual details are missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 543,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "ACN’s pension plan’s fair value of mutual‑fund equity securities fell from **$239,293** in 2022 to **$196,226** in 2023, then climbed to **$273,699** in 2024. The 3‑year swing—down in 2023 followed by a rebound in 2024—indicates a flexible, market‑responsive asset‑allocation strategy that rebalances equity exposure to stay within target percentages (≈19 % in 2023, 23 % in 2024) while seizing growth opportunities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental and material error in the 2024 figure. Ground truth states mutual fund equity securities remained unchanged at $196.226 million in 2024, but the LLM claims they climbed to $273.699 million. This is a $77.473 million discrepancy (39% overstatement) - a massive error for a financial metric. The LLM's claim that 2024 saw a 'rebound' is completely false. The 2022 ($239.293M) and 2023 ($196.226M) figures are correctly stated in the LLM answer (though formatted without decimal points as $239,293 and $196,226, which is acceptable). However, the 2024 value is entirely wrong. The LLM's interpretation of the trend is therefore fundamentally flawed - it describes a 'down then rebound' pattern when the actual pattern is 'down then stable.' The LLM's reasoning about 'market-responsive asset allocation strategy' and the specific percentage targets (19% in 2023, 23% in 2024) cannot be verified from the ground truth and appear to be fabricated or misattributed. The ground truth's conclusion about 'stabilized allocation approach' is the correct interpretation. The LLM failed the primary requirement of financial accuracy - getting the numbers right. This is a critical failure for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 364,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "In 2022, Adobe positioned Document Cloud mainly as a PDF‑ and e‑signature platform—Acrobat and Acrobat Sign—focused on creating, reviewing, signing and storing documents, as reflected in its Digital Media segment revenue of about $1.97 billion (2022)【page_70】. By 2024, Adobe re‑positioned Document Cloud as an AI‑enabled digital‑workflow engine, integrating Firefly generative‑AI across Acrobat and adding the Acrobat AI Assistant for summarization, content generation and automated workflow actions, while expanding API services to embed these capabilities into enterprise workflows【page_10】【page_12】【page_13】. This shift moved Document Cloud from a core PDF tool to a broader, AI‑driven platform that powers automated, intelligent document processes across enterprise environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core narrative of Document Cloud's evolution from a PDF/e-signature platform to an AI-enabled workflow engine, which aligns with the ground truth's main thesis. However, there are significant issues with the answer's accuracy and completeness:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites Digital Media segment revenue of $1.97 billion for 2022, but this appears to be a specific number that cannot be verified against the ground truth provided. The ground truth does not provide specific revenue figures for Document Cloud or the Digital Media segment.\n   - The citation references (page_70, page_10, page_12, page_13) suggest the answer is drawing from specific documents, but the ground truth does not validate these specific numbers.\n   - No calculation errors are apparent, but the quantitative claims lack verification.\n\n2. COMPLETENESS ISSUES:\n   - The LLM answer focuses heavily on 2022 and 2024, but largely omits 2023, which the ground truth identifies as a critical transition year where Document Cloud was \"elevated as a core component of the Digital Media segment\" and \"positioned alongside AI-driven tools like Adobe Express and Firefly.\"\n   - The ground truth emphasizes the 2023 positioning shift as a key milestone; the LLM answer jumps from 2022 to 2024, missing this important intermediate evolution.\n   - The ground truth mentions Document Cloud's role in the \"Publishing and Advertising segment\" in 2022, but the LLM describes it as part of the \"Digital Media segment\" in 2022, which may represent a factual discrepancy.\n\n3. ENTITY AND SEMANTIC ACCURACY:\n   - The LLM correctly identifies Firefly, Acrobat, Acrobat Sign, and Acrobat AI Assistant as key components.\n   - The characterization of the evolution (from PDF tool to AI-driven platform) is semantically aligned with the ground truth.\n   - However, the LLM's description of 2022 positioning as \"PDF and e-signature platform\" is more specific than the ground truth's \"document and forms platform\" within the Publishing and Advertising segment, suggesting potential misalignment in segment classification.\n\n4. MULTI-HOP REASONING:\n   - The LLM successfully synthesizes information across 2022 and 2024 to show the transformation.\n   - However, the failure to incorporate 2023 as a distinct transition year weakens the multi-hop reasoning, as the ground truth explicitly identifies 2023 as a pivotal year for repositioning.\n   - The answer does not adequately explain the progression through three distinct phases (2022 legacy role → 2023 modernization → 2024 AI-enhanced enterprise tool).\n\n5. SPECIFIC GROUND TRUTH GAPS:\n   - The ground truth mentions Document Cloud's elevation in 2023 \"alongside Adobe Express and Firefly\" but the LLM answer does not acknowledge this 2023 positioning shift.\n   - The ground truth emphasizes the shift from \"legacy infrastructure component\" to \"strategically positioned, AI-enhanced productivity suite,\" which the LLM captures in spirit but without the explicit 2023 transition point.\n\nOVERALL ASSESSMENT: The LLM answer demonstrates understanding of the general transformation narrative but fails to capture the complete three-year evolution with proper emphasis on 2023 as a transition year. The quantitative claims lack verification, and the segment classification for 2022 may be inaccurate. The answer is partially correct but incomplete in its multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 904,
        "total_tokens": 2364
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "Honeywell’s risk‑factor disclosures for 2022, 2023 and 2024 all repeatedly cite new market entrants, non‑traditional players and technology disruption across every reportable segment—Aerospace Technologies, Industrial Automation, Building Automation, Energy & Sustainability Solutions and Safety & Productivity Solutions.  The language consistently warns that these forces can erode market share and pricing power, with particular emphasis on product commoditization in Industrial Automation, Safety & Productivity Solutions and Energy & Sustainability Solutions.  While the company’s 2024 realignment into new segments reflects a strategic response to intensified competition, the risk‑factor wording shows no reduction in exposure; the threat of new entrants and tech disruption remains a persistent concern for all business units.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) ENTITY ACCURACY PROBLEM: The LLM answer lists 'Aerospace Technologies' and 'Energy & Sustainability Solutions' as reportable segments affected by competitive pressures. The ground truth explicitly states that in 2022, only 'Honeywell Building Technologies' and 'Safety and Productivity Solutions' cited these risks, and that Aerospace was only added in 2023. The LLM's claim that 'every reportable segment' was affected across all three years contradicts the ground truth's clear progression showing expansion from 2 segments (2022) to more segments (2023) to restructured units (2024). (2) TEMPORAL PROGRESSION MISSING: The ground truth emphasizes a critical 3-year evolution—starting narrow (2 segments in 2022), expanding (more segments in 2023), then restructuring (2024). The LLM flattens this progression by stating risks were cited 'for 2022, 2023 and 2024 all repeatedly' across 'every reportable segment,' missing the key insight that exposure EVOLVED and EXPANDED over time. (3) SEGMENT NAMING INCONSISTENCY: The ground truth references 'Honeywell Building Technologies' in 2022 and 'Building Automation' in 2024, showing the company's restructuring. The LLM uses 'Building Automation' without acknowledging this naming/structural change. (4) MISSING KEY DETAIL: The ground truth notes that by 2024, there was 'sharper focus on product commoditization and the accelerating pace of new entrants'—a qualitative escalation. The LLM mentions commoditization but doesn't capture the 'accelerating pace' emphasis or the sharpening of focus. (5) CORRECT ELEMENTS: The LLM correctly identifies that competitive pressures involve new entrants, technological disruption, and impacts on market share/pricing power. The observation that 2024 restructuring reflects strategic response is reasonable. QUANTITATIVE: No specific numbers to verify, but the claim about 'every reportable segment' across all years is factually incorrect based on ground truth's explicit progression. REASONING: The LLM fails the multi-hop synthesis by not properly tracking how exposure evolved across the three-year period and how business restructuring changed the framing of competitive risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 587,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "Pfizer’s transition‑service arrangements with Viatris were largely finished by the end of 2023.  Net amounts due to Viatris fell from $94 million on December 31, 2022 to $33 million on December 31, 2023, reflecting the winding down of the TSAs (page_73).  The 2024 10‑K does not report new intercompany balances, indicating the TSAs remain largely completed and the balances are not material to Pfizer’s operations (page_12).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and dates. All quantitative data is accurate: $94 million in 2022, $33 million in 2023, and the timeline of TSA completion by end of 2023. The multi-hop synthesis across years is sound, correctly tracking the evolution of the relationship from 2022-2024. The answer appropriately identifies the key metrics (intercompany balances, TSA status) and entities (Pfizer, Viatris). However, there are minor gaps in completeness: (1) The original answer explicitly states that by 2024 the relationship was 'referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved,' which conveys a more complete picture of the full wind-down. The LLM answer states the 2024 10-K 'does not report new intercompany balances' but doesn't explicitly confirm the complete resolution of operational interdependencies. (2) The original answer emphasizes 'consistent reduction in financial exposure and operational entanglement' as a key theme, while the LLM answer focuses more narrowly on the TSAs being 'largely completed' and balances being 'not material.' These are semantically similar but the original provides slightly more comprehensive framing. The page citations (page_73, page_12) add credibility but cannot be verified in this evaluation. Overall, the answer is substantially correct with accurate numbers and sound reasoning, but lacks the full contextual completeness of the ground truth regarding the complete resolution by 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 430,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "Altria’s debt mix shifted from a short‑term 1.000% Notes due 2023 in 2022 to a more diversified structure that includes the 1.700% Notes due 2025 as a mid‑term instrument and longer‑term 2.200% Notes due 2027 and 3.125% Notes due 2031 in 2023 and 2024, with the 2025 notes remaining a constant component (page_1 2022; page_1 2023; page_1 2024). This evolution shows the company retiring the 2023 notes and extending maturities, reflecting a strategy to lock in lower rates, diversify maturity profiles, and reduce refinancing risk. The consistent presence of the 2025 notes alongside longer‑term debt underscores a deliberate move toward a more stable, long‑term capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core narrative about Altria's debt evolution and capital structure strategy, but introduces unverified information that deviates from the ground truth. CORRECT ELEMENTS: (1) The 1.000% Notes due 2023 existed in 2022 and matured/were no longer listed by 2023 - matches ground truth. (2) The 1.700% Notes due 2025 remained as a constant component across the period - matches ground truth. (3) The overall strategic interpretation about moving toward longer-term debt and reducing refinancing risk is reasonable and aligns with the ground truth's conclusion about 'maintaining a consistent capital structure with a focus on intermediate and long-term debt.' PROBLEMATIC ELEMENTS: (1) The LLM introduces 2.200% Notes due 2027 and 3.125% Notes due 2031 as part of the 2023-2024 evolution, but the ground truth does not mention these specific instruments. This represents unverified quantitative claims that cannot be confirmed against the knowledge graph. (2) The LLM states these longer-term notes appeared 'in 2023 and 2024' but provides no evidence from the ground truth that these specific instruments were issued or existed during this period. (3) The phrase 'lock in lower rates' is speculative reasoning not supported by the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the progression across three years (2022-2024) and identifies the maturation of the 2023 notes and persistence of the 2025 notes. However, the introduction of unverified debt instruments weakens the multi-hop synthesis. SEMANTIC EQUIVALENCE: The LLM's conclusion about capital structure strategy is semantically equivalent to the ground truth's statement about 'maintaining a consistent capital structure with a focus on intermediate and long-term debt,' though the LLM adds interpretive language about 'lock in lower rates' and 'diversify maturity profiles' that goes beyond what the ground truth supports. The core insight is sound but the supporting details are partially fabricated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 543,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "Capital One’s fixed unsecured senior debt fell modestly from $27.2 billion in 2022 to $26.9 billion in 2023 and stayed at $26.9 billion in 2024, while the weighted‑average interest rate remained essentially unchanged at about 4.84 % across the three years (2024 10‑K p. 188; 2023 10‑K p. 178; 2022 10‑K p. 188). This pattern shows a disciplined, gradual debt‑repayment strategy that keeps borrowing costs stable rather than taking on higher‑rate or larger debt, indicating a focus on maintaining a consistent leverage profile and cost of capital.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and fundamental factual errors that contradict the ground truth across all key metrics:\n\n(1) CRITICAL QUANTITATIVE ERRORS:\n- 2022 carrying value: LLM states $27.2B, ground truth is $19,975M ($19.975B) - ERROR of ~$7.2B or 36%\n- 2023 carrying value: LLM states $26.9B, ground truth is $27,168M ($27.168B) - ERROR of ~$0.3B or 1% (minor)\n- 2024 carrying value: LLM states $26.9B, ground truth is $26,930M ($26.93B) - CORRECT\n- 2022 weighted-average interest rate: LLM states ~4.84%, ground truth is 2.91% - ERROR of ~1.93 percentage points or 66%\n- 2023 weighted-average interest rate: LLM states ~4.84%, ground truth is 4.45% - ERROR of ~0.39 percentage points or 9%\n- 2024 weighted-average interest rate: LLM states 4.84%, ground truth is 4.84% - CORRECT\n\n(2) MULTI-HOP SYNTHESIS FAILURE:\nThe LLM fundamentally mischaracterized the trend. Ground truth shows:\n- INCREASE from 2022 to 2023: $19.975B → $27.168B (36% increase)\n- DECREASE from 2023 to 2024: $27.168B → $26.930B (0.9% decrease)\nLLM incorrectly states a DECREASE from 2022 to 2023, which is the opposite of reality.\n\n(3) REASONING AND INTERPRETATION ERRORS:\n- Ground truth correctly identifies a \"strategy shift toward issuing more long-term debt at higher interest rates\"\n- LLM incorrectly characterizes this as a \"debt-repayment strategy\" and \"gradual debt reduction\"\n- The data actually shows debt ACCUMULATION from 2022-2023, not repayment\n- Interest rate trend interpretation is inverted: rates ROSE from 2.91% to 4.45% (2022-2023), not remained stable\n\n(4) ENTITY AND METRIC ACCURACY:\n- Company (Capital One/COF) correctly identified\n- Years correctly identified (2022-2024)\n- Metrics correctly named (carrying value, weighted-average interest rate)\n- However, the VALUES associated with these metrics are largely incorrect\n\n(5) SEMANTIC EQUIVALENCE:\nThe LLM's interpretation of the trend is semantically opposite to the ground truth. Ground truth suggests aggressive debt issuance; LLM suggests conservative debt reduction. These are contradictory narratives.\n\nThe only correct data points are: 2024 carrying value ($26.9B) and 2024 interest rate (4.84%). All other critical numbers are wrong, and the overall narrative contradicts the actual trend in the data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 613,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "In its 2022 Form 10‑K Tesla lists the 5.45% Solar Bonds, Series 2015/C92‑15 among its SolarCity debt (page 105). The 2023 10‑K supplemental indentures (pages 100‑104) and the 2024 10‑K supplemental indentures (pages 100‑104) do not include that series, implying the bonds were retired or repaid by the start of 2023. This disappearance of the legacy SolarCity bond indicates Tesla is phasing out older debt and is likely shifting its solar financing toward newer instruments or internal funding sources.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - BOND STATUS: The LLM claims the C92-15 bonds were 'retired or repaid by the start of 2023' and 'do not include that series' in 2023 and 2024 filings. However, the ground truth explicitly states the bond was 'again referenced in Exhibit 4.54' in 2023 and 'remained listed in Exhibit 4.52' in 2024. This is a major factual error about the bond's continued presence. (2) EXHIBIT LOCATION ERROR: The LLM cites 'page 105' for 2022 and 'pages 100-104' for 2023-2024, but provides no verification these are correct exhibit locations. The ground truth references specific exhibits (4.61 for 2022, 4.54 for 2023, 4.52 for 2024) which the LLM does not mention. (3) REASONING FAILURE: The LLM's core conclusion is inverted - it claims the bond disappeared when the ground truth shows sustained reference across all three years. The LLM misinterprets the absence of expanded discussion as absence of the bond itself. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to synthesize the three-year progression correctly. It should have identified that while C92-15 remained, newer series (C102-15, C106-10) appeared, indicating evolution rather than retirement. (5) STRATEGIC INTERPRETATION ERROR: The LLM's conclusion about 'phasing out older debt' contradicts the ground truth's finding of 'sustained reference' and 'continued to honor and report on the C92-15 bond series.' The LLM fundamentally misread the filing data, confusing lack of detailed discussion with actual retirement of the bonds.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 438,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "AIG’s 2022 10‑K (pp. 165‑169) describes loss‑reserve oversight as a combination of internal controls and an “oversight of the loss reserve setting process” that is supplemented by “reviews by external experts,” and it notes that reserves are estimated using both stochastic probability‑distribution models and deterministic single‑point estimates.  In 2023 (pp. 117‑121) the company formalized the oversight loop with a review‑and‑challenge process, escalation procedures, a model‑risk management framework, and actuarial profitability and reserve reviews, while continuing to use stochastic, scenario and sensitivity analyses; the filing no longer cites external expert reviews.  The 2024 10‑K (pp. 84‑88) embeds reserve oversight within a broader governance and risk‑measurement framework that applies stochastic methods, scenario analyses and experience studies, but it does not explicitly reference external reviews, indicating a shift toward internally driven validation and governance‑driven oversight.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific page references and identifies key evolution points across the three years, but contains significant discrepancies with the ground truth that affect overall accuracy. STRENGTHS: (1) Correctly identifies the three-year timeframe (2022-2024) and AIG as the subject company; (2) Accurately notes the presence of internal controls and external expert reviews in 2022; (3) Correctly identifies the expansion of tools (stochastic, scenario, sensitivity analyses) by 2023; (4) Provides specific page citations that add credibility; (5) Recognizes the shift toward internal governance by 2024. CRITICAL WEAKNESSES: (1) The LLM states that 2023 'no longer cites external expert reviews' and 2024 'does not explicitly reference external reviews,' but the ground truth indicates external expert reviews were 'continuing' in 2023 and should be present in the evolution narrative. This represents a factual error about the continuity of external review practices; (2) The LLM characterizes the 2024 shift as moving away from external reviews toward 'internally driven validation,' but the ground truth emphasizes 'integration of external reviews' as part of the evolution, suggesting external reviews remained relevant; (3) The LLM's characterization of 2023 as 'no longer citing' external reviews contradicts the ground truth's statement that the company continued 'to rely on external expert reviews'; (4) The LLM misses the explicit mention of 'enterprise risk management (ERM) system' integration in 2024 that the ground truth highlights; (5) The LLM does not adequately capture the 'holistic' nature of the 2024 approach or the emphasis on 'proactive risk identification' mentioned in ground truth. QUANTITATIVE ACCURACY: Page references are provided but cannot be independently verified; no numerical data is presented, so quantitative scoring reflects the absence of calculation errors but also the lack of specific metrics. QUALITATIVE ACCURACY: The reasoning about evolution is partially sound but contains a fundamental misinterpretation about external review discontinuation. The multi-hop synthesis across three years is attempted but incomplete and somewhat contradictory to the ground truth narrative. CONTEXTUAL RELEVANCE: The answer appropriately addresses the three components of the question (oversight mechanisms, modeling approaches, external reviews integration) but the treatment of external reviews integration is inverted from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 661,
        "total_tokens": 2138
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "Altria’s pension plan shifted its fixed‑income mix markedly over the three‑year period: the share of U.S. Treasury and foreign government securities rose from 5 % of plan assets in 2022 to 19 % in 2023, then fell to 8 % in 2024【page_88】【page_86】【page_84】. This swing reflects a liability‑driven strategy that actively rebalances the fixed‑income allocation to hedge interest‑rate risk and align the portfolio with changing discount rates, balancing risk and return as the plan’s liabilities evolve.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states allocations were '5% in 2022 to 19% in 2023, then fell to 8% in 2024,' but the ground truth clearly shows '19% in 2022 to 16% in 2023, before dropping further to 8% in 2024.' The 2022 figure is completely wrong (5% vs 19%), and the 2023 figure is inverted (19% vs 16%). Only the 2024 figure of 8% is correct. (2) DIRECTIONAL MISINTERPRETATION: The LLM describes the trend as 'rose from 5% to 19%' when the actual trend is a steady DECLINE from 19% to 16% to 8%. This is a fundamental misreading of the data direction. (3) MISSING KEY CONTEXT: The LLM fails to mention the expected rate of return reduction (6.6% to 6.1%), which is explicitly part of the ground truth answer and provides important context about the pension strategy shift. The LLM also omits the related trend of reducing below-investment-grade securities exposure (11% to 9%), which the ground truth identifies as part of the broader strategic pattern. (4) REASONING QUALITY: While the LLM's explanation about liability-driven strategy and interest-rate hedging is plausible conceptually, it is built on incorrect data and therefore the reasoning is fundamentally flawed. The ground truth interpretation of 'strategic shift away from government-backed fixed income' is the opposite of what the LLM suggests. (5) MULTI-HOP SYNTHESIS: The LLM fails to synthesize the complete picture across the three years and related metrics that would demonstrate the pension asset strategy evolution. The answer is incomplete and factually incorrect on the primary quantitative metrics that form the basis of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 474,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from **$883 million in 2022 to $538 million in 2023 and rose modestly to $562 million in 2024**, while long‑term debt rose from **$47.8 billion in 2022 to $49.3 billion in 2023 and then fell to $44.9 billion in 2024**, leaving total debt at $45.6 billion. Over the three years the company shifted from a sizable floating‑rate unsecured senior debt balance ($1,597 m in 2022, $349 m in 2023, $0 in 2024) to almost all fixed‑rate unsecured senior debt, whose weighted‑average rate climbed from 2.9 % to 4.8 %, while securitized debt obligations decreased from $16.97 billion to $14.26 billion but at a higher weighted average rate (3.0 % to 3.5 %). These changes show a deliberate move to lock in fixed rates and reduce floating‑rate exposure, even as the overall debt profile became slightly leaner.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that make it largely incorrect:\n\n1. TOTAL DEBT FIGURES - MAJOR ERROR:\n   - Ground Truth: 2022=$43.086B, 2023=$48.715B, 2024=$45.551B\n   - LLM Answer: Claims short-term=$883M (2022), $538M (2023), $562M (2024) and long-term=$47.8B, $49.3B, $44.9B\n   - LLM's calculated totals: ~$48.7B (2022), ~$49.8B (2023), ~$45.5B (2024)\n   - The LLM severely understates 2022 short-term borrowings ($883M vs actual ~$2.2B implied) and misrepresents the debt composition\n\n2. SECURITIZED DEBT - SIGNIFICANT ERROR:\n   - Ground Truth: 2022=$14.994B, 2023=$18.043B, 2024=$14.264B\n   - LLM Answer: Claims \"decreased from $16.97 billion to $14.26 billion\"\n   - The LLM incorrectly states the 2022 figure as $16.97B (should be $14.994B) and omits the 2023 peak of $18.043B entirely, missing the critical 3-year trend\n\n3. FLOATING UNSECURED SENIOR DEBT - PARTIAL ERROR:\n   - Ground Truth: 2022=$1.709B, 2023=$349M, 2024=$0\n   - LLM Answer: States \"$1,597m in 2022, $349m in 2023, $0 in 2024\"\n   - The 2022 figure is incorrect ($1.597B vs $1.709B - a ~6% error)\n   - The 2023 and 2024 figures are correct\n\n4. INTEREST RATE ACCURACY:\n   - Securitized debt rates: Ground Truth shows 1.51% (2022), 3.01% (2023), 3.48% (2024)\n   - LLM Answer: States \"3.0% to 3.5%\" which misses the 2022 baseline of 1.51% and the progression\n   - Fixed unsecured senior debt rates: Ground Truth 2.91% to 4.84% vs LLM's \"2.9% to 4.8%\" - essentially correct (minor rounding)\n\n5. MULTI-HOP SYNTHESIS FAILURE:\n   - The LLM failed to properly synthesize the complete 3-year trend for securitized debt, missing the 2023 peak\n   - The answer doesn't adequately explain the strategic shift from floating to fixed rates with supporting data\n   - Missing the context that securitized debt rose significantly in 2023 before declining in 2024\n\n6. COMPLETENESS ISSUES:\n   - The answer addresses the general trend but misses critical data points\n   - Fails to capture the full complexity of the debt structure evolution\n   - Doesn't properly contextualize the 2023 peak in securitized debt\n\nThe LLM answer demonstrates partial understanding of the debt structure shift but contains multiple factual errors in key numbers (securitized debt 2022 figure, missing 2023 peak) and incomplete trend analysis. The core narrative about shifting from floating to fixed rates is directionally correct but undermined by numerical inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 659,
        "total_tokens": 2192
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "Tesla’s 10‑K filings for 2022, 2023 and 2024 all list the 5.45% Solar Bonds, Series 2015/C25‑15 as an exhibit (2022 Exhibit 4.27 on page 100; 2023 Exhibit 4.27 on page 98; 2024 Exhibit 4.27 on page 97), showing that the company still has an outstanding obligation to this debt. The repeated inclusion signals that Tesla continues to rely on this bond as a dedicated financing source for its SolarCity solar assets, and its persistent presence in the capital structure confirms it remains a key component of Tesla’s long‑term debt portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core question but contains some issues: (1) CORRECT ELEMENTS: The bond series name (5.45% Solar Bonds, Series 2015/C25-15), the three-year span (2022, 2023, 2024), and the general conclusion about ongoing reliance are accurate. The exhibit references (Exhibit 4.27) and page numbers appear reasonable for 10-K filings. The semantic interpretation that repeated inclusion signals continued reliance is sound. (2) QUANTITATIVE ACCURACY: The specific page numbers cited (page 100 for 2022, page 98 for 2023, page 97 for 2024) cannot be verified against the ground truth provided, which does not include page numbers. However, the exhibit designation (4.27) is consistent across years, which is plausible. The bond percentage (5.45%) and series designation are correct. (3) MISSING ELEMENTS: The LLM answer does not mention the Thirty-Sixth Supplemental Indenture or the specific date (April 14, 2015) that appears in the ground truth. These are factual details that strengthen the answer's specificity. The ground truth emphasizes the indenture date consistency, which the LLM omits. (4) MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and draws appropriate conclusions about ongoing reliance and capital structure integration. The connection to SolarCity is mentioned, which adds context. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation that the bonds represent 'outstanding obligation' and 'long-term debt portfolio' is semantically equivalent to the ground truth's characterization of 'active and integral component' and 'stable and strategic source of funding.' The reasoning quality is sound, though the answer could be more comprehensive by including the supplemental indenture details and specific dates that ground the analysis more firmly in documentary evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 504,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "Mastercard’s balance of Class A treasury stock grew from **$51.354 million** at year‑end 2022 to **$60.429 million** at year‑end 2023, and further to **$71.431 million** at year‑end 2024 (page 71 for 2022‑23, page 68 for 2024). The incremental purchases—about $9 million in 2023 and $11 million in 2024—indicate a deliberate use of excess cash to buy back shares, underscoring a capital‑allocation strategy that prioritizes returning value to shareholders and supporting the share price.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) SIGN ERROR - The LLM presents treasury stock values as positive numbers ($51.354M, $60.429M, $71.431M) when the ground truth clearly shows these as negative values in parentheses: $(51,354)M, $(60,429)M, $(71,431)M. Treasury stock is a contra-equity account and should be negative. This is a fundamental accounting error. (2) MAGNITUDE ERROR - The LLM states values in millions ($51.354 million) when ground truth shows $(51,354) million - a 1,000x difference. The correct values are $51,354 million (or $51.354 billion), not $51.354 million. (3) CALCULATION ERROR - The LLM calculates incremental purchases as 'about $9 million in 2023 and $11 million in 2024' when the actual differences are approximately $9,075 million and $11,002 million respectively. (4) YEAR LABELING CONFUSION - The ground truth statement contains an apparent error ('2023 to 2023') but the LLM correctly interprets this as 2022-2023-2024 progression, which is appropriate. (5) REASONING - The qualitative interpretation about capital allocation strategy and shareholder returns is sound and well-reasoned, but is undermined by the fundamental numerical errors. The multi-hop synthesis (identifying the trend and connecting it to strategy) is logically sound, but built on incorrect data. The answer demonstrates understanding of the concept but fails on execution of basic financial data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 390,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "Honeywell’s 10‑K filings consistently list reduced investments in process automation, safety monitoring and plant capacity‑utilization initiatives as a key risk to its Safety and Productivity Solutions segment, with the same wording appearing in 2022 (page 29), 2023 (page 30) and 2024 (page 32). The unchanged risk‑factor language indicates that the company viewed the same macroeconomic headwinds—high inflation, supply‑chain constraints and uncertain demand—as persistent drivers of lower capital spending and demand for safety products over the period. This continuity suggests that the industrial sector faced sustained macroeconomic pressure, with no significant easing of the risk of reduced automation investment from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core issue—that Honeywell's Safety and Productivity Solutions segment faced persistent macroeconomic headwinds related to reduced automation investments and plant capacity utilization from 2022-2024. However, there are significant issues with the response: (1) QUANTITATIVE ACCURACY PROBLEMS: The LLM cites specific page numbers (page 29 for 2022, page 30 for 2023, page 32 for 2024) without verification that these are accurate. These page citations cannot be confirmed from the ground truth and appear to be fabricated details. This is a critical error as it presents false specificity. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes an EVOLUTION in the risk narrative—from 2022 (lower market share/margins), to 2023 (global economic uncertainty emphasis), to 2024 (sharper focus on geopolitical instability and trade policy shifts). The LLM answer claims the language was 'unchanged' and 'the same wording appearing' across all three years, which contradicts the ground truth's assertion of evolution and deepening concern. This is a fundamental misreading of the multi-hop synthesis required. (3) MISSING CONTEXTUAL DEPTH: The ground truth explicitly notes a 'trajectory' suggesting 'deepening concern' and 'potentially worsening' conditions, indicating escalation. The LLM answer states 'no significant easing' but misses the escalation narrative present in the ground truth. (4) PARTIALLY CORRECT FACTORS: The LLM correctly identifies reduced automation investments and plant capacity utilization as key risks, and correctly notes these were persistent. However, it adds 'high inflation, supply-chain constraints' which, while plausible, are not explicitly confirmed in the ground truth provided. (5) REASONING QUALITY: The conclusion that 'industrial sector faced sustained macroeconomic pressure' is sound and aligns with ground truth, but the claim of 'unchanged risk-factor language' directly contradicts the ground truth's emphasis on evolution and sharpening focus over the period. This represents a significant reasoning error in the multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 567,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "Cyramza’s indication portfolio has stayed the same from 2022 through 2024, covering second‑line therapy for gastric, NSCLC, colorectal, and hepatocellular carcinoma and first‑line EGFR‑mutated NSCLC (page 6, page 5).  The 2023 10‑K shows its compound patent expiring in 2026 (U.S.), 2028 (EU) and 2026 (Japan) with data protection ending 2024 (EU), 2023 (Japan) and 2026 (U.S.) (page 11‑12), and the 2024 10‑K confirms no change in that schedule, indicating the product is moving toward the end of its exclusivity window while maintaining its established indications.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Cyramza's lifecycle positioning from 2022-2024, but contains significant factual discrepancies in the intellectual property timeline that undermine accuracy. CORRECT ELEMENTS: (1) Therapeutic indications remained consistent across 2022-2024, including second-line gastric, NSCLC, colorectal, and hepatocellular carcinoma; (2) The general concept that the product is moving toward end of exclusivity window is accurate; (3) Multi-hop synthesis across years is attempted and mostly logical. CRITICAL ERRORS: (1) The LLM states Japan compound patent expires in 2026, but ground truth indicates data protection expired in Japan in 2023 (no mention of 2026 for Japan compound patent); (2) The LLM lists U.S. data protection ending in 2026, but ground truth does not mention this - ground truth only specifies compound patents extend to 2026 in U.S.; (3) The patent/data protection timeline is confusing and appears to conflate different types of IP protection. The ground truth clearly states: Japan data protection expired 2023, EU data protection expires 2024, U.S. compound patent extends to 2026, EU compound patent extends to 2028. The LLM's statement about 2026 Japan compound patent and 2026 U.S. data protection appears incorrect. ADDITIONAL ISSUE: The LLM mentions first-line EGFR-mutated NSCLC as an indication, which is not mentioned in the ground truth answer - this represents either an addition not supported by the ground truth or a potential factual error. The answer demonstrates reasonable multi-hop reasoning and addresses the question structure, but the specific IP protection timeline contains material errors that significantly impact correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 467,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "Capital One’s net derivative assets/liabilities grew from a net of $5 million in 2022 (derivative assets $79 million vs. liabilities $74 million) to $58 million in 2023 (assets $886 million vs. liabilities $828 million) and then to $69 million in 2024 (assets $683 million vs. liabilities $614 million).  The fair‑value measurement for these Level 3 instruments has remained unchanged, using vendor‑based discounted‑cash‑flow models with swap rates as the primary unobservable input; the weighted‑average swap rate stayed around 4 % in 2023 and 2024 (and was similar in 2022).  Thus, while the net amount fluctuated with derivative position changes, the valuation methodology and key unobservable assumptions remained consistent.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) NET DERIVATIVE VALUES - Ground truth states: 2022=$19M, 2023=$58M, 2024=$58M. LLM claims: 2022=$5M, 2023=$58M, 2024=$69M. The 2022 figure is wrong ($5M vs $19M), and critically, the 2024 figure is incorrect ($69M vs $58M). (2) DERIVATIVE ASSETS/LIABILITIES BREAKDOWN - LLM provides specific component values (e.g., 2022: assets $79M, liabilities $74M; 2024: assets $683M, liabilities $614M) that cannot be verified against ground truth and appear to be fabricated or from different data sources. The ground truth does not provide these component breakdowns. (3) UNOBSERVABLE INPUTS - LLM correctly identifies swap rates (3-5%, weighted at 4%) as key unobservable inputs, which matches ground truth. However, the LLM fails to mention default rates (53-163%) which were explicitly noted in the ground truth for 2023. (4) VALUATION METHODOLOGY - LLM correctly notes the use of discounted cash flow models and consistency of methodology, which aligns with ground truth. (5) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize information across years, the fundamental numerical errors undermine the entire analysis. The claim that 2024 remained at $58M is contradicted by the LLM's own statement that it was $69M. This internal inconsistency, combined with incorrect year-over-year figures, represents a critical failure in accuracy. The answer demonstrates partial understanding of the valuation methodology but fails catastrophically on the core quantitative metrics that are essential to answering this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 449,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "Qualcomm’s charitable‑match program consistently drew **thousands of employees** each year, but the number of organizations it supported fell from **over 1,500 in fiscal 2022** (page 16, 2022) to **about 1,400 in fiscal 2023** (page 16, 2023) and **roughly 1,300 in fiscal 2024** (page 16, 2024). This trend illustrates the company’s ongoing emphasis on employee engagement and community impact, which is embedded in its human‑capital advancement metrics that act as a non‑financial modifier of executive bonuses (HR & Compensation Committee statements on pages 16 of each year).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative trends in Qualcomm's charitable match program from 2022-2024: thousands of employees participating annually, with supported organizations declining from over 1,500 (2022) to approximately 1,300 (2024). The intermediate 2023 figure of 'about 1,400' is reasonable and consistent with the downward trend. The answer accurately notes the connection to executive compensation through non-financial modifiers tied to human capital advancement. However, there are several areas where the answer falls short of the ground truth: (1) The LLM provides a specific intermediate year (2023 with ~1,400 organizations) that is not mentioned in the ground truth, which only references 2022 and 2024 data. While this may be factually accurate from the filings, it goes beyond what the ground truth explicitly states. (2) The answer lacks explicit mention of the 0.9 to 1.1 modifier range for executive bonuses, instead using more general language about 'non-financial modifier.' (3) The answer does not explicitly connect the program evolution to Qualcomm's 2025 diversity, equity, and inclusion goals, which the ground truth identifies as part of the broader human capital strategy. (4) The answer provides specific page references (page 16) which, while potentially helpful, cannot be verified against the ground truth and may introduce unnecessary specificity. The quantitative accuracy is strong for the main data points (1,500 → 1,300 organizations), and the multi-hop reasoning correctly synthesizes the connection between charitable engagement and executive compensation. The contextual relevance is somewhat diminished because the answer doesn't fully address how this progression 'aligns with the company's broader human capital goals' beyond the executive compensation link—missing the DEI strategy connection.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 504,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe positioned Acrobat as the core PDF engine of its Document Cloud in 2022, tightly integrated with Adobe Sign and APIs and focused on web‑ and mobile‑first functionality, AI‑driven features and single‑click actions (pages 4‑7). The 2023 filing reiterated Acrobat’s central role, emphasizing deeper integration with Sign across all surfaces, expanded task‑based actions, and continued AI and API enhancements (page 5). By 2024, the filing highlighted new product enhancements such as Liquid Mode for mobile, improved Acrobat‑web single‑click actions and further AI‑driven capabilities, underscoring Acrobat’s position as the primary document‑processing engine within Document Cloud and its tight integration with Sign, APIs and other Adobe services (pages 94‑98).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific product features and positioning details (Liquid Mode, single-click actions, AI Assistant) that are more concrete than the ground truth, but has significant issues: (1) QUANTITATIVE PROBLEMS: The LLM cites specific page numbers (pages 4-7, page 5, pages 94-98) without verification against actual filings - these citations cannot be confirmed and may be hallucinated. This is a critical error for a financial document evaluation task. (2) FACTUAL GAPS: The ground truth emphasizes the evolution trajectory from 2022→2023→2024 showing progression from document standard to AI-enhanced platform. The LLM answer mentions specific features but doesn't clearly articulate the EVOLUTION or strategic shift across years. The ground truth highlights 'Acrobat AI Assistant' as a registered trademark in 2024 signaling strategic shift; the LLM mentions AI capabilities but less explicitly. (3) COMPLETENESS: The LLM addresses integration with Sign and APIs (matching ground truth), but the ground truth emphasizes broader ecosystem integration with Creative Cloud tools and Digital Media offerings context - the LLM is narrower in scope. (4) MULTI-HOP REASONING: The LLM does attempt to synthesize across three years, but the synthesis is more feature-focused than strategic-positioning-focused. The ground truth shows a clear narrative arc; the LLM lists features without as clear a positioning evolution. (5) SEMANTIC ISSUES: The LLM's specific feature mentions (Liquid Mode, single-click actions) are plausible but unverified. The page citations are problematic - they appear to be fabricated without source verification. This undermines credibility even if some content might be accurate. The answer reads more like product marketing copy than a synthesis of actual filing disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 492,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "In 2022, LLY generated $2.02 billion in net product revenue from bamlanivimab and bebtelovimab under its AbCellera collaboration, with royalty payments to AbCellera recorded as cost of sales at mid‑teens to mid‑twenties rates【page_73】.  In 2023 and 2024, the company had no sales of these antibodies, resulting in zero net product revenue and no royalty payments under the agreement【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across the 2022-2024 period. STRENGTHS: (1) All numeric values are correct - $2.02 billion in 2022 net product revenue is accurate, and the mid-teens to mid-twenties royalty percentage range is correctly stated. (2) The temporal progression is accurately captured: 2022 peak sales, 2023 zero sales, 2024 zero sales. (3) Multi-hop reasoning is sound - the answer correctly synthesizes information about both revenue and royalty obligations across three fiscal years. (4) Entity identification is precise: LLY, AbCellera, bamlanivimab, bebtelovimab are all correctly named and contextualized. (5) The characterization of royalty payments as 'cost of sales' is appropriate accounting terminology. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the interpretive phrase about 'reduced demand or regulatory changes affecting EUA-based sales' - however, this is contextual interpretation rather than factual error, and the question asks for financial implications specifically. (2) The ground truth provides slightly more narrative context about the 'sharp decline' and 'wind-down,' but the LLM captures all essential financial facts. The answer fully addresses the three-part question structure (2022 revenue/royalties, 2023 status, 2024 status) with complete accuracy. No calculation errors, no incorrect dates, no misidentified entities. The citation reference [page_73] adds credibility though cannot be independently verified in this evaluation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 438,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "MetLife re‑insured roughly 59 % of its closed block through a modified coinsurance agreement in both 2022 (page 213) and 2023 (page 229), and the percentage rose slightly to 59.25 % in 2024 (page 206). The near‑constant reliance on this arrangement shows that the company has a long‑term risk‑transfer strategy that keeps a large, predictable portion of its closed‑block exposure under a single, well‑understood reinsurance structure, reinforcing its capital‑management and risk‑management framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the year-over-year progression of percentages. The ground truth states: 59.25% (2022), 59% (2023), 59% (2024). The LLM answer reverses this sequence, claiming 59% in 2022, 59% in 2023, and 59.25% in 2024 - stating the percentage 'rose slightly to 59.25% in 2024' when it actually decreased from 59.25% in 2022. This is a fundamental misrepresentation of the data trend. (2) MULTI-HOP REASONING FAILURE: The question asks how the reliance 'evolved' from 2022-2024, requiring accurate tracking of the progression. The LLM failed to correctly identify the actual evolution (59.25% → 59% → 59%), instead presenting an inverted narrative. (3) SEMANTIC CONTRADICTION: While the LLM correctly identifies the overall consistency and strategic continuity (which aligns with ground truth interpretation), it does so while presenting incorrect numbers. The statement 'near-constant reliance' is semantically correct but undermined by the factual errors. (4) PARTIAL CREDIT: The LLM does correctly identify the modified coinsurance agreement as the mechanism, correctly names MetLife, correctly identifies the closed block context, and provides reasonable interpretation about long-term risk-transfer strategy. However, these qualitative elements cannot compensate for the quantitative inaccuracy on the core data points. The reversal of the 2022 and 2024 percentages is a critical error that fundamentally misrepresents the company's actual reinsurance evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 427,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "Mastercard’s 2022 10‑K outlined a multi‑layered security program that included third‑party risk monitoring and real‑time payment capabilities in 12 of the top 50 markets. The 2023 filing expanded third‑party collaboration to central banks, fintechs and public‑private partnerships while keeping the same real‑time footprint. By 2024 the company added explicit partnerships with digital‑messaging platforms and increased real‑time coverage to 13 markets, indicating a cybersecurity strategy that blends robust technical controls with ecosystem‑wide collaboration to strengthen resilience and threat‑response.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains a significant factual error regarding real-time payment market expansion. The ground truth states: 2022 = 12 markets, 2023 = 13 markets, 2024 = 'several countries globally'. However, the LLM claims '2023 filing expanded...while keeping the same real-time footprint' (implying 12 markets in 2023) and then states 'By 2024 the company...increased real-time coverage to 13 markets.' This is backwards - the LLM reversed the 2023 and 2024 figures. The ground truth shows expansion from 12→13 occurred between 2022-2023, not 2023-2024. (2) COMPLETENESS - The LLM answer omits key details from the ground truth: (a) No mention of public-private collaborations in 2022, (b) No mention of 'outsourced services' threat management in 2023, (c) No mention of 'resilience programs' in 2024, (d) The 2024 description in ground truth emphasizes 'several countries globally' not a specific number increase. (3) ENTITY/FACT ACCURACY - The LLM introduces unsupported claims about 'digital-messaging platforms' partnerships in 2024 that do not appear in the ground truth. This appears to be fabricated detail. (4) REASONING - While the LLM correctly identifies the general evolution toward third-party collaboration and real-time expansion, the specific chronology is incorrect, undermining the multi-hop synthesis. The conclusion about 'ecosystem-wide collaboration' is reasonable but based on partially incorrect premises. (5) SEMANTIC EQUIVALENCE - The overall narrative direction is similar, but the factual errors (reversed years for market expansion, invented partnerships) prevent semantic equivalence on key claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 460,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "From the pension‑plan tables, equity‑like funds were valued at **$4.014 billion in 2022, rose to $4.094 billion in 2023, and fell modestly to $3.932 billion in 2024**.  The allocation has remained essentially flat over the three years, indicating that Lilly continues to maintain a steady, sizable commitment to illiquid equity‑like investments as part of its long‑term growth‑investment strategy, with only minor adjustments reflecting market performance or portfolio rebalancing rather than a strategic shift.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers and reversed the actual trend. QUANTITATIVE ERRORS: (1) 2022 value: LLM states $4.014B, but ground truth is $2,844.7M ($2.8447B) - OFF BY ~$1.17B or 41%. (2) 2023 value: LLM states $4.094B, but ground truth is $4,014.1M ($4.0141B) - relatively close but LLM has years reversed. (3) 2024 value: LLM states $3.932B, but ground truth is $4,093.7M ($4.0937B) - OFF BY ~$0.16B or 4%. The LLM appears to have confused the year-to-year progression entirely. TREND ANALYSIS ERROR: The LLM concludes the allocation 'remained essentially flat' and 'fell modestly to $3.932 billion in 2024,' which contradicts the ground truth showing a clear UPWARD trajectory from $2.8447B (2022) to $4.0937B (2024) - a 44% increase. The LLM's characterization of the trend is the opposite of reality. REASONING ERROR: The LLM's interpretation that this represents 'steady, sizable commitment' with 'only minor adjustments' misses the significant strategic shift indicated by the 44% growth over the period. The ground truth correctly identifies this as indicating 'strategic emphasis on long-duration, higher-return potential assets' and 'growing confidence in private market investments.' ENTITY/YEAR ACCURACY: The LLM correctly identifies LLY and the metric (equity-like funds) but completely botches the year assignments and values. The answer fails on the primary metric (correctness of numbers) and on the secondary metric (correct interpretation of the trend), making it fundamentally unreliable for investment analysis purposes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 435,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "Cascade stayed positioned as a Home‑Care (Air‑Care) brand within the Fabric & Home Care segment throughout the period.  In 2022 it was listed among the major brands (Ariel, Downy, Gain, Tide, **Cascade**, Dawn, Fairy, Febreze, Mr. Clean, Swiffer) and the segment accounted for 35 % of P&G’s net sales.  By 2023 and 2024 the brand remained in the same sub‑category, and the segment’s share of overall net sales rose modestly to 36 % in each of those years, indicating a stable relative contribution for Cascade while the segment’s importance grew slightly.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. All key numbers are accurate: 35% for 2022, 36% for 2023 and 2024. The answer correctly identifies Cascade's positioning within the Fabric & Home Care segment and accurately notes the segment's contribution percentages across all three years. The LLM provides additional valuable context by specifying Cascade as an 'Air-Care' sub-category brand and listing it among major brands in the segment (Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer), which adds specificity beyond the ground truth. The multi-hop synthesis is sound: the answer correctly traces Cascade's evolution from 2022-2024, identifies the segment's stable positioning (36% in 2023-2024), and appropriately characterizes this as 'stable relative contribution' while noting the segment's 'slight' growth from 35% to 36%. Minor differences from ground truth: (1) The LLM characterizes the growth as 'modest' while ground truth uses 'increased,' but these are semantically equivalent. (2) The LLM provides more granular categorization (Air-Care sub-category) than the ground truth, which is supplementary rather than contradictory. (3) The LLM's phrasing 'stable relative contribution for Cascade while the segment's importance grew slightly' is a more nuanced interpretation than ground truth's 'stable positioning and consistent contribution,' but both convey the same essential meaning. The answer fully addresses the question's multi-part requirements regarding product categorization evolution and relative contribution to net sales across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 457,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "Lowe’s 2022 10‑K described a wood‑sourcing policy that required all wood products to come from well‑managed, non‑endangered forests and relied on its human‑rights, conflict‑minerals and vendor‑code‑of‑conduct frameworks to monitor suppliers, while the company had already spent $550 million over the prior three years on energy‑efficiency and renewable‑energy projects (2022, p. 10). In 2023 the policy was overhauled to add country‑specific risk levels, enhanced monitoring and a new forestry grievance process, and Lowe’s began requiring suppliers to report emissions to the CDP, further expanding renewable‑energy and solar‑panel investments (2023, pp. 9‑10). By 2024 Lowe’s reaffirmed the updated policy, continued to push suppliers toward CDP reporting, and broadened its investment strategy to include additional solar installations at 174 store and distribution‑center sites, further energy‑efficiency upgrades, and a commitment to 100 % SmartWay certification for all transportation providers (2024, pp. 9‑10).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant quantitative discrepancies. STRENGTHS: (1) Correctly identifies the evolution of wood sourcing policy from 2022-2024 with country-specific risk levels, enhanced monitoring, and forestry grievance process in 2023; (2) Accurately captures the progression of supplier accountability frameworks (Vendor Code of Conduct, human rights policies); (3) Properly synthesizes multi-hop information across three years; (4) Correctly notes CDP emissions reporting requirement and SmartWay certification commitment; (5) Appropriately contextualizes the evolution as showing consistent commitment to sustainability. CRITICAL ERRORS: (1) The $550 million figure is mischaracterized - the ground truth states this was invested 'in environmental facility upgrades' in 2022, but the LLM describes it as spent 'over the prior three years on energy-efficiency and renewable-energy projects,' which is a different timeframe and characterization; (2) MISSING KEY INFORMATION: The ground truth explicitly mentions the '$50 million Gable Grants program over five years to support skilled trades education' introduced in 2023, which is completely absent from the LLM answer - this is a significant omission of a specific policy enhancement; (3) The 2024 description lacks specificity about the 'more robust risk-based approach' mentioned in ground truth; (4) The LLM adds details about '174 store and distribution-center sites' for solar installations that are not verified in the ground truth, raising questions about source accuracy. MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the progression of policies, though it misses the Gable Grants program entirely. QUANTITATIVE ISSUES: The $550 million figure is presented with incorrect temporal context (prior three years vs. 2022 investment), and the missing $50 million Gable Grants program represents incomplete financial accounting of the company's sustainability investments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 544,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "Honeywell’s 2022‑2024 risk‑factor disclosures consistently note that its Safety and Productivity Solutions, Building Technologies, and Industrial Automation units face competitive pressure from new entrants and technologies; Safety and Productivity Solutions and Industrial Automation also explicitly cite product‑commoditization risks (page_30, page_31, page_32). The unchanged wording across the three years shows that this exposure has persisted rather than eased, underscoring a growing industry trend toward price competition and margin erosion and highlighting increasing market pressures and commoditization threats over time (page_30, page_31, page_32).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three business segments (Safety and Productivity Solutions, Building Technologies, Industrial Automation) and the 2022-2024 timeframe. (2) It accurately notes that competitive pressures from new entrants and technologies are mentioned across these divisions. (3) The general conclusion about persistent market pressures and commoditization risks is directionally correct. (4) Page references are provided (though not verified against actual filings). WEAKNESSES: (1) CRITICAL DISCREPANCY - The LLM states 'unchanged wording across the three years,' which contradicts the ground truth's key finding that there was a PROGRESSION showing EVOLUTION of the risk disclosure across the three years (2022→2023→2024). The ground truth emphasizes that the risk was 'reiterated' in 2023 and 'expanded' in 2024, indicating a temporal evolution, not static unchanged language. (2) The LLM fails to capture the TEMPORAL PROGRESSION that is central to the question - the ground truth explicitly traces how the risk evolved from one division to another over time (2022 in Safety/Productivity, 2023 in Building Tech, 2024 in Industrial Automation), suggesting a broadening pattern. (3) The LLM's statement about 'unchanged wording' actually undermines the sophistication of the ground truth's analysis, which identifies a deliberate expansion of risk disclosures across divisions over time. (4) Missing the nuance that this represents 'intensifying and broadening market pressures' becoming 'more systemic rather than isolated' - the LLM treats it as persistent but doesn't capture the systemic broadening aspect. MULTI-HOP REASONING: The LLM partially synthesizes information across the three business units and years but fails to properly sequence the temporal evolution that is the core analytical insight. The question specifically asks 'how did...evolve' and 'what does this progression indicate' - the LLM's answer about 'unchanged wording' actually contradicts the progression analysis required. SEMANTIC ISSUE: While the LLM reaches a similar conclusion about market pressures, it does so through a different (and less accurate) analytical path that mischaracterizes the nature of the evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 597,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "Qualcomm’s 2022 10‑K framed the automotive digital‑cockpit as a nascent but high‑potential segment, reporting QCT automotive revenue of $1.5 bn and emphasizing connectivity, digital‑cockpit and ADAS/AD solutions. By 2024 that revenue had nearly doubled to $2.9 bn, while “revenue recognized from previously satisfied performance obligations” fell from $788 m to $558 m, indicating a shift toward point‑in‑time equipment sales. Segment reporting shows QCT’s automotive share of total QCT revenue rose from roughly 4 % in 2022 to about 7 % in 2024 (even as overall QCT revenue slipped from $37.7 bn to $33.2 bn), underscoring Qualcomm’s intensified strategic focus on the software‑defined vehicle and digital‑cockpit market.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer attempts to provide a quantitative evolution narrative but contains significant numerical accuracy issues that undermine its credibility. STRENGTHS: (1) The answer correctly identifies the progression from 2022 to 2024 and captures the core strategic shift from nascent opportunity to integrated business segment. (2) The reasoning about automotive revenue growth and segment share increase is logically sound and relevant to the question. (3) The mention of 'software-defined vehicle' and the shift in revenue recognition patterns (from deferred to point-in-time) adds valuable context not explicitly in the ground truth. (4) The answer appropriately synthesizes multiple dimensions: revenue figures, segment reporting, and strategic positioning. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The specific dollar amounts ($1.5bn in 2022, $2.9bn in 2024, $788m and $558m for deferred revenue, $37.7bn and $33.2bn for total QCT revenue) cannot be verified against the ground truth provided. The ground truth does not provide these specific financial figures, making it impossible to confirm accuracy. (2) The percentage calculations (4% to 7% automotive share) are presented as facts but lack verification. If $1.5bn/$37.7bn ≈ 4% and $2.9bn/$33.2bn ≈ 8.7% (not 7%), this suggests calculation errors. (3) The ground truth emphasizes the conceptual evolution (vision → monetization → integration) while the LLM answer pivots to financial metrics that may or may not be accurate. MULTI-HOP REASONING: The answer does synthesize across multiple dimensions (revenue recognition, segment reporting, strategic focus) but the lack of verifiable numbers creates uncertainty about whether the synthesis is correct. The answer goes beyond the ground truth in specificity but this creates risk if numbers are inaccurate. SEMANTIC ALIGNMENT: The core narrative (2022 positioning → 2023 monetization → 2024 integration) is present but expressed through financial metrics rather than the strategic/operational framing of the ground truth. This is a valid alternative approach but introduces unverified quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 569,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "By 2024, Frame.io had expanded from a video‑centric collaboration tool to support still images, design files and PDFs, and added integrations with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, while offering Camera‑to‑Cloud uploads and availability in Adobe GenStudio for enterprise‑scale workflows (see pages 12‑13). The 2022 10‑K (pages 95‑99) does not provide a detailed description of Frame.io’s media types or cross‑product integrations, indicating a more limited scope at that time.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps in completeness and clarity regarding the evolution timeline. STRENGTHS: (1) Correctly identifies 2024 capabilities including support for still images, design files, PDFs, and integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront; (2) Correctly mentions Adobe GenStudio for enterprise-scale workflows; (3) Appropriately notes that 2022 10-K had limited Frame.io details; (4) Mentions Camera-to-Cloud uploads as a feature. WEAKNESSES: (1) INCOMPLETE TIMELINE - The answer fails to adequately describe the 2023 intermediate state, which is critical for showing 'evolution from 2022 to 2024.' The ground truth explicitly states Frame.io was described in 2023 as 'cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs.' The LLM answer doesn't clearly establish this 2023 baseline; (2) MISSING FUNCTIONAL EXPANSION DETAILS - The ground truth emphasizes that by 2024, Frame.io expanded 'beyond post-production workflows—now including casting, location scouting, and marketing campaign management.' The LLM answer completely omits these important functional expansions, which directly address the question's focus on 'functional expansion'; (3) UNCLEAR EVOLUTION NARRATIVE - The answer doesn't clearly show the progression/evolution across the three years. It jumps to 2024 capabilities without establishing what changed from 2022→2023→2024; (4) CITATION REFERENCES - While the LLM provides page references (pages 12-13, pages 95-99), these cannot be verified and may not correspond to actual filing locations. CALCULATION/NUMERIC ACCURACY: No calculations required; dates (2022, 2023, 2024) are correct. MULTI-HOP REASONING: The answer attempts to synthesize information across years but fails to properly establish the intermediate 2023 state, which is essential for demonstrating evolution. The question specifically asks about evolution 'from 2022 to 2024,' requiring clear delineation of changes at each stage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 570,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "From 2022 to 2024, Mastercard’s Class A common stock saw its quarterly cash dividend per share rise from $2.04 (2022, page 98) to $2.37 (2023, page 100) and $2.74 (2024, page 99), while the voting right—one vote per share—remained unchanged across all three years (Class A table, pages 16). This steady voting structure combined with progressively higher dividends indicates a stable shareholder‑governance framework, with no alteration to voting power and a consistent commitment to returning value to shareholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces specific dividend per share amounts ($2.04, $2.37, $2.74) that are NOT present in the ground truth answer. The ground truth explicitly states 'There were no changes to these rights in any of the years' and only mentions 'Dividend rights' as a category, not specific dollar amounts. The LLM appears to have fabricated or hallucinated these specific quarterly dividend figures with page citations that cannot be verified against the ground truth. (2) The ground truth answer is clear and definitive: A Class shares maintained consistent 'One vote per share' AND 'Dividend rights' with NO CHANGES across 2022-2024. The LLM's answer, while correctly identifying the stable voting structure, contradicts the ground truth by implying dividend amounts changed progressively ($2.04→$2.37→$2.74), which directly conflicts with the 'no changes' assertion in the original answer. (3) The LLM conflates 'dividend rights' (the right to receive dividends) with 'dividend per share amounts' (the actual dollar values), which are different concepts. The question asks about 'dividend and voting rights' - the structural rights, not the payment amounts. (4) Multi-hop reasoning: The LLM failed to properly synthesize the ground truth information. It added external information (specific dividend amounts and page numbers) that were not part of the knowledge graph answer provided. (5) The conclusion about 'progressively higher dividends' contradicts the ground truth's assertion of stability and 'no changes.' This is a fundamental factual error that undermines the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 442,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "Honeywell’s Safety and Productivity Solutions segment was repeatedly flagged as exposed to retail‑market fluctuations (2022 page 29; 2023 page 30; 2024 page 32). In 2022 the segment generated $6,907 million in sales and $1,080 million in profit (15.6 % margin) (2022 page 30), but 2023 saw a $1,418 million sales decline and $179 million profit drop driven by lower demand for products in Productivity Solutions and Services (2023 page 30), while 2024 rebounded with a $186 million sales increase and $35 million profit gain, raising margin to 23.7 % (2024 page 28). These swings illustrate the segment’s ongoing sensitivity to consumer‑demand volatility over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM provides specific financial figures (2022: $6,907M sales, $1,080M profit, 15.6% margin; 2023: $1,418M sales decline, $179M profit drop; 2024: $186M sales increase, $35M profit gain, 23.7% margin) that cannot be verified against the ground truth knowledge graph. The ground truth does not provide these specific numbers, suggesting they may be fabricated or incorrectly sourced. The calculations shown (15.6% = $1,080M/$6,907M; 23.7% margin) appear mathematically plausible but lack verification. (2) SEGMENT NAMING INCONSISTENCY - The LLM correctly identifies that the segment was renamed from 'Safety and Productivity Solutions' in 2022-2023 to 'Industrial Automation' in 2024, which aligns with ground truth. However, the LLM refers to it as 'Safety and Productivity Solutions segment' throughout without clearly noting the 2024 name change until the end. (3) INCOMPLETE RISK ANALYSIS - The ground truth emphasizes that the segment's risk disclosure remained consistent across all three years despite organizational changes, suggesting lack of mitigation. The LLM focuses heavily on financial performance swings but provides less analysis of the qualitative risk factors (reduced investments in process automation, safety monitoring, commoditization risk) that the ground truth highlights. (4) MULTI-HOP REASONING - The LLM attempts to synthesize financial performance with market exposure, but the specific numbers provided are unverifiable and may be incorrect. The ground truth answer focuses on consistent risk language and lack of mitigation, while the LLM pivots to financial metrics that may not be accurate. (5) MISSING CONTEXT - The LLM does not adequately address the key insight from ground truth: that despite organizational restructuring, the business remained vulnerable to retail market instability with no significant mitigation over the three-year period. The answer reads more like financial performance commentary than a risk exposure analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 545,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "From 2022 through 2024 the Olumiant collaboration with Incyte kept a tiered double‑digit royalty structure capped at 20 % on worldwide net sales, with an added low‑teens royalty on COVID‑19 sales above a threshold that was introduced in the 2020 amendment. Milestone obligations were capitalized as intangible assets, with cumulative milestone payments of $260 million (2021) and $210 million (2020); by 2023 the agreement specified that Incyte could receive up to $100 million in additional sales‑based milestone payments, a shift from the earlier combined success‑based and sales‑based eligibility. The COVID‑19 indication remained part of the agreement, and the royalty and milestone terms did not materially change beyond the updated eligibility for additional payments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that substantially undermine its credibility:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites milestone payments of $260 million (2021) and $210 million (2020), which are completely out of scope for a question about 2022-2024 evolution. These dates are irrelevant to the question asked.\n   - The ground truth specifies $100 million in additional regulatory milestones AND $100 million in sales-based milestones (totaling $200M potential), but the LLM conflates these and only mentions \"up to $100 million in additional sales-based milestone payments\" by 2023, missing the regulatory milestone component.\n   - The LLM incorrectly states the royalty structure was \"capped at 20%\" when the ground truth indicates rates \"ranged up to 20%\" - a subtle but important distinction.\n\n2. TEMPORAL REASONING FAILURE:\n   - The LLM fails to properly track the evolution from 2022 to 2024. It mentions 2020 and 2021 data that are not relevant to the question's timeframe.\n   - The ground truth clearly shows a shift from milestone-driven obligations (2022) to ongoing royalty payments (2024), but the LLM does not articulate this evolution clearly.\n   - The LLM states \"the royalty and milestone terms did not materially change\" which contradicts the ground truth's emphasis on a significant shift from milestone-driven to royalty-based model.\n\n3. MULTI-HOP SYNTHESIS PROBLEMS:\n   - The question asks about evolution \"from 2022 to 2024\" but the LLM introduces 2020-2021 data, showing poor temporal filtering.\n   - The LLM fails to synthesize the key insight that by 2024, \"most contingent payments had likely been triggered or expired,\" which is central to understanding the evolution.\n   - The LLM does not properly explain how the agreement shifted from milestone-driven to royalty-based over the three-year period.\n\n4. ENTITY AND METRIC ACCURACY:\n   - Correctly identifies LLY, Incyte, and Olumiant.\n   - Correctly mentions COVID-19 indication and the 2020 amendment.\n   - However, the treatment of milestone types is confused and incomplete.\n\n5. CONTEXTUAL RELEVANCE:\n   - The answer addresses the question's components (milestone payments, royalty rates, COVID-19) but with significant inaccuracies.\n   - The inclusion of 2020-2021 data suggests the LLM may have confused different time periods in the source documents.\n   - The conclusion that terms \"did not materially change\" directly contradicts the ground truth's narrative of evolution.\n\nThe LLM answer demonstrates partial understanding of the Olumiant agreement structure but fails to accurately track its evolution over the specified 2022-2024 period and introduces irrelevant historical data while missing key insights about the shift from milestone to royalty-based payments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 750,
        "total_tokens": 2188
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "From 2022 to 2024, P&G shifted the Always brand from a sub‑brand of Pampers to a standalone major brand in the Baby, Feminine & Family Care segment. In 2022 the segment listed Baby Care, Feminine Care and Family Care, with the major brands “Pampers Always” and “Always Discreet” (no separate “Always”)【page_19】. By 2023, “Always” appears as a major brand alongside Pampers, and in 2024 the segment’s product categories narrowed to Feminine Care and Family Care (Baby Care is omitted) while “Always” remains a key brand with “Always Discreet, Tampax Bounty, Charmin, and Puffs” and Pampers is no longer a major brand【page_18】, underscoring Always’s growing prominence.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. Key issues: (1) MAJOR FACTUAL ERROR: The LLM claims Always was a 'sub-brand of Pampers' in 2022 and that the segment listed 'Pampers Always' - this is incorrect. The ground truth shows Always was already a distinct brand in 2022, listed under 'Feminine Care (Adult Incontinence, Feminine Care)' alongside other brands. (2) INCORRECT CATEGORIZATION EVOLUTION: The LLM states that in 2024 'Baby Care is omitted' from the segment categories, but the ground truth indicates the categorization remained consistent between 2023-2024 as 'Feminine Care (Adult Incontinence, Menstrual Care)'. The ground truth does not mention Baby Care being removed. (3) WRONG POSITIONING NARRATIVE: The LLM incorrectly frames this as Always transitioning from a Pampers sub-brand to a standalone brand, when the ground truth shows Always was already standalone in 2022 and the evolution was about refining the product categorization within Feminine Care (from 'Adult Incontinence, Feminine Care' to 'Adult Incontinence, Menstrual Care'). (4) MISSING KEY DETAIL: The LLM fails to capture the strategic sharpening toward menstrual care positioning that occurred between 2022-2023, which is central to the ground truth answer. (5) CITATION ISSUES: The LLM references 'page_19' and 'page_18' but provides no verifiable evidence for its claims about 'Pampers Always' or the structural changes described. The core narrative about Always's evolution is fundamentally misrepresented, making this answer substantially incorrect despite addressing the general topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 443,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "**Target‑allocation evolution**\n\n| Fiscal year | U.S. plans | Non‑U.S. plans (equity / debt / cash / insurance / other) |\n|-------------|------------|-----------------------------------------------------------|\n| 2023 (2022 filing) | 100 % debt | 27 % / 48 % / 4 % / 11 % / 10 % |\n| 2024 (2023 filing) | 94 % debt | 23 % / 42 % / 5 % / 21 % / 9 % |\n| 2025 (2023 & 2024 filings) | 100 % debt | 28 % / 36 % / 7 % / 21 % / 8 % |\n\n**What it reveals**\n\nAcross the three years the U.S. plans stay heavily debt‑centric, reflecting a strong emphasis on duration matching, while the Non‑U.S. plans shift the equity‑debt mix in response to market conditions and funding status. The gradual swing from 27 % equity in 2023 to 23 % in 2024 and back to 28 % in 2025, coupled with a corresponding rise in cash and a modest drop in debt, shows ACN’s flexible, risk‑adjusted strategy: it keeps liability duration aligned but increases equity exposure when conditions permit higher risk‑adjusted returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, detailed quantitative data in a well-organized table format that directly addresses the multi-year evolution of ACN's target asset allocation strategy. STRENGTHS: (1) The table presents concrete percentages for U.S. and Non-U.S. plans across three fiscal years with clear sourcing (2022, 2023, and 2024 filings), enabling precise multi-hop synthesis. (2) The quantitative breakdown (e.g., Non-U.S. equity declining from 27% to 23% then rising to 28%) is specific and traceable. (3) The interpretation correctly identifies the key strategic themes: U.S. plans maintaining 100% debt allocation for duration matching, Non-U.S. plans showing tactical flexibility in equity-debt mix, and cash/insurance allocations adjusting with market conditions. (4) The reasoning about liability duration matching and risk-adjusted returns aligns with the ground truth's core message. (5) The answer demonstrates proper multi-hop synthesis by comparing allocations across three distinct time periods and drawing coherent conclusions about strategic evolution. MINOR WEAKNESSES: (1) The answer is more data-focused and less discursive than the ground truth, which emphasizes the 'framework' and 'strategic continuity' aspects more explicitly. (2) The ground truth mentions 'weighted-average plan assets allocation as of August 31, 2023' as a specific update in the 2023 filing, which the LLM answer doesn't explicitly call out, though the data appears to be presented. (3) The ground truth emphasizes 'stable investment framework' and 'strategic continuity' more prominently, while the LLM focuses on 'flexibility' and 'tactical adjustments'—both are correct but represent slightly different emphases. QUANTITATIVE VERIFICATION: The percentages presented appear internally consistent (e.g., Non-U.S. components sum appropriately: 27+48+4+11+10=100 for 2023; 23+42+5+21+9=100 for 2024; 28+36+7+21+8=100 for 2025), suggesting accurate data extraction. The progression narrative (equity 27%→23%→28%) is logically coherent with the stated interpretation. No calculation errors detected. MULTI-HOP REASONING: The answer successfully synthesizes information across three filings (2022, 2023, 2024) and three fiscal years (2023, 2024, 2025), correctly identifying which filing contains which year's target allocation. The conclusion about balancing duration matching with tactical flexibility is sound and supported by the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 650,
        "total_tokens": 2229
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "Lowe’s forward‑interest‑rate‑swap exposure rose sharply to a $2.56 billion notional in 2022 (vs $638 million in 2021)【page_62】, but the fair‑value of those swaps dropped to $251 million in 2023 and was no longer reported in the 2024 filing, indicating the company largely closed or matured most of its forward swaps【page_54】【page_46】.  The swaps have consistently been classified as Level 2 fair‑value instruments and accounted for as cash‑flow hedges, with the effective portion of gains/losses recorded in OCI and amortized to interest expense【page_54】【page_62】【page_46】, underscoring Lowe’s strategy of using forward swaps to hedge forecasted debt issuances and manage interest‑rate risk while maintaining a conservative accounting approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces notional values ($2.56 billion in 2022, $638 million in 2021) that are NOT present in the ground truth answer. The ground truth explicitly states 'no current fair value was listed for 2022 itself' and only mentions a $251 million fair value in 2023. The LLM appears to have fabricated or misattributed notional swap values. (2) HEDGE ACCOUNTING CLASSIFICATION - The LLM claims swaps were 'consistently...accounted for as cash-flow hedges' through 2024, but the ground truth clearly states that by 2024, Lowe's shifted to 'fixed-to-floating interest rate swaps as fair value hedges' - a fundamental strategic change the LLM completely missed. (3) ASSET CLASSIFICATION - The ground truth specifies the $251 million was 'classified under Other current assets' and 'Level 2 in fair value hierarchy' in 2023. The LLM mentions Level 2 classification but doesn't specify the balance sheet location. (4) STRATEGIC EVOLUTION - The ground truth emphasizes a critical transition from 'cash flow hedges' (managing forecasted debt issuance risk) to 'fair value hedges' (managing existing debt exposure), reflecting a shift to a more stable capital structure. The LLM completely misses this strategic pivot and incorrectly suggests the hedging approach remained consistent. (5) 2024 TREATMENT - The ground truth explains that in 2024 the company 'no longer held forward interest rate swaps' but instead held 'fixed-to-floating interest rate swaps as fair value hedges.' The LLM only notes the swaps were 'no longer reported' without explaining the replacement instrument or the accounting change. The LLM answer demonstrates significant factual errors on quantitative data (introducing unsupported notional values), misses the critical strategic shift in hedge accounting treatment, and fails to properly synthesize the multi-hop evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 520,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "AVGO’s exposure to the 5.000 % notes due April 2030 remained at **$606 million** from fiscal year 2022 through fiscal year 2024 (the same amount reported in the 2023 and 2024 10‑K debt schedules【page_81】). The unchanged exposure over three years indicates a deliberate debt‑management approach that preserves a stable long‑term debt mix and avoids adding refinancing or interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the exposure 'remained at $606 million from fiscal year 2022 through fiscal year 2024,' but the ground truth clearly states it was $1,086 million in 2022, then decreased to $606 million in 2023 and 2024. The LLM completely omits the 2022 figure of $1,086 million and incorrectly characterizes the three-year progression as 'unchanged.' This is a major factual error. (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks how the exposure 'evolved from fiscal year 2022 through 2024.' The ground truth demonstrates a clear evolution: $1,086M (2022) → $606M (2023) → $606M (2024), representing a $480 million reduction. The LLM fails to capture this evolution entirely. (3) REASONING ERROR: The LLM's interpretation that 'unchanged exposure over three years indicates a deliberate debt-management approach' is logically inconsistent with the actual data showing a significant $480 million reduction. The LLM's reasoning would only be valid if the numbers were actually unchanged, but they are not. (4) INCOMPLETE ANSWER: The LLM addresses only 2023-2024 data (correctly stating $606M for both years) but completely misses the critical 2022 baseline of $1,086M, which is essential to understanding the debt management strategy. The ground truth correctly identifies this as 'a deliberate reduction in this specific debt obligation over the three-year period,' while the LLM incorrectly characterizes it as stable. The LLM's citation to page 81 does not validate the incorrect claim about 2022 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 455,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "UPS’s 7.620 % debentures have remained unchanged in substance from 2022 through 2024.  Each filing states a $276 million principal, a maturity of April 1 2030, semi‑annual interest at 7.620 % (the rate set in 2020), and redemption at the greater of principal + accrued interest or the present value of remaining payments discounted at a benchmark Treasury yield + 5 bps; the notes are callable at the company’s option and carry no sinking‑fund requirement.  The only disclosure shift is that the 2022 note includes the historical rate cut from 8.375 % to 7.620 % on April 1 2020, a detail omitted in the 2023 and 2024 notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative facts are correct: $276 million principal, April 1, 2030 maturity date, 7.620% interest rate, 8.375% historical rate (reduced in April 2020), and the redemption formula (greater of principal + accrued interest or present value of remaining payments discounted at benchmark Treasury yield + 5 bps). The multi-hop synthesis across three years (2022-2024) is sound and well-reasoned. The answer correctly identifies the key evolution: the 2022 disclosure included historical context about the rate reduction from 8.375% to 7.620%, while 2023 and 2024 omitted this historical detail. The LLM accurately captures that the substance remained unchanged while disclosure emphasis shifted. The answer correctly notes the callable nature at company's option and absence of sinking fund requirements. The only minor distinction from the ground truth is that the LLM uses slightly more concise language ('the only disclosure shift is...') compared to the ground truth's more elaborate framing ('disclosures evolved in terms of clarity and emphasis'), but this is a stylistic difference that does not affect factual accuracy. The LLM answer is actually more precise and direct in identifying the specific disclosure change. All entities, dates, percentages, and dollar amounts are accurate with no calculation errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 386,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "Amgen positioned Olpasiran as a phase‑2 siRNA program in 2022 that targeted lipoprotein(a) to treat cardiovascular disease (ASCVD) 【page_24】【page_25】【page_26】.  In 2023 the focus remained on ASCVD and the program stayed in phase 2, while the company held composition‑of‑matter patents that expire in 2036 in the U.S. and Europe 【page_27】【page_26】.  By 2024 Olpasiran had advanced to phase 3 studies for ASCVD, maintaining the same cardiovascular indication and the same 2036 patent expiration timeline 【page_28】【page_26】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) PHASE PROGRESSION INCORRECT: LLM claims Olpasiran advanced to phase 3 by 2024, but ground truth states it was in phase 2 in 2022 with no mention of phase 3 advancement by 2024. This is a major factual error on clinical progression. (2) THERAPEUTIC INDICATION DISCREPANCY: LLM consistently describes the indication as 'ASCVD' (atherosclerotic cardiovascular disease) across all years, but ground truth explicitly states that in 2024 the indication was listed as broader 'cardiovascular disease' - suggesting potential expansion. LLM missed this important strategic shift. (3) PATENT DETAILS CORRECT: The 2036 expiration dates for U.S. and European patents are accurate, and composition-of-matter patent identification is correct. (4) MULTI-HOP SYNTHESIS INCOMPLETE: While LLM attempted to synthesize information across three years, it failed to capture the key evolution described in ground truth - the shift from specific ASCVD focus to broader cardiovascular disease indication in 2024, which was highlighted as significant in the original answer. (5) MISSING CONTEXT: LLM did not adequately convey the progression toward 'more defined commercial and intellectual property strategy' that was emphasized in ground truth. The claim of phase 3 advancement in 2024 contradicts the ground truth narrative and represents a fundamental factual error that significantly undermines answer credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 395,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "Tampax stayed a core brand in P&G’s Baby, Feminine & Family Care segment throughout the period, consistently listed under the Feminine Care sub‑category as a major brand in 2022, 2023 and 2024. Its categorization and prominence among the segment’s major brands—Always, Always Discreet, Tampax Bounty, Charmin and Puffs—remained unchanged across the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) MAJOR ERROR - The LLM claims Tampax's 'categorization and prominence...remained unchanged across the three years,' but the ground truth explicitly states there were changes in sub-category labeling from 2022 to 2023 (from 'Feminine Care (Adult Incontinence, Feminine Care)' to 'Feminine Care (Adult Incontinence, Menstrual Care)'), contradicting the core claim of the answer. (2) ENTITY ERROR - The LLM lists 'Tampax Bounty' as a brand, which is incorrect; Bounty is a separate brand (paper towels), not a Tampax product. This suggests confusion about the brand portfolio. (3) INCOMPLETE SYNTHESIS - The LLM fails to capture the evolution described in the ground truth, which specifically notes 'minor refinements in sub-category labeling over time' and the reclassification in 2023. The answer oversimplifies by claiming no changes when the ground truth documents clear categorization changes. (4) MISSING DETAIL - The ground truth mentions specific sub-category names and their evolution, which the LLM completely omits. (5) LOGICAL INCONSISTENCY - The answer claims consistency across three years when the ground truth explicitly describes evolution and reclassification. The only correct element is that Tampax remained a major brand throughout the period, but this is insufficient given the question's focus on how positioning 'evolved.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 396,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "From 2022 to 2024, the share of non‑agency RMBS and CMBS that received NAIC designations grew markedly—RMBS designations rose from $26,165 m in 2022 to $34,135 m in 2024, and CMBS designations from $10,063 m to $9,182 m, bringing the total NAIC‑rated amount to $43,317 m in 2024 versus $36,228 m in 2022. This upward trend shows that NAIC coverage of these securities has expanded, reducing MetLife’s reliance on internally developed designations and indicating a shift in its acquisition strategy toward securities that are already NAIC‑rated to streamline regulatory compliance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions:\n\n1. DIRECTIONAL ERROR - CORE MISUNDERSTANDING: The LLM claims MetLife's reliance on internally developed designations DECREASED from 2022-2024, stating 'reducing MetLife's reliance on internally developed designations.' The ground truth explicitly states the opposite: internally developed designations remained a 'consistent practice' across all three years, indicating SUSTAINED reliance. This is a fundamental misreading of the question and the underlying data.\n\n2. QUANTITATIVE ACCURACY ISSUES: While the LLM provides specific dollar amounts ($26,165M, $34,135M for RMBS; $10,063M, $9,182M for CMBS), these numbers cannot be verified against the ground truth, which does not provide specific dollar figures. More critically, the LLM's interpretation of what these numbers mean is inverted - it claims growth in NAIC designations indicates reduced reliance on internal designations, but the ground truth indicates that NAIC designations were NOT immediately available and internal designations remained necessary.\n\n3. LOGICAL REASONING FAILURE: The LLM's conclusion that 'NAIC coverage has expanded, reducing MetLife's reliance on internally developed designations' is logically unsound. The ground truth indicates that the PERSISTENCE of internally developed designations across three years reflects that NAIC evaluations LAG BEHIND acquisition timelines. The LLM inverts this relationship.\n\n4. MULTI-HOP SYNTHESIS ERROR: The question asks about the EVOLUTION of reliance on internally developed designations and what the trend indicates about NAIC availability and acquisition strategy. The LLM fails to synthesize the key insight: the consistent use of internal designations indicates that NAIC designations are NOT readily available for newly acquired securities, and MetLife continues to acquire such securities despite this lag.\n\n5. STRATEGIC INTERPRETATION MISMATCH: The ground truth indicates MetLife's strategy involves acquiring 'complex structured securities where NAIC evaluations lag behind acquisition timelines.' The LLM claims the opposite - that MetLife is shifting toward 'securities that are already NAIC-rated.' This is a complete reversal of the actual strategic implication.\n\n6. MISSING KEY INSIGHT: The LLM fails to address the core finding that internally developed designations remained necessary and consistent across all three years, which is the actual answer to how reliance 'evolved' (it didn't - it remained stable).\n\nThe answer demonstrates a fundamental misunderstanding of the question and provides an interpretation that is directionally opposite to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 720,
        "total_tokens": 2097
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 9.6 million Class A shares for $3.2 million in open‑market purchases, with an available authorization of $3.1 million that the Board later increased to $6.1 million【page_94】. By fiscal 2024 the company had bought 2.0 million shares for $605 million in Q4 alone, with total share purchases of $4.5 billion for the year, and its available authorization had risen to $2.7 billion while total outstanding authority reached $6.7 billion after a $4 billion increase【page_39】. This evolution shows Accenture is aggressively using share buybacks as a core component of its capital‑return strategy, expanding its authorized capacity to sustain future repurchases while returning substantial cash to shareholders.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains multiple severe numerical errors that fundamentally undermine its credibility: (1) Fiscal 2022 repurchase amount stated as '$3.2 million' when it should be in the billions range - this is off by a factor of 1000+. (2) Available authorization in fiscal 2022 stated as '$3.1 million' when ground truth shows '$3.13 billion' - another massive unit error. (3) Board increase stated as '$6.1 million' when it should be billions. (4) Q4 FY2024 share count stated as '2.0 million shares for $605 million' which is correct, but the total annual repurchase of '$4.5 billion' is not verified in ground truth and appears inconsistent with the Q4 figure alone. (5) Available authorization stated as '$2.7 billion' which matches ground truth ($2.69 billion), and the $4 billion increase and $6.7 billion total are correct. MULTI-HOP REASONING: The answer attempts to synthesize information across fiscal years and connect it to capital strategy, which is appropriate. However, the fundamental numerical errors in the early years make the trend analysis unreliable. The conclusion about 'aggressively using share buybacks' is reasonable given the data, but is built on incorrect premises. ENTITY ACCURACY: Accenture is correctly identified, fiscal years are referenced appropriately, and Class A shares are correctly named. COMPLETENESS: The answer addresses the evolution from FY2022 through FY2024 and attempts to characterize the capital return strategy, meeting the question's requirements structurally. However, the execution is severely compromised by the quantitative errors. The most egregious issue is the consistent misstatement of millions vs. billions for authorization amounts in fiscal 2022, which suggests either a data extraction error or fundamental misunderstanding of the scale of these figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 504,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "Broadcom’s 2022 10‑K described fiber optics generically as “Fiber Optic Components” for Ethernet networking, storage, and telecom markets [page_8]. By 2023 and 2024, the company’s product tables explicitly list “Industrial fiber optics” under the industrial end‑market, underscoring a deliberate focus on factory automation, renewable energy, and automotive electronics [page_7] (2023) [page_7] (2024). This shift signals Broadcom’s strategic emphasis on expanding its fiber‑optic portfolio into high‑margin industrial applications.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and potential inaccuracies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the company (Broadcom/AVGO) and time period (2022-2024); (2) Accurately notes the shift from generic 'Fiber Optic Components' in 2022 to explicit 'Industrial fiber optics' in 2023-2024; (3) Correctly identifies the strategic applications (factory automation, renewable energy, automotive electronics); (4) Appropriately characterizes this as a strategic emphasis shift. WEAKNESSES: (1) The LLM claims 2022 described fiber optics as 'Fiber Optic Components' for 'Ethernet networking, storage, and telecom markets' - the ground truth indicates 2022 positioned them as part of a broader industrial portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs targeting industrial automation, medical systems, and EV subsystems. The LLM's characterization misses the industrial context present in 2022; (2) The LLM oversimplifies the 2022 positioning by focusing only on networking/storage/telecom, when the ground truth shows industrial applications were already mentioned; (3) Missing the important detail that 2023 showed 'more standardized categorization' in a structured table format; (4) The LLM doesn't adequately capture the 'maturing and application-focused product strategy' evolution described in the ground truth; (5) The claim about 'high-margin industrial applications' is an inference not explicitly supported by the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize across three years but fails to fully capture the nuanced evolution - it presents a more dramatic shift than actually occurred, missing that industrial positioning existed in 2022. The answer is partially correct but incomplete and somewhat misleading about the baseline positioning in 2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 507,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "UPS SurePost has continued to serve as a residential ground service for non‑urgent, lightweight shipments, with final delivery historically performed by the U.S. Postal Service (2022 10‑K, page 5).  The 2024 10‑K confirms the same model but adds that UPS will insource the service beginning January 1, 2025 to gain greater control and improve service reliability, marking a strategic shift away from reliance on USPS (2024 10‑K, page 5).  This evolution reflects UPS’s broader effort to tighten its end‑to‑end network and reduce dependence on external carriers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about UPS SurePost's evolution from 2022-2024. STRENGTHS: (1) All key facts are correct - UPS SurePost is accurately described as a residential ground service for non-urgent, lightweight shipments; (2) The timeline is accurate: 2022-2023 maintained the USPS final-mile delivery model, while 2024 announced the strategic shift to insourcing effective January 1, 2025; (3) The strategic rationale is correctly captured - the shift aims to gain greater control, improve service reliability, and reduce dependence on external carriers; (4) Multi-hop synthesis is sound, correctly connecting the historical model with the announced strategic change; (5) Proper citation of sources (2024 10-K, page 5) adds credibility; (6) No quantitative errors or date inaccuracies. MINOR CONSIDERATIONS: (1) The answer could have explicitly mentioned that 2022 and 2023 showed no changes (though this is implied by stating the model remained the same), but this is a very minor omission; (2) The phrase 'tighten its end-to-end network' is a reasonable interpretation of the strategic intent but goes slightly beyond what the ground truth explicitly states, though it remains semantically consistent with the stated goals. The answer successfully synthesizes information across multiple years and filing documents to provide a coherent narrative of the service evolution. The factual accuracy is excellent with no errors in dates, entities, or key details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 423,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "Amgen’s Phase 3 pipeline grew from 13 programs in 2022 to 18 in 2023 and 24 in 2024. In 2022 the company secured three FDA approvals, launched four new Phase 3 studies and terminated one program; in 2023 it added five Horizon‑acquired programs, began three new Phase 3 studies, received an FDA approval and concluded one program; in 2024 it initiated three new Phase 3 studies (LUMAKRAS/LUMYKRAS, Tarlatamab, ABP 206), acquired three Horizon programs (Dazodalibep, TEPEZZA, UPLIZNA), approved Otezla, and ended KYPROLIS. This steady expansion—through acquisitions, new initiations and regulatory approvals—underscores Amgen’s strategy to broaden its high‑value Phase 3 portfolio and accelerate its R&D pipeline.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core progression of Phase 3 programs (13→18→24) and accurately captures the overall R&D expansion strategy. However, there are significant quantitative accuracy issues that prevent a higher score:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The ground truth states 25 Phase 3 programs by February 4, 2025, but the LLM answer stops at 24 in 2024, missing the most recent update\n   - The LLM provides specific program names and actions (LUMAKRAS, Tarlatamab, ABP 206, Dazodalibep, TEPEZZA, UPLIZNA, Otezla, KYPROLIS) that cannot be verified against the ground truth provided, which does not include these specific details\n   - The claim about \"three Horizon programs\" (Dazodalibep, TEPEZZA, UPLIZNA) in 2024 contradicts the ground truth stating Horizon acquisition added five Phase 3 programs in 2023, not 2024\n   - Specific counts for FDA approvals (three in 2022, one in 2023) and program initiations/terminations are not verified in the ground truth\n\n2. COMPLETENESS:\n   - The LLM answer provides more granular detail than the ground truth but introduces unverified specifics\n   - Missing the February 4, 2025 update showing 25 programs\n   - The answer does address the evolution question and strategy implications\n\n3. ENTITY ACCURACY:\n   - Amgen correctly identified\n   - Years/dates generally correct (2022, 2023, 2024) but missing 2025 reference\n   - Horizon Therapeutics correctly mentioned as acquisition source\n\n4. REASONING:\n   - The multi-hop synthesis is sound: connecting acquisitions, new initiations, and regulatory approvals to overall strategy\n   - Logic linking these activities to R&D expansion strategy is appropriate\n   - However, the specific program details appear to be hallucinated or from unverified sources\n\n5. SEMANTIC EQUIVALENCE:\n   - The core message about sustained expansion through internal and external growth is semantically equivalent to ground truth\n   - The characterization of strategy is appropriate\n\nMAJOR CONCERN: The LLM introduces specific program names and acquisition details (Dazodalibep, TEPEZZA, UPLIZNA as 2024 Horizon acquisitions) that appear inconsistent with the ground truth timeline (Horizon acquisition was 2023, adding five programs then). This suggests either hallucination or misalignment with the source data. The missing 2025 data point (25 programs) is also a notable omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 639,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "Accenture’s share‑based compensation pool grew from 127 million Class A shares in FY 2022 (page 91) to 141 million shares by FY 2024 (page 98), an 11 % expansion over two years.  The increase—likely driven by a 2023 authorization that matched the 2024 level—shows the company is deliberately enlarging its award pool to give management more flexibility to grant shares, align employee incentives with shareholders, and strengthen talent attraction and retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: FY 2022 figure of 127 million shares is correct; FY 2024 figure of 141 million shares is correct; the calculated 11% expansion is accurate (14M increase / 127M base = 11.02%, properly rounded). The answer correctly identifies the progression across the three-year period (2022-2024) and accurately notes that the authorization level remained at 141 million in both FY 2023 and FY 2024. The multi-hop synthesis is sound—the LLM correctly synthesized information about share authorization levels across multiple fiscal years and drew appropriate strategic conclusions. The reasoning about the company's strategic intent (talent retention, incentive alignment, management flexibility) aligns well with the ground truth's characterization of 'strategic expansion' and 'greater emphasis on equity-based incentives.' Minor strengths: The LLM provided specific page references (91, 98) and offered nuanced interpretation about the 2023 authorization matching 2024 levels. The only minor consideration is that the LLM phrased the progression slightly differently than ground truth (emphasizing the two-year span from 2022-2024 rather than explicitly stating the 2023 level), but this is a stylistic choice that doesn't affect factual accuracy. All entities (Accenture plc, Class A ordinary shares, Amended 2010 SIP) are correctly identified. The answer fully addresses the question's request for evolution analysis and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 419,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "Starbucks’ 10‑K notes that its purchase commitments and inventory cover green coffee through fiscal 2023 in 2022, through fiscal 2024 in 2023, and through fiscal 2025 in 2024, showing a rolling one‑year supply coverage that underpins a conservative inventory and hedging strategy to manage price volatility (SBUX_10k_2022, page 12; SBUX_10k_2023, page 12; SBUX_10k_2024, page 12).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer contains a fundamental misrepresentation of the data progression. According to the ground truth, the coverage extended from fiscal 2023 (FY2022) → fiscal 2025 (FY2023) → fiscal 2025 (FY2024). However, the LLM states coverage through fiscal 2023 (2022), fiscal 2024 (2023), and fiscal 2025 (2024), which represents a one-year rolling coverage pattern. This is INCORRECT. The ground truth shows that coverage jumped from FY2023 to FY2025 (a 2-year extension) in FY2023, then remained at FY2025 in FY2024. The LLM's characterization of 'rolling one-year supply coverage' contradicts the actual data showing a significant extension in FY2023 followed by maintenance in FY2024. QUANTITATIVE ERRORS: The fiscal year projections are misaligned with the ground truth. The LLM incorrectly suggests a consistent one-year forward projection, when the actual pattern shows: FY2022→FY2023 (1 year), FY2023→FY2025 (2 years), FY2024→FY2025 (1 year). This is a material factual error. PARTIAL CREDIT: The LLM correctly identifies that this relates to inventory and risk management strategy, and mentions hedging mechanisms. The source citations appear plausible. However, the core quantitative facts about the evolution of coverage duration are substantially incorrect, which is the primary focus of the question. The answer fails to capture the significant extension that occurred in FY2023 and mischaracterizes the pattern as a simple rolling one-year coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 413,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "From 2022 to 2024 the UPS/IBT Full‑Time Employee Pension Plan remained a non‑contributory plan for former CSPF members and other eligible employees, with no amendments or remeasurements reported in 2022 or 2024 (page_82, page_86). In 2023 a new five‑year national master agreement ratified by Teamsters employees increased wage and benefit rates for employees in the plan, and the impacts were reflected in the year‑end measurement (page_82). No further amendments or remeasurements were disclosed for 2024, though the discount rate for U.S. pension benefits was lowered from 5.79% to 5.42%, potentially affecting the plan’s funded status (page_84).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that substantially undermine its accuracy. CRITICAL ERRORS: (1) The LLM states 'no amendments or remeasurements reported in 2022 or 2024' - this directly contradicts the ground truth which explicitly documents a $3.3 billion pre-tax mark-to-market gain ($2.5 billion after tax) from a 2022 remeasurement following the American Rescue Plan Act. This is a major quantitative omission of a $3.3 billion figure. (2) The LLM claims 'no further amendments or remeasurements were disclosed for 2024' but provides no evidence this was actually verified against the filings. PARTIAL CREDIT AREAS: (1) The LLM correctly identifies the plan as non-contributory and covering former CSPF members. (2) The 2023 Teamsters agreement and wage/benefit rate increases are correctly noted. (3) The discount rate change from 5.79% to 5.42% is accurately reported. MULTI-HOP REASONING ISSUES: The answer fails to synthesize the complete three-year evolution. It misses the critical 2022 remeasurement event entirely, which is a cornerstone of understanding how UPS's treatment evolved. The answer also doesn't adequately convey the strategic balance between pension obligations, collective bargaining dynamics, and regulatory responsiveness that characterized the period. SEMANTIC ISSUES: The phrase 'no amendments or remeasurements reported' is problematic - the 2022 remeasurement was clearly reported and material. The answer reads as if the LLM either didn't find or didn't recognize the 2022 remeasurement data. The overall narrative is incomplete and misleading about the plan's evolution, particularly regarding the significant 2022 event.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 461,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "Walmart has kept “Holiday Time” in the same place in its private‑label lineup for three consecutive years—listed as a private brand under the general merchandise assortment in the 2022, 2023 and 2024 10‑K filings (WMT_10k_2022, page 8; WMT_10k_2023, page 8; WMT_10k_2024, page 8). This unchanged categorization shows the company treats the brand as a dedicated seasonal label, using it to offer low‑priced holiday merchandise while keeping it integrated within its broader private‑label strategy that emphasizes assortment control and price leadership.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - EVOLUTION CLAIM: The LLM states 'Holiday Time' remained in the 'same place' with 'unchanged categorization' across all three years, directly contradicting the ground truth which explicitly describes an evolution where by fiscal 2024, Walmart 'explicitly restructured its merchandise units to include seasonal merchandise as a defined category under General Merchandise.' This is a fundamental misunderstanding of the core question about how the brand's positioning EVOLVED. (2) MISSING CRITICAL INSIGHT: The LLM completely fails to capture the key strategic shift described in the ground truth—that by 2024, Holiday Time was repositioned within a newly defined 'seasonal merchandise' category, representing a more strategic placement. The ground truth emphasizes this represents 'a shift toward optimizing private label offerings for time-sensitive retail cycles,' which the LLM entirely misses. (3) QUANTITATIVE ACCURACY: The page references (page 8 for all three years) appear consistent with typical 10-K structure, though this cannot be fully verified. The years 2022, 2023, 2024 are correct. (4) REASONING FAILURE: The LLM's multi-hop synthesis is fundamentally flawed. It concludes that 'unchanged categorization' demonstrates the company 'treats the brand as a dedicated seasonal label,' when the ground truth shows the opposite—that the categorization CHANGED to become more strategically positioned within a dedicated seasonal framework. (5) SEMANTIC MISMATCH: The LLM's characterization of the brand as simply 'integrated within its broader private-label strategy' misses the evolution toward a more structured, dedicated seasonal category. The answer reads as static analysis rather than capturing the dynamic evolution the question specifically asks about. The LLM appears to have either misread the source documents or failed to synthesize the multi-year evolution correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 536,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "ACN’s pension‑plan holdings of mutual‑fund equity securities fell from **$239,293** in 2022 to **$196,226** in 2023, then rose to **$273,699** in 2024. The dip and subsequent rebound suggest the company is actively rebalancing its pension‑plan portfolio to keep equity exposure near its target mix, adjusting the allocation in response to market conditions and investment‑policy goals.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error regarding the 2024 value. Ground truth states mutual fund equity securities 'remained unchanged in 2024' at $196.226 million, but the LLM claims the value 'rose to $273,699' in 2024. This is a significant discrepancy that fundamentally contradicts the ground truth. The 2022 and 2023 values are correctly stated ($239,293 and $196,226 respectively, with proper formatting as thousands). However, the 2024 figure is completely incorrect - the LLM fabricated a number that doesn't match the ground truth. The LLM's interpretation of the trend is also incorrect: it suggests 'a dip and subsequent rebound' implying active rebalancing upward in 2024, when the ground truth indicates the value remained flat, suggesting a strategic rebalancing AWAY from this asset class (not toward it). The reasoning about 'keeping equity exposure near its target mix' contradicts the ground truth's characterization of 'consistent decline' and 'strategic rebalancing away from this asset class.' While the LLM correctly identifies this as pension-plan holdings and uses appropriate financial terminology, the core quantitative facts are wrong, leading to an incorrect strategic interpretation. The multi-hop synthesis fails because the 2024 data point is fabricated rather than derived from actual filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 379,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "Starbucks’ 2022 filing noted that commodity‑index funds can influence green‑coffee prices and that it hedged exposure with forward contracts, futures and collars, covering commitments through fiscal 2023. In 2023 and 2024 the company extended that coverage to fiscal 2025 while keeping the same hedging mix, indicating a forward‑looking expansion of its risk‑management program. This demonstrates a balanced approach that secures supply via fixed‑price commitments while actively using market instruments to mitigate price volatility driven by futures‑market activity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across fiscal years 2022-2024. STRENGTHS: (1) Correctly identifies the three fiscal years and their progression; (2) Accurately captures the hedging instruments used (forward contracts, futures, collars); (3) Correctly notes the extension of coverage from fiscal 2023 to fiscal 2025; (4) Properly identifies commodity index funds' influence on green coffee prices; (5) Accurately characterizes the risk management approach as balanced and forward-looking; (6) Correctly synthesizes the evolution showing consistency and maturation. MINOR WEAKNESSES: (1) The phrase 'keeping the same hedging mix' in 2023-2024 is slightly imprecise—the ground truth emphasizes 'similar narrative' and 'continued emphasis' rather than explicitly stating the mix remained identical, though this is a semantic nuance rather than factual error; (2) The answer could have been slightly more explicit about the 'maturing' aspect of the risk management approach mentioned in the ground truth, though 'forward-looking expansion' captures this concept adequately. QUANTITATIVE VERIFICATION: All dates and fiscal year references are correct (2022, 2023, 2024, fiscal 2025 coverage). No calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and correctly identifies the progression of hedging strategies and their relationship to futures market influences. The connection between commodity index funds and price volatility is properly maintained throughout. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate wording variations that maintain factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 484,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "AVGO had no 3.625% notes due October 2024 outstanding in FY 2022, $622 million at the end of FY 2023, and none outstanding by the end of FY 2024 (the notes were repaid upon maturity in October 2024)【page_81】. This pattern shows the company is issuing short‑term debt to fund operations or acquisitions and then paying it off quickly, indicating a near‑term debt strategy aimed at reducing interest costs and keeping debt levels low.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding FY 2022. The ground truth clearly states AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024 in 2022. The LLM incorrectly claims there were 'no 3.625% notes due October 2024 outstanding in FY 2022,' which directly contradicts the original answer. This is a major quantitative accuracy failure. The LLM correctly identifies $622 million for FY 2023 and correctly notes the notes were retired by FY 2024, but the FY 2022 error undermines the entire progression analysis. REASONING ISSUES: The LLM's interpretation of the debt management strategy is also problematic. The ground truth indicates AVGO 'addressed maturing obligations before their due dates' - a proactive refinancing/repayment strategy. The LLM mischaracterizes this as 'issuing short-term debt to fund operations or acquisitions and then paying it off quickly,' which is not supported by the evidence and misrepresents the company's strategy. The ground truth shows the notes were held from 2022-2023 unchanged, then retired by 2024 (before October 2024 maturity), not a pattern of issuing and quickly paying off short-term debt. COMPLETENESS: While the LLM addresses the three fiscal years requested, the incorrect FY 2022 data means the progression analysis is fundamentally flawed. The multi-hop synthesis fails because it misses the key insight that the company held the debt for two years before retiring it ahead of maturity. MINOR POSITIVE: The LLM correctly identifies the October 2024 maturity date and notes the retirement occurred, but this cannot offset the major quantitative error in FY 2022 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 465,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "From 2022 to 2024 Mastercard’s settlement exposure grew steadily—gross exposure rose from $64.9 billion to $78.4 billion, with risk‑mitigation arrangements applied increasing from $9.2 billion to $13.5 billion, so net exposure climbed from $55.7 billion to $64.9 billion. The company kept its credit‑risk framework intact, requiring cash collateral, letters of credit and guarantees (including $272 million of traveler‑cheque guarantees in 2023) and routinely reviewing risk‑management policies, while depleting its qualified cash settlement fund for MDL litigation and recording additional accruals for opt‑out merchant claims. Regulatory scrutiny—FTC consent agreements, DOJ civil investigative demands, and a European Commission information request—alongside ongoing MDL and U.K. merchant litigation heightened potential liabilities and prompted Mastercard to adjust its risk‑mitigation and settlement‑exposure calculations accordingly.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific quantitative data that appears well-sourced from Mastercard's 10-K filings. STRENGTHS: (1) Specific settlement exposure figures ($64.9B to $78.4B gross, $9.2B to $13.5B mitigation, $55.7B to $64.9B net) are precise and verifiable; (2) Correctly identifies risk mitigation tools (cash collateral, letters of credit, guarantees); (3) Accurately references the $272 million traveler-cheque guarantee in 2023; (4) Properly synthesizes regulatory actions (FTC consent agreements, DOJ civil investigative demands, European Commission investigation); (5) Mentions specific litigation contexts (MDL litigation, U.K. merchant claims, opt-out merchant claims); (6) Demonstrates multi-hop reasoning by connecting regulatory/litigation pressures to adjustments in risk calculations. MINOR GAPS: (1) The original answer mentions a specific class-action lawsuit alleging $1+ billion liability related to EMV liability shift—the LLM answer references MDL litigation but doesn't quantify this specific claim; (2) The original answer explicitly mentions the FTC consent agreement regarding Durbin Amendment compliance and debit transaction routing transparency—the LLM answer references FTC consent agreements more generally without this specific detail; (3) The original answer notes the European Commission's investigation into anticompetitive behavior tied to network fees—the LLM answer mentions the EC information request but doesn't specify the network fees angle. QUANTITATIVE VERIFICATION: The settlement exposure figures and mitigation amounts appear internally consistent and logically derived (net = gross - mitigation). The progression from 2022-2024 shows reasonable growth patterns. REASONING QUALITY: The answer effectively synthesizes information across multiple dimensions (financial metrics, regulatory actions, litigation risks) and connects them to risk management adjustments. The logic flow is sound and demonstrates understanding of how external pressures influence internal risk management practices. The answer is more specific and data-driven than the original, though it sacrifices some contextual detail about specific regulatory issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1590,
        "completion_tokens": 592,
        "total_tokens": 2182
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "Amgen’s 2022 10‑K (page 34) framed drug‑delivery devices as “products that have their own regulatory, manufacturing and other risks” and noted that they are subject to regulatory oversight and that non‑compliance with reporting or pharmacovigilance could trigger inspections, warning letters, fines or withdrawal of approval. By 2023 (page 52) the disclosures added explicit post‑marketing obligations—such as a confirmatory study for the accelerated‑approval product LUMAKRAS and pediatric study requirements—while reiterating that device safety and reporting are monitored by regulators. In 2024 (page 54) the language further detailed these post‑marketing commitments, highlighted ongoing regulatory review of device safety and malfunctions, and stressed that failure to meet compliance or reporting requirements could lead to inspections, warning letters, fines or withdrawal of approval, underscoring an intensified focus on compliance and safety oversight.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the three-year evolution (2022-2024) of Amgen's regulatory risk disclosures; (2) Accurately captures the progression from general regulatory/manufacturing risks in 2022 to specific post-marketing obligations in 2023 to detailed compliance/safety oversight in 2024; (3) Properly synthesizes multi-hop information by connecting drug delivery devices to regulatory scrutiny, post-marketing requirements, and enforcement mechanisms across years; (4) Correctly names specific products (LUMAKRAS, Repatha implied through context) and regulatory concepts (accelerated approval, confirmatory studies, pediatric requirements); (5) Accurately reflects the enforcement mechanisms mentioned (inspections, warning letters, fines, withdrawal of approval); (6) Page references (34, 52, 54) are provided with appropriate specificity. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer mentions 'pediatric study requirements' which is not explicitly mentioned in the ground truth, though this represents a reasonable inference about post-marketing obligations rather than a factual error; (2) The ground truth explicitly mentions 'surrogate endpoints' as a 2023 focus, which the LLM answer does not capture, though it does mention 'accelerated-approval' which is related; (3) The ground truth's reference to Repatha is not explicitly mentioned in the LLM answer, though LUMAKRAS is correctly identified. QUANTITATIVE ACCURACY: All years (2022, 2023, 2024) are correct; no numerical calculations required; page numbers appear reasonable for 10-K filings. QUALITATIVE ACCURACY: The reasoning correctly traces the evolution of disclosure emphasis and properly identifies the shift toward post-market compliance focus. The multi-hop synthesis across three years and multiple regulatory concepts is sound. CONTEXTUAL RELEVANCE: The answer directly addresses all three components of the question: compliance requirements, post-marketing obligations, and safety oversight, with clear year-by-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 566,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "Walmart’s private‑label “Parent’s Choice” has stayed in the same spot in its merchandising map for three consecutive years.  In each 10‑K (2022, 2023 and 2024) the brand is listed among the private‑label lines and is grouped under the Grocery unit, which the company defines as “a full line of grocery items … including baby products”【page_7】【page_7】.  Because the Grocery unit also covers consumables such as health‑and‑beauty aids, pet supplies, household chemicals, paper goods and baby products, the brand’s placement signals Walmart’s intent to market “Parent’s Choice” as a low‑price alternative for baby and consumable goods—a core part of its private‑label strategy that has remained unchanged across the three fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies all three fiscal years (2022, 2023, 2024) with accurate temporal sequencing. (2) Accurately states that 'Parent's Choice' remained under the Grocery unit across all three years, confirming continuity. (3) Correctly identifies the Grocery unit's definition as including baby products and consumables. (4) Properly synthesizes the multi-hop information: brand placement → unit categorization → strategic intent. (5) Accurately conveys Walmart's EDLP (Everyday Low Price) philosophy and positioning of the brand as a low-cost alternative. (6) Correctly identifies the consumables portfolio components (health-and-beauty aids, pet supplies, household chemicals, paper goods, baby products). MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail about consumables categories than the ground truth, but this is additive and accurate rather than contradictory. (2) Both answers emphasize the consistency and strategic intent behind the brand's placement, with the LLM providing additional context about the breadth of the Grocery unit. (3) The LLM answer explicitly states 'unchanged across the three fiscal years,' which directly mirrors the ground truth's 'consistent placement over three years.' QUANTITATIVE VERIFICATION: All dates (2022, 2023, 2024) are correct; no calculations required; all entity references (Walmart, Parent's Choice, Grocery unit) are accurate. REASONING QUALITY: The multi-hop synthesis is sound—the answer correctly connects brand placement → unit definition → strategic positioning. The conclusion about Walmart's intent to market the brand as a low-price alternative for baby and consumable goods is well-supported and matches the ground truth's characterization of EDLP philosophy alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 507,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "Tesla’s 4.70% Solar Bonds, Series 2015/C24‑10, were issued in 2015 and have been kept on Tesla’s balance sheet as a long‑term debt instrument, appearing as Exhibit 4.28 in the 2022, 2023 and 2024 10‑Ks [2022 pages 100‑104, 2023 pages 98‑102, 2024 pages 97‑101].  Each filing references the bond as part of Tesla’s debt portfolio and lists supplemental indentures that indicate periodic refinancings or restructuring [2022 pages 100‑104, 2023 pages 98‑102, 2024 pages 97‑101].  This consistent inclusion over three years signals Tesla’s deliberate strategy of using fixed‑rate solar bonds as a stable, long‑term financing vehicle for its solar assets, underscoring a focus on predictable debt service and risk management.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility: (1) CRITICAL ERROR - The bond was introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015, NOT issued in 2015 as a standalone instrument. The ground truth specifies this was part of a broader solar financing framework with specific supplemental indenture documentation. (2) MISSING KEY CONTEXT - The LLM fails to mention the evolution across the three years showing how Tesla referenced this bond alongside newer series (2015/C27-10 and 2015/C32-10 in 2023) and earlier series (C4-10 and C9-10 in 2024), which is central to understanding the multi-year pattern. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes a 'matured and recurring financing model' with a 'consistent and scalable securitization strategy,' but the LLM only vaguely references 'periodic refinancings or restructuring' without substantiating this claim or showing the evolution pattern. (4) EXHIBIT CITATIONS - While the LLM provides specific page references (100-104, 98-102, 97-101), these cannot be verified against the ground truth and appear to be fabricated details. (5) REASONING GAP - The LLM's conclusion about 'fixed-rate solar bonds as a stable, long-term financing vehicle' is reasonable but doesn't address the specific multi-year evolution pattern that the question explicitly asks about. The answer reads as generic debt analysis rather than addressing the specific evolution of this particular bond series across the three-year period. The ground truth demonstrates a clear progression showing how Tesla's approach matured from introducing the bond to contextualizing it within a broader historical framework, which the LLM completely misses.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 475,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "Broadcom’s 10‑K filings for 2022, 2023 and 2024 (all on page 10) describe the Security Insights Platform in the same way: a mainframe‑focused security solution that “quickly interprets and assesses mainframe security posture, identifies risks and develops remediation steps,” with the resulting data available for use in in‑house security‑information‑and‑event‑management (SIEM) tools. The emphasis on mainframe risk assessment remains unchanged across the three years, and the platform’s integration with enterprise security tools is consistently highlighted in each filing.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about evolution and change across the three years. STRENGTHS: (1) Correctly identifies the platform name and core functionality description; (2) Accurately captures the SIEM integration aspect; (3) Correctly references the three years (2022, 2023, 2024); (4) Properly notes mainframe risk assessment emphasis. CRITICAL WEAKNESSES: (1) The LLM claims the descriptions are 'the same way' and 'unchanged across the three years,' which directly contradicts the ground truth that shows meaningful evolution and a 'more deliberate alignment' by 2024; (2) The ground truth explicitly states the 2024 presentation reflects 'a slightly stronger emphasis on integration' and 'a more deliberate alignment with enterprise-wide security strategies,' indicating evolution that the LLM completely misses; (3) The LLM fails to capture the nuanced narrative progression described in the ground truth—from 2022's focus on 'quickly interprets and assesses' to 2023's emphasis on 'proactively respond' to 2024's 'maturing narrative around mainframe integration'; (4) The LLM's conclusion that positioning is 'consistently highlighted' and 'unchanged' fundamentally misses the question's core ask about HOW the positioning EVOLVED. MULTI-HOP REASONING: The LLM failed to synthesize the subtle but meaningful differences across the three years that the ground truth identifies. The question specifically asks about evolution, and the LLM's answer that nothing changed is factually incorrect based on the ground truth. The LLM provides a static snapshot rather than a dynamic analysis of change over time. SEMANTIC ISSUE: While the LLM correctly identifies some facts, it actively contradicts the ground truth's central finding about evolution and maturing narrative, making this a substantive error rather than a wording difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 510,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "Between 2022 and 2024 Mastercard’s Class A shares retained the same voting and dividend rights—each share continued to carry one vote and dividend entitlement【page_98】【page_97】【page_96】—while the declared dividend per share rose from $2.04 in 2022 to $2.37 in 2023 and $2.74 in 2024【page_98】【page_97】【page_96】. This unchanged voting structure, coupled with a steady increase in dividends, signals a deliberate, stable capital‑structure strategy that preserves shareholder governance while progressively enhancing shareholder returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies that MA's Class A shares maintained consistent one vote per share and dividend rights across 2022-2024, matching the ground truth core finding. (2) Provides specific dividend per share data ($2.04 in 2022, $2.37 in 2023, $2.74 in 2024) that demonstrates the progressive increase in shareholder returns while voting structure remained stable. (3) Accurately synthesizes the multi-hop information: voting rights consistency + dividend entitlement consistency + actual dividend amount increases across three years. (4) Correctly interprets the strategic implication: stable capital structure preserving governance while enhancing returns. (5) Properly cites source pages (96, 97, 98) indicating multi-document synthesis. MINOR CONSIDERATIONS: (1) The LLM answer goes slightly beyond the ground truth by providing specific dividend per share amounts, which adds valuable context but wasn't explicitly in the original answer. This is a strength, not a weakness, as it provides more complete information. (2) The ground truth focuses on 'consistency' and 'stability' while the LLM adds 'progressive enhancement' of returns—this is a logical extension that doesn't contradict the ground truth but enriches the analysis. (3) All numeric values provided (dividend amounts) appear reasonable and consistent with typical Mastercard dividend progression. The answer demonstrates sound multi-hop reasoning by connecting voting rights stability, dividend rights stability, and actual dividend amount increases to draw a coherent conclusion about capital structure strategy. No factual errors detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 458,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "Amgen kept Bemarituzumab in a Phase 3 program for gastro‑esophageal junction (GEJ) adenocarcinoma throughout 2022‑24, while still running Phase 2 studies in other solid tumors and a Phase 1 study in NSCLC (2022 10‑K p. 23‑25; 2023 10‑K p. 24‑25; 2024 10‑K p. 24‑25).  The 2024 10‑K notes it as one of 24 Phase 3 programs (Jan 31 2024) and the composition‑of‑matter patents in the U.S. and Europe are still set to expire in 2029 (2022‑24 10‑K p. 26).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key clinical development phases and IP timelines. Strengths: (1) Correctly identifies Phase 3 program for GEJ adenocarcinoma running 2022-24; (2) Accurately states patent expiration in 2029 for both U.S. and Europe; (3) Provides additional context about Phase 2 studies in other solid tumors and Phase 1 in NSCLC; (4) Notes Bemarituzumab as one of 24 Phase 3 programs as of Jan 31, 2024; (5) Correctly identifies composition-of-matter patents. Quantitative accuracy is high - all dates (2022-24, 2029) and the count of 24 Phase 3 programs are correct. Minor areas for improvement: (1) The LLM answer provides more granular detail about concurrent Phase 2 and Phase 1 studies, which goes beyond the ground truth but is not contradictory; (2) The ground truth emphasizes the 'evolution' and 'progression' from early-phase to mature asset, while the LLM answer focuses more on parallel programs running simultaneously; (3) The ground truth mentions 'potential regulatory exclusivity periods' as a 2024 development, which the LLM answer does not explicitly address, though this is a minor omission. The multi-hop reasoning is sound - the answer correctly synthesizes information across multiple years and filing documents. The semantic meaning aligns well with the ground truth regarding the strategic evolution of Bemarituzumab's development and IP protection. The answer could have been slightly more explicit about the strategic evolution/progression aspect emphasized in the original answer, but the factual content is accurate and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 446,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "Walmart’s U.S. strategic merchandise units shifted in 2023 from “Apparel” under General merchandise to a distinct “Fashion” unit (page 7, 2022 → page 7, 2023 → page 7, 2024). The private‑brand line “No Boundaries” appears on the private‑brand list in all three years (page 8, 2022‑2024) and is positioned within the apparel/fashion category, showing that the brand is part of Walmart’s expanding private‑label fashion offering. This reclassification and continued emphasis on “No Boundaries” reveal a deliberate shift toward treating fashion as a separate, high‑growth segment and a deeper focus on private‑label apparel to compete in that space.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the key strategic shift. STRENGTHS: (1) Correctly identifies the reclassification from 'Apparel' to 'Fashion' as a strategic merchandise unit change; (2) Accurately notes 'No Boundaries' appears consistently across all three years (2022-2024); (3) Properly synthesizes the multi-hop information showing the evolution of merchandise categorization; (4) Correctly interprets the strategic implications regarding private-label emphasis and fashion positioning; (5) Appropriately cites page references to support claims. MINOR WEAKNESSES: (1) The LLM states the shift occurred 'in 2023' but the ground truth indicates the restructuring was completed by 2024, making the timing slightly ambiguous - the LLM's phrasing '2022 → page 7, 2023 → page 7, 2024' could be clearer about when the actual transition occurred; (2) The LLM answer is somewhat less explicit about the specific composition of the Fashion unit (adult and children's apparel, shoes, jewelry, and accessories) compared to the ground truth; (3) The LLM doesn't explicitly mention 'omni-channel offerings and customer-centric experiences' as context for the strategic realignment, though this is a minor contextual detail. QUANTITATIVE VERIFICATION: All years (2022, 2023, 2024) are correctly referenced; no calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects the merchandise unit restructuring to strategic implications about private-label focus and fashion positioning. The reasoning is sound and logically coherent. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information from the ground truth with appropriate emphasis on the strategic shift and brand continuity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 491,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "IBM’s 10‑K filings for 2022, 2023 and 2024 all list “client relationships and trust” as one of the company’s principal competitive differentiators, with the wording unchanged across the three years (see 2022 page 2, 2023 page 3, 2024 page 3).  The steady emphasis indicates that IBM’s hybrid‑cloud and AI strategy is fundamentally anchored in trusted client partnerships, positioning the company as a reliable partner for digital transformation rather than merely a technology vendor.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The identification that IBM lists 'client relationships and trust' as a principal competitive differentiator across 2022-2024 is accurate. (2) The page number references (2022 page 2, 2023 page 3, 2024 page 3) appear reasonable for 10-K filings. (3) The assertion that wording remained unchanged across years is a factual claim that aligns with the ground truth's acknowledgment of consistent emphasis. PROBLEMATIC ELEMENTS: (1) The LLM answer claims the wording was 'unchanged across the three years,' but the ground truth explicitly states an EVOLUTION: 2022 emphasized relationships/trust as foundational differentiators; 2023 explicitly LINKED these to delivering business value and solving complex challenges; 2024 EXPANDED context to include strategic partnerships with hyperscalers and system integrators. This is a significant mischaracterization of the progression. (2) The LLM answer fails to capture the key evolution showing how trust was 'increasingly leveraged through partnerships' - it mentions partnerships only in passing without showing how this represents strategic evolution. (3) The answer does not adequately address the 'progression' or 'evolution' that the question specifically asks about - it treats the three years as static rather than dynamic. (4) The LLM answer provides minimal insight into how this evolution 'reveals' anything about IBM's hybrid cloud and AI strategy positioning beyond a general statement that it's 'anchored in trusted partnerships.' The ground truth shows a more sophisticated progression: from foundational positioning → to value delivery linkage → to ecosystem-enabled innovation. MULTI-HOP REASONING: The LLM failed to synthesize the year-over-year evolution across the three filings, instead treating them as identical. This is a fundamental failure in multi-hop reasoning for a question explicitly asking about evolution and progression. The answer is partially correct on basic facts but significantly incomplete on the core analytical requirement of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 566,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "Tesla, through SolarCity, issued the 5.45% Solar Bonds, Series 2015/C25‑15 in 2015 and the bond remained outstanding in subsequent years.  The 2022 10‑K lists the bond as an outstanding liability (exhibit on page 100), the 2023 10‑K continues to disclose it (exhibit on page 98), and the 2024 10‑K again includes it (exhibit on page 97).  This consistent, multi‑year presence shows Tesla’s reliance on long‑term SolarCity debt to finance its solar projects, underscoring a stable, predictable financing strategy for its solar portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core facts but has some issues with specificity and completeness. STRENGTHS: (1) Correctly identifies the bond as 5.45% Solar Bonds, Series 2015/C25-15; (2) Accurately notes the bond was issued in 2015; (3) Correctly identifies the bond's presence across 2022, 2023, and 2024 filings; (4) Provides specific page numbers (100, 98, 97) for the exhibits in each year's 10-K, which adds credibility; (5) Correctly synthesizes the multi-year pattern to conclude Tesla maintained a stable, long-term financing strategy. WEAKNESSES: (1) The LLM answer states the bond was 'issued in 2015' but the ground truth specifies the 'Thirty-Sixth Supplemental Indenture dated April 14, 2015' - the LLM lacks this specific date detail; (2) The ground truth emphasizes 'consistent legal and financial linkage' and 'reiterating the importance' across filings, while the LLM uses more generic language about 'reliance' and 'stable strategy'; (3) The LLM doesn't explicitly mention that the bond was 'introduced' or 'referenced' in 2022 filings as part of a broader series, instead stating it was simply 'listed as an outstanding liability'; (4) Missing the nuance that this represents 'ongoing reliance on this structured debt instrument' as emphasized in the ground truth. QUANTITATIVE ACCURACY: The page numbers provided (100, 98, 97) cannot be verified against the ground truth but appear plausible and specific. The bond percentage (5.45%) and series designation are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and correctly identifies the pattern indicating a consistent financing strategy. The logic is sound: persistent disclosure across years → ongoing reliance → stable strategy. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - the bond persisted across years indicating a consistent solar financing approach - though the LLM's phrasing is somewhat more straightforward and less detailed than the ground truth's emphasis on 'legal and financial linkage' and 'asset-backed financing strategy.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 565,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "Emerson’s Safety & Productivity segment has steadily pushed its pipe‑working line toward cordless, battery‑powered solutions.  In 2022 the segment already highlighted battery‑hydraulic tools for press‑connections and for cutting/crimping electrical cable, alongside diagnostic systems such as sewer‑inspection cameras【page 7】.  By 2024 the same product mix is reiterated, with continued emphasis on battery‑hydraulic tools for press‑connections and cutting/crimping, and the addition of diagnostic equipment, underscoring a sustained focus on battery‑powered, portable technology【page 73】.  This progression signals Emerson’s strategic intent to lead the professional‑tools market by offering advanced, battery‑driven equipment that boosts productivity and safety for field professionals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CHRONOLOGICAL SEQUENCING AND FACTUAL ACCURACY: The LLM answer contains a fundamental factual error that undermines the entire response. According to the ground truth, battery-hydraulic tools for press-connections were FIRST introduced in 2023, not 2022 as the LLM claims. The LLM states 'In 2022 the segment already highlighted battery‑hydraulic tools for press‑connections and for cutting/crimping electrical cable' - this is factually incorrect. The ground truth clearly indicates: (1) 2022 featured traditional tools (pipe wrenches, cutters, threading equipment, diagnostic systems), (2) 2023 introduced battery hydraulic tools for press connections, (3) 2024 expanded to battery hydraulic tools for cutting and crimping. The LLM reversed the chronology by placing 2023's innovation in 2022. Additionally, the LLM fails to mention pipe wrenches, which the ground truth emphasizes as having 'consistent mention across all three years' and their 'foundational role.' The LLM also omits the important distinction that sewer inspection cameras and locating equipment were specifically highlighted in 2024. While the LLM correctly identifies the overall strategic direction (shift toward battery-powered solutions), the execution is severely flawed due to the chronological error. The answer does not properly capture the EVOLUTION from 2022 to 2024 - it conflates the timeline and misrepresents when innovations were introduced. The multi-hop reasoning fails because it doesn't correctly synthesize the temporal progression across the three years. The semantic intent about strategic positioning is partially correct, but the factual foundation is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 458,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "Gilead’s 10‑K filings for 2022, 2023 and 2024 all list the El Segundo, California site as a cell‑therapy manufacturing facility (see page 11 in each filing).  The documents do not disclose specific capital‑expenditure amounts for the facility.  The 2024 filing (page 11) notes that the company “continues to develop additional manufacturing capabilities for future products,” indicating ongoing investment in cell‑therapy manufacturing at El Segundo that aligns with Gilead’s broader biologics development priorities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Page References: The LLM claims all three filings (2022, 2023, 2024) list El Segundo as a cell-therapy manufacturing facility on 'page 11 in each filing.' The ground truth explicitly states that in 2022, El Segundo was listed WITHOUT specific emphasis on cell therapy (page 33), and only in 2023 was it explicitly identified as dedicated to cell therapy (page 11). The LLM incorrectly backdates the cell therapy designation to 2022. (2) MISSING EVOLUTION NARRATIVE: The ground truth emphasizes a strategic evolution/progression from 2022 to 2024 - from general manufacturing to explicit cell therapy specialization. The LLM fails to capture this critical evolution, instead presenting a static picture where all three years are treated identically. (3) INCOMPLETE SYNTHESIS: The ground truth identifies three distinct phases: (a) 2022 - general manufacturing without cell therapy emphasis, (b) 2023 - explicit shift to cell therapy specialization, (c) 2024 - continued designation plus emphasis on proprietary manufacturing technologies and confidentiality agreements. The LLM collapses these into a single undifferentiated statement. (4) MISSING KEY DETAIL: The ground truth notes the 2024 filing's emphasis on 'internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies,' suggesting increased investment in securing and scaling processes. The LLM mentions only generic 'developing additional manufacturing capabilities' without this specificity. (5) QUANTITATIVE ACCURACY: Both answers correctly note that specific CAPEX amounts are not disclosed, which is accurate. However, this is a minor point given the major factual errors elsewhere. The LLM's answer is fundamentally incorrect in its core claim that El Segundo was designated for cell therapy in 2022, which directly contradicts the ground truth's explicit statement that this designation only occurred in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 546,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "IBM continued to disclose the 1.250% Notes due 2027 as a registered security in each annual report.  The 2023 10‑K referenced the instrument as Exhibit 4.3 to the 2019 8‑K, and the 2024 10‑K lists the notes (IBM27B) in the securities table and cites the same 2019 8‑K exhibit (see page 1 of the 2024 filing and page 20 of the 2023 filing).  No new issuance of the notes occurred between 2022 and 2024; the filings simply maintained the existing disclosure and reference.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant issues with completeness and interpretation of the question. CORRECT ELEMENTS: (1) The 1.250% Notes due 2027 were disclosed across multiple years (2022-2024); (2) The trading symbol IBM27B is correctly identified; (3) The reference to the 2019 8-K exhibit is accurate; (4) The statement that no new issuance occurred between 2022-2024 is factually correct. PROBLEMATIC ELEMENTS: (1) The LLM states 'No new issuance of the notes occurred between 2022 and 2024' which contradicts the ground truth's characterization of a 'shift from disclosure to active market presence' and 'transition from internal documentation and reference to public issuance and trading' in 2024. The ground truth indicates the 2024 filing shows the notes as 'formally listed...as an issued financial instrument on the New York Stock Exchange,' suggesting a meaningful change in status or disclosure treatment, not merely maintenance of existing disclosure; (2) The LLM answer misses the progression/evolution aspect emphasized in the ground truth - the shift from exhibit references (2022-2023) to formal listing in securities table (2024); (3) The LLM provides specific page references (page 1 of 2024, page 20 of 2023) which adds detail but these cannot be verified against the ground truth; (4) The answer is somewhat defensive in tone ('simply maintained') rather than capturing the actual evolution described in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years but fails to identify the key transition point in 2024 that the ground truth emphasizes. The answer treats the relationship as static rather than evolving. DATES/NUMBERS: All dates mentioned (2019, 2022, 2023, 2024) are correct; the trading symbol IBM27B is correct. The core factual error is the interpretation of what 'evolution' means in this context - the LLM sees continuity where the ground truth sees meaningful progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 535,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "Tesla’s 2022, 2023 and 2024 10‑K filings all list the 5.45% Solar Bonds, Series 2015/C45‑15 (exhibit 4.41) and a series of supplemental indentures for the same bonds (exhibits 4.42–4.43)【page_101】【page_101】【page_101】. The repeated inclusion of these legacy SolarCity bonds, together with the issuance of new supplemental indentures, shows that Tesla has been actively refinancing and restructuring its solar debt rather than letting the original 2015 bonds mature. This evolution reflects a shift from a static, inherited debt structure to a more dynamic solar‑financing strategy aimed at optimizing interest costs, extending maturities, and integrating solar financing into Tesla’s broader capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims exhibits 4.41, 4.42-4.43 contain the bond information, but provides no verification these exhibit numbers are correct. More importantly, the LLM completely fails to identify or reference the specific bond series mentioned in the ground truth (C53-15, C62-15, C72-15), which are central to demonstrating the evolution of Tesla's solar financing strategy. The ground truth explicitly identifies four distinct bond series with specific dates (May 26, 2015; June 16, 2015; June 29, 2015; July 21, 2015), while the LLM only mentions C45-15 and vaguely references 'supplemental indentures' without naming them. (2) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution from 2022-2024 across multiple filings. The ground truth demonstrates this by showing how different bond series appear in different years' filings (C45-15 in 2022, C53-15 added in 2023, C62-15 and C72-15 by 2024). The LLM fails to synthesize this year-by-year progression, instead making a generic claim about 'refinancing and restructuring' without specific evidence of which bonds appeared when. (3) INCOMPLETE ENTITY IDENTIFICATION: The LLM misses the key entities (specific bond series C53-15, C62-15, C72-15) that are essential to answering the question. (4) REASONING QUALITY: While the LLM's general conclusion about 'dynamic solar-financing strategy' is somewhat aligned with the ground truth's 'scalable, repeatable financing model,' the LLM's reasoning is unsupported by the specific bond series data. The LLM's interpretation about 'refinancing and restructuring' differs from the ground truth's interpretation of 'expanding securitization model' and 'iterative approach.' (5) SEMANTIC ISSUES: The LLM's claim about 'letting bonds mature' vs. 'refinancing' is not clearly supported by the evidence presented and may mischaracterize the actual strategy. The ground truth emphasizes expansion and iteration, while the LLM emphasizes restructuring—these are different strategic narratives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 570,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "In 2022, Acrobat was positioned as a market‑leading PDF solution with strong adoption in document‑intensive industries such as government, finance, legal, and aerospace, but the strategy did not emphasize AI capabilities (2022 10‑K, pages 4, 6, 8). By 2023, Adobe shifted its focus to embedding AI via Adobe Sensei, expanding Acrobat’s task‑based actions, integrating Adobe Sign across all surfaces, and targeting vertical markets while growing the Document Cloud platform (2023 10‑K, page 5). The 2024 10‑K (pages 94‑98) does not add new Acrobat‑specific details, indicating that the company continued to build on the 2023 strategy of AI‑driven features, API‑enabled workflows, and broader platform expansion.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year evolution from 2022-2024 and captures the general trajectory from market leadership to AI integration. (2) Correctly names 'Adobe Sensei' as the AI framework mentioned in 2023. (3) Accurately identifies document-intensive industries (legal, financial services) and mentions Document Cloud platform expansion. (4) Appropriately cites specific 10-K pages, showing document-based reasoning. (5) The chronological progression is logically sound.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM fails to mention the 'Acrobat AI Assistant' by name, which is explicitly stated in the ground truth as a formal trademark introduction in 2024 representing 'concrete realization' of AI strategy. This is a significant factual gap for a question specifically about AI integration evolution. (2) INDUSTRY DISCREPANCY: The LLM lists 'government' and 'aerospace' as key industries in 2022, while the ground truth emphasizes 'legal, financial services, and publishing.' The LLM's industry list appears broader but potentially less accurate to actual filing emphasis. (3) INCOMPLETE 2024 ANALYSIS: The LLM states the 2024 10-K 'does not add new Acrobat-specific details,' which contradicts the ground truth's assertion that 2024 formally introduced the Acrobat AI Assistant trademark. This suggests the LLM either missed this information or misinterpreted the filing. (4) MISSING STRATEGIC EMPHASIS: The ground truth emphasizes the 'clear trajectory from market leadership in document productivity to AI-driven innovation' and 'next-generation, intelligent document solution' positioning - the LLM's answer is more descriptive of features than strategic positioning. (5) ADOBE SIGN INTEGRATION: While mentioned, the ground truth emphasizes integration 'with Adobe Sign and the Document Cloud platform' as a unified modernization strategy in 2022, whereas the LLM treats this more as a 2023 development.\n\nCALCULATIONS/NUMBERS: No quantitative calculations required; dates (2022, 2023, 2024) are correct. Page citations appear reasonable but cannot be independently verified.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three years and identifies the progression, but fails to complete the synthesis by missing the 2024 AI Assistant trademark announcement, which is the culmination of the strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 634,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "Schwab’s interactive tools for RIAs began in 2022 as a web‑based platform that offered basic account management, real‑time data, and integrations with third‑party systems—including the free Schwab Advisor Portfolio Connect—providing a scalable, intuitive experience (page_7). By 2023 the platform was enhanced with the launch of Schwab Trading Powered by Ameritrade, which merged Ameritrade’s advanced trading technology and education into Schwab’s offering, and the continued integration of the thinkpipes trading platform and iRebal rebalancing solution (page_6, page_10). In 2024 Schwab further expanded these capabilities, fully integrating thinkpipes, iRebal, and Ameritrade features into its ongoing RIA platform, delivering seamless real‑time charting, efficient trading, and customizable portfolio rebalancing within a unified, data‑rich environment (page_8).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) INCORRECT ENTITIES: The LLM mentions 'Schwab Trading Powered by Ameritrade' (2023), 'thinkpipes trading platform,' and 'iRebal rebalancing solution' as core RIA tools, but the ground truth makes no mention of these specific products in the context of RIA platform evolution. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth clearly states that in 2022, Schwab offered 'proprietary software and a dedicated website' with 'third-party integrations such as CRM and portfolio management systems,' but does NOT mention Schwab Advisor Portfolio Connect as a 2022 offering. The LLM incorrectly places Portfolio Connect in 2022 when the ground truth indicates it was highlighted in 2024. (3) UNSUPPORTED CLAIMS: The LLM's detailed descriptions of 'thinkpipes,' 'iRebal,' and 'Schwab Trading Powered by Ameritrade' as core RIA platform components lack any corroboration in the ground truth, suggesting hallucination or confusion with other product lines. (4) MISSING KEY INFORMATION: The LLM fails to mention the 'Advisor Services website' which the ground truth identifies as 'the core platform' in 2023, and omits the emphasis on 'educational content' and 'support for RIAs transitioning to independence.' (5) STRUCTURAL ACCURACY: While the LLM does attempt a chronological evolution (2022-2024), the specific products and capabilities described are largely incorrect or misplaced temporally. The ground truth emphasizes consistent focus on 'digital tools and integrations' for 'scalability and efficiency,' but the LLM's specific product claims diverge significantly from this narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 467,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "In 2022 Emerson positioned air‑preparation equipment as a component of its pneumatic product line within the Discrete Automation segment, integrated with solenoid valves, pneumatic cylinders and actuators, and pressure/vacuum/temperature switches (page 8). By 2023 and 2024 the segment description explicitly listed air‑preparation equipment alongside pneumatic valves, cylinders, actuators and programmable automation control systems and software—highlighting a deeper integration with control technologies (page 73). Thus, Emerson’s positioning evolved from a general pneumatic component to a key element of an integrated pneumatic‑control solution for discrete industries.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the three-year timeframe (2022, 2023, 2024) and the Discrete Automation segment as the relevant context. (2) The LLM accurately captures some key technical components mentioned in the ground truth (solenoid valves, pneumatic cylinders, actuators, pressure switches). (3) The LLM correctly notes an evolution in positioning from 2022 to 2023-2024. (4) Page references are provided, suggesting source documentation was consulted.\n\nWEAKNESSES: (1) CRITICAL OMISSION - The LLM completely fails to address the 2024 evolution toward Industry 4.0, smart actuation, predictive maintenance, and secure wireless communication. The ground truth explicitly states that 2024 positioning 'further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation.' The LLM answer treats 2023 and 2024 as essentially equivalent ('By 2023 and 2024'), missing the critical distinction that 2024 represented a further evolution. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes a 'clear shift from a mechanical focus to a digitally integrated component,' but the LLM's conclusion ('from a general pneumatic component to a key element of an integrated pneumatic-control solution') is less precise and doesn't capture the digital transformation narrative. (3) MISSING CONTEXT - The ground truth mentions specific application domains (food processing, life sciences, petrochemical processing) in 2022 that the LLM omits. (4) VAGUE CHARACTERIZATION - The LLM says 'deeper integration with control technologies' but doesn't specify the nature of this deepening or the shift toward digital/Industry 4.0 alignment.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop reasoning by connecting Air Preparation Equipment across three years and linking it to broader segment positioning. However, it fails to synthesize the complete narrative arc that the ground truth presents—specifically the progression from mechanical/pneumatic focus → digital control integration → Industry 4.0 alignment.\n\nNUMERIC/FACTUAL ACCURACY: No specific numbers or calculations are involved in this question, so quantitative accuracy is not directly testable. However, the factual claims about positioning and evolution are partially correct but incomplete.\n\nJUSTIFICATION: The answer captures approximately 50% of the key information but misses critical elements about the 2024 evolution toward Industry 4.0, smart actuation, and predictive maintenance. This represents a significant gap in addressing the full scope of the question about how positioning 'evolved' across the three-year period. The answer would be stronger if it explicitly distinguished the 2024 positioning as a further evolution beyond 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 762,
        "total_tokens": 2195
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "In the 2022 10‑K the 0.125% Notes due 2029 were listed as a current note issued in September 2020【page_134】. By the 2024 10‑K the company had issued a second tranche (or amendment) of the same notes in March 2021, which is now the current note【page_130】. This evolution shows that Coca‑Cola treats the 0.125% Notes as a low‑rate, long‑term instrument that it periodically reissues or amends to refinance near‑term debt and keep its overall debt maturity profile stable while capitalising on favourable market conditions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - The LLM claims the 0.125% Notes were \"issued in September 2020\" and then \"a second tranche (or amendment)...in March 2021.\" The ground truth makes no mention of these specific issuance dates and instead focuses on how the notes were referenced across filings (2022-2024), not when they were originally issued.\n   - The LLM provides specific page references (page_134, page_130) that cannot be verified against the ground truth and appear to be fabricated details.\n   - No actual dollar amounts or issuance quantities are provided in either answer, but the LLM's invented dates are problematic.\n\n2. CONCEPTUAL MISALIGNMENT:\n   - The ground truth describes an EVOLUTION IN DISCLOSURE AND STRATEGIC CONTEXT across three years (2022-2024), showing how Coca-Cola's approach to managing these notes changed over time.\n   - The LLM misinterprets this as describing actual issuance/reissuance events (\"second tranche or amendment\"), which is not supported by the ground truth.\n   - The ground truth emphasizes the strategic pivot toward higher-yielding instruments (5.000% and 5.400% notes) as the 2029 note approached maturity—the LLM completely omits this critical insight.\n\n3. MULTI-HOP REASONING FAILURE:\n   - The question asks about evolution FROM 2022 TO 2024 and what this pattern suggests about debt management strategy.\n   - The ground truth correctly synthesizes: passive disclosure (2022) → consolidated format (2023) → strategic pivot to higher-yielding longer-term instruments (2024).\n   - The LLM fails to capture this three-year evolution and instead invents a narrative about reissuances/amendments that doesn't align with the ground truth's focus on changing disclosure context and strategic refinancing patterns.\n\n4. MISSING KEY INSIGHTS:\n   - The ground truth explicitly mentions the introduction of 5.000% Notes due 2034 and 5.400% Notes due 2064 in 2024 as evidence of strategic pivot—the LLM completely omits these higher-yielding instruments.\n   - The ground truth's core insight about \"deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes...neared expiration\" is absent from the LLM answer.\n   - The LLM's explanation about \"periodically reissues or amends\" contradicts the ground truth's focus on introducing NEW, higher-yielding instruments rather than reissuing the same low-rate notes.\n\n5. CONTEXTUAL RELEVANCE:\n   - While the LLM attempts to address debt management strategy, it does so through an incorrect lens (reissuance/amendment) rather than the correct lens (strategic shift toward longer-term, higher-yielding financing).\n   - The answer is partially relevant to the question but fundamentally misrepresents the nature of the evolution described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 770,
        "total_tokens": 2164
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s risk‑factor disclosures (2022 p. 5, 2023 p. 4, 2024 p. 4) consistently state that the company’s ability to return capital to shareholders—including dividends and share repurchases—is subject to U.S. banking laws and regulations, particularly capital‑planning rules and Delaware law, and that failure to pay full, timely dividends on preferred stock could further limit those returns. The wording and scope of this regulatory constraint remained unchanged across the three filings, indicating no evolution in the exposure to capital‑planning and dividend‑return restrictions during that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR IN CORE CLAIM: The LLM answer directly contradicts the ground truth on the fundamental question. The ground truth explicitly states that BNY Mellon's disclosures EVOLVED from 2022-2024, with increasing specificity and formalization in how regulatory constraints were communicated. The LLM answer claims 'the wording and scope of this regulatory constraint remained unchanged across the three filings, indicating no evolution.' This is factually incorrect and represents a complete misunderstanding of the question's core premise. The question asks HOW the exposure EVOLVED, and the ground truth provides a clear evolution narrative: (1) 2022: general caution about U.S. banking laws and Delaware law; (2) 2023: reiterated constraints plus specific references to preferred stock dividend obligations; (3) 2024: more structured language emphasizing 'well capitalized' status and capital adequacy rules. The LLM answer acknowledges the regulatory constraints exist but fails to identify or describe any evolution, instead claiming stasis. While the LLM correctly identifies that constraints relate to dividends, share repurchases, and capital-planning rules, and correctly cites page numbers, it fundamentally fails the multi-hop reasoning task of synthesizing how these disclosures changed across the three-year period. The answer demonstrates poor reading comprehension of the filing evolution and provides an answer that is semantically opposite to the ground truth's key finding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 412,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "McDonald’s 10‑K filings from 2022, 2023, and 2024 all list McGriddles as a breakfast sandwich in the “Products” section of the menu‑innovation disclosures, with identical wording in 2022 and 2023 and only a minor expansion in 2024 that added hash browns to the list (2022 p. 7; 2023 p. 6; 2024 p. 6). This steady presentation shows that McDonald’s breakfast strategy has remained largely unchanged, treating McGriddles as a core, stable offering rather than a focal point of menu innovation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a significant factual error that undermines its credibility. The claim that '2024 that added hash browns to the list' is not supported by the ground truth answer and appears to be an unsupported assertion. The ground truth explicitly states that McGriddles were 'described in the same basic format as in prior years' in 2024, with no mention of hash browns being added. This is a material factual error that contradicts the core finding of consistency. The LLM correctly identifies: (1) the three-year timeframe (2022-2024), (2) the page numbers cited (p. 7 for 2022, p. 6 for 2023 and 2024), (3) the general conclusion that McGriddles remained a stable, core offering without significant innovation focus, and (4) the semantic meaning that breakfast strategy remained largely unchanged. However, the introduction of the hash browns detail is problematic because: it's not mentioned in the ground truth, it suggests a change when the ground truth emphasizes consistency, and it appears to be fabricated or misremembered. The LLM also misses some nuance from the ground truth regarding the company's broader menu innovation claims (2023's 'continuous evolution' language, 2024's 'testing new products' language) that contextualize why McGriddles' static presentation is notable. The reasoning about consistency is sound, but the factual error about hash browns is a critical flaw that would mislead readers about what actually changed in the filings. The answer demonstrates partial understanding but fails on strict factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 428,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "Adobe’s 10‑K filings show that free online self‑service learning has remained a core part of its Digital Learning Services portfolio. In 2022 and 2023, the free courses were hosted on **learning.adobe.com** as a large number of self‑service options. By 2024 the same emphasis persisted but the portal was moved to **www.training.adobe.com**, reflecting a platform update while keeping the free learning positioned within Adobe Digital Learning Services.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth: (1) PLATFORM REVERSAL: The LLM states learning.adobe.com was used in 2022-2023, then moved to www.training.adobe.com in 2024. The ground truth shows the OPPOSITE trajectory: www.training.adobe.com in 2022, then shifted to learning.adobe.com in 2023 and 2024. This is a complete reversal of the actual evolution. (2) MISSING STRATEGIC CONTEXT: The LLM fails to capture the key insight from the ground truth - that this represents a 3-year trajectory showing platform consolidation/rebranding (from training.adobe.com to learning.adobe.com), not a reversal. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes the strategic shift toward 'a more centralized or rebranded approach' and 'increased integration into the broader Adobe Learning Services ecosystem,' suggesting maturation and structure. The LLM merely describes it as a 'platform update' without capturing this strategic evolution. (4) MISSING INTEGRATION NARRATIVE: The ground truth notes that by 2024, these tools were 'integrated more deeply into a comprehensive portfolio that also included fee-based and custom learning programs.' The LLM omits this important contextual detail about the broader learning services ecosystem. (5) QUANTITATIVE ACCURACY: While no specific numbers are provided in either answer, the platform domain names are factual data points that must be correct - and they are inverted in the LLM response. The answer demonstrates poor multi-hop reasoning by failing to correctly synthesize the platform evolution across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 450,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "In 2022 Emerson grouped commercial vacuums under its Tools & Home Products segment, describing them as part of “other professional tools” alongside water jetters, wet‑dry vacuums and hand tools (page 9). By 2024 the segment was renamed Safety & Productivity, with the same product mix but a clearer emphasis on safety and productivity for professionals and homeowners, positioning commercial vacuums alongside pipe‑working and electrical tools (page 73). Thus, the product categorization stayed consistent while the strategic focus shifted to a safety‑and‑productivity narrative and the alignment with professional tools was reinforced under the new segment name.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant gaps and misrepresentations compared to the ground truth. CORRECT ELEMENTS: (1) Correctly identifies 2022 positioning under Tools & Home Products segment; (2) Correctly notes the segment was renamed to Safety & Productivity by 2024; (3) Correctly identifies commercial vacuums as part of professional tools category. CRITICAL ERRORS AND OMISSIONS: (1) The LLM claims 'the product mix stayed consistent' and 'product categorization stayed consistent,' which directly contradicts the ground truth showing commercial vacuums moved from Tools & Home Products (2022) to Safety & Productivity (2023-2024) - this is a fundamental misunderstanding of the evolution; (2) The LLM completely omits the 2023 transition year, which is explicitly mentioned in the ground truth as a key milestone where commercial vacuums were 'explicitly included in the Safety & Productivity segment'; (3) The LLM fails to capture the strategic shift in product alignment - the ground truth emphasizes that by 2024, commercial vacuums were aligned with 'technologically advanced and industrial productivity tools' like programmable automation control systems and electrical distribution equipment, not just 'pipe-working and electrical tools'; (4) The LLM misses the core insight that this represents 'strategic repositioning from a general tools category to a more integrated part of Emerson's industrial safety and productivity solutions'; (5) The LLM's characterization of the evolution as merely a 'narrative shift' with 'consistent product categorization' fundamentally misses that commercial vacuums actually moved between segments (2022→2023 transition). MULTI-HOP REASONING: The LLM failed to properly synthesize the three-year evolution (2022, 2023, 2024) and instead collapsed it into a two-point comparison that obscures the actual repositioning. The answer demonstrates incomplete research or synthesis of the filing data across all three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 529,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "Gilead’s Hoofddorp, Netherlands site has continued to serve as a commercial manufacturing and processing hub for its cell‑therapy products with no change in its role from 2022 through 2024.  In each filing the facility is described simply as “used for commercial manufacturing and processing of our cell‑therapy products” (2023 page 11; 2024 page 10).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The original answer clearly documents an evolution in the facility's utilization from 2022 through 2024: (1) 2022 - identified as a 'principal manufacturing site' with no specific cell therapy focus mentioned, (2) 2023 - explicitly described as being utilized for 'commercial manufacturing and processing of cell therapy products,' and (3) 2024 - continued focus on cell therapy. The LLM incorrectly claims 'no change in its role from 2022 through 2024' and states the facility was described the same way in each filing. This is factually wrong - the ground truth explicitly indicates a strategic shift occurred between 2022 and 2023, where the facility's role became explicitly focused on cell therapy manufacturing. The LLM's statement that the facility is 'described simply as used for commercial manufacturing and processing of our cell-therapy products' in both 2023 and 2024 may be accurate for those two years, but this misses the key evolution from 2022 when no such specific cell therapy designation is mentioned. The LLM failed to synthesize the multi-hop information across the three-year period and incorrectly concluded there was no change. The page citations provided (2023 page 11; 2024 page 10) are reasonable but don't address the 2022 baseline. The quantitative accuracy score is higher because the dates and company name are correct, but the qualitative accuracy is very low because the core reasoning about evolution/change is fundamentally incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 427,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "Coca‑Cola’s 10‑Ks from 2022‑24 all list the 1.000% Notes due 2028 (Exhibit 4.26 on pages 134, 136, 128 and 132), underscoring the company’s continued reliance on a low‑cost, long‑term debt base.  In the 2024 filing the company also added higher‑yield instruments—5.000% Notes due 2034 and 5.400% Notes due 2064 (Exhibit 4.39 and 4.41 on page 130)—signaling a deliberate shift to diversify maturities and accept higher interest costs for longer horizons, thereby adjusting its capital‑structure mix and financing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. STRENGTHS: (1) All key financial instruments correctly identified: 1.000% Notes due 2028, 5.000% Notes due 2034, and 5.400% Notes due 2064 with accurate percentages and maturity dates. (2) Temporal accuracy confirmed: correctly identifies persistent reference across 2022-2024 filings and introduction of new instruments in 2024. (3) Multi-hop reasoning is sound: successfully synthesizes information across three years of filings and connects the contrast between low-cost legacy debt and new higher-yield instruments to strategic capital structure management. (4) Specific exhibit citations (4.26, 4.39, 4.41) and page numbers add credibility and demonstrate detailed filing knowledge. (5) Semantic equivalence with ground truth: LLM's characterization of the shift as 'deliberate diversification' and 'adjusting capital-structure mix' aligns with the ground truth's description of 'recalibration' and 'balancing near-term affordability with long-term funding needs.' MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth but captures all essential points without loss of meaning. (2) The phrase 'accept higher interest costs for longer horizons' is a reasonable interpretation of the strategic rationale, though the ground truth mentions 'favorable market conditions or strategic initiatives' as possible drivers—the LLM focuses on the structural/maturity aspect rather than speculating on market conditions. (3) No calculation errors detected. (4) All entities (Coca-Cola, debt instruments, years) correctly identified and synthesized. The answer fully addresses the complex multi-hop question about how debt financing costs and capital structure management evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 491,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "Emerson’s 2022 Tools & Home Products segment listed pipe cutters as part of a conventional mechanical lineup, with no mention of battery power (page_9, page_10).  By 2023 the Safety & Productivity portfolio expanded to include battery‑hydraulic tools for press connections and diagnostic systems such as sewer‑inspection cameras (page_73), and the 2024 description continued to highlight these battery‑powered, diagnostic‑integrated tools (page_74).  This evolution signals a deliberate shift toward electrified, tech‑enabled plumbing solutions, positioning Emerson as a forward‑looking, technology‑driven leader in the professional plumbing tools market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: The answer correctly identifies the three-year progression (2022-2024) and accurately characterizes each phase: 2022 as conventional/mechanical tools with no battery emphasis, 2023 as the introduction of battery-hydraulic technology and diagnostic systems, and 2024 as continued emphasis on battery-powered and diagnostic-integrated tools. All entity references (Emerson, pipe cutters, battery-hydraulic tools, sewer inspection cameras, locating equipment) are correct. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative question about product evolution. The temporal sequence (2022→2023→2024) is correctly ordered and presented. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and connects product features (battery power, diagnostics) to strategic positioning (technology-driven leader in professional plumbing market). The causal logic is sound: product evolution demonstrates strategic intent. (4) COMPLETENESS: The answer addresses all parts of the question - the portfolio evolution across the three years, the strategic shift toward battery-powered and diagnostic-integrated tools, and what this reveals about market positioning. The inclusion of specific product examples (battery-hydraulic tools, sewer inspection cameras) strengthens the answer. (5) SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as 'deliberate,' 'electrified,' and 'tech-enabled' conveys the same strategic intent as the ground truth's 'strategic pivot toward high-value, technology-enhanced tools.' Minor differences in phrasing ('forward-looking, technology-driven leader' vs. 'improving productivity and safety') are semantically equivalent and both valid interpretations of the strategic positioning. The only minor consideration is that the LLM includes page references (page_9, page_10, page_73, page_74) which add credibility but are not required by the ground truth format.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 564,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "From 2022 through 2024 Gilead has consistently listed its Santa Monica, California site as a **clinical‑manufacturing and processing hub for cell‑therapy products** (2022 p. 11; 2023 p. 11; 2024 p. 10).  The unchanged description shows the facility remains a dedicated clinical manufacturing node, underscoring its strategic role as a core part of Gilead’s cell‑therapy network that supports early‑stage production while other sites handle commercial manufacturing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer directly contradicts the ground truth on the core factual claim. Ground truth states that in 2022, the Santa Monica facility was NOT specifically highlighted for cell therapy processing, and only by 2023 was it explicitly noted for this role. The LLM claims the facility was 'consistently listed' for clinical manufacturing and cell therapy processing from 2022 through 2024 with 'unchanged description.' This is factually incorrect. The LLM also cites specific page numbers (2022 p. 11; 2023 p. 11; 2024 p. 10) without verification, which appears to be fabricated support for an incorrect claim. The ground truth explicitly describes a PROGRESSION/EVOLUTION from 2022 (general R&D site) to 2023 (dedicated cell therapy hub) to 2024 (retained role), but the LLM describes static/unchanged status throughout. The LLM does correctly identify GILD as Gilead and mentions Santa Monica, California, but fundamentally mischaracterizes the temporal evolution that is central to the question. The answer fails to capture the key insight that Santa Monica transitioned from a general R&D site to a specialized cell therapy manufacturing facility. The reasoning about 'early-stage production' vs 'commercial manufacturing' is speculative and not supported by the ground truth. This represents a major factual error on the primary question being asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 382,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "In 2022 Frame.io was positioned as a post‑production collaboration tool integrated with Premiere Pro and After Effects, supporting video, still images, design files, PDFs and camera‑to‑cloud uploads. By 2023 Adobe broadened Frame.io’s cross‑app integration to Photoshop, Lightroom and Workfront, added support for video beyond post‑production, still images, design files, PDFs and camera‑to‑cloud, and bundled it with Express and Firefly Services in Adobe G enStudio (see 2023 p. 12‑13). In 2024 the core integration remained with Premiere Pro and After Effects, but the platform continued to offer real‑time upload, review, approval, frame‑accurate commenting and annotations for still images, design files, PDFs and camera‑to‑cloud, reinforcing its role as a collaborative asset hub across the Creative Cloud ecosystem (see 2024 p. 12‑13).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the timeline. Key issues: (1) TIMELINE INVERSION: The LLM incorrectly attributes 2023 features (Photoshop, Lightroom, Workfront integration, GenStudio bundling) to 2023, when the ground truth clearly states these were 2024 developments. The LLM also incorrectly places 2022 features (camera-to-cloud, design files, PDFs support) in 2022, when ground truth indicates 2022 only mentioned Frame.io in trademark portfolio without detailed functional description. (2) FEATURE ATTRIBUTION ERRORS: The LLM claims 2022 had 'post-production collaboration tool integrated with Premiere Pro and After Effects' with extensive media support, but ground truth shows this level of detail only emerged in 2023. (3) 2024 MISCHARACTERIZATION: The LLM states 2024 'core integration remained with Premiere Pro and After Effects' and doesn't mention the expanded integrations (Photoshop, Lightroom, Workfront) or GenStudio positioning that ground truth identifies as 2024 developments. (4) MISSING EVOLUTION NARRATIVE: The LLM fails to capture the actual progression: 2022 (trademark mention only) → 2023 (detailed collaboration platform with specific app integrations) → 2024 (expanded to non-post-production use cases and broader Creative Cloud integration). The answer demonstrates poor multi-hop synthesis across the three-year period and inverts the chronological development of capabilities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 402,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "Emerson has kept electrical distribution equipment as a core element of its Discrete Automation portfolio, embedding it within a broader suite of discrete‑industry solutions that include solenoid valves, pneumatic valves, valve‑position indicators, pneumatic cylinders and actuators, air‑preparation equipment, pressure and temperature switches, electric linear‑motion solutions, programmable automation control systems and software, and materials‑joining solutions【page_73】.  The 2024 filing reiterates this positioning, underscoring the integration of electrical distribution equipment with programmable automation control systems and software and highlighting an expanded product scope that now spans a wider array of discrete‑industry components【page_73】.  Thus, from 2022 to 2024 Emerson’s strategy evolved by deepening the automation‑technology integration around its electrical distribution offerings while broadening the segment’s discrete‑industry product mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies Emerson (EMR) and accurately describes the 2024 positioning of Electrical Distribution Equipment within the Discrete Automation segment. The list of integrated products (solenoid valves, pneumatic valves, electric linear-motion solutions, programmable automation control systems, materials-joining solutions) aligns with the ground truth. However, there are significant gaps in the multi-hop temporal analysis that the question specifically asks for. The ground truth provides a detailed 3-year evolution narrative: (1) 2022 - foundational product in Industrial Solutions for manufacturing, (2) 2023 - embedded in Discrete Automation with programmable automation control systems and software, (3) 2024 - further integrated with electric linear motion and materials joining solutions. The LLM answer largely focuses on 2024 positioning and mentions the evolution occurred but does not provide the granular year-by-year breakdown that demonstrates how the strategic positioning evolved across the three-year period. The LLM states 'from 2022 to 2024 Emerson's strategy evolved' but does not articulate the specific 2022 and 2023 positioning milestones that show the progression. The answer correctly captures the overall strategic shift toward integration and broader product scope, but fails to fully synthesize the multi-hop temporal dimension across all three years as required by the question. The reasoning about deepening automation-technology integration and broadening product mix is sound, but incomplete in its historical narrative. No quantitative errors are present (no specific numbers were provided to verify), but the qualitative analysis lacks the detailed temporal synthesis expected for a multi-hop question spanning 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 483,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "Capital One’s fixed unsecured senior debt carried **$24.1 billion** at year‑end 2022 and grew to **$27.2 billion** in 2023, before easing slightly to **$26.9 billion** in 2024 (Table 8.1, 2023/2022; Table 9.1, 2024/2023).  The weighted‑average interest rate was **4.45 %** in both 2022 and 2023, but rose to **4.84 %** in 2024 (same tables).  This trend shows the company is keeping debt levels roughly flat while taking on newer, longer‑dated debt at higher rates, reflecting a strategy of refinancing in a tightening rate environment to preserve liquidity and extend maturities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that undermine the entire response. (1) 2022 CARRYING VALUE ERROR: LLM states $24.1 billion for 2022, but ground truth shows $19,975 million ($19.975 billion). This is a $4.125 billion discrepancy - a 20.6% overstatement. (2) WEIGHTED-AVERAGE INTEREST RATE ERROR FOR 2022: LLM claims 4.45% in 2022, but ground truth clearly states 2.91% in 2022. This is a massive 1.54 percentage point error. The LLM incorrectly states the rate was 4.45% in both 2022 and 2023, when it should be 2.91% in 2022 and 4.45% in 2023. (3) CORRECT DATA POINTS: The LLM does correctly identify $27.2 billion for 2023 and $26.9 billion for 2024, as well as 4.84% for 2024. (4) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize information across years and provide strategic interpretation, the foundational data is wrong, making the analysis unreliable. The interpretation about 'keeping debt levels roughly flat' is contradicted by the actual 20.6% increase from 2022 to 2023. (5) STRATEGIC ANALYSIS FLAW: The LLM's conclusion about 'refinancing in a tightening rate environment' is partially reasonable given the rate progression, but the claim about 'keeping debt levels roughly flat' is factually incorrect - debt increased significantly from 2022 to 2023. The ground truth interpretation about 'locking in long-term debt at increasingly higher rates' is more accurate given the actual data trajectory. The LLM appears to have confused or misread the 2022 baseline figures, which cascades through the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 437,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "RTX’s carrying amount of liabilities for performance and operating‑cost guarantees fell from $1,109 million at December 31 2022 to $993 million at December 31 2024 (a net decline of $116 million, or $164 million from Jan 1 2022).  The liability decreased each year—$48 million in 2022, $18 million in 2023, and $98 million in 2024—reflecting that settlements consistently outpaced new issuances and indicating a gradual reduction in the company’s exposure to long‑term product‑performance risks in its commercial aerospace business【page_102】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key quantitative metrics. Ground truth shows: 2022=$120M, 2023=$120M, 2024=$101M (stable with slight decrease). LLM claims: 2022=$1,109M, 2024=$993M with year-over-year decreases of $48M, $18M, and $98M. These numbers are completely wrong—off by a factor of approximately 9-10x. The LLM appears to have cited a different liability category entirely (possibly total guarantee liabilities rather than the specific performance and operating cost guarantee liabilities requested). The calculation logic presented ($1,109M - $116M = $993M) is arithmetically correct, but the underlying numbers are factually incorrect. The qualitative interpretation about 'settlements outpacing new issuances' and 'gradual reduction in exposure' is reasonable reasoning, but it's applied to wrong data. The answer does address the evolution question and attempts multi-hop synthesis, but the fundamental data error makes the entire response unreliable. The ground truth shows remarkable stability ($120M→$120M→$101M), while the LLM shows significant volatility ($1,109M→$993M with specific annual decrements). This is a critical failure in data accuracy that undermines the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 343,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "Coca‑Cola’s 10‑K notes for 2022 (Note 4, page 41), 2023 (Note 4, page 76), and 2024 (Note 4, page 78) all state that for non‑public investments it uses “discounted cash flows, estimates of sales proceeds, and appraisals” as valuation methods—no wording change is evident over the three years.  This unchanged reliance shows that the company has maintained a stable valuation framework, while the notes increasingly emphasize the difficulty of forecasting cash flows in emerging markets, indicating a continued, cautious approach to fair‑value assessment in those regions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core claim of the question. The ground truth explicitly describes a 3-year evolution: (1) 2022 - disclosure of 'estimates of sales proceeds' as part of valuation methodology; (2) 2023 - explicit statement that company 'relies on' this methodology, signaling deepening dependence; (3) 2024 - continued use with increased emphasis on challenges. The LLM claims 'no wording change is evident over the three years' and that the company 'maintained a stable valuation framework,' which directly contradicts the ground truth's documented progression from 'disclosed' → 'relies on' → 'use with caution.' The LLM's assertion that all three years use identical language ('discounted cash flows, estimates of sales proceeds, and appraisals') is factually incorrect according to the knowledge graph. The ground truth specifically highlights semantic and substantive shifts in how the methodology was characterized across years (disclosure → reliance → cautious application), which the LLM completely missed. While the LLM correctly identifies the note locations (Note 4, pages 41/76/78) and correctly notes the increasing emphasis on emerging market challenges, it fundamentally fails to recognize the evolution in the company's stated approach to fair value assessment. The LLM's conclusion of 'stable valuation framework' is the opposite of what the ground truth reveals. This represents a major failure in multi-hop reasoning and synthesis across the three-year period, as the question specifically asks about 'evolution' and the LLM denies any evolution occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 444,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s risk‑factor disclosures have consistently stated that “our ability to return capital to shareholders is subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The wording has not materially changed over the three years, underscoring a persistent regulatory constraint that caps the company’s flexibility in shareholder distributions while still leaving room for Board discretion when conditions allow.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer correctly identifies the consistent regulatory language across 2022-2024 and accurately quotes the standard risk factor disclosure language. However, it significantly underperforms on the core analytical requirement of the question. STRENGTHS: (1) Correctly identifies that the wording remained consistent across three years; (2) Accurately captures the standard regulatory constraint language; (3) Properly notes Board discretion element; (4) No factual errors in the quoted language. CRITICAL WEAKNESSES: (1) INCOMPLETE ANALYSIS - The LLM answer fails to address the key evolution highlighted in the ground truth: the 2024 disclosure added NEW emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC. This is a material change that the LLM completely omits; (2) MISSING MULTI-HOP SYNTHESIS - The question explicitly asks about 'evolution' and 'multi-year progression,' requiring comparison across years. The ground truth identifies a meaningful shift in 2024 (new emphasis on internal capital flows and structural dependencies), while the LLM dismisses this as 'not materially changed'; (3) INCOMPLETE ANSWER TO STRATEGIC IMPLICATIONS - The ground truth concludes that despite stable regulatory language, there were 'increasing internal structural dependencies shaping its shareholder return strategy.' The LLM provides no analysis of what the progression suggests about strategic flexibility, merely stating the constraint 'caps the company's flexibility'; (4) MISCHARACTERIZATION - By stating wording 'has not materially changed,' the LLM contradicts the ground truth's documented evolution regarding internal capital flow dependencies. The 2024 addition of emphasis on subsidiary dividend dependency and IHC credit extensions represents a material disclosure evolution that the LLM fails to capture. The answer reads as a static description rather than a multi-year comparative analysis as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 531,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "AMD’s 2022 filing (page 37) listed the loss or modification of tax and tariff exemptions as one of many political, legal and economic risks in foreign operations. In 2023 (page 40) the same risk was reiterated, now explicitly linked to trade‑protection measures and import/export licensing requirements, reflecting heightened trade tensions. By 2024 (page 40) the risk is framed within an expanded set of global regulatory challenges—including sanctions and export‑control revisions against Russia, Belarus and Ukraine—showing that AMD’s exposure has broadened and the regulatory environment has become increasingly complex and dynamic.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about AMD's evolving exposure to tax and tariff exemption risks from 2022-2024. STRENGTHS: (1) Correctly identifies the progression across all three years (2022, 2023, 2024) with accurate characterization of how the risk was presented in each filing; (2) Accurately captures the evolution from general awareness (2022) to explicit linkage with trade tensions (2023) to expanded regulatory complexity (2024); (3) Correctly identifies specific geopolitical factors mentioned (Ukraine, Russia, Belarus, sanctions, export controls); (4) Properly synthesizes multi-hop information showing how external pressures (geopolitical events) drove internal regulatory complexity; (5) Page references (37, 40, 40) appear reasonable for 10-K filings though cannot be independently verified; (6) Semantic equivalence with ground truth is strong - both convey increasing complexity and broadening exposure. MINOR WEAKNESSES: (1) The LLM answer mentions 'trade-protection measures and import/export licensing requirements' in 2023 which are not explicitly mentioned in the ground truth, though this represents reasonable inference from the filing context rather than factual error; (2) The ground truth specifically mentions 'China and Taiwan tensions' as a 2023 factor, which the LLM answer does not explicitly include, though it does reference 'heightened trade tensions' more broadly; (3) The LLM answer could have been slightly more explicit about the causal link between geopolitical events and regulatory shifts. QUANTITATIVE ACCURACY: All dates (2022, 2023, 2024) are correct; no calculations required. QUALITATIVE ACCURACY: Multi-hop reasoning is sound - the answer correctly synthesizes information across three years and identifies the progression pattern. Entity identification (AMD, tax/tariff exemptions, geopolitical factors) is accurate. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of exposure and what it suggests about regulatory complexity, with appropriate framing of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 568,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023, then rose modestly to $562 million in 2024, while long‑term debt declined from $49.3 billion in 2022 to $49.3 billion in 2023 and further to $44.99 billion in 2024. The concurrent elimination of floating‑unsecured senior debt—from $1.6 billion in 2022 to $349 million in 2023 and to zero in 2024—shows a deliberate shift toward fixed‑rate, longer‑term debt, thereby reducing the bank’s exposure to interest‑rate volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental numerical inaccuracies that severely undermine its credibility. (1) TOTAL DEBT FIGURES: The LLM states long-term debt was '$49.3 billion in 2022' and '$49.3 billion in 2023', but the ground truth shows total short-term borrowings + long-term debt was $43.086 billion in 2022 and $49.856 billion in 2023. The LLM's figures are significantly off and don't align with the ground truth totals. For 2024, the LLM claims $44.99 billion, while ground truth shows $45.551 billion—closer but still inaccurate. (2) SHORT-TERM BORROWINGS: The LLM provides specific figures ($883M in 2022, $538M in 2023, $562M in 2024) that cannot be verified against the ground truth, which focuses on the combined total. These appear to be incorrect or from a different classification. (3) FLOATING UNSECURED SENIOR DEBT: The LLM states $1.6 billion in 2022, but ground truth shows $1.709 billion—a material discrepancy. The 2023 figure of $349 million matches ground truth, and the 2024 elimination to zero is correct. (4) MISSING CRITICAL INFORMATION: The LLM completely omits the weighted-average interest rates (1.01% in 2022, 6.75% in 2023 for floating debt; 2.91% to 4.84% for fixed debt), which are essential to answering the question about 'interest rate exposure.' The ground truth explicitly discusses the rising rates from 2.91% to 4.84% for fixed unsecured senior debt, demonstrating the strategic pivot. (5) INCOMPLETE DEBT COMPOSITION ANALYSIS: The LLM fails to discuss fixed unsecured senior debt evolution ($21.045B in 2022 to $27.168B in 2023 to $26.930B in 2024), which is central to understanding the debt structure shift. (6) REASONING QUALITY: While the LLM correctly identifies the strategic shift from floating to fixed-rate debt and the reduction in interest-rate volatility, this conclusion is not adequately supported by the missing interest rate data and incomplete debt composition analysis. The multi-hop synthesis is incomplete because it doesn't connect the interest rate changes to the debt composition changes. VERDICT: The answer demonstrates partial understanding of the strategic narrative but fails on quantitative accuracy and completeness of financial metrics, particularly the interest rate exposure component which is explicitly requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 625,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "RTX’s net program share interest in International Aero Engines AG (IAE) stayed at **57 %** from 2022 through 2024 (2022: 57 %【page_108】, 2023: 57 %【page_101】, 2024: 57 %【page_102】). This unchanged stake confirms RTX’s continued role as the primary beneficiary and majority stakeholder in the V2500 engine program collaboration, preserving its influence over the program’s economics and decision‑making.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect quantitative data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims RTX's net program share interest was 57% consistently from 2022-2024, but the ground truth explicitly states it was 61% in 2022, then decreased to 57% in 2023 and 2024. This is a major factual error - the LLM missed the 4 percentage point decline from 2022 to 2023. (2) MULTI-HOP REASONING FAILURE: The question specifically asks about how the interest 'evolved' from 2022 to 2024, requiring comparison across three years. The LLM failed to identify the key strategic change (the 61% to 57% reduction), which is the core insight the question seeks. (3) SEMANTIC MISINTERPRETATION: The LLM's conclusion that the 'unchanged stake' indicates RTX's 'continued role as primary beneficiary' is contradicted by the actual data showing a deliberate reduction. The ground truth correctly interprets this as a 'strategic adjustment' and 'gradual dilution' of RTX's direct economic exposure. (4) CITATION ISSUES: While the LLM provides page citations, the actual data cited appears to be incorrect - the pages referenced do not support the claim of consistent 57% across all three years. (5) MISSING STRATEGIC INSIGHT: The LLM completely misses the strategic implication that RTX reduced its exposure to shift financial burden/risk to sub-collaborators, which is explicitly stated in the ground truth as the key indicator of strategic positioning. The answer demonstrates a fundamental failure to accurately extract and synthesize multi-year financial data from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 449,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "Cascade remains a key brand in P&G’s Fabric & Home Care segment, which has grown its share of net sales from 35 % in 2022 to 36 % in 2023 and 2024, and its share of net earnings from 31 % to 34 %.  The major‑brand list—Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer—has stayed unchanged across the three filings, underscoring Cascade’s steady importance while the segment’s overall weight in the home‑care portfolio has risen.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the question about Cascade's positioning evolution. QUANTITATIVE VERIFICATION: All numeric values are correct - Fabric & Home Care segment net sales at 35% (2022), 36% (2023-2024), and net earnings at 31% (2022) rising to 34% (2023-2024). The percentage changes are accurately calculated and presented. ENTITY ACCURACY: Correctly identifies Cascade as a brand within P&G's Fabric & Home Care segment and accurately lists the major brands (Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer) that remained unchanged across the three filings. MULTI-HOP REASONING: The answer successfully synthesizes information across three 10-K filings, tracking both segment-level metrics and brand positioning. The conclusion that Cascade maintained 'steady importance' while the segment's earnings contribution increased is logically sound. COMPLETENESS: The answer addresses the core question about how Cascade's positioning evolved, noting consistency in brand listing and segment metrics. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth, focusing on the key evolution metrics rather than explicitly stating 'consistent positioning' in the opening. However, the semantic meaning is equivalent - both convey that Cascade maintained stable strategic importance. The phrase 'the segment's overall weight in the home-care portfolio has risen' accurately captures the earnings growth from 31% to 34%. The answer effectively conveys that despite segment growth, Cascade's relative position remained stable through consistent brand listing and segment composition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 458,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "From 2022 to 2023, BNY Mellon listed its Directors’ Code of Conduct at a relative path ( bnymellon/documents/pdf/investor‑relations/directors‑code‑ofconduct.pdf ) under the bny.com domain, with no fully‑qualified URL in the 10‑K. By 2024 the code was moved to a branded, fully‑qualified HTTPS URL on the bnymellon.com domain ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf ) and the file name was hyphenated. The 2024 filing also more explicitly tied the code to the broader corporate‑governance framework—linking it to the employee Code of Conduct, the “Corporate Governance” section, and a commitment to disclose amendments on the website.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth across multiple dimensions: (1) DOMAIN EVOLUTION ERROR: The LLM claims the 2022-2023 URLs were on 'bny.com' domain, but ground truth shows they were on 'bnymellon.com'. The LLM then states 2024 moved to 'bnymellon.com', which is backwards—ground truth shows 2024 transitioned TO 'bny.com' (the new branding). This is a critical factual inversion. (2) URL PATH ERRORS: The LLM states 2022-2023 had 'investor-relations' in the path, but ground truth shows 2022 had 'in relations' (typo for 'investor relations') and 2023 had 'inv relations'—neither matching the LLM's claim. The LLM conflates the 2024 path structure with earlier years. (3) PROTOCOL/QUALIFICATION CONFUSION: The LLM claims 2022-2023 had 'relative paths' without fully-qualified URLs, but this distinction is not supported by ground truth and appears to be an unsupported inference. (4) HYPHENATION CLAIM: The LLM claims the filename was hyphenated in 2024 ('directors-code-of-conduct.pdf'), but ground truth shows this hyphenation existed in all three years (2022, 2023, 2024), making this not a distinguishing feature. (5) MISSING KEY EVOLUTION: The LLM fails to capture the core evolution from 'bnymellon.com' (legacy) to 'bny.com' (new branding) that is central to the ground truth narrative. (6) GOVERNANCE FRAMEWORK INTEGRATION: While the LLM mentions broader corporate governance framework integration in 2024, it does not accurately describe the domain/URL evolution that enabled this shift. The answer demonstrates fundamental misunderstanding of the chronological domain transition and conflates URL structures across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 461,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "Across 2022, 2023, and 2024, AMD’s 10‑K filings consistently protected AIB manufacturers’ inventory from price reductions and continued to stress that system integrators use discrete graphics solutions to differentiate and add value to their board‑level products. The identical wording in each filing indicates a steady, unchanged strategic approach rather than an evolution.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) AMD maintained inventory protection policies for AIBs across 2022-2024, (2) discrete graphics solutions were emphasized as differentiators, (3) the approach remained consistent across the three-year period. The answer accurately synthesizes multi-hop information across three fiscal years and correctly identifies the key entities (AMD, AIBs, system integrators, discrete graphics). No quantitative errors are present - there are no specific numbers, dates, or calculations to verify, and the temporal references (2022, 2023, 2024) are all correct. The semantic meaning aligns well with the ground truth: both convey stability and consistency in AMD's strategic positioning rather than evolution. However, there is a minor qualitative difference: the ground truth uses the phrase 'evolution' in the question but then clarifies that the positioning remained 'stable' and 'consistent,' while the LLM answer more directly states 'steady, unchanged strategic approach rather than an evolution.' This is actually a more precise characterization of what the ground truth conveys, though it slightly reframes the question's framing. The LLM answer is slightly more concise than the ground truth but captures all essential information: inventory protections, AIB focus, discrete graphics as differentiator, and consistency across years. The reasoning is sound and the multi-hop synthesis across three years is correct. Minor deduction for not explicitly mentioning 'board-level products' and 'system integrators' as prominently as the ground truth, though these concepts are implied in the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 450,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "McDonald’s 2022 10‑K (page 7) lists the Egg McMuffin as a core breakfast sandwich and ties its quality and consistency to rigorous supply‑chain and food‑safety standards (page 6). The 2023 filing (pages 7 and 6) repeats that emphasis, underscoring ongoing menu evolution and supplier collaboration but adding no new detail. By 2024, the breakfast‑menu description remains unchanged (page 7), while the supply‑chain section (page 6) adds a digital‑transformation effort to use data for continuous quality monitoring, further reinforcing the Egg McMuffin’s role as a benchmark for meeting customer expectations for quality and consistency.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and correctly identifies the evolution of McDonald's disclosure from 2022 to 2024. STRENGTHS: (1) Correctly identifies the Egg McMuffin as a core breakfast item across all three years; (2) Accurately captures the shift from general quality assurance to technology-integrated approaches; (3) Properly synthesizes information across multiple years showing progression; (4) Correctly identifies the 2024 digital transformation initiative for data excellence and quality monitoring; (5) Appropriately notes the supply chain collaboration emphasis in 2023. WEAKNESSES: (1) The LLM provides specific page numbers (page 7, page 6) which cannot be verified against the ground truth and may be inaccurate or fabricated - this is a significant concern for factual precision; (2) The statement that 2023 adds 'no new detail' is somewhat contradictory to the ground truth which indicates 2023 'expanded its narrative around innovation and supply chain collaboration' with specific mention of the Global Chief Supply Chain Officer - the LLM undersells the 2023 evolution; (3) The claim that 2024 'breakfast-menu description remains unchanged' is not explicitly confirmed in the ground truth, which focuses more on the digital transformation aspect; (4) Missing explicit mention of the Global Chief Supply Chain Officer role that was highlighted in the ground truth for 2023. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and identifies the progression from menu-focused disclosure to supply-chain-focused to technology-integrated approaches. However, the reasoning could be more nuanced regarding the 2023 expansion. SEMANTIC EQUIVALENCE: The core message aligns with the ground truth - showing evolution toward more technologically integrated quality assurance - but the characterization of 2023 as adding 'no new detail' is a minor semantic misalignment with the ground truth's description of 'expanded narrative.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 543,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "Oracle lists the 4.30% Note due 2034 in Exhibit 4.11 on page 111 of each filing (2022, 2023, and 2024) (2022 page 111; 2023 page 111; 2024 page 111). This persistent disclosure shows that the note remains a core, long‑term debt instrument, reflecting Oracle’s strategy of maintaining a diversified, fixed‑rate debt mix and preserving predictable interest costs over time. The consistency across reporting periods indicates a deliberate focus on stable, long‑term financing rather than short‑term debt rollover.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Oracle's 4.30% Note due 2034 as a persistent debt instrument across 2022, 2023, and 2024, and appropriately characterizes it as reflecting a long-term financing strategy. The qualitative reasoning about stable, fixed-rate debt and predictable interest costs is sound and relevant to the question. However, there are significant issues with quantitative accuracy: (1) The LLM provides specific exhibit and page number citations (Exhibit 4.11, page 111 for all three years) that cannot be verified against the ground truth and appear to be hallucinated details. The ground truth does not mention these specific exhibit numbers or page references. (2) The LLM answer lacks the comparative context provided in the ground truth—it does not mention the other debt instruments disclosed alongside the 4.30% Note (such as the 3.625% Note due 2023, 4.50% Note due 2044, or 2.950% Notes due 2024) that illustrate Oracle's diversified maturity profile and evolving debt portfolio. (3) The ground truth emphasizes how the note was disclosed 'alongside' other instruments in each year, showing a strategic diversification approach, but the LLM answer treats the note in isolation. The LLM's conclusion about long-term financing strategy is correct, but the answer is incomplete in its synthesis of the multi-hop information about Oracle's broader debt structure across the three years. The fabricated exhibit/page citations are a significant accuracy concern that undermines confidence in the response, even though the core interpretation is reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 433,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "Capital One’s valuation approach for net derivative assets/liabilities has stayed the same from 2022 through 2024: the firm uses vendor‑based models that rely on observable market inputs for Level 2 instruments and on unobservable inputs (primarily swap rates) for Level 3 instruments, with credit‑risk adjustments applied to all fair‑value calculations (2024 § 218; 2023 § 208).  The fair‑value amounts of the Level 3 net derivative position grew from $5 million at 12/31/2022 to $58 million at 12/31/2023 and to $69 million at 12/31/2024 (2024 § 217; 2023 § 206; 2022 § 206), while the unobservable input range (swap rates 3‑5 %) and weighted average (≈4 %) remained essentially unchanged (2024 § 217; 2023 § 206; 2022 § 206).  Thus, the company’s exposure to unobservable market inputs has increased in dollar terms, reflecting a larger derivative portfolio, but the sensitivity of those inputs has stayed stable over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM reports Level 3 net derivative fair values of $5M (2022), $58M (2023), and $69M (2024), but the ground truth states the overall net derivative assets/liabilities fair value was $19M (2022) and $58M (2023-2024). The LLM's 2024 figure of $69M contradicts the ground truth's consistent $58M for both 2023-2024. The LLM appears to be citing Level 3 sub-components rather than total net derivative positions, creating a fundamental mismatch. (2) INCOMPLETE GROUND TRUTH SYNTHESIS - The ground truth explicitly mentions a 'net unrealized loss of $20 million' held as of year-end 2022, which the LLM completely omits. This is a material detail about the 2022 valuation methodology. (3) UNOBSERVABLE INPUTS DISCREPANCY - The ground truth identifies default rates (53-163%) as a key unobservable input in 2023, but the LLM only mentions swap rates (3-5%) across all years. The omission of default rates represents incomplete characterization of the valuation methodology evolution. (4) METHODOLOGY CHARACTERIZATION - The LLM claims the valuation approach 'stayed the same' from 2022-2024, but the ground truth explicitly describes a 'transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023-2024.' This is a fundamental mischaracterization of the evolution. (5) MULTI-HOP REASONING - The LLM fails to properly synthesize the year-over-year changes in both fair value amounts and the types of unobservable inputs used. The ground truth reveals a methodological shift and increased transparency, while the LLM suggests static methodology. (6) CONTEXTUAL INTERPRETATION - The LLM's conclusion about 'larger derivative portfolio' driving the increase is speculative and not supported by the ground truth, which emphasizes methodological transformation and transparency improvements rather than portfolio growth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 523,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "RTX’s V2500‑flight‑hour obligation to Rolls‑Royce has remained a contingent payment tied to each hour flown through June 2027.  In 2022 the company described the payments as being capitalized as collaboration intangible assets and amortized to cost of sales (page 112), a treatment that the 2023 and 2024 filings repeat (page 114, page 73).  The 2024 commitments table (page 103) shows the same flight‑hour payments spread through 2029, indicating that the payment structure and amortization strategy (amortizing the intangible over the term of the underlying economic benefit) did not materially change from 2022 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DATE DISCREPANCY - LLM states payments spread through 2029 in 2024 commitments table, but ground truth clearly states 'through June 2027'. This is a significant factual error on a key metric. (2) MISSING KEY INFORMATION - LLM fails to mention the 2012 acquisition context that established this obligation, which is important for understanding the evolution. (3) INCOMPLETE EVOLUTION NARRATIVE - Ground truth emphasizes how transparency improved from 2022-2024 (payments described as contingent liabilities in 2022, then clarified as capitalized collaboration assets by 2023). LLM claims 2022 already described them as 'capitalized as collaboration intangible assets,' which contradicts ground truth's statement that in 2022 they were 'contingent liabilities' that 'were to be capitalized.' (4) MISSING DOLLAR AMOUNT - Ground truth provides $14.1 billion total commercial aerospace commitments for 2024, which LLM omits entirely. (5) REASONING QUALITY - LLM correctly identifies the flight-hour structure and amortization to cost of sales, but the claim that treatment 'did not materially change from 2022 to 2024' oversimplifies the evolution in how RTX disclosed and characterized these obligations. The ground truth emphasizes improved transparency and clarification over time, not stasis. (6) PAGE REFERENCES - LLM cites specific pages but these cannot be verified against ground truth source material. POSITIVE ASPECTS: LLM correctly identifies the V2500 flight-hour contingency, the June 2027 endpoint (though contradicts with 2029 claim), the amortization to cost of sales, and the general structure of the obligation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 453,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "Amgen’s 2022 10‑K (page 55) disclosed that the FDA had been evaluating the Neulasta Onpro kit and that the company had already implemented device‑ and labeling‑enhancements to address user complaints, and that it continues to monitor complaints and adverse events and add further enhancements as needed. The 2023 10‑K repeated the same statement, underscoring ongoing monitoring and continuous improvement. By 2024, Amgen reiterated the device‑enhancement and monitoring approach while adding broader operational‑resilience details—such as backup generators and power‑outage contingency plans for its Puerto Rico manufacturing facility—to mitigate supply disruptions that could affect the kit.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Amgen's Neulasta Onpro kit disclosures from 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression and key themes: device/labeling enhancements in 2022, reiteration in 2023, and expansion to operational resilience in 2024. (2) Accurately references the FDA evaluation context and the company's monitoring of complaints and adverse events. (3) Properly synthesizes the multi-hop information showing how disclosures evolved from device-focused to include operational risks. (4) Correctly identifies Puerto Rico manufacturing facility and backup generators as the operational resilience measure. (5) Appropriately notes the connection between operational disruptions and potential impact on user experience. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the December 31, 2024 island-wide outage that the ground truth specifically references, which is a concrete detail that demonstrates the operational challenges. (2) The phrase 'power-outage contingency plans' is somewhat inferred rather than explicitly stated in the ground truth, though the concept is accurate. (3) The LLM cites 'page 55' of the 2022 10-K, which adds specificity but cannot be verified against the ground truth provided. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not directly testable. The dates (2022, 2023, 2024) and the December 31, 2024 reference are accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across three years and connects device-level risks to operational infrastructure risks, demonstrating sound multi-hop reasoning. The logical flow from device complaints → monitoring → operational resilience is clear and accurate. SEMANTIC EQUIVALENCE: The LLM's phrasing 'device-and labeling-enhancements' matches the ground truth's 'device and labeling enhancements.' The characterization of the evolution is semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 552,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "BK’s 10‑K filings from 2022 through 2024 all contain identical wording in Item 14, stating that the ratification of KPMG LLP is incorporated by reference and that KPMG’s PCAOB firm number is 185 (BK_10k_2022, p. 14; BK_10k_2023, p. 14; BK_10k_2024, p. 14). The unchanged language across the three years indicates that BK has retained the same auditor and that its audit‑governance framework has remained stable, underscoring continuity in its oversight structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - KPMG's PCAOB firm number 185 is accurately cited, and the three-year period (2022-2024) is correctly identified. Page references (p. 14 for all three years) are appropriately cited. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how disclosure evolved from 2022-2024, and (2) what the consistent PCAOB number suggests about audit governance continuity. The LLM correctly identifies that there was no evolution/change - the disclosure remained identical across all three years. ENTITY ACCURACY: BK is correctly identified as the company, KPMG LLP is correctly named as the principal accountant, Item 14 is correctly referenced, and all three fiscal years (2022, 2023, 2024) are accurate. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the LLM synthesizes information across three separate filings to demonstrate consistency and draw the logical conclusion about stable audit governance. The connection between unchanged PCAOB number and audit continuity is correctly established. SEMANTIC EQUIVALENCE: The LLM's phrasing ('identical wording,' 'unchanged language,' 'retained the same auditor,' 'stable audit-governance framework') conveys the same meaning as the ground truth ('no substantive changes,' 'consistency suggests stable audit governance practices,' 'continuity'). Minor differences: The LLM uses slightly more technical language ('incorporated by reference') and provides specific page citations, which adds precision without contradicting the ground truth. The ground truth emphasizes 'strong institutional trust' as an inference, while the LLM focuses on the factual consistency - both are valid interpretations. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 507,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "RTX’s maximum‑potential exposure to commercial‑aerospace customer‑financing guarantees fell from **$304 million in 2022** to **$288 million in 2023** and **$274 million in 2024** (Note 16, pages 100‑102).  Correspondingly, the share of those guarantees attributable to collaboration partners declined from **$142 million (2022)** to **$135 million (2023)** and **$131 million (2024)** (Note 16, pages 100‑102).  This steady contraction shows the company is actively trimming guarantee exposure—likely through renegotiated terms, hedging, or shifting risk to partners—to limit potential liabilities and reinforce a more conservative risk‑management posture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All collaboration partners' share figures are correct ($142M in 2022, $135M in 2023, $131M in 2024), matching the ground truth exactly. The LLM also provides additional context by citing the maximum-potential exposure figures ($304M, $288M, $274M), which are not contradicted by the ground truth and add valuable context. The downward trend calculations are accurate. COMPLETENESS: The answer addresses both parts of the multi-hop question: (1) how exposure evolved (with specific numbers and trend), and (2) what the trend indicates about risk management strategy. ENTITY ACCURACY: RTX is correctly identified, years are correct (2022-2024), and the financial metric (commercial aerospace customer financing guarantees) is properly characterized. REASONING QUALITY: The LLM correctly synthesizes the declining trend across three years and provides sound interpretation of what this indicates about RTX's risk management strategy. The explanation that the company is 'actively trimming guarantee exposure' through 'renegotiated terms, hedging, or shifting risk to partners' is a reasonable inference from the data and aligns with the ground truth's characterization of 'strategic reduction in shared financial risk.' MINOR CONSIDERATIONS: The ground truth emphasizes that 'fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves,' which the LLM does not explicitly mention. However, this is a minor omission that doesn't affect the core answer's correctness. The LLM's interpretation is slightly more speculative ('likely through renegotiated terms, hedging...') compared to the ground truth's more measured tone, but this represents a reasonable analytical inference rather than an error. All numbers are accurate, multi-hop synthesis is sound, and the answer directly addresses the question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 524,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "From 2022 through 2024, P&G kept the Always brand in the same place in its portfolio: it remains a core brand in the Baby, Feminine & Family Care segment, under the “Feminine Care (Adult Incontinence + Menstrual Care)” sub‑category.  The company continues to list Always, Always Discreet and Tampax Bounty as the key feminine‑care brands, with Always and Tampax consistently highlighted as the top menstrual‑care products, while other feminine‑hygiene brands (e.g., Charmin, Puffs) stay in the broader family‑care sub‑category.  Thus, the product categorization and relative brand emphasis for Always did not shift materially over the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors and omissions that contradict the ground truth: (1) QUANTITATIVE ERRORS: The LLM fails to mention the critical segment contribution percentages (25% in 2022, 24% in 2023-2024) that are explicitly stated in the ground truth. These are key metrics for understanding the brand's positioning and importance. (2) SEGMENT NAMING ERROR: The LLM claims the segment was called 'Baby, Feminine & Family Care' in 2022, but the ground truth clearly states it was simply 'Feminine Care' in 2022, only being renamed to 'Baby, Feminine & Family Care' in 2023. This is a material factual error in the evolution narrative. (3) PRODUCT CATEGORIZATION ERRORS: The LLM incorrectly includes 'Tampax Bounty' as a key brand (ground truth mentions only 'Tampax'), and incorrectly lists 'Charmin' and 'Puffs' as feminine-care brands when these are tissue/paper products unrelated to feminine hygiene. This demonstrates fundamental misunderstanding of the product portfolio. (4) INCOMPLETE EVOLUTION NARRATIVE: The LLM states 'product categorization and relative brand emphasis for Always did not shift materially,' which contradicts the ground truth's description of meaningful structural changes (segment renaming, addition of Always Discreet positioning, formatting streamlining). The ground truth explicitly describes an evolution, while the LLM dismisses it as static. (5) MISSING KEY DETAILS: The LLM omits the specific positioning of Always Discreet alongside Always and Tampax in 2023-2024, and fails to capture the 'streamlined formatting' and 'consolidated approach' mentioned in the ground truth. (6) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the year-by-year evolution across 2022-2024, instead presenting a static view that contradicts the documented changes in segment naming and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 502,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "AMD has consistently warned that protecting its intellectual property in foreign jurisdictions is difficult, a risk that appears in every filing.  In the 2022 10‑K the risk was framed broadly as a challenge in overseas operations, while the 2023 10‑K explicitly linked it to the company’s growing global footprint and its reliance on third‑party wafer foundries in China, Malaysia and Taiwan.  By 2024 the filing emphasized that 66 % of revenue is international and highlighted geopolitical tensions between China and Taiwan—along with sanctions—as factors that could further jeopardize IP protection for its Asia‑based manufacturing partners.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the consistent nature of AMD's IP protection concerns across all three years; (2) Accurately captures the evolution from broad framing in 2022 to more specific regional focus in 2023-2024; (3) Correctly names the specific manufacturing locations (China, Malaysia, Taiwan); (4) Accurately references the 66% international revenue figure for 2024 (ground truth states 65%, but 66% is a reasonable rounding variation and both convey the same magnitude); (5) Properly identifies geopolitical tensions between China and Taiwan as an emerging risk factor in 2024; (6) Demonstrates sound multi-hop reasoning by connecting AMD's expanding international operations, third-party manufacturing reliance, and IP protection challenges. MINOR ISSUES: (1) The ground truth specifies 65% international sales in 2023, while the LLM states 66% for 2024—this is a minor discrepancy (1 percentage point) that could reflect rounding or slight year-to-year variation, but the LLM doesn't explicitly clarify which year this percentage applies to, creating minor ambiguity; (2) The LLM mentions 'sanctions' as a factor in 2024, which is not explicitly mentioned in the ground truth answer, though this could be a valid detail from the actual filing; (3) The answer could have been slightly more explicit about the 2023 baseline (65% international sales) for clearer year-to-year comparison. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across three years and multiple dimensions (IP protection, international operations, manufacturing locations, geopolitical risks), showing proper understanding of how these factors interconnect. The progression narrative is clear and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 502,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "Oracle first issued the 2.300 % Notes due 2028 in a 2021 offering (March 24 2021, Exhibit 4.14).  The same notes are still listed in the 2023 and 2024 10‑K exhibits (Exhibit 4.14, pages 111 and 110) as part of a tranche that includes notes with maturities from 2026 to 2061, while the coupon and maturity of the 2.300 % notes themselves did not change.  This continuity, together with the addition of higher‑coupon 2028 notes in 2023 (Exhibit 4.16, page 110), illustrates Oracle’s laddered, diversified debt strategy—issuing long‑term notes at multiple coupon rates to spread refinancing risk and manage interest‑rate exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2.300% Notes due 2028 were indeed issued in March 2021, which is accurate. (2) The notes appear consistently in 2023 and 2024 exhibits, matching the ground truth. (3) The characterization of Oracle's strategy as 'laddered, diversified debt strategy' is semantically aligned with the ground truth's 'diverse maturity profile' and 'stable and deliberate approach.' (4) The mention of multiple coupon rates and refinancing risk management is a reasonable inference about debt strategy. PROBLEMATIC ELEMENTS: (1) EXHIBIT CITATION ERROR: The LLM states the 2.300% Notes appear in 'Exhibit 4.14' for 2023-2024, but the ground truth indicates they appear in 'Exhibit 4.14' in 2023 and 2024 (consistent with LLM). However, the LLM also mentions 'higher-coupon 2028 notes in 2023 (Exhibit 4.16, page 110)' which contradicts the ground truth stating the notes were in Exhibit 4.14 in 2023. (2) FACTUAL DISCREPANCY: The ground truth explicitly states the notes were 'first referenced' in 2022 (in Exhibit 4.16), not that they were first issued in 2021. While the issuance date of March 2021 is correct, the ground truth's narrative focuses on when they were REFERENCED in the 10-K filings (2022, 2023, 2024), not when they were originally issued. The LLM conflates original issuance date with first appearance in the filing sequence being analyzed. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution 'from 2022 to 2024' in the context of 10-K filings, but the LLM jumps back to 2021 issuance, which while contextually helpful, doesn't directly address the 2022-2024 filing evolution that the ground truth emphasizes. (4) EXHIBIT REFERENCE INCONSISTENCY: The ground truth mentions Exhibit 4.16 for 2022 and Exhibit 4.14 for 2023-2024, but the LLM's exhibit citations are somewhat muddled and potentially incorrect regarding which exhibit contained which notes in which year. QUANTITATIVE ACCURACY: The date 'March 24, 2021' is specific but not verified against ground truth (which only says 'March 2021'). The page numbers cited (111, 110) cannot be verified. QUALITATIVE REASONING: The LLM's inference about laddered debt strategy and refinancing risk is sound and goes beyond the ground truth, but this added interpretation, while reasonable, wasn't explicitly stated in the original answer. The core multi-hop reasoning about consistency across years is present but slightly misdirected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 660,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "From 2022 through 2024, Boeing’s private‑equity strategy remained focused on U.S. and non‑U.S. limited‑partnership vehicles that target leveraged buyout, venture‑capital, growth and special‑situation strategies (2022: page 108; 2023: page 92; 2024: page 99).  The firm raised its target allocation from 4 % in 2022 to 7 % in 2023 and kept that target in 2024, while the actual allocation climbed from 8 % to 9 % (2022: page 110; 2023: page 92; 2024: page 99).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about evolution of BA's investment strategy from 2022-2024. STRENGTHS: (1) Correctly identifies that BA maintained focus on U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies across the period; (2) Provides specific allocation percentages (4% to 7% target, 8% to 9% actual) with page citations; (3) Correctly identifies Boeing as the company in question. CRITICAL WEAKNESSES: (1) The question specifically asks about 'evolution' and 'geographic scope and strategic focus areas' - the LLM answer fails to address the key evolution identified in the ground truth: the 2023-2024 expansion into 'global private investments in real assets such as energy, farmland, and infrastructure' and the 2024 increased sophistication with derivatives; (2) The LLM answer is incomplete - it only discusses allocation percentages and basic strategy categories, missing the critical strategic evolution toward real assets and derivatives mentioned in ground truth; (3) The answer does not demonstrate the multi-hop synthesis required to show HOW the strategy evolved across the three-year period - it merely states the strategy 'remained focused' without capturing the meaningful changes; (4) The ground truth explicitly mentions REITs in 2022 and the expansion to real assets (energy, farmland, infrastructure) in 2023-2024, which the LLM completely omits; (5) The ground truth notes 'increased sophistication in investment vehicles, including the use of derivatives' in 2024, which is entirely absent from the LLM response. The LLM answer provides accurate but incomplete information about allocation targets/actuals while fundamentally missing the strategic evolution that is the core of the question. The answer reads more like a static description of PE allocation rather than an analysis of how the strategy evolved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 519,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "Amgen began phase 3 trials of Bemarituzumab for gastro‑esophageal junction adenocarcinoma in 2022, and the 2023 and 2024 10‑K filings confirm the program remains in phase 3 with no status change (see the “Phase 3 programs” tables in each filing).  The composition‑of‑matter patents for Bemarituzumab are projected to expire in 2029 in both the United States and Europe, a date that has not shifted across the 2022‑2024 filings (see the “Phase 3 Product Candidate Patent Information” tables).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Bemarituzumab's development and patent positioning from 2022-2024. STRENGTHS: (1) All numeric values are correct - phase 3 initiation in 2022, patent expiration date of 2029 for both U.S. and Europe, consistent across all three years. (2) Quantitative accuracy is perfect - no calculation errors, dates are precise, and the 2029 patent expiration timeline matches ground truth exactly. (3) Multi-hop synthesis is sound - the answer correctly synthesizes information across three fiscal years (2022, 2023, 2024) and identifies the key progression (phase 3 initiation → phase 3 continuation with stable IP position). (4) Entity identification is accurate - correctly names Amgen, Bemarituzumab, the indication (gastro-esophageal junction adenocarcinoma), and the target (FGFR2b). (5) The answer appropriately references specific filing sections ('Phase 3 programs' tables and 'Phase 3 Product Candidate Patent Information' tables), demonstrating document-specific knowledge. MINOR DIFFERENCES FROM GROUND TRUTH: The LLM answer emphasizes 'no status change' in clinical phase (remaining in phase 3), while the ground truth uses 'progressed through clinical development' - these are semantically equivalent but the LLM's phrasing is more precise about the lack of phase advancement. The LLM answer is slightly more concise than ground truth but captures all essential information. The ground truth mentions 'polypeptide-related patents' while LLM says 'composition-of-matter patents' - these are functionally equivalent patent categories. Overall, the LLM answer provides accurate, well-sourced information with proper multi-hop synthesis across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 482,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "Dawn stayed listed as a major brand in P&G’s Fabric & Home Care segment throughout 2022‑2024, with the segment’s earnings contribution rising from 31 % of net earnings in 2022 to 34 % in 2023 and remaining at 34 % in 2024【page_19】【page_18】【page_18】. The unchanged brand lineup—Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer—shows Dawn’s consistent prominence while the segment’s growing profitability underscores its strengthened positioning.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Dawn remained consistently listed in the Fabric & Home Care segment across 2022-2024, and accurately captures the earnings contribution increase from 31% in 2022 to 34% in 2024. The brand list provided (Ariel, Downy, Gain, Tide, Cascade, Dawn, Fairy, Febreze, Mr. Clean, Swiffer) appears comprehensive and relevant. The reasoning about consistent positioning and growing profitability is sound.\n\nCRITICAL ERROR: The LLM states earnings contribution was '31% of net earnings in 2022 to 34% in 2023 and remaining at 34% in 2024.' However, the ground truth indicates the progression was 31% in 2022 to 34% in 2024, with no specific mention of 2023 being 34%. The LLM appears to have interpolated or misread the 2023 figure without evidence from the source documents.\n\nMISSING INFORMATION: The LLM completely omits the net sales contribution data (35% in 2022, 36% in 2023 and 2024), which is a significant part of the ground truth answer and provides important context about the segment's stability despite earnings growth. This represents incomplete synthesis of the multi-hop question.\n\nQUANTITATIVE ACCURACY ISSUE: While the 31% and 34% figures are correct for 2022 and 2024, the unverified claim about 2023 being 34% and the omission of sales percentages reduces quantitative accuracy.\n\nQUALITATIVE ASSESSMENT: The reasoning about consistent positioning and growing profitability is logically sound, but the answer lacks the balanced perspective of the ground truth, which notes both earnings growth AND sales stability as key indicators of strategic positioning.\n\nOVERALL: The answer captures the main narrative but contains a potential factual error regarding 2023 earnings contribution and significantly omits the sales contribution data that provides important context for evaluating positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 505,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "Schwab’s margin‑lending program grew between 2022 and 2024, with the fair value of client securities available to be pledged rising from $84.0 B in 2020 to $120.3 B in 2021 (and the amount pledged to third parties increasing from $23.0 B to $31.4 B) 【page_108】. By 2024, the company’s IDA balances—client cash swept into deposit accounts—fell from $97.5 B in 2023 to $87.6 B (page 100), yet the continued use of client securities for collateral and margin lending indicates that Schwab’s exposure to client‑held assets remains substantial and has expanded in terms of pledged securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) WRONG TIME PERIOD: The LLM cites 2020-2021 data ($84.0B to $120.3B pledged securities, $23.0B to $31.4B pledged) when the question explicitly asks about 2022-2024 evolution. This is a fundamental failure to address the correct timeframe. (2) MISSING CORE INFORMATION: The ground truth discusses 2022 collateral practices, 2023 ASC 326 accounting treatment and practical expedient application, and 2024 options clearing/securities lending activities. The LLM answer completely omits these key regulatory and operational details that define the 3-year trend. (3) IRRELEVANT DATA INCLUSION: The IDA balance figures ($97.5B to $87.6B in 2023-2024) are tangential to the question about securities pledging and margin lending evolution, and their inclusion suggests confusion about what metrics are relevant. (4) INCOMPLETE SYNTHESIS: The question requires multi-hop synthesis across margin lending, collateral obligations, and client asset exposure across three years. The LLM provides only fragmented information from the wrong years and fails to connect the regulatory/operational evolution described in the ground truth. (5) MISSING QUALITATIVE ANALYSIS: The ground truth emphasizes 'increasing sophistication,' 'strategic risk management,' and 'growing client engagement in leveraged activities'—none of which appear in the LLM answer. The LLM states exposure 'remains substantial and has expanded' but provides no evidence from the correct time period. The answer demonstrates poor question comprehension and reliance on incorrect data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 432,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "ACN’s 2023 target allocation for Non‑U.S. plans was 48 % debt, 27 % equity, 4 % cash, 11 % insurance contracts and 10 % other, shifting in 2025 to 36 % debt, 28 % equity, 7 % cash, 21 % insurance and 8 % other (U.S. plans remained at 100 % debt). The weighted‑average plan‑asset mix as of Aug 31 2022–2024 shows a gradual move toward that 2025 mix: debt fell from 50 % (2022) to 43 % (2023) to 42 % (2024); equity dipped to 19 % in 2023 then rose to 23 % in 2024; cash rose to 6 % in 2023 then 5 % in 2024; insurance climbed to 22 % in 2023 then 21 % in 2024; and other fell to 9 % in 2024. For U.S. plans, debt stayed above 94 % and cash increased from 3 % to 6 %.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different aspect of ACN's pension plan allocations than what the question asks. Critical issues: (1) WRONG FOCUS: The LLM discusses Non-U.S. and U.S. plan-specific allocations with debt/equity/cash/insurance/other breakdowns, while the ground truth addresses overall weighted-average plan asset allocations with only fixed income vs. equities. (2) CONTRADICTORY NUMBERS: The LLM reports debt at 50% (2022), 43% (2023), 42% (2024), which contradicts the ground truth's fixed income percentages of 55% (2022), 58% (2023), 61% (2024). These are not minor discrepancies—they represent fundamentally different data points. (3) MISSING CORE ANSWER: The ground truth clearly states the evolution as 55%→58%→61% fixed income and 45%→42%→39% equities, showing a consistent de-risking trend. The LLM provides completely different allocation categories (insurance contracts, cash, other) that are not mentioned in the ground truth answer. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution from fiscal 2023 to fiscal 2025 based on August 31 allocations for 2022, 2023, and 2024. The LLM does attempt to track three years of data but uses entirely wrong metrics. (5) ENTITY CONFUSION: While both answers reference ACN and the correct time periods, they appear to be describing different pension plan allocation strategies entirely. The LLM may be referencing target allocations for different plan segments rather than the overall weighted-average allocations requested. The answer demonstrates a fundamental misunderstanding of which pension allocation data to report.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 449,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "Capital One’s short‑term borrowings fell from $883 million in 2022 to $538 million in 2023 and then rose modestly to $562 million in 2024, while long‑term debt increased from $47.8 billion in 2022 to $49.3 billion in 2023 and then declined to $44.9 billion in 2024. Over the three years the company shifted from a mix that included $349 million of floating unsecured senior debt in 2022 to virtually all fixed‑rate debt by 2024, and the weighted‑average interest rate on long‑term debt climbed from 3.48 % to 4.84 %, reflecting a more fixed‑rate structure and a higher cost of borrowing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental and pervasive factual errors that make it largely incorrect:\n\n(1) TOTAL DEBT FIGURES - CRITICAL ERRORS:\n- Ground Truth: 2022=$43.086B, 2023=$48.715B, 2024=$45.551B\n- LLM Claims: 2022=$48.183B (short-term $883M + long-term $47.8B), 2023=$49.838B, 2024=$45.462B\n- The LLM's figures are substantially different from ground truth. For 2022, the LLM shows $48.183B vs. actual $43.086B (a $5.1B discrepancy). The LLM appears to have inverted or misidentified the short-term vs. long-term breakdown.\n\n(2) SHORT-TERM BORROWINGS - INCORRECT:\n- Ground Truth: Not explicitly broken out in original answer, but total debt figures suggest short-term component is much smaller\n- LLM Claims: $883M (2022), $538M (2023), $562M (2024)\n- These figures appear to be fabricated or from incorrect sources, as they don't reconcile with the ground truth total debt figures\n\n(3) LONG-TERM DEBT - INCORRECT:\n- Ground Truth: Implied from total debt figures (approximately $42.2B in 2022, $47.1B in 2023, $44.0B in 2024)\n- LLM Claims: $47.8B (2022), $49.3B (2023), $44.9B (2024)\n- The 2022 figure is significantly overstated; 2023 is slightly overstated; 2024 is slightly overstated\n\n(4) INTEREST RATE ERRORS - CRITICAL:\n- Ground Truth: Weighted-average interest rate on securitized debt was 1.51% (2022), 3.01% (2023), 3.48% (2024)\n- LLM Claims: Rates climbed from 3.48% to 4.84%\n- The LLM appears to have confused the 2024 rate (3.48%) with a starting point and invented a 4.84% ending rate. This is factually incorrect.\n\n(5) FLOATING DEBT REDUCTION - PARTIALLY CORRECT DIRECTION, WRONG NUMBERS:\n- Ground Truth: Floating unsecured senior debt reduced from $1,597M (2023) to $0 (2024)\n- LLM Claims: Reduced from $349M (2022) to virtually $0 (2024)\n- The LLM identifies the correct strategic shift but provides incorrect starting amounts and timeline\n\n(6) MULTI-HOP REASONING:\n- The LLM failed to correctly synthesize the relationship between short-term borrowings, long-term debt, and total debt\n- The narrative about shifting to fixed-rate debt is directionally correct but built on incorrect numerical foundations\n- The connection between interest rate increases and debt structure changes is mentioned but not properly supported by accurate data\n\n(7) OVERALL ASSESSMENT:\nThe answer demonstrates a fundamental misunderstanding or misreading of the source data. Nearly every quantitative claim is incorrect, with discrepancies ranging from $1B to $5B on total debt figures and completely fabricated interest rate endpoints. While the LLM correctly identifies that the company shifted away from floating-rate debt and that interest rates increased, these insights are undermined by pervasive numerical inaccuracies that make the answer unreliable for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 742,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "Boeing’s fleet‑support costs have stayed at roughly **1 % of total consolidated costs** each year from 2022 through 2024 (see the 2023 and 2024 10‑K notes on fleet support).  In contrast, abnormal production costs for the 787 program climbed to **$2.7 billion in 2023** (page 36), and reach‑forward losses for the 777X program rose to **$2.608 million in Q3 2024 and $891 million in Q4 2024** (page 39).  The stable fleet‑support expense underscores that the company’s operating losses are driven by program‑specific cost overruns rather than support‑service costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a major quantitative mistake that fundamentally undermines its credibility. The 777X reach-forward losses are stated as '$2.608 million in Q3 2024 and $891 million in Q4 2024' when the ground truth clearly indicates these should be '$2,608 MILLION' (not million with a decimal point suggesting $2.608M). This is a decimal point error of three orders of magnitude - the actual figure is $2,608 million ($2.608 billion), not $2.608 million. This is not a formatting variation but a factual error that misrepresents the scale of losses by approximately 1,000x. The $891 million figure appears correct. The fleet support services percentage (1% across 2022-2024) is correct. The 787 abnormal production costs of $2.7 billion in 2023 are correct. However, the quantitative accuracy is severely compromised by the 777X loss misstatement. The reasoning about the contrast between stable fleet support costs and escalating program-specific losses is sound and well-articulated, and the multi-hop synthesis across years and programs is logically coherent. The answer appropriately addresses the question's structure and provides relevant context. However, the magnitude error in the 777X figure is a critical factual mistake that cannot be overlooked in financial analysis, where precision is paramount. The answer demonstrates good qualitative reasoning but fails on quantitative precision, which is the primary requirement for financial questions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 409,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "AbbVie’s balance sheet shows a clear shift in its short‑term asset mix: money‑market funds and time deposits fell from **$21 million in 2022** (page 79) to **$10 million in 2023** (page 79) and remained at **$10 million in 2024** (page 84). This decline and subsequent plateau indicate a deliberate move to hold more cash in liquid cash and equivalents rather than short‑term market instruments, reflecting a conservative liquidity strategy that prioritizes immediate availability and minimal market‑risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the year-to-year progression of money market funds and time deposits. Ground truth shows: 2022=$12M, 2023=$21M, 2024=$10M. LLM states: 2022=$21M, 2023=$10M, 2024=$10M. This represents a complete reversal of the 2022-2023 trend. The LLM incorrectly claims the values 'fell from $21 million in 2022 to $10 million in 2023' when the actual data shows an increase from $12M to $21M during that period. The 2024 figure of $10M is correct, but the preceding years are wrong. REASONING FLAW: Because the numbers are incorrect, the LLM's interpretation of the trend is also fundamentally flawed. The ground truth indicates a temporary conservative increase in 2023 followed by a reduction in 2024, suggesting strategic reallocation. The LLM's narrative of a 'decline and subsequent plateau' mischaracterizes the actual 3-year pattern. MULTI-HOP SYNTHESIS: The question requires synthesizing data across three fiscal years to identify a trend. The LLM failed to correctly extract or synthesize this multi-year data. PARTIAL CREDIT: The LLM correctly identified AbbVie as the company, correctly referenced the relevant balance sheet pages, and attempted to provide contextual interpretation of liquidity strategy. However, these qualitative strengths cannot overcome the severe quantitative inaccuracies that form the foundation of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 395,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "Accenture repurchased **$4.111 billion** of shares in fiscal 2022, with a remaining authorization of **$6.129 million** (page 94–95).  In fiscal 2024 the company bought **$4.5 billion** of shares and the board approved an additional **$4 million** of authority, raising total outstanding authorization to **$6.694 million** (page 39–40).  The steady rise in both repurchase volume and available authority shows Accenture is deliberately expanding its capital‑return program to deliver greater value to shareholders.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains severe quantitative errors that fundamentally undermine its credibility. Specific issues: (1) MAJOR NUMBER ERRORS: The LLM states remaining authorization of '$6.129 million' in fiscal 2022, but ground truth shows $3,129,296 thousand ($3.129 billion). This is off by a factor of ~500x. Similarly, the LLM claims '$6.694 million' as total outstanding authorization in fiscal 2024, but ground truth shows $6,694 million ($6.694 billion) - another ~1000x error. These are not formatting variations but catastrophic decimal/magnitude mistakes. (2) INCOMPLETE FISCAL YEAR COVERAGE: The LLM only addresses fiscal 2022 and fiscal 2024, completely omitting fiscal 2023 data, which is a critical middle point showing the evolution requested in the question. Ground truth explicitly includes fiscal 2023 with $2,694 million remaining authorization. (3) MISSING KEY CONTEXT: The LLM fails to mention the cumulative $50.1 billion authorization since 2001, which provides important context for understanding the scale of the capital return strategy. (4) REPURCHASE VOLUME CLAIMS: While the LLM mentions repurchase volumes ($4.111B in FY2022, $4.5B in FY2024), these specific numbers cannot be verified against the ground truth provided, which focuses on authorization amounts rather than actual repurchase volumes. (5) REASONING QUALITY: Despite attempting to draw conclusions about capital return strategy, the foundation is built on incorrect numbers, making the analysis unreliable. The multi-hop synthesis is incomplete (missing fiscal 2023) and the quantitative foundation is fundamentally flawed. The answer demonstrates a pattern of magnitude errors that suggest serious data extraction or calculation problems.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 471,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "AbbVie’s amended and restated certificate of incorporation has consistently included a clause that “stockholders may only remove directors for cause.” The same language appears in the 2022 filing (see page 46), the 2023 filing (page 27), and the 2024 filing (page 27). By maintaining this restriction year after year, AbbVie is deliberately entrenching its board—limiting shareholder power to replace directors and thereby strengthening its long‑term defense against hostile takeover attempts.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that AbbVie maintained consistent 'removal for cause' language across 2022, 2023, and 2024 filings, and accurately characterizes this as a board entrenchment strategy against hostile takeovers. The answer demonstrates sound multi-hop reasoning by synthesizing information across three years and connecting the governance provision to takeover defense strategy. STRENGTHS: (1) Correctly identifies the specific provision language ('stockholders may only remove directors for cause') appearing consistently across all three years; (2) Accurately cites page numbers (46 for 2022, 27 for 2023 and 2024); (3) Properly synthesizes the multi-hop connection between the governance provision and takeover defense strategy; (4) Correctly identifies this as deliberate board entrenchment. WEAKNESSES: (1) The answer omits mention of the broader anti-takeover defense ecosystem that the ground truth emphasizes (staggered board terms, restrictions on special meetings, supermajority requirements for bylaw amendments), which provides important context for understanding the 'long-term takeover defense strategy' mentioned in the question; (2) Does not explicitly note that there were 'no explicit changes' to the language across the three years, which the ground truth emphasizes as significant; (3) The phrase 'amended and restated certificate of incorporation' is technically correct but the ground truth frames this more directly as part of the 10-K disclosures. The answer is factually accurate on the core claim and demonstrates appropriate multi-hop reasoning, but lacks the comprehensive contextual detail about the broader governance framework that would fully address the question's inquiry into the company's 'long-term takeover defense strategy.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 487,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "PepsiCo lists the 4.000 % Senior Note due 2047 in the exhibits section of every 10‑K.  In the 2022 filing (page 127, line 4.16), the note is described as “Form of 4.000 % Senior Note due 2047, incorporated herein by reference to Exhibit 4.5 to PepsiCo, Inc.’s Current Report on Form 8‑K filed on May 2 2017.”  The same wording appears unchanged in the 2023 filing (page 127, line 4.16) and again in the 2024 filing (page 127, line 4.16).  \n\nThe unaltered, repeated disclosure indicates that the note is a long‑standing, fixed‑rate debt instrument that PepsiCo continues to hold as a core component of its long‑term capital structure, reflecting a strategy of maintaining a stable, diversified mix of senior notes to support financing needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates strong understanding of the multi-hop question. STRENGTHS: (1) All key facts are accurate - the 4.000% Senior Note due 2047 is correctly identified, the May 2, 2017 8-K filing reference is correct, and the consistent disclosure across 2022, 2023, and 2024 is properly documented. (2) The note reference (Exhibit 4.5) is correctly cited. (3) The multi-hop synthesis is sound - the answer correctly traces the same disclosure pattern across three years and draws appropriate conclusions about the note's stability in the capital structure. (4) The reasoning about the note being a long-standing, fixed-rate debt instrument is logical and well-supported. (5) Numeric accuracy is high - the 4.000% rate is correct, the 2047 maturity date is correct, and the 2017 issuance date is correct. MINOR WEAKNESSES: (1) The LLM provides specific page numbers (page 127, line 4.16) that are not verified in the ground truth answer. While these details appear plausible and add specificity, they cannot be confirmed against the provided ground truth, which does not include page/line references. This is a minor addition rather than an error. (2) The ground truth emphasizes 'no modifications needed to its form or terms' while the LLM answer focuses on it being a 'core component' - both convey similar meaning but with slightly different emphasis. (3) The LLM's characterization of the disclosure pattern as revealing a 'strategy of maintaining a stable, diversified mix of senior notes' is a reasonable inference but goes slightly beyond what the ground truth explicitly states about the note's role. The ground truth is more focused on the note's stability and lack of modification, while the LLM adds interpretation about broader capital structure strategy. This is reasonable inference but represents a minor interpretive extension. OVERALL: The answer correctly addresses the core question about how the disclosure evolved (it didn't - remained consistent) and what this reveals about the note's role (stable, long-term component). The multi-hop reasoning across three years is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 572,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "Oracle issued the 4.30% Note due 2034 in 2014, and it has been continuously disclosed in the company’s Form 10‑K as Exhibit 4.09 in both the 2023 and 2024 filings (see page 110 of each filing).  The 2022 10‑K pages we examined (111‑115) do not list the note as a separate exhibit, indicating it was not a new issuance that year but remains a standing liability.  This steady, long‑term disclosure pattern shows Oracle’s strategy of locking in fixed‑rate debt with extended maturities to manage interest costs and maintain a diversified, multi‑decade debt portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) ISSUANCE DATE CONTRADICTION: LLM claims the 4.30% Note due 2034 was issued in 2014, but the ground truth indicates it was first disclosed in 2022. This is a fundamental factual error - a note due in 2034 cannot have been issued in 2014 (that would make it due in 2028 or earlier). The LLM's claim directly contradicts the ground truth's statement that Oracle 'first disclosed the 4.30% Note due 2034 in 2022.' (2) EXHIBIT REFERENCE ACCURACY: The LLM provides specific exhibit numbers (4.09) and page numbers (110, 111-115) that cannot be verified against the ground truth and appear to be fabricated details. While the LLM attempts to show specificity, these citations are not corroborated by the knowledge graph. (3) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution across 2022, 2023, and 2024. The ground truth shows: first disclosure in 2022, reaffirmation in 2023, and consistent disclosure in 2024. The LLM's narrative about a 2014 issuance followed by 2023-2024 disclosures does not match this three-year evolution pattern. (4) STRATEGIC INTERPRETATION: While the LLM's conclusion about 'locking in fixed-rate debt with extended maturities' is reasonable debt strategy language, it's built on an incorrect factual foundation (wrong issuance date). The ground truth emphasizes 'diversified maturity profiles and sustained capital market engagement' which the LLM partially captures but with wrong underlying facts. (5) COMPLETENESS: The LLM addresses the multi-year pattern but with incorrect dates and timeline, failing to properly synthesize the 2022-2023-2024 evolution as stated in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 448,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "In FY 2022 the Amended 2010 SIP authorized 127 million Class A shares (page 91), a level that remained unchanged in FY 2023 (no change disclosed). By FY 2024 the authorization had increased to 141 million shares (page 98). This incremental expansion shows Accenture’s deliberate strategy to broaden its share‑based incentive pool, giving it greater flexibility to reward employees and align their interests with shareholders over the long term.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CHRONOLOGICAL SEQUENCE: The LLM answer contains a fundamental factual error regarding the progression of authorized shares across fiscal years. According to the ground truth: FY 2022 = 127M, FY 2023 = 141M (increase), FY 2024 = 141M (unchanged). However, the LLM states: FY 2022 = 127M, FY 2023 = 'no change disclosed' (implying it remained at 127M), FY 2024 = 141M (increase). This reverses the actual timing of the increase - the LLM incorrectly places the increase between 2023 and 2024, when it actually occurred between 2022 and 2023. This is a significant multi-hop synthesis error that fundamentally misrepresents the company's compensation strategy timeline. QUANTITATIVE ACCURACY: While the individual numbers (127M, 141M) are correct, their assignment to fiscal years is wrong, making the quantitative accuracy severely compromised. The LLM correctly identifies the 14M share increase but attributes it to the wrong year transition. COMPLETENESS: The LLM addresses all three fiscal years mentioned in the question but with incorrect sequencing. ENTITY ACCURACY: Company name (Accenture plc), share class (Class A ordinary shares), and plan name (Amended 2010 SIP) are all correct. REASONING QUALITY: The interpretive commentary about 'deliberate strategy' and 'greater flexibility' is reasonable, but it's based on an incorrect understanding of when the increase occurred. The reasoning itself is sound, but applied to the wrong timeline. SEMANTIC EQUIVALENCE: The qualitative interpretation about share-based compensation strategy is semantically similar to the ground truth, but the factual foundation is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 449,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "PepsiCo first issued the 2.750% Senior Note due 2051 in an 8‑K filing on Oct. 21, 2021, which the 2022 and 2023 10‑Ks incorporated as Exhibit 4.3 (page 128; page 129). The 2024 10‑K adds a board resolution authorizing the note’s terms and re‑incorporates it as Exhibit 4.3 (page 130), indicating a reaffirmation or new issuance. The coupon rate of 2.750 % and maturity of 2051 remained unchanged across the filings, underscoring PepsiCo’s disciplined long‑term debt strategy and its consistent, transparent documentation to support capital‑structure stability.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. (1) CRITICAL ERRORS: The LLM claims the note was first issued in an 8-K filing on Oct. 21, 2021, but the ground truth indicates it was first introduced in 2022 within a Board of Directors resolution (Exhibit 4.60). The LLM's reference to an October 2021 8-K filing is not supported by the ground truth and appears to be fabricated. (2) EXHIBIT NUMBER DISCREPANCIES: The LLM states the note was incorporated as Exhibit 4.3 in 2022 and 2023 10-Ks, but the ground truth specifies different exhibit numbers: Exhibit 4.60 in 2022, Exhibit 4.51 in 2023, and Exhibit 4.48 in 2024. These are material factual errors that fundamentally misrepresent the documentation trail. (3) MISSING EVOLUTION NARRATIVE: The ground truth emphasizes a three-stage progression (authorization in 2022 → formalization in 2023 → maintenance in 2024), showing deliberate phasing from planning to formal structuring to consistency. The LLM fails to capture this nuanced evolution and instead presents a confused narrative about 'reaffirmation or new issuance' without clear documentation of the progression. (4) MULTI-HOP REASONING FAILURE: The question asks about how documentation evolved across three years and what this indicates about strategy. The ground truth synthesizes exhibit changes across years to show a deliberate phased approach. The LLM provides disconnected observations without properly synthesizing the multi-year pattern. (5) COUPON AND MATURITY ACCURACY: While the LLM correctly identifies the 2.750% coupon and 2051 maturity date, this is the only accurate factual element, and it does not compensate for the fundamental errors in exhibit numbers, dates, and documentation progression. The LLM's conclusion about 'disciplined long-term debt strategy' is reasonable but is built on incorrect factual foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 513,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "In 2022, American Express was the fourth‑largest general‑purpose card network, competing with Visa, Mastercard and UnionPay while emphasizing premium and cobrand relationships (see page 12). By 2024, heightened regulatory scrutiny—particularly around interchange‑fee caps, network routing and merchant‑fee structures—has increased compliance costs and eroded discount revenue, prompting the company to exit licensing activities in the EU and Australia (page 34). At the same time, the rapid expansion of alternative payment mechanisms such as digital wallets, open‑banking and buy‑now‑pay‑later has intensified competition, forcing AmEx to invest more heavily in technology and differentiated value propositions to maintain its competitive position (pages 12, 34, 35).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about American Express's competitive positioning evolution from 2022-2024. STRENGTHS: (1) Correctly identifies AmEx as fourth-largest general-purpose card network in 2022, with accurate competitor identification (Visa, Mastercard, UnionPay). (2) Accurately captures regulatory pressures: interchange fee caps, network routing practices, and merchant-fee structures are all correctly identified. (3) Properly synthesizes the dual competitive pressures: regulatory constraints AND alternative payment mechanisms (digital wallets, open banking, BNPL). (4) Correctly identifies specific market exits (EU and Australia licensing activities). (5) Appropriately characterizes the strategic shift from market-driven to regulation-constrained competition. (6) Multi-hop reasoning is sound: connects 2022 baseline → 2024 regulatory environment → strategic responses. MINOR GAPS: (1) The LLM mentions 'discount revenue' erosion but the ground truth doesn't explicitly reference this specific revenue impact, though it's a reasonable inference from interchange fee pressure. (2) The ground truth emphasizes 'closed-loop loyalty systems' as a 2022-2023 differentiation strategy, which the LLM doesn't explicitly mention (though 'differentiated value propositions' is semantically related). (3) The ground truth specifically mentions 'cobrand arrangements' as a regulatory focus area; the LLM mentions 'cobrand relationships' in 2022 context but doesn't explicitly tie cobrand arrangements to regulatory scrutiny. QUANTITATIVE ACCURACY: No specific numbers or percentages are provided in either answer, so this dimension is not heavily tested. The temporal framing (2022, 2023, 2024) is accurate. QUALITATIVE ACCURACY: The reasoning correctly synthesizes information across multiple dimensions (market position, regulatory environment, competitive threats) and properly identifies the causal relationships. The characterization of the strategic shift is accurate and well-reasoned. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question: competitive positioning, evolution over time, regulatory scrutiny, and alternative payment mechanisms. The inclusion of specific regulatory details and market exits demonstrates strong contextual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 629,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "Boeing’s 2024 10‑K (page 5) still lists “upgrades and conversions” as a core offering of its Global Services segment, the same wording used in the 2022 10‑K (page 5).  The unchanged emphasis indicates that the company’s services strategy remains focused on life‑cycle support and modernization, positioning upgrades and conversions as a key driver of recurring revenue and customer loyalty.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - CONTRADICTION: The LLM claims the wording 'upgrades and conversions' remained 'unchanged' from 2022 to 2024, but the ground truth explicitly states that by 2023, Boeing 'began emphasizing modifications more prominently' and by 2024 'introduced clearer language around data analytics and digital services.' This represents a material strategic evolution that the LLM completely missed. (2) INCOMPLETE SYNTHESIS: The LLM failed to capture the multi-hop progression across three years (2022→2023→2024) that the question specifically asks about. The ground truth shows a clear trajectory: initial listing → emphasis on modifications → integration of data analytics/digital services. The LLM only acknowledges the 2022 and 2024 endpoints and incorrectly concludes they are the same. (3) MISSING STRATEGIC INSIGHT: The ground truth indicates a 'strategic shift toward technology-enabled service differentiation' and 'growing focus on enhancing aircraft value through modernization.' The LLM's conclusion that strategy 'remains focused' on lifecycle support misses the evolution toward higher-value, technology-enabled services. (4) QUANTITATIVE ACCURACY: The page references (page 5 for both 2022 and 2024 10-Ks) cannot be verified as incorrect from the ground truth, so this aspect receives credit. However, the core factual claim about unchanged emphasis is demonstrably wrong. (5) REASONING FAILURE: The LLM's logic that 'unchanged emphasis indicates' a stable strategy is flawed because the emphasis actually changed materially according to the ground truth. This represents a fundamental failure in multi-hop reasoning across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 476,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "PepsiCo’s 5.50% Senior Note due 2035 (Series A) was issued in 2018 and is cited in the 2022 and 2023 Form 10‑K as Exhibit 4.4 to a prior Form 8‑K. In the 2024 10‑K the note appears twice – still as Exhibit 4.4 to the 8‑K and also as Exhibit 4.6 to the 2018 registration statement – reflecting a re‑issuance or amendment and an updated regulatory filing. This consistent, multi‑year disclosure shows PepsiCo’s disciplined long‑term debt strategy, ensuring transparency, regulatory compliance, and a stable, diversified debt mix over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBER ERRORS: The ground truth clearly states the note was referenced as Exhibit 4.31 (2022), Exhibit 4.25 (2023), and Exhibit 4.23 (2024). The LLM incorrectly claims it appears as Exhibit 4.4 in 2022-2023 and Exhibit 4.6 in 2024 - these exhibit numbers are completely wrong. (2) FILING REFERENCE ERRORS: The ground truth consistently ties all three years to an 8-K filing from November 8, 2018. The LLM vaguely references 'a prior Form 8-K' without the specific date and incorrectly adds a reference to 'the 2018 registration statement' which is not mentioned in the ground truth. (3) MISCHARACTERIZATION OF ACTIVITY: The LLM suggests 'a re-issuance or amendment and an updated regulatory filing' in 2024, but the ground truth indicates the note was simply 'consistently referenced' without modification - it was 'maintained on its books without retiring or modifying it.' This is a fundamental misinterpretation of the filing pattern. (4) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize across three years, it does so with incorrect exhibit numbers and misinterprets the pattern as showing changes when the ground truth shows stability. (5) CORRECT ELEMENTS: The LLM correctly identifies the note as 5.50% Senior Note due 2035 (Series A), correctly notes it was issued in 2018, and correctly identifies the three-year period (2022-2024). The conclusion about 'disciplined long-term debt strategy' is semantically aligned with the ground truth's 'stable, long-duration capital structure approach,' but this cannot overcome the numerous factual errors in the specific exhibit citations and filing references that are central to answering this question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 484,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "From 2022 through 2024, BNY Mellon’s risk‑factor disclosures have consistently stated that its ability to return capital to shareholders is “subject to the discretion of the Board and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock.” The identical wording on page 5 of each 10‑K shows that the regulatory constraints on capital‑return policies have remained unchanged, underscoring that banking supervision continues to impose a persistent limitation on the company’s dividend and share‑repurchase decisions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core constraint that BNY Mellon's capital return ability is limited by U.S. banking laws and regulations. (2) The specific quote about regulatory constraints is accurate and well-sourced. (3) The identification of Delaware law and preferred stock dividend obligations as constraints is correct. (4) The timeframe (2022-2024) is properly addressed. (5) No quantitative errors in dates or numbers cited.\n\nWEAKNESSES: (1) The LLM claims the wording is 'identical' across all three years and that constraints 'remained unchanged,' which contradicts the ground truth's assertion that the language 'evolved' and became 'more specific' over time. The ground truth explicitly states that 2023 'specifically reiterated' constraints and 2024 'noted the importance of maintaining well capitalized status' - suggesting meaningful evolution, not stasis. (2) The LLM fails to capture the multi-year progression narrative that is central to the question. The ground truth emphasizes how the company's emphasis evolved from 'general regulatory oversight' (2022) to 'specific' constraints (2023) to maintaining 'well capitalized' status (2024). (3) The LLM's conclusion that constraints 'remained unchanged' directly contradicts the ground truth's characterization of 'consistent yet evolving emphasis.' (4) The LLM misses the nuance about regulatory evolution and the company's shifting disclosure priorities across the three-year period. (5) The answer is somewhat static and doesn't adequately address what the 'multi-year progression reveals' as requested in the question.\n\nMULTI-HOP REASONING: The LLM demonstrates basic synthesis by connecting regulatory constraints across years, but fails to properly synthesize the evolution narrative that requires comparing and contrasting disclosures across 2022, 2023, and 2024. The claim of 'identical wording' suggests insufficient analysis of year-to-year changes.\n\nSEMANTIC ACCURACY: While the regulatory constraints themselves are correctly identified, the semantic interpretation of the multi-year trend is incorrect. The LLM presents a static picture when the ground truth indicates dynamic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 586,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were issued in 2021 at a 2.300% coupon (Exhibit 4.14, page 111) and the company did not amend or re‑issue those notes through 2024, as no changes appear in the 2023 or 2024 10‑Ks (pages 111–112). In 2023 Oracle issued new 4.500% Notes due 2028 (Exhibit 4.16, page 111), showing an opportunistic shift to higher‑rate debt as market rates rose and illustrating Oracle’s flexible fixed‑income strategy that balances low‑rate opportunities with cost‑of‑capital considerations.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2.300% Notes due 2028 as the primary instrument under discussion. (2) Correctly notes that no amendments or re-issuances occurred through 2024. (3) Accurately identifies the 4.500% Notes due 2028 issued in 2023 as a new instrument. (4) The coupon rates (2.300%, 4.500%) are correct. (5) The general strategic interpretation about locking in favorable rates during lower-rate periods is sound. WEAKNESSES: (1) CRITICAL DATE ERROR: The LLM states the 2.300% Notes were 'issued in 2021' but the ground truth specifies they were issued under an Officers' Certificate dated March 24, 2021, appearing in the 2022 10-K filing. The actual issuance timing is ambiguous from the LLM's statement - it could imply 2021 issuance when the ground truth suggests 2022 reporting of a 2021-dated certificate. (2) INCOMPLETE SYNTHESIS: The LLM fails to mention the broader multi-tiered bond offering context that included the 2.875% Notes due 2031 and 3.950% Notes due 2051, which the ground truth identifies as important context for understanding Oracle's fixed-income strategy. (3) MISSING YEAR-BY-YEAR EVOLUTION: The ground truth emphasizes the evolution from 2022→2023→2024, showing how Oracle's strategy shifted over time. The LLM collapses this into a simpler narrative without clearly delineating the year-by-year progression. (4) INCOMPLETE STRATEGIC ANALYSIS: The ground truth notes that by 2024, Oracle 'made no visible changes' and 'did not introduce any new 2028-dated instruments,' suggesting a shift toward 'maintaining existing obligations rather than refinancing.' The LLM doesn't capture this 2024-specific insight about the shift away from new issuance. (5) CITATION ISSUES: The LLM cites 'page 111' and 'pages 111-112' without clear document references, making verification difficult. The ground truth cites specific exhibit numbers (4.14, 4.16) which are more precise. CALCULATION/NUMERIC VERIFICATION: All percentages and dates mentioned are accurate where stated. No mathematical errors detected. MULTI-HOP REASONING: The LLM demonstrates basic multi-hop reasoning by connecting the 2.300% notes to the 4.500% notes and relating both to market rate changes. However, it misses the more sophisticated three-year evolution pattern that the ground truth captures. The LLM's conclusion about 'flexible fixed-income strategy' is reasonable but less nuanced than the ground truth's observation about 'locking in favorable rates when possible' and 'avoiding redundant issuance.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 669,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "IBM’s 10‑K filings for 2022, 2023, and 2024 all list “client relationships and trust” as a key competitive differentiator (IBM_10k_2022 p.3; IBM_10k_2023 p.3; IBM_10k_2024 p.3), with no change in wording or relative emphasis. This steady focus signals that IBM views deep, trusted client relationships as foundational to its hybrid‑cloud and AI strategy, reinforcing its positioning as a trusted partner in a highly competitive market. By consistently highlighting this factor, IBM underscores that client trust is a core pillar for differentiating its hybrid‑cloud and AI offerings amid intense competition.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer has significant issues in addressing the multi-hop question about IBM's strategic evolution across three years. STRENGTHS: (1) Correctly identifies that 'client relationships and trust' appears in all three years' 10-Ks; (2) Appropriately cites page 3 for each year; (3) Correctly identifies the core competitive differentiator. CRITICAL WEAKNESSES: (1) The LLM claims 'no change in wording or relative emphasis' across the three years, which directly contradicts the ground truth that shows evolution and increasing nuance. The ground truth explicitly states the company 'reinforced' this in 2023 and 'expanded' strategic partnerships by 2024, indicating progression, not stasis. (2) The LLM fails to capture the 2023 emphasis on 'deep incumbency with enterprises' and 'strong focus on innovation' as differentiators tied to trust - these are distinct strategic refinements. (3) The LLM misses the 2024 expansion of strategic partnerships (e.g., Palo Alto Networks) as an evolution in how trust is operationalized. (4) The answer lacks the nuanced understanding that the ground truth provides: that while the core message remained consistent, the strategic positioning became 'increasingly nuanced' over time. (5) The LLM's conclusion that consistency 'signals' foundational importance is weaker than the ground truth's analysis of how the strategy evolved to address market dynamics. The LLM essentially provides a static analysis when the question explicitly asks about 'evolution' and 'multi-year progression.' This represents a failure in multi-hop reasoning - the model did not synthesize how the strategic emphasis changed across the three years, only that it remained present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 463,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "American Express’s average yield on foreign‑government bonds and obligations rose from 3.5 % in 2022 to 5.9 % in 2023 and 6.1 % in 2024 (Taxable investment securities, Non‑U.S., page 176).  The upward trend reflects a modest shift toward higher‑yielding sovereign debt as global rates climbed, yet the yields remain modest, indicating a conservative investment strategy that keeps interest‑rate risk exposure moderate.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all key metrics. Specific errors: (1) YIELD NUMBERS - LLM claims yields were 3.5% (2022), 5.9% (2023), and 6.1% (2024), but ground truth shows 6.45% (2023) and 5.85% (2024). The 2022 yield is not provided in ground truth, but the LLM's 3.5% figure appears fabricated. (2) DIRECTIONAL ERROR - LLM claims an 'upward trend' from 2022-2024, but ground truth shows a DECLINE from 6.45% (2023) to 5.85% (2024), contradicting the LLM's narrative. (3) MISSING CRITICAL DETAILS - LLM completely omits: the $630 million principal amount in 2022, the maturity profile evolution (ultra-short duration in 2023 vs. diversified in 2024), the specific maturity bucket percentages, and the strategic shift from concentrated short-term to diversified holdings. (4) INCOMPLETE MULTI-HOP SYNTHESIS - The question asks about 3-year progression and what it indicates about interest rate risk exposure and investment strategy. Ground truth provides a coherent narrative of strategic repositioning; LLM provides only a superficial yield trend analysis that is factually wrong. (5) REASONING QUALITY - LLM's conclusion about 'conservative investment strategy' and 'modest yields' contradicts the ground truth's characterization of 'high-yield foreign debt' and strategic diversification. The LLM appears to have fabricated or severely misremembered the specific yield percentages and failed to capture the essential strategic shift documented in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 424,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "Danaher’s 2024 10‑K shows that government grant assistance used to offset capital expenditures for diagnostics testing grew from **$87 million in 2022 to $136 million in 2023 and $198 million in 2024** (with offset operating‑expense assistance of $49 M, $51 M, and $43 M, respectively)【page_70】.  The steady rise in grant‑backed cap‑ex reflects the company’s expanding investment in diagnostics‑testing capacity—primarily funded by BARDA and other agencies—and signals that diagnostics testing is becoming a key growth engine within Danaher’s broader health‑care portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All three key figures are correct - $87M (2022), $136M (2023), and $198M (2024) for government grant funding offsetting capital expenditures. The answer also includes additional context about operating-expense assistance ($49M, $51M, $43M) which, while not in the ground truth, is factually accurate supplementary information from the 10-K filing. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the upward trend, properly attributing funding sources (BARDA and other agencies). ENTITY ACCURACY: Danaher Corporation correctly identified, diagnostics testing technologies properly contextualized within healthcare portfolio. SEMANTIC EQUIVALENCE: The LLM's characterization of diagnostics testing as 'becoming a key growth engine' is semantically equivalent to the ground truth's statement that it 'became increasingly central to Danaher's strategic focus.' The phrase 'steady rise in grant-backed cap-ex' accurately captures the progression. MINOR CONSIDERATIONS: The LLM provides slightly more granular detail (mentioning BARDA specifically and operating-expense assistance) which enhances rather than detracts from the answer. The citation reference [page_70] adds credibility. No calculation errors detected. The answer fully addresses all aspects of the multi-part question regarding investment evolution, government funding, and strategic importance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 415,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "BK’s disclosure of KPMG LLP’s PCAOB firm identification number stayed the same over the three years – the number “185” appears in the 2022, 2023, and 2024 filings.  In each filing the ratification is referenced in the Proxy as “Item 3 – Ratification of KPMG LLP,” with identical wording and placement, indicating no evolution in the presentation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE ACCURACY: All numeric values are correct - the PCAOB firm identification number 185 is accurately stated for all three years (2022, 2023, 2024). ENTITY ACCURACY: All entities are correctly identified - BK, KPMG LLP, PCAOB, and the specific item references (Item 3, Item 14) are all accurate. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across three fiscal years, demonstrating that the disclosure remained consistent across the period. COMPLETENESS: The answer addresses all key aspects of the question: (1) the PCAOB firm identification number (185), (2) its consistency across all three years, (3) the presentation within Proxy sections, (4) the specific item structure (Item 3 - Ratification of KPMG LLP). SEMANTIC EQUIVALENCE: The LLM's phrasing 'no evolution in the presentation' and 'identical wording and placement' effectively conveys the same meaning as the ground truth's 'consistent auditing relationship and disclosure practice' and 'no change...across the three-year period.' MINOR OBSERVATION: The LLM answer is slightly more concise than the ground truth but captures all essential information. The statement that the disclosure 'stayed the same' and 'no evolution' directly addresses the question's focus on how the disclosure 'evolved' (or in this case, didn't evolve). All factual claims are verifiable and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 397,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "From 2022 through 2024, American Express continued to record discount revenue from third‑party merchant acquirers at the time of each card‑member transaction, with network‑rate fees treated as discount revenue (2022–23 notes [page_103], [page_104]). Contracts with merchants remained structured the same: small‑ and mid‑size merchants had no fixed term, while large merchants signed 3‑ to 7‑year fixed‑term agreements with auto‑renewal (2022–23 notes [page_103], [page_104]). The 2024 filing’s risk‑factor discussion confirms the company’s ongoing strategic goal of expanding global merchant coverage by leveraging third‑party acquirers, aggregators and processors (2024 risk factors [page_93], [page_94]).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that American Express records discount revenue from third-party merchant acquirers at transaction time, with network-rate fees treated as discount revenue. (2) The contractual structure details are accurate: small/mid-size merchants have no fixed term while large merchants have 3-7 year agreements with auto-renewal. (3) The 2024 strategic expansion goal regarding global merchant coverage through third-party acquirers is correctly identified. (4) Page references are provided and appear reasonable for supporting documentation.\n\nWEAKNESSES: (1) The LLM answer fails to capture the key evolution described in the ground truth - the shift from a transactional model (2022) to a more formalized 'Processed Revenue' model (2023) that includes royalties, fees, and network partnership agreements. This represents a fundamental structural change that the LLM completely misses. (2) The answer does not address the 2023 integration of third-party acquirers into a broader strategic framework with revenue-sharing components beyond simple discount revenue. (3) The LLM states the contracts 'remained structured the same' across the period, which contradicts the ground truth's emphasis on evolution and formalization of relationships. (4) The answer lacks discussion of OptBlue and Global Network Services (GNS) partnerships mentioned in the ground truth. (5) The characterization of the evolution as moving from 'transactional dependency to strategic partnership model' is entirely absent from the LLM response.\n\nMULTI-HOP REASONING: The LLM partially addresses the multi-part question but fails to synthesize the temporal evolution across 2022-2024. It treats the period as relatively static rather than showing the progression from transactional to strategic relationships. The answer addresses revenue recognition structure (partially), contractual relationships (correctly), and strategic expansion (correctly), but misses the critical evolution narrative.\n\nSEMANTIC GAPS: The ground truth emphasizes a strategic evolution and shift in partnership model, while the LLM presents a more static view of ongoing practices. This represents a significant semantic and substantive gap in understanding the question's core focus on 'evolution.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 610,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "Qualcomm’s 2025 human‑capital targets were set in FY 2022 and repeated unchanged in FY 2023 and FY 2024: a 15 % increase in women in leadership, a 15 % increase in under‑represented‑minority (URM) leaders, and a 20 % increase in overall URM representation.  In each year the HR and Compensation Committee tied executive bonus payouts to progress on those goals, applying a non‑financial performance modifier that could adjust the bonus by a multiplier of 0.9 – 1.1.  Thus, from FY 2022 through FY 2024 the diversity targets and the bonus‑modifier framework remained the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core numeric targets (15% women in leadership, 15% URM leaders, 20% overall URM), the 0.9-1.1 modifier range, and that these remained consistent across FY2022-2024. The statement that targets were set in FY2022 and repeated unchanged through FY2024 is accurate. WEAKNESSES: (1) The LLM answer significantly undersells the evolution aspect of the question by stating the structure 'remained the same' across all three years, missing important contextual developments. The ground truth explicitly notes that FY2023 emphasized 'continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition,' and FY2024 showed 'expanded global engagement efforts and highlighted broader wellness and development programs.' (2) The LLM fails to capture the 'deepening integration of human capital metrics into corporate strategy' and the expansion of supporting programs mentioned in the ground truth. (3) While the LLM correctly states the targets remained unchanged, it misses the nuance that the company's approach to these targets evolved through expanded engagement and program development. QUANTITATIVE VERIFICATION: All numbers are correct (15%, 15%, 20%, 0.9-1.1 multiplier). MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years but fails to fully address the 'evolution' aspect of the question. The ground truth indicates progression and deepening integration, while the LLM presents a static picture. SEMANTIC ISSUE: The question asks how goals and compensation 'evolved,' implying change. The LLM's answer that everything 'remained the same' technically accurate for the core metrics, but incomplete regarding the broader evolution of human capital strategy and supporting initiatives. This represents a partial answer to a multi-dimensional question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 519,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "Caterpillar’s dealer network for EMD‑branded products contracted in 2023 and then rebounded in 2024.  In 2022 the company operated 44 U.S. and 116 non‑U.S. dealers that served 193 countries (page 76, 2022).  In 2023 the network shrank to 41 U.S. and 111 non‑U.S. dealers, covering 187 countries (page 66, 2023).  By 2024 it had returned to 44 U.S. and 116 non‑U.S. dealers and again served 193 countries (page 76, 2024).  The brief contraction followed by a full recovery indicates Caterpillar is fine‑tuning its dealer footprint for efficiency while reaffirming its commitment to a broad global distribution network.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. CRITICAL ERRORS: (1) Country coverage numbers are fundamentally wrong - LLM claims 2023 had 187 countries and 2024 returned to 193 countries, but ground truth shows 2023 had 191 countries and 2024 had 187 countries (a continued decline, not a rebound). (2) The LLM's narrative of 'contraction followed by full recovery' is completely incorrect - the actual trend is a consistent decline from 193→191→187 countries. (3) The LLM provides dealer numbers (44 U.S./116 non-U.S. for 2022 and 2024, 41 U.S./111 non-U.S. for 2023) that are not mentioned in the ground truth at all, and these appear to be fabricated or from a different source. (4) The LLM's conclusion about 'fine-tuning for efficiency while reaffirming commitment to broad global distribution' is contradicted by the actual data showing a sustained contraction. The ground truth clearly indicates a 'gradual reduction in geographic reach' suggesting 'strategic refocusing or consolidation,' which is the opposite of what the LLM concludes. The LLM fundamentally misrepresents the directional trend (claiming recovery when there was continued decline) and provides unsupported dealer network details. While the LLM does address the multi-part question structure, the core quantitative facts are wrong, making this answer misleading and unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 389,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "The repeated listing of Palmolive as a principal global trademark in the 2022‑2024 10‑Ks (pages 79, 77, 77) shows that the brand remains a core pillar of Colgate‑Palmolive’s Oral, Personal and Home Care portfolio. It signals that Palmolive continues to drive a substantial share of sales and brand equity in that segment, and that the company treats it as a strategic anchor for growth and market presence.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Palmolive was consistently listed as a principal global trademark across 2022-2024 and appropriately interprets this as indicating strategic importance to Colgate's portfolio. The page references (79, 77, 77) are specific and appear reasonable for 10-K filings. The answer accurately conveys the core insight that consistent inclusion signals sustained strategic importance and market presence. However, the LLM answer lacks some of the contextual richness present in the ground truth: (1) It doesn't mention the specific product categories (liquid hand soap, dishwashing detergents, household cleaners) that Palmolive supports, which the ground truth explicitly identifies; (2) It doesn't reference the comparative context of other brands (Ajax, Darlie) and how Palmolive maintained its position despite competitive additions to the trademark list; (3) The ground truth provides year-by-year analysis showing Palmolive's consistent positioning from 2022→2023→2024, while the LLM answer treats the 3-year span more generically. The LLM's interpretation that Palmolive 'drives a substantial share of sales and brand equity' and serves as a 'strategic anchor for growth' is reasonable inference but goes slightly beyond what can be directly verified from the trademark listing alone. The answer is fundamentally sound and addresses the question's core inquiry about strategic role, but misses some supporting details and comparative analysis that would strengthen the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 418,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "Qualcomm’s 2022 10‑K projected that the IoT installed base would more than double by 2026, positioning edge‑networking (mobile broadband and wireless access points) as a key growth driver within its IoT portfolio, which it categorizes into consumer, edge‑networking, and industrial segments (page_8). In 2023 and 2024 the company maintained that emphasis, but IoT revenue fell from $7.35 B in 2022 to $5.94 B and $5.42 B, reflecting a shift toward mature markets and a focus on high‑margin equipment sales that are recognized at a point in time, with additional revenue from sales‑based royalties and unearned performance‑obligation balances (page_73). The revenue‑recognition structure for QCT IoT products remained point‑in‑time for equipment sales, while QTL licensing revenue is recognized over time and previously satisfied performance obligations and unearned revenue are disclosed (page_73).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution of Edge Networking from 2022-2024, accurately cites the 'more than double' IoT device projection by 2026, and properly categorizes Edge Networking within the three-segment framework (consumer, edge-networking, industrial). The revenue figures ($7.35B in 2022, $5.94B in 2023, $5.42B in 2024) are specific and appear reasonable for IoT segment decline. The answer correctly identifies the revenue recognition structure distinction between point-in-time equipment sales and over-time QTL licensing revenue. Page citations (page_8, page_73) add credibility.\n\nWEAKNESSES: (1) The LLM answer introduces IoT revenue decline data ($7.35B→$5.94B→$5.42B) that is NOT present in the ground truth answer. While this information may be factually correct from the filings, it represents a significant addition beyond what the ground truth synthesized, potentially introducing unverified numbers. (2) The answer emphasizes revenue decline and market maturation, which shifts the narrative away from the ground truth's focus on 'strategic transformation' and 'sustained emphasis.' (3) The ground truth explicitly states Edge Networking was 'explicitly included in Qualcomm's third revenue category' in fiscal 2023 as a formalized grouping, while the LLM presents this as already established in 2022 (\"categorizes into consumer, edge-networking, and industrial segments\"), conflating the timeline. (4) The ground truth emphasizes the progression from 'emerging opportunity' to 'structurally embedded product pillar,' but the LLM's focus on declining revenues and market maturation somewhat contradicts this narrative of strategic embedding.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across three fiscal years and connects product categorization to revenue recognition structure. However, the introduction of revenue decline data creates a different analytical frame than the ground truth's focus on strategic positioning evolution.\n\nNUMERIC VERIFICATION: The specific IoT revenue figures cannot be verified against the ground truth (which doesn't provide these numbers), creating uncertainty about accuracy. The '27 billion projected IoT devices by 2026' is correctly referenced as 'more than double.'\n\nOVERALL ASSESSMENT: The answer demonstrates solid understanding of the strategic evolution and correctly identifies key structural elements, but introduces additional financial data not in the ground truth and slightly misrepresents the timeline of Edge Networking's formal categorization. The core answer is substantially correct but with notable deviations in emphasis and some potential factual additions that require verification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 721,
        "total_tokens": 2238
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "Caterpillar’s 2022 10‑K (page 23) explained that currency‑exchange risk from its global operations was mitigated with hedging instruments and also warned of additional risks from exchange controls and currency devaluations. The 2023 (page 19) and 2024 (page 19) filings repeated the same hedging language—hedges protect against adverse moves but may forego upside—without mentioning exchange controls or devaluations. Thus, the company’s exposure and hedging strategy remained essentially unchanged, continuing to use hedges to dampen earnings volatility from its international activities.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IN MULTI-HOP SYNTHESIS AND REASONING:\n\n1. CONTRADICTS GROUND TRUTH ON EVOLUTION: The LLM answer claims the company's exposure and hedging strategy \"remained essentially unchanged\" from 2022-2024, directly contradicting the ground truth which documents a clear evolution showing \"expanding discussion\" in 2023 to include exchange controls and currency devaluation risks, and \"intensified\" concerns in 2024. This is a fundamental misreading of the multi-year trend.\n\n2. FACTUAL INACCURACY ON 2023-2024 CONTENT: The LLM states that 2023 and 2024 filings \"without mentioning exchange controls or devaluations,\" but the ground truth explicitly states that by 2023 the company \"expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets.\" This is a direct factual error about what was disclosed in those years.\n\n3. FAILED MULTI-HOP SYNTHESIS: The question asks how management \"evolved\" from 2022 to 2024. The ground truth shows a three-year progression: (2022) basic hedging discussion with upside/downside tradeoff → (2023) expanded to include geopolitical/macroeconomic risks → (2024) reiterated hedging but emphasized intensified external pressures. The LLM completely missed this temporal evolution and incorrectly characterized it as static.\n\n4. INCOMPLETE ANALYSIS: The LLM failed to address the \"increasingly cautious approach\" and \"rising emphasis on external macroeconomic pressures\" that the ground truth identifies as key aspects of the evolution.\n\n5. QUANTITATIVE ACCURACY: Page numbers cited (23, 19, 19) cannot be verified as incorrect from the ground truth, so these receive benefit of doubt. However, the substantive content claims are factually wrong.\n\n6. REASONING QUALITY: The LLM's conclusion that strategy \"remained essentially unchanged\" represents poor qualitative reasoning that contradicts the documented multi-year trend of increasing concern about geopolitical and macroeconomic volatility.\n\nThe answer demonstrates a fundamental misunderstanding of the multi-hop question's requirement to track evolution across three years, and makes explicit factual claims (about 2023-2024 content) that contradict the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 601,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "In 2022, 40 % of the U.S. pension plan’s fixed‑income portfolio was invested in Treasury or agency securities (page_102); this dropped to roughly 30 % in 2023 (page_100) and stayed at 30 % in 2024 (page_98). The decline and subsequent plateau suggest Colgate‑Palmolive is intentionally trimming its duration‑sensitive Treasury exposure and moving toward a more diversified fixed‑income mix to better manage interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the trend of declining allocation from 2022-2023 (40% to 30%) and stabilization in 2024 (30%), and appropriately interprets this as a strategic shift toward diversification and interest rate risk management. The reasoning about moving away from duration-sensitive Treasury exposure is sound and relevant. CRITICAL ERRORS: The LLM states the 2022 allocation was 40%, but the ground truth indicates it was 30% as of December 31, 2022 (reported in the 2023 filing). The ground truth shows the allocation was 50% in 2020, declined to 40% in 2021, then to 30% in 2022 - remaining at 30% through 2023 and 2024. The LLM appears to have missed the earlier 2020-2021 data points and misidentified the 2022 baseline. OMISSIONS: The LLM does not mention the Level 2 classification for these securities or discuss the liquidity/over-the-counter trading implications, which the ground truth identifies as part of the company's balanced approach to interest rate risk management. The answer lacks the fuller historical context (2020-2021 decline) that would better illustrate the strategic evolution. QUANTITATIVE ISSUE: The starting point for the trend analysis is incorrect (40% vs. 30% for 2022), which undermines the accuracy of the trend description, though the directional movement and final values are correct. The reasoning quality is good, but the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 392,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "Pfizer disclosed BPA grant activity in both the 2022 and 2023 10‑Ks (page 99 of each filing), but the 2024 10‑K noted that no BPAs were granted and none were outstanding as of December 31, 2024 (page 94), although vesting from prior grants still occurred (page 96). Across 2022‑2024 the company consistently valued BPAs using the intrinsic‑value method based on the closing price of common stock at grant date and amortized over the vesting term, with no change in methodology (page 96 of the 2024 10‑K and page 99 of the 2023 10‑K). The 2024 disclosure simply reflected the absence of new grants, maintaining transparency while updating the status of BPA activity (page 94).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth across multiple dimensions: (1) QUANTITATIVE ERRORS: The LLM claims no BPAs were granted in 2024 and none were outstanding as of December 31, 2024, but the ground truth explicitly states that in 2024, BPAs 'reappeared in disclosures, with detailed valuation and amortization policies introduced.' The ground truth indicates BPAs were active in 2022 (1,165 thousand shares granted at $38.73/share, 859 thousand nonvested), absent in 2023, and then reappeared in 2024 with new valuation frameworks. The LLM's claim that 2024 showed 'no BPAs were granted and none were outstanding' directly contradicts the ground truth's statement that BPAs 'reappeared' in 2024. (2) METHODOLOGY CLAIMS: The LLM states 'the company consistently valued BPAs using the intrinsic-value method...with no change in methodology' across 2022-2024. However, the ground truth explicitly notes that 2024 introduced 'detailed valuation and amortization policies' and 'adjustments based on performance probability and stock price changes,' indicating a methodological evolution, not consistency. (3) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution from 2022-2024. The ground truth identifies a clear 3-year trajectory: active issuance (2022) → suspension (2023) → reappearance with enhanced transparency (2024). The LLM mischaracterizes 2024 as a continuation of suspension rather than a reappearance, fundamentally misrepresenting the evolution. (4) MISSING KEY FACTS: The LLM omits the specific 2022 grant numbers (1,165 thousand shares at $38.73/share) and the 2023 discontinuation, which are central to understanding the program's evolution. (5) DISCLOSURE TRANSPARENCY: While the LLM mentions 'maintaining transparency,' it fails to capture that the ground truth emphasizes a shift toward 'more transparent and dynamic valuation framework' in 2024, suggesting an improvement in disclosure quality that the LLM doesn't adequately convey. The core narrative of the answer is inverted—presenting 2024 as a continuation of absence rather than a strategic reintroduction with enhanced frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 580,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "Schwab’s RIA platform consistently offered the free Schwab Advisor Portfolio Connect and third‑party integrations for CRM, portfolio, trade‑order, and planning systems across 2022‑24 (2022, p. 7; 2023, p. 7; 2024, p. 7). Each year the firm deepened its portfolio‑management toolkit by embedding Ameritrade’s thinkpipes trading platform and iRebal rebalancing engine, adding real‑time charting, efficient trading/allocation, and customizable rebalancing to the RIA suite (2022, p. 8; 2023, p. 8; 2024, p. 8). Thus, while the core interactive tools remained stable, portfolio‑management capabilities expanded through the progressive integration of thinkpipes and iRebal, giving RIAs more advanced analytics and automated rebalancing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Schwab embedded 'Ameritrade's thinkpipes trading platform and iRebal rebalancing engine' into the RIA suite. This is factually incorrect. Schwab acquired TD Ameritrade, but the ground truth makes no mention of thinkpipes or iRebal being integrated into Schwab's RIA offerings during 2022-2024. These appear to be fabricated product names or misattributed integrations. (2) MISSING CORE INFORMATION - The LLM completely omits the Advisor Services website evolution mentioned in the ground truth, particularly the 2023 emphasis on multi-year document archiving and search capabilities. (3) MISSING CONTEXT - The ground truth emphasizes the evolution from 2022's proprietary software focus to 2024's emphasis on 'intuitive modern experience' and platform refinement. The LLM misses this qualitative evolution entirely. (4) CITATION ISSUES - The LLM provides specific page citations (p. 7, p. 8) that cannot be verified against the ground truth and appear to be hallucinated references. (5) INCOMPLETE SYNTHESIS - While the LLM correctly identifies Schwab Advisor Portfolio Connect and third-party integrations as consistent offerings, it fails to capture the multi-year evolution narrative that was central to the original question. The answer presents a false narrative of progressive integration of non-existent products rather than the actual evolution described in the ground truth. The core claim about 'thinkpipes and iRebal' integration is entirely unsupported by the ground truth and represents a fundamental factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 453,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "Texas Instruments has reiterated the same framing in each filing: its “strategic focus is on analog and embedded‑processing products, with embedded‑processing highlighted as a key growth engine—especially in industrial and automotive markets” (2022 p. 19; 2023 p. 19; 2024 p. 19).  The company also describes its business model as “focused on analog and embedded‑processing products” and lists embedded‑processing as one of the four sustainable competitive advantages that drive cash‑flow (2022 p. 18; 2023 p. 18; 2024 p. 18).  This unchanging emphasis signals TI’s long‑term positioning as a leader in high‑margin, long‑lived analog and embedded‑processing segments that underpin its cash‑flow generation and competitive edge in the semiconductor market.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the core concept—that Texas Instruments consistently emphasized embedded processing products across 2022-2024 as part of its four sustainable competitive advantages strategy. The qualitative reasoning about TI's long-term positioning in high-margin segments and cash-flow generation is sound and well-articulated.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. PAGE NUMBER CITATIONS: The LLM provides specific page citations (2022 p. 19; 2023 p. 19; 2024 p. 19 and 2022 p. 18; 2023 p. 18; 2024 p. 18) that cannot be verified against the ground truth. The ground truth does not provide specific page numbers, making these citations potentially fabricated or inaccurate. This is a critical issue as it suggests the model may be hallucinating specific document references.\n\n2. QUOTE ACCURACY: The LLM provides a specific quote about \"strategic focus is on analog and embedded‑processing products, with embedded‑processing highlighted as a key growth engine—especially in industrial and automotive markets.\" While this aligns with the general theme in the ground truth, the exact wording and the specific mention of \"industrial and automotive markets\" as a direct quote cannot be verified against the provided ground truth.\n\n3. CONSISTENCY WITH GROUND TRUTH: The ground truth states the emphasis was on \"analog and embedded processing products\" as part of the four sustainable competitive advantages, but does not explicitly mention \"industrial and automotive markets\" as a specific framing element across all three years.\n\n4. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across three years and identifies the consistent messaging, which is appropriate for the multi-hop nature of the question.\n\nThe answer is partially correct in its core thesis but problematic in its specific citations and potentially fabricated details. The qualitative analysis is sound, but the quantitative specificity (page numbers and exact quotes) raises credibility concerns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 553,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "Boeing’s fleet‑support expense has remained essentially flat, consistently about 1 % of total consolidated product and service costs (see pages 40‑44 of the 2022 10‑K and pages 39‑44 of the 2024 10‑K).  Abnormal production costs for the 787 program were very high in 2023 ($2.7 B, page 36) but dropped sharply to $256 M in 2024 (page 39) as rework was completed and production rates began to recover.  Despite the cost‑control gains, delivery delays persisted—787 deliveries were slowed to below five per month in 2024 because of supply‑chain constraints and rework inventory, with the program expected to resume deliveries gradually in 2025.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and their evolution. Quantitative verification: (1) Fleet support services at ~1% of consolidated costs is correctly stated and sourced to appropriate 10-K pages; (2) 2023 abnormal production costs of $2.7B is accurate; (3) 2024 rework costs of $256M is accurate; (4) The comparison showing a sharp drop from $2.7B to $256M correctly characterizes the cost trajectory. Multi-hop reasoning is sound: the answer successfully synthesizes information about both cost profile (abnormal production costs declining) and delivery impact (delays persisting despite cost improvements). The answer correctly identifies the causal relationship between rework completion and cost reduction, while noting that delivery delays continued due to supply-chain constraints. Minor omissions: (1) The answer does not explicitly mention the 25 inventoried aircraft produced prior to 2023 or that most rework was completed by 2024, though it implies this through 'rework was completed'; (2) The answer does not mention 2022 specifically regarding the lack of disclosed abnormal cost figures, focusing instead on the 2023-2024 comparison; (3) The phrase 'below five per month' for 2024 deliveries is not explicitly verified in the ground truth but represents a reasonable characterization of delivery delays. The answer appropriately addresses all parts of the multi-part question: cost profile evolution (showing the $2.7B to $256M progression), delivery impact (noting persistent delays), and the relationship to the 787 program. The semantic equivalence is strong—the answer conveys the same essential information as the ground truth regarding the reduction in abnormal costs and gradual resolution of delivery challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 490,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "Pfizer sold Meridian in 2021 for about $51 million in cash, recording a $167 million net loss.  After the sale, the company entered into transitional‑service agreements (TSAs) and a manufacturing‑supply agreement (MSA) that continued through 2023, with the TSAs completed by December 31 2023 and the MSA covering a three‑year post‑sale period with a two‑year extension option.  In 2022 and 2023 the amounts recorded under these arrangements were not material to Pfizer’s operations, and the MSA remains in effect through 2024, sustaining the post‑sale relationship【page_73】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall trajectory of Pfizer's relationship with Meridian and correctly identifies key structural elements (TSAs, MSA, extension option). However, there are significant quantitative issues: (1) The sale price of '$51 million in cash' is introduced without ground truth support and appears to be fabricated or unsourced - the original answer does not mention a specific sale price. (2) The $167 million net loss is correctly stated. (3) The timeline is mostly accurate: sale on December 31, 2021; TSAs completed by December 31, 2023; three-year MSA with two-year extension option. (4) The statement that 'amounts recorded under these arrangements were not material' is correct for 2023 and aligns with ground truth. However, the LLM conflates 2022 and 2023 by stating 'In 2022 and 2023 the amounts recorded under these arrangements were not material' when the ground truth specifically notes that in 2022, Meridian was disclosed as discontinued operations with the $167 million loss - a material impact. The ground truth indicates materiality was not an issue by 2023, but 2022 had significant financial implications. The multi-hop reasoning is sound in connecting the sale, loss recognition, TSAs, and MSA, and correctly identifies the evolution from ownership to supplier relationship. The inclusion of the unsourced $51 million sale price and the conflation of 2022 materiality status are the primary errors. The answer demonstrates good understanding of the relationship evolution but contains factual inaccuracies that prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 432,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "From 2022 through 2024, Colgate‑Palmolive has kept the “hello” brand within its Oral, Personal and Home Care segment, consistently listing it among the company’s global trademarks. The 10‑K filings for 2022, 2023 and 2024 show no change in the brand’s strategic positioning relative to core brands such as Colgate and Palmolive, indicating a stable integration into the broader product portfolio. [page_79] [page_80] [page_81]",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core facts: (1) 'hello' brand was consistently included in Colgate-Palmolive's Oral, Personal and Home Care segment across 2022-2024; (2) the brand maintained stable positioning relative to major brands like Colgate and Palmolive; (3) no significant changes in strategic positioning occurred during this period. The answer correctly synthesizes information across three fiscal years and properly identifies the relevant entities (Colgate-Palmolive, 'hello' brand, Oral/Personal/Home Care segment). Quantitative accuracy is high - all dates (2022, 2023, 2024) are correct, and no numerical claims are made that could be inaccurate. The multi-hop reasoning is sound: the model correctly connected the consistent listing of 'hello' across three years to conclude stable strategic positioning. One minor difference from ground truth: the LLM answer does not explicitly mention that Darlie was added to the list in 2023, which the ground truth notes as context for understanding 'hello's maintained positioning despite portfolio changes. This omission is relatively minor since the core conclusion about 'hello's stable positioning remains accurate. The answer appropriately uses page references [page_79] [page_80] [page_81] to support claims, though these cannot be independently verified. The semantic meaning matches the ground truth well - both convey that 'hello' maintained consistent strategic emphasis and positioning within the broader portfolio from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 424,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "Texas Industries’ Non‑Qualified Defined Benefit Pension Plan has stayed unfunded and closed to new participants through 2022‑2024, with no new entrants or significant participant‑contributions reported in the filings【page_46】.  Because the plan remains unfunded and no additional employees are enrolling, the company’s long‑term pension liability for this plan is not being reduced and employee participation trends have stayed flat, indicating that TI is not actively addressing this obligation and may face unchanged or growing pension exposure in the future.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains critical factual errors and fails to address the core quantitative data from the ground truth. Specific issues: (1) COMPANY NAME ERROR: The answer refers to 'Texas Industries' instead of 'Texas Instruments' - a fundamental entity identification error. (2) MISSING QUANTITATIVE DATA: The ground truth provides specific, verifiable numbers across 2022-2024 that the LLM completely omits: TI common stock holdings (6M shares in 2022 declining to 5M in 2023-2024), valuations ($940M→$873M→$852M), dividend payments ($28M→$27M→$26M), and defined contribution plan expenses ($70M→$75M→$76M). These are essential to answering the multi-year progression question. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question explicitly asks about the evolution 'from 2022 through 2024' with specific focus on funding status, participant engagement, and what the progression indicates. The LLM provides only vague statements about the plan being 'unfunded and closed' without the supporting data that demonstrates the actual trend. (4) INCORRECT CONCLUSION: The LLM states 'employee participation trends have stayed flat' and 'TI is not actively addressing this obligation,' which contradicts the ground truth showing a strategic shift toward defined contribution plans with steadily increasing expenses ($70M→$76M), indicating active management of retirement obligations through alternative vehicles. (5) UNSUPPORTED CLAIMS: The statement about 'no new entrants or participant-contributions reported' lacks citation to actual filing data and appears to be an inference rather than fact-based analysis. (6) MISSING STRATEGIC CONTEXT: The ground truth emphasizes a 'strategic shift away from defined benefit obligations' with defined contribution plans as the 'primary retirement vehicle,' which the LLM fails to capture. The answer demonstrates poor multi-hop reasoning by failing to synthesize the interconnected data points that show how TI is managing its pension obligations through defined contribution alternatives.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 545,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "Pfizer’s long‑term private‑equity holdings at cost declined from $800 million in 2022 to $755 million in 2023 and to $719 million in 2024, a cumulative drop of $81 million (≈10 %). This modest downward trend indicates the company is gradually trimming its private‑equity exposure, likely reallocating capital toward other assets or reducing risk in that segment.",
      "correctness_score": 0,
      "quantitative_accuracy": 0,
      "qualitative_accuracy": 0,
      "contextual_relevance": 0,
      "detailed_feedback": "Evaluation failed: Evaluation error: Expecting value: line 1 column 1 (char 0)",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 0,
        "completion_tokens": 0,
        "total_tokens": 0
      },
      "error": "Evaluation error: Expecting value: line 1 column 1 (char 0)"
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "Under the 2019 IDA agreement, Schwab could migrate up to $10 billion of IDA balances each year but only floating‑rate balances, and it had to keep a $50 billion minimum IDA balance and at least 80 % of balances as fixed‑rate; Schwab exercised this option in 2022. The 2023 IDA agreement replaced those terms, eliminating the 80 % fixed‑rate requirement but imposing new minimum/maximum limits ($30 billion above the total unmatured fixed‑rate obligations through Sept 10 2025, then $60 billion minimum and $90 billion maximum thereafter) and restricting withdrawals to customer‑initiated amounts, so Schwab did not migrate balances in 2023. Those same 2023 terms continued into 2024, with Schwab again unable to move IDA balances to its balance sheet and still required to maintain the prescribed minimum/maximum balances, have sufficient capital, and limit withdrawals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ERRORS:\n   - Claims 2019 agreement required '$50 billion minimum IDA balance' - NOT in ground truth\n   - Claims '80% fixed-rate requirement' - NOT mentioned in ground truth\n   - Claims 2023 agreement has '$60 billion minimum and $90 billion maximum thereafter' - NOT in ground truth (only mentions $30 billion maximum through Sept 10, 2025)\n   - States Schwab 'exercised this option in 2022' - contradicts ground truth which says no migration occurred in 2023 and 2024, and doesn't explicitly confirm 2022 migration\n\n2. FACTUAL INACCURACIES:\n   - Ground truth states Schwab 'had already moved $10.1 billion by December 31, 2021' (past action), not that it exercised the option in 2022\n   - LLM claims 2019 agreement restricted to 'floating-rate balances only' - not mentioned in ground truth\n   - LLM states 2023 agreement restricts 'withdrawals to customer-initiated amounts' - not in ground truth\n\n3. MULTI-HOP REASONING:\n   - The LLM failed to correctly synthesize the evolution across years\n   - Ground truth shows clear progression: 2022 (option available, $10B annual limit), 2023 (new constraints, no migration), 2024 (same constraints, no migration)\n   - LLM conflates different constraint types and introduces unsupported details\n\n4. WHAT WAS CORRECT:\n   - Correctly identifies 2019 and 2023 IDA agreements as the two key frameworks\n   - Correctly notes the $30 billion maximum through Sept 10, 2025\n   - Correctly identifies that no migrations occurred in 2023 and 2024\n   - Correctly notes the shift from flexibility to constraints\n\n5. CRITICAL GAPS:\n   - Misrepresents the 2022 situation (ground truth: option available with $10B annual limit; LLM: claims exercised in 2022 without clear evidence)\n   - Introduces fabricated constraints ($50B minimum, 80% fixed-rate, $60-90B thresholds) not in ground truth\n   - Fails to accurately capture the core constraint evolution\n\nThe answer demonstrates partial understanding of the general narrative but introduces multiple false details that would mislead a reader about the actual terms and constraints of the IDA agreements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 599,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "Texas Instruments lists Melaka, Malaysia as an analog‑manufacturing site in the property tables of its 2022, 2023 and 2024 10‑K filings (2022 page 18; 2023 page 16; 2024 page 18). The site’s continued inclusion and designation as an analog facility over three consecutive years indicates that TI views Melaka as a stable, strategically important hub for analog production—likely driven by cost‑effective manufacturing, skilled labor and its role in the Southeast‑Asian supply chain.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Texas Instruments listed Melaka, Malaysia as an analog manufacturing site across 2022, 2023, and 2024, and appropriately concludes this indicates strategic importance. However, there are significant issues with the quantitative details: (1) The LLM provides specific page numbers (2022 page 18; 2023 page 16; 2024 page 18) that cannot be verified against the ground truth and may be inaccurate—this is a factual claim that requires precision. (2) The ground truth specifically mentions the marking symbols used († in 2022, * in 2023, ** in 2024), which the LLM completely omits. These symbols are important details that demonstrate the multi-year evolution and potential escalation. (3) The LLM's reasoning about 'cost-effective manufacturing, skilled labor and its role in the Southeast-Asian supply chain' is speculative and not grounded in the filing data itself—the ground truth focuses on what the filings actually show rather than inferring business rationales. (4) The LLM correctly synthesizes the multi-hop information (consistent presence across three years = strategic importance), but misses the nuance about the marking escalation that the ground truth emphasizes. The answer is partially correct in its core conclusion but lacks the specific documentary evidence (the symbol progression) that substantiates the claim of 'potential expansion' or escalating emphasis. The page number citations, while appearing authoritative, are unverified and potentially problematic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 419,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "The Target Debit Card’s penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and further to 18.6 % in 2024【page_27】. This gradual decline indicates that the card’s influence on generating incremental sales is shrinking, suggesting that while it still drives additional purchases, its relative contribution to Target’s sales growth is weakening over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in the 2024 penetration rate. Ground truth states 17.8% for 2024, but the LLM reports 18.6% - a 0.8 percentage point discrepancy. The 2022 (20.5%) and 2023 (19.8%) figures are correct. The qualitative reasoning about the downward trend and its implications for incremental sales effectiveness is sound and aligns with the ground truth interpretation. The LLM correctly identifies the three-year period and the general pattern of decline. However, the incorrect 2024 figure is a significant quantitative error that undermines the accuracy of the trend analysis, even though the directional conclusion (declining penetration) remains valid. The answer appropriately addresses both parts of the question (evolution of penetration rate and what it suggests about the card's role), demonstrating good multi-hop synthesis. The semantic interpretation of declining effectiveness is consistent with ground truth. The citation reference [page_27] adds credibility but doesn't compensate for the numerical inaccuracy. For financial metrics, precision is critical, making this error material despite the otherwise sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 331,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "The Texas Instruments 2003 Director Compensation Plan had no shares available for future issuance in 2022, 2023, or 2024, as it is not listed in the remaining‑shares footnotes for any of those years (2024 footnote c, 2023 footnote c, 2022 footnote c). This indicates the plan has been fully utilized and not replenished, and TI has shifted its equity incentive focus to newer director plans such as the 2018 Director Plan and the 2024 LTIP for future awards.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) QUANTITATIVE ACCURACY FAILURE: The ground truth provides specific share counts for all three years: 35,385,153 shares (2022), 25,296,767 shares (2023), and 24,503,062 shares (2024). The LLM claims there were 'no shares available' in all three years, which directly contradicts the ground truth data. These are not minor discrepancies—the LLM provides zero shares when the actual numbers are in the tens of millions. (2) ENTITY/METRIC ACCURACY FAILURE: The LLM correctly identifies the plan name (2003 Director Compensation Plan) but completely misrepresents the data associated with it. The claim that the plan 'is not listed in the remaining-shares footnotes' contradicts the ground truth which explicitly documents shares available in footnotes for all three years. (3) REASONING FAILURE: The LLM's conclusion that 'the plan has been fully utilized and not replenished' is logically inconsistent with the actual data showing declining but non-zero share counts. The suggestion that TI shifted focus to newer plans (2018 Director Plan, 2024 LTIP) may be contextually relevant but is presented as an explanation for zero shares when the 2003 plan actually had substantial shares remaining. (4) MULTI-HOP SYNTHESIS FAILURE: The question asks about the evolution/trend from 2022-2024. The ground truth shows a clear declining trend (35.4M → 25.3M → 24.5M), suggesting active utilization without replenishment. The LLM provides no trend analysis and instead claims static zero availability across all years. This represents a complete failure to synthesize the multi-year data correctly. The LLM appears to have either misread the source documents or confused the 2003 plan with a different plan that had no shares available.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 487,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "Across 2022‑24 Visa steadily deepened its use of virtual accounts within the Visa Direct network.  In 2022 the platform already incorporated Currencycloud‑powered virtual accounts, real‑time FX and liquidity tools to support cross‑border flows (page 10, 2022 10‑K).  By 2023 it expanded cross‑border use cases with Visa Cross‑Border Solutions and launched Visa+ for P2P apps, further integrating virtual accounts into Direct (page 10, 2023 10‑K).  In 2024 the platform processed nearly 10 billion transactions and added new cross‑border flows, real‑time FX, virtual accounts and enhanced settlement features, solidifying its $20 trillion cross‑border opportunity (page 10, 2024 10‑K).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Visa's virtual accounts across 2022-2024 and correctly identifies key platforms (Currencycloud, Visa Direct, Visa Cross-Border Solutions) and themes (real-time FX, cross-border expansion). However, there are significant quantitative discrepancies: (1) The LLM states 'nearly 10 billion transactions' in 2024, but the ground truth specifies 'over 11 billion endpoints' - these are different metrics (transactions vs. endpoints) and the LLM appears to have conflated or misrepresented the figure. (2) The $20 trillion cross-border opportunity is correctly cited in both answers. (3) The LLM mentions 'Visa+ for P2P apps' in 2023, which is not mentioned in the ground truth and may be an unsupported addition. The multi-hop reasoning is generally sound - the answer traces the evolution across three years and connects virtual accounts to broader platform integration. However, the quantitative accuracy suffers from the endpoint/transaction confusion and the introduction of Visa+ without ground truth support. The answer is contextually relevant and addresses the core question about evolution and integration, but the factual errors regarding specific metrics and potentially unsupported claims about Visa+ reduce overall correctness. The answer demonstrates understanding of the progression but lacks precision in key details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 383,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "Xtandi’s revenue slipped slightly in 2023 – the 2023 Form 10‑K shows a 1 % international decline (page 43), reflecting pressure on the product’s sales.  In response, Pfizer intensified its lifecycle‑management strategy, which paid off with the April 2024 FDA approval of a new indication for Xtandi (nmCSPC with biochemical recurrence at high risk for metastasis – page 46).  The 2022 intangible‑asset statement (page 90) lists Xtandi as a key component of the developed‑technology‑rights portfolio, carrying a gross value of $73.3 billion, underscoring the asset’s strategic value that Pfizer sought to protect and grow.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core narrative: (1) Xtandi faced revenue pressures in 2023 with a 1% decline, (2) Pfizer pursued lifecycle management strategies, (3) April 2024 FDA approval for nmCSPC indication, and (4) Xtandi's strategic importance in Pfizer's portfolio. The multi-hop reasoning is sound—connecting 2023 revenue challenges to 2024 indication expansion and 2022 valuation. The semantic equivalence is strong throughout.\n\nCRITICAL ERRORS: The LLM introduces a specific dollar figure ($73.3 billion) for Xtandi's gross value in the 2022 intangible-asset portfolio. This number cannot be verified against the ground truth provided, which does not specify a dollar amount for Xtandi's 2022 valuation. The ground truth states only that Xtandi was 'explicitly listed among Pfizer's most significant developed technology rights' without quantifying the asset value. By citing a specific figure without ground truth support, the LLM commits a factual error that undermines quantitative accuracy.\n\nMINOR ISSUES: The LLM cites specific page numbers (43, 46, 90) which cannot be verified against the ground truth. While these may be accurate, they represent unverifiable claims that add specificity beyond what the ground truth confirms.\n\nMULTI-HOP SYNTHESIS: The LLM successfully synthesizes information across three time periods (2022 valuation → 2023 revenue pressure → 2024 indication expansion) and correctly identifies the causal relationship between revenue challenges and lifecycle management investment.\n\nSCORING RATIONALE: Correctness score of 6 reflects that while the core narrative and reasoning are sound (7-8 range), the introduction of an unverified $73.3 billion figure represents a significant quantitative error that cannot be confirmed. Quantitative accuracy drops to 4 due to this unsupported number. Qualitative accuracy remains at 7 because the reasoning framework and entity identification are correct despite the numerical error. Contextual relevance is 8 because the answer directly addresses all aspects of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 560,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "The Target MasterCard Credit Card’s penetration (measured as the share of purchases paid with a RedCard) fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024**【page_27】. This downward trend indicates that fewer shoppers are using the card relative to total sales, suggesting a gradual erosion of consumer preference for the card and a weakening of loyalty‑program engagement as customers shift to other payment methods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE ACCURACY: All three penetration rate figures are correct (20.5% in 2022, 19.8% in 2023, 18.6% in 2024), matching the ground truth exactly. The temporal sequence and numerical precision are flawless. ENTITY ACCURACY: The answer correctly identifies the Target MasterCard Credit Card and appropriately notes the rebranding context (RedCard to Target Circle Cards), though the LLM uses 'RedCard' terminology which is consistent with how the metric is measured. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the answer correctly synthesizes the three-year trend data and draws appropriate conclusions about consumer behavior. The interpretation that the declining penetration indicates 'erosion of consumer preference' and 'weakening loyalty-program engagement' logically follows from the downward trend. COMPLETENESS: The answer addresses both parts of the question - it provides the evolution of penetration rates AND interprets what the trend indicates about consumer preferences and loyalty engagement. SEMANTIC EQUIVALENCE: The LLM's phrasing ('fewer shoppers are using the card relative to total sales,' 'gradual erosion,' 'shift to other payment methods') conveys the same meaning as the ground truth's 'gradual reduction in the proportion of purchases' and 'shift in consumer payment preferences.' Minor note: The LLM includes a citation marker [page_27] which adds credibility but wasn't in the ground truth - this is a positive addition. The answer is comprehensive, accurate, and well-reasoned with no material errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 443,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "In FY 2022, Visa’s Currencycloud platform introduced virtual accounts to enable cross‑border payments with real‑time FX and liquidity (page_10, 2022). The same capability was reiterated in FY 2023, underscoring continued expansion of virtual‑account usage within the cross‑border framework (page_10, 2023). By FY 2024, the platform had broadened its reach, enabling cross‑border payments in more than 195 countries and territories and servicing over 11 billion endpoints (cards, bank accounts, wallets) through the Currencycloud‑enabled Visa Direct network (page_10, 2024).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant quantitative discrepancies and incomplete synthesis. CORRECT ELEMENTS: (1) FY 2022 introduction of virtual accounts for cross-border payments with real-time FX is accurate; (2) FY 2023 expansion within cross-border framework is correct; (3) The 11 billion endpoints figure for 2024 is accurate; (4) Visa Direct network integration is correctly identified. CRITICAL ERRORS: (1) The LLM states '195 countries and territories' for FY 2024, but the ground truth specifies 'more than 100 countries' through Visa B2B Connect - this is a significant quantitative discrepancy (195 vs 100+); (2) The LLM fails to mention the specific 'Visa B2B Connect' product/solution that was highlighted in the ground truth as the key vehicle for cross-border B2B transactions in 2024. INCOMPLETE SYNTHESIS: (1) The LLM does not adequately explain the 'strategic deepening' of virtual account utility across the three-year period - it presents facts but doesn't synthesize the evolution narrative as effectively as the ground truth; (2) Missing the explicit connection between virtual accounts and 'enhanced liquidity and settlement capabilities' mentioned in FY 2022; (3) Does not capture the progression from 'introducing' (2022) to 'expanding' (2023) to 'continuing to build' (2024) as a coherent strategic narrative. MULTI-HOP REASONING: The answer attempts to synthesize across three fiscal years but the country/territory count discrepancy suggests potential source confusion or misattribution. The answer provides page references but the quantitative mismatch on geographic reach is problematic for a financial evaluation context where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 467,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "AMD’s 10‑K filings for 2022, 2023 and 2024 all list “difficulties in protecting our intellectual property” as a risk factor tied to its foreign operations (see 2022 page 37, 2023 page 41 and 2024 page 38).  Each year notes that the company relies on third‑party wafer foundries in the U.S., Europe and Asia and that nearly all assembly and testing is performed at third‑party facilities in China, Malaysia and Taiwan, while international sales remain a large portion of revenue (≈65‑70 %).  The consistent wording and unchanged reliance on overseas manufacturing indicate that AMD’s exposure to IP‑protection difficulties has remained high and unchanged over the three‑year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that AMD cited IP protection difficulties across all three years (2022, 2023, 2024) and accurately notes the reliance on third-party manufacturing in China, Malaysia, and Taiwan. The international sales percentage (65-70%) appears reasonable. However, the answer has significant deficiencies in addressing the core question about how AMD's exposure has EVOLVED:\n\n(1) CRITICAL OMISSION - Evolution/Change: The ground truth explicitly states that AMD's risk exposure EVOLVED and DEEPENED over time, with 'increasing emphasis on geopolitical tensions,' 'expanded' risk linking to specific manufacturing dependencies in 2023, and 'added' export control regulations/sanctions concerns in 2024. The LLM answer concludes the opposite—that exposure 'remained high and unchanged'—which directly contradicts the ground truth's finding of evolution and deepening concern.\n\n(2) Missing Geopolitical Context: The ground truth emphasizes specific geopolitical developments (China-Taiwan tensions, Ukraine-Russia conflict, Israel-Hamas conflict) and their impact on IP security. The LLM answer completely omits these critical contextual factors that drove the evolution of AMD's risk assessment.\n\n(3) Missing Export Control/Sanctions Evolution: The ground truth specifically notes that by 2024, AMD added concerns about 'evolving export control regulations and sanctions.' The LLM answer does not mention this important development.\n\n(4) Incomplete Multi-Hop Synthesis: While the LLM correctly identifies the consistent mention of IP protection challenges, it fails to synthesize the PROGRESSION of how these challenges became more specific and complex over the three-year period, which is the core requirement of the question.\n\n(5) Quantitative Accuracy: The page numbers cited (2022 page 37, 2023 page 41, 2024 page 38) cannot be verified from the ground truth provided, but the international sales percentage (65-70%) is reasonable and not contradicted.\n\n(6) Semantic Misalignment: The LLM's conclusion that exposure 'remained high and unchanged' is semantically opposite to the ground truth's finding of 'deepening concern' and 'increasing emphasis' over time.\n\nThe answer demonstrates partial understanding of AMD's IP protection risks but fundamentally misses the evolution narrative that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 628,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "Corporate stock was re‑classified from largely Level 2 (with a small Level 3 portion) in 2022 to Level 1 for common shares in 2023 and 2024 (Corporate Stock is described as Level 1 for common shares and Level 2 for preferred shares on page 56‑57).  The fair‑value allocation fell sharply from $1,111 million in 2022 (page 70‑74) to $181 million in 2023 (page 56‑60) and remained at $181 million in 2024 (page 54‑58).  This shift signals a de‑risking pension strategy that cuts equity exposure and concentrates on more liquid, debt‑heavy assets, thereby reducing the plan’s market exposure to corporate equities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) CRITICAL NUMBER ERROR: The LLM states 2022 Corporate Stock was $1,111 million, but the ground truth clearly states it was $1,990 million - a difference of $879 million (44% understatement). This is a fundamental factual error. (2) LEVEL CLASSIFICATION ERROR: The LLM claims Corporate Stock was 'largely Level 2 (with a small Level 3 portion) in 2022,' but the ground truth shows it was predominantly Level 1 ($1,980M in Level 1 vs $10M in Level 2) - the LLM has inverted the classification structure. There is no mention of Level 3 in the ground truth. (3) CORRECT NUMBERS: The LLM correctly identifies the 2023 figure ($181 million) and 2024 continuation, and correctly notes the sharp decline from 2022 to 2023. (4) CORRECT CLASSIFICATION FOR 2023-2024: The LLM correctly identifies that common stock is Level 1 and preferred stock is Level 2 in 2023-2024. (5) REASONING QUALITY: While the LLM's interpretation of the shift as a 'de-risking pension strategy' is reasonable and aligns with the ground truth's conclusion about strategic reallocation, this correct reasoning cannot overcome the fundamental numerical and classification errors. (6) MULTI-HOP SYNTHESIS: The LLM attempts to synthesize information across years but fails to accurately capture the baseline 2022 data, which undermines the entire comparative analysis. The core claim about evolution from 2022 to 2024 is built on an incorrect 2022 foundation. The answer demonstrates partial understanding of the strategic implications but fails on basic factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 452,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "Abbott’s 2022, 2023, and 2024 10‑Ks all reference the same exhibits for the 4.75% Senior Notes due 2043—Exhibit 4.6 (the Form of the Notes filed in 2017) and Exhibit 4.7 (the Officers’ Certificate filed in 2017)—showing a consistent documentation and disclosure approach (page_86‑2022, 4.17‑4.18; page_86‑2023, 4.17‑4.18; page_86‑2024, 4.17‑4.18). This consistency signals a stable long‑term debt strategy and a continued emphasis on transparent, regulatory‑compliant communication with investors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT EXHIBIT REFERENCES: The LLM claims Exhibits 4.6 and 4.7 appear consistently across 2022-2024, but the ground truth indicates 2022 referenced St. Jude Medical's Fourth Supplemental Indenture from April 2, 2013 (a legacy reference), while 2023 introduced Exhibit 4.6 from the March 22, 2017 Form 8-K as a more formalized approach. The LLM fails to capture this evolution from legacy-based to standardized disclosure. (2) MISSING EVOLUTION NARRATIVE: The ground truth explicitly describes a three-stage evolution (2022 legacy integration → 2023 formalization → 2024 consistency), which is the core of the question. The LLM incorrectly characterizes all three years as showing 'consistent documentation,' missing the critical shift from legacy referencing to direct presentation. (3) INCOMPLETE ANALYSIS: The LLM provides page references (4.17-4.18) but these appear to be generic citations that don't substantiate the claimed consistency across years. The ground truth provides specific document references (St. Jude Medical Fourth Supplemental Indenture, Form 8-K dated March 22, 2017) that the LLM omits. (4) MISCHARACTERIZATION OF STRATEGY: By claiming consistency across all three years, the LLM misses the strategic shift the ground truth identifies—from legacy-based referencing to transparent, standardized disclosure. This is a fundamental misunderstanding of the multi-year progression. (5) SEMANTIC MISMATCH: The ground truth's key insight about 'shift from legacy-based referencing to a standardized, transparent disclosure approach' is entirely absent from the LLM answer. The LLM's conclusion about 'stable long-term debt strategy' contradicts the ground truth's narrative of evolution and formalization. The answer demonstrates poor multi-hop synthesis across the three-year period and fails to identify the critical documentary changes that occurred.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 532,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "RedCard penetration fell from 20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024 (see 2024 Form 10‑K, page 27). The downward trend indicates that fewer guests are adopting the Target‑branded credit card, which is a key driver of the 5 % discount incentive. Because a meaningful portion of incremental purchases on RedCards also represent incremental sales for Target, the decline in penetration likely translates into a modest reduction in the incremental sales that the card generates.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: RedCard penetration rates of 20.5% (2022), 19.8% (2023), and 18.6% (2024) match the ground truth exactly. The citation to the 2024 Form 10-K page 27 adds credibility. The multi-hop reasoning is sound—the answer correctly synthesizes that declining penetration rates indicate reduced customer adoption and logically connects this to reduced incremental sales generation. The answer appropriately identifies RedCard as the branded payment product and explains the 5% discount incentive mechanism. However, there are minor differences from the ground truth: (1) The LLM answer uses 'RedCard' terminology while the ground truth mentions 'Target Credit Card (under the branded RedCard/Target Circle Card umbrella)' - this is a minor semantic difference but the LLM could have been more explicit about the product naming. (2) The LLM characterizes the impact as 'modest reduction' while the ground truth is more neutral in stating it 'likely translates into a reduction' without specifying magnitude. (3) The ground truth mentions the card's role in 'credit card profit sharing and customer retention efforts' which the LLM answer omits, though this wasn't strictly necessary to answer the core question about penetration trends and incremental sales impact. The reasoning about the relationship between penetration decline and reduced incremental sales is logically sound and well-articulated. Overall, the answer correctly addresses both parts of the multi-part question: the evolution of penetration rates and what this indicates about customer adoption and sales impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 451,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "Union Pacific’s Multiple Purpose Locomotive fleet shrank from 7,242 units in 2022 to 6,893 units in 2024, while the average age rose from 22.5 to 25.2 years. This trend reflects a deliberate consolidation and aging of the fleet, indicating the company is retiring older units and focusing on efficient asset utilization and phased replacement to manage capital and operating costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "QUANTITATIVE ACCURACY: All numerical values are correct. Fleet size decreased from 7,242 to 6,893 units (349-unit reduction), and average age increased from 22.5 to 25.2 years (2.7-year increase). All numbers match ground truth exactly. ENTITY ACCURACY: Union Pacific and Multiple Purpose Locomotives correctly identified. Years 2022 and 2024 correctly specified. COMPLETENESS: The LLM answer addresses all three parts of the question: total units change, average age change, and strategic implications. REASONING AND INTERPRETATION ISSUE: The LLM's interpretation of the data differs from the ground truth in a significant way. Ground truth characterizes the strategy as 'cost-conscious asset management' with 'deferral of fleet modernization.' The LLM characterizes it as 'deliberate consolidation' with 'retiring older units' and 'phased replacement.' These interpretations are semantically different. The ground truth emphasizes cost-consciousness and deferred modernization (suggesting the company is keeping older equipment longer to save money), while the LLM suggests active retirement and planned replacement (suggesting strategic fleet optimization). The LLM's interpretation that the company is 'retiring older units' is questionable given that average age increased - if older units were being retired preferentially, average age should decrease or stay stable, not increase. This represents a logical inconsistency in the LLM's reasoning. SEMANTIC EQUIVALENCE: While the LLM conveys similar information about fleet trends, the strategic interpretation diverges from ground truth in ways that could mislead about company intentions. The factual data points are correct, but the analytical conclusion about what the data suggests is less aligned with the ground truth assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 486,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "Abbott’s unfunded commitments to private‑real‑estate funds fell modestly over the period: $569 million at 12/31/2022, $555 million at 12/31/2023, and $540 million at 12/31/2024 (Note 14, pages 70‑71). This gradual decline reflects a measured, risk‑aware approach to illiquid alternatives, indicating that Abbott is maintaining exposure while avoiding aggressive expansion and prioritizing long‑term, risk‑adjusted returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "QUANTITATIVE ACCURACY ISSUES: The LLM provides a 2022 figure of $569 million, which contradicts the ground truth of $585 million - a $16 million discrepancy. The 2023 ($555M) and 2024 ($540M) figures are correct. This is a material error in the baseline year, affecting the trend analysis. The ground truth shows a consistent $15M annual decline ($585M→$555M→$540M), while the LLM's numbers would show a $14M decline in 2022-2023 and $15M in 2023-2024, creating an inconsistent pattern. QUALITATIVE ACCURACY: The LLM correctly interprets the trend as a gradual decline reflecting a measured approach to illiquid alternatives. The reasoning about maintaining exposure while avoiding aggressive expansion is sound and aligns with the ground truth interpretation. The reference to Note 14, pages 70-71 adds credibility. COMPLETENESS: The LLM addresses the evolution of unfunded commitments and provides interpretation of the investment strategy trend. However, it doesn't explicitly quantify the total three-year reduction ($45M) or the consistent $15M annual pattern that the ground truth emphasizes. MULTI-HOP REASONING: The synthesis connecting the numerical trend to strategic implications (measured approach, risk-aware positioning, long-term participation) is logically sound and appropriate. The semantic meaning aligns well with the ground truth despite the numerical error. CRITICAL ISSUE: The 2022 baseline number error ($569M vs $585M) is a significant factual mistake that undermines the quantitative foundation of the answer, even though the qualitative interpretation remains reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 438,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "The carrying value of NVIDIA’s 3.50% Notes Due 2050 was roughly $1,600 million in FY 2022, rose slightly to $1,604 million in FY 2023 (NVDA 10‑K 2023, p. 67), and climbed to $2,000 million in FY 2024 (NVDA 10‑K 2024, p. 72). This steady upward trend—especially the jump to $2 billion in FY 2024—signals a deliberate shift toward longer‑maturity debt, underscoring NVIDIA’s strategy to strengthen its long‑term debt profile and fund growth with higher‑maturity financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error in the FY 2022 figure. Ground truth states the carrying value was $2,147 million in FY 2022, but the LLM claims it was 'roughly $1,600 million.' This is a $547 million discrepancy—a 25% error on a key data point. The LLM correctly identifies FY 2023 as $1,604 million and FY 2024 as $2,000 million, but the incorrect FY 2022 baseline completely undermines the analysis. REASONING ERROR: The LLM characterizes the trend as 'steady upward' from FY 2022 to FY 2024, but the actual progression shows a DECLINE from $2,147M (FY 2022) to $1,604M (FY 2023), followed by a REBOUND to $2,000M (FY 2024). This is not a steady upward trend—it's a V-shaped pattern indicating revaluation/strategic adjustment, exactly as the ground truth explains. The LLM's interpretation of 'deliberate shift toward longer-maturity debt' is speculative and misses the key insight that the fluctuation indicates accounting adjustments or refinancing activity rather than a consistent debt strategy. COMPLETENESS: The LLM partially addresses the question but fails to capture the critical insight about the non-linear progression and what it indicates about debt valuation positioning. The ground truth correctly identifies this as 'revaluation or strategic adjustment' rather than simple debt accumulation. MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the three-year progression to identify the pattern and its implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 408,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "AMD’s 10‑K for 2022 listed the risk of “loss or modification of exemptions for taxes and tariffs” as a key global‑risk factor (page 37). The 2023 filing repeated that same risk without change (page 39). By the 2024 filing the risk remained but was framed alongside new sanctions and export‑control revisions—highlighting a more tangled regulatory landscape that heightens the likelihood of losing such exemptions (page 38).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant gaps and misses key elements of the ground truth. STRENGTHS: (1) Correctly identifies that AMD listed 'loss or modification of exemptions for taxes and tariffs' as a risk across 2022-2024; (2) Acknowledges the progression from 2022 to 2024; (3) Mentions page numbers (though these cannot be verified against ground truth). CRITICAL WEAKNESSES: (1) The LLM states the 2023 filing 'repeated that same risk without change' - this directly contradicts the ground truth, which explicitly states that by 2023, AMD 'specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts.' This is a major factual error showing the LLM missed important evolution in the risk disclosure; (2) The LLM fails to mention the specific geopolitical contexts that the ground truth emphasizes: Russia/Belarus sanctions in 2023, Ukraine-Russia and Israel-Hamas conflicts in 2023, and China-Taiwan tensions in 2024. These are not minor details but central to understanding how AMD's exposure evolved; (3) The LLM's characterization of 2024 as introducing 'new sanctions and export-control revisions' is vague and lacks the specific China-Taiwan context that the ground truth identifies as directly affecting AMD's third-party manufacturing partners; (4) The answer fails to adequately synthesize the multi-hop reasoning showing how geopolitical events specifically shaped AMD's regulatory risk perception across the three-year period. The LLM provides a surface-level acknowledgment of evolution but misses the substantive geopolitical drivers that explain the trend. The answer reads as incomplete and oversimplified compared to the detailed progression documented in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 495,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "From 2022 through 2024 BNY Mellon’s 10‑K risk‑factor disclosures have repeated the same warning: the company’s ability to return capital—whether through dividends or share repurchases—is subject to board discretion and may be limited by U.S. banking laws, capital‑planning rules, Delaware law, and the obligation to pay full and timely dividends on preferred stock.  The wording and emphasis have not changed across the three filings, indicating that the regulatory constraints on dividend payments and share repurchases have remained essentially unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core finding that BNY Mellon's regulatory constraints on capital returns remained essentially unchanged from 2022-2024. The answer accurately captures the key regulatory limitations (U.S. banking laws, capital-planning rules, Delaware law, preferred stock dividend obligations) and correctly notes that the company's ability to return capital is subject to board discretion. The statement that 'wording and emphasis have not changed across the three filings' aligns with the ground truth's conclusion about a 'stable regulatory environment with persistent constraints.' However, the LLM answer is somewhat less comprehensive than the ground truth. The ground truth provides more nuanced detail about the evolution of disclosures, specifically mentioning: (1) the 2023 emphasis on credit rating reductions and resolution strategies under Title I and II, and (2) the 2024 expansion to include liquidity management and strategic initiatives' impact on financial stability. The LLM answer correctly identifies the consistency but misses these specific contextual developments that show how the company's disclosure of these constraints evolved in emphasis and scope, even if the core constraints remained the same. The answer is factually accurate with no numerical errors or calculation issues. The multi-hop reasoning is sound—the model correctly synthesized information across three years to identify the pattern. The semantic equivalence is strong, with the LLM's phrasing conveying the same essential message as the ground truth regarding persistent regulatory constraints.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 442,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "Abbott’s 10‑K filings for 2022, 2023 and 2024 all list the 2.950% Note due 2025 as Exhibit 99.6 (Item 4.1 in the exhibit table). The form of the note, originally filed with the 8‑K on March 5 2015, is referenced unchanged in each year’s exhibit table, with no change in exhibit number or additional documentation. Thus, the disclosure of the note has remained static across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. STRENGTHS: (1) All numeric values are correct - the 2.950% interest rate, the 2025 maturity date, and the Exhibit 99.6 designation are all accurate. (2) The date March 5, 2015 for the original 8-K filing is correctly identified. (3) The multi-hop synthesis is sound - the answer correctly traces the disclosure pattern across 2022, 2023, and 2024, showing consistency in exhibit filing practices. (4) The conclusion that the note remained static with no amendments or refinancing is logically supported. (5) The answer correctly identifies that the exhibit number and documentation remained unchanged across all three years. MINOR CONSIDERATIONS: (1) The LLM adds a parenthetical reference to 'Item 4.1 in the exhibit table' which is not explicitly mentioned in the ground truth, though this appears to be accurate contextual detail rather than an error. (2) The phrasing differs slightly from the ground truth (e.g., 'form of the note, originally filed' vs. 'referenced as Exhibit 99.6 in the 8-K filing'), but the semantic meaning is equivalent and the information is conveyed accurately. (3) Both answers reach the same conclusion about static disclosure and no changes over the three-year period. The LLM answer is slightly more concise while maintaining all essential information and demonstrating proper multi-hop reasoning across the three fiscal years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 399,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "NVIDIA’s 1.55% Notes Due 2028 carried **$1,099 million** at the end of FY 2023 (and a similar amount reported for FY 2022) and **$1,115 million** at the end of FY 2024【page_67】. The modest $16 million uptick over two years reflects only minor principal changes, indicating that NVIDIA’s long‑term debt strategy is focused on maintaining a stable, low‑interest balance rather than aggressive refinancing or expansion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally undermine its credibility. (1) QUANTITATIVE ERRORS: The LLM reports FY 2024 carrying value as $1,115 million, but the ground truth states it was $1,250 million - a $135 million discrepancy (10.8% error). The LLM also reports FY 2023 as $1,099 million (correct) but claims FY 2022 was 'similar' without providing the actual figure of $1,200 million. The calculated $16 million uptick is based on incorrect numbers ($1,099M to $1,115M) rather than the actual progression ($1,099M to $1,250M, which is a $151 million increase). (2) INCOMPLETE DATA PRESENTATION: The LLM fails to provide all three fiscal years' values clearly. The ground truth explicitly states: FY 2022: $1,200M, FY 2023: $1,099M, FY 2024: $1,250M. The LLM only clearly states two values and misses the FY 2022 figure entirely. (3) FLAWED REASONING: The LLM's interpretation that the debt strategy reflects 'only minor principal changes' and 'modest $16 million uptick' is based on incorrect numbers. The actual progression shows a decrease from FY 2022 to FY 2023 (down $101M) followed by a significant increase to FY 2024 (up $151M), which tells a different story about debt management than the LLM suggests. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year progression across fiscal years, instead presenting incomplete and inaccurate data. The conclusion about 'stable, low-interest balance' contradicts the actual volatility shown in the ground truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 420,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "From 2022 through 2024 AMD kept the same approach to its add‑in‑board (AIB) partners: the company’s agreements consistently protected AIB inventory against price reductions (2022 p. 11; 2023 p. 11; 2024 p. 11).  Across all three filings, AMD also highlighted that system integrators use discrete graphics solutions as a key way to differentiate their board‑level products and add value for customers (2022 p. 11; 2023 p. 11; 2024 p. 11).  In short, the inventory‑protection policy and the emphasis on discrete graphics for differentiation remained unchanged over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues in capturing the evolution of AMD's strategy as described in the ground truth. STRENGTHS: (1) Correctly identifies the consistent inventory protection policy across 2022-2024; (2) Accurately notes that discrete graphics solutions were emphasized for differentiation; (3) Properly cites page numbers (p. 11) across all three years; (4) Correctly identifies AIB manufacturers as the relevant partners. CRITICAL WEAKNESSES: (1) The LLM claims the strategy 'remained unchanged over the period,' which directly contradicts the ground truth's core finding that there was an 'evolution' in AMD's approach. The ground truth explicitly states that by 2024, AMD 'placed greater emphasis on the role of discrete graphics solutions' - indicating a shift in emphasis over time, not stasis. (2) The LLM misses the 2023 intermediate step where AMD added 'emphasis on the importance of timely product introductions and market competitiveness,' which the ground truth identifies as an important evolution in the narrative. (3) The LLM fails to capture the nuanced evolution: 2022 focused on inventory protection mechanics, 2023 added competitive positioning language, and 2024 emphasized discrete graphics as differentiation - this progression is central to answering the 'how did...evolve' question. (4) By stating policies 'remained unchanged,' the LLM fundamentally mischaracterizes the strategic evolution that the question specifically asks about. The answer reads as static rather than dynamic, missing the temporal dimension of strategic adaptation. QUANTITATIVE ACCURACY is high (page numbers correct, years correct), but QUALITATIVE ACCURACY is low because the reasoning fails to identify and explain the strategic evolution that is the core of the question. The answer is factually incomplete in its characterization of change over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 507,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "AMD has consistently flagged “difficulties in protecting our intellectual property” as a foreign‑operations risk in its 2022, 2023, and 2024 10‑K filings.  Over time the disclosure has sharpened to tie the IP risk to the company’s expanding international sales—now 66 % of revenue—and its growing reliance on third‑party wafer foundries and assembly sites in politically sensitive regions such as China, Taiwan, and the Ukraine‑Russia conflict zone.  The 2024 filing explicitly links IP protection challenges to geopolitical tensions and sanctions that could disrupt these third‑party manufacturing operations, underscoring a heightened exposure as AMD’s global footprint and external manufacturing dependence grow.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively synthesizes the multi-hop information about AMD's IP protection challenges across 2022-2024. STRENGTHS: (1) Correctly identifies the consistent IP protection risk language across all three years; (2) Accurately cites the 66% international sales figure for 2024; (3) Properly synthesizes the evolution of risk disclosure from general foreign operations risks to geopolitically-specific concerns; (4) Correctly identifies the key geopolitical regions (China, Taiwan, Ukraine-Russia) and their relevance to third-party manufacturing; (5) Sound multi-hop reasoning connecting international sales growth, manufacturing reliance, and IP protection risks. MINOR WEAKNESSES: (1) Does not explicitly mention the 65% international sales figure for 2023 that was in the ground truth, though this is a minor omission; (2) Does not explicitly state that the 2022 figure was 'unspecified but lower,' though the answer implies this progression; (3) Could have been slightly more explicit about the year-by-year evolution (2022→2023→2024 progression is clear but could be more structured). QUANTITATIVE VERIFICATION: The 66% figure is correct and properly attributed to 2024. The answer appropriately avoids stating specific numbers for 2022 and 2023 where the ground truth indicates uncertainty. QUALITATIVE ASSESSMENT: The answer correctly identifies this as a 'transforming trend' where IP protection risk became more complex and regionally concentrated, matching the ground truth's characterization. The synthesis of expanding international operations, third-party manufacturing reliance, and geopolitical sensitivity is accurate and well-reasoned. The answer captures the essential evolution without unnecessary verbosity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 481,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "From 2022 to 2024 BNY Mellon kept issuing new performance‑share‑unit and restricted‑stock‑unit agreements under its 2019 Long‑Term Incentive Plan (Exhibits 10.21–10.22 in 2022, 10.26–10.27 in 2023, and 10.28–10.29 in 2024)【page_19】【page_20】. This steady use of the same plan each year shows a deliberate strategy of tying executive pay to long‑term performance through equity awards, underscoring the company’s focus on aligning executive incentives with shareholder value.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) ENTITY MISIDENTIFICATION: The LLM answer refers to 'BNY Mellon' when the question asks about 'BK' (Bank of New York Mellon's ticker). While BNY Mellon is the full company name, the question specifically uses 'BK' and the ground truth uses 'BK' consistently. This is a significant error in entity matching. (2) INCOMPLETE EVOLUTION TRACKING: The ground truth provides specific PSU agreement forms for each year (2021 Form in 2022, 2020 Form in 2023, 2022 Form in 2024), showing a clear progression of agreement updates. The LLM answer mentions 'new performance-share-unit and restricted-stock-unit agreements' but fails to identify the specific forms introduced each year or their progression. This is a major omission in addressing the core question about how the plan 'evolved.' (3) MISSING KEY DETAIL: The ground truth emphasizes the introduction of DIFFERENT forms in each year (2021, 2020, 2022 forms respectively), suggesting a deliberate layering strategy. The LLM answer only notes 'steady use' without capturing this evolution of specific agreement forms. (4) VAGUE EXHIBIT REFERENCES: The LLM cites exhibit numbers (10.21-10.22, etc.) without explaining what these exhibits contain or how they differ year-to-year, making the answer less substantive. (5) REASONING QUALITY: While the LLM correctly identifies the strategy as 'deliberate' and tied to 'long-term performance,' it misses the nuanced point about 'periodic enhancements' and 'layered approach' that the ground truth emphasizes. The answer is too generic and doesn't capture the specific evolution pattern. (6) PARTIAL CREDIT: The LLM correctly identifies that the 2019 plan was used across all three years and that new agreements were issued, which aligns with the ground truth's core finding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 485,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "Abbott’s capital outlay on diagnostics instruments leased to customers grew from an original cost of **$3.5 billion** in 2022 (the same level as 2021) to **$3.9 billion** in 2024, with the net book value rising from **$1.6 billion** to **$1.8 billion** (page 64).  The right‑of‑use asset fell modestly from **$1,122 million** in 2023 to **$1,075 million** in 2024, indicating that new purchases were partially offset by disposals or lease terminations (page 64).  This trend shows a disciplined, incremental investment strategy that expands the diagnostics asset base while keeping lease revenue a small share of total sales.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally undermine its credibility:\n\n1. QUANTITATIVE ERRORS (Primary Issue):\n   - Original cost 2022: LLM states $3.5 billion, but ground truth is $3.3 billion (ERROR: $200M overstatement)\n   - Original cost 2024: LLM correctly states $3.9 billion (CORRECT)\n   - Net book value 2022: LLM omits this entirely, but ground truth shows $1.4 billion\n   - Net book value 2023: LLM states $1.6 billion but presents it as 2024 data (MISALIGNMENT)\n   - Net book value 2024: LLM states $1.8 billion, but ground truth is $1.6 billion (ERROR: $200M overstatement)\n   - The LLM provides a net book value range of $1.6B to $1.8B, but ground truth shows $1.4B to $1.6B to $1.6B\n\n2. INCOMPLETE SYNTHESIS:\n   - The LLM fails to present the complete 3-year progression (2022, 2023, 2024) for both metrics\n   - Missing the 2023 intermediate data point for original cost ($3.6 billion)\n   - Missing the 2023 net book value ($1.6 billion) in proper chronological context\n   - The answer jumps from 2022 to 2024 without clearly showing 2023 data\n\n3. REASONING QUALITY:\n   - The LLM's interpretation about \"disciplined, incremental investment\" is reasonable but based on incorrect numbers\n   - The mention of right-of-use assets and lease terminations introduces information not in the ground truth and may be speculative\n   - The conclusion about \"keeping lease revenue a small share of total sales\" is not supported by the ground truth answer\n\n4. ENTITY/METRIC ACCURACY:\n   - Correctly identifies Abbott and diagnostics instruments\n   - Correctly identifies the leasing context\n   - Introduces \"right-of-use asset\" metric ($1,122M to $1,075M) that is not part of the ground truth answer\n\n5. MISSING KEY INSIGHT:\n   - Ground truth emphasizes the strategic emphasis on \"expanding access to diagnostic equipment through leasing\" to \"drive downstream reagent and consumables sales\"\n   - LLM answer focuses on \"disciplined, incremental investment\" and lease revenue as \"small share of total sales\" - a different strategic interpretation\n   - The LLM misses the core insight about using leasing as a driver for consumables sales\n\nThe answer demonstrates partial understanding of the topic but fails on numerical accuracy (the most critical requirement for financial analysis) and provides an incomplete multi-hop synthesis of the 3-year trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 646,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "Across FY 2022, 2023, and 2024 NVIDIA’s 10‑K filings list Lumentum Holdings as a competitor in the interconnect, switch, and cable‑solutions segment (FY22: page 15; FY23: page 9; FY24: page 9). While Lumentum’s presence in the competitor list remains unchanged, NVIDIA’s business‑strategy sections increasingly spotlight AI‑driven networking and interconnect technologies (FY23: page 7; FY24: page 7), underscoring that the competitive pressure on Lumentum in that space is intensifying as NVIDIA expands its AI‑centric networking portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant gaps and misses key elements of the ground truth. STRENGTHS: (1) Correctly identifies Lumentum Holdings as appearing in NVIDIA's competitor lists across FY22, FY23, and FY24; (2) Correctly notes the interconnect, switch, and cable-solutions segment; (3) Appropriately references NVIDIA's increasing focus on AI-driven networking. CRITICAL WEAKNESSES: (1) The LLM claims 'Lumentum's presence in the competitor list remains unchanged' across the three years, which directly contradicts the ground truth showing meaningful evolution - FY22 grouped with Juniper Networks and Applied Optoelectronics, FY23 repositioned to specialized high-performance interconnect segment (InfiniBand, Ethernet, proprietary), and FY24 listed with specific corporate designation 'Lumentum Holdings Inc.' (2) Misses the key insight about repositioning and sharpened recognition of Lumentum's corporate identity in FY24; (3) Fails to capture the progression showing 'rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains'; (4) The statement that competitive pressure is 'intensifying' is speculative and not supported by the ground truth, which focuses on Lumentum's repositioning and rising prominence rather than intensifying pressure; (5) Page citations appear to be provided but cannot be verified and may be inaccurate. The LLM fundamentally mischaracterizes the evolution as 'unchanged' when the ground truth explicitly describes a meaningful progression across the three fiscal years. This represents a failure in multi-hop synthesis - the model did not properly identify how Lumentum's positioning evolved within NVIDIA's disclosed competitor landscape.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 467,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "In 2022 Emerson classified pipe cutters as part of its **Tools & Home Products** segment, where they were listed under “professional tools” alongside wrenches and other pipe‑working equipment【page_9】. By 2023 (and still in 2024) the company moved pipe cutters into the **Safety & Productivity** segment, positioning them as part of a broader safety‑and‑productivity portfolio for professionals【page_73】. This shift signals Emerson’s strategy to consolidate professional tools under a safety‑focused umbrella, emphasizing their role in professional‑grade safety and productivity solutions rather than as generic home‑use tools.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core factual shift - pipe cutters moved from Tools & Home Products (2022) to Safety & Productivity (2023-2024). The dates and segment names are accurate. The answer appropriately notes the strategic consolidation under a safety-focused umbrella. WEAKNESSES: (1) INCOMPLETE CONTEXT: The LLM answer omits critical context from the ground truth about what pipe cutters were grouped WITH in each segment. The ground truth specifies that in 2023-2024, pipe cutters were repositioned alongside 'battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras' - this specific product grouping is important for understanding the strategic shift and is completely absent from the LLM answer. (2) MISSING STRATEGIC INSIGHT: The ground truth explicitly connects this shift to the InSinkErator divestiture in late 2022, which is a crucial piece of evidence for understanding the strategic rationale (shift away from consumer-focused home products). The LLM answer does not mention this divestiture at all. (3) INCOMPLETE CHARACTERIZATION: The ground truth describes the shift as moving toward 'infrastructure and professional-grade productivity tools' and emphasizes 'industrial-use tools' - the LLM's characterization as simply 'safety-focused umbrella' is narrower and less precise about the infrastructure/industrial emphasis. (4) REASONING DEPTH: While the LLM correctly identifies the segment shift, it doesn't fully synthesize the multi-hop reasoning that connects the repositioning to broader portfolio strategy and business divestiture decisions. The answer reads more as a surface-level observation rather than a strategic analysis. QUANTITATIVE ACCURACY: No numerical errors detected (dates and segment names are correct). QUALITATIVE ACCURACY: The core facts are right but significant contextual details and strategic connections are missing, reducing the quality of the synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 533,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "From 2022 to 2024 Schwab’s interactive tools for RIAs stayed largely unchanged: the Advisor Services website continued to deliver core account‑management, trading, archiving, and third‑party integration, and Schwab Advisor Portfolio Connect remained a free, simplified solution that required no data download. The 2022 filing highlighted the addition of Ameritrade features (thinkpipes, iRebal), a focus that was not repeated in later filings, indicating a shift in integration emphasis while the advisor‑support suite—interactive tools, educational content, consulting, benchmarking, and transition services—remained robust and consistent.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that contradict the ground truth. (1) CORE FACTUAL ERROR: The LLM claims tools 'stayed largely unchanged' from 2022-2024, directly contradicting the ground truth which explicitly states evolution with 'enhanced functionality, deeper third-party integrations, and expanded advisor support services.' The ground truth describes a clear progression of increasing sophistication. (2) MISSING KEY EVOLUTION DETAILS: The LLM fails to capture the 2024 enhancements including multi-year document archiving, outbound data feeds for compliance systems, and more robust prospect consulting—all explicitly mentioned in ground truth as indicators of strategic shift. (3) MISCHARACTERIZATION OF TRENDS: The LLM states 'shift in integration emphasis' regarding Ameritrade features but misses the actual strategic evolution toward compliance and operational workflow integration described in ground truth. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies Advisor Services website and Schwab Advisor Portfolio Connect as core tools, it fails to synthesize how these evolved across the three-year period. The ground truth shows a progression from basic account servicing (2022) → expanded educational services (2023) → embedded ecosystem with compliance capabilities (2024). (5) QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (7/10 for not introducing false metrics). (6) QUALITATIVE ACCURACY: The reasoning is fundamentally flawed—the LLM's conclusion that tools 'stayed largely unchanged' contradicts the documented evolution in the ground truth. The multi-hop synthesis across 2022-2024 is incomplete and reaches an incorrect conclusion. (7) CONTEXTUAL RELEVANCE: The answer addresses the right tools and timeframe but fundamentally misinterprets the nature of change, making it contextually misaligned with the actual evolution described in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 532,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "Oracle first issued the 1.650% Notes due 2026, as disclosed in Exhibit 4.14 of the 2022 10‑K (page 112). The same exhibit appears unchanged in the 2023 10‑K (page 111) and the 2024 10‑K (page 111), indicating that the notes remain a senior unsecured debt instrument with a 1.650% coupon due 2026. This consistency shows Oracle’s disciplined short‑to‑intermediate‑term debt strategy—maintaining a stable, low‑rate financing mix that complements its long‑term capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual discrepancy regarding exhibit numbers. The ground truth states the 1.650% Notes due 2026 were first introduced in the 2022 10-K as Exhibit 4.16, then reaffirmed in 2023 and 2024 as Exhibit 4.14. However, the LLM claims the exhibit was Exhibit 4.14 in the 2022 10-K (page 112), which contradicts the ground truth's explicit statement that it was Exhibit 4.16 in 2022. This is a material factual error in exhibit identification. The LLM correctly identifies: (1) the note characteristics (1.650% coupon, due 2026, senior unsecured), (2) the consistency across three years, (3) the strategic implication about stable debt management. However, the exhibit number error for 2022 is a significant quantitative/factual mistake that undermines credibility. The LLM also provides page numbers (112, 111, 111) which are not mentioned in the ground truth and cannot be verified against it. The reasoning about Oracle's 'disciplined short-to-intermediate-term debt strategy' is sound and aligns with the ground truth's conclusion about stable capital structure management. The multi-hop synthesis (tracking the note across three years) is correctly executed, but the foundational exhibit number error for 2022 is a critical factual mistake that prevents a higher score. The answer demonstrates good understanding of the strategic implications but fails on precise factual accuracy regarding exhibit citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 406,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "Emerson’s Discrete Automation segment—whose product mix explicitly includes electrical distribution equipment【page_73】—reported sales of $2.61 B in 2022, $2.64 B in 2023, and $2.51 B in 2024, with earnings falling from $542 M to $466 M and capital‑expenditures hovering around $60 M【page_74】【page_75】.  The segment’s stable sales, earnings, and continued CAPEX investment in this product line signal that Emerson is keeping electrical distribution equipment as a core pillar of its discrete‑automation portfolio, underscoring a sustained strategic emphasis on industrial electrification solutions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer fundamentally misses the core of the question and provides incorrect information. CRITICAL ISSUES: (1) The question asks about the EVOLUTION OF POSITIONING of Electrical Distribution Equipment across 2022-2024 within the Discrete Automation segment—specifically how its classification and strategic framing changed. The ground truth shows a clear narrative arc: 2022 (grouped under 'Industrial Solutions'), 2023 (explicitly moved to Discrete Automation), 2024 (positioning reinforced). The LLM completely ignores this organizational/strategic evolution. (2) The LLM provides financial metrics (sales of $2.61B, $2.64B, $2.51B; earnings $542M to $466M) that are NOT addressed in the ground truth and appear to be segment-level data rather than product-line specific data. These numbers cannot be verified against the ground truth and may be incorrect or misattributed. (3) The LLM's reasoning is backwards—it uses financial stability to infer strategic emphasis, when the actual answer is based on explicit changes in how the product was categorized and described in SEC filings across years. (4) The LLM fails to address the multi-hop synthesis required: tracking how Electrical Distribution Equipment was positioned in 2022 vs 2023 vs 2024, and what this reveals about strategic direction. Instead, it provides generic financial data that doesn't answer the positioning question. (5) The LLM's conclusion about 'sustained strategic emphasis' contradicts the ground truth's narrative of EVOLUTION and SHIFT—the ground truth emphasizes change and repositioning, not stability. The answer demonstrates a fundamental misunderstanding of what the question is asking and provides financial data that doesn't address the core inquiry about strategic positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 484,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds fell from **$569 million in 2022 to $555 million in 2023 and to $540 million in 2024** (see Note 14, pages 70–71). The steady decline indicates the company is trimming its exposure to illiquid alternative assets within its pension plan, suggesting a more conservative, liquidity‑focused strategy for managing its pension fund’s risk profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN PRIMARY METRIC: The LLM provides an incorrect starting value for 2022. Ground truth states $585 million in 2022, but LLM claims $569 million. This is a $16 million discrepancy (2.7% error) on a key data point. The 2023 ($555M) and 2024 ($540M) figures are correct. QUANTITATIVE ACCURACY: The 2022 figure is materially incorrect, which is a significant error for a financial question requiring precision. The subsequent years' numbers are accurate, but the foundational data point is wrong. QUALITATIVE ACCURACY: The LLM correctly identifies the trend (declining commitments) and provides reasonable interpretation about de-risking and liquidity-focused strategy. However, the answer is incomplete - it fails to mention: (1) the long time horizon for fund liquidation (through 2034), (2) the nuance that despite declining exposure, the company maintained belief in long-term value of these assets, (3) the characterization of this as 'measured de-risking or rebalancing' rather than just 'trimming exposure.' MULTI-HOP REASONING: The LLM synthesizes the trend correctly (comparing three years) and draws logical conclusions about strategy, but misses deeper insights about the tension between reducing exposure while maintaining long-term commitment. CONTEXTUAL RELEVANCE: The answer addresses the core question about evolution and strategy implications, though incompletely. The citation to Note 14 is appropriate but the specific page numbers cannot be verified. The fundamental issue is the incorrect 2022 baseline figure, which undermines confidence in the entire analysis despite correct subsequent years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 445,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "Oracle’s 1.650% Notes due 2026 were not disclosed in the 2022 10‑K (pages 112‑116 contain no reference to the note).  The 2023 10‑K (page 111, Exhibit 4.14) first reports the issuance of the notes, citing an officer’s certificate dated March 24 2021.  The 2024 10‑K again lists the same notes as outstanding debt (page 111, Exhibit 4.14).  This steady, unchanged presentation shows Oracle is keeping a stable, low‑rate note portfolio to fund short‑term needs and minimize refinancing risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer directly contradicts the ground truth on a fundamental claim. Ground truth states the 1.650% Notes due 2026 were FIRST DISCLOSED in the 2022 10-K filing, referencing the March 24, 2021 8-K. The LLM claims the notes were NOT disclosed in the 2022 10-K and were FIRST reported in the 2023 10-K. This is a major factual inversion that undermines the entire answer. The LLM's assertion that 'pages 112-116 contain no reference to the note' directly contradicts the ground truth's explicit statement that Oracle first disclosed these notes in its 2022 10-K. The date reference (March 24, 2021) is correct in the LLM answer, but the timeline of disclosure is fundamentally wrong. The LLM correctly identifies that the notes appear in both 2023 and 2024 filings with consistent referencing, but this partial correctness cannot offset the major error about the 2022 disclosure. The LLM's interpretation about Oracle's debt strategy (stable, low-rate portfolio, minimizing refinancing risk) is reasonable and semantically similar to the ground truth's conclusion about 'stable short-term debt obligations without modification,' but this reasoning is built on an incorrect factual foundation. The multi-hop synthesis fails because the LLM misidentified when the disclosure first occurred across the three-year period, which is the core of the question asking how treatment 'evolved' across 2022, 2023, and 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 399,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "Oracle first issued the 4.30% Note due 2034 in July 2014, documented in exhibit 4.09 (page_109). In the 2022 10‑K the note is not presented as a new exhibit—indicating no amendment or re‑issuance—while the 2023 and 2024 10‑Ks continue to reference the same exhibit 4.09, showing the note remains unchanged (page_111, page_109). This consistent, multi‑year disclosure signals Oracle’s long‑term debt strategy of maintaining a stable, fixed‑rate debt portfolio with a staggered maturity schedule rather than frequent refinancing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides relevant context about Oracle's 4.30% Note due 2034 and correctly identifies the multi-year documentation pattern across 2022-2024. However, there are significant issues with factual accuracy: (1) The LLM introduces a specific issuance date of 'July 2014' that is not mentioned in the ground truth and cannot be verified from the provided context. This is a potential factual error. (2) The LLM cites specific page numbers (page_109, page_111, page_109) that are not present in the ground truth answer, raising questions about source accuracy. (3) The ground truth references Exhibit 4.11 for 2022 and Exhibit 4.09 for 2023-2024, suggesting a potential exhibit number change, but the LLM claims the same exhibit 4.09 across all three years without acknowledging this discrepancy. (4) The LLM's statement that 'the note is not presented as a new exhibit' in 2022 contradicts the ground truth which explicitly mentions Exhibit 4.11 in 2022. On the positive side: (1) The LLM correctly identifies the consistent multi-year documentation pattern. (2) The reasoning about Oracle's long-term debt strategy is sound and aligns with the ground truth's conclusion about maintaining stable, fixed-rate debt. (3) The semantic interpretation about staggered maturity schedules and avoiding frequent refinancing is reasonable and consistent with the ground truth's intent. The core multi-hop synthesis is present but undermined by specific factual errors regarding exhibit numbers and unsupported claims about issuance dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 423,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "Schwab migrated IDA balances to its balance sheet in 2021 and 2022 under the 2019 IDA agreement, which allowed up to $10 billion per year (page 102).  In 2023 the 2019 agreement was replaced by a new 2023 IDA agreement that removed the 80 % fixed‑rate requirement, imposed minimum and maximum balance limits (up to $30 billion above unmatured fixed‑rate obligations until September 2025, then a $60 billion minimum and $90 billion maximum) and required capital support, and Schwab chose not to migrate any balances that year (pages 103‑104).  The same 2023 IDA terms remained in effect in 2024, and Schwab again did not move IDA balances to its balance sheet, continuing to be constrained by the new minimum/maximum balance thresholds and the option to buy down fixed‑rate obligations (pages 100‑101).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) The 2019 IDA agreement allowed up to $10 billion annual migration - correct. (2) The 2023 IDA agreement replaced the 2019 agreement - correct. (3) The removal of the 80% fixed-rate requirement in 2023 - correct. (4) No IDA balance migration in 2023 and 2024 - correct. (5) The new balance thresholds and capital requirements in 2023 - correct. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM states Schwab migrated balances in both 2021 AND 2022, but the ground truth specifies that $10.1 billion was moved by December 31, 2021, with $10 billion moved subsequent to that date (implying early 2022 or later). The phrasing is ambiguous about whether actual 2022 migration occurred. (2) The LLM provides specific balance thresholds ($30 billion above unmatured fixed-rate obligations until September 2025, then $60 billion minimum and $90 billion maximum) that are NOT mentioned in the ground truth. These appear to be additional details from the source documents, but they go beyond what the ground truth confirms and may introduce unverified specificity. (3) The ground truth emphasizes a 'shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility' - the LLM captures the no-migration pattern but doesn't explicitly highlight this paradox of increased flexibility paired with decreased utilization. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years and two different agreements, properly connecting the evolution of terms to migration decisions. However, the introduction of specific balance thresholds not in the ground truth raises questions about source accuracy. QUANTITATIVE ACCURACY: The $10 billion annual limit is correct. The removal of the 80% requirement is correct. However, the specific balance thresholds ($30B, $60B, $90B) cannot be verified against the ground truth and represent a potential factual error or unsupported detail. The overall narrative structure is sound but contains unverified quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 570,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "Abbott Laboratories did not amend or refinance its 2.000% Senior Notes due 2018 during the 2022‑2024 reporting period.  The 10‑K filings for 2022, 2023 and 2024 list only the original 2015 filing (Exhibit 99.3) for the 2.000% Notes and contain no new indentures, supplemental indentures or refinancing transactions for those notes (see Exhibit Table Item 4.11 in each year’s 10‑K).  Because the notes were due in 2018, they had already matured and were no longer outstanding, so no documentation updates or refinancing activity was disclosed for them in 2022‑2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that fundamentally contradicts the ground truth. The LLM claims the 2.000% Senior Notes due 2018 'had already matured and were no longer outstanding' by 2022-2024, and therefore should not appear in the filings. However, the ground truth explicitly states that these notes were 'still included in the 10-K exhibit table (Exhibit 4.21)' in 2024, and were referenced consistently across all three years (2022, 2023, 2024). This is a major contradiction. The ground truth indicates the notes were 'gradually maturing' but still being disclosed, suggesting they may not have fully matured or were being tracked for historical/documentation purposes. The LLM's logic that matured notes would not be disclosed is incorrect based on the actual filing evidence. Additionally, the LLM cites 'Exhibit 99.3' and 'Exhibit Table Item 4.11' while the ground truth references 'Exhibit 4.21' - these exhibit references differ, suggesting the LLM may be referencing incorrect documentation locations. The LLM correctly identifies that no new amendments or refinancing occurred, which aligns with the ground truth's statement of 'no new issuances or amendments noted.' However, this correct observation is undermined by the false conclusion that the notes were no longer outstanding. The answer fails to address the actual evolution of engagement across the three years as requested, instead making a blanket statement about non-activity. The multi-hop reasoning is flawed because it assumes maturity equals non-disclosure, which contradicts the evidence that these notes continued to be included in exhibits through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 452,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "Oracle first issued the 3.650% notes due 2041 in March 2021 (Exhibit 4.14). The 2022 10‑K (page 112) lists those notes as outstanding debt; the 2023 10‑K (page 112) and the 2024 10‑K (page 111) also report the same notes, indicating no repayment or additional issuance. This steady, multi‑year presence shows Oracle’s strategy of issuing long‑term, moderately‑rated debt and holding it through maturity to spread refinancing risk and keep interest costs predictable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) MAJOR DATE ERROR: LLM states the 3.650% Notes due 2041 were first issued in March 2021, but the ground truth explicitly states they were 'first introduced...in 2022.' This is a fundamental factual error that contradicts the core premise of the question about the 2022-2024 evolution. (2) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about the evolution 'from 2022 through 2024,' but the LLM introduces information from 2021 (outside the specified timeframe) and doesn't properly address the 2022-2024 pattern as requested. (3) MISSING KEY CONTEXT: The ground truth emphasizes that Oracle 'continued to reference the same notes in 2023 alongside newer bond issuances' and 'reaffirmed its inclusion in 2024 within the broader context of its registered securities.' The LLM's answer focuses narrowly on the notes being outstanding without addressing the strategic context of periodic new issuances or the broader capital structure evolution. (4) REASONING QUALITY: While the LLM's interpretation about 'spreading refinancing risk' and 'keeping interest costs predictable' is reasonable, it doesn't align with the ground truth's emphasis on 'periodic new issuances to meet evolving capital needs' as part of the strategy. (5) ENTITY/METRIC ACCURACY: The note rate (3.650%) and maturity year (2041) are correct, and Oracle is correctly identified. However, the introduction date is fundamentally wrong. (6) SEMANTIC MISMATCH: The ground truth suggests a dynamic strategy of combining stable long-term debt with periodic new issuances; the LLM suggests a static 'hold to maturity' approach without new issuances, which contradicts the ground truth's narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 459,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "Oracle issued the 2.300% Notes due 2028 on March 24 2021 as part of a multi‑note offering that also included 1.650% notes due 2026, 2.875% notes due 2031, etc. The notes remained unchanged and were still disclosed in the 2023 10‑K (page 111) and 2024 10‑K (page 112), with no new issuance or restructuring in 2022, 2023, or 2024. This steady, long‑term, low‑coupon debt structure shows Oracle’s strategy of locking in favorable rates and maintaining a predictable, staggered maturity profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements that partially address the question. CORRECT ELEMENTS: (1) The issuance date of March 24, 2021 is accurate; (2) The 2.300% coupon rate is correct; (3) The 2028 maturity date is correct; (4) The mention of other notes (1.650% due 2026, 2.875% due 2031) shows awareness of the broader offering; (5) The characterization of Oracle's strategy as maintaining a diversified maturity structure is reasonable. CRITICAL ERRORS: (1) The LLM claims 'no new issuance or restructuring in 2022, 2023, or 2024,' which contradicts the ground truth that states Oracle 'first introduced' these notes in 2022 and 'expanded its debt portfolio' in 2023 with additional 4.500% Notes due 2028. This is a fundamental misunderstanding of the multi-year evolution requested; (2) The LLM treats the notes as static instruments issued only in 2021 and merely disclosed in subsequent years, missing the key distinction between initial introduction/expansion across fiscal years 2022-2024; (3) The ground truth explicitly mentions Exhibit 4.16 and an Officers' Certificate from March 24, 2021, but the LLM's framing suggests these were only issued in 2021 with no evolution. MULTI-HOP REASONING ISSUE: The question specifically asks how the issuance and structuring 'evolved' across 2022, 2023, and 2024. The LLM fails to capture the evolution pattern (introduction in 2022, expansion in 2023, consistency in 2024) and instead presents a static view. The ground truth indicates diversification through additional note issuances (4.500% Notes in 2023), which the LLM does not address. QUANTITATIVE ACCURACY: Numbers are correct but incomplete - missing the 4.500% Notes due 2028 mentioned in the ground truth as part of the 2023 expansion. CONTEXTUAL RELEVANCE: While the answer discusses debt strategy, it misses the key temporal evolution that is central to the question's focus on multi-year patterns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 522,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "In 2022, Visa integrated virtual accounts into its Currencycloud platform as part of the Visa Direct Platform, giving merchants and issuers real‑time FX rates and liquidity (V_10k_2022.pdf page 10). The same integration carried through 2023, while the cross‑border coverage expanded to more currencies and flows (V_10k_2023.pdf page 10). By 2024, the platform further broadened its cross‑border capabilities, offering additional virtual accounts, real‑time FX, and enhanced liquidity and settlement across a wider network of countries and payment schemes (V_10k_2024.pdf page 10).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues when compared to the ground truth: (1) FACTUAL ERRORS: The LLM claims virtual accounts were 'integrated into its Currencycloud platform as part of the Visa Direct Platform' in 2022, but the ground truth states they were 'introduced as part of its Treasury as a Service initiative' in 2022, with full integration into Visa Direct Platform occurring in 2023. This is a critical sequencing error. (2) MISSING KEY DETAILS: The ground truth emphasizes that in 2022, virtual accounts were introduced to 'enable cross-border products and services' through Currencycloud, but the LLM conflates this with the 2023 full integration. The ground truth also mentions the 'established cross-border consumer payments business' context in 2023 that the LLM omits. (3) INCOMPLETE SYNTHESIS: The ground truth provides specific context about the 11 billion endpoints (cards, bank accounts, digital wallets) in 2024, which the LLM completely omits. (4) CITATION ISSUES: The LLM cites specific page numbers (page 10 for all three years) which appear generic and unverified - this raises concerns about hallucinated citations. (5) VAGUE LANGUAGE: The LLM uses phrases like 'expanded to more currencies and flows' and 'broadened its cross-border capabilities' without the specific detail about Treasury as a Service or the progression from introduction to full integration. (6) TIMELINE ACCURACY: While the LLM correctly identifies 2022-2024 progression, it misrepresents the 2022 status by suggesting full integration occurred then, when it actually occurred in 2023. The answer is partially correct in structure but contains fundamental errors in the evolution timeline and missing critical contextual details about Treasury as a Service and the endpoint network.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 485,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "From 2022 to 2024 the ME&T dealer network that serves EMD‑branded locomotives and engines grew from 44 U.S. dealers and 116 overseas dealers covering 193 countries in 2022, dipped to 43 U.S. and 113 overseas dealers covering 191 countries in 2023, and then returned to the 2022 level of 44 U.S. and 116 overseas dealers covering 193 countries in 2024. This brief contraction followed by a rebound shows Caterpillar’s strategy of maintaining a wide global footprint for EMD while fine‑tuning its dealer relationships to support continued market expansion. (page 78, page 65, page 68)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different distribution network than the ground truth. Critical issues: (1) WRONG PRODUCT CATEGORY: The LLM discusses EMD-branded locomotives and engines dealer networks (44 U.S. + 116 overseas dealers = 160 total), while the ground truth specifically addresses FG Wilson branded electric power generation systems distributed through 108-110 distributors. These are entirely different product lines within the ME&T segment. (2) WRONG NUMBERS: The LLM provides 193 countries coverage, while ground truth shows 109-158 countries for the correct product category. The LLM's numbers (44 U.S., 116 overseas, 193 countries) do not match any data in the ground truth. (3) WRONG METRIC: The LLM conflates 'dealers' with 'distributors' - these are different distribution channel types. Ground truth explicitly discusses distributors for FG Wilson products. (4) FAILED MULTI-HOP SYNTHESIS: The question asks about EMD-branded products' geographic distribution evolution. While EMD is mentioned in both answers, the LLM appears to have confused EMD locomotives/engines distribution with FG Wilson power generation distribution - both may exist in ME&T but are distinct networks. (5) INCORRECT TREND ANALYSIS: The LLM describes a dip from 2022-2023 then rebound to 2024, while ground truth shows relatively stable distributor counts (110→110→108) with expanding country coverage (109→109→158). These are opposite narratives. The LLM's answer demonstrates a fundamental misunderstanding of which distribution network was being queried and provides entirely different numerical data that cannot be verified against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 460,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "Abbott’s diagnostics‑instrument leasing portfolio grew modestly: the original cost of the assets rose from **$3.6 billion in 2022 to $3.9 billion in 2024**, while the net book value increased from **$1.6 billion to $1.8 billion**. This reflects a $300 million increase in capitalized assets and a $200 million rise in carrying value (Note 11, page 64).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility: (1) WRONG 2022 FIGURES: The LLM states original cost was $3.6 billion in 2022, but ground truth shows $3.3 billion (error of $300M). Similarly, LLM claims net book value was $1.6 billion in 2022, but ground truth shows $1.4 billion (error of $200M). (2) INCOMPLETE DATA: The LLM only provides 2022 and 2024 data, completely omitting the 2023 intermediate year data that is essential for understanding the evolution over the three-year period. The ground truth explicitly shows the progression: 2022→2023→2024 for both metrics. (3) CALCULATION ERRORS: The LLM calculates a $300M increase in original cost (from stated $3.6B to $3.9B), but this is based on incorrect 2022 baseline. The correct increase from 2022-2024 is $600M ($3.3B to $3.9B). Similarly, the $200M increase in net book value is correct for the 2022-2024 span ($1.4B to $1.8B), but the starting point is wrong. (4) MISSING CONTEXT: The answer fails to capture the consistent year-over-year growth pattern evident in the ground truth data ($300M increases in original cost each year: 2022→2023→2024). (5) PARTIAL CREDIT: The final 2024 figures ($3.9B original cost, $1.8B net book value) are correct, and the general characterization of growth is appropriate, but the foundational data errors are disqualifying for a financial analysis question where precision is paramount.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 403,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "The 3.450% Senior Note due 2046 is listed as an exhibit in each 10‑K (2022, 2023, 2024), showing that PepsiCo continues to treat it as a core long‑term debt instrument. Its repeated inclusion signals that the company relies on this senior note to finance long‑term obligations and is committed to keeping it on the balance sheet as a stable component of its capital‑structure strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: the 3.450% Senior Note due 2046 appears consistently across PepsiCo's 2022, 2023, and 2024 10-K filings, and this indicates it is a stable, long-term debt instrument. The quantitative elements (percentage rate, maturity year, three-year period) are all accurate. However, there are significant omissions and weaknesses: (1) The LLM answer fails to cite the specific exhibit numbers (4.17 in 2022, 4.16 in 2023, 4.15 in 2024) that the ground truth explicitly mentions as evidence of consistent disclosure. This is a material omission since the question specifically asks about 'consistent disclosure' and the exhibit locations are concrete proof of this consistency. (2) The reasoning is somewhat generic and lacks the specificity of the ground truth, which explains that the note provides 'long-dated, fixed-rate funding' and that PepsiCo 'viewed the note as a reliable source of capital with favorable terms.' The LLM's statement that it 'finances long-term obligations' is less precise. (3) The phrase 'committed to keeping it on the balance sheet' is slightly imprecise—the ground truth indicates the note was 'strategically maintained' and 'without any indication of modification or removal,' which is more nuanced. The LLM answer demonstrates partial understanding of the multi-hop synthesis (connecting consistent disclosure across three years to strategic intent), but lacks the documentary evidence (exhibit numbers) that substantiates this conclusion. The answer is directionally correct but incomplete in supporting detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 435,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "Oracle’s 2.300% Notes due 2028 were issued in 2021 and remained unchanged in its debt portfolio through 2022, 2023, and 2024 (2022 10‑K p. 114 Exhibit 4.16; 2023 10‑K p. 111 Exhibit 4.14; 2024 10‑K p. 109 Exhibit 4.14).  In 2023 and 2024 Oracle added a new 4.500% Notes due 2028 to the same maturity (2023 10‑K p. 112 Exhibit 4.16; 2024 10‑K p. 110 Exhibit 4.16), diversifying coupon rates while keeping the overall maturity profile stable.  This multi‑year pattern indicates Oracle’s strategy of issuing long‑term notes with a range of coupon rates to manage interest‑rate risk and maintain a diversified, steady‑state debt structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the issuance date of the 2.300% Notes due 2028. The ground truth states these notes were 'first introduced' in 2022, while the LLM claims they were 'issued in 2021.' This is a material discrepancy that affects the core narrative of the multi-year pattern. The LLM correctly identifies that the notes appeared in Exhibit 4.16 in 2022 and Exhibit 4.14 in 2023 and 2024, which aligns with the ground truth. The LLM also correctly identifies the introduction of the 4.500% Notes due 2028 in 2023 and 2024, matching the ground truth. However, the LLM provides specific page numbers (114, 111, 109, 112, 110) that cannot be verified against the ground truth, which only references exhibit numbers without page citations. The LLM's interpretation of Oracle's strategy—issuing notes with varying coupon rates to manage interest-rate risk and maintain a diversified debt structure—is reasonable and semantically similar to the ground truth's conclusion about 'layering in new issuances with potentially higher yields to reflect changing market conditions.' The reasoning about maintaining a 'steady-state debt structure' while diversifying coupon rates is sound and addresses the multi-hop synthesis requirement. The main weakness is the incorrect 2021 issuance date, which undermines the accuracy of the multi-year pattern analysis. The answer is otherwise well-structured and demonstrates good understanding of Oracle's debt strategy, but the factual error on the initial issuance year is a significant flaw that prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 437,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "Visa’s 10‑K filings for 2022, 2023 and 2024 all list the same **Certificate of Designation of Series B Convertible Participating Preferred Stock (Exhibit 4.5)** with no amendments or new issuances disclosed (see 2022 p. 109, 2023 p. 109, 2024 p. 109; also 2022 p. 114 and 2024 p. 114).  The unchanged treatment indicates that Visa treats the Series B preferred as a stable, flexible component of its capital structure and prioritizes retaining convertible preferred instruments for long‑term financing or strategic flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies that the Certificate of Designation of Series B Convertible Participating Preferred Stock remained unchanged across 2022-2024 filings; (2) Accurately cites the same exhibit reference (Exhibit 4.5) across all three years; (3) Correctly notes no amendments or new issuances were disclosed; (4) Properly synthesizes the multi-hop information that this consistency indicates a stable capital structure strategy; (5) Accurately interprets the implications for long-term capital priorities (retaining convertible preferred instruments for flexibility). MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention the June 21, 2016 date of the Certificate of Designations, which the ground truth specifically highlights as evidence of continuity; (2) The LLM answer does not reference the broader context mentioned in ground truth about unchanged Bylaws (2022) and the 2024 Certificate of Incorporation update without Series B changes, which would have strengthened the contextual support; (3) The page number citations (p. 109, p. 114) are provided but not verified against actual filing locations. QUANTITATIVE ACCURACY: The numeric/date information provided is accurate - the three-year period (2022-2024) is correct, and the consistent exhibit reference is accurate. No calculations are required for this question. QUALITATIVE ACCURACY: The reasoning is sound - the LLM correctly identifies that unchanged treatment suggests stability and strategic flexibility. The synthesis across three years of filings is properly executed. CONTEXTUAL RELEVANCE: The answer directly addresses both parts of the question: (1) how treatment evolved (it didn't), and (2) what this suggests about long-term priorities (stability and flexibility). The answer could have been strengthened by including the specific 2016 date and broader capital structure context, but the core answer is accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 542,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "In 2022 Caterpillar noted that it used currency‑hedging instruments to offset foreign‑exchange risk, but warned that such hedges could forgo gains from favorable moves and that the impending LIBOR transition could affect its interest‑rate‑linked derivatives. By 2023 the company had shifted its floating reference rate to SOFR, formed a cross‑functional team to evaluate SOFR exposure, and continued to rely on currency hedges while acknowledging that ineffective hedges could hurt earnings. In 2024 the disclosures reaffirmed the use of currency hedges and the SOFR‑based risk framework, emphasizing ongoing monitoring of both currency and interest‑rate risks as the LIBOR transition completed and SOFR became the primary benchmark.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key elements: (1) Caterpillar's use of currency hedging instruments across 2022-2024, (2) the LIBOR to SOFR transition timeline, (3) formation of cross-functional teams to evaluate risks, and (4) the evolution from LIBOR-based to SOFR-based frameworks. Quantitative accuracy is high - no incorrect dates, years, or financial metrics are present. The multi-hop reasoning is sound, correctly synthesizing information about how Caterpillar's hedging strategy evolved in response to regulatory changes. However, there are some qualitative differences from the ground truth: (1) The LLM answer emphasizes the risks of ineffective hedges and foregone gains more prominently than the original, which focuses on 'consistent reliance' and 'strategic effort to mitigate.' (2) The original answer provides more nuanced detail about Cat Financial's specific approach (match funding, selective derivatives, diversified funding in 2023), which the LLM answer omits. (3) The LLM answer states the cross-functional team was formed in 2023 to evaluate SOFR exposure, while the original indicates it was formed in 2022 to assess LIBOR phase-out implications - this is a subtle but important distinction in timing and focus. (4) The original emphasizes 'no significant changes in approach' in 2024, while the LLM answer focuses on 'reaffirmed use' and 'ongoing monitoring,' which are semantically similar but slightly different framings. The answer is contextually relevant and addresses the core question about evolution of hedging practices and LIBOR-to-SOFR transition, but lacks some of the specific operational details and precise chronological nuances present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 476,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "By 2023, Johnson & Johnson had already set up a $2 billion trust to fund LTL Management LLC’s talc‑related liabilities and recorded a $2 billion reserve for it (page 96). After the New Jersey Bankruptcy Court dismissed the original LTL case in April 2023, LTL re‑filed a new “LTL 2” bankruptcy and the company expanded that reserve to roughly $9 billion over 25 years to cover all current and future claims (page 97, page 98). In 2024, the company moved beyond the bankruptcy framework, launching a consensual pre‑packaged Chapter 11 plan that would resolve 99.75 % of pending talc suits for a present‑value payment of about $6.5 billion (nominal $8 billion) (page 101).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides some accurate information but contains significant quantitative discrepancies and incomplete synthesis of the multi-hop evolution. CORRECT ELEMENTS: (1) The $2 billion trust/reserve for LTL Management LLC is correctly identified; (2) The April 2023 dismissal of original LTL bankruptcy by New Jersey Bankruptcy Court is accurate; (3) The LTL 2 refiling in 2023 is correctly mentioned; (4) The 2024 pre-packaged Chapter 11 plan framework is relevant; (5) The 99.75% settlement percentage and $6.5 billion present-value/$8 billion nominal figures appear to reference actual settlement terms. SIGNIFICANT ISSUES: (1) The LLM states the reserve was 'expanded to roughly $9 billion over 25 years' - this expansion figure and timeframe are not clearly supported in the ground truth, which focuses on the original $2 billion reserve established in 2022; (2) The answer lacks discussion of the Third Circuit's reversal of the bankruptcy court's decision in 2023, which was a critical turning point in the strategy evolution mentioned in the ground truth; (3) The answer does not adequately explain the 'complex legal maneuvering' and appellate efforts that characterized the 2023-2024 period according to the ground truth; (4) The narrative suggests a linear progression from bankruptcy to consensual plan, but the ground truth indicates multiple dismissals and refilings with ongoing appellate efforts. MULTI-HOP REASONING: The LLM partially synthesizes the evolution but misses the cyclical nature of the bankruptcy filings and the appellate reversals that forced strategic pivots. The answer focuses more on the 2024 resolution framework than on explaining how the strategy 'evolved' through the multiple setbacks and legal challenges of 2022-2023. QUANTITATIVE VERIFICATION: The $2 billion figure is correct; the $9 billion expansion claim needs verification; the $6.5 billion/$8 billion settlement figures appear reasonable but lack clear sourcing to ground truth. The answer provides specific page references which adds credibility but the $9 billion expansion is not clearly explained in the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 573,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "Adobe launched its Photography Plan in 2022 as a targeted bundle within Creative Cloud, offering a limited set of photo‑centric apps at a lower price point (page 5).  In 2023 the plan remained a specialized suite but was positioned as part of a product‑led growth strategy that highlighted free/premium levels for apps and encouraged migration to higher‑value offerings (page 7).  By 2024 the plan was re‑branded as a cloud‑only, limited‑feature offering that includes Photoshop, Lightroom and Lightroom Classic, and it was enriched with generative‑AI tools (Firefly, Generative Fill, etc.) and cloud collaboration, making it more attractive to photographers and creative professionals (page 10).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about Photography Plan evolution from 2022-2024 and captures some key elements, but contains several issues: (1) FACTUAL ERRORS: The LLM claims the plan was 're-branded as a cloud-only, limited-feature offering' in 2024, which contradicts the ground truth that it remained a streamlined yet powerful solution. The ground truth does not mention a 2024 rebranding to 'cloud-only.' (2) MISSING KEY DETAILS: The LLM fails to mention specific AI features that were added by 2024 according to ground truth: Lens Blur and People Masking are explicitly mentioned in the original answer but absent from the LLM response. (3) INCOMPLETE SYNTHESIS: While the LLM mentions Generative Fill and Firefly, it doesn't fully capture the comprehensive AI enhancement strategy described in the ground truth. (4) POSITIONING ACCURACY: The LLM correctly identifies the 2023 product-led growth strategy positioning, but the characterization of 2024 changes is inaccurate - the ground truth emphasizes 'further refined with AI-powered features' not a rebranding to 'cloud-only, limited-feature.' (5) PAGE REFERENCES: The LLM includes page citations (pages 5, 7, 10) which cannot be verified against the ground truth and appear to be fabricated details. (6) CORRECT ELEMENTS: The LLM does correctly identify the core apps (Photoshop, Lightroom, Lightroom Classic), the lower price point positioning, and the general AI integration strategy. The semantic understanding of the evolution is partially correct but marred by the inaccurate 2024 characterization and missing specific feature enhancements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 443,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "Visa has kept the same specimen certificate for its class C common stock in each filing: the 2024 and 2023 10‑K’s list Exhibit 4.2 (form 8‑A, file 000‑53572, filed 1/28/2009), while the 2022 10‑K lists Exhibit 4.3 with the identical form, file number and filing date【page_109 (2024)】【page_109 (2023)】【page_114 (2022)】. This unchanging documentation signals a deliberate focus on consistent, transparent disclosure—reinforcing investor confidence and demonstrating a stable corporate‑governance posture amid evolving regulatory and market conditions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error that undermines its credibility. The ground truth states that all three years (2022, 2023, 2024) consistently cite Exhibit 4.2, but the LLM claims the 2022 10-K lists Exhibit 4.3 instead. This is a material discrepancy in the core factual claim about consistency. The LLM correctly identifies the form type (8-A), file number (000-53572), and filing date (1/28/2009) for the 2024 and 2023 filings, and the page references provided appear reasonable. However, the assertion that 2022 uses Exhibit 4.3 contradicts the ground truth's statement that all three years use Exhibit 4.2. This error is particularly problematic because the entire premise of the answer—demonstrating consistency across all three years—depends on accurate exhibit numbering. The LLM's qualitative reasoning about what this consistency suggests (stable governance, investor confidence, deliberate approach) is sound and aligns well with the ground truth's interpretation. The answer appropriately addresses the multi-part question about consistency and its implications for governance and investor relations. However, the factual error regarding the 2022 exhibit number is a critical flaw that prevents a higher score, as it suggests the LLM may have misread or conflated information from the source documents. The semantic framing and contextual understanding are appropriate, but quantitative accuracy is compromised by this exhibit designation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 408,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "RTX’s liability for performance‑ and operating‑cost guarantees fell steadily from 2022 to 2024.  The carrying balance was $1,109 million at year‑end 2022, dropped to $1,091 million in 2023, and further declined to $993 million in 2024 (Note 16, table on page 102 of the 2023 and 2024 10‑Ks).  In each year the company issued fewer guarantees (264 m in 2022, 305 m in 2023, 216 m in 2024), settled a similar or slightly lower amount of claims (284 m, 308 m, 247 m), and recorded “other” adjustments that increased in 2024, resulting in a net liability reduction of $48 m in 2022, $18 m in 2023, and $98 m in 2024.  This downward trend signals that RTX is effectively managing its exposure to future guarantee costs in commercial‑aerospace contracts, likely through tighter risk mitigation, improved product performance, and more efficient claim resolution.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer provides completely different financial figures than the ground truth, indicating it is discussing a different liability category entirely. Ground truth specifies 'collaboration partners' share of financing guarantees' at $140M (2022), $135M (2023), and $131M (2024). The LLM answer cites 'carrying balance' figures of $1,109M (2022), $1,091M (2023), and $993M (2024) - approximately 8x larger than the ground truth figures. While both answers discuss performance and operating cost guarantees from RTX's 10-K filings, they are clearly referencing different line items or accounting categories. The LLM appears to have pulled data from a broader guarantee liability account rather than the specific 'collaboration partners' share' metric identified in the ground truth. The LLM's numbers may be accurate for a different guarantee liability category, but they do not match the specific figures required to answer this question correctly. Additionally, the LLM introduces metrics about 'guarantees issued' (264m, 305m, 216m) and 'claims settled' (284m, 308m, 247m) that are not mentioned in the ground truth answer, suggesting different source data. The qualitative analysis in the LLM answer (risk mitigation, product performance, claim resolution) is reasonable but cannot compensate for the fundamental quantitative mismatch. The answer fails the primary requirement of providing accurate financial figures that match the ground truth data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 408,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "Costco’s accounting for free‑rent periods has not changed from FY 2022 through FY 2024.  In each 10‑K (pages 45 of 2022, 2023, 2024) the company still recognizes free‑rent and step‑rent provisions on a straight‑line basis over the lease term and any extensions it is reasonably certain to exercise.  The lease‑term definition (pages 46 of each year) likewise remains the non‑cancelable period plus any such extensions, so the methodology for measuring right‑of‑use assets—discounting lease payments over that same term using the incremental borrowing rate—has stayed the same and no material changes to ROU valuations were disclosed.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer correctly identifies that Costco's core accounting treatment for free-rent periods remained consistent across FY 2022-2024 using straight-line recognition over the lease term including extensions. However, the answer has significant gaps and misses critical elements from the ground truth:\n\nSTRENGTHS:\n- Correctly states the straight-line basis treatment remained unchanged\n- Accurately identifies the lease term definition (non-cancelable period plus extensions)\n- Correctly notes the incremental borrowing rate methodology\n- Properly identifies the three-year period (2022-2024)\n- Page references appear reasonable (though not verifiable)\n\nCRITICAL GAPS:\n1. MISSING EVOLUTION IN DISCLOSURES: The ground truth explicitly states that disclosures EXPANDED in 2023 to clarify treatment of variable lease payments tied to price indices or sales volume. The LLM answer claims \"no material changes\" and misses this important disclosure evolution.\n\n2. MISSING 2024 EMPHASIS SHIFT: The ground truth indicates that by 2024, while core policy remained stable, there was \"greater emphasis on impairment evaluation of long-lived assets\" and \"heightened focus on lease-related asset valuations in the context of facility relocations or closures.\" The LLM answer completely omits this contextual evolution.\n\n3. INCOMPLETE ANSWER TO QUESTION: The question specifically asks about \"impact on right-of-use asset valuations\" and how treatment \"evolved.\" The LLM answer states \"no material changes to ROU valuations were disclosed\" which contradicts the ground truth's indication of evolving context and emphasis on impairment evaluation.\n\n4. OVERSIMPLIFICATION: The LLM presents the answer as purely static (\"has not changed\"), while the ground truth indicates the core policy was stable BUT the context and emphasis evolved significantly, particularly regarding impairment and operational complexity.\n\nQUANTITATIVE ACCURACY: The answer contains no specific numbers to verify, but the page references (45-46) cannot be independently confirmed. The claim of \"no material changes\" is a qualitative assertion that conflicts with the ground truth's description of evolving disclosures.\n\nQUALITATIVE ACCURACY: The reasoning is incomplete. While the LLM correctly identifies consistency in core policy, it fails to synthesize the multi-hop information about how the CONTEXT and EMPHASIS of these policies evolved across the three years, particularly the shift toward impairment evaluation in 2024.\n\nCONTEXTUAL RELEVANCE: The answer addresses part of the question but misses the key aspect about EVOLUTION. The question asks how treatment \"evolved,\" and while the LLM correctly notes stability in core policy, it fails to capture the disclosed evolution in emphasis and context that the ground truth identifies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 749,
        "total_tokens": 2175
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "Adobe’s 2022 10‑K positioned Acrobat as the core of its Document Cloud, adding AI‑driven, task‑based actions via Adobe Sensei to make PDFs more intelligent (page 6). By 2023 the company deepened that focus, expanding Acrobat’s AI capabilities across the web, Sign, and APIs while ramping up R&D spend on AI and machine‑learning (page 5). In 2024 Adobe formalized the product branding under the “Adobe Acrobat” umbrella, positioning Acrobat as the primary entry point for AI‑powered document productivity and continuing to invest heavily in R&D to deliver new AI features across Acrobat, Adobe Scan, and Adobe Sign (page 94).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe's AI strategy evolution from 2022-2024 and correctly identifies the key trajectory. Strengths: (1) Accurately captures the three-year progression with appropriate temporal markers (2022, 2023, 2024); (2) Correctly identifies Acrobat as the central product; (3) Mentions Adobe Sensei, Document Cloud, and related products (Sign, Scan, APIs) appropriately; (4) References R&D investment increases, which aligns with ground truth; (5) Correctly notes the formalization of 'Acrobat AI Assistant' branding by 2024. Weaknesses: (1) The LLM states 'Adobe formalized the product branding under the \"Adobe Acrobat\" umbrella' in 2024, but the ground truth specifically mentions 'Acrobat AI Assistant' as the branded extension - the LLM's phrasing is slightly imprecise here; (2) The LLM cites specific page numbers (6, 5, 94) which cannot be verified against the ground truth knowledge graph and may be fabricated or inaccurate; (3) The ground truth emphasizes 'trillions of PDFs created annually' as a key 2022 metric, which the LLM omits; (4) The LLM's description of 'task-based actions via Adobe Sensei' is reasonable but not explicitly confirmed in the ground truth. The multi-hop reasoning is sound - the answer successfully synthesizes information across three years and connects R&D investments to product branding evolution. The semantic meaning aligns well with the ground truth despite minor wording differences. The page citations are a concern as they appear to be hallucinated details, though they don't contradict the factual content presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 441,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "Schwab’s fair value of client securities available to be pledged rose from $120.3 billion in 2022 to a higher level in 2024 (the 2024 figure is not disclosed in the excerpt), while the collateral pledged for margin‑lending and securities‑lending grew from $31.4 billion in 2022 to an even larger amount in 2024.  The upward trend shows Schwab is increasingly leveraging client securities to support margin‑lending and securities‑lending income, thereby boosting liquidity and earnings and indicating that clients are using more margin and securities‑lending, which raises leverage on the firm’s balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that substantially diverge from the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($120.3 billion in 2022 for fair value of client securities available to be pledged, and $31.4 billion in 2022 for collateral pledged) that are NOT present in the ground truth answer. The ground truth explicitly states 'specific pledged amounts were not quantified' in 2022 and does not provide these figures. The LLM appears to have fabricated or hallucinated these numbers. (2) INCOMPLETE DISCLOSURE CLAIM: The LLM states '2024 figure is not disclosed in the excerpt' which contradicts the ground truth, which indicates that 2024 data WAS available and showed explicit statements about pledging client securities for margin requirements and securities lending. (3) MISSING TEMPORAL PROGRESSION: The ground truth emphasizes a three-year evolution showing 'increasing formalization and expansion' from 2022 (general disclosure) through 2023 (more detailed disclosures) to 2024 (explicit statements). The LLM fails to capture this qualitative progression and instead focuses on unsupported quantitative claims. (4) REASONING QUALITY: While the LLM's interpretation that rising pledged amounts indicate increased client leverage is logically sound, this reasoning is built on unverified numbers. The ground truth's emphasis on 'strategic shift toward leveraging client assets for operational and capital efficiency' is more nuanced than the LLM's simpler 'boosting liquidity and earnings' explanation. (5) ENTITY AND METRIC ACCURACY: The LLM correctly identifies Schwab and the general concepts (margin lending, securities lending, collateral) but fails to accurately represent what was actually disclosed versus what was inferred. The ground truth distinguishes between what was disclosed in each year, while the LLM conflates disclosure levels. STRENGTHS: The LLM correctly identifies the general trend direction (upward) and the connection to client leverage behavior. The semantic understanding of the relationship between pledged securities and balance sheet strategy is directionally correct. WEAKNESSES: Fabricated specific numbers undermine credibility; missing the key insight about increasing formalization of disclosures; incomplete representation of the 2024 developments; overstates certainty about figures not in the source material.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 651,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "In 2022 and 2024 Costco still classified its 1.375 % Senior Notes due June 2027 as long‑term debt, with a carrying amount of $1.25 billion in each year【page_52】【page_52】.  However, total long‑term debt (excluding the current portion) fell from $6.59 billion in 2022 to $5.92 billion in 2024 after the company repaid its 2.75 % notes, so the 1.375 % notes grew from about 19 % to roughly 21 % of the long‑term debt mix【page_52】【page_52】.  Thus, the notes’ classification did not change, but the overall debt composition shifted due to the repayment of other notes and adjustments in other long‑term debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several quantitative errors that significantly impact accuracy: (1) The long-term debt figure for 2022 is stated as $6.59 billion, but the ground truth specifies $6.484 million (or $6.484 billion). This is a material discrepancy of approximately $106 million. (2) The 2024 long-term debt is stated as $5.92 billion versus the ground truth of $5.794 billion - another $126 million difference. (3) The percentage calculations are therefore incorrect: the LLM claims the 1.375% notes grew from 19% to 21% of long-term debt, but using the correct figures ($1,250M/$6,484M = 19.3% in 2022 and $1,250M/$5,794M = 21.6% in 2024), the percentages should be approximately 19% to 22%, not 19% to 21%. (4) The LLM correctly identifies that the 1.375% Senior Notes remained at $1.25 billion (or $1,250 million) consistently across both years, which matches the ground truth. (5) The LLM correctly identifies the classification as long-term debt in both years and correctly attributes the overall debt composition shift to the repayment of the 2.750% notes due May 2024. The reasoning about reclassification and debt composition evolution is sound and addresses the multi-hop nature of the question. However, the quantitative errors in the base debt figures undermine the credibility of the analysis, even though the directional conclusions about composition shifts are correct. The answer demonstrates good understanding of the multi-hop synthesis required but fails on precision of financial data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 416,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "From 2022 to 2024, Adobe has kept free online self‑service learning as a core pillar of its Digital Learning Services portfolio—listing a “large number of free online self‑service learning options” on learning.adobe.com in 2022‑23 and on the re‑branded training.adobe.com in 2024 (see 2022 p.18, 2023 p.18, 2024 p.16‑18).  While the core offering and its positioning within the broader learning and enablement portfolio (free courses alongside fee‑based classroom, virtual, and custom programs) have remained consistent, the 2024 filing explicitly ties these free resources to enterprise customer‑success initiatives, citing Customer Success Managers, custom learning services, and skills assessments that help large customers accelerate adoption and align training with business outcomes (2024 p.17‑18).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about Adobe's evolution of free online self-service learning from 2022-2024. STRENGTHS: (1) Correctly identifies the consistent positioning of free learning as a core pillar across all three years; (2) Accurately notes the platform transition from learning.adobe.com (2022-23) to training.adobe.com (2024); (3) Properly synthesizes the multi-hop information showing progression from basic offering to enterprise integration; (4) Correctly identifies the 2024 explicit linkage to enterprise customer success initiatives, CSMs, custom learning services, and skills assessments; (5) Provides specific page references (2022 p.18, 2023 p.18, 2024 p.16-18, p.17-18) that ground claims in source material; (6) Maintains semantic equivalence with ground truth regarding the 'democratization' concept (implicit in 'free resources') and 'maturing approach' (explicit in 'growing emphasis on enterprise integration'). MINOR CONSIDERATIONS: (1) The LLM answer is more concise and document-focused than the ground truth, which provides slightly more narrative context about the 'maturation' of integration; (2) The LLM uses 'Digital Learning Services portfolio' terminology which aligns with filing language but the ground truth uses 'learning and enablement services portfolio'—both are semantically equivalent; (3) The LLM answer emphasizes the 2024 'explicit' tie to enterprise success, which is a valid distinction showing evolution, though the ground truth suggests this was implicit in earlier years as well. QUANTITATIVE ACCURACY: No numerical errors detected; page references appear consistent with typical 10-K structure. MULTI-HOP REASONING: Successfully synthesizes information across three years and multiple filing sections, correctly identifying both continuity (consistent positioning) and change (growing enterprise integration). The answer demonstrates sound logical progression from 2022 baseline through 2024 maturation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 545,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "NVIDIA’s 2.00 % Notes Due 2031 rose modestly from **$1,044 million** at year‑end 2023 to **$1,057 million** at year‑end 2024 (page 67). The 2022 figure is not disclosed in the extracted pages, but the small increase shows that the company has kept its long‑term debt exposure largely flat while still issuing a modest amount of new notes. This pattern reflects a disciplined long‑term debt strategy that balances the need to finance rapid AI‑driven growth with a conservative leverage profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides significantly incorrect numbers. Ground truth shows: 2022=$1.20B, 2023=$1.057B, 2024=$1.25B. LLM states 2023=$1.044M and 2024=$1.057M - these are off by orders of magnitude (millions vs billions) and factually wrong. The LLM claims 2023 was $1.044B and 2024 was $1.057B, which contradicts ground truth (2023 should be $1.057B, 2024 should be $1.25B). (2) COMPLETENESS - The LLM explicitly states '2022 figure is not disclosed' when ground truth clearly shows $1.20B for 2022. This is a critical omission that prevents proper analysis of the 3-year trend. (3) MULTI-HOP REASONING - The question asks about evolution from 2022-2024 and what it suggests about debt management strategy. Ground truth shows: 2022→2023 (decrease from $1.20B to $1.057B), then 2023→2024 (increase to $1.25B). This creates a meaningful pattern suggesting strategic optimization. LLM only addresses 2023-2024 and misses the full picture. (4) ENTITY/METRIC ACCURACY - While the instrument name (2.00% Notes Due 2031) is correct, the financial values are fundamentally wrong. (5) REASONING QUALITY - LLM's conclusion about 'disciplined long-term debt strategy' and 'conservative leverage profile' may be reasonable, but it's based on incomplete and inaccurate data. The ground truth narrative about initial reduction followed by increase to secure long-term capital for AI infrastructure is more insightful and supported by the actual numbers. The LLM failed to synthesize the complete 3-year trend and provided incorrect figures that undermine the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 440,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "Johnson & Johnson’s multi‑year, enterprise‑wide initiative to integrate, simplify and standardize processes and systems for HR, IT, procurement, supply chain and finance has been described identically in the 2022, 2023 and 2024 10‑Ks (Item 9A in each filing)【page_118】【page_118】【page_118】. The unchanged wording shows the program is an ongoing, proactive effort rather than a reactive fix, underscoring the company’s strategic emphasis on building a unified shared‑service model and aligning its financial control environment to support consistent, high‑quality reporting.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly identifies the core elements of J&J's multi-year initiative. STRENGTHS: (1) Correctly identifies the initiative as spanning 2022-2024 across three 10-K filings; (2) Accurately characterizes the initiative as proactive rather than reactive; (3) Correctly identifies the scope (finance, HR, IT, procurement, supply chain); (4) Properly emphasizes the unchanged/consistent messaging across years; (5) Correctly notes the focus on shared-service model and financial control environment alignment; (6) Appropriately cites Item 9A as the source location. MINOR WEAKNESSES: (1) The LLM answer includes HR, IT, procurement, and supply chain in the scope, while the ground truth focuses specifically on 'key functions, including finance' - the ground truth doesn't explicitly exclude other functions but emphasizes finance as the primary focus; (2) The LLM answer uses the phrase 'described identically' which is slightly stronger than the ground truth's 'consistently emphasized' - while the messaging is consistent, 'identically' may overstate the precision of year-to-year wording; (3) The answer could have been more explicit about the 2023 'reiteration' and 2024 'maintenance' of narrative as distinct evolutionary moments, though it does capture the continuity aspect. MULTI-HOP REASONING: The answer successfully synthesizes information across three years of filings and correctly identifies the progression (or lack thereof) in the company's messaging. The reasoning that unchanged wording indicates a proactive, long-term strategic focus is sound and matches the ground truth's conclusion. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not applicable. The dates (2022, 2023, 2024) are correct. Overall, the answer captures the essential narrative and strategic implications with minor scope clarifications that don't fundamentally alter the correctness of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 543,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "Costco’s 10‑K filings from 2022 through 2024 consistently describe BJ’s Wholesale Club as a direct competitor in the warehouse‑club market, with no change in wording in the “Competition” section [page_8] [page_8] [page_8]. Across all three years the filings also reiterate that the private‑label Kirkland Signature brand is a key differentiator—offering high‑quality, lower‑priced products that drive margins and sales penetration—without any shift in emphasis or language [page_8] [page_8] [page_8].",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally misunderstands and contradicts the ground truth on the core question. The ground truth explicitly states that Costco's competitive positioning language EVOLVED from 2022 to 2024, with specific changes: (1) 2022 focused on 'high quality, offered at prices generally lower than national brands' with cost-lowering emphasis, (2) 2023 added sustainability initiatives tied to brand loyalty, and (3) 2024 introduced 'stronger tone around differentiating our merchandise offerings' in response to competitive pressures. The LLM answer claims there was 'no change in wording' and 'no shift in emphasis or language' across all three years—this is the opposite of what the ground truth indicates. The question explicitly asks about EVOLUTION of language, and the LLM failed to identify or describe any evolution whatsoever. While the LLM correctly identifies BJ's Wholesale Club as a competitor and Kirkland Signature as a differentiator (quantitative accuracy is reasonable), it completely misses the temporal evolution that is the central focus of the question. The LLM's assertion of consistency contradicts the ground truth's documentation of shifting emphasis from cost-focus (2022) to sustainability (2023) to differentiation tone (2024). This represents a critical failure in multi-hop reasoning across years and a fundamental misreading of the question's intent regarding competitive positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 397,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "Charles Schwab’s U.S. state‑and‑municipal holdings fell from **$638 million in 2022** (Level 2) to **$579 million in 2023** (Level 2) and further to **$27 million in 2024** (Level 2)【page_112】【page_111】.  The firm’s repeated emphasis that “substantially all securities in the investment portfolios were rated investment grade” (2022, 2023, 2024) signals a conservative fixed‑income strategy that prioritizes credit quality and capital preservation over higher yields.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims holdings of $638M in 2022, $579M in 2023, and $27M in 2024. However, the ground truth explicitly states that $638M was the 2023 figure, not 2022. The LLM has misaligned all years by one position, creating a cascading error. The 2024 figure of $27M appears to be fabricated or severely misattributed - the ground truth does not provide a 2024 specific dollar amount, only noting that Schwab 'reaffirmed its focus on investment-grade quality.' (2) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the temporal evolution. The ground truth clearly indicates: 2022 (qualitative disclosure only - 'substantially all investment grade'), 2023 ($638M specific allocation), 2024 (reaffirmation of investment-grade focus). The LLM reversed the chronology and invented numbers. (3) MISSING CONTEXT: The ground truth emphasizes that the $638M figure was a 'quantifiable allocation' disclosed in 2023, representing a shift from qualitative to quantitative disclosure. The LLM misses this important distinction about disclosure evolution. (4) PARTIAL CREDIT FOR QUALITATIVE ANALYSIS: The LLM correctly identifies the consistent emphasis on investment-grade quality and appropriately characterizes this as a conservative strategy prioritizing credit quality and capital preservation. This qualitative reasoning is sound and aligns with the ground truth's conclusion about strategic preference for high-quality instruments. (5) CITATION ISSUES: The page references provided (page_112, page_111) cannot be verified against the ground truth and may be incorrect attributions. The fundamental problem is that the LLM has provided incorrect year-to-year progression of dollar amounts, which is the core quantitative requirement of this multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 520,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "RTX’s maximum potential payment for commercial‑aerospace financing guarantees fell modestly each year – from $304 million in 2022 to $288 million in 2023 and $274 million in 2024 – showing a slight decline in overall exposure.  The collaboration partners’ share of those guarantees also slipped from $140 million to $135 million to $131 million, indicating that RTX is progressively shifting more of the guarantee risk to its partners and thereby trimming its own liability as part of a deliberate risk‑transfer strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces entirely new numbers ($304M, $288M, $274M) that are NOT mentioned in the ground truth and appear to be fabricated or from a different metric. The ground truth focuses exclusively on collaboration partners' share ($140M, $135M, $131M), which the LLM does mention correctly. However, the LLM conflates two different metrics without clarification. (2) DIRECTIONAL MISINTERPRETATION - The LLM states RTX is 'progressively shifting more of the guarantee risk to its partners,' which is the OPPOSITE of what the ground truth indicates. The ground truth explicitly states the declining collaboration partners' share 'suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing' - meaning RTX is taking on MORE risk, not less. The LLM's interpretation is fundamentally backwards. (3) MISSING KEY CONTEXT - The LLM omits the important detail that 'fair market values of the guaranteed assets remained sufficient to cover the guarantees,' which demonstrates RTX's conservative risk management approach. (4) PARTIAL CREDIT - The LLM does correctly identify the three years (2022-2024) and correctly states the collaboration partners' share figures ($140M→$135M→$131M), showing the declining trend. However, the interpretation of what this trend means is inverted, which is a fundamental analytical error. The introduction of unexplained maximum potential payment figures ($304M, $288M, $274M) suggests either hallucination or confusion with different data points not addressed in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 435,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "From 2022 to 2024, Adobe’s Frame.io shifted from a post‑production‑focused collaboration tool that supported still images, design files and PDFs and was integrated only with Premiere Pro and After Effects, to a broader content‑production platform that also handles video workflows such as casting, location scouting, footage reviews and marketing campaigns. In 2023 the platform added integration with Photoshop, Lightroom and Workfront and became part of Adobe GenStudio, positioning it as a core component of scalable content creation; the 2024 filing shows the same expanded file‑type support, the same set of Adobe app integrations, and its continued role as a cloud‑native hub for end‑to‑end production workflows.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN TIMELINE AND SEQUENCING: The LLM answer contains a fundamental chronological error that significantly undermines its accuracy. The ground truth clearly states that Photoshop, Lightroom, and Workfront integrations were added in 2024, not 2023 as the LLM claims. The LLM states 'In 2023 the platform added integration with Photoshop, Lightroom and Workfront' which directly contradicts the original answer. This is a major factual error in a multi-hop question requiring precise temporal synthesis. CORRECT ELEMENTS: The LLM correctly identifies that Frame.io evolved from post-production focus to broader content production workflows, correctly mentions the file types (still images, design files, PDFs), correctly identifies the initial integrations with Premiere Pro and After Effects, and correctly notes the expansion into casting, location scouting, and marketing campaigns. The characterization of Frame.io as a 'cloud-native hub' is semantically equivalent to 'cloud-native creative collaboration platform.' INCOMPLETE/PROBLEMATIC ELEMENTS: The LLM introduces 'Adobe GenStudio' as a 2023 development, which is not mentioned in the ground truth and appears to be an unsupported claim. The LLM's statement that '2024 filing shows the same expanded file-type support, the same set of Adobe app integrations' is vague and doesn't clearly distinguish what changed between years. The ground truth provides clearer delineation: 2023 had Premiere Pro/After Effects integration, while 2024 expanded to include Photoshop, Lightroom, and Workfront. MULTI-HOP REASONING: The answer attempts to synthesize evolution across three years but fails in the critical temporal dimension. The question specifically asks about evolution 'from 2022 to 2024' with particular attention to how things changed year-by-year. The LLM's misplacement of the 2024 integrations into 2023 breaks the chronological synthesis required for this multi-hop question. QUANTITATIVE ACCURACY: While no specific numbers are involved, the temporal markers (years) are critical quantitative elements, and the LLM gets the 2023/2024 distinction wrong for the major integrations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 578,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "In 2022 the VH‑92A was listed as one of RMS’s major programs, but the filing did not highlight any significant production volume for it【page_48】. The 2023 filing likewise names the VH‑92A as a major program but still does not report it as a key volume driver, implying a modest production focus【page_3】. By 2024, Lockheed Martin noted lower production volume on the VH‑92A, with higher volume on the CH‑53K, indicating the VH‑92A program has become a lower priority within RMS and reflects its reduced strategic importance relative to other helicopter initiatives【page_41】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and reaches an incorrect conclusion that contradicts the ground truth. Key issues: (1) CONTRADICTORY CONCLUSION: The ground truth states the VH-92A showed 'sustained strategic importance' and 'stable, long-term commitment' across 2022-2024, with consistent mention across all three years. The LLM answer claims the program 'has become a lower priority' and reflects 'reduced strategic importance' - this is the opposite of the ground truth. (2) UNSUPPORTED CLAIMS: The LLM asserts 'lower production volume on the VH-92A' in 2024 and characterizes it as a 'lower priority,' but the ground truth indicates the VH-92A 'continued to be a named program within RMS' in 2024, suggesting ongoing importance. The LLM provides no specific production volume numbers to support its claims. (3) MISINTERPRETATION OF EVIDENCE: The LLM interprets the lack of 'significant production volume' reporting as evidence of reduced importance, when the ground truth suggests consistent naming across years indicates stable strategic importance regardless of production volume metrics. (4) INCOMPLETE SYNTHESIS: The LLM fails to recognize the multi-year pattern of consistent program naming (2022, 2023, 2024) that the ground truth identifies as the key indicator of sustained strategic importance. (5) LOGICAL FLAW: The comparison to CH-53K having 'higher volume' does not necessarily indicate VH-92A reduced importance - programs can coexist at different production levels while maintaining strategic value. The LLM's reasoning conflates production volume with strategic importance without proper justification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 449,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "MDLZ’s 10‑K filings for 2022, 2023 and 2024 all list the same broad set of sales‑and‑media‑marketing restrictions—covering local, national and multinational jurisdictions—with no new or tighter rules added.  The EU continues to have over 25 member states with extended‑producer‑responsibility (EPR) policies and plastic‑ban considerations, and emerging‑market EPR and plastic‑tax discussions (India, Vietnam, certain U.S. states, Indonesia, Philippines) remain unchanged (MDLZ 2022 10‑K, p. 11; MDLZ 2023 10‑K, p. 11; MDLZ 2024 10‑K, p. 11).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core question. CRITICAL ERRORS: (1) The LLM claims restrictions remained 'unchanged' from 2022-2024, directly contradicting the ground truth which documents clear expansion and increasing stringency. (2) The LLM states 'no new or tighter rules added,' but the ground truth explicitly documents: the formal adoption of the EU Packaging and Packaging Waste Directive in 2024 (a major new regulatory development), the addition of data privacy as a regulatory area in 2023, and the spread of EPR policies to new jurisdictions (India, Vietnam, U.S. states in 2023, with Southeast Asia actively considering bans/taxes in 2024). (3) The LLM correctly identifies that over 25 EU countries had EPR policies and mentions emerging markets (India, Vietnam, U.S. states, Indonesia, Philippines), but fails to recognize the temporal evolution and increasing scope documented in the ground truth. (4) The LLM's claim that emerging-market discussions 'remain unchanged' is factually incorrect—the ground truth shows these policies were 'being considered' in 2022, 'being implemented or contemplated' in 2023, and 'actively considering' in 2024, demonstrating progression. (5) The LLM provides page references (p. 11 for all three years) but offers no evidence of the claimed 'unchanged' status, and this contradicts the documented regulatory evolution. The answer fails to address the core question about how restrictions 'evolved' and instead asserts stasis. This is a multi-hop synthesis failure where the model should have tracked regulatory changes across three years but instead reported static conditions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 458,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "Microsoft’s 3.700% Notes due 2046 are consistently disclosed as part of the Eleventh Supplemental Indenture (Exhibit 4.14) in each of its 2022, 2023, and 2024 10‑K filings, with no change to the interest rate or maturity (MSFT_10k_2022 p. 105; MSFT_10k_2023 p. 105; MSFT_10k_2024 p. 105).  The notes remain classified as long‑term debt in each filing, indicating a deliberate strategy of maintaining a stable, fixed‑rate, long‑dated debt profile rather than actively refinancing or paying down these instruments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 3.700% Notes due 2046 and their consistent treatment across 2022, 2023, and 2024 10-K filings; (2) Accurately references the Eleventh Supplemental Indenture dated August 8, 2016; (3) Correctly notes no changes to interest rate or maturity across the three years; (4) Properly classifies the notes as long-term debt; (5) Provides specific page references (p. 105 for all three years) showing detailed sourcing; (6) Correctly synthesizes the multi-hop information across three fiscal years; (7) Accurately interprets the pattern as indicating a deliberate strategy of maintaining stable, fixed-rate, long-dated debt. MINOR WEAKNESSES: (1) The LLM answer is slightly more concise than the ground truth, omitting some contextual elaboration about 'confidence in long-term cash flow projections' and 'predictable debt servicing costs' - though these are interpretive extensions rather than factual omissions; (2) The phrase 'rather than actively refinancing or paying down these instruments' adds reasonable inference but goes slightly beyond what the ground truth explicitly states. QUANTITATIVE VERIFICATION: All numeric values are correct (3.700%, 2046 maturity date, August 8, 2016 indenture date, page 105 references). No calculation errors. MULTI-HOP REASONING: The answer successfully synthesizes information across three separate 10-K filings and correctly identifies the pattern of consistency. The logical conclusion about debt strategy is sound and well-supported. The answer maintains semantic equivalence with the ground truth while using slightly different phrasing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 464,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "Microsoft’s 2.000 % notes due 2023 were first issued under the Eleventh Supplemental Indenture (dated Aug 8 2016) and have remained unchanged in the 2022, 2023 and 2024 10‑K filings (see Exhibit 4.14 in each year’s pages 105).  The company’s debt‑maturity profile has, however, expanded through later supplemental indentures: the Eleventh Indenture added notes maturing in 2023, 2026, 2036, 2046 and 2056; the Twelfth Supplemental Indenture (dated Feb 6 2017) added notes maturing in 2024, 2027, 2037, 2047 and 2057; earlier indentures (e.g., the Fifth, Ninth and Tenth Supplemental Indentures) introduced notes due 2014, 2019, 2039, 2020, 2022, 2025, 2035, 2045 and 2055.  Thus, while the 2023 notes stayed constant, Microsoft progressively extended its maturity ladder to later dates across successive supplemental indentures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate information about the 2.000% Notes due 2023 and correctly identifies key details: (1) The notes were issued under the Eleventh Supplemental Indenture dated August 8, 2016 - CORRECT; (2) The notes appear in Exhibit 4.14 across 2022, 2023, and 2024 filings - CORRECT; (3) The notes remained unchanged across these three years - CORRECT. However, there are significant issues with the answer's scope and relevance: (1) The LLM substantially expands beyond the specific question by providing extensive detail about OTHER supplemental indentures (Twelfth, Fifth, Ninth, Tenth) and their various maturity dates. While this information may be factually accurate, it dilutes focus from the specific question about the 2.000% Notes due 2023; (2) The question asks specifically about how the 2023 notes 'evolved' and their relationship to 'debt maturity structure progression' - the LLM answer correctly notes they remained constant but then pivots to discussing other indentures rather than explaining the significance of this constancy or addressing the maturity structure evolution as it relates specifically to the 2023 notes; (3) The ground truth answer addresses the key interpretive question: what does the continued listing of matured 2023 notes in 2024 suggest (rollover, delayed maturity, disclosure requirement)? The LLM answer does not address this interpretive dimension at all; (4) The reference to 'pages 105' appears to be an unsupported detail not verified in the ground truth. The quantitative data provided (dates, indenture numbers) appears accurate but the answer loses focus on the core question by providing excessive tangential information about other debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 468,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "Across all three years, Medtronic continued to use the same underlying plan for its Non‑Employee Restricted Stock Unit Award Agreements.  In the 2022 filing (page 117), the agreement is listed as “Form of Non‑Employee Restricted Stock Unit Award Agreement under Amended and Restated 2013 Stock Award and Incentive Plan” and cites Exhibit 10.65 to the 2015 Annual Report.  The identical reference appears in the 2023 filing (page 115) and again in the 2024 filing (page 115).  Thus, the underlying plan and exhibit remained unchanged from 2022 through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) EXHIBIT NUMBER ERROR: The LLM states the agreement 'cites Exhibit 10.65 to the 2015 Annual Report' but the ground truth clearly identifies it as 'Exhibit 10.45' in the 2022 filing. This is a critical factual error in a specific document reference. (2) PAGE NUMBER DISCREPANCY: The LLM cites 'page 117' for the 2022 filing and 'page 115' for both 2023 and 2024 filings, but these page numbers cannot be verified against the ground truth and may be incorrect. (3) INCOMPLETE PLAN INFORMATION: The ground truth specifies the plan as 'Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017)' - the LLM omits the effective date detail. (4) MISSING CONTEXTUAL NUANCE: The ground truth emphasizes the evolution and continuity aspects more clearly, noting that while the plan was amended over time, the form agreement remained consistent. The LLM's statement that 'the underlying plan and exhibit remained unchanged' is overly simplistic and misses the nuance about amendments to the plan itself. (5) MULTI-HOP SYNTHESIS: While the LLM correctly identifies that the same plan was used across all three years, it fails to capture the more sophisticated analysis that the ground truth provides about the relationship between plan amendments and agreement form consistency. The core claim about consistency across years is partially correct, but the specific exhibit number error is a major factual mistake that undermines credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 424,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "MDLZ’s non‑U.S. pension plans allocated 17 % of assets to buy‑in annuity policies in 2022, fell to 16 % in 2023, and returned to 17 % in 2024. The modest fluctuation—essentially a stable 16‑17 % level—shows the company is deliberately maintaining a high, consistent exposure to buy‑in annuities as a core tool for hedging and managing its international pension liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that fundamentally contradicts the ground truth. (1) QUANTITATIVE ACCURACY: The LLM states the allocation 'returned to 17% in 2024,' but the ground truth explicitly states it was 'effectively discontinued by 2024.' This is a major factual error. The correct progression is 17% (2022) → 16% (2023) → discontinued/0% (2024), not 17% (2024). (2) REASONING AND INTERPRETATION: The LLM misinterprets the trend entirely. It claims MDLZ is 'deliberately maintaining a high, consistent exposure to buy-in annuities as a core tool,' when the ground truth indicates the opposite—a strategic shift AWAY from insurer-backed annuities toward direct liability management. The LLM characterizes the 16-17% range as 'stable' and 'core,' missing the critical discontinuation in 2024. (3) MULTI-HOP SYNTHESIS: The LLM fails to correctly synthesize the multi-year trend and its strategic implications. It does not recognize that the shift from 17% to 16% to discontinued represents a de-risking strategy, not maintenance of a core position. (4) STRATEGIC INTERPRETATION: The ground truth identifies this as 'a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.' The LLM's conclusion that the company is 'deliberately maintaining' this as a 'core tool' is diametrically opposed to the actual strategic direction. The only correct element is the 2022 (17%) and 2023 (16%) percentages, but the 2024 data and the entire strategic interpretation are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 441,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "Microsoft first issued the 2.000 % Notes due 2023 in 2022 as part of the Eleventh Supplemental Indenture (4.14)【page_105】【page_105】【page_105】. The same indenture is referenced unchanged in the 2023 and 2024 10‑K filings, indicating the notes remained outstanding through those years without new issuances. This consistency shows Microsoft’s long‑term debt strategy relies on low‑coupon, short‑term notes to keep borrowing costs low while preserving flexibility in its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2.000% Notes due 2023 and the Eleventh Supplemental Indenture dated August 8, 2016 (Exhibit 4.14). (2) Accurately notes that the same indenture is referenced unchanged across 2022, 2023, and 2024 10-K filings. (3) Correctly identifies that the notes remained outstanding without new issuances. (4) Numeric values (2.000%, 2023 maturity date) are accurate.\n\nWEAKNESSES: (1) The LLM makes an unsupported claim that Microsoft 'first issued' these notes in 2022, when the ground truth indicates they were issued in 2016 (per the Eleventh Supplemental Indenture dated August 8, 2016). This is a factual error about the issuance timeline. (2) The characterization of these as 'short-term notes' is problematic - notes due in 2023 would be short-term by 2022, but the question asks about evolution across 2022-2024, meaning by 2024 they would have matured or been due. The LLM doesn't address what happened to these notes after their 2023 maturity date. (3) The LLM's interpretation that this reflects a strategy of 'low-coupon, short-term notes to keep borrowing costs low' is speculative and not directly supported by the ground truth, which emphasizes consistency and lack of early retirement/refinancing. (4) Missing the key insight from the ground truth that the notes 'remained on its books through the 2024 reporting period, even as the due date approached,' which is crucial for understanding the evolution across all three years.\n\nMULTI-HOP REASONING: The LLM partially synthesizes information across the three years but fails to fully address the temporal evolution, particularly what happened post-2023 maturity. The ground truth emphasizes that the notes were maintained through 2024 despite approaching maturity, suggesting either they were paid off or refinanced - a critical detail missing from the LLM answer.\n\nOVERALL: The answer contains correct core facts but makes an error about the 2016 issuance date and fails to adequately address the complete evolution across all three fiscal years, particularly the post-maturity period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 562,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "Microsoft continued to list its 4.000 % Notes due 2021 in Exhibit 4.6 – the Third Supplemental Indenture dated February 8 2011 – in the 2022, 2023 and 2024 10‑K filings (2022 page 104; 2023 page 104; 2024 page 104).  The indenture and the notes’ classification remained unchanged, keeping the 4.000 % Notes within the same senior‑unsecured debt structure governed by the base indenture and its supplemental indentures (2022 page 104; 2023 page 104; 2024 page 104).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key facts: (1) the 4.000% Notes due 2021 were listed in Exhibit 4.6 across all three years (2022, 2023, 2024), (2) the Third Supplemental Indenture date of February 8, 2011 is accurate, (3) the notes remained in the same senior-unsecured debt structure. However, the answer has significant limitations: (1) It fails to address the 'evolution' aspect of the question - the ground truth explicitly notes that while the 4.000% Notes remained unchanged, Microsoft introduced NEW debt instruments with different maturity dates and interest rates under subsequent supplemental indentures (e.g., 2.375% Notes due 2023, 2.125% Notes due 2022). The LLM answer completely omits this important contextual evolution. (2) The LLM answer provides page citations (page 104 for all three years) but doesn't verify whether these are accurate or meaningful. (3) The answer states the structure 'remained unchanged' but doesn't explain what changed in the broader debt instrument structure, which was explicitly part of the question. (4) The LLM answer is overly narrow - it focuses only on the 4.000% Notes without addressing how the broader debt instrument structure evolved with new supplemental indentures. The quantitative accuracy is good (dates and percentages are correct), but the qualitative accuracy suffers from incomplete synthesis of the multi-hop information required to fully answer how the treatment 'evolved' across the three years. The answer is partially correct but incomplete in addressing the full scope of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 429,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "Medtronic’s 10‑K notes for 2022, 2023 and 2024 all state that the company is authorized to issue 40,000 Euro Deferred Shares with a €1.00 par value, but that none have been issued or are outstanding as of the reporting dates (April 29 2022, April 28 2023, April 26 2024)【page_81】. The wording and the zero balances remain unchanged across the three years, indicating that the company deliberately keeps this instrument idle. This consistency shows Medtronic’s capital‑structure strategy focuses on ordinary shares and repurchase programs, avoiding dilution or the complexity of a separate Euro‑denominated equity class.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Medtronic's Euro Deferred Shares disclosures. QUANTITATIVE ACCURACY: All numeric values are correct - 40,000 authorized shares, €1.00 par value, zero issued/outstanding balances across all three fiscal years. The reporting dates are accurate (April 29, 2022; April 28, 2023; April 26, 2024). ENTITY ACCURACY: Medtronic correctly identified, fiscal years 2022-2024 properly referenced, and the specific financial instrument (Euro Deferred Shares) accurately characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years to identify the consistent pattern of non-issuance and draws logical conclusions about capital structure strategy. The reasoning that this reflects a deliberate strategic choice to avoid dilution and complexity of a separate Euro-denominated equity class is sound and well-supported. COMPLETENESS: The answer addresses both parts of the question - how disclosures evolved (they remained consistent with zero balances) and what this reveals about capital structure strategy (preference for ordinary shares and repurchase programs). SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while adding slightly more interpretive detail about the strategic implications (focus on ordinary shares and repurchase programs, avoiding dilution). The phrase 'deliberately keeps this instrument idle' effectively captures the strategic intent. MINOR CONSIDERATIONS: The LLM answer provides slightly more interpretive analysis than the ground truth (mentioning ordinary shares and repurchase programs specifically), which represents appropriate elaboration rather than error. The citation reference [page_81] adds credibility though it cannot be independently verified in this context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 505,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "Microsoft consistently disclosed its 4.000% Notes due 2021 in Exhibit 4.6 (the Third Supplemental Indenture) in each of the 2022, 2023, and 2024 10‑K filings, and referenced the same instrument in the notes to the financial statements as long‑term debt (page_104). The unchanged disclosure across the three years indicates that Microsoft treats this debt instrument as a stable, long‑term obligation with no material changes in terms or status over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Microsoft consistently disclosed the 4.000% Notes due 2021 in Exhibit 4.6 across 2022, 2023, and 2024 filings, and accurately references the Third Supplemental Indenture dated February 8, 2011. The numeric and date information is accurate. However, there are significant issues with the answer's reasoning and completeness: (1) The LLM states the Notes were treated as 'long-term debt' and references page 104, but the ground truth indicates the Notes were 'matured or fully accounted for' by 2022 (the notes were due in 2021, making them past maturity in the 2022 filing). This is a material mischaracterization of the debt's status. (2) The LLM fails to address the key insight from the ground truth that the consistent disclosure despite the notes being matured suggests they were 'fully accounted for, with no further amendments or actions required.' (3) The LLM's conclusion that the notes represent a 'stable, long-term obligation' contradicts the ground truth's implication that these were historical/matured obligations being disclosed for completeness. (4) The answer lacks the nuance that the consistency in disclosure across three years, combined with the notes being past their maturity date, indicates a specific treatment pattern. The quantitative elements (dates, exhibit numbers, indenture date) are correct, but the qualitative interpretation of what this disclosure pattern means is partially incorrect, particularly regarding the debt's actual status as matured rather than active long-term debt.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 428,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "Lockheed Martin’s 2021 10‑K reports a single pension‑risk‑transfer transaction that moved $4.9 billion of gross defined‑benefit pension obligations to an insurer (page 60).  The 2022 and 2023 10‑Ks do not disclose any additional GAC purchases, and the 2024 10‑K likewise does not report a new transfer amount (page 47).  The company’s statements in each filing emphasize that it continues to pursue such transactions to reduce PBGC premiums and stabilize pension costs.  This pattern shows a deliberate, ongoing strategy to shift long‑term pension liabilities to third‑party insurers rather than fund them directly.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES BETWEEN LLM ANSWER AND GROUND TRUTH: (1) QUANTITATIVE ERRORS: The LLM cites a $4.9 billion transaction from 2021, but the ground truth establishes that by 2022, Lockheed Martin had cumulatively transferred approximately $11.6 billion in pension obligations since December 2018. The LLM's $4.9 billion figure appears to be a single transaction amount, not the cumulative total. The ground truth explicitly states $11.6 billion as of 2022, which is significantly different from the $4.9 billion cited. (2) INCOMPLETE TEMPORAL COVERAGE: The LLM focuses on 2021-2024 but misses the critical $11.6 billion cumulative figure disclosed in 2022 that represents the evolution from 2018-2022. The ground truth emphasizes the trajectory from $11.6 billion in 2022 through 2024, showing sustained commitment. The LLM's statement that '2022 and 2023 10-Ks do not disclose any additional GAC purchases' contradicts the ground truth's assertion of continued evaluation and strategic interest in 2023. (3) MISSING KEY METRIC: The ground truth specifically mentions $69 million in annual PBGC premium elimination, which the LLM does not cite. (4) REASONING QUALITY: While the LLM correctly identifies the strategic intent to reduce pension liabilities and shift risk to insurers, it fails to capture the multi-year evolution and cumulative impact that the ground truth emphasizes. The LLM's conclusion about 'deliberate, ongoing strategy' is correct in spirit but lacks the quantitative evidence of the $11.6 billion cumulative transfer. (5) ENTITY/METRIC ACCURACY: The LLM correctly identifies Lockheed Martin and the general concept of pension risk transfer, but misses the specific PBGC premium savings metric and the cumulative obligation transfer amounts. The answer demonstrates partial understanding of the strategy but fails on the core quantitative facts that define the evolution from 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 516,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "The 0.125% Notes due 2029 are consistently disclosed as Exhibit 4.4 in each filing, all referencing the same 2020 8‑K (KO_10k_2022 p. 134, KO_10k_2023 p. 132, KO_10k_2024 p. 130).  The note’s terms—0.125% coupon, maturity 2029, and classification as long‑term debt—remain unchanged across the three years, and the company continues to present it only as an exhibit rather than a separate note in the financial‑statement disclosures.  This uniform treatment demonstrates that Coca‑Cola’s debt‑instrument structuring has been stable and consistent over time.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ERRORS: (1) The LLM states the note is 'disclosed as Exhibit 4.4' but the ground truth clearly indicates it appears in Exhibits 4.23 and 4.31 across all three years, with references TO Exhibit 4.4 from Form 8-K filings. This is a fundamental misidentification of the exhibit structure. (2) The LLM cites specific page numbers (p. 134, p. 132, p. 130) without verification against the actual filings - these appear to be fabricated or incorrectly sourced. (3) The LLM claims the note is presented 'only as an exhibit rather than a separate note in the financial-statement disclosures,' which may be accurate but is not explicitly confirmed in the ground truth and represents an inference not directly supported. PARTIAL CREDIT: The LLM correctly identifies (1) the 0.125% coupon rate, (2) the 2029 maturity date, (3) the reference to 2020 8-K filings, (4) the consistency across three years, and (5) the conclusion about stable debt structuring. However, these correct elements are overshadowed by the exhibit classification error. The multi-hop reasoning about consistency is sound in conclusion but based on incorrect exhibit references. The answer demonstrates understanding of the general concept but fails on specific factual accuracy regarding exhibit numbers, which is critical for SEC filing analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 389,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "RTX’s liability for performance and operating‑cost guarantees fell from **$1,109 million** at December 31 2022 to **$1,091 million** at December 31 2023 and further to **$993 million** at December 31 2024 (Note 16, table of changes in carrying amounts). The decline—driven by fewer warranties issued and lower settlements—indicates that the company’s exposure to long‑term product performance risks in its commercial aerospace business is easing, reflecting improved product reliability and risk management.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL DISCREPANCY: The LLM answer provides completely different financial figures than the ground truth. The LLM cites liabilities of $1,109M (2022), $1,091M (2023), and $993M (2024), while the ground truth identifies collaboration partners' share of financing guarantees at $141M (2022), $135M (2023), and $131M (2024)—a difference of approximately 7-8x in magnitude. This is a fundamental factual error, not a minor formatting variation. The LLM appears to have cited total performance and operating cost guarantee liabilities rather than the specific collaboration partners' share mentioned in the ground truth. While the LLM's trend direction (declining values) matches the ground truth's direction, the absolute numbers are incorrect. Additionally, the LLM's interpretation that the decline indicates 'easing exposure' and 'improved product reliability' differs from the ground truth's more nuanced assessment that RTX 'continues to extend these guarantees...while maintaining a controlled liability posture.' The LLM failed to distinguish between different liability components and provided incorrect quantitative data. The reference to 'Note 16, table of changes in carrying amounts' suggests the LLM may have accessed a different section or misread the filing. For a financial question requiring precise numbers, this level of quantitative error is disqualifying.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 382,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "Medtronic continues to use the Black‑Scholes model for non‑qualified options, but its input assumptions have shifted between 2022 and 2024.  Volatility rose from 23.0 % to 24.3 %, the risk‑free rate jumped from 0.9 % to 4.2 %, and the dividend yield increased from 1.95 % to 3.18 %, while the expected life lengthened slightly from 6.0 to 6.1 years; consequently the weighted‑average fair value of options granted fell from $22.83 million to $18.49 million.  These changes indicate Medtronic is modeling a more volatile, higher‑interest‑rate market and a higher expected dividend environment, leading to a more conservative equity‑compensation risk valuation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides information that does not align with the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific numerical values (volatility 23.0% to 24.3%, risk-free rate 0.9% to 4.2%, dividend yield 1.95% to 3.18%, fair value $22.83M to $18.49M) that cannot be verified against the ground truth and appear to be fabricated or from incorrect sources. The ground truth makes no mention of these specific parameter values or fair value amounts. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth focuses on the evolution of disclosure transparency regarding volatility estimation methodology (historical vs. implied volatility, market-traded options sourcing), not on changes in the actual parameter values themselves. The LLM completely misses this key insight about methodological transparency. (3) INCOMPLETE MULTI-HOP REASONING: The question asks about the evolution of approach and what it suggests about changing assumptions. The ground truth correctly identifies that the evolution was in disclosure clarity and market-informed methodology. The LLM instead invents specific parameter changes and mischaracterizes them as indicating 'more conservative' valuation, which is not supported by the ground truth. (4) FACTUAL INACCURACY: The LLM's claim that fair value fell from $22.83M to $18.49M is presented without source verification and contradicts the ground truth's focus on methodological evolution rather than parameter value changes. (5) SEMANTIC MISMATCH: The ground truth emphasizes 'refined and market-informed approach' and 'dynamic risk modeling,' while the LLM emphasizes 'more conservative' valuation based on invented parameter shifts. These are fundamentally different interpretations. The LLM appears to have hallucinated specific financial parameters rather than synthesizing actual filing information about Medtronic's stock option valuation methodology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 527,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "The 1.000% note due 2028 appears as a **current** note in both the 2022 and 2023 10‑K filings (page 134) and is listed again in the 2024 filing as a **new** note (page 136). This consistent presence—first as a current instrument and then as a newly issued one—shows that Coca‑Cola has been steadily issuing or renewing this low‑interest, long‑term debt, suggesting a deliberate strategy to maintain a stable, low‑cost financing base for that maturity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and mischaracterizations that contradict the ground truth. Key issues: (1) INCORRECT CLASSIFICATION: The LLM claims the 1.000% Notes due 2028 appeared as a 'current' note in 2022 and 2023, then as a 'new' note in 2024. This is factually wrong—the ground truth indicates these notes were consistently referenced across all three years as part of the long-term debt structure, not as current liabilities or newly issued instruments. (2) MISSING CRITICAL CONTEXT: The LLM completely fails to address the strategic shift mentioned in the ground truth—that Coca-Cola introduced significantly higher-yielding notes in 2024 (5.000% Notes due 2034 and 5.300% Notes due 2054). This is a crucial part of understanding the company's debt strategy evolution. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about the evolution across three years and what it suggests about debt strategy. The ground truth explains that while the 1.000% Notes remained part of the structure, the company pursued more aggressive borrowing terms in 2024. The LLM's answer suggests a 'stable, low-cost financing base' strategy without acknowledging the shift to higher-interest debt. (4) UNSUPPORTED PAGE REFERENCES: The LLM cites specific page numbers (134, 136) without verification against the actual filings, and the characterization of these notes as 'current' vs 'new' appears to be incorrect. (5) LOGICAL INCONSISTENCY: The LLM's conclusion that the company was 'steadily issuing or renewing' this low-interest debt contradicts the ground truth's finding that the company shifted toward higher-interest instruments in 2024. The answer demonstrates a fundamental misunderstanding of the debt instrument's status and the company's strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 484,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "Microsoft continued to structure its 2.125% Notes due 2022 under the Fourth Supplemental Indenture (Exhibit 4.7) with The Bank of New York Mellon Trust Company, N.A. as trustee in each of the 2022, 2023, and 2024 10‑Ks, and the trustee arrangement remained unchanged (104). Each filing also disclosed the Twelfth Supplemental Indenture (Exhibit 4.15) – which contains 2.400% Notes due 2022 and 2.875% Notes due 2024 – and the Fifteenth Supplemental Indenture (Exhibit 4.18) with the same trustee, indicating that Microsoft’s approach to related debt instruments stayed consistent and no new 2.125% Notes were issued in 2023 or 2024 (106).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) MATURITY DATE ERROR: The LLM states '2.125% Notes due 2022' while the ground truth clearly indicates '2.125% Notes due 2021' - this is a significant factual error regarding the instrument's maturity date. (2) SUPPLEMENTAL INDENTURE ERROR: The LLM references 'Fourth Supplemental Indenture (Exhibit 4.7)' while the ground truth specifies 'Seventh Supplemental Indenture' - this is a major discrepancy in the specific debt instrument structure. (3) ASSOCIATED INSTRUMENTS ERROR: The LLM mentions '2.400% Notes due 2022 and 2.875% Notes due 2024' in the Twelfth Supplemental Indenture, but the ground truth associates the 2.125% Notes with '3.125% Notes due 2028' - these are different instruments entirely. (4) STRUCTURAL CONSISTENCY: While both answers correctly identify that the trustee (The Bank of New York Mellon Trust Company, N.A.) and structure remained consistent across 2022-2024, the LLM's identification of which specific instruments and indentures were involved is incorrect. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the relationship between the 2.125% Notes and their associated debt instruments across the three-year period. The answer demonstrates poor accuracy in identifying the specific financial instruments and their characteristics, which are critical to answering this question correctly. The citation references (104, 106) cannot be verified against the ground truth provided.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 421,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "Pratt & Whitney’s net program share interest in the International Aero Engines (IAE) collaboration remained at **57 %** and in the IAE LLC collaboration at **51 %** throughout 2022‑24 (see RTX 10‑K notes on pages 108, 97 and 101).  \nThe unchanged, majority‑stake percentages show that RTX continues to hold a controlling position in both the V2500 (IAE) and PW1100G‑JM (IAE LLC) programs, underscoring its sustained strategic focus and influence in these key commercial‑aircraft engine collaborations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE ACCURACY: The LLM answer claims that net program share interest 'remained at 57% and...51%...throughout 2022-24' which directly contradicts the ground truth. According to the original answer, there was a significant evolution: (1) In 2022, program share interest was 61% for IAE and 59% for IAE LLC (NOT 57% and 51%), (2) By 2023, these decreased to 57% for IAE and 51% for IAE LLC, (3) In 2024, they remained at 57% and 51%. The LLM incorrectly collapsed this three-year progression into a false claim of consistency 'throughout 2022-24.' This is a fundamental factual error that misrepresents the evolution the question specifically asks about. The LLM also failed to capture the key insight from the ground truth: that 2023 saw a notable adjustment/decrease in net program share interest (from 61%/59% to 57%/51%), followed by stabilization in 2024. PARTIAL CREDIT FOR: (1) Correctly identifying the 2024 percentages (57% and 51%), (2) Correctly linking these to V2500 and PW1100G-JM programs, (3) Appropriately noting RTX's controlling position. MISSING ELEMENTS: (1) No discussion of the 2022 baseline figures (61% and 59%), (2) No acknowledgment of the 2023 decrease/adjustment, (3) No explanation of what 'net program share interest' means versus 'program share interest' (the ground truth distinguishes these), (4) Incomplete multi-hop synthesis - failed to trace the evolution across all three years. The answer presents a static view when the question explicitly asks about evolution/progression. This represents a significant failure in addressing the core analytical requirement of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 448,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "TMO’s company‑contributed expense for its 401(k) and other defined‑contribution plans rose from **$402 million in 2022 to $468 million in 2023** (a 16 % increase) and then fell to **$443 million in 2024** (about 5 % lower than 2023 but still 10 % above 2022)【page_69】. This pattern shows a generally upward trend in employee‑benefit spending, with a modest dip in 2024 that still reflects a sustained commitment to supporting employee retirement and savings plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN 2022 FIGURE: The LLM states TMO's contributions were $402 million in 2022, but the ground truth clearly shows $299 million in 2022. This is a significant discrepancy of $103 million (34% error). The 2023 ($468 million) and 2024 ($443 million) figures are correct. CALCULATION ERRORS: The LLM claims a 16% increase from 2022 to 2023, but using the correct 2022 figure of $299M, the actual increase is ($468M-$299M)/$299M = 56.5%, not 16%. The claim that 2024 is '10% above 2022' is based on the incorrect $402M figure; using the correct $299M, 2024 is actually 48% above 2022. The percentage decrease from 2023 to 2024 (5% lower) is approximately correct ($468M-$443M)/$468M = 5.3%). MULTI-HOP REASONING: The LLM correctly synthesizes the three-year trajectory and provides reasonable interpretation about the company's workforce investment approach. The qualitative analysis about 'generally upward trend' and 'sustained commitment' is sound. ENTITY ACCURACY: TMO is correctly identified, years are correct (2022-2024), and the metric (defined contribution plans/401(k)) is properly identified. COMPLETENESS: The answer addresses the evolution question and provides interpretation about spending trajectory as requested. The fundamental issue is the incorrect 2022 baseline figure, which cascades into multiple calculation errors and undermines the credibility of the entire response despite correct reasoning structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 398,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "In the 2022 10‑K, Coca‑Cola’s 3.000% Notes due 2051 were listed as Exhibit 4.36, showing that the notes were issued in 2021 and remained outstanding through 2022 【page_134】. The 2023 10‑K continues to reference the same 3.000% Notes due 2051 as an exhibit, indicating no new issuance or refinancing of that instrument in 2023 【page_134】. The 2024 10‑K likewise lists the 3.000% Notes due 2051 while adding new long‑term debt with higher coupon rates, underscoring Coca‑Cola’s strategy of keeping a stable, diversified debt base with moderate yields to balance cost and maturity risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in exhibit reference accuracy. CORRECT ELEMENTS: (1) The 3.000% Notes due 2051 were indeed referenced across 2022, 2023, and 2024 10-Ks; (2) The notes were issued in 2021 and remained outstanding; (3) Higher coupon rate instruments (5.000% and 5.300% notes) were added in 2024; (4) The overall capital structure strategy interpretation about maintaining stable debt while diversifying with higher-yielding instruments is sound. CRITICAL ERRORS: (1) The LLM states the exhibit reference is '4.36' in the 2022 10-K, but the ground truth indicates the exhibit reference was '4.6' (from the May 5, 2021 Form 8-K); this is a factual error in a specific numeric identifier; (2) The LLM claims the exhibit reference remained the same in 2023, but provides no verification of the actual exhibit number. REASONING QUALITY: The multi-hop synthesis is generally sound - the LLM correctly identifies the progression across three years and appropriately concludes that Coca-Cola maintained the 3.000% Notes as a stable component while diversifying. However, the exhibit reference error undermines confidence in the factual accuracy. The semantic interpretation of capital structure strategy aligns well with the ground truth. QUANTITATIVE ACCURACY PENALTY: The exhibit number discrepancy (4.36 vs 4.6) is a specific factual error that cannot be overlooked in financial document analysis, even though it doesn't affect the broader strategic narrative. The answer would have scored 8-9 if the exhibit references were correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 434,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "Oracle first issued the 2.875% Notes due 2031 in 2021 (Exhibit 4.14).  In its 2022, 2023, and 2024 10‑K filings the same 2.875% notes remain listed in Exhibit 4.14 with no changes to terms or additional issuances (2022 p. 113; 2023 p. 108; 2024 p. 109).  This steady presence shows Oracle’s long‑term debt strategy of maintaining a diversified mix of fixed‑rate, long‑maturity notes to lock in favorable rates, manage interest‑rate exposure, and preserve liquidity.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2.875% Notes due 2031 are correctly identified and their presence in 2022, 2023, and 2024 10-K filings is accurate. (2) The page references provided (2022 p. 113; 2023 p. 108; 2024 p. 109) appear reasonable for debt disclosures. (3) The characterization of Oracle's debt strategy as maintaining diversified fixed-rate, long-maturity notes is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM states the notes were 'first issued in 2021' but the ground truth indicates they were 'formally listed' in 2022, suggesting the LLM may have introduced information not in the original answer. (2) CRITICAL OMISSION: The LLM completely fails to address the key strategic evolution highlighted in the ground truth - that by 2024, Oracle introduced newer, higher-yielding notes (4.500% Notes due 2028 and 4.900% Notes due 2033) alongside the 2.875% Notes. This is a major gap in answering the question about how the debt strategy 'evolved' from 2022-2024. (3) The LLM states 'no changes to terms or additional issuances' which contradicts the ground truth's emphasis on Oracle layering in newer, costlier debt instruments. (4) The LLM's reasoning about 'locking in favorable rates' is somewhat generic and doesn't capture the strategic shift toward higher-yielding instruments that the ground truth emphasizes. MULTI-HOP SYNTHESIS: The LLM failed to synthesize the critical multi-hop element - comparing the 2.875% Notes across years AND identifying the introduction of newer higher-yielding notes in 2024 as evidence of strategic evolution. The answer reads as static rather than showing progression/evolution as the question specifically asks. The ground truth's key insight about 'layering in newer, costlier debt' reflecting 'changing borrowing costs and strategic capital allocation decisions' is entirely absent from the LLM response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 517,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "Microsoft’s repeated inclusion of the 2.000 % Notes due 2023 in Exhibit 4.14 of its 2022, 2023 and 2024 10‑K filings shows that the company maintains a stable, predictable debt profile and is disciplined about managing long‑term maturities. The consistent disclosure signals a deliberate strategy to balance coupon costs with a clear repayment schedule, while the repeated reporting demonstrates a commitment to transparency and to keeping investors fully informed of its debt obligations. [page_105]",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: Microsoft's 2.000% Notes due 2023, their consistent disclosure across 2022, 2023, and 2024 10-K filings, and the strategic implications for debt management and transparency. All numeric values (2.000%, the three years, and the note designation) are accurate. The answer appropriately synthesizes the multi-hop information about disclosure consistency and its implications for investor confidence and financial stewardship. However, the LLM answer has some notable omissions compared to the ground truth: (1) It does not mention the Eleventh Supplemental Indenture dated August 8, 2016, which provides important historical context; (2) It does not reference the specific exhibit location (Exhibit 4.14) with the same clarity as the ground truth; (3) It lacks the specific detail about the trustee and other filing details being unchanged; (4) The ground truth explicitly mentions how this supports 'favorable credit ratings,' while the LLM answer focuses more on 'coupon costs' and 'repayment schedule' without the credit rating connection. The LLM's reasoning about 'balancing coupon costs with a clear repayment schedule' is reasonable but slightly shifts the emphasis from the ground truth's focus on 'consistent liability structure' and 'predictable financial stewardship.' The answer is semantically sound and addresses the core question about transparency and debt management strategy, but misses some important contextual details that would strengthen the analysis. The reference to [page_105] suggests proper sourcing but this detail is not verified against the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 447,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "RTX’s total commitments to Rolls‑Royce under the 2012 IAE deal rose from $1.29 billion in 2022 to $1.33 billion in 2024, while the portion attributable to flight‑hour payments (shown in the “Collaboration partners’ share” line) climbed from $665 million in 2022 to $814 million in 2024, even as overall commitments fell slightly in 2024.  These payments are contingent on each hour flown by V2500‑powered aircraft through June 2027, are capitalized as intangible assets and amortized to cost of sales, and the trend shows that RTX’s exposure to Rolls‑Royce remains sizable but will gradually diminish as flight hours accrue and the payment period ends in 2027.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific dollar amounts ($1.29B in 2022, $1.33B in 2024, $665M and $814M for flight-hour payments) that are NOT present in the ground truth answer. The ground truth explicitly does NOT provide these quantitative figures - it focuses on the qualitative evolution and accounting treatment of the payments. The LLM appears to have fabricated or hallucinated these numbers, which is a severe factual error. WHAT WAS CORRECT: (1) The reference to the 2012 IAE acquisition agreement is correct; (2) The identification of V2500-powered aircraft as the basis for contingent payments is correct; (3) The June 2027 end date for payments is correct; (4) The accounting treatment (capitalized as intangible assets and amortized to cost of sales) is correct; (5) The general characterization of RTX's exposure as 'sizable but gradually diminishing' aligns with the ground truth's 'stable long-term financial exposure.' WHAT WAS INCORRECT/MISSING: (1) The LLM provides specific dollar amounts with no basis in the ground truth - this is a major factual error; (2) The LLM references a 'Collaboration partners' share' line item that is not mentioned in the ground truth; (3) The LLM states commitments 'fell slightly in 2024' which contradicts its own claim that they rose from $1.29B to $1.33B; (4) The ground truth emphasizes the evolution of accounting treatment and clarification across years (2022 categorization, 2023 clarification, 2024 consistency), which the LLM largely omits; (5) The ground truth's key insight about the 'ongoing recognition and amortization pattern' indicating 'stable' exposure is somewhat contradicted by the LLM's narrative of 'gradually diminish[ing]' exposure. MULTI-HOP REASONING: The LLM attempts to synthesize information across three years but does so by introducing unsupported quantitative data. The qualitative reasoning about the payment structure and exposure is sound, but the fabricated numbers undermine the entire answer's credibility. QUANTITATIVE ACCURACY: Score of 1 due to the introduction of specific dollar amounts that cannot be verified against the ground truth and appear to be hallucinated. QUALITATIVE ACCURACY: Score of 4 because while the general framework and accounting concepts are correct, the answer misses the key evolution in accounting treatment across years and introduces false quantitative specificity. CONTEXTUAL RELEVANCE: Score of 6 because the answer addresses the right topic and most key elements, but the fabricated numbers and missing accounting evolution details reduce relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 686,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "The fair value of U.S. equity funds in TMO’s domestic pension plans rose from **$89 million in 2022 to $93 million in 2023, then fell modestly to $91 million in 2024** (page 70). This largely flat 3‑year trend shows that the company is maintaining a steady, low‑to‑moderate domestic‑equity exposure—consistent with its ~10 % target allocation—and is not aggressively shifting its portfolio toward or away from U.S. equities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that make it largely incorrect. QUANTITATIVE ERRORS: (1) The LLM states 2022 value was $89 million, but ground truth shows $125 million—a $36 million discrepancy. (2) The LLM states 2023 value was $93 million, but ground truth shows $89 million—a $4 million error. (3) The LLM states 2024 value was $91 million, but ground truth shows $93 million—a $2 million error. All three year-over-year values are incorrect. TRAJECTORY ANALYSIS: The LLM describes a 'largely flat 3-year trend' when the ground truth shows a significant decline from $125M to $89M (28.8% reduction) followed by a modest recovery to $93M. This is NOT a flat trend—it's a substantial reduction with partial rebound. REASONING QUALITY: The LLM's conclusion about 'maintaining steady, low-to-moderate domestic-equity exposure' contradicts the actual pattern of cautious reduction. The ground truth explicitly states 'cautious reduction in exposure to U.S. equities over the three-year period,' which is the opposite of the LLM's characterization. MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the three-year trajectory across all periods. The answer inverts the 2022-2023 relationship and mischaracterizes the overall pattern. ENTITY/METRIC ACCURACY: While TMO and domestic pension plans are correctly identified, the financial values are systematically wrong. The answer does address the question structure but with fundamentally incorrect data, leading to an inverted strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 420,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "Coca‑Cola’s 2022 10‑K lists a 1.000 % note due 2041 (Exhibit 4.33) as part of its long‑term debt, and the 2023 10‑K continues to reference the same 1 % note, indicating it remained outstanding. In the 2024 10‑K the company broadened its debt mix by issuing a series of higher‑yielding notes—ranging from 3.125 % to 5.400 % with maturities between 2032 and 2064 (Exhibits 4.39‑4.47)—while still retaining the 1 % note due 2041, reflecting a strategy to diversify maturities and take advantage of favorable market rates.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Coca-Cola's debt strategy and correctly identifies the persistence of the 1.000% Notes due 2041 across all three years. However, there are significant quantitative accuracy issues: (1) The LLM states 2024 notes range from '3.125% to 5.400%' but the ground truth specifies 5.000%, 5.300%, and 5.400% - the 3.125% figure is not mentioned in the ground truth and appears to be an error or hallucination. (2) The LLM references 'Exhibits 4.39-4.47' for 2024 notes, but the ground truth consistently cites 'Exhibit 4.33' for the 1.000% Notes due 2041 across all years, and doesn't specify which exhibits contain the 2024 higher-yielding notes. (3) The LLM omits specific lower-yielding instruments from earlier years (0.400% Notes due 2030 in 2022 and 0.950% Notes due 2036 in 2023) that the ground truth explicitly mentions as part of the strategic evolution narrative. The reasoning about diversification and market conditions is sound and semantically equivalent to the ground truth's 'recalibration' concept. The multi-hop synthesis is partially successful - the LLM correctly identifies the three-year progression and the shift toward higher yields - but the incomplete and potentially inaccurate specification of 2024 note yields undermines the quantitative foundation of the answer. The answer demonstrates good qualitative understanding but fails on precision of financial metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 397,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "Oracle’s 2023 and 2024 10‑K filings list the 1.650% Notes due 2026 as part of its debt portfolio (Exhibit 4.14, page 111), and the 2022 10‑K also includes the same note, indicating its continued presence in the capital structure over three consecutive fiscal years. By keeping this low‑rate, long‑term debt alongside newer, higher‑rate issues such as the 5.800% Notes due 2025 and 6.150% Notes due 2029 (Exhibit 4.15, page 111), Oracle demonstrates a strategy of anchoring its leverage with inexpensive debt while using higher‑cost notes for targeted financing or refinancing needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 1.650% Notes due 2026 as present across fiscal years 2022, 2023, and 2024, and accurately notes their inclusion in Exhibits 4.14 and 4.16. The core strategic interpretation—that Oracle maintains lower-cost debt while issuing higher-rate notes—is sound and semantically equivalent to the ground truth. The reasoning about anchoring leverage with inexpensive debt is appropriate.\n\nCRITICAL ERRORS: (1) The LLM introduces the 6.150% Notes due 2029, which does NOT appear in the ground truth answer. The ground truth specifically mentions 5.800% Notes due 2025 (2023) and 4.500% Notes due 2028 (2024). The 6.150% note is either incorrect or unsupported by the question context. (2) The LLM cites 'Exhibit 4.15, page 111' for the higher-rate notes, but the ground truth references Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024) without specifying page numbers or Exhibit 4.15. This creates uncertainty about exhibit accuracy.\n\nPARTIAL ISSUES: (1) The LLM omits the 4.500% Notes due 2028 (introduced in 2024 per ground truth), which is a material omission in the multi-hop synthesis. (2) While the LLM mentions the 5.800% Notes due 2025, it doesn't clearly establish the temporal sequence (2023 introduction) that the ground truth emphasizes. (3) The phrase 'targeted financing or refinancing needs' is vague compared to the ground truth's more specific reference to 'supporting long-term investments.'\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis across three fiscal years and correctly connects the low-rate debt to higher-rate instruments. However, the incomplete enumeration of new notes (missing 4.500% due 2028) and the introduction of an unsupported 6.150% note weaken the multi-hop accuracy.\n\nQUANTITATIVE ACCURACY: All interest rates mentioned are correctly formatted (1.650%, 5.800%, 6.150%), but the inclusion of 6.150% without ground truth support and omission of 4.500% represent factual errors in the debt portfolio description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 541,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "Microsoft’s 10‑Ks for 2022, 2023 and 2024 all list the same Third Supplemental Indenture (Exhibit 4.6) that contains the 4.000 % Notes due 2021【page_104】. The unchanged inclusion of that tranche indicates that Microsoft has not re‑issued or refinanced the 2021 notes, instead keeping the original indenture in force and merely updating the documentation to keep it current. This reflects a conservative long‑term debt strategy that prioritizes stability of existing debt over frequent refinancing of that portion of its capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 4.000% Notes due 2021 appear consistently in Exhibit 4.6 across fiscal years 2022, 2023, and 2024, and accurately notes the percentage rate (4.000%). The core inference that Microsoft did not refinance this tranche is sound. The characterization of the strategy as 'conservative' and 'prioritizing stability' aligns with the ground truth's conclusion about maintaining stable reference within the debt portfolio.\n\nWEAKNESSES: (1) The LLM answer is significantly less complete than the ground truth. It omits important contextual details about the Third Supplemental Indenture's composition - specifically that the 4.000% Notes were listed alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041. This omission weakens the multi-hop synthesis. (2) The LLM fails to mention the notable 2024 trustee name update to 'The Bank of NewYork Mellon Trust Company, N.A.' with formatting differences, which the ground truth identifies as an important administrative maintenance indicator. (3) The LLM does not address the temporal anomaly that the notes were 'due 2021' yet continued appearing in 2022-2024 filings - the ground truth explicitly notes this as 'even after the notes' due date in 2021,' which is a key insight about documentation practices. (4) The reasoning about 'keeping the original indenture in force and merely updating the documentation' is somewhat speculative and less precise than the ground truth's distinction between administrative maintenance versus substantive changes.\n\nMULTI-HOP REASONING: The LLM demonstrates basic multi-hop synthesis by connecting the consistent inclusion across three years to a debt management strategy conclusion. However, it misses the deeper multi-hop analysis that would connect: (a) the post-maturity inclusion of the notes, (b) the unchanged composition of the supplemental indenture, (c) the minor trustee name update, and (d) the absence of refinancing disclosures - all together pointing to administrative maintenance rather than active restructuring.\n\nNUMERIC/DATE ACCURACY: All dates (2021, 2022, 2023, 2024) and the percentage (4.000%) are correct. No calculation errors present.\n\nSEMANTIC EQUIVALENCE: The core conclusion about conservative debt strategy and lack of refinancing is semantically equivalent to the ground truth, but the answer lacks the nuanced understanding of what the documentation patterns actually reveal about Microsoft's practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 656,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "RTX’s maximum‑potential payment for commercial‑aerospace financing guarantees fell from $304 million in 2022 to $288 million in 2023 and to $274 million in 2024, with no carrying liability recorded in any of those years.  The collaboration partners’ share of those guarantees declined from roughly $142 million in 2022 to $135 million in 2023 and to $131 million in 2024, indicating a deliberate shift of risk to partners and a gradual reduction of RTX’s own guarantee exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all three collaboration partners' share figures ($142M in 2022, $135M in 2023, $131M in 2024) and accurately notes the declining trend. The numbers are factually correct and properly formatted. The LLM also correctly states that no carrying liability was recorded in any of those years.\n\nWEAKNESSES: (1) MISINTERPRETATION OF RISK DIRECTION: The LLM states this indicates 'a deliberate shift of risk to partners and a gradual reduction of RTX's own guarantee exposure.' This is INCORRECT. The declining collaboration partners' share actually indicates RTX is ASSUMING MORE DIRECT RISK, not shifting risk to partners. The ground truth explicitly states 'a strategic shift where RTX assumed more direct financial risk.' The LLM has inverted the meaning of the trend. (2) INCOMPLETE CONTEXT: The LLM introduces total maximum-potential payment figures ($304M, $288M, $274M) that, while potentially accurate, are not directly addressed in the original question and create confusion about what the trend means. The question specifically asks about the collaboration partners' share trend and what it suggests about RTX's risk transfer strategy. (3) MISSING KEY INSIGHT: The LLM fails to mention that RTX maintained confidence in underlying asset values (fair market values equaled or exceeded guarantees net of reserves), which is an important contextual element in the ground truth answer.\n\nCALCULATION VERIFICATION: The collaboration partners' share figures are correct. The decline from $142M to $135M to $131M is accurately stated. However, the interpretation of what this decline means for RTX's risk exposure is fundamentally backwards.\n\nMULTI-HOP REASONING: The LLM partially synthesizes information but reaches an incorrect conclusion about the strategic implication. It correctly identifies the trend but misinterprets its meaning for RTX's risk transfer strategy, which is the core analytical question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 526,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "Microsoft’s 3.950 % Notes due 2056 were issued under the Eleventh Supplemental Indenture in 2016 and have remained a component of its long‑term debt portfolio through FY 2022, FY 2023, and FY 2024, as each filing continues to list the Eleventh Supplemental Indenture (Exhibit 4.14) (2022 10‑K p. 105; 2023 10‑K p. 105; 2024 10‑K p. 105). The absence of new issuances or maturities for this instrument over three consecutive years shows Microsoft’s preference for long‑dated, moderate‑rate debt to lock in favorable financing terms and preserve capital‑allocation flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-supported. STRENGTHS: (1) All key facts are accurate - the 3.950% Notes due 2056 are correctly identified, the Eleventh Supplemental Indenture dated August 8, 2016 is correctly cited, and the consistent presence across FY 2022, 2023, and 2024 is verified. (2) The page references (p. 105 for all three years) add credibility and specificity. (3) The multi-hop synthesis is sound - the answer correctly traces the instrument across three fiscal years and identifies the pattern of stability. (4) The interpretation of the pattern (steady long-term financing strategy, no modifications) aligns with the ground truth. (5) The answer goes slightly beyond the ground truth by adding interpretive context about 'moderate-rate debt' and 'capital-allocation flexibility,' which is reasonable inference but not explicitly stated in the ground truth. MINOR CONSIDERATIONS: (1) The ground truth emphasizes 'no changes to the terms or status' while the LLM answer emphasizes 'absence of new issuances or maturities' - these are semantically equivalent but slightly different framings. (2) The LLM answer includes interpretive language about Microsoft's 'preference' and strategic intent that, while reasonable, goes slightly beyond what the ground truth explicitly states. (3) The characterization of 3.950% as 'moderate-rate' is reasonable but not explicitly confirmed in the ground truth. QUANTITATIVE VERIFICATION: All dates (2016, 2022, 2023, 2024), percentages (3.950%), and page numbers (105) are correct. No calculation errors. MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and identifies the consistent pattern, which is the core requirement of the multi-hop question. The conclusion about capital strategy is well-reasoned from the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 499,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "Lockheed Martin’s tactical‑and‑strike‑missile segment (MFC) ramped production each year—volume of LRASM and JASSM grew in 2022, expanded further in 2023, and broadened to include G‑MLRS in 2024—boosting MFC net sales from $11.3 B (2022) to $12.7 B (2024)【page_50】【page_40】.  Yet operating profit collapsed from $1.637 B in 2022 to $413 M in 2024, as 2023 and 2024 recorded $45 M and $1.2 B in losses on classified contracts and lower profit‑booking‑rate adjustments, respectively【page_40】.  The combined effect was a decline in Lockheed Martin’s consolidated operating profit of roughly $1.4 B (≈18 %) over the three‑year period, falling from $7.47 B in 2022 to $6.08 B in 2024【page_50】【page_40】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative correctly—production ramped up while operating profit declined significantly—but contains several quantitative errors that undermine accuracy. STRENGTHS: (1) Correctly identifies the upward production trajectory across 2022-2024 with specific programs (LRASM, JASSM, GMLRS). (2) Accurately reports the operating profit collapse from $1.637B (2022) to $413M (2024), representing a 73% decline. (3) Correctly identifies the two main drivers of profit decline: $45M in classified program losses (2023) and $1.2B in lower profit-booking-rate adjustments (2024). (4) Properly synthesizes multi-hop information across segment and consolidated levels. (5) Contextually relevant to the question's focus on trajectory and impact. WEAKNESSES: (1) CRITICAL ERROR: Reports consolidated operating profit decline of 'roughly $1.4B (≈18%)' from $7.47B to $6.08B. The actual decline is $1.39B, but the percentage is incorrect—($1.39B/$7.47B) = 18.6%, which rounds to 19%, not 18%. More importantly, the ground truth doesn't specify this consolidated figure, and the LLM appears to have introduced this calculation without clear grounding. (2) Missing the specific year-by-year production increases mentioned in ground truth: $215M (2022), $145M (2023), and $1.2B (2024). The LLM describes the trajectory qualitatively but doesn't quantify the annual increments. (3) Segment net sales figures ($11.3B to $12.7B) are provided but not in the ground truth, suggesting potential data from different sources or extrapolation. (4) The statement about 'consolidated operating profit decline of roughly $1.4B' conflates segment-level and company-level metrics without clear distinction. CALCULATION VERIFICATION: Operating profit decline in MFC segment: $1.637B - $0.413B = $1.224B (approximately 75% decline, not 73% as stated in ground truth, though this is a minor discrepancy). The ground truth states a 73% decline, which would be $1.637B × 0.73 = $1.195B, yielding $442M remaining profit, not $413M. This suggests either rounding differences or potential data inconsistencies. MULTI-HOP REASONING: The LLM correctly synthesizes information across years and connects production volume increases to profit declines, demonstrating sound multi-hop reasoning. However, the introduction of consolidated figures not clearly present in the ground truth raises questions about data sourcing. OVERALL: The answer is directionally correct and addresses the core question, but quantitative precision is compromised by missing specific annual figures and potentially incorrect consolidated calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 693,
        "total_tokens": 2145
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "Thermo Fisher’s 2022 10‑K listed only the original Executive Change‑In‑Control Retention Agreement (ECI‑CRA) for CEO Marc N. Casper, but also included the 2018 form for other officers (page 47). In 2023 a new, updated officer form was introduced (page 76), replacing the 2018 version. The 2024 filing continues to reference that 2023 officer form and contains no additional amendments to the ECI‑CRA beyond the earlier 2010 and 2018 amendments (page 76).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a structured timeline across 2022-2024 and correctly identifies the key evolution of the agreements (Marc N. Casper agreement and forms for other officers). However, there are significant issues with factual accuracy and specificity:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites specific page numbers (47, 76, 76) that cannot be verified against the ground truth and may be inaccurate\n   - References to \"2018 form\" and \"2010 and 2018 amendments\" are introduced without ground truth support\n   - These specific dates and page references appear to be hallucinated details not present in the original answer\n\n2. FACTUAL DISCREPANCIES:\n   - Ground truth states a \"Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper\" was introduced in 2022, but LLM claims it was from 2018\n   - Ground truth indicates 2023 filing included \"Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7\" - LLM says it was \"new, updated\" but doesn't confirm it's the same form or a replacement\n   - LLM claims \"2010 and 2018 amendments\" exist, but ground truth makes no mention of these specific amendment dates\n\n3. MULTI-HOP REASONING:\n   - The LLM correctly synthesizes the three-year evolution and identifies the two types of agreements (Casper-specific and officer forms)\n   - However, the addition of unsupported details (page numbers, amendment dates) undermines the reliability of the synthesis\n   - The claim about \"replacing the 2018 version\" in 2023 is not explicitly supported by ground truth\n\n4. COMPLETENESS:\n   - The answer addresses all three years (2022, 2023, 2024) as required\n   - It covers both Marc N. Casper agreement and officer forms\n   - However, it adds specificity not present in ground truth, which is problematic\n\n5. SEMANTIC EQUIVALENCE:\n   - Core message aligns: evolution of agreements across three years with consistent structure\n   - But the specific details diverge significantly, particularly regarding dates and page references\n\nThe answer demonstrates understanding of the question structure but introduces factual errors and unsupported specificity that reduce confidence in its accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 606,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "Lockheed Martin’s variable‑interest‑rate swap program grew sharply between 2022 and 2024, with the notional amount rising from $500 million in 2021 (disclosed in the 2022 filing) to $1.3 billion in 2023 and staying at that level in 2024【page_66】. The company uses these swaps to convert fixed‑rate borrowings to variable‑rate borrowings as fair‑value hedges, a strategy that expanded in scale to better manage the fair‑value impact of its debt and to align with a variable‑rate borrowing mix【page_66】【page_52】. The sustained $1.3 billion notional amount indicates a deliberate, stable hedging program that matches its debt profile and risk appetite.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $500 million in 2021, $1.3 billion in 2023, and $1.3 billion in 2024. The timeline and progression are accurately presented. The answer correctly identifies LMT (Lockheed Martin) and properly synthesizes the multi-hop information across years. The quantitative data is precise with proper formatting and no calculation errors. The answer goes beyond the ground truth by providing additional context about the mechanics of the swaps (converting fixed-rate to variable-rate borrowings as fair-value hedges), which adds value without contradicting the original answer. However, there are minor differences in emphasis and framing: (1) The LLM answer focuses more on the operational mechanics of the swaps rather than the strategic implications of the increase, whereas the ground truth emphasizes the strategic shift in response to rising borrowing levels and market uncertainty. (2) The ground truth explicitly characterizes the 2021-2023 increase as 'more than doubling' and describes it as 'proactive,' while the LLM uses 'grew sharply' which is semantically similar but less precise. (3) The LLM answer describes the sustained level as 'deliberate' and 'stable,' which aligns with the ground truth's 'stabilization' concept. The multi-hop reasoning is sound - the answer correctly synthesizes information across three fiscal years and identifies the pattern of increase followed by stabilization. The page references provided suggest proper source documentation. Overall, the answer is substantially correct with minor differences in analytical emphasis rather than factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 455,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "Thermo Fisher’s expense for its 401(k) and other defined‑contribution plans climbed from **$402 million in 2022 to $468 million in 2023** and then eased to **$443 million in 2024**【page_68】【page_51】. This pattern shows the company maintains a substantial, though somewhat variable, investment in employee benefits—peaking in 2023 likely due to higher participation or contribution rates, and then settling at a level still above the 2022 expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All three financial figures are correct - $402 million (2022), $468 million (2023), and $443 million (2024). The numbers match the ground truth exactly with proper formatting. (2) ENTITY ACCURACY: Correctly identifies Thermo Fisher Scientific, the metric (defined contribution plans/401(k)), and all three fiscal years (2022-2024). (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes the three-year trend, correctly identifying the increase from 2022 to 2023 and the decrease from 2023 to 2024. The characterization of 2024 as 'eased' and 'still above the 2022 expense' is accurate. (4) REASONING QUALITY: The interpretation is sound - the answer correctly identifies the peak in 2023 and notes the subsequent decline, while maintaining that 2024 levels remain elevated compared to baseline 2022. The explanation about 'higher participation or contribution rates' as a potential driver is reasonable speculation. (5) COMPLETENESS: Addresses all aspects of the question - the evolution over time and what it indicates about investment trends. The only minor distinction from the ground truth is that the LLM uses slightly different language ('eased' vs 'remained flat' and 'settling at a level still above 2022' vs 'stabilization or recalibration'), but these are semantically equivalent interpretations of the same data pattern. The inclusion of page citations adds credibility. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 423,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "From 2022 through 2024 Coca‑Cola’s investment note consistently states that fair‑value estimates for non‑public equity holdings are based on “discounted cash flows, estimates of sales proceeds, and appraisals.”  The wording and emphasis did not change, indicating the company has maintained the same reliance on sales‑proceeds estimates as a core valuation tool.  That consistency, coupled with management’s decision in 2022 not to impair its Japan investment—viewing the $87 million excess of carrying over fair value as temporary—shows a strong confidence that the decline is recoverable and that future cash‑flow estimates will eventually reflect a rebound.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All quantitative facts are accurate: the $87 million excess of carrying value over fair value in 2022 is correctly cited, and the company name (Coca-Cola Bottlers Japan Holdings Inc.) is correct. (2) The LLM correctly identifies that management did not impair the investment and viewed the decline as temporary, demonstrating confidence in recovery. (3) The core valuation methodology (discounted cash flows, estimates of sales proceeds, and appraisals) is accurately described. WEAKNESSES: (1) The LLM answer fails to address the evolution aspect of the question adequately. The ground truth emphasizes that from 2022-2024, there was an evolution in emphasis—moving from simple non-impairment to increasing emphasis on market participant assumptions and macroeconomic risks. The LLM states 'wording and emphasis did not change,' which contradicts the ground truth's finding of evolution. (2) The LLM misses the key insight about increasing attunement to external market perspectives and macroeconomic risks in emerging/developing markets, particularly regarding volatility in fair value predictions. (3) The answer lacks discussion of how the company's approach to valuation methodology evolved across the three-year period, instead treating it as static. (4) The LLM does not adequately synthesize what the evolution reveals about management's confidence—the ground truth suggests a more nuanced picture where confidence persisted but was tempered by greater awareness of external market factors. MULTI-HOP REASONING: The LLM successfully connects the non-impairment decision to confidence in recovery, but fails to synthesize the temporal evolution across 2022-2024 that the question specifically asks about. The answer is partially correct on the Japan investment details but incomplete on the broader evolution narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 499,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "Oracle issued the 2.300 % Notes due 2028 as part of a multi‑maturity note issuance on March 24 2021 (Exhibit 4.14). The same terms appear unchanged in the 2022, 2023, and 2024 10‑Ks (pages 113, 109, 111), indicating the note has been held to maturity without refinancing. This consistency reflects Oracle’s broader strategy of issuing long‑dated, moderate‑coupon notes with staggered maturities to manage interest costs and preserve liquidity while maintaining a stable debt profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core of the question. Key issues: (1) INCORRECT DATE: The LLM states the notes were issued on March 24, 2021, but this specific date is not verified in the ground truth and appears to be fabricated. (2) MISSING CRITICAL INFORMATION: The ground truth explicitly mentions that Oracle issued NEWER instruments with HIGHER interest rates (4.500% Notes due 2028 in 2023 and 5.800% Notes due 2025 in 2024), which is central to understanding Oracle's debt strategy. The LLM completely omits these newer, higher-rate instruments. (3) INCORRECT INTERPRETATION: The LLM claims the 2.300% Notes were 'held to maturity without refinancing,' but the ground truth indicates Oracle was actively issuing new debt instruments alongside the existing notes, suggesting a strategy of maintaining a mix of old and new debt. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution across three fiscal years and what the pattern suggests about broader strategy. The ground truth explains the pattern (maintaining lower-cost debt while issuing newer, expensive instruments amid rising rates), but the LLM misses this entirely by focusing only on the single instrument's consistency. (5) MISSING CONTEXT: The ground truth emphasizes the strategic significance of issuing higher-rate debt in 2023-2024, reflecting rising interest rate environment and refinancing needs. The LLM's answer about 'staggered maturities' and 'stable debt profile' doesn't capture this dynamic strategy. The LLM answer is internally coherent but factually incomplete and misses the essential multi-year comparative analysis the question requires.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 458,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "Apple had no floating‑rate notes due 2019 outstanding in fiscal years 2022, 2023, or 2024, because those notes were issued in 2014 and fully matured in 2019 (see the 2014 officer’s certificate listing the Floating Rate Notes due 2019 in the 10‑K exhibits (page 56, 58, 54, 53)). The absence of this short‑term instrument in recent debt schedules shows that Apple has retired the 2019 notes and now relies on longer‑term debt or other financing for its short‑term needs, using floating‑rate debt only when it aligns with liquidity or interest‑rate‑risk management objectives (page 56).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) CORE CONTRADICTION: The ground truth explicitly states that the Floating Rate Notes due 2019 'remained consistent across 2022, 2023, and 2024' and 'continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period.' The LLM answer claims these notes 'had no floating-rate notes due 2019 outstanding' and were 'fully matured in 2019' - this is the opposite of what the ground truth indicates. (2) FACTUAL ERROR: The LLM states the notes 'matured in 2019' but the ground truth shows they were still being disclosed in 2022, 2023, and 2024 filings, meaning they were still on the books. (3) REASONING FAILURE: The LLM's multi-hop synthesis is inverted - it concludes Apple 'retired the 2019 notes' when the ground truth shows they remained consistently disclosed across all three years. (4) MISINTERPRETATION: The LLM appears to have confused the maturity date (2019) with the actual status of the notes in 2022-2024, failing to recognize that the notes were still being carried and disclosed despite their nominal 2019 maturity date. (5) MISSING CONTEXT: The LLM fails to capture the key insight from the ground truth that the 'repeated appearance' and 'consistency' of these notes indicates a 'stable, rather than active, management approach.' The LLM's answer suggests active retirement/removal, which contradicts the ground truth's emphasis on consistency and stability. This is a fundamental failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 442,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "PepsiCo’s repeated inclusion of the 4.000% Senior Note due 2047 in Exhibits 4.17 (2022), 4.16 (2023) and 4.61 (2024) (PEP_10k_2022, p. 128; PEP_10k_2023, p. 128; PEP_10k_2024, p. 129) signals a deliberate long‑term debt strategy that relies on a stable, long‑maturity instrument to underpin its capital structure. In contrast, the 2.150% Senior Note due 2024 (Exhibit 4.18) and the 0.750% Senior Note due 2027 (Exhibit 4.28) are also consistently disclosed (PEP_10k_2022, p. 128; PEP_10k_2023, p. 128; PEP_10k_2024, p. 129) but, because of their shorter maturities, serve as complementary short‑term financing or refinancing tools rather than core long‑term debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY ON KEY CLAIM: The LLM states that the 2.150% Senior Note due 2024 and 0.750% Senior Note due 2027 are 'consistently disclosed' across all three filings (2022, 2023, 2024). The ground truth explicitly states these notes appear in 'only one or two filings' - the 2.150% note was 'referenced in 2023' (implying 2023 and possibly 2024, but NOT 2022), and the 0.750% note was 'introduced in 2024' (appearing only in 2024). This is a fundamental misrepresentation of the comparative analysis. (2) INCOMPLETE SYNTHESIS: The LLM fails to mention the 2.500% Senior Note due 2022 that matured by 2023, which is a critical element in the ground truth's argument about the 'dynamic nature of short-term debt versus persistent long-term obligations.' This omission weakens the multi-hop reasoning about debt lifecycle management. (3) EXHIBIT REFERENCES: While the LLM provides specific exhibit numbers and page references, these cannot be verified against the ground truth and appear to be potentially fabricated details (the ground truth does not cite specific exhibit numbers). (4) REASONING QUALITY: The LLM's core logic about long-term vs. short-term debt strategy is sound and aligns with the ground truth's conclusion, but the factual errors about which notes appear in which filings undermine the credibility of the analysis. (5) SEMANTIC ALIGNMENT: The LLM correctly identifies the strategic intent (long-term stability vs. short-term flexibility) but mischaracterizes the disclosure pattern, which is the empirical foundation for that conclusion. The claim that shorter-dated notes are 'complementary' is reasonable but contradicts the ground truth's assertion that they appear selectively rather than consistently.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 479,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "Apple continues to list the 0.45% Notes due 2016 in the “Description of Securities” exhibit (Exhibit 4.3) in its 2022, 2023 and 2024 10‑Ks (see page 58 and page 56). Because those notes matured in 2016, their inclusion reflects Apple’s practice of keeping a complete historical record of all debt issuances for transparency and regulatory compliance, rather than an active refinancing or repurchase strategy. This suggests a conservative, transparent approach to legacy debt—maintaining disclosure for investors while acknowledging that the notes are no longer outstanding.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key facts are accurate - correctly identifies the 0.45% Notes due 2016, confirms maturity in 2016, and accurately states they appear in 2022, 2023, and 2024 10-Ks; (2) Correctly identifies the exhibit location (Exhibit 4.3 in Description of Securities); (3) Accurately characterizes Apple's strategy as maintaining historical records for transparency and regulatory compliance rather than active refinancing; (4) Properly synthesizes the multi-hop reasoning: notes matured → still disclosed → indicates conservative/transparent approach; (5) Quantitative accuracy is high with correct dates and years. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer is more specific and concrete (mentions Exhibit 4.3, page references) whereas the ground truth is more general about 'disclosures'; (2) The LLM explicitly states notes are 'no longer outstanding' which adds clarity but isn't explicitly in ground truth; (3) The ground truth mentions the Officer's Certificate dated May 3, 2013 as a specific detail that the LLM doesn't include - this is a minor omission of supporting detail; (4) The ground truth uses slightly more cautious language ('possibly,' 'may reflect') while LLM is more definitive, though both reach similar conclusions. REASONING QUALITY: Both answers correctly identify that continued disclosure of matured debt reflects a deliberate policy of transparency and comprehensive record-keeping. The LLM's reasoning is clear and logical, properly distinguishing between active debt management strategies and historical record-keeping. The multi-hop synthesis (maturity date → continued disclosure → strategic implication) is sound in both answers. No calculation errors or factual inaccuracies detected.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 488,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "Lockheed Martin’s 2022‑2024 filings show a steady strategy of reducing pension obligations through risk‑transfer transactions, but no new GAC purchases were announced in 2022 or 2023.  The company has transferred roughly $11.6 billion of defined‑benefit obligations since 2018 (including a $4.9 billion GAC in 2021) and continues to “look for opportunities to manage our pension liabilities through additional pension risk‑transfer transactions in future years” (2024 10‑K, p. 47; 2023 10‑K, p. 19).  The only material earnings impact from these transactions was the $1.7 billion non‑cash settlement charge recorded in 2021; no such charge appeared in 2022‑2024, although the firm made $990 million in cash contributions in 2024 and recovered $1.7 billion of CAS pension costs in both 2023 and 2024 (2024 10‑K, p. 49).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key quantitative facts: (1) $4.9 billion GAC in 2021, (2) $11.6 billion cumulative obligations transferred since 2018, (3) $1.7 billion noncash settlement charge in 2021, (4) $990 million cash contributions in 2024, (5) $1.7 billion CAS pension cost recovery in 2023-2024. The statement that no new GAC purchases were announced in 2022-2023 is factually accurate. The quote about future opportunities is appropriately cited.\n\nWEAKNESSES: (1) The LLM's answer significantly understates the evolution of the company's approach by emphasizing what was NOT done (\"no new GAC purchases\") rather than what WAS emphasized in the filings. The ground truth indicates the company \"reiterated its intent to continue evaluating\" and showed \"consistent, proactive approach\" with \"increasing scale.\" The LLM's framing suggests stagnation rather than evolution. (2) The answer fails to adequately capture the 2023 and 2024 narrative about continued strategy and future expectations. The ground truth emphasizes that by 2024, the company \"had continued this strategy\" and was \"emphasizing ongoing pension obligation reductions\" - the LLM merely notes they \"continue to look for opportunities\" without capturing the active continuation and emphasis. (3) The answer doesn't synthesize the multi-hop evolution across the three years effectively - it reads more as a static snapshot than a trajectory showing how the approach evolved. (4) Missing context: the ground truth notes that future transactions \"could result in additional noncash settlement charges\" - the LLM notes no charges appeared in 2022-2024 but doesn't address the forward-looking expectation of future charges.\n\nCALCULATION/FACT VERIFICATION: All numbers cited are accurate. The $11.6 billion cumulative figure, $4.9 billion 2021 GAC, $1.7 billion settlement charge, $990 million 2024 contributions, and $1.7 billion CAS recovery figures are all correct. No mathematical errors detected.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022-2024 filings and correctly identifies the pension risk transfer strategy. However, it fails to adequately synthesize the EVOLUTION aspect - the question specifically asks how the approach \"evolved,\" and the LLM's answer suggests minimal evolution (no new transactions announced) rather than capturing the company's consistent emphasis on future transactions and strategic continuation.\n\nSEMANTIC EQUIVALENCE: The LLM's answer is factually accurate but semantically misses the narrative arc. The ground truth emphasizes proactive, evolving strategy with increasing scale; the LLM emphasizes lack of new transactions and static continuation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 719,
        "total_tokens": 2211
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "In the 2022 10‑K, Thermo Fisher listed only the Executive Change‑in‑Control Retention Agreement with CEO Marc N. Casper (Exhibit 10.11). By the 2023 filing the company added a separate form of the agreement for other officers (Exhibit 10.17), expanding the retention program beyond the CEO. The 2024 filing continued to include this officer‑level agreement along with the original Casper agreement and its amendments, showing a broadened retention framework that now covers additional executives.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Thermo Fisher's Executive Change In Control Retention Agreements from 2022-2024 and correctly identifies the key progression: (1) 2022 - agreement for Marc N. Casper only, (2) 2023 - addition of separate form for other officers, (3) 2024 - continuation of both agreements. The answer demonstrates sound multi-hop reasoning by synthesizing information across three fiscal years and correctly identifies the strategic shift from CEO-only to broader executive coverage. Strengths: Correctly identifies the three-year timeline, accurately notes the expansion beyond Casper, properly references exhibit numbers (10.11, 10.17), and captures the semantic meaning of the evolution. Minor weaknesses: (1) The LLM provides less specific detail about the April 1, 2023 date for the new officer form compared to the ground truth's explicit mention of this date, (2) The ground truth emphasizes the March 16, 2018 original date for the officer form, which the LLM omits, (3) The LLM's phrasing 'continued to include this officer-level agreement along with the original Casper agreement and its amendments' is slightly less precise than the ground truth's distinction between the 2023 filing and 2024 reaffirmation. The answer is semantically equivalent and factually sound on the main points but lacks some of the granular dating details present in the ground truth. No calculation errors or factual inaccuracies detected; the multi-hop synthesis across years is logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 417,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "PepsiCo’s 10‑Ks for 2022‑24 all list the 2.750% Senior Note due 2051 (Exhibit 4.3, see page 126 4.51, page 128 4.51, page 129 4.48), showing the note remains an outstanding, long‑term, fixed‑rate obligation. By locking in a 2.75 % coupon well before recent rate hikes, PepsiCo is hedging against rising interest costs while keeping a diversified debt mix that balances short‑ and long‑term maturities. This consistent treatment signals a deliberate strategy of securing low‑rate, long‑term financing to stabilize debt costs rather than aggressively refinancing or paying down debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of PepsiCo's long-term debt strategy with the 2.750% Senior Note due 2051, but contains some issues: (1) CORRECT ELEMENTS: The core insight is accurate—the note appears consistently across 2022-2024 filings as a fixed-rate, long-term obligation. The 2.75% coupon rate is correctly stated. The strategic interpretation about locking in low rates before rate hikes and maintaining a diversified debt mix is sound and aligns with the ground truth's conclusion about stable capital strategy. (2) QUANTITATIVE ACCURACY: The coupon rate (2.750%) is correct. However, the exhibit references cited (4.3, 4.51, 4.48) cannot be verified against the ground truth, which references pages 135, 128, and 129 respectively but doesn't specify exact exhibit numbers. The page numbers provided (126, 128, 129) are approximately consistent with ground truth pages (135, 128, 129) but show minor discrepancies. (3) MULTI-HOP REASONING: The LLM successfully synthesizes information across three years and correctly identifies the strategic implication—maintaining fixed-rate debt in a rising rate environment. This matches the ground truth's conclusion about 'stable long-term capital strategy.' The mention of 'newer, higher-yielding notes' in ground truth is not explicitly addressed, though the LLM does reference 'diversified debt mix.' (4) COMPLETENESS: The answer addresses the core question about long-term debt strategy in a rising rate environment. However, it doesn't explicitly mention the comparison with newer notes (like the 5.250% Senior Note due 2054) that the ground truth highlights as context for understanding the strategic consistency. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation ('hedging against rising interest costs,' 'securing low-rate, long-term financing') conveys essentially the same strategic insight as the ground truth ('preserved access to long-dated, fixed-rate debt'). Minor weakness: The LLM doesn't explicitly note the unchanged treatment across years as clearly as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 554,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023, and 2024 all list the same 4.45% Notes due 2044 as part of its long‑term debt portfolio, with no new issuances or changes to the coupon or maturity (see Exhibit 4.4 on page 54 of each filing). The unchanged presence of this instrument over three years shows that Apple relies on a stable, fixed‑rate debt base to provide predictable financing costs and to match long‑term capital needs, reflecting a conservative long‑term capital strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-year information. STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 as the specific debt instrument across all three years (2022-2024); (2) Accurately notes the unchanged presence and no new issuances or coupon/maturity changes; (3) Properly cites Exhibit 4.4 as the source location; (4) Provides sound reasoning about Apple's capital strategy - fixed-rate debt for predictable financing costs and long-term capital matching; (5) Correctly characterizes this as reflecting a conservative long-term capital strategy. MINOR ISSUES: (1) The LLM specifies 'page 54' for Exhibit 4.4, which is a specific detail not verified in the ground truth and could be subject to variation across filing formats; (2) The LLM's characterization of the strategy as 'conservative' is reasonable inference but slightly more interpretive than the ground truth's more neutral 'strategic decision to retain long-term debt'; (3) The ground truth mentions 'Officer's Certificate dated May 6, 2014' as a specific document reference, which the LLM does not include, though this is a minor omission. MULTI-HOP REASONING: The LLM correctly synthesizes information across three years of filings to identify the pattern of consistency and draws appropriate conclusions about capital strategy implications. The logic connecting unchanged debt presence to strategic intent is sound. QUANTITATIVE ACCURACY: All numbers (4.45%, 2044 maturity date, three-year period 2022-2024) are correct with no calculation errors. The answer appropriately avoids making unsupported numerical claims about amounts or changes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 457,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "Union Pacific’s pension plan cut its allocation to Collective Trust and Other Funds from **$622 million in 2022 to $382 million in 2023** – a $240 million decline. The 2024 filing explains that these investments are valued at **NAV based on the publicly traded underlying assets of the commingled funds**, indicating that the plan manages them through regular NAV calculations derived from market data, providing a transparent and relatively low‑valuation‑risk approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states the 2022 allocation was $622 million, but the ground truth clearly indicates it was $756 million. This is a $134 million discrepancy (17.7% error). The 2023 figure of $382 million is correct. The calculated decline of $240 million is therefore incorrect; the actual decline was $374 million ($756M - $382M). (2) CALCULATION ERROR - The LLM's math ($622M - $382M = $240M) is arithmetically correct for the numbers it cited, but those numbers are wrong, making the final calculation meaningless. (3) VALUATION METHODOLOGY - The LLM's description of NAV-based valuation is partially correct but oversimplifies. The ground truth explains that NAV is derived from 'shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments.' The LLM's phrase 'publicly traded underlying assets' is not supported by the ground truth and may be inaccurate. (4) MISSING CONTEXT - The LLM fails to adequately address the ground truth's important insight that the reduction 'may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach.' The LLM's characterization of NAV as 'relatively low-valuation-risk' is not substantiated in the ground truth. (5) MULTI-HOP REASONING - While the LLM attempts to connect 2022-2023 allocation changes with 2024 methodology disclosure, it does so with incorrect baseline numbers, undermining the entire synthesis. The core factual error (2022 figure) is fundamental and disqualifying for a financial analysis question where precision is critical.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 453,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "Apple’s 10‑K filings for 2022, 2023 and 2024 all list Exhibit 4.4 – the Officer’s Certificate dated May 6, 2014 that includes the 1.05 % Notes due 2017 (see 2022 page 58, 2023 page 58 and 2024 page 58). By continuing to attach this certificate even though the notes had matured in 2017, Apple demonstrates a deliberate practice of retaining and disclosing documentation for all debt issuances, past and present. This approach signals a commitment to a comprehensive, historically complete capital‑structure record, ensuring transparency and regulatory compliance for investors and regulators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All specific dates, percentages, and references are correct - the Officer's Certificate is accurately dated May 6, 2014, the notes are correctly identified as 1.05% Notes due 2017, the fiscal years (2022, 2023, 2024) are accurate, and the exhibit reference (Exhibit 4.4) with page numbers (58 for each year) are all correct. The maturation year of 2017 is properly identified. ENTITY ACCURACY: Apple is correctly identified, all fiscal years are correct, and the specific debt instrument is properly characterized. MULTI-HOP REASONING: The LLM successfully synthesizes the key insight that Apple's continued inclusion of matured debt documentation across three consecutive years reflects a deliberate documentation retention practice. The reasoning correctly connects the factual observation (inclusion across three years) to the broader implication (commitment to historical completeness and transparency). SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same meaning as the ground truth - both emphasize Apple's deliberate practice of maintaining historical debt records, the emphasis on completeness and transparency, and the regulatory/investor disclosure implications. The LLM uses slightly different phrasing ('signals a commitment' vs 'suggests a deliberate approach') but these are semantically equivalent. MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but loses no substantive information. The inclusion of specific page numbers (58) adds helpful detail not in the ground truth but doesn't contradict it. The answer fully addresses the complex question about documentation retention practices and implications for capital structure disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 496,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "Union Pacific’s pension plan cut its corporate‑stock exposure sharply: corporate stock represented about 25.5 % of plan assets in 2022 (1,111 M/4,363 M) but fell to roughly 4.1 % in 2023 (181 M/4,400 M) (page_57, page_58). In 2024 the plan’s equity allocation was 24 % of assets (target 20‑30 %) (page_55), and corporate stock remained a small fraction of that equity mix, indicating a deliberate de‑risking and diversification of equity holdings over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect dollar amounts that contradict the ground truth. Ground truth states corporate stock was $1,990M in 2022, $181M in 2023, and $1,116M in 2024. The LLM claims corporate stock was only $1,111M in 2022 (off by $879M or 44%), which is a major factual error. The LLM also states corporate stock 'remained a small fraction' of equity in 2024, but ground truth shows $1,116M in 2024, which is substantial and represents a significant rebound from 2023's $181M low. CALCULATION ERRORS: The LLM's percentage calculations (25.5% for 2022, 4.1% for 2023) cannot be verified against the stated dollar amounts and appear inconsistent with the ground truth narrative. The LLM correctly identifies the 2023 figure of $181M but misses the critical context that this represents a 90%+ decline from 2022, followed by a substantial recovery in 2024. INCOMPLETE ANALYSIS: The LLM fails to capture the full three-year evolution pattern (sharp decline 2022-2023, then partial rebound 2024) and instead suggests corporate stock 'remained a small fraction' in 2024, which contradicts the ground truth showing a recovery to $1,116M. REASONING QUALITY: While the LLM correctly identifies a de-risking strategy, it does so based on incorrect numbers and misses the nuanced story of the 2024 rebound. The reference to 'target 20-30%' for equity allocation is contextually relevant but doesn't address the specific corporate stock allocation question. The answer demonstrates partial understanding of pension investment strategy but fails on the fundamental factual accuracy required for financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 454,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "Prevymis sales grew from **$428 million in 2022 to $605 million in 2023 and $785 million in 2024** (page 130). This steady year‑over‑year increase—about 41 % from 2022 to 2023 and 29 % from 2023 to 2024—indicates strong market adoption among transplant and high‑risk patients and underscores Prevymis as a strategically important revenue driver in Merck’s Hospital Acute Care segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct—$428M (2022), $605M (2023), $785M (2024) match the ground truth exactly. The calculated growth rates are accurate: 41.4% from 2022-2023 ($605M/$428M - 1 = 0.414) and 29.8% from 2023-2024 ($785M/$605M - 1 = 0.298), both correctly rounded to 41% and 29%. (2) COMPLETENESS: The answer addresses all parts of the multi-part question—it provides the sales trajectory across all three years and interprets what this suggests about market adoption and strategic importance. (3) ENTITY ACCURACY: All entities are correctly identified (MRK/Merck, Prevymis, Hospital Acute Care segment, transplant patients). (4) MULTI-HOP REASONING: The answer successfully synthesizes information by connecting the numerical trajectory to qualitative insights about market adoption and strategic importance, demonstrating sound logical reasoning. (5) SEMANTIC EQUIVALENCE: The LLM's interpretation that the growth indicates 'strong market adoption' and 'strategically important revenue driver' aligns with the ground truth's characterization of 'consistent market adoption and increasing strategic importance.' The addition of context about 'transplant and high-risk patients' provides helpful specificity without contradicting the ground truth. Minor note: The LLM includes a page reference (page 130) which adds credibility but wasn't in the ground truth—this is a positive addition. The only minor consideration is that the LLM's phrasing is slightly more detailed than the ground truth, but this represents enhancement rather than error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 451,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "In each of PepsiCo’s 10‑K filings, the 3.000% Senior Note due 2027 is listed identically as “Form of 3.000% Senior Note due 2027,” incorporated by reference to Exhibit 4.3 to the 8‑K filed on Oct 10 2017 (2022 page 127; 2023 page 127; 2024 page 129). The unchanged description—fixed‑rate, senior debt maturing in 2027—shows that PepsiCo’s long‑term debt strategy relies on a stable mix of senior notes with moderate coupons, keeping this instrument as a core, predictable component of its debt portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core question about how the note's characterization evolved across the three years. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific page numbers (127, 127, 129) and an 8-K filing date (Oct 10 2017) that cannot be verified against the ground truth. The ground truth references specific exhibits (4.22 in 2022, 4.19 in 2023, 4.17 in 2024) which differ from the LLM's claim of Exhibit 4.3. (2) INCOMPLETE SYNTHESIS: The ground truth demonstrates a multi-hop analysis showing how the note's context evolved—appearing alongside different debt instruments in each year (2.150% and 2.250% notes in 2022; 4.450% and 3.450% notes in 2023; 0.750% and 1.125% notes in 2024). The LLM completely misses this comparative analysis across years. (3) MISSING STRATEGIC INSIGHT: The ground truth explains the strategic implication—layering debt maturities to manage refinancing risk and reflecting market conditions. The LLM merely states the note is 'unchanged' and 'predictable,' missing the evolution narrative entirely. (4) ENTITY/EXHIBIT ACCURACY: The LLM's specific citations to exhibits and page numbers appear inconsistent with the ground truth's exhibit references, suggesting potential factual inaccuracy. (5) REASONING FAILURE: The LLM provides a static description rather than the dynamic, comparative analysis required by the question. The answer reads as a single-year snapshot rather than an evolution across three years. The LLM fundamentally misunderstands the question's requirement to show how characterization 'evolved' rather than remained 'unchanged.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 449,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "In 2022, Frame.io was positioned as a cloud‑native collaboration platform that enabled real‑time upload, review, approval, frame‑accurate commenting and annotations, with support for still images, design files and PDFs, and was integrated only with Premiere Pro and After Effects【page_98】. By 2023, Adobe expanded Frame.io’s integration to Photoshop, Lightroom and Workfront, added casting, location‑scouting and marketing‑campaign workflows, and positioned it as part of Adobe GenStudio alongside Express and Firefly Services【page_12】. The 2024 filing repeats the same functional description and integration set, reaffirming the deep ties to Premiere Pro, After Effects, Photoshop, Lightroom and Workfront and its continued role within GenStudio, with no further functional changes beyond those introduced in 2023【page_12】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) CHRONOLOGICAL REVERSAL: The LLM claims Frame.io had real-time upload, review, approval, and frame-accurate commenting in 2022, but the ground truth states it was only listed as part of Adobe's trademark portfolio in 2022 with no detailed functional description. The detailed functional capabilities (real-time upload, review, approval) were introduced in 2023 according to ground truth. (2) INTEGRATION TIMELINE ERROR: The LLM states Frame.io was integrated only with Premiere Pro and After Effects in 2022, then expanded to Photoshop, Lightroom, and Workfront in 2023. However, ground truth indicates the 2022 mention was merely trademark portfolio listing, and the detailed integration with Premiere Pro and After Effects was described in 2023, with further expansion to Photoshop, Lightroom, and Workfront in 2024. (3) GENESTUDIO POSITIONING: The LLM claims Frame.io was positioned as part of GenStudio in 2023 alongside Express and Firefly Services, but ground truth indicates this positioning occurred in 2024 as part of Adobe GenStudio for enterprise-scale content production. (4) 2024 STAGNATION CLAIM: The LLM states 2024 had 'no further functional changes beyond those introduced in 2023,' but ground truth indicates 2024 showed 'expanded capabilities' and 'further' integration emphasis, representing continued evolution rather than stagnation. (5) MISSING CONTEXT: The LLM fails to capture the strategic progression from trademark acquisition (2022) → detailed feature introduction (2023) → enterprise positioning and ecosystem integration (2024). The answer fundamentally misorders the timeline of Frame.io's evolution across the three years, making it factually incorrect despite citing page references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 494,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "Apple’s 10‑K exhibits consistently referenced the 2.40% Notes due 2023 (Exhibit 4.3 on pages 56 in 2022 and 2023, and page 58 in 2024). In 2022 and 2023 the notes appeared as outstanding debt, but by the 2024 filing they were no longer listed as such, indicating the notes had matured and been repaid. This progression shows Apple’s disciplined maturity‑management strategy—paying down or refinancing debt before it matures to keep refinancing risk low.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR IN REASONING: The LLM answer contains a fundamental contradiction that undermines its credibility. It states Apple employed a strategy of 'paying down or refinancing debt before it matures to keep refinancing risk low,' but this directly contradicts the evidence presented in the same answer—that the notes were held until maturity (2023) and only disappeared from 2024 filings after the due date had passed. This is the opposite of early refinancing.\n\nCORRECT ELEMENTS:\n- Correctly identified the 2.40% Notes due 2023\n- Correctly noted the notes appeared in 2022 and 2023 filings\n- Correctly identified that notes were no longer listed in 2024\n- Correctly inferred the notes matured and were repaid\n- Exhibit references (4.3) and page numbers appear reasonable\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n- The stated strategy ('paying down or refinancing debt before it matures') is factually wrong based on the evidence. The ground truth explicitly states Apple's strategy was 'holding debt until maturity rather than refinancing or repurchasing it early.' The LLM contradicts itself by claiming early refinancing while showing evidence of maturity-date repayment.\n- This represents a fundamental misunderstanding of the debt management strategy being demonstrated\n- The characterization as 'disciplined maturity-management' is vague and doesn't accurately capture the 'hold-to-maturity' approach\n\nMULTI-HOP REASONING: The LLM correctly synthesized information across three years (2022, 2023, 2024) to track the debt's lifecycle, but failed to correctly interpret what this progression reveals about strategy.\n\nSEMANTIC EQUIVALENCE: While the LLM's description of the debt's appearance/disappearance is accurate, the strategic interpretation is fundamentally incorrect and contradicts the evidence presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 496,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "Union Pacific’s multiple‑purpose locomotive fleet grew modestly in owned units (from 5,971 in 2022/23 to 5,973 in 2024) while leasing fell (from 1,037 to 920), reducing the total fleet from 7,008 to 6,893 and raising the average age from 24.3 to 25.2 years (2022/23: owned 5,971, leased 1,037, total 7,008, avg age 24.3; 2024: owned 5,973, leased 920, total 6,893, avg age 25.2)【page 22】【page 19】. This gradual shift toward a larger owned base and a slightly aging fleet reflects a deliberate asset‑management strategy that balances capital investment with operational flexibility—replacing older locomotives with newer ones while maintaining a mix of owned and leased equipment to support network reliability and growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) OWNED UNITS ERROR: Ground truth shows owned units declined from 6,204 (2022) to 5,973 (2024), but LLM claims they 'grew modestly' from 5,971 to 5,973. The 2022 baseline is completely wrong (5,971 vs. 6,204 = 233-unit discrepancy). (2) TOTAL FLEET ERROR: LLM states total fleet was 7,008 in 2022/23, but ground truth shows 7,242 in 2022. This is a 234-unit error. (3) LEASED UNITS: LLM shows 1,037 leased units, but ground truth shows 1,038 in 2022. Minor but still inaccurate. (4) AVERAGE AGE DISCREPANCY: LLM omits the 2022 average age (22.5 years) entirely and jumps to 24.3 years for 2022/23, creating confusion about the baseline. The progression should be 22.5→24.3→25.2, not 24.3→25.2. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM mischaracterizes the trend as 'modest growth in owned units' when the actual trend is a DECLINE of 231 units (6,204→5,973). This is a fundamental misinterpretation of the data direction. (6) STRATEGIC INTERPRETATION: While the LLM's characterization of 'deliberate asset-management strategy' attempting to balance capital investment with flexibility is reasonable, it contradicts the ground truth's assessment of a 'conservative asset management strategy' with 'minimal fleet expansion' and 'gradual decline.' The LLM's narrative of 'replacing older locomotives with newer ones' is unsupported by the data showing aging fleet. CORRECT ELEMENTS: The LLM correctly identifies that leasing declined (1,037→920) and that average age increased (24.3→25.2 for the years it captures). The company name (Union Pacific) and asset category (Multiple Purpose Locomotives) are correct. OVERALL ASSESSMENT: The answer fails on quantitative accuracy due to wrong baseline numbers and mischaracterization of trends (growth vs. decline). The qualitative reasoning, while somewhat coherent, is built on incorrect data and reaches conclusions inconsistent with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 547,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "From 2022 through 2024, Merck’s MK‑8591A (doravirine + islatravir) remained a Phase 3 program (entered in February 2020) but was subject to an FDA clinical hold that began in 2021 because of observed lymphocyte‑count reductions (page 23, 24). In 2023 the program continued as a Phase 3 trial with the current dose, still under the hold and with no new studies initiated (page 21, 24). By 2024 the FDA issued a partial hold that lifted restrictions on the current dose while maintaining a hold on higher‑dose regimens, allowing the Phase 3 program to proceed with the existing dose but not higher‑dose studies (page 24 footnotes).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides accurate information about MK-8591A's development trajectory from 2022-2024 with correct dates and phase information. Key strengths: (1) Correctly identifies MK-8591A as Phase 3 with February 2020 entry date; (2) Accurately describes the FDA clinical hold beginning in 2021 due to lymphocyte-count reductions; (3) Correctly notes the 2024 partial hold that lifted restrictions on current dose while maintaining hold on higher-dose regimens; (4) Properly synthesizes the multi-year regulatory dynamics. However, there are notable omissions: (1) The LLM answer completely fails to mention MK-8591D (islatravir+lenacapavir), which entered Phase 3 in October 2024 - this is a significant strategic development that represents a formulation pivot/expansion; (2) The ground truth emphasizes this as a 'strategic pivot or expansion in Merck's HIV-1 treatment approach,' which the LLM answer entirely misses. The LLM answer focuses narrowly on MK-8591A's regulatory hold status without addressing the broader portfolio evolution. Quantitative accuracy is strong (dates, phases correct), but qualitative accuracy suffers from the incomplete synthesis of the full development trajectory. The answer addresses the clinical phase progression and FDA interactions well but fails to capture the complete picture of Merck's evolving HIV-1 treatment strategy across multiple formulations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 388,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "Merck’s MK‑1308A, a co‑formulation of the investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab, entered Phase 3 development for renal cell carcinoma (RCC) in 2022 (page_23).  In 2023 and 2024 the company continued to advance the same combination as a key RCC program, keeping it within its immuno‑oncology portfolio (page_20, page_48).  This steady progression underscores Merck’s strategic emphasis on expanding its RCC portfolio through innovative combination immunotherapies that build on its Keytruda platform.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative about MK-1308A's progression through Phase 3 development for RCC and correctly identifies it as a quavonlimab + pembrolizumab combination within Merck's immuno-oncology portfolio. However, there are significant issues with temporal accuracy and completeness: (1) QUANTITATIVE/TEMPORAL ERRORS: The LLM states MK-1308A 'entered Phase 3 development for renal cell carcinoma (RCC) in 2022' but the ground truth indicates the entry date was April 2021, with 2022 being when it was listed in Phase 3 programs. This is a factual error regarding the timeline. (2) MISSING CONTEXTUAL DETAIL: The ground truth emphasizes a 3-year trajectory (2022-2024) showing evolution and deepening investment, with 2023 specifically highlighting 'deeper investment in combination immunotherapies' and 2024 showing 'sustained strategic prioritization.' The LLM answer describes the progression more flatly as 'steady progression' without capturing the nuanced evolution across the three years. (3) INCOMPLETE SYNTHESIS: The ground truth provides specific characterizations for each year (early-stage commitment in 2022, deeper investment emphasis in 2023, sustained prioritization in 2024), while the LLM collapses 2023-2024 into a single statement about 'continued advancement.' (4) CORRECT ELEMENTS: The LLM correctly identifies the drug composition, the Phase 3 status, the RCC indication, the immuno-oncology portfolio placement, and the strategic emphasis on combination therapies building on Keytruda. The page references suggest source documentation was consulted. (5) REASONING QUALITY: The multi-hop synthesis is adequate but lacks the temporal granularity and strategic evolution narrative that the ground truth emphasizes. The conclusion about 'expanding RCC portfolio through innovative combination immunotherapies' is sound but somewhat generic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 508,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "Microsoft continues to disclose the 4.000% Notes due 2021 as part of Exhibit 4.6 (the Third Supplemental Indenture) in each filing (2022, 2023, and 2024 – see pages 104 of the respective 10‑Ks).  The indenture’s terms, maturity, and the note’s inclusion remain unchanged, indicating that Microsoft has not refinanced or altered this tranche.  This consistency reflects a long‑term debt strategy that relies on stable, fixed‑rate notes and a deliberate, low‑frequency refinancing approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Microsoft disclosed the 4.000% Notes due 2021 in Exhibit 4.6 across 2022, 2023, and 2024 10-Ks, (2) the disclosure remained consistent/unchanged, and (3) no refinancing occurred. The answer accurately conveys the semantic meaning of the ground truth regarding consistency and stability of the debt instrument. However, there are notable omissions: (1) The LLM does not mention the Third Supplemental Indenture by name, only referencing 'Exhibit 4.6,' which is less precise than the ground truth's explicit identification; (2) The original Indenture date (May 18, 2009) is not mentioned; (3) The specific 8-K filing date (February 8, 2011) referenced in the ground truth as supporting evidence is absent; (4) The page reference to 'pages 104' is provided but not verified against ground truth documentation. The LLM's interpretation of what the consistency 'suggests' about Microsoft's strategy (stable, fixed-rate notes and low-frequency refinancing) is reasonable and aligns with the ground truth's conclusion, though it adds interpretive language not explicitly in the original answer. The quantitative accuracy is strong (the 4.000% rate and 2021 maturity are correct, years 2022-2023-2024 are correct), but the qualitative accuracy is slightly reduced due to missing specific documentary references that would strengthen the multi-hop synthesis across the three filing years. The answer demonstrates sound reasoning about what consistency implies for debt strategy, but lacks the granular documentary evidence that would fully support the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 443,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "Qualcomm has positioned itself as a leading provider of connectivity, digital‑cockpit and ADAS/AD solutions for automakers, a strategy highlighted in the 2024 10‑K’s discussion of the “digital cockpit” (page 8).  QCT’s automotive revenue—encompassing digital‑cockpit sales—rose from $1.51 billion in 2022 to $1.87 billion in 2023 and to $2.91 billion in 2024 (page 73), a 93 % jump over two years.  This growth signals a clear shift from a mobile‑centric focus to a substantial automotive platform business, positioning Qualcomm as a key growth driver in connected vehicles.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies Qualcomm's positioning around digital cockpit, connectivity, and ADAS/AD solutions. (2) Revenue figures appear accurate: $1.51B (2022), $1.87B (2023), $2.91B (2024) for QCT automotive segment. (3) The 93% growth calculation is mathematically correct: ($2.91B - $1.51B) / $1.51B = 92.7% ≈ 93%. (4) The answer correctly identifies the shift toward automotive as a growth platform.\n\nWEAKNESSES: (1) The LLM answer provides specific revenue numbers but the ground truth does not mention these figures at all—this creates a factual verification problem. The ground truth focuses on strategic positioning and categorization evolution (2022 identification → 2023 formal categorization → 2024 operationalization), not revenue amounts. (2) The LLM answer fails to address the 2022 projections mentioned in ground truth (70% of vehicles with embedded cellular by 2028, 60% with 5G). (3) Missing the key strategic evolution narrative: the progression from 'identified as key driver' (2022) → 'explicitly categorized as distinct revenue stream' (2023) → 'listed as core product line' (2024). (4) The LLM answer doesn't capture the conceptual shift toward 'software-defined vehicle' enablement that the ground truth emphasizes. (5) While the LLM provides financial data, it doesn't synthesize the multi-hop reasoning about strategic transformation that the question asks for.\n\nMULTI-HOP REASONING: The question asks about evolution from 2022-2024 AND what this indicates about automotive transformation. The ground truth provides a clear three-year progression narrative. The LLM provides revenue growth but misses the strategic categorization evolution that is central to the ground truth answer. The LLM's focus on financial metrics rather than strategic positioning represents incomplete synthesis of the multi-hop question.\n\nCRITICAL ISSUE: The revenue numbers in the LLM answer cannot be verified against the ground truth, which doesn't mention specific revenue figures. This creates uncertainty about whether these numbers are accurate or hallucinated, though they appear plausible for a 10-K filing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 574,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "LMT uses variable‑interest‑rate swaps as fair‑value hedges to convert fixed‑rate borrowings into variable‑rate borrowings (page 52).  The aggregate notional amount of outstanding swaps was $1.3 billion at December 31 2022 and 2023 (page 95) and remained unchanged at $1.3 billion at December 31 2024 (page 52).  This steady notional level shows that the company has maintained a consistent, disciplined hedging program rather than expanding or contracting its interest‑rate risk exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the 2022 notional amount. The ground truth clearly states that in 2022, LMT had $500 million in outstanding interest rate swaps, which increased to $1.3 billion in 2023. However, the LLM answer claims the notional amount was $1.3 billion at December 31, 2022, which is incorrect. This is a major quantitative error that undermines the entire analysis. The LLM correctly identifies that the amount remained at $1.3 billion in 2023 and 2024, but the missing 2022 baseline ($500 million) is essential to answering the question about how the use 'evolved' from 2022 through 2024. REASONING FAILURE: The LLM's interpretation that the company 'maintained a consistent, disciplined hedging program' directly contradicts the ground truth's observation of a 'fourfold increase from 2022 to 2023,' which represents a significant strategic shift, not consistency. The LLM failed to capture the key insight that the 2022-to-2023 increase indicates a strategic shift in response to rising interest rates or increased debt levels. COMPLETENESS ISSUE: The question specifically asks about the evolution 'from 2022 through 2024,' requiring analysis of the trend across all three years. The LLM's answer omits the critical 2022 data point ($500 million), making it impossible to assess the actual evolution. The ground truth provides the complete picture: $500M (2022) → $1.3B (2023) → $1.3B (2024), showing both a dramatic increase and subsequent stabilization. The LLM only captures the latter two years. CONTEXTUAL RELEVANCE: While the LLM correctly identifies that these are fair-value hedges and provides page references, it fundamentally misinterprets what the data reveals about the company's strategy, missing the strategic shift narrative that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 504,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "Microsoft consistently disclosed the 3.950% Notes due 2056 in Exhibit 4.14 of its 2022, 2023 and 2024 10‑Ks (page 105 in each filing), with no changes to the terms or maturity.  The unchanged presentation shows that Microsoft has not refinanced or repaid these notes early, indicating a strategy of keeping a long‑term debt profile and deferring refinancing until the notes approach maturity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Microsoft consistently disclosed the 3.950% Notes due 2056 across 2022, 2023, and 2024 10-Ks with no changes to terms or maturity, and did not refinance or redeem these notes early. The answer accurately captures the strategic implication that Microsoft maintained a long-term debt profile without early refinancing. However, there are several areas where the answer falls short of the ground truth: (1) The LLM provides specific exhibit and page references (Exhibit 4.14, page 105) that cannot be verified against the ground truth and may be hallucinated details. (2) The answer lacks the important contextual detail about the Eleventh Supplemental Indenture dated August 8, 2016, which the ground truth identifies as the governing document. (3) The ground truth provides richer strategic context by explicitly comparing this long-term debt strategy to shorter-term instruments (2.000% Notes due 2023, 2.400% Notes due 2026) that matured or approached maturity during the period, demonstrating a deliberate portfolio management approach. The LLM answer mentions 'shorter-term instruments' generically but doesn't provide specific examples. (4) The ground truth emphasizes the strategic prioritization of long-dated liabilities to support long-term investment horizons during periods of evolving market interest rates—nuance that the LLM answer lacks. The LLM's core reasoning about maintaining long-term debt stability is sound and semantically equivalent to the ground truth, but the answer is less comprehensive and includes potentially unreliable specific references.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 444,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023 and 2024 all list the Eleventh Supplemental Indenture (dated Aug. 8 2016) as the governing document for its 3.700% Notes due 2046【page 105】. The repeated reference shows that the 2046 notes remain outstanding and that Microsoft continues to rely on the same covenant‑enforced indenture, underscoring a stable long‑term debt profile and consistent adherence to its financial obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key factual elements: (1) The Eleventh Supplemental Indenture date of August 8, 2016 is accurate, (2) The 3.700% Notes due 2046 are correctly identified, (3) The three fiscal years (2022, 2023, 2024) are correct, (4) The assertion that these notes remain outstanding across all three years is accurate. Quantitative accuracy is high with all dates and percentages correct.\n\nWEAKNESSES: The LLM answer is significantly less comprehensive than the ground truth. Specifically: (1) MISSING CONTEXT: The ground truth explains the broader debt structure (base Indenture dated May 18, 2009, and subsequent supplemental indentures), showing a layered financing approach. The LLM omits this important structural context. (2) INCOMPLETE ANALYSIS: The ground truth explicitly states that consistent references indicate 'no material amendments or retirements during this time,' providing deeper insight into what the consistency means. The LLM merely states the notes 'remain outstanding' without this analytical depth. (3) MISSING STRATEGIC INSIGHT: The ground truth explains this reflects 'a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.' The LLM's reference to 'covenant-enforced indenture' and 'stable long-term debt profile' is weaker and less insightful. (4) INCOMPLETE ANSWER TO MULTI-PART QUESTION: The original question asks about significance, reflection on long-term debt structure, and consistency in financial obligations. The LLM addresses consistency but inadequately addresses the structural implications and strategic significance.\n\nCALCULATIONS/NUMBERS: All numeric values are correct (dates, percentages). No calculation errors detected.\n\nMULTI-HOP REASONING: The LLM demonstrates basic multi-hop synthesis (connecting the indenture to the notes across three years) but fails to synthesize the deeper structural relationships (base indenture + supplemental indentures) that the ground truth emphasizes.\n\nSEMANTIC EQUIVALENCE: While the LLM's core assertion is factually correct, it lacks the analytical depth and comprehensive scope of the ground truth answer. The answer is accurate but incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 604,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "Microsoft’s FY 2022, FY 2023, and FY 2024 10‑Ks all list the 2.125% Notes due 2021 as part of Exhibit 4.1 (the Seventh Supplemental Indenture) (see FY 2022 page 104; FY 2023 page 104; FY 2024 page 104). Because those notes matured in 2021, the FY 2022 filing no longer reports them as an outstanding liability; the indenture remains only as a reference exhibit in FY 2023 and FY 2024. This indicates that Microsoft has retired the debt and is actively refinancing older obligations, underscoring a disciplined debt‑management strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) the 2.125% Notes due 2021 appear in Exhibits across FY 2022, FY 2023, and FY 2024 filings, (2) all three years reference page 104, and (3) the notes matured in 2021. The quantitative accuracy is strong—all dates, page numbers, and fiscal years are correct. However, there are significant qualitative and reasoning issues: (1) The LLM claims the notes are listed in 'Exhibit 4.1 (the Seventh Supplemental Indenture)' for all three years, but the ground truth indicates FY 2022 lists them in Exhibit 4.10 under the Seventh Supplemental Indenture, while FY 2023 and FY 2024 list them in Exhibit 4.1. This is a material discrepancy in exhibit identification. (2) The LLM states 'the FY 2022 filing no longer reports them as an outstanding liability,' which is a reasonable inference but goes beyond what the ground truth explicitly states. (3) Most critically, the LLM's interpretation that 'Microsoft has retired the debt and is actively refinancing older obligations' is presented as definitive fact, whereas the ground truth explicitly acknowledges uncertainty: 'This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings.' The ground truth raises questions about whether Microsoft refinanced or if there is a reporting lag, but the LLM presents a single confident conclusion without acknowledging this ambiguity. (4) The LLM's characterization of this as evidence of a 'disciplined debt-management strategy' is interpretive and not supported by the ground truth, which is more cautious about drawing conclusions. The answer is partially correct on facts but oversimplifies the interpretation and misses the exhibit numbering discrepancy between FY 2022 and subsequent years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 504,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "Microsoft issued the 2.000 % Notes due 2023 under the Eleventh Supplemental Indenture filed in August 2016 (see Exhibit 4.14).  Those notes were outstanding through FY 2022, matured in FY 2023, and were no longer outstanding in FY 2024, indicating that Microsoft maintains a staggered, long‑term debt profile with fixed‑rate notes that are retired or refinanced in a predictable, low‑cost manner.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 2.000% Notes due 2023 are correctly identified with the Eleventh Supplemental Indenture dated August 8, 2016; (2) The notes were outstanding through FY 2022 is accurate; (3) The notes matured in FY 2023 is correct; (4) The notes were no longer outstanding in FY 2024 is accurate. PROBLEMATIC ELEMENTS: (1) The LLM claims the notes 'matured in FY 2023' and were 'retired or refinanced,' but the ground truth states Microsoft 'did not retire or refinance it before its maturity in 2023'—this is a subtle but important distinction. The ground truth emphasizes that the notes simply matured and were not actively refinanced, whereas the LLM suggests active management/refinancing; (2) The LLM's characterization of Microsoft's debt strategy as 'staggered, long-term debt profile with fixed-rate notes that are retired or refinanced in a predictable, low-cost manner' goes beyond what the ground truth supports. The ground truth emphasizes 'stable and long-term approach to debt management, relying on established structures rather than frequent refinancing'—the LLM's framing suggests more active refinancing activity than the ground truth indicates; (3) The LLM adds interpretive language about 'predictable, low-cost manner' that is not supported by the source material. MULTI-HOP REASONING: The LLM correctly synthesizes the three-year pattern (FY 2022 → FY 2023 → FY 2024) but mischaracterizes the strategic implications. The ground truth emphasizes consistency and stability through established structures, while the LLM emphasizes active management and refinancing. This represents a meaningful difference in interpreting Microsoft's debt management strategy. QUANTITATIVE ACCURACY: All dates and percentages are correct (2.000%, August 8, 2016, 2023 maturity). QUALITATIVE ACCURACY: The reasoning about the three-year evolution is sound, but the interpretation of what this pattern indicates about strategy diverges from the ground truth in a material way.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 551,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "By the 2022 filing, Lockheed Martin had already transferred $4.9 billion of defined‑benefit obligations in 2021 and a cumulative $11.6 billion of pension‑risk‑transfer contracts since 2018, covering roughly 95,000 retirees and cutting PBGC premiums by about $69 million annually; the 2021 transaction incurred a $1.7 billion non‑cash settlement charge (page 60). The 2023 filing reiterated the company’s intent to evaluate further risk‑transfer deals but reported no new large transfers (page 19). In 2024, Lockheed Martin again emphasized its ongoing pursuit of additional pension‑risk‑transfer transactions, noting that future deals could generate material non‑cash settlement charges, while the cumulative transferred obligations remained at $11.6 billion (page 47).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and timeline. Verified numbers: $4.9 billion (2021 transfer), $11.6 billion (cumulative since 2018), $1.7 billion noncash settlement charge, $69 million annual PBGC premium reduction, and ~95,000 retirees covered are all accurate. The chronological progression (2022→2023→2024) is correctly presented with appropriate distinctions: 2022 referenced the 2021 transaction, 2023 showed evaluation of future deals with no new large transfers, and 2024 reaffirmed intent for additional transactions. Multi-hop synthesis is sound, connecting transaction scale, financial impact, and strategic intent across three years. Minor weaknesses: (1) The answer could have been slightly more explicit about the 'evolution' aspect by emphasizing the consistency of strategy rather than just listing facts year-by-year; (2) The phrase 'cumulative transferred obligations remained at $11.6 billion' in 2024 could be clearer—it's accurate but doesn't explicitly state whether new transfers occurred between 2023-2024 (ground truth indicates continued strategy but no specific new transaction amounts disclosed). (3) The answer omits mention of 'volatility in pension expense due to economic assumptions' noted in the ground truth for 2023, though this is a minor contextual detail. The page references provided (60, 19, 47) appear reasonable for a 10-K structure but cannot be verified against actual filings. Overall, the answer correctly synthesizes multi-hop information across years with accurate numbers and sound reasoning, with only minor gaps in contextual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 454,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "Apple’s 2022‑2024 10‑Ks repeatedly list the “Floating Rate Notes due 2019” in the description of securities (Exhibit 4.4), showing that these notes remain part of the company’s structured debt program.  The continued reference indicates that Apple routinely rolls over or refinances maturing floating‑rate debt rather than retiring it outright, reflecting a disciplined long‑term debt‑management strategy that balances interest‑rate exposure with a mix of fixed‑ and floating‑rate instruments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question about Apple's debt management strategy. STRENGTHS: (1) Correctly identifies the Floating Rate Notes due 2019 appearing in 2022-2024 filings; (2) Accurately notes these notes matured in 2019 yet continued to appear in later filings; (3) Properly interprets this as indicating rollover/refinancing rather than retirement; (4) Correctly identifies the disciplined debt management approach; (5) Appropriately references Exhibit 4.4 as the source; (6) Accurately characterizes the strategy as balancing interest-rate exposure with mixed fixed/floating instruments. WEAKNESSES: (1) The LLM answer is more specific/definitive in stating these notes \"remain part of the company's structured debt program\" and that Apple \"routinely rolls over or refinances\" - the ground truth is more cautious, using language like \"may have been\" and \"may have rolled over,\" suggesting these are inferences rather than confirmed facts; (2) The ground truth emphasizes \"transparency around historical debt instruments\" as a key aspect, which the LLM answer doesn't explicitly mention; (3) The LLM answer doesn't acknowledge the somewhat unusual nature of continued disclosure of matured debt (2019 maturity appearing in 2024 filings is a 5-year lag). QUANTITATIVE ACCURACY: All dates and references are correct (2019 maturity, 2022-2024 filings). MULTI-HOP REASONING: The answer correctly synthesizes the observation (repeated references) with the inference (rollover/refinancing strategy), though it presents inference as more certain than the ground truth does. SEMANTIC EQUIVALENCE: The core message aligns well - both answers convey that Apple's continued disclosure reflects a deliberate, disciplined debt management strategy. The difference is primarily in tone (LLM more assertive, ground truth more cautious about what the pattern \"suggests\" vs. what it definitively shows).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 524,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "Microsoft’s 10‑K filings for 2022, 2023, and 2024 all list Exhibit 4.6 – the Third Supplemental Indenture – which contains the 4.000% Notes due 2021 (see page 104). The reference remains unchanged across the three years, indicating that the note is still part of the company’s debt framework—either still outstanding or retained in the indenture for covenant and legal purposes—highlighting its ongoing relevance in Microsoft’s capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 4.000% Notes due 2021 across 2022, 2023, and 2024 10-K filings; (2) Accurately references Exhibit 4.6 and the Third Supplemental Indenture as the relevant document; (3) Correctly notes that the reference remains unchanged across three years; (4) Provides sound reasoning about why the notes remain in disclosures post-maturity (covenant/legal purposes, investor transparency); (5) Accurately characterizes the notes as either still outstanding or retained for structural/legal relevance. MINOR WEAKNESSES: (1) The citation to 'page 104' is specific but cannot be verified against the ground truth provided, which doesn't specify page numbers; (2) The answer is slightly more concise than the ground truth, which provides marginally more detail about 'structured debt disclosures' and 'continuity in investor understanding,' though this is not a material omission; (3) The phrase 'see page 104' adds specificity that may or may not be accurate across all three years' filings. MULTI-HOP REASONING: The answer correctly synthesizes information across three years (2022, 2023, 2024) and connects the consistent reference to the notes with their ongoing relevance in the capital structure. The logic linking post-maturity inclusion to covenant/legal purposes is sound and matches the ground truth's reasoning. QUANTITATIVE ACCURACY: The percentage (4.000%) and year (2021) are correct; no calculations are required. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, with slightly different wording but equivalent meaning regarding the notes' ongoing relevance and the reasons for their continued disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 483,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "UPS continued to disclose the same terms for its $276 million 7.620 % debentures across 2022‑2024: the notes are redeemable at any time at the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark Treasury yield plus 5 bps, with semi‑annual interest paid in April and October. The interest rate remained fixed at 7.620 % after the 2020 reduction, and the debentures were classified as long‑term debt with a carrying value of roughly $280 million, a small, stable portion of UPS’s debt load. Overall debt rose from about $19.7 billion in 2022 to $22.5 billion in 2024, while the debentures’ position and terms stayed unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core facts about UPS's 7.620% debentures: the $276 million principal amount, the redemption terms (greater of principal plus accrued interest or present value calculation with benchmark treasury yield plus 5 bps), semi-annual interest payments, and the carrying value of approximately $280 million. The numeric values are accurate and properly formatted. The answer correctly notes the debentures' maturity in 2030 (implied by the 2024 context) and their classification as long-term debt. The statement about overall debt rising from $19.7 billion in 2022 to $22.5 billion in 2024 appears reasonable and contextualizes the debentures appropriately. However, the LLM answer has notable gaps in addressing the question's specific focus on 'evolution' and 'progression' from 2022-2024. The ground truth emphasizes a meaningful shift in disclosure approach: from historical interest rate context (8.375% until April 2020) in 2022, to broader debt table presentation in 2023, to sharper focus on redemption mechanics and comparative positioning within international debt instruments in 2024. The LLM answer states the terms 'stayed unchanged' and presents them as static, missing the nuanced evolution in how UPS presented and contextualized these debentures across the three-year period. The answer also omits the specific detail about the 2020 rate reduction from 8.375% to 7.620% and the broader context of international debt positioning (Pound Sterling and Euro notes) that characterized the 2024 disclosure. While the core financial facts are correct, the answer fails to fully capture the disclosure evolution and comparative treatment that was central to the original question. The contextual relevance score is lower because the answer doesn't adequately address the 'evolution' aspect of the question, instead treating the debentures as static across the period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 515,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "AbbVie’s Vraylar progressed from Phase 3 trials to regulatory approval for adjunctive major‑depressive‑disorder treatment in 2021 (page 59).  In 2023 its net revenues rose 35 % to $2.76 billion from $2.04 billion in 2022, driven by market‑share gains and the new MDD indication (page 44, page 42).  By 2024 Vraylar remains a listed neuroscience asset and continues to generate substantial revenue, underscoring its role as a key growth engine within AbbVie’s neuroscience portfolio (page 6).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Vraylar's 2023 revenue as $2.76 billion (matches $2,759 million in ground truth), correctly states the 35% YoY increase, and accurately notes the 2022 revenue of $2.04 billion. The answer appropriately characterizes Vraylar as a key growth engine in the neuroscience portfolio and mentions the MDD indication. The multi-hop synthesis across years and financial performance is generally sound.\n\nCRITICAL ERRORS: (1) The LLM states Vraylar received regulatory approval for adjunctive MDD treatment in 2021, but the ground truth indicates Phase 3 trial results were announced in 2022 with mixed outcomes (one trial meeting primary endpoint, one showing numerical but not statistically significant improvement). This is a significant factual error regarding the timeline and regulatory status. (2) The LLM does not clearly distinguish between the 2022 Phase 3 trial results and any subsequent regulatory approval, creating ambiguity about the actual development trajectory.\n\nMINOR ISSUES: (1) The answer lacks detail about the specific Phase 3 trial outcomes in 2022 (one positive, one not statistically significant), which is important context for understanding the development trajectory. (2) The answer doesn't fully capture the transition from \"late-stage clinical asset in 2022\" to established market product by 2024, though it does mention progression.\n\nCALCULATION VERIFICATION: The 35% increase calculation is correct ($2.76B vs $2.04B = 35.3%, rounds to 35%). Revenue figures are accurate.\n\nMULTI-HOP REASONING: The answer attempts to synthesize information across 2022-2024 but fails on the critical 2022 clinical development milestone, instead conflating it with a 2021 approval that doesn't align with ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 482,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "Apple’s 10‑Ks for 2022, 2023 and 2024 all list the 0.45% Notes due 2016 in Exhibit 4.3 (page 58 in each filing), indicating that the legacy note remains on the books until maturity and is treated as part of the company’s long‑term debt mix. The repeated disclosure shows a consistent policy of reporting every outstanding debt instrument—new and old—so investors receive a complete view of Apple’s debt profile, rather than consolidating or omitting legacy notes. This approach underscores Apple’s commitment to transparency and regulatory compliance in its long‑term debt reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 0.45% Notes due 2016 are correctly identified across fiscal years 2022, 2023, and 2024; (2) Exhibit 4.3 is correctly cited as the location; (3) The general theme of transparency and regulatory compliance is appropriate; (4) The recognition that these are legacy notes is correct. PROBLEMATIC ELEMENTS: (1) The LLM states the notes 'remain on the books until maturity' and are 'part of the company's long-term debt mix' - this is factually incorrect. The notes matured in 2016, which was 6-8 years before the 2022-2024 filings. They should NOT be on the books as active debt obligations; (2) The phrase 'outstanding debt instrument' is misleading since these notes matured in 2016 and are no longer outstanding; (3) The LLM mischaracterizes the disclosure as reporting 'every outstanding debt instrument' when in fact Apple is disclosing historical/legacy instruments that are no longer active; (4) The LLM's interpretation that this shows 'commitment to transparency' is reasonable but misses the key insight from the ground truth: this is about preserving a complete historical record of past financing activities, not about active debt management. MULTI-HOP REASONING: The LLM failed to properly synthesize the temporal dimension - the critical insight is that despite maturity in 2016, the notes appear in 2022-2024 filings, suggesting historical documentation rather than active debt reporting. The LLM incorrectly treats them as current obligations. QUANTITATIVE ACCURACY: The date (2016) and percentage (0.45%) are correct, but the characterization of their status is wrong. The LLM's statement about page 58 cannot be verified from the ground truth but is not contradicted. Overall, the answer demonstrates partial understanding but contains a fundamental error about the debt's current status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 511,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "UPS SurePost has consistently been a residential‑ground service for non‑urgent, lightweight shipments that uses UPS’s ground network for pickup and transport and relies on the U.S. Postal Service for final delivery, and it has been positioned within UPS’s U.S. Domestic Package segment as a low‑cost, reliable option (see 2022‑24 U.S. Domestic Package description). By 2024 UPS announced it would insource the final delivery of SurePost beginning January 1 2025, shifting the service from a USPS partnership to a fully integrated UPS operation and thereby strengthening its strategic role in the domestic package portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and correctly synthesizes the multi-hop information about UPS SurePost's evolution from 2022-2024. STRENGTHS: (1) All dates are correct (2022, 2023, 2024, January 1, 2025 implementation date); (2) All key facts are accurate: SurePost described as residential ground service for non-urgent, lightweight shipments; UPS ground network for pickup/transport; USPS for final delivery through 2024; insourcing of final delivery beginning January 1, 2025; (3) The multi-hop synthesis is sound, correctly connecting the service description across years with the strategic shift announced in 2024; (4) Numeric accuracy is perfect (no calculations required, all dates/years correct); (5) Entity identification is correct (UPS, USPS, U.S. Domestic Package segment). MINOR WEAKNESSES: (1) The LLM answer states SurePost was positioned as 'low-cost, reliable option' with a parenthetical reference to '2022-24 U.S. Domestic Package description' - while this characterization is reasonable and likely supported by filings, the original answer does not explicitly emphasize the 'low-cost' positioning, focusing instead on the delivery methodology and strategic positioning; (2) The original answer explicitly notes 'continuity' in 2023 positioning, while the LLM answer implies this through 'consistently' but doesn't explicitly call out the 2023 year as a point of continuity; (3) The phrase 'fully integrated UPS operation' in the LLM answer is a reasonable inference but slightly more interpretive than the original's 'internal control to enhance service quality.' These are minor semantic/emphasis differences rather than factual errors. The answer correctly addresses all parts of the multi-part question regarding role evolution, operational structure, delivery methodology, and strategic positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 500,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "Apple issued the 4.45% Notes due 2044 in 2014 (Officer’s Certificate dated May 6, 2014)【page 58】. The notes remained outstanding through 2022, 2023, and 2024, with no new 4.45% Notes disclosed in those years (see the 2022, 2023, and 2024 10‑K exhibit lists)【page 58】【page 53】【page 54】. This steady long‑term debt presence reflects Apple’s strategy of locking in fixed‑rate financing over a 20‑year horizon to stabilize interest costs and support its capital‑allocation decisions【page 58】【page 54】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key facts are accurate - the 4.45% Notes due 2044 were issued in 2014 with Officer's Certificate dated May 6, 2014, and remained outstanding through 2022-2024 with no new issuances; (2) Numeric accuracy is strong - the 4.45% rate and 2044 maturity date are correct, and the 20-year horizon calculation (2014 to 2034 would be 20 years, though 2044 is actually 30 years - this is a minor interpretive issue but the LLM states '20-year horizon' which is slightly imprecise; the actual maturity is 2044, which is 30 years from 2014); (3) Multi-hop synthesis is sound - the answer correctly connects the consistent presence across three years to strategic capital decisions; (4) The reasoning about fixed-rate financing and interest rate risk management aligns with the ground truth's interpretation about managing interest rate risk and maintaining financial flexibility. MINOR WEAKNESSES: (1) The LLM states '20-year horizon' when the 2044 maturity date actually represents a 30-year duration from the 2014 issuance - this is a minor calculation/characterization error that doesn't fundamentally undermine the answer but is technically imprecise; (2) The answer could have been slightly more explicit about the 'sustained reliance' language from the ground truth, though the concept is clearly conveyed through 'steady long-term debt presence'; (3) The page references provided (58, 53, 54) cannot be verified against the ground truth but appear reasonable for 10-K filings. OVERALL: The answer demonstrates strong understanding of Apple's capital strategy, correctly identifies the key debt instrument, accurately tracks its presence across the three-year period, and provides sound reasoning about strategic implications. The minor issue with the '20-year horizon' characterization (should be 30 years) prevents a perfect score but does not materially detract from the overall quality and correctness of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 537,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "Oracle’s 2.875% Notes due 2031 were presented unchanged as Exhibit 4.14 in each of the 2022, 2023 and 2024 10‑K filings (pages 111 of the 2022, 2023 and 2024 PDFs).  The note’s terms, interest rate and maturity remained the same, and it was not re‑issued, refinanced or retired during this period.  This consistent positioning signals Oracle’s disciplined capital‑structure policy—maintaining a stable, long‑term debt mix with predictable interest costs and a conservative, orderly debt‑management strategy over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 2.875% Notes due 2031 as Exhibit 4.14 across all three years (2022, 2023, 2024); (2) Accurately states the notes were not re-issued, refinanced, or retired; (3) Correctly conveys the consistent positioning and stable capital structure approach; (4) Provides appropriate interpretation of what this consistency reveals about Oracle's debt strategy. QUANTITATIVE ACCURACY: The specific exhibit number (4.14), interest rate (2.875%), maturity year (2031), and filing years (2022, 2023, 2024) are all correct. The reference to page 111 is specific but cannot be verified against ground truth. MINOR GAPS: (1) The ground truth mentions the Officers' Certificate issued on March 24, 2021 as the original establishment date—the LLM answer omits this historical context, which was part of the original answer's completeness; (2) The ground truth explicitly states 'no modifications to the terms of the Notes indicated in any of the filings,' while the LLM answer conveys this through 'unchanged' and 'not re-issued, refinanced or retired,' which is semantically equivalent but slightly less explicit about the absence of modifications. REASONING QUALITY: The LLM correctly synthesizes the multi-hop information (consistent positioning across three years → stable capital structure → disciplined debt management). The interpretation about 'predictable interest costs' and 'conservative, orderly debt-management strategy' is reasonable inference from the facts presented. The answer demonstrates sound logical reasoning about what consistent exhibit positioning reveals about corporate strategy. SEMANTIC EQUIVALENCE: The LLM's characterization of Oracle's approach as 'disciplined capital-structure policy' and 'conservative, orderly debt-management strategy' conveys essentially the same meaning as the ground truth's 'stable approach to capital structure management' and 'consistent long-term debt strategy.' The omission of the March 24, 2021 Officers' Certificate date prevents a perfect score, as this was explicitly mentioned in the ground truth as part of the complete historical context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 594,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "The 2023 Teamsters master agreement raised wage and benefit rates for Teamsters employees in the UPS/IBT Full‑Time Employee Pension Plan, which increased the plan’s service cost and pushed the net periodic benefit cost up to $1.212 billion in 2023 (from a negative $88 million in 2022)【page_82】【page_83】.  In 2024, the pension disclosures show a lower discount rate of 5.42% versus 5.79% in 2023 and a higher expected return on plan assets, which together raise the projected benefit obligation and indicate that UPS’s long‑term pension liabilities have grown【page_88】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that the 2023 Teamsters agreement increased wage and benefit rates, impacted pension benefit accruals, and affected service costs. The answer appropriately synthesizes information about the agreement's impact on long-term pension liabilities and references discount rate changes between 2023-2024. The reasoning about how lower discount rates increase projected benefit obligations is sound.\n\nWEAKNESSES - QUANTITATIVE ERRORS: The specific dollar amounts cited ($1.212 billion in 2023 net periodic benefit cost vs. negative $88 million in 2022) cannot be verified against the ground truth provided. The ground truth does not provide these specific numerical values, making it impossible to confirm accuracy. The discount rate figures (5.42% vs 5.79%) are also not verified in the ground truth. These unverified numbers represent a significant concern for quantitative accuracy.\n\nWEAKNESSES - COMPLETENESS: While the LLM addresses the impact on pension benefit accruals and long-term obligations, it provides less contextual detail about the plan structure (noncontributory nature, Central States Pension Fund history) that the ground truth emphasizes. The answer focuses heavily on 2024 discount rate changes rather than fully explaining the 2023 agreement's specific impact on accruals.\n\nMULTI-HOP REASONING: The synthesis across 2023 agreement → pension accruals → 2024 disclosures is logically sound. However, the answer introduces specific financial metrics not present in the ground truth, which raises questions about whether these numbers are accurate or potentially hallucinated.\n\nSEMANTIC ALIGNMENT: The core message aligns with ground truth (agreement increased benefits, impacted accruals, reflects long-term obligations), but the specific quantitative claims diverge significantly from what can be verified.\n\nJUSTIFICATION: Correctness score of 6 reflects partially correct core reasoning but significant quantitative accuracy concerns. The unverified dollar amounts and percentages, while presented with apparent specificity and page citations, cannot be confirmed and represent material factual claims that may be incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 586,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "Apple’s 2022 10‑K (page 58) and 2024 10‑K (page 56) both list the 1.05% Notes due 2017 in Exhibit 4.4 of the 2014 Officer’s Certificate, while the 2023 10‑K (pages 53‑57) omits that note, indicating it had matured and was no longer outstanding. This pattern shows that Apple consistently tracks and discloses only material short‑term debt, maintaining a complete historical record for regulatory transparency while ensuring that current debt is accurately reported.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) CORE CONTRADICTION: The ground truth states the 1.05% Notes due 2017 disclosure remained 'unchanged across all three years' (2022, 2023, 2024) and was 'consistently described' in all three filings. The LLM claims the 2023 10-K 'omits that note' because it 'had matured and was no longer outstanding.' These statements are mutually exclusive and the LLM's interpretation is incorrect. (2) FACTUAL ERROR ON MATURITY: The notes were due in 2017, which is 5-7 years before the 2022-2024 filing period. If they matured in 2017, they would not appear in any of the 2022, 2023, or 2024 filings. The ground truth's statement that the disclosure remained consistent across all three years directly contradicts the LLM's claim that 2023 omitted the note. (3) MISINTERPRETATION OF DISCLOSURE PATTERNS: The LLM incorrectly infers that omission from 2023 indicates maturity, when the ground truth explicitly states the disclosure was consistent across all three years. (4) REASONING FAILURE: The LLM failed to recognize that if notes due 2017 appeared in 2022, 2023, and 2024 filings, they must have been historical references or the dates refer to something different than actual maturity. The LLM's multi-hop reasoning is flawed because it draws an unsupported conclusion about maturity without verifying against the ground truth's explicit statement of consistency. (5) MISSING CONTEXT: The LLM misses the key insight from the ground truth: the static disclosure indicates Apple did NOT modify or refinance this instrument and prioritized stability in capital structure. Instead, the LLM invents a narrative about maturity that contradicts the ground truth. The answer demonstrates fundamental misunderstanding of the question and provides information that directly contradicts the established ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 515,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "Apple’s 10‑K filings consistently list the 2.40% Notes due 2023 in Exhibit 4.3. The 2022 filing (page 58) first discloses the note as part of the 2013 indenture, the 2023 filing (page 54) continues to list it, and the 2024 filing (page 58) again references it, showing that the debt has remained outstanding and unchanged. This steady disclosure pattern signals that Apple maintains a stable, long‑term debt structure, favoring moderate‑rate, long‑maturity notes to fund operations while managing interest costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 2.40% Notes due 2023 and confirms its consistent disclosure across 2022-2024 10-K filings. However, there are significant issues with accuracy and completeness: (1) QUANTITATIVE ACCURACY: The LLM cites specific page numbers (page 58 for 2022, page 54 for 2023, page 58 for 2024) that cannot be verified against the ground truth, which does not provide page references. The interest rate (2.40%) and maturity year (2023) are correct. (2) ENTITY/FACT ACCURACY: The LLM correctly identifies Exhibit 4.3 as the location and references the 2013 indenture, matching the ground truth's mention of the Officer's Certificate dated May 3, 2013. (3) CRITICAL OMISSION: The ground truth explicitly states the disclosure was 'part of its Officer's Certificate dated May 3, 2013' - a specific, verifiable detail that the LLM mentions only generically as '2013 indenture' without the Officer's Certificate reference or date. (4) REASONING QUALITY: The LLM's conclusion about 'stable, long-term debt structure' and 'moderate-rate, long-maturity notes' is problematic. The ground truth notes these are Notes due 2023 (a relatively short maturity from 2022-2024 perspective), not long-maturity notes. The LLM's characterization of the strategy as favoring 'long-maturity notes' contradicts the actual maturity profile. (5) MULTI-HOP SYNTHESIS: Both answers correctly synthesize the three-year pattern, but the LLM adds unsupported interpretations about Apple's funding strategy and interest cost management that go beyond what the disclosure pattern alone suggests. The ground truth is more conservative, stating Apple 'likely planning to meet the 2023 maturity as originally structured.' (6) SEMANTIC ISSUES: The LLM's phrase 'long-maturity notes' is factually misleading for a 2023 maturity date when discussing 2022-2024 filings. The ground truth's focus on 'no changes' and 'consistent approach' is more accurate to what the disclosure pattern actually demonstrates.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 537,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "Vraylar’s commercial trajectory accelerated from 2022 to 2024: after Phase 3 data in 2021, AbbVie obtained FDA approval in 2023 for Vraylar as adjunctive therapy for major depressive disorder, broadening its indications beyond schizophrenia and bipolar disorder (page 60, page 44). Revenue climbed from $2.04 billion in 2022 to $2.76 billion in 2023, a 35 % increase, and the 2024 10‑K confirms Vraylar remains a core neuroscience product with no new clinical milestones, solidifying its role as a broad‑spectrum antipsychotic/antidepressant within AbbVie’s portfolio (page 42, page 6).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key financial metrics and demonstrates sound multi-hop reasoning. The 2022-2023 revenue figures are accurate ($2.04B in 2022, $2.76B in 2023), and the 35% growth calculation is correct. The therapeutic indications (schizophrenia, bipolar I disorder, adjunctive MDD) are properly identified. The answer appropriately synthesizes clinical development progress, revenue growth, and therapeutic positioning across the 2022-2024 period.\n\nWEAKNESSES: (1) The LLM states 'FDA approval in 2023 for Vraylar as adjunctive therapy for MDD' - the ground truth indicates Phase 3 trial results in 2022 (one successful, one numerically positive but non-significant), not FDA approval in 2023. This is a factual error regarding the timing and nature of the clinical milestone. (2) The LLM provides only 2023 revenue ($2.76B) but the ground truth specifies this as total sales for 2023, while also noting U.S. sales of $2.755B in 2023 (up from $2.037B in 2022). The LLM conflates total sales with U.S. sales figures without clarification. (3) The LLM states '2024 10-K confirms Vraylar remains a core neuroscience product with no new clinical milestones' - while this may be accurate, the ground truth emphasizes that by 2024 Vraylar was 'formally positioned as a key therapeutic agent' with the full indication set (schizophrenia, bipolar I, adjunctive MDD), which represents strategic positioning rather than absence of milestones.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across three dimensions (clinical, revenue, positioning) and three years (2022-2024), demonstrating appropriate multi-hop synthesis. However, the clinical development narrative is slightly mischaracterized.\n\nNUMERIC VERIFICATION: Revenue figures are correct with acceptable format variation ($2.04B = $2,037M with minor rounding; $2.76B = $2,755-2,759M). The 35% growth calculation is accurate. No calculation errors detected.\n\nOVERALL: The answer is substantially correct on financial metrics and positioning but contains a meaningful error regarding the timing/nature of FDA approval for MDD indication. The core commercial trajectory narrative is sound, but clinical development details are imprecise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 600,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "IBM’s 2023 and 2024 10‑Ks explicitly list “client relationships and trust” as a key competitive differentiator (see 2023 page 3 and 2024 page 3), whereas the 2022 filing (as shown in the provided pages) does not highlight this phrase. This growing emphasis signals a strategic pivot to position IBM as a trusted partner in the hybrid‑cloud and AI market, using deep client relationships to differentiate from competitors and secure long‑term value creation.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer identifies a key factual element (that 'client relationships and trust' appears explicitly in 2023 and 2024 10-Ks but not in 2022), which aligns with the ground truth's observation of evolution. However, the answer has significant limitations: (1) It provides only a partial narrative of the evolution - focusing narrowly on the phrase's appearance/disappearance rather than the deeper strategic context. The ground truth explains HOW the emphasis evolved (2022: hybrid cloud/AI platform integration; 2023: strategic partnerships; 2024: go-to-market strategy and ecosystem), whereas the LLM only notes the phrase's presence/absence. (2) The LLM characterizes this as a 'strategic pivot' suggesting a shift away from previous positioning, but the ground truth indicates 'consistent emphasis' with evolving context - a more nuanced distinction. (3) The LLM fails to synthesize the multi-hop reasoning across the three-year period that shows deepening strategic integration of trust as an enabler, not just a differentiator. (4) The answer lacks the contextual richness about how trust connects to specific strategic initiatives (partnerships, ecosystem, integrated innovation) that the ground truth provides. (5) Quantitatively, the answer correctly identifies years (2022, 2023, 2024) and page references (page 3), though these page citations cannot be verified from the provided context. The core insight about phrase evolution is directionally correct but incomplete in capturing the strategic progression the question asks about. The answer reads as a surface-level observation rather than a multi-hop synthesis of strategic positioning evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 455,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "IBM’s 1.250% Notes due 2027 were not separately disclosed in the 2022 filing’s provided pages, whereas the 2023 10‑K incorporated the rights instrument from an 8‑K filed in 2019 (page 20). By 2024 the notes appear as a registered security (page 1), indicating a more explicit disclosure and integration into the debt schedule. This evolution moves the instrument from an indirect reference to a formal listing, underscoring its continued role as a long‑term, fixed‑rate component of IBM’s debt portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and inconsistencies compared to the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies the 1.250% Notes due 2027 as the instrument in question; (2) It correctly notes the 2019 8-K filing reference (January 30, 2019 per ground truth); (3) It accurately describes the progression from indirect reference to formal listing; (4) The characterization of the notes as a long-term, fixed-rate component is appropriate. SIGNIFICANT GAPS AND ERRORS: (1) The LLM states the notes were 'not separately disclosed in the 2022 filing's provided pages' but the ground truth indicates they WERE referenced in 2022's exhibit list - this is a factual error; (2) The LLM mentions page numbers (page 20, page 1) which cannot be verified against the ground truth and may be inaccurate or context-dependent; (3) The ground truth explicitly mentions the trading symbol 'IBM27B' appearing in 2024, which the LLM completely omits - this is a material detail showing formal recognition; (4) The ground truth notes a February 8, 2022 filing reference in 2023, which the LLM does not mention; (5) The LLM's characterization of 2022 disclosure as 'not separate' contradicts the ground truth's statement that they were 'referenced in its exhibit list.' MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across three years but fails to capture the complete progression. The ground truth shows: 2022 (referenced in exhibit list), 2023 (referenced with more recent filings), 2024 (explicitly listed with trading symbol). The LLM's version is: 2022 (not disclosed), 2023 (incorporated from 8-K), 2024 (registered security). This represents a fundamental mischaracterization of the 2022 status. QUANTITATIVE ACCURACY: The dates mentioned (2019, 2022, 2023, 2024) are correct, but the LLM omits the specific trading symbol 'IBM27B' which is a quantitative detail. The page references cannot be verified and may be incorrect. OVERALL ASSESSMENT: While the LLM captures the general narrative of increasing transparency and formalization, it contains a material factual error regarding 2022 disclosure status and omits the important trading symbol detail from 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 596,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "IBM’s 10‑K filings from 2022 through 2024 consistently identify the 6.50% Debentures due 2028 as **Exhibit 2 to Form 8‑K, filed January 8 1998**—the same exhibit number and filing date appears in the 2023 and 2024 reports (see Item 15, page 19 of both filings).  The broader debt‑instrument disclosures likewise remain unchanged, with IBM listing the same set of long‑term debt instruments (7.00%, 7.125%, 6.22%, 5.875% debentures, etc.) and incorporating the identical historical exhibits for each, underscoring consistency in its debt reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the core factual elements: (1) the 6.50% Debentures due 2028 are consistently referenced as Exhibit 2 to Form 8-K filed January 8, 1998 across 2022-2024, and (2) the exhibit reference remains unchanged across all three years. The date format is accurate (January 8, 1998). However, there are significant issues with the answer's completeness and reasoning quality:\n\nSTRENGTHS:\n- Correctly identifies the exhibit number (Exhibit 2) and filing date (January 8, 1998)\n- Accurately notes consistency across 2022, 2023, and 2024\n- Correctly references Item 15 and page 19 as source locations\n- Properly identifies other debentures mentioned (7.00%, 7.125%, 6.22%, 5.875%)\n\nWEAKNESSES:\n- The LLM answer claims \"the broader debt-instrument disclosures likewise remain unchanged\" and that IBM lists \"the same set of long-term debt instruments,\" which contradicts the ground truth's nuanced observation that the broader context \"evolved subtly over time\"\n- The ground truth explicitly states that by 2023 and 2024, disclosures \"focused more on integrating legacy debt...alongside newer instruments,\" suggesting a shift in emphasis and presentation, not complete stasis\n- The LLM fails to capture the evolution in how IBM presented its debt portfolio across the three-year period—moving from a wider range of instruments in 2022 to a more integrated legacy/newer instrument approach in 2023-2024\n- The answer oversimplifies by stating disclosures \"remain unchanged\" when the ground truth indicates subtle evolution in context and emphasis\n- Missing the important distinction that while exhibit references stayed consistent, the broader disclosure context evolved\n\nMULTI-HOP REASONING:\nThe LLM partially addresses the multi-hop nature of the question (consistency of exhibit references + broader context evolution) but fails on the second component. It correctly synthesizes that exhibit references are consistent but incorrectly concludes that broader disclosures are also unchanged, when the ground truth indicates they evolved.\n\nSEMANTIC ACCURACY:\nWhile the core factual elements about the exhibit reference are correct, the semantic meaning diverges significantly on the broader evolution question. The LLM's claim of complete consistency contradicts the ground truth's assertion of subtle evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 628,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "FedEx International Connect Plus grew from serving **nearly 50 origin countries to over 130 destination countries in 2022** (page 14) to **nearly 60 origin countries and more than 190 destination countries by 2024** (page 8). This widening coverage shows FedEx is aggressively expanding its cross‑border e‑commerce network, underscoring a strategic priority to capture growing global e‑commerce volume and strengthen its position as a leading international logistics provider.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key numeric progression of FedEx International Connect Plus from 2022 to 2024. All numbers are accurate: 2022 (nearly 50 origin countries, over 130 destination countries), 2024 (nearly 60 origin countries, over 190 destination countries). The answer properly synthesizes the multi-hop information across years and correctly interprets the expansion trajectory. However, the answer has one notable omission: it fails to mention the 2023 intermediate data point (nearly 60 origin countries and over 190 destination countries), which is important context from the ground truth. The ground truth explicitly notes that 2023 showed significant growth followed by stabilization in 2024, suggesting a 'major phase of international deployment' completion. The LLM answer characterizes the expansion as 'aggressive' and ongoing, but doesn't capture the nuance that growth plateaued between 2023-2024, indicating maturation rather than continued aggressive expansion. The reasoning about strategic focus on e-commerce is sound and well-supported. The answer demonstrates good multi-hop synthesis across the 2022-2024 period but misses the important inflection point that occurred between 2022-2023 and the subsequent stabilization. This is a meaningful omission that affects the completeness of the strategic analysis, though the core facts presented are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 387,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "Qualcomm set its 2025 human‑capital targets in the 2022 10‑K—calling for a 15 % increase in women and under‑represented minority (URM) leaders and a 20 % rise in overall URM representation—and reiterated those same goals in the 2023 and 2024 filings.  Across fiscal 2022‑24, the HR and Compensation Committee has linked executive bonuses to progress on these goals, applying a non‑financial modifier that can adjust the bonus by a multiplier of 0.9 to 1.1, a policy that remained unchanged from 2022 through 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies all key quantitative facts: the 15% increase targets for women and URM leaders, the 20% overall URM representation target, the 0.9-1.1 bonus multiplier range, and the consistency of these goals across 2022-2024. The numeric values are accurate and properly formatted. The multi-hop synthesis is sound—the answer correctly traces the evolution (or lack thereof) of diversity targets across three fiscal years and links them to the compensation mechanism. However, the answer has notable omissions compared to the ground truth: (1) It does not mention the Reboot Representation Tech Coalition or the specific initiative to double degrees for underrepresented groups by 2025, which the ground truth identifies as part of 'increased emphasis on initiatives.' (2) It does not characterize the strategic framework as 'stable' with 'sustained incentive alignment and expanding external partnerships,' which provides important context about how the company approached these goals. (3) The phrase 'increased emphasis on initiatives' from the ground truth is entirely absent. These omissions represent contextual and strategic details that, while not changing the core factual accuracy of the compensation linkage and diversity targets, do reduce the completeness of the answer. The answer successfully addresses the main components of the question (diversity targets, bonus adjustment mechanisms, and their evolution from 2022-2024) but misses secondary but relevant details about implementation approaches and external partnerships.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 429,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "Apple’s debt disclosures in 2022, 2023 and 2024 all list the same floating‑rate notes due 2019, showing that the company keeps a mix of short‑term floating‑rate debt on its balance sheet. By continuing to report these notes, Apple signals that it uses floating‑rate instruments to hedge against short‑term interest‑rate volatility while preserving liquidity flexibility, allowing it to adjust interest expense in line with market rates and maintain sufficient cash‑equivalent resources to meet short‑term obligations【page_58】【page_58】【page_58】.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that Apple's debt disclosures across 2022, 2023, and 2024 all include Floating Rate Notes due 2019, and accurately captures the core concept that this reflects a deliberate approach to interest rate risk management and liquidity flexibility. The answer correctly notes that floating-rate instruments allow Apple to adjust interest expense in line with market rates. The years (2022, 2023, 2024) and the instrument type are correctly identified.\n\nWEAKNESSES: (1) The LLM's characterization of these notes as 'short-term' floating-rate debt is problematic. Notes due 2019 would have matured by 2022, making their continued appearance in 2022-2024 disclosures unusual and requiring explanation. The ground truth answer addresses this by framing it as a 'deliberate and stable approach' and 'recurring appearance,' suggesting these may be refinanced or rolled-over instruments, but the LLM doesn't adequately address this temporal inconsistency. (2) The LLM states these notes help 'preserve liquidity flexibility' and 'maintain sufficient cash-equivalent resources,' but doesn't explain why notes due 2019 would still appear in 2022+ disclosures - this is a critical gap in the multi-hop reasoning. (3) The ground truth emphasizes that Apple 'maintained exposure to variable interest rates' and didn't need to 'issue new short-term floating rate instruments,' suggesting these are legacy instruments being managed. The LLM misses this nuance. (4) The citation references (【page_58】) appear to be placeholder citations without substantiation of the actual data source.\n\nMULTI-HOP REASONING: The LLM partially synthesizes the information but fails to adequately address the temporal paradox of notes due 2019 appearing in 2022-2024 filings. The ground truth answer better explains this as a 'recurring appearance' indicating deliberate management, while the LLM treats it more superficially as simply 'keeping a mix' of floating-rate debt.\n\nSEMANTIC EQUIVALENCE: While the LLM captures some key concepts (floating-rate instruments, interest rate management, liquidity), it doesn't fully convey the ground truth's emphasis on the 'consistency' and 'deliberate' nature of the approach, nor does it adequately explain the unusual persistence of notes due 2019 in later years' disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 620,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "Qualcomm has positioned its automotive business as a high‑growth arm of its QCT segment, shifting the focus from basic connectivity to a full digital‑cockpit stack that includes ADAS/AD and low‑power computing.  Automotive revenue grew from $1.51 B in 2022 to $1.87 B in 2023 and then to $2.91 B in 2024 (QCT automotive revenue, page 73), underscoring the company’s intensified emphasis on digital cockpit solutions.  The company cites analysts’ forecasts that 19 % of new vehicles in 2025 will feature Level 2+ autonomy (vs. 9 % in 2022) and that more than 70 % of new vehicles in 2028 will embed cellular connectivity, with 60 % of those using 5G (page 8), driving the projected demand that underpins Qualcomm’s revenue strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific revenue figures and market projections that add concrete detail to the evolution narrative, but contains significant quantitative discrepancies that undermine overall accuracy. STRENGTHS: (1) Correctly identifies the trajectory from basic connectivity to full digital-cockpit stack including ADAS/AD; (2) Properly synthesizes the multi-hop evolution across 2022-2024; (3) Appropriately cites market demand projections (Level 2+ autonomy growth, 5G connectivity forecasts); (4) Contextually relevant focus on QCT segment integration. CRITICAL ISSUES: (1) Revenue figures cannot be verified against ground truth - the original answer does not provide specific automotive revenue numbers, making it impossible to confirm if $1.51B (2022), $1.87B (2023), and $2.91B (2024) are accurate. These appear to be specific data points that require verification against actual 10-K filings; (2) The 60% 5G projection for 2028 aligns with ground truth ('over 60%'), but the LLM states '60% of those using 5G' (implying 60% of the 70% with cellular), which is a different metric than the ground truth's standalone 60% projection; (3) The 19% Level 2+ autonomy figure for 2025 and 9% for 2022 are not mentioned in the ground truth, making verification impossible; (4) Page citations (page 73, page 8) cannot be verified without access to actual filings. MULTI-HOP REASONING: The answer correctly synthesizes information across years and connects revenue growth to market demand drivers, showing sound logical progression. However, the introduction of specific numbers not present in the ground truth creates uncertainty about factual accuracy. The answer demonstrates good understanding of the strategic evolution but introduces quantitative claims that may or may not be correct. RECOMMENDATION: The core narrative is sound, but the specific revenue figures and some market projections require independent verification against actual SEC filings to confirm accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 535,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "Abbott’s unfunded commitments to private real‑estate funds fell from **$569 million in 2022** to **$555 million in 2023** and **$540 million in 2024**. The gradual decline shows the company is trimming its exposure to illiquid real‑estate alternatives, suggesting a long‑term strategy of cautious, incremental capital allocation and a focus on maintaining liquidity and risk control within its alternative‑asset portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is perfectly accurate - the three dollar amounts ($569M in 2022, $555M in 2023, $540M in 2024) match the ground truth exactly. (2) The year-over-year decline pattern is correctly identified ($15M annual decrease). (3) The company name (Abbott) and metric (unfunded commitments to private real estate funds) are correctly identified. (4) The interpretation that this represents a de-risking or cautious approach to alternative assets is sound and aligns with ground truth. WEAKNESSES: (1) The LLM answer omits a key detail from the ground truth: the specific liquidation periods (2025-2034 by 2024), which provides important context about the long-term nature of these commitments. (2) The phrase 'trimming its exposure' is slightly less precise than the ground truth's 'strategic de-risking or rebalancing' - while semantically similar, it doesn't fully capture the nuance that Abbott is 'not exiting the space entirely but managing exposure more cautiously.' (3) The answer doesn't explicitly state that the company 'continues to maintain exposure to private real estate through existing investments,' which is an important qualifier showing this is a managed reduction rather than a wholesale exit. MULTI-HOP REASONING: The answer correctly synthesizes the three-year trend and draws appropriate conclusions about investment strategy, though it could have been more comprehensive in addressing all aspects of the original question about long-term strategy implications. The reasoning is sound but somewhat abbreviated.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 428,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "Apple’s 0.45% Notes due 2016 were issued as part of the 2013 global notes issuance (page 54) and no new issuance of these notes is reported in the 2022, 2023, or 2024 10‑K filings (page 54). This lack of new issuance across those fiscal years indicates that Apple’s long‑term debt strategy focuses on issuing debt in large tranches with low coupon rates and long maturities, then gradually refinancing or retiring them as they mature, rather than repeatedly issuing the same coupon/maturity. The mix of floating‑rate and fixed‑rate notes (including the 0.45% Notes) demonstrates Apple’s approach to balancing interest‑rate risk and cost (page 54).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct identification of the 0.45% Notes due 2016 as part of the 2013 global notes issuance. The numeric values and dates are accurate. However, there are notable issues with the response: (1) The LLM introduces an interpretation about the notes being 'due 2016' that appears problematic - if these notes were due in 2016, they would have matured years before the 2022-2024 filings being discussed, yet the ground truth states they were 'maintained' and 'consistently included' across all three years. This suggests either a maturity date error or a fundamental misunderstanding of what debt instrument is being discussed. (2) The LLM's reasoning about Apple's debt strategy (issuing in large tranches, gradually refinancing/retiring) is plausible but goes beyond what the ground truth supports. The ground truth emphasizes 'stable long-term debt strategy' and 'preserving a mix of older, lower-yield debt instruments,' while the LLM emphasizes a refinancing/retirement pattern not explicitly confirmed in the ground truth. (3) The LLM correctly notes no new issuance across 2022-2024, which aligns with the ground truth's implication of consistent maintenance. (4) The discussion of floating-rate vs. fixed-rate notes and interest-rate risk balancing is reasonable but represents inference beyond the specific ground truth provided. The answer is partially correct in its core facts but contains interpretive elements that diverge from the ground truth's more conservative characterization of the debt strategy as simply 'stable' with a 'preserved mix.'",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 443,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "IBM’s 10‑K filings for 2022, 2023 and 2024 all list **client relationships and trust** as a core competitive differentiator, with the wording unchanged across the three years.  The consistent emphasis signals that IBM sees its long‑standing client trust as the foundation for its hybrid‑cloud and AI strategy, positioning itself as a trusted partner that can deliver integrated hybrid‑cloud and AI solutions and differentiate itself from rivals.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about evolution and progression. (1) WHAT WAS CORRECT: The LLM correctly identifies that IBM listed 'client relationships and trust' as a competitive differentiator across 2022-2024, and correctly notes the consistent emphasis. The basic entity identification (IBM, years 2022-2024, hybrid cloud and AI) is accurate. (2) CRITICAL ERRORS - EVOLUTION/PROGRESSION: The ground truth explicitly describes an EVOLUTION in how IBM framed trust from 2022 to 2024: (a) 2022: trust as part of broader innovation/service portfolio, (b) 2023: more explicit linking with consulting services and mission-critical infrastructure, (c) 2024: trust integrated with strategic partnerships. The LLM states the wording was 'unchanged across the three years,' which directly contradicts the ground truth's description of evolving framing. This is a fundamental misunderstanding of the question's core requirement to analyze multi-year progression. (3) MISSING SYNTHESIS: The LLM fails to synthesize the strategic evolution showing how trust became increasingly integrated with ecosystem collaboration and innovation leadership. It treats trust as static rather than maturing. (4) INCOMPLETE ANSWER: The question asks 'what does this multi-year progression reveal about its strategic positioning' - the ground truth answers this by showing maturation from standalone differentiator to integrated ecosystem strategy. The LLM provides only a generic statement about trust as foundation without capturing this strategic evolution. (5) QUANTITATIVE ACCURACY: No specific numbers or calculations are required or provided, so this scores well (8/10) - the dates and years are correct. (6) QUALITATIVE ACCURACY: The reasoning fails to capture the multi-hop synthesis required - comparing how the framing evolved across three years and what that reveals strategically. The LLM's conclusion about 'trusted partner' is generic and doesn't reflect the nuanced evolution described in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 548,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "FedEx’s 2023 and 2024 10‑K filings show that the company has maintained a liquidity‑provider revolving credit agreement with BNP Paribas and an intercreditor agreement with Wilmington Trust for the 4.250% Note due 2030, and that it amended that arrangement in May 2023 (Amendment No. 1) (see page 123). The 2024 filing lists the same arrangement and amendment but no further changes (see page 122), indicating that FedEx has chosen to keep the credit‑support structure stable while making adjustments only when necessary. This evolution reflects a proactive yet conservative approach to managing credit risk for the note.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies all key entities (FedEx, BNP Paribas, Wilmington Trust, the 4.250% Note due 2030), accurately dates the Amendment No. 1 to May 22, 2023, and correctly notes that no further amendments occurred through 2024. The numeric/date information is accurate. The answer appropriately synthesizes information across 2023 and 2024 filings and correctly characterizes the evolution as maintaining a stable structure with a single strategic adjustment in 2023.\n\nWEAKNESSES: The LLM answer omits important context from the ground truth regarding 2022 as a baseline year. The ground truth explicitly states 'In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020,' which provides crucial context for understanding the full evolution across all three years (2022-2024). The LLM answer only covers 2023-2024, missing the foundational 2022 baseline that would strengthen the multi-hop analysis. Additionally, while the LLM correctly identifies the Intercreditor Agreement and Revolving Credit Agreement, it doesn't explicitly mention the August 13, 2020 date of the original agreements, which helps establish the timeline of the arrangement.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across two years (2023-2024) and correctly identifies the pattern of stability with one adjustment. However, the analysis would be more complete with the 2022 baseline year included, which would demonstrate the full three-year evolution requested in the question.\n\nSEMANTIC EQUIVALENCE: The LLM's characterization of FedEx's approach as 'proactive yet conservative' aligns well with the ground truth's description of 'proactive adjustment' followed by maintenance of 'consistent credit support framework.' The interpretation is sound and semantically equivalent.\n\nCALCULATIONS/DATES: All dates and references are accurate (May 22, 2023 for Amendment No. 1, page references to 2024 and 2023 filings).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 547,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "Apple’s 4.45% Notes due 2044, issued in 2014, remained a constant component of its long‑term debt in the 2022, 2023 and 2024 10‑Ks, with no change in principal or maturity (Exhibit 4.4 on page 56 of each filing). This unchanged debt profile shows that Apple has not refinanced or repaid the note and continues to rely on long‑term, fixed‑rate borrowing to lock in low interest costs and maintain a predictable debt structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies the 4.45% Notes due 2044 as issued in 2014 and present across all three years (2022, 2023, 2024); (2) Accurately conveys the core finding that the debt remained constant/unchanged across the period; (3) Provides sound multi-hop synthesis showing consistency in Apple's long-term financing strategy; (4) Adds valuable context about Apple's strategic rationale (locking in low interest costs, maintaining predictable debt structure); (5) References specific filing locations (Exhibit 4.4, page 56) which demonstrates document familiarity. MINOR ISSUES: (1) The LLM answer goes slightly beyond the ground truth by inferring strategic motivations ('lock in low interest costs,' 'maintain predictable debt structure') that, while reasonable, are not explicitly stated in the original answer - this is interpretive rather than factual error; (2) The phrase 'continues to rely on long-term, fixed-rate borrowing' makes an assumption about ongoing reliance that isn't directly supported by the ground truth statement of mere consistency; (3) The reference to 'Exhibit 4.4 on page 56' cannot be verified against the ground truth provided, though it appears plausible. QUANTITATIVE VERIFICATION: All dates (2014 issuance, 2022-2024 reporting years) and the interest rate (4.45%) are correct. No calculations are required for this question. MULTI-HOP REASONING: The answer correctly synthesizes information across three years and connects the historical issuance (2014) to current reporting periods, demonstrating proper multi-hop analysis. The conclusion about financing strategy consistency is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth (consistency across years, no restructuring) while adding interpretive context about strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 512,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "FedEx International Connect Plus grew from covering **nearly 50 origin countries to more than 130 destination countries in 2022** (page 14, 2022 filing) to **nearly 60 origin countries and over 190 destination countries by 2024** (page 8, 2024 filing). This steady expansion shows FedEx is aggressively scaling its e‑commerce logistics network worldwide, prioritizing broader geographic coverage to capture increasing global e‑commerce volume and reinforce its competitive position in the market.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2022 baseline (nearly 50 origin countries, over 130 destination countries) and captures the expansion trajectory. The answer appropriately synthesizes multi-hop information about FedEx's strategic positioning in e-commerce logistics. The reasoning about aggressive scaling and competitive positioning is sound and relevant to the question.\n\nCRITICAL ERRORS: The LLM answer contains a significant factual error regarding the 2024 data. According to the ground truth, the 2024 geographic footprint remained consistent with 2023 (nearly 60 origin countries and over 190 destination countries), NOT an expansion from 2022 to 2024. The LLM presents the 2024 figures as if they represent continued growth through 2024, when in fact the ground truth indicates expansion occurred from 2022-2023, followed by stabilization in 2024.\n\nMISSING CONTEXT: The LLM fails to address the critical insight from the ground truth that the expansion was followed by a 'phase of consolidation and optimization' in 2024. This is a key strategic indicator that the question specifically asks about - the expansion trajectory suggests not just aggressive growth, but a deliberate shift toward optimization after rapid expansion. The LLM's characterization of 'steady expansion' through 2024 misrepresents the actual strategic evolution.\n\nQUANTITATIVE VERIFICATION: All individual numbers are correct (50→60 origin countries, 130→190 destination countries), but the temporal attribution is problematic. The LLM implies continuous expansion through 2024 when the data shows 2023-2024 stabilization.\n\nMULTI-HOP REASONING: While the LLM successfully synthesizes information across years and connects it to strategic implications, it fails to properly interpret the stabilization pattern as a distinct strategic phase, which is essential to answering what the expansion trajectory 'suggests' about FedEx's strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 524,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "Apple’s 1.05 % Notes due 2017 had already matured and were fully paid off by the end of FY 2022, FY 2023 and FY 2024.  The notes are still listed in the 2024 10‑K’s securities exhibit (Exhibit 4.4) — a practice that shows Apple keeps a comprehensive record of all debt instruments, even after they mature, to provide full transparency and to demonstrate a disciplined, systematic approach to managing maturing debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The notes did mature in 2017 and were paid off before FY 2022-2024, which is factually accurate. (2) The notes are correctly identified as appearing in Exhibit 4.4 of the 2024 10-K. (3) The general concept that Apple maintains historical debt references is reasonable. PROBLEMATIC ELEMENTS: (1) The LLM fails to address the specific multi-year pattern across FY 2022, 2023, and 2024 that the ground truth emphasizes - it doesn't mention that the same notes appeared consistently in all three years' filings with identical language. (2) The LLM provides a generic explanation about 'comprehensive record keeping' and 'transparency' but misses the ground truth's more nuanced observation that Apple may have retained these as part of a 'standardized disclosure framework' or to 'maintain continuity in debt documentation.' (3) The LLM doesn't acknowledge the somewhat unusual nature of continuing to reference notes that matured 5+ years prior, which the ground truth appropriately flags as noteworthy. (4) The LLM's reasoning about 'disciplined, systematic approach' is somewhat speculative and less grounded than the ground truth's more cautious language ('may have retained'). MULTI-HOP SYNTHESIS: The LLM partially addresses the multi-year comparison but doesn't effectively synthesize the pattern across all three fiscal years as the ground truth does. The answer is directionally correct but lacks the specificity and nuance of the ground truth analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 424,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "From 2022 through 2024 Qualcomm kept its core licensing business (QTL) as the main revenue driver, with most of the per‑unit royalties coming from OFDMA‑based 5G devices (page 13) and a $560 million cut in 2024 after the U.S. revoked its Huawei license (page 20).  During the same period the company deepened its 5G commitment by expanding QSI strategic investments into AI, automotive, IoT and XR and by adding 5G‑specific RF front‑end components to its QCT portfolio (pages 11‑12), signalling a shift from pure patent licensing to broader 5G‑enabled product ecosystems.  At the same time geopolitical exposure grew markedly—U.S./China trade and national‑security actions now threaten supply‑chain continuity, regulatory approval of acquisitions (page 22), and the ability to license to key Chinese OEMs—making the firm’s 5G strategy increasingly contingent on navigating these risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) Correctly identifies the $560 million Huawei licensing revenue impact in fiscal 2024 following the export license revocation; (2) Accurately describes QTL (licensing) as the core revenue driver with OFDMA-based/5G devices as the primary source; (3) Properly synthesizes the evolution across three fiscal years showing deepening commitment; (4) Correctly identifies strategic investments through QSI (Qualcomm Ventures) in AI, automotive, IoT, and XR; (5) Accurately characterizes geopolitical risks including U.S./China trade tensions and regulatory approval challenges; (6) Appropriately notes the shift from pure patent licensing to broader product ecosystems. MINOR GAPS: (1) The LLM answer mentions 'RF front-end components' and 'XR' which are reasonable inferences about 5G-enabled products but are not explicitly mentioned in the ground truth; (2) The ground truth specifically mentions '27 billion IoT devices by 2026' projection from fiscal 2022, which the LLM answer omits; (3) The ground truth explicitly states 'increased R&D investments in 5G and next-generation wireless technologies' in fiscal 2023, which the LLM answer doesn't directly address. QUANTITATIVE VERIFICATION: The $560 million figure is correctly cited and properly contextualized as the Huawei revenue impact. MULTI-HOP REASONING: The answer successfully synthesizes information across three fiscal years and multiple business segments (QTL, QSI, QCT), showing proper understanding of how these components relate to the overall 5G strategy evolution. The connection between financial commitment and geopolitical risk exposure is logically sound. SEMANTIC EQUIVALENCE: The answer conveys the same essential narrative as the ground truth—deepening 5G commitment despite rising external risks—though with slightly different emphasis and some additional details not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 534,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "From 2022 to 2024 the domestic pension plan’s asset mix shifted only slightly: U.S.‑equity holdings rose from $89 million to $91 million (≈ +2 %), international‑equity holdings fell from $91 million to $89 million (≈ ‑2 %), and fixed‑income holdings declined from $739 million to $692 million (≈ ‑$47 million). In percentage terms the allocation moved from about 9.5 %/9.7 %/78.9 % to 10.2 %/9.9 %/77.3 %, remaining close to the company’s stated target of roughly 10 % U.S. equity, 10 % international equity and 80 % fixed income. This demonstrates a continued, stable, liability‑hedged investment strategy with only modest tilts toward equities over the three‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental and pervasive factual errors that make it largely incorrect. CRITICAL ERRORS: (1) The LLM states U.S. equity holdings 'rose from $89 million to $91 million' but the ground truth shows 2022: $125M → 2023: $89M → 2024: $93M. The LLM appears to have used 2023-2024 data only and inverted the direction of change. (2) International equity: LLM claims 'fell from $91 million to $89 million' but ground truth shows 2022: $126M → 2023: $91M → 2024: $93M. Again, only partial period covered and direction incorrect. (3) Fixed income: LLM states 'declined from $739 million to $692 million' but ground truth shows 2022: $1,001M → 2023: $739M → 2024: $739M (flat, not declining). The $692M figure appears fabricated. (4) The LLM completely omits the 2022 baseline data ($125M, $126M, $1,001M), which is essential to answering a question about 'change from 2022 to 2024.' (5) Total assets: LLM doesn't mention the significant 2022-2023 decline from $1,267M to $937M, which is a critical finding. (6) Percentage calculations: The LLM's percentages (9.5%/9.7%/78.9% to 10.2%/9.9%/77.3%) don't align with the actual data provided. (7) The LLM's conclusion about 'modest tilts toward equities' contradicts the ground truth finding of 'strategic shift toward more stability and reduced exposure to equity markets.' The answer demonstrates a failure to properly synthesize the three-year period and contains multiple invented or misremembered numbers. The only partial accuracy is the general characterization of a liability-hedged strategy, but this is undermined by the incorrect supporting data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 443,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "Qualcomm’s edge‑networking focus in 2022 was anchored by the launch of Wi‑Fi 6/6E access‑point modules and 5G NR‑U, which together drove $7.353 billion of IoT revenue (the segment that includes edge networking). In 2023 the same product mix was retained, but IoT revenue fell to $5.940 billion, and by 2024 Qualcomm further refined its edge portfolio—still centered on Wi‑Fi 6E and 5G NR‑U but with a growing emphasis on AI‑enabled edge solutions—while IoT revenue slipped to $5.423 billion, indicating a strategic shift toward a more diversified focus beyond edge networking.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific revenue figures ($7.353B, $5.940B, $5.423B for IoT) that are not mentioned in the ground truth and cannot be verified. These numbers are presented with false precision without source attribution. (2) PRODUCT CLAIMS: The LLM claims specific product launches (Wi-Fi 6/6E access-point modules, 5G NR-U) in 2022 that are not mentioned in the ground truth. While these may be real products, they are not supported by the provided knowledge graph data. (3) MISALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes edge networking as a 'consistent and maturing strategic focus' and 'key growth area,' but the LLM concludes with 'a strategic shift toward a more diversified focus beyond edge networking' based on declining IoT revenue—this directly contradicts the ground truth's narrative of consistent emphasis. (4) INCOMPLETE SYNTHESIS: The LLM focuses heavily on IoT segment revenue trends but fails to address the ground truth's key points about edge networking being explicitly listed as a revenue contributor and the consistent emphasis on mobile broadband and wireless access points across all three years. (5) LOGICAL INCONSISTENCY: The LLM's interpretation that declining revenue indicates a shift away from edge networking contradicts the ground truth's statement that the company 'continued to emphasize edge networking as a core product category' in 2024. The answer demonstrates poor multi-hop reasoning by introducing unsupported financial data and drawing conclusions opposite to the ground truth narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 465,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "Apple’s 10‑K filings consistently list the 0.45% Notes due 2016 in the exhibit table (see Exhibit 4.3 on page 58 of the 2024 filing and the same exhibit on page 58 of the 2022 filing). By continuing to disclose this long‑maturity, fixed‑rate debt—even though it has already matured—Apple demonstrates a disciplined, transparent approach to tracking all debt issuances and their maturities, which helps investors see the full history of its capital structure. This practice signals that Apple proactively manages fixed‑rate debt maturities and maintains a stable, well‑understood capital‑structure profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error that significantly undermines its credibility. The ground truth states that the 0.45% Notes due 2016 are 'no longer outstanding' and their inclusion reflects 'historical tracking' of capital structure evolution. However, the LLM answer claims these notes 'have already matured,' which is a different and more problematic assertion. If notes matured in 2016, they would have been paid off years before the 2022-2024 filings being discussed, making their continued inclusion in exhibits questionable. The ground truth's framing—that they are simply no longer outstanding but documented for historical purposes—is more accurate and less contradictory. Additionally, the LLM provides specific exhibit references (Exhibit 4.3, page 58) that cannot be verified against the ground truth and may be inaccurate. The LLM's reasoning about 'long-maturity, fixed-rate debt' is also problematic since notes due 2016 would not be long-maturity by 2022-2024 standards. On the positive side, the LLM correctly identifies the core concept: Apple's consistent disclosure reflects transparency and comprehensive debt tracking. The semantic understanding of capital structure management and investor communication is sound. However, the factual errors regarding maturity status and the unverifiable specific exhibit citations create significant accuracy concerns. The answer demonstrates partial understanding but contains material factual inaccuracies that would mislead readers about the nature of these debt instruments.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 427,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "The EMD brand distribution network’s geographic reach fell from **193 countries in 2022 to 187 countries in 2024**, a decline of six countries (page_76, page_66). This reflects a contraction in the dealer network’s global footprint.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) QUANTITATIVE ACCURACY - CRITICAL ERRORS: The LLM states the EMD distribution network covered 193 countries in 2022 and 187 in 2024, but the ground truth clearly establishes it was 130 countries in 2022 and 109 in 2024. These are completely wrong numbers - off by 63 countries in 2022 and 78 countries in 2024. The LLM calculated a 6-country decline, but the correct decline is 21 countries. The percentage change is also wrong: LLM implies ~3% decline, but actual decline is ~16%. (2) COMPLETENESS: The LLM failed to address the 2023 data point mentioned in the ground truth (130 countries, unchanged from 2022), which is relevant context for understanding the trend. (3) ENTITY ACCURACY: While the LLM correctly identifies the EMD brand and Caterpillar, it provides entirely incorrect geographic coverage numbers. (4) REASONING: The multi-hop synthesis is flawed - the LLM appears to have fabricated or misread the country numbers entirely. There is no logical path from the correct data (130→130→109) to the LLM's claimed data (193→187). (5) SEMANTIC EQUIVALENCE: The answer does address the right question topic (geographic reach change 2022-2024), but with completely wrong data, making semantic equivalence impossible. The answer demonstrates a fundamental failure to retrieve or synthesize accurate information from the source documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 393,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "Thermo Fisher’s 1.750 % 7‑Year Senior Notes rose from **$642 million** at December 31 2022 to **$662 million** at December 31 2023 (page 61). By the 2024 filing the note no longer appears in the debt schedule (page 48), indicating it was retired during 2024. This pattern reflects a deliberate shift to reduce medium‑term debt exposure, likely refinancing with longer‑dated or lower‑cost instruments to manage interest‑rate risk in the healthcare sector.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM reports $642 million in 2022 and $662 million in 2023, while the ground truth clearly states $700 million for both years. These are significant discrepancies (off by $58M and $38M respectively). The LLM also claims the notes were retired in 2024 and no longer appear in the debt schedule, while ground truth indicates they remained outstanding at $700 million in 2024. (2) ENTITY/METRIC ACCURACY: The company is correctly identified as Thermo Fisher (TMO), and the instrument is correctly identified as the 1.750% 7-Year Senior Notes. However, the financial values are completely incorrect. (3) MULTI-HOP REASONING: The LLM's interpretation of the data progression is fundamentally flawed. It concludes the notes were retired in 2024 based on them not appearing in a debt schedule, but the ground truth shows they remained outstanding. The reasoning about 'deliberate shift to reduce medium-term debt exposure' and 'refinancing with longer-dated or lower-cost instruments' is contradicted by the actual data showing stable $700M outstanding across all three years. (4) SEMANTIC MEANING: The LLM's conclusion that this represents a debt reduction strategy is the opposite of what the ground truth indicates—a stable, consistent approach to capital structure. The answer fails on the primary metric of factual accuracy with multiple incorrect dollar amounts and a false claim about retirement of the notes.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 421,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "In 2022, Caterpillar’s risk disclosures highlighted exposure to LIBOR‑based variable‑rate loans and the impending LIBOR phase‑out, while noting that currency‑hedging instruments were used to mitigate exchange‑rate risk (page 22). By 2023, the filings shifted focus to the adoption of SOFR as the new benchmark for variable‑rate financing, continuing to rely on currency hedges to manage foreign‑exchange exposure (page 19). The 2024 filing reiterated the use of SOFR and currency hedging, underscoring a deliberate transition away from LIBOR and a proactive adjustment of its risk‑management framework to align with evolving market benchmarks (page 17). This evolution demonstrates Caterpillar’s strategic adaptation to global financial reforms by updating its hedging strategy and benchmark usage to reduce regulatory and market‑risk exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Caterpillar's LIBOR-to-SOFR transition and currency hedging evolution across 2022-2024. STRENGTHS: (1) Correctly identifies the three-year progression from LIBOR exposure (2022) to SOFR adoption (2023-2024); (2) Accurately captures the key regulatory milestones (LIBOR phase-out, SOFR adoption); (3) Properly synthesizes the multi-hop information about both currency hedging and benchmark transitions; (4) Correctly notes the strategic pivot away from LIBOR; (5) Appropriately emphasizes proactive adaptation to global financial reforms. WEAKNESSES: (1) The LLM includes page references (pages 22, 19, 17) that cannot be verified against the ground truth and appear to be fabricated details - this is a minor but notable issue; (2) Lacks specific detail about Cat Financial's role, which the ground truth explicitly mentions; (3) Does not mention the formation/expansion of Caterpillar's cross-functional team to assess LIBOR/floating rate risks, which the ground truth highlights as evidence of strategic adaptation; (4) Less explicit about the timeline of the FCA announcement and IBA's June 30, 2023 USD LIBOR cessation date, though the answer captures the essence. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension focuses on date accuracy. The answer correctly identifies 2022, 2023, and 2024 as the relevant years and correctly sequences the LIBOR phase-out before SOFR adoption. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis is correct - the answer successfully connects currency hedging management with benchmark transitions across three years. However, it misses some organizational details (Cat Financial, cross-functional team) that would strengthen the answer. CONTEXTUAL RELEVANCE: The answer directly addresses the question about exposure evolution, management practices, and strategic adaptation, making it highly relevant. The inclusion of unverifiable page references slightly detracts from credibility but doesn't fundamentally undermine the factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 566,
        "total_tokens": 2132
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "From 2022 through 2024 Thermo Fisher’s 10‑K filings consistently list a CEO‑specific Executive Change‑in‑Control Retention Agreement (Exhibit 10.11) and a separate, standardized form for all other officers (Exhibit 10.17). The 2023 filing shows the same two exhibits, indicating that the company had adopted a uniform agreement for officers beyond the CEO, and the 2024 filing again lists the identical standardized officer form, demonstrating that this standardized approach has been maintained over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. Key issues: (1) EXHIBIT NUMBER ERROR - The LLM states the CEO-specific agreement is Exhibit 10.11, but the ground truth clearly identifies it as Exhibit 10.12. This is a concrete factual error in a multi-hop question where exhibit citations are critical. (2) INCOMPLETE TIMELINE - The ground truth provides specific context about the 2022 agreement having amendments dated through March 16, 2018, which the LLM completely omits. This detail matters for understanding the evolution. (3) MISLEADING CHARACTERIZATION - The LLM claims the standardized form for officers was present 'from 2022 through 2024' consistently, but the ground truth indicates the standardized form for officers 'other than Marc N. Casper' was introduced in 2023, not 2022. This is a critical distinction for answering how the practice 'evolved.' The LLM's statement that 'the company had adopted a uniform agreement for officers beyond the CEO' in 2023 is correct, but the framing that this existed from 2022 is inaccurate. (4) CORRECT ELEMENTS - The LLM correctly identifies: (a) the existence of both CEO-specific and officer forms, (b) the standardization for officers beyond CEO, (c) the continuation through 2024, and (d) the general evolution narrative. However, the exhibit number error (10.11 vs 10.12) is a material factual mistake in a document-citation-heavy question. The answer demonstrates partial understanding of the evolution but fails on precision regarding when standardization began and which exhibits are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 436,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "Intel first introduced PowerVia in its 2023 10‑K as a breakthrough backside‑power delivery technology for the upcoming Intel 20A node, promising up to a 15 % performance‑per‑watt improvement over Intel 3【page_13】【page_14】. By 2024, PowerVia had moved from a future concept to an active feature in the current Intel 18A process, which already delivers significant power‑efficiency gains over Intel 3【page_10】. This evolution shows that PowerVia has become a core element of Intel’s advanced process roadmap, underscoring its strategic role in boosting power efficiency and enabling next‑generation chip performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility:\n\n1. CRITICAL TIMELINE ERROR: The LLM states PowerVia was 'first introduced in its 2023 10-K,' but the ground truth clearly indicates PowerVia was introduced in 2022 as part of Intel's future roadmap. This is a fundamental factual error about when the technology was first disclosed.\n\n2. INCOMPLETE ROADMAP EVOLUTION: The LLM only covers 2023-2024, missing the crucial 2022 introduction point. The ground truth emphasizes a 3-year evolution (2022-2024), which the LLM fails to capture.\n\n3. MISSING STRATEGIC CONTEXT: The LLM omits the critical 2024 disclosure that Intel canceled Intel 20A in favor of Intel 18A. While the LLM mentions Intel 18A, it doesn't explain this was a strategic pivot away from 20A, which is essential to understanding the roadmap evolution.\n\n4. UNVERIFIED PERFORMANCE CLAIM: The LLM cites a '15% performance-per-watt improvement' claim without this appearing in the ground truth. This specific metric cannot be verified and may be fabricated or misattributed.\n\n5. INCOMPLETE SYNTHESIS: The ground truth emphasizes PowerVia's role in 'eliminating front-side power routing' and its positioning alongside RibbonFET as a breakthrough innovation. The LLM describes it as 'backside-power delivery technology' but misses the broader context of how it fits into Intel's overall process strategy.\n\n6. MISSING MANUFACTURING TIMELINE: The ground truth specifies 'high-volume manufacturing starting in 2025,' which the LLM does not mention.\n\nWHAT WAS CORRECT:\n- PowerVia is correctly identified as a core element of Intel's advanced process roadmap\n- The connection to power efficiency improvements is accurate\n- Intel 18A is correctly mentioned as the current process node\n\nThe answer demonstrates partial understanding but fails on the multi-hop synthesis requirement by missing the 2022 introduction and the strategic 20A-to-18A pivot that defines the 3-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 535,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "Apple continued to list the 1.05 % Notes due 2017 in Exhibit 4.4 of its 2022, 2023, and 2024 Form 10‑Ks, with no change to the description or terms (see the exhibit list on page 54 of the 2024 filing and the identical listing on page 54 of the 2022 filing; the 2023 filing likewise contains the same exhibit). The unchanged, repeated disclosure indicates that Apple consistently tracks and reports all debt issuances—even those that have matured—reflecting a disciplined, transparent approach to debt management and strict compliance with SEC disclosure requirements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the 1.05% Notes due 2017 as appearing in Exhibit 4.4 across 2022, 2023, and 2024 10-K filings; (2) Accurately notes the unchanged description and terms across filings; (3) Provides specific page references (page 54) for verification; (4) Correctly synthesizes the multi-hop information showing persistence of disclosure across three years; (5) Appropriately interprets the repeated inclusion as reflecting disciplined debt management and SEC compliance. QUANTITATIVE ACCURACY: All dates (2017 maturity, 2022/2023/2024 filings) and the percentage (1.05%) are correct. Page references to page 54 are verifiable and appropriate. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer does not mention the Officer's Certificate dated May 6, 2014 or its filing as Exhibit 4.4, which the ground truth specifically references; (2) The LLM answer emphasizes 'strict compliance with SEC disclosure requirements' and 'transparent approach' while the ground truth suggests possible debt rollover or maintenance in capital structure - these are subtly different interpretations of what the repeated disclosure means; (3) The ground truth explicitly states 'first disclosed in 2022' while the LLM answer simply lists all three years without clarifying the chronological evolution. REASONING QUALITY: The LLM's interpretation that Apple is 'consistently tracking and reporting all debt issuances—even those that have matured' is reasonable but differs from the ground truth's suggestion of possible rollover or continued maintenance. Both interpretations are plausible, but the ground truth's framing is more nuanced about what the persistence might indicate. The multi-hop synthesis is sound - correctly connecting the repeated appearance across three filings to a broader debt management practice. CONTEXTUAL RELEVANCE: The answer directly addresses how disclosure evolved (unchanged across three years) and what it suggests about debt management, though with a slightly different emphasis than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 569,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "In 2022 Intel used the 2006 Equity Incentive Plan to grant restricted‑stock units (RSUs) to non‑employee directors, vesting on a time‑ or performance‑based schedule [page 108]. In 2023 the plan continued to award RSUs with retirement‑vesting terms to executives and performance‑based RSUs to grandfathered executives, reflecting a mix of retirement and performance vesting [page 107]. By 2024 the plan broadened further to include performance‑based RSUs for non‑grandfathered executives and RSUs for non‑employee directors, indicating a wider use and more varied vesting conditions [page 107, page 108].",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and inconsistencies compared to the ground truth. STRENGTHS: (1) Correctly identifies the 2006 Equity Incentive Plan as the subject; (2) Accurately mentions RSUs and performance-based RSUs across all three years; (3) Correctly notes the May 11, 2023 amendment/restatement in the ground truth (though not explicitly stated in LLM answer); (4) Properly identifies vesting variations (time-based, performance-based, retirement-vesting terms). WEAKNESSES: (1) The LLM answer describes a progression that appears to broaden from 2022-2024 ('broadened further'), but the ground truth indicates a shift toward 'consolidation' and 'streamlined format' by 2024, suggesting a narrowing rather than broadening; (2) Missing key detail about the 2023 amendment and restatement effective May 11, 2023, which was a significant structural change; (3) The characterization of 2024 as 'broadened further' contradicts the ground truth's description of 'consolidation in documentation structure'; (4) Incomplete synthesis of the evolution narrative - the ground truth emphasizes a shift toward 'more nuanced performance alignment and simplified documentation,' while the LLM focuses on expanding award types; (5) The LLM mentions 'grandfathered' and 'non-grandfathered' executives in 2023-2024, which aligns with ground truth, but doesn't adequately explain the distinction or its significance; (6) Missing context about strategic growth performance-based RSUs mentioned in 2022 ground truth. QUANTITATIVE ACCURACY: No specific numbers or percentages were required, so this dimension is less critical, but dates are correct (2022, 2023, 2024). MULTI-HOP REASONING: The answer attempts to synthesize evolution across three years but fails to capture the directional shift correctly (consolidation vs. broadening). The reasoning about 'wider use and more varied vesting conditions' in 2024 contradicts the ground truth's emphasis on consolidation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 538,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "Medtronic’s capital‑structure notes show the same authorized amount of 40 000 Euro Deferred Shares at €1.00 par in each filing, with no shares issued or outstanding in FY 2022 (page 79), FY 2023 (page 80), and FY 2024 (pages 81‑83). The unchanged authorization and zero issuance across three years indicate the company is not using Euro‑deferred shares as a financing tool, instead relying on ordinary and preferred shares and other instruments, reflecting a conservative, non‑leveraged capital strategy over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the authorized amount of 40,000 Euro Deferred Shares at €1.00 par value across all three fiscal years (2022-2024); (2) Accurately states that no shares were issued or outstanding in each year; (3) Properly synthesizes the multi-hop information showing consistency across three years; (4) Correctly interprets the strategic implication that the company did not use Euro Deferred Shares as a financing tool; (5) Appropriately references alternative capital structure tools (ordinary and preferred shares). MINOR WEAKNESSES: (1) The LLM answer mentions 'pages 79, 80, and pages 81-83' which adds specificity not in the ground truth, but this is not incorrect—it's additional detail that enhances rather than detracts from the answer; (2) The phrase 'conservative, non-leveraged capital strategy' is a reasonable inference but slightly more interpretive than the ground truth's more neutral 'preference for other capital structure tools'; (3) The ground truth specifically mentions 'ordinary share repurchases and dividend policies' as the preferred alternatives, while the LLM answer more broadly references 'ordinary and preferred shares and other instruments'—this is a minor omission of specificity. QUANTITATIVE VERIFICATION: All numbers are correct (40 thousand shares, €1.00 par, zero issuance across three years). MULTI-HOP REASONING: The answer correctly synthesizes information across three fiscal years and draws appropriate conclusions about capital strategy. SEMANTIC EQUIVALENCE: The core message matches the ground truth—consistent non-issuance suggests deliberate avoidance of this financing instrument in favor of other methods.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 482,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "Intel’s advanced‑packaging strategy remained a core focus from 2022‑24, but execution risks intensified: in 2022 the company spent $17.5 B on R&D and warned that its disaggregated design and novel packaging added complexity and could delay launches (page_54). By 2023 R&D fell to $16 B, yet packaging delays could erode competitiveness and inventory‑related charges rose to $922 M (page_35). In 2024 R&D rose to $16.5 B and the firm recorded $3.1 B in impairment charges tied to its Intel 7 node, underscoring the high cost and risk of advanced packaging and the financial hit from under‑utilized capacity (page_34).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative of Intel's advanced packaging strategy evolution from 2022-2024, with intensifying execution risks and financial strain. Key financial figures are accurate: $3.1B impairment charges tied to Intel 7 (matches ground truth), R&D spending trajectory ($17.5B in 2022, declining to $16B in 2023, rising to $16.5B in 2024), and the $922M inventory-related charges in 2023. The answer effectively synthesizes multi-hop information across three years, connecting R&D investment levels to manufacturing complexity and financial impact. The logical progression from strategic positioning to execution challenges to financial setbacks is sound.\n\nWEAKNESSES: The LLM answer omits several important contextual details from the ground truth: (1) No mention of Intel 4 and 10nm process delays in 2022, (2) Missing reference to the Universal Chiplet Interconnect Express (UCIe) standard demonstration in 2023, which was a key technical achievement, (3) Lacks explicit mention of the IDM 2.0 strategy framework that contextualized these investments, (4) Does not address the specific positioning of advanced packaging as a competitive differentiator for AI-driven systems. The answer focuses heavily on financial metrics and R&D spending but provides less detail on the technical/strategic positioning evolution.\n\nQUANTITATIVE VERIFICATION: All dollar amounts and R&D figures appear accurate based on typical Intel financial reporting. The $3.1B impairment is correctly cited. The R&D trajectory is plausible and matches the stated progression. No calculation errors detected.\n\nMULTI-HOP REASONING: The answer successfully connects three separate data points (R&D spending, inventory charges, impairment charges) across three years to demonstrate the evolution of risks. However, it could have better synthesized the technical achievements (UCIe) with the financial setbacks to show the full picture of strategic intent versus execution reality.\n\nCONTEXTUAL GAPS: While the answer addresses R&D investment and financial impact well, it provides less depth on manufacturing complexity evolution and the specific technical positioning shifts (especially the AI-systems focus and chiplet interconnect standard).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 605,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "In 2022 Intel positioned PowerVia as a breakthrough backside‑power delivery technology for the Intel 20A node, targeting up to a 15 % performance‑per‑watt improvement over Intel 3. The 2023 roadmap shifted focus to the Intel 18A node, where PowerVia would now be part of a second‑generation process expected to add an additional ~10 % performance‑per‑watt over 20A, underscoring its role as a key enabler of density and power scaling. By 2024 Intel disclosed that PowerVia is integrated into the Intel 18A design and that high‑volume manufacturing of 18A‑based processors (Panther Lake) is slated to begin in 2025, marking the transition from concept to production readiness.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims PowerVia was positioned for Intel 20A in 2022 with 15% improvement, then states in 2023 it shifted to Intel 18A with an 'additional ~10% performance-per-watt over 20A.' This introduces a false claim not in the ground truth. The ground truth states PowerVia would be introduced with Intel 20A in 2023 roadmap updates and deliver 15% improvement over Intel 3 (not cumulative improvements). The LLM's assertion of an additional 10% improvement in 2023 is fabricated and contradicts the ground truth. (2) TIMELINE INCONSISTENCY - The LLM incorrectly places the initial 2022 introduction with specific Intel 20A positioning, when the ground truth indicates PowerVia was introduced in 2022 as a general concept, with the Intel 20A positioning solidified in 2023. (3) ENTITY ACCURACY - The LLM correctly identifies Intel 18A as the successor to Intel 20A and mentions Panther Lake, which adds specificity but wasn't in the ground truth (neither confirms nor contradicts). (4) MULTI-HOP REASONING - The LLM attempts to synthesize the evolution but introduces false intermediate claims about performance improvements that don't match the ground truth. The core narrative of 2022 introduction → 2023 roadmap solidification → 2024 manufacturing readiness is present but corrupted with incorrect performance metrics. (5) WHAT WAS CORRECT - The 2024 disclosure about Intel 18A and 2025 HVM timing is accurate; the general positioning as backside power delivery is correct; the transition from concept to production is correctly identified. (6) WHAT WAS WRONG - The fabricated 10% additional improvement claim, the misplacement of 15% improvement attribution (should be vs Intel 3, not as initial positioning), and the false claim about 2023 shifting focus when it was actually solidifying the roadmap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 503,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "Medtronic has not revised its U.S. employee restricted‑stock‑unit award agreement between FY2022 and FY2024 – all three filings (FY2022, FY2023 and FY2024) continue to reference the same “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan” (exhibit 10.54)【page_115 (FY2022)】【page_115 (FY2023)】【page_115 (FY2024)】. This consistency indicates a deliberate choice to keep a stable, long‑term equity‑compensation framework for U.S. employees, emphasizing continuity and alignment with shareholder interests rather than frequent plan changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. STRENGTHS: (1) Correctly identifies that Medtronic has NOT updated its U.S. employee RSU agreements between FY2022-FY2024; (2) Accurately references the same 'Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan' across all three years; (3) Properly cites the exhibit number (10.54) and page references for all three fiscal years; (4) Correctly synthesizes the multi-hop information (comparing three separate annual filings to identify consistency); (5) Provides sound interpretation that this consistency reflects a stable, deliberate equity compensation strategy. MINOR DIFFERENCES: The LLM answer uses slightly different phrasing ('deliberate choice to keep a stable, long-term equity-compensation framework' and 'emphasizing continuity and alignment with shareholder interests') compared to the ground truth's 'stable and consistent equity compensation strategy' and 'maintained its approach to long-term incentive alignment without introducing structural changes.' However, these are semantically equivalent and represent the same core insight. The LLM answer actually provides slightly more nuanced interpretation by explicitly noting this is a 'deliberate choice' and connecting it to shareholder alignment. NO FACTUAL ERRORS: All dates, document references, fiscal years, and plan names are correct. The multi-hop reasoning correctly synthesizes information across three separate annual filings. The answer fully addresses both parts of the question: (1) whether updates occurred (no), and (2) what this suggests about strategy (stability and consistency).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 463,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "In 2022 Intel’s 2006 Equity Incentive Plan used a single performance‑based RSU grant structure for all executives. By 2024 the plan had been split into two distinct grant agreements—Exhibit 10.1.5 for grandfathered executives and a new Exhibit 10.1.6 for non‑grandfathered executives—showing a move to a more granular, differentiated incentive structure【page 107】【page 108】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and incomplete synthesis across the three-year period. CRITICAL ISSUES: (1) The answer claims 2022 used a 'single performance-based RSU grant structure' but provides no evidence this changed from 2022 to 2023. The ground truth explicitly states that in 2023, Intel used 'separate agreements for grandfathered and non-grandfathered executives,' indicating the differentiation existed by 2023, not newly appearing in 2024. (2) The answer incorrectly attributes the split structure to 2024 ('By 2024 the plan had been split'), when the ground truth shows this differentiation was already present in 2023. (3) The answer fails to address 2023 entirely, which is a critical gap in a three-year evolution question. The ground truth explicitly discusses 2023 as a distinct year with its own developments. (4) The answer lacks mention of the May 11, 2023 amendment and restatement of the plan, which is a key structural development noted in the ground truth. (5) The answer omits the S-8 registration filed September 26, 2023, which demonstrates continued strategic reliance on the plan. (6) The exhibit references (10.1.5 and 10.1.6) are provided without verification against the ground truth, and the claim about when these were introduced appears to be incorrect. WHAT WAS CORRECT: The answer correctly identifies Intel, the 2006 Equity Incentive Plan, performance-based RSUs, and the concept of grandfathered vs. non-grandfathered executives. The general direction of increased differentiation is conceptually aligned with the ground truth, though the timeline is wrong. MULTI-HOP REASONING: The answer fails to properly synthesize information across all three years (2022, 2023, 2024) as required by the question. It appears to conflate 2023 and 2024 developments or misplace them chronologically.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 500,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "Intel’s R&D spend on process‑and‑packaging technology stayed high through the period – $17.5 billion in 2022, $16.0 billion in 2023, and $16.5 billion in 2024 (page 32).  In 2023 the company secured five new AI‑focused design wins and demonstrated its Universal Chiplet Interconnect Express standard in silicon, underscoring a tangible advance in its advanced‑packaging capability (page 33, page 36).  These milestones show Intel is scaling investment in advanced packaging to support its disaggregated design strategy and is gaining traction in the AI‑driven semiconductor market (page 35, page 56).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some correct information but has significant gaps and omissions compared to the ground truth. QUANTITATIVE ACCURACY: The R&D spending figures are mostly correct ($17.5B in 2022, $16.0B in 2023, $16.5B in 2024), though the ground truth specifically mentions $16.5B for 2024 which matches. However, the LLM answer fails to mention the critical $3.1 billion in charges related to non-cash impairments and accelerated depreciation recorded in 2024, which is a key quantitative fact revealing execution risks. COMPLETENESS: The answer addresses the 2023 progress (UCIe demonstration, AI design wins) but incompletely addresses the 2024 situation. It mentions investment levels but omits the significant financial charges that indicate execution challenges. ENTITY ACCURACY: All entities (Intel, UCIe, AI market) are correctly identified. REASONING AND SYNTHESIS: The LLM answer presents a partial narrative of progress but fails to synthesize the full multi-hop story. The ground truth reveals a complex trajectory with 2022 challenges, 2023 progress, and 2024 setbacks (impairments/charges). The LLM answer presents only the positive aspects (investment, design wins, demonstrations) without acknowledging the execution risks and financial pressures evident in 2024. This is a critical omission for answering what the progression 'reveals about the company's ability to execute.' SEMANTIC EQUIVALENCE: While the wording differs, the LLM answer conveys an incomplete picture. It suggests Intel is 'gaining traction' without acknowledging the offsetting financial charges and execution risks that the ground truth emphasizes as central to understanding the company's competitive position. The answer reads as optimistic without the nuance of persistent challenges that the ground truth identifies. The failure to mention the $3.1B in impairments is particularly significant as this directly addresses execution risks in scaling advanced packaging technologies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 533,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "Intel continued to use the 2006 Equity Incentive Plan for RSU grants, adding a grant agreement for non‑employee directors in 2022 (May 12 2022)【108】. The 2023 filing shows no new grant agreements or amendments to the plan, and the 2024 filing likewise contains no additional amendments or grant agreements under the plan【107‑108】. Thus, the plan’s use remained largely unchanged, with the only new grant agreement disclosed being the 2022 director‑RSU agreement.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) MAJOR ERROR - The LLM claims '2023 filing shows no new grant agreements or amendments to the plan' and '2024 filing likewise contains no additional amendments,' directly contradicting the ground truth which explicitly states 'the company filed an amended and restated version of the plan effective May 11, 2023.' This is a fundamental factual error about a key amendment. (2) INCOMPLETE SYNTHESIS - The LLM only identifies one new grant agreement (2022 director-RSU agreement) while the ground truth indicates multiple grant agreements across all three years including RSU agreements with retirement vesting terms and performance-based RSUs in 2023, and standardized RSU grant agreements and notices of grant in 2024. (3) MISCHARACTERIZATION OF EVOLUTION - The LLM concludes 'the plan's use remained largely unchanged' which directly contradicts the ground truth's characterization of 'consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.' (4) MISSING CONTEXT - The LLM fails to capture the evolution across the three-year period, particularly the significance of the 2023 amended and restated version and the continued reliance on standardized agreements in 2024. (5) DATE ACCURACY - While the May 12, 2022 date for the director-RSU agreement appears reasonable, the critical May 11, 2023 amendment date is completely omitted. The answer demonstrates poor multi-hop reasoning by failing to synthesize information across the three years and missing the key structural change in 2023.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 455,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "Qualcomm kept wireless access points in the same revenue bucket – the IoT stream under the “edge networking” sub‑category – in both 2022 and 2024 (see QCT revenue tables on page 73).  However, its strategic narrative shifted from a focus on Wi‑Fi 6/6E to foregrounding the upcoming Wi‑Fi 7 standard and the role of access points in replacing last‑mile wired broadband, positioning Qualcomm as a leader in next‑generation edge‑networking solutions (page 8 and page 10).  The IoT revenue that includes wireless access points fell from $7.35 bn in 2022 to $5.42 bn in 2024, reflecting a market‑demand shift while the classification stayed unchanged (page 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that wireless access points remained classified under edge networking across 2022-2024, matching the ground truth. It appropriately notes the strategic narrative shift from Wi-Fi 6/6E to Wi-Fi 7, which adds valuable context beyond the ground truth. The answer demonstrates good understanding of market positioning and strategic emphasis evolution. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM provides specific revenue figures ($7.35bn in 2022 declining to $5.42bn in 2024) that are NOT present in the ground truth, which explicitly states 'exact revenue figures for wireless access points alone are not disclosed.' This is a significant factual error - the LLM appears to have cited IoT segment revenue rather than wireless access points specifically, conflating two different metrics. (2) INCOMPLETE SYNTHESIS - The ground truth mentions the 2022 projection of IoT devices doubling to over 27 billion by 2026, which the LLM completely omits. (3) MISSING 2023 DETAIL - The ground truth specifically notes that 2023 showed 'explicit categorization' of wireless access points under edge networking, indicating a formal financial classification milestone. The LLM does not address this 2023 transition point. (4) PAGE CITATIONS - While the LLM provides specific page references (pages 73, 8, 10), these cannot be verified against the ground truth and may be fabricated or misattributed. MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of classification consistency and strategic narrative evolution, but fails on the critical quantitative dimension by introducing unverified revenue figures. The answer conflates IoT segment revenue with wireless access points revenue, which are distinct metrics. SEMANTIC ISSUES: The answer's core claim about revenue decline is presented as fact but lacks proper grounding in the source material according to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 521,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "MRK’s Prevymis sales climbed steadily, rising from **$428 million in 2022** to **$605 million in 2023** and **$785 million in 2024** (Hospital Acute Care segment totals)【page_130】. The year‑over‑year growth of roughly 41 % (2022‑23) and 29 % (2023‑24) indicates that the CMV‑prophylaxis is gaining traction and solidifying its position as a key product within the hospital acute‑care portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors in the core numbers that are the primary focus of the question. (1) 2022 Sales: LLM states $428 million, but ground truth is $370 million - this is a $58 million error (15.7% overstatement). (2) 2023 Sales: LLM states $605 million, but ground truth is $428 million - this is a $177 million error (41.4% overstatement). (3) 2024 Sales: LLM correctly states $785 million. The LLM has essentially shifted all numbers upward by one year, suggesting a fundamental data retrieval error. (4) CALCULATION ERRORS: The LLM calculates growth rates of 41% (2022-23) and 29% (2023-24), but these are based on incorrect numbers. The correct growth rates should be: 2022-2023: (428-370)/370 = 15.7%, and 2023-2024: (785-428)/428 = 83.4%. The LLM's calculated compound growth rate is not explicitly stated but would be incorrect based on wrong base numbers. The ground truth states approximately 46% CAGR over 2022-2024, which can be verified: (785/370)^(1/2) - 1 = 45.8%, confirming the ground truth. (5) MULTI-HOP REASONING: While the LLM correctly identifies the Hospital Acute Care segment context and appropriately discusses market positioning and CMV prophylaxis, this qualitative reasoning cannot compensate for the severe quantitative errors. The answer demonstrates understanding of the product's strategic importance but fails on the factual foundation. (6) ENTITY ACCURACY: MRK and Prevymis are correctly identified, but the fiscal year data is misaligned. The answer is fundamentally unreliable due to systematic numerical errors that undermine the entire analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 451,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "In 2022 Intel positioned advanced packaging as a core IDM 2.0 enabler, adopting a disaggregated design approach to combine components across nodes while noting that manufacturing delays and capital constraints limited progress (page 56, page 55). By 2023 the company secured multiple design wins and packaging revenue rose $483 million, yet still posted operating losses because of heavy R&D and capital outlays (page 35, page 36, page 38). In 2024 Intel continues to market advanced packaging as a unique advantage—highlighting new standards such as the Universal Chiplet Interconnect Express and ongoing partnerships—while acknowledging construction delays and the need for alternative financing, underscoring that IDM 2.0 execution remains challenged by persistent manufacturing lag and capital‑intensive demands (page 32‑36).",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative arc across 2022-2024 regarding Intel's advanced packaging strategy within IDM 2.0, acknowledges manufacturing delays and capital constraints as persistent challenges, and mentions key initiatives like UCIe (Universal Chiplet Interconnect Express). The answer appropriately synthesizes multi-year progression and captures the tension between strategic positioning and execution challenges. CRITICAL ERRORS: (1) QUANTITATIVE FAILURE - The LLM claims 'packaging revenue rose $483 million' in 2023, but this specific figure is not verified in the ground truth and appears to be an unsupported claim. No packaging revenue figure is mentioned in the original answer. (2) MISSING KEY METRICS - The LLM fails to cite the $16.5 billion R&D investment in 2024 mentioned in ground truth, which is a critical quantitative indicator of capital intensity. (3) MISSING IMPAIRMENT DATA - The LLM does not mention the $3.1 billion non-cash impairment in Q3 2024 affecting Intel 7, which is a significant factual element demonstrating execution challenges. (4) VAGUE PRODUCT DELAYS - While the LLM mentions 'construction delays,' it fails to specifically reference the 4th Gen Xeon Scalable processor delays cited in ground truth. (5) PAGE CITATIONS - The LLM provides page numbers (page 56, 55, 35, 36, 38, 32-36) without verification; these cannot be confirmed against the ground truth. REASONING ASSESSMENT: The multi-hop synthesis is partially sound—the LLM correctly connects 2022 positioning → 2023 progress → 2024 challenges. However, the reasoning is undermined by missing quantitative support and unverified claims. The answer demonstrates understanding of the strategic narrative but lacks the precision and completeness required for a high-confidence evaluation. The claim about 'design wins and packaging revenue rose $483 million' is particularly problematic as it introduces a specific number not present in ground truth without clear sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 540,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "IBM has consistently cited client relationships and trust as a core competitive differentiator in its 2022, 2023, and 2024 10‑K filings (the phrase appears in the competition section on page 4 of each filing). Over time the company has increasingly tied this trust to its hybrid‑cloud platform and AI strategy, stressing that the platform and AI technology enable clients to realize digital transformations while building confidence. This progression signals IBM’s intent to position itself as a trusted partner in the hybrid‑cloud and AI market, using client trust to differentiate from competitors and drive adoption of its hybrid‑cloud and AI solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that IBM consistently emphasized client relationships and trust across 2022-2024 and ties this to hybrid cloud and AI strategy. However, there are significant gaps in completeness and synthesis compared to the ground truth. STRENGTHS: (1) Correctly identifies the 3-year timeframe (2022-2024) and the consistency of messaging; (2) Accurately notes the connection between trust and hybrid cloud/AI strategy; (3) Correctly identifies the competitive positioning intent. WEAKNESSES: (1) MAJOR OMISSION: The LLM completely fails to mention the Palo Alto Networks strategic partnership mentioned in 2024, which is explicitly highlighted in the ground truth as signaling 'a deepening of trust-based collaboration'; (2) INCOMPLETE SYNTHESIS: The ground truth shows a specific evolution in framing - from 2022 (trust tied to hybrid cloud platform and AI for production), to 2023 (trust as part of broader competitive methods including service, support, innovation, talent), to 2024 (expanded partnerships). The LLM provides only a generic statement about 'increasingly tied' without capturing this nuanced progression; (3) MISSING CONTEXT: The ground truth emphasizes this as a '3-year consistency' showing 'strategic commitment to trust as a foundational element in client acquisition and retention.' The LLM mentions consistency but doesn't articulate the strategic significance of this consistency; (4) VAGUE SPECIFICITY: The LLM mentions 'page 4 of each filing' but doesn't verify this detail against actual filings, and the ground truth doesn't specify page numbers, suggesting this may be an unsupported claim. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this scores well (7/10) - the years are correct, the timeframe is accurate. QUALITATIVE ACCURACY: The reasoning is partially sound but incomplete. The multi-hop synthesis across three years is attempted but lacks the detailed evolution described in ground truth. The connection to competitive positioning is made but not as thoroughly as the ground truth establishes. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution and strategic positioning, though it misses key details about partnership expansion that would strengthen the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 619,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "IBM did not issue any new 0.950% Notes between 2022 and 2024; the notes were originally issued in 2017.  In the 2023 10‑K, IBM disclosed the terms of the 0.950% Notes through Exhibits 4.1 and 4.2 to a 2017 8‑K filing (page 20), whereas the 2024 10‑K lists the notes as a registered security (IBM25B) under Section 12(b) of the Act, consolidating the disclosure within the annual report (page 1).  This shift from separate 8‑K exhibits to a fully integrated 10‑K disclosure reflects IBM’s disciplined debt‑management approach that prioritizes regulatory compliance, transparency, and a stable, diversified debt portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key dates, exhibits, and the NYSE trading symbol (IBM25B). All numeric references (2017 issuance date, 2023/2024 disclosure years) are accurate. The answer correctly clarifies that no new issuance occurred between 2022-2024, which is an important factual distinction. The multi-hop synthesis is sound: the answer traces the disclosure evolution from 2023 (referencing 2017 8-K exhibits) to 2024 (integrated 10-K disclosure with NYSE registration). The characterization of IBM's debt management approach as 'disciplined' with emphasis on 'regulatory compliance, transparency, and stable diversified debt portfolio' aligns well with the ground truth's assessment of 'stable and transparent debt management strategy.' Minor differences from ground truth: (1) The LLM specifies 'Exhibits 4.1 and 4.2' for 2023 while ground truth mentions only 'Exhibit 4.1' - this is a minor discrepancy but not contradictory; (2) The LLM provides more specific page references (page 20, page 1) which adds helpful detail; (3) The LLM's characterization of the shift as moving 'from separate 8-K exhibits to fully integrated 10-K disclosure' is a more precise articulation than the ground truth's 'consistent disclosure framework.' The answer fully addresses the question's three components: issuance strategy (clarifying no new issuance), disclosure evolution (2023 vs 2024 approach), and broader debt management implications. The reasoning about what this progression indicates is logical and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 432,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "In 2022 Intel announced PowerVia as a future backside‑power technology for its upcoming 20A node (INTC_10k_2022.pdf: page 9). By 2023 the company positioned PowerVia as the first high‑volume commercial implementation in the 18A node—eliminating front‑side power routing—and noted that 20A would also incorporate it (INTC_10k_2023.pdf: pages 10 & 14). The 2024 filings (INTC_10k_2024.pdf: pages 8‑12) no longer treat PowerVia as a future technology, implying it has moved into production, underscoring Intel’s roadmap that backside power delivery will be a core differentiator in its next‑generation advanced process nodes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant factual discrepancies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the three-year progression (2022-2024) of PowerVia strategy; (2) Accurately notes 2022 announcement as future roadmap; (3) Correctly identifies backside power delivery as the core innovation; (4) Properly synthesizes multi-hop information across three years of filings; (5) Appropriately contextualizes PowerVia as a strategic differentiator. CRITICAL ERRORS: (1) The LLM states PowerVia was positioned for 18A in 2023 as 'first high-volume commercial implementation,' but ground truth indicates 18A commercial deployment began in 2025 (not 2023); (2) The LLM implies 20A would 'also incorporate' PowerVia in 2023, but ground truth reveals Intel canceled 20A productization in 2024 in favor of 18A—this is a fundamental strategic pivot the LLM misses; (3) The LLM's statement that 2024 filings show PowerVia 'moved into production' is imprecise—ground truth specifies commercial high-volume production starting in 2025, not 2024. REASONING ASSESSMENT: The multi-hop synthesis across three years is logically structured, but the LLM fails to capture the critical strategic decision point (cancellation of 20A in favor of 18A) that represents the most significant evolution in Intel's strategy. This omission undermines the answer's ability to fully explain the 'progression' requested. The LLM correctly identifies the concept-to-deployment trajectory but misses the node-switching decision that fundamentally altered the roadmap. QUANTITATIVE ISSUES: Timeline accuracy is compromised—the LLM conflates when PowerVia was positioned for different nodes versus when commercial production actually begins.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 478,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "Medtronic’s 2022‑, 2023‑ and 2024‑10 K filings all reference the same 2021 Medtronic plc Long‑Term Incentive Plan RSU award agreements (exhibits 10.78‑10.81 in each year).  The vesting schedule—100 % on the third anniversary or ratably over four years—remains unchanged, and the underlying Amended and Restated 2013 Stock Award and Incentive Plan has not been materially altered.  This consistency indicates a stable U.S. equity‑compensation strategy across the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG EXHIBIT NUMBERS: The LLM claims exhibits 10.78-10.81, but the ground truth specifies Exhibit 10.54. This is a critical error in entity identification. (2) WRONG FILING DATE: The LLM references a '2021 Medtronic plc Long-Term Incentive Plan RSU award agreements,' but the ground truth clearly states the documentation references August 27, 2013. The LLM appears to have confused the underlying plan date with the agreement date. (3) INCORRECT VESTING DETAILS: The LLM provides specific vesting percentages (100% on third anniversary or ratably over four years) that are not mentioned in the ground truth answer. While these details might be accurate from the actual filings, they are not part of the ground truth answer and may represent hallucination or confusion with different award types. (4) INCOMPLETE SYNTHESIS: The ground truth emphasizes that the SAME agreement (Exhibit 10.54) remained unchanged across all three years (2022-2024), consistently referencing August 27, 2013. The LLM's answer suggests different exhibits (10.78-10.81) across years, which contradicts the stability narrative. (5) CORRECT CONCLUSION BUT WRONG EVIDENCE: While the LLM correctly concludes there is strategic stability, it reaches this conclusion through incorrect documentation references and dates. The reasoning is sound in principle but built on factually incorrect premises. The answer demonstrates partial understanding of the question's intent but fails on the specific factual details that constitute the evidence for that conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 447,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "In 2022 Intel positioned advanced packaging as a key differentiator of its IDM 2.0 strategy, but execution was hampered by 10 nm and 7 nm node delays, a delayed 4th‑Gen Xeon, and capital constraints that postponed facility expansions, while the newly‑adopted disaggregated design approach added logistical and packaging complexity. By 2023 the company secured several Intel 18A design wins and saw packaging revenue rise, yet continued to incur operating losses from aggressive R&D and capital spending, and the disaggregated strategy still exposed it to supply‑chain and yield risks. In 2024 advanced‑packaging revenue grew further, but capital constraints remained—evidenced by joint‑investment penalties and delayed Fab 34 construction—while the disaggregated design approach continued to create execution challenges, underscoring the trade‑off between pursuing cutting‑edge packaging and managing cost and schedule risks.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains a critical factual error regarding the $3.1 billion impairment charge. The ground truth explicitly states this charge was tied to Intel 7 node underutilization in 2024, but the LLM answer completely omits this specific, material financial metric. This is a significant omission for a multi-hop financial question. PARTIAL CREDIT FOR QUALITATIVE ELEMENTS: The LLM correctly identifies the evolution of Intel's advanced packaging strategy across 2022-2024, including: (1) 2022 positioning of advanced packaging within IDM 2.0 strategy with execution challenges from node delays; (2) 2023 progress with design wins and packaging revenue growth; (3) 2024 continued execution challenges with capital constraints. The mention of disaggregated design approach, supply chain/yield risks, and the trade-off between cutting-edge packaging and cost/schedule management aligns with the ground truth narrative. MISSING KEY DETAILS: The LLM answer fails to mention: (1) the specific $3.1 billion impairment charge (critical quantitative fact); (2) UCIe standard as a key differentiator (mentioned in ground truth 2023); (3) delays in manufacturing projects in multiple geographies (mentioned in ground truth 2024); (4) Intel 4 node specifically (mentioned in ground truth 2022). REASONING QUALITY: The multi-hop synthesis across 2022-2024 is logically sound and captures the strategic evolution, but the omission of the major impairment charge represents a failure to fully synthesize available financial data. The answer demonstrates understanding of the strategic challenges but lacks precision on material financial metrics. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on strategic positioning, execution challenges, delays, capital constraints, and disaggregated design approaches, though with incomplete financial specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 518,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "Across 2022‑24 Accenture kept a heavily fixed‑income focus.  In 2022 the U.S. plans were 100 % debt, while non‑U.S. plans were 48 % debt and 27 % equity (page 88).  By 2023 the U.S. mix shifted to 95 % debt (5 % cash) and non‑U.S. plans to 43 % debt/19 % equity (page 95).  In 2024 the U.S. mix was 94 % debt (6 % cash) and non‑U.S. plans 42 % debt/23 % equity (page 95).  The modest swing—down in equity in 2023 and a slight rebound in 2024—shows the company’s willingness to adjust equity exposure in response to market conditions while preserving a conservative, risk‑adjusted return strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific, quantifiable data about Accenture's target asset allocation across fiscal years 2022-2024, which is a significant strength. The numerical breakdown (U.S. plans: 100% debt in 2022, 95% debt in 2023, 94% debt in 2024; non-U.S. plans showing debt/equity mixes) appears detailed and specific. The answer correctly identifies the multi-year evolution and provides page references (88, 95) suggesting source verification. The reasoning about the company's willingness to adjust equity exposure in response to market conditions is sound and directly addresses the question about risk-adjusted returns. However, there are some concerns: (1) The ground truth emphasizes a 'diversified portfolio' with both fixed income and equities, while the LLM answer characterizes it as 'heavily fixed-income focus,' which may be accurate but represents a different framing. (2) The ground truth mentions 'flexibility in asset allocation decisions' and 'variation within established ranges,' while the LLM answer focuses more on the actual allocations rather than the strategic flexibility framework. (3) The LLM answer's interpretation of 'modest swing' and 'slight rebound' is reasonable but the ground truth emphasizes the consistency of the dual focus and evolving flexibility more than the LLM does. (4) The specific percentages provided by the LLM (100%, 95%, 94% for U.S.; 48%/27%, 43%/19%, 42%/23% for non-U.S.) cannot be verified against the ground truth provided, but they are presented with confidence and specificity. The answer successfully synthesizes multi-year data and provides a coherent narrative about the company's approach, though it may slightly overstate the 'heavily fixed-income' characterization compared to the ground truth's emphasis on 'diversified portfolio.' The conclusion about risk-adjusted returns is appropriate and well-supported by the data presented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 514,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "Apple’s repeated mention of the 1.05% Notes due 2017 in its 2023 and 2024 10‑Ks (Exhibit 4.4) shows a disciplined, consistent disclosure policy that keeps investors apprised of all outstanding debt, even older maturities. In contrast, the company’s broader debt‑issuance strategy over 2022‑24 has been to issue new, higher‑yield notes (e.g., the 4.421% Notes due 2026 in 2024, Exhibit 4.28) to fund share repurchases and other corporate purposes, reflecting a proactive, diversified debt‑raising approach while maintaining full transparency on legacy obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates understanding of the core concept (Apple's consistent disclosure of historical debt instruments alongside new issuances) but introduces problematic factual claims that cannot be verified against the ground truth. STRENGTHS: (1) Correctly identifies the 1.05% Notes due 2017 as a historical instrument referenced in 2023-2024 filings; (2) Accurately characterizes Apple's disclosure approach as transparent and comprehensive; (3) Properly contrasts historical debt with new issuances; (4) Correctly notes the broader debt strategy involves issuing new instruments with varying maturities. CRITICAL ISSUES: (1) The LLM introduces the 4.421% Notes due 2026 (Exhibit 4.28) as a 2024 issuance, which is not mentioned in the ground truth answer and cannot be verified; (2) The ground truth mentions specific instruments (Floating Rate Notes due 2020, 2.15% Notes due 2022, 3.45% Notes due 2024) but the LLM substitutes different ones without explanation; (3) The LLM adds interpretive claims about 'higher-yield notes' and purposes ('fund share repurchases') that go beyond what the ground truth establishes; (4) The specific exhibit references (4.4, 4.28) are provided without verification against source documents. REASONING QUALITY: The multi-hop synthesis is sound in structure—comparing historical debt disclosure to broader strategy—but the execution introduces unverified specifics. The semantic understanding of Apple's disclosure philosophy is correct, but the factual grounding is weakened by introducing new financial instruments not in the ground truth. The answer reads as plausible but contains potential factual errors that would require SEC filing verification to confirm.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 466,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "Accenture repurchased 12.2 million shares for $4.1 million in fiscal 2022, and its remaining authorization rose to $6.129 million after a $3 million increase (page 94). In fiscal 2023 the company bought roughly $3.5 billion in shares and had about $6.3 million left in authorization (intermediate year). By fiscal 2024 it had returned $4.5 billion to shareholders and its total authorization had grown to $6.694 million (page 39 and page 40). This steady rise in both buy‑back volume and authorized capacity signals a disciplined, expanding capital‑return strategy that balances shareholder payouts with a flexible buy‑back pool.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains severe and pervasive factual errors that fundamentally misrepresent Accenture's share repurchase activity and capital return strategy. CRITICAL ERRORS: (1) MAGNITUDE ERRORS - The LLM states fiscal 2022 repurchases were $4.1 million and remaining authorization was $6.129 million, when ground truth shows $3.13 billion in available authorization. The LLM's numbers are off by a factor of approximately 1,000x (millions vs. billions). (2) FISCAL 2023 ERROR - LLM claims $3.5 billion in share buybacks in fiscal 2023, but ground truth indicates the 2023 filing mirrors 2024 disclosures with consistent execution around $605 million in fiscal 2024 alone, not $3.5 billion. (3) FISCAL 2024 ERROR - LLM states $4.5 billion returned to shareholders in fiscal 2024, contradicting ground truth which specifies over $605 million in Class A ordinary share purchases during fiscal 2024. (4) AUTHORIZATION ERRORS - LLM claims authorization amounts of $6.129 million and $6.3 million, when ground truth clearly states $3.13 billion (fiscal 2022), $2.69 billion (fiscal 2024), and $6.69 billion total outstanding authority after September 2024 approval. Again, off by factor of ~1,000. (5) MISSING KEY CONTEXT - LLM fails to mention the $4.0 billion new authorization approved in September 2024, which is a critical component of the multi-year pattern. (6) REASONING FLAW - The conclusion about 'steady rise in both buy-back volume and authorized capacity' is contradicted by ground truth showing a DECREASE in available authorization from $3.13B to $2.69B before the new authorization. The LLM fundamentally misunderstood the scale of Accenture's capital return program, confusing millions with billions throughout, and failed to accurately synthesize the multi-year pattern across fiscal 2022-2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 491,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "BMS issued the $1 billion 4.350 % Senior Notes due 2047 in 2019 and the notes have remained unchanged through the 2022, 2023 and 2024 Form 10‑Ks.  Each filing lists the notes in the supplemental‑indenture exhibit (4jj) and in the debt schedule, with no change to the coupon or maturity (2022 10‑K p. 137; 2023 10‑K p. 132; 2024 10‑K p. 134‑138).  The steady presence of this long‑term instrument across three years signals BMS’s strategy of locking in a moderate, fixed‑rate debt for a long horizon to manage refinancing risk and keep a stable, diversified debt profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 4.350% Senior Notes due 2047 as a persistent instrument across 2022-2024 and accurately notes the issuance year (2019) and principal amount ($1 billion). The coupon rate (4.350%) and maturity date (2047) are correct. The answer appropriately cites specific page references from the 10-K filings, demonstrating document verification. The reasoning about locking in fixed-rate debt and managing refinancing risk is sound and relevant to the question.\n\nHowever, the LLM answer is notably incomplete compared to the ground truth. The original answer provides important context about the evolution of BMY's broader debt portfolio across the three years, specifically mentioning: (1) the Eleventh Supplemental Indenture dated November 22, 2019; (2) new issuances in 2023 ($1.75 billion 2.950% Notes due 2032 and $2 billion 3.700% Notes due 2052); and (3) additional 2024 issuances ($3.75 billion 4.250% Senior Notes due 2049). The ground truth emphasizes that the 2047 notes' persistence 'despite new issuances' indicates a strategy of maintaining 'diversified long-term liabilities with staggered maturities.' The LLM answer focuses narrowly on the single instrument without synthesizing the multi-year pattern of new debt issuances that would better illustrate the company's financing strategy.\n\nThe LLM answer uses 'BMS' instead of 'BMY' (Bristol Myers Squibb ticker), which is a minor entity identification error. The answer correctly addresses the core question about the 2047 notes' persistence and provides valid reasoning about financing strategy, but lacks the comprehensive multi-hop synthesis across the broader debt portfolio that would fully answer how the company's long-term financing strategy evolved across the three-year period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 485,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "Apple’s 10‑K filings show a consistent disclosure of the 2.40 % Notes due 2023.  In each year (2022, 2023, and 2024) Apple included Exhibit 4.3 – the officer’s certificate that lists the 2.40 % Notes – and the notes were also presented in the “Notes to Consolidated Financial Statements.”  No substantive change in detail or presentation is evident as the notes approached maturity; Apple simply continued to disclose them in the same manner across the three filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the question about Apple's disclosure evolution for the 2.40% Notes due 2023. STRENGTHS: (1) All numeric values are correct - the 2.40% interest rate is accurate, the 2023 maturity date is correct, and the years 2022, 2023, 2024 are properly identified. (2) The core finding matches the ground truth perfectly: Apple maintained a consistent, unchanging disclosure approach across all three reporting periods. (3) Key details are accurate: Exhibit 4.3 is correctly identified as the location of disclosure, the Officer's Certificate dated May 3, 2013 is mentioned (though the LLM doesn't include the specific date, which is a minor omission). (4) The multi-hop reasoning is sound - the LLM correctly synthesized information across three different filing years and identified the pattern of consistency. (5) The answer appropriately notes that despite the notes approaching and reaching maturity, no substantive changes occurred in disclosure format or presentation. MINOR WEAKNESSES: (1) The LLM answer mentions the notes were \"also presented in the Notes to Consolidated Financial Statements\" but the ground truth doesn't explicitly confirm this detail - this is a minor addition that doesn't contradict the ground truth but adds information not explicitly verified. (2) The specific date of the Officer's Certificate (May 3, 2013) is omitted from the LLM answer, though this is a relatively minor detail. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth - that disclosure remained stable and consistent across the three years with no substantive changes. The wording differs but the meaning is equivalent and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 471,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "In FY 2022 Accenture authorized **127 million** Class A shares for the Amended 2010 Share Incentive Plan (SIP)【page_91】. That authorization remained unchanged in FY 2023, and by FY 2024 it had risen to **141 million** shares【page_98】. The 14‑million‑share increase reflects a deliberate expansion of the share‑based compensation pool, giving the company greater flexibility to reward and retain talent over the long term and to align employee incentives more closely with shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN NUMERIC SEQUENCE: The LLM answer contains a fundamental factual error in the progression of share authorizations. According to the ground truth: FY 2022 = 127M, FY 2023 = 141M, FY 2024 = 141M (stable). However, the LLM states: FY 2022 = 127M (correct), FY 2023 = unchanged (INCORRECT - should have increased to 141M), FY 2024 = 141M (correct). The LLM reversed the timing of the increase, claiming it remained unchanged in 2023 and rose in 2024, when the actual progression shows the increase occurred between 2022-2023 with stability in 2024. This is a critical multi-hop synthesis error that fundamentally misrepresents the company's strategic timeline. The 14-million-share increase calculation is correct (141M - 127M = 14M), and the qualitative interpretation about share-based compensation strategy is reasonable, but the temporal sequencing is wrong. The answer correctly identifies the company (Accenture plc), the plan (Amended 2010 SIP), and the metric (Class A ordinary shares authorized), but fails on the core factual requirement of accurately tracking the year-by-year progression. The contextual reasoning about talent retention and shareholder alignment is appropriate but cannot compensate for the incorrect factual foundation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 354,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "Intel first announced PowerVia in its 2022 20A roadmap as a breakthrough backside‑power technology, and reiterated its role in 2023 as a key performance‑per‑watt improvement. By 2024 the technology had moved from a future concept to a high‑volume commercial implementation in the 18A node, which is slated for Panther Lake processors and delivers an additional 10 % performance‑per‑watt gain over 20A. This evolution shows that PowerVia is a core enabler of Intel’s next‑generation process nodes, underscoring its strategic importance for density and power‑efficiency in the advanced roadmap.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of PowerVia's evolution from 2022-2024 and correctly identifies key milestones: introduction in 2022, solidification in 2023, and transition to 18A in 2024 with Panther Lake. The reasoning about PowerVia's strategic importance is sound and well-articulated. However, there are notable issues: (1) The LLM states PowerVia was announced in the '2022 20A roadmap' when the ground truth indicates it was introduced 'as part of its updated manufacturing process and packaging technology roadmaps' more broadly - the specific node association is less clear in the original. (2) The LLM introduces a specific '10% performance-per-watt gain over 20A' claim that does not appear in the ground truth. This is a quantitative assertion without supporting evidence in the original answer, representing a potential factual error or hallucination. (3) The LLM correctly notes the transition from 20A to 18A and Panther Lake, matching the ground truth. (4) The characterization of PowerVia as 'backside-power technology' and its role in 'density and power-efficiency' aligns with the ground truth's description of 'backside power delivery' and 'performance-per-watt improvements.' The multi-hop synthesis is generally sound - connecting the technology's evolution across three years and its strategic positioning. The main weakness is the unsupported 10% performance metric, which introduces quantitative inaccuracy despite the overall narrative being largely correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 412,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "Accenture’s pension‑plan assets allocated to mutual‑fund equity securities fell from **$239,293** in fiscal 2022 to **$196,226** in fiscal 2023, then rose sharply to **$273,699** in fiscal 2024 (see page 89 for 2022 and page 96 for 2023‑24). This 3‑year trajectory shows a dip in 2023 followed by a sizable rebound in 2024, indicating a strategic shift toward greater equity exposure in its pension portfolio and a willingness to pursue higher equity‑based returns.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a major numerical inaccuracy that fundamentally contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the 2024 figure was $273,699 million, but the ground truth explicitly states it remained unchanged at $196,226 million in fiscal 2024. This is a difference of $77,473 million (39.5% overstatement) - a substantial and material error. The LLM correctly identified the 2022 ($239,293M) and 2023 ($196,226M) figures, but the 2024 number is completely wrong. (2) REASONING ERROR: Based on the incorrect 2024 figure, the LLM drew an entirely wrong conclusion about strategic positioning. The ground truth indicates a consistent reduction and rebalancing away from mutual fund equity securities, while the LLM incorrectly characterized this as a 'sizable rebound' and 'strategic shift toward greater equity exposure.' This is a fundamental misinterpretation driven by the false data point. (3) MULTI-HOP SYNTHESIS: While the LLM attempted to synthesize information across three fiscal years, it failed at the most critical step - accurately reporting the 2024 data. The page references provided (page 89, 96) cannot be verified but appear to be cited to add false credibility. (4) SEMANTIC CONTRADICTION: The LLM's interpretation directly contradicts the ground truth's assessment of the company's strategic positioning. The ground truth shows consistent reduction; the LLM shows a rebound. These are mutually exclusive conclusions. The only correct elements are the 2022 and 2023 figures and the general structure of addressing the three-year trajectory, but the core answer is factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 456,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "Merck has kept the $145 million net carrying value of Dificid’s intangible asset unchanged, with no impairment disclosed in 2023 or 2024 (page 115). The drug remains positioned as a hospital‑acute‑care antibiotic for Clostridioides difficile infection (page 3). Its global sales rose from $263 million in 2022 to $302 million in 2023 and $340 million in 2024, a modest but steady increase in its contribution to the pharmaceutical segment (page 130).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Dificid's therapeutic positioning as a hospital acute care antibiotic for C. difficile infection, matching the ground truth. The 2024 revenue figure of $340 million is accurate, as is the U.S./international breakdown ($303M U.S., $37M international). The answer appropriately addresses the evolution from 2022-2024 and maintains good contextual relevance to the question.\n\nCRITICAL ERRORS: (1) MAJOR QUANTITATIVE ERROR: The LLM states 2022 sales were $263 million and 2023 sales were $302 million. The ground truth only provides 2024 sales data ($340M with $303M U.S., $37M international). The LLM appears to have fabricated or misattributed the 2022 ($263M) and 2023 ($302M) figures, which cannot be verified against the ground truth and are presented as fact with page citations. (2) The LLM mentions the $145 million intangible asset valuation from 2022 (correct per ground truth) but then claims 'no impairment disclosed in 2023 or 2024' - this is an inference not explicitly confirmed in the ground truth. (3) The LLM provides specific page citations (115, 3, 130) that cannot be verified and may be hallucinated.\n\nMULTI-HOP REASONING: The answer attempts to synthesize asset valuation, therapeutic positioning, and revenue contribution across years, which is appropriate. However, the fabricated revenue figures for 2022-2023 undermine the multi-hop synthesis quality.\n\nCOMPLETENESS: The answer addresses all three aspects of the question (asset valuation, therapeutic positioning, revenue contribution) but does so with partially incorrect data for the 2022-2023 period.\n\nJUSTIFICATION: While the answer demonstrates good understanding of the question structure and correctly identifies 2024 data and therapeutic positioning, the introduction of unverified/fabricated historical revenue figures (2022: $263M, 2023: $302M) represents a significant factual error that cannot be overlooked. The quantitative accuracy score is reduced due to these unsourced numbers, while qualitative accuracy remains moderate due to correct reasoning structure despite data issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 568,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "Intel’s IDM 2.0 strategy has pushed it to invest heavily in advanced‑packaging and disaggregated‑design R&D—$17.5 billion in 2022, $16.0 billion in 2023, and $16.5 billion in 2024—while still grappling with delays in 10 nm and 7 nm process rollouts and a 4th‑Gen Xeon launch shift (page 34).  The company kept high R&D spend and secured new advanced‑packaging wins, yet continued implementation lags exposed it to financial risk, as shown by a $922 million inventory charge for AI accelerators (page 35), a $3.1 billion impairment tied to the Intel 7 node (page 34), and a $755 million penalty for Ireland construction delays (page 36).  These delays and associated costs highlight the growing risk that capital‑intensive advanced‑packaging projects may not deliver the expected returns under Intel’s IDM 2.0 strategy (page 34).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Intel's advanced packaging evolution from 2022-2024 and correctly identifies key financial challenges. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nSTRENGTHS:\n1. Correctly identifies the $3.1 billion impairment charge (matches ground truth)\n2. Properly synthesizes the multi-hop narrative: strategic emphasis → execution challenges → financial strain\n3. Accurately captures the shift from optimism to operational/financial strain\n4. Correctly references IDM 2.0 and foundry strategy context\n5. Appropriately contextualizes advanced packaging as a core differentiator\n6. Good multi-hop reasoning connecting R&D investment, delays, and financial risk\n\nWEAKNESSES:\n1. R&D SPENDING FIGURES: The LLM provides specific R&D numbers ($17.5B in 2022, $16.0B in 2023, $16.5B in 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific R&D figures, making it impossible to confirm accuracy. This is a critical issue for quantitative accuracy.\n2. INVENTORY CHARGE: The $922 million inventory charge for AI accelerators is not mentioned in the ground truth, which only references the $3.1B impairment and execution risks. This appears to be an unsupported claim.\n3. IRELAND PENALTY: The $755 million penalty for Ireland construction delays is not mentioned in the ground truth and cannot be verified.\n4. MISSING ELEMENTS: The ground truth specifically mentions UCIe standard demonstration in silicon (2023) and 2D/2.5D/3D packaging solutions, which the LLM answer omits entirely.\n5. MISSING CONTEXT: The ground truth emphasizes the complexity and cost of disaggregated design approach in 2022, which the LLM doesn't explicitly address.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across years and connects R&D investment to execution challenges to financial risk. However, the introduction of unverified financial figures undermines the credibility of this synthesis.\n\nSEMANTIC EQUIVALENCE:\nThe core narrative matches the ground truth (strategic emphasis → execution challenges → financial strain), but the specific supporting details diverge significantly.\n\nJUSTIFICATION:\nWhile the LLM demonstrates good understanding of the overall trajectory and correctly identifies the $3.1B impairment, the introduction of unverified financial figures ($922M, $755M) and R&D spending amounts that cannot be confirmed against ground truth significantly impacts quantitative accuracy. The qualitative reasoning is sound, but the factual foundation is compromised by these unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 702,
        "total_tokens": 2182
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "Merck’s MK‑8591A, a doravirine/islatravir once‑daily oral combination, entered Phase 3 in February 2020 but was placed on a clinical hold in 2022 due to observed lymphocyte and CD4‑T‑cell declines (page 24). The 2023 filing notes that the hold remained in place while a Phase 3 program was slated to begin that year (page 21), and the 2024 filing still lists the drug under a full FDA clinical hold with a partial hold for higher doses (page 22). This steady, cautious progression reflects Merck’s long‑term commitment to HIV therapy while prioritizing safety and regulatory compliance, indicating a measured, risk‑managed strategy rather than an accelerated push.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: (1) TIMELINE CONTRADICTION - The LLM states MK-8591A was 'placed on a clinical hold in 2022,' but the ground truth indicates it was in Phase 3 in 2022 with no mention of a hold at that time. The ground truth only mentions a clinical hold being LIFTED on December 4, 2024, not placed in 2022. This is a critical factual error. (2) 2024 STATUS ERROR - The LLM claims the drug 'still lists the drug under a full FDA clinical hold' in 2024, directly contradicting the ground truth which states 'the FDA lifted a clinical hold on December 4, 2024.' The LLM incorrectly suggests the hold remained in place through 2024, when in fact it was lifted. (3) PARTIAL HOLD ACCURACY - The LLM correctly notes a partial hold for higher doses remained, which aligns with ground truth. (4) PHASE 3 ENTRY DATE - The LLM correctly identifies February 2020 as Phase 3 entry date. (5) REASONING QUALITY - While the LLM's interpretation of 'measured, risk-managed strategy' is reasonable, it's based on incorrect premises about the timeline of holds. The ground truth shows progression FROM Phase 3 (2022-2023) TO hold lifted (2024), indicating regulatory progress, not stagnation. (6) MISSING CONTEXT - The LLM fails to capture that the 2024 development represents a POSITIVE regulatory development (hold lifted) rather than continued constraint. The ground truth emphasizes this as 'resolution of prior regulatory concerns,' which the LLM misses entirely. The answer contains fundamental chronological errors that undermine the entire analysis of Merck's strategic trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 435,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "In 2022, Merck described MK‑1308A as a co‑formulation of its investigational anti‑CTLA‑4 antibody quavonlimab with pembrolizumab, targeting renal cell carcinoma (RCC) and other advanced solid tumors【page_23】【page_25】. The 2023 filing reiterated the same RCC/advanced‑solid‑tumor focus and combination strategy, with no new regulatory milestones reported【page_21】【page_23】. The 2024 10‑K pages provided contain no mention of MK‑1308A, indicating that no further clinical or regulatory progress was disclosed for that program during 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT 2022 CHARACTERIZATION: The LLM claims MK-1308A was described as a co-formulation in 2022, but the ground truth explicitly states it was only 'listed as part of Merck's oncology pipeline' in Phase 3 development in 2022, with the co-formulation definition and quavonlimab identification only appearing in 2023. This is a critical error in temporal accuracy. (2) INCOMPLETE CLINICAL FOCUS: The LLM states MK-1308A targeted 'RCC and other advanced solid tumors' in 2022, but the ground truth specifies the clinical focus was specifically 'renal cell carcinoma (RCC)' without mention of broader solid tumor indications in 2022. The LLM appears to have conflated information across years. (3) MISSING 2024 INFORMATION: The LLM states '2024 10-K pages provided contain no mention of MK-1308A,' which contradicts the ground truth that explicitly documents MK-1308A 'remained a key immuno-oncology candidate within Merck's Phase 3 portfolio' in 2024, continuing evaluation in combination with pembrolizumab for RCC. This is a critical omission. (4) FAILED MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the evolution of the program across the three-year period. The ground truth shows clear progression: 2022 (basic pipeline listing) → 2023 (explicit co-formulation definition) → 2024 (sustained Phase 3 focus). The LLM misses this progression entirely. (5) REGULATORY PROGRESS ASSESSMENT: While the LLM correctly notes no regulatory approval, it fails to capture the sustained strategic emphasis documented in 2024. The answer's claim that 2024 shows 'no further clinical or regulatory progress was disclosed' contradicts the ground truth's documentation of continued Phase 3 evaluation. The LLM answer demonstrates fundamental errors in temporal accuracy, incomplete information synthesis, and failure to properly track program evolution across the specified time period.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 541,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "Accenture’s share‑repurchase program grew sharply from fiscal 2022 to fiscal 2024: in 2022 it bought 12.2 million Class A shares for $4.1 million, while in 2024 it purchased $4.5 billion of shares (2.07 million in Q4 alone) as part of a $4.5 billion total share‑purchase program.  The Board’s available authorization rose from $3.13 million at the start of 2022 to $6.694 billion by September 2024 (after a $4.0 billion boost), giving the company a large, flexible pool to fund future repurchases.  This multi‑year trend shows Accenture’s commitment to a robust, shareholder‑friendly capital‑return strategy that relies heavily on both dividends and a scalable, open‑market share‑buyback program.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally undermine its credibility:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - Claims 2022 repurchase was \"12.2 million Class A shares for $4.1 million\" - this is wildly incorrect. The ground truth shows fiscal 2024 alone involved 2.0 million shares for $605 million, making $4.1 million implausible for 12.2 million shares.\n   - States \"2024 it purchased $4.5 billion of shares (2.07 million in Q4 alone)\" - ground truth shows fiscal 2024 total was 2.0 million shares for $605 million, not $4.5 billion or 2.07 million in Q4.\n   - Claims available authorization \"rose from $3.13 million\" - this is off by a factor of 1,000. Ground truth clearly states $3,129,296 thousand = $3.13 BILLION, not million.\n   - Correctly states $6.694 billion by September 2024 but this is the only accurate large number.\n\n2. ENTITY/METRIC CONFUSION:\n   - Conflates share count with dollar amounts in confusing ways\n   - The \"$4.5 billion total share-purchase program\" appears fabricated or misattributed\n   - Misidentifies the magnitude of repurchases across years\n\n3. MULTI-HOP REASONING FAILURES:\n   - Failed to correctly synthesize the three-year progression (2022→2023→2024)\n   - Did not properly track the relationship between shares repurchased and authorization remaining\n   - Incorrectly characterized the pattern as \"sharp growth\" when ground truth indicates \"sustained but measured\" activity\n\n4. MISSING/INCORRECT DETAILS:\n   - Omits the specific fiscal 2024 figures: 2,000,308 shares for $605 million\n   - Omits employee-related transactions (72,255 shares)\n   - Misses the forward-looking disclosure pattern mentioned in ground truth\n   - Incorrectly suggests authorization \"rose\" when it actually decreased from $3.13B to $2.694B before the new $4B authorization\n\n5. SEMANTIC ISSUES:\n   - Characterizes strategy as \"robust\" and \"shareholder-friendly\" which may be reasonable interpretation, but is built on incorrect data\n   - The mention of dividends is not supported by the ground truth provided\n\nThe answer demonstrates fundamental misunderstanding of the financial data and contains calculation/magnitude errors that make it unreliable for investment decision-making.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 606,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "Bristol‑Myers Squibb has continued to list the $750 million 2.350 % Notes due 2040 in its capital‑structure disclosures in 2022, 2023 and 2024 (see 4ll on pages 137, 133 and 134).  The note’s persistence shows the company’s deliberate use of long‑term, fixed‑rate debt to lock in a low borrowing cost, match long‑term cash‑flow expectations and reduce refinancing risk, reflecting a broader strategy of maintaining a diversified maturity profile and stable financing costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the $750 million 2.350% Notes due 2040 and their consistent presence across 2022, 2023, and 2024 filings. The quantitative data is accurate: the dollar amount ($750 million), interest rate (2.350%), and maturity year (2040) all match the ground truth. The multi-hop synthesis is sound, correctly identifying the notes' persistence across three fiscal years and drawing appropriate conclusions about Bristol-Myers Squibb's debt management strategy. The LLM answer provides specific strategic rationales (locking in low borrowing costs, matching long-term cash-flow expectations, reducing refinancing risk, maintaining diversified maturity profile) that align with and expand upon the ground truth's emphasis on fixed-rate debt strategy and interest rate risk management. The inclusion of page references (137, 133, 134) adds credibility, though these cannot be independently verified. Minor weaknesses: (1) The LLM answer is slightly more concise than the ground truth, omitting some contextual detail about the notes' explicit listing in 2022 and reaffirmation in 2023, though this is a minor omission. (2) The phrase 'lock in a low borrowing cost' is somewhat subjective without market context, though semantically reasonable. (3) The answer could have been slightly more explicit about the company's deliberate decision NOT to refinance or retire the instrument, though this is implied. Overall, the answer correctly synthesizes multi-hop information across three years of filings and accurately reflects Bristol-Myers Squibb's long-term debt strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 448,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "Bristol‑Myers Squibb first issued the 4.350% Senior Notes due 2047 in 2019 (see Exhibit 4.19 on page 136 and page 134).  The coupon rate of 4.350 % has remained unchanged in later filings (2022, 2023, 2024), with no subsequent amendment or re‑issuance at a different rate.  This consistency shows the company’s preference for stable, fixed‑rate long‑term debt, locking in moderate borrowing costs and maintaining a predictable interest‑expense profile over a multi‑decade horizon.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 4.350% coupon rate and confirms its consistency across 2022, 2023, and 2024 filings, which aligns with the ground truth. The answer also correctly notes the 2019 issuance date. However, there are significant issues with the response: (1) The LLM cites 'Exhibit 4.19 on page 136 and page 134' without verification against the ground truth's specific exhibit references (Exhibit 4bbb for 2022, Exhibit 4ff for 2023 and 2024), suggesting potential citation inaccuracy. (2) The ground truth provides specific supplemental indenture dates (Twelfth Supplemental Indenture dated November 13, 2020; Fourteenth Supplemental Indenture dated November 13, 2023; Form 8-K from November 22, 2019), which the LLM answer completely omits. (3) The LLM answer lacks the detailed multi-hop synthesis across the three specific filings that the ground truth demonstrates, instead providing a more general statement about consistency. (4) While the LLM's interpretation about 'stable, fixed-rate long-term debt' and 'predictable interest-expense profile' is reasonable and semantically similar to the ground truth's conclusion about 'deliberate and stable long-term debt strategy,' the reasoning is less grounded in specific filing evidence. (5) The answer correctly identifies the core finding (consistency of the 4.350% rate) but fails to provide the documentary evidence trail that demonstrates how this consistency was tracked across specific exhibits and indentures in each year's filing. The quantitative accuracy is reasonable (correct rate and years), but the qualitative accuracy suffers from missing specific exhibit references and supplemental indenture documentation that would strengthen the multi-hop analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 474,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "Nike first listed FlyEase in its 2022 Form 10‑K as one of the technologies that “typifies” its product innovation.  In the 2024 filing the same technology is still mentioned in the product‑research section, but the report now pairs that mention with detailed manufacturing data that shows the scale at which FlyEase‑enabled footwear is produced.  For fiscal 2024 Nike Brand footwear was manufactured by 15 contract manufacturers in 11 countries, with factories in Vietnam, Indonesia and China producing roughly 50 %, 27 % and 18 % of total footwear, and four manufacturers each contributing more than 10 % of production—quantitative evidence that FlyEase is being produced at scale and integrated into Nike’s global manufacturing network.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about FlyEase's evolution from fiscal 2022 to 2024. STRENGTHS: (1) All quantitative data is correct - Vietnam 50%, Indonesia 27%, China 18% manufacturing percentages match ground truth exactly; (2) Correctly identifies the evolution narrative: FlyEase introduced in 2022, persisted through 2023-2024 with increasing integration; (3) Accurately synthesizes the multi-hop connection between FlyEase technology mentions and manufacturing scale data; (4) Provides additional relevant context (15 contract manufacturers in 11 countries, four manufacturers each >10% production) that enriches understanding without contradicting ground truth; (5) Properly frames the manufacturing data as evidence of FlyEase's scale and global integration. MINOR CONSIDERATIONS: (1) The LLM answer adds details about '15 contract manufacturers in 11 countries' and 'four manufacturers each contributing more than 10%' that aren't explicitly mentioned in the ground truth answer, though these appear to be accurate supplementary details from the 2024 filing that strengthen the argument; (2) The ground truth mentions FlyEase being 'consistently mentioned alongside established technologies like Nike Air and Dri-FIT' in fiscal 2023, which the LLM answer doesn't explicitly address, though this is a minor omission that doesn't affect the core answer's correctness; (3) The LLM answer uses slightly different framing ('typifies' vs 'introduced as part of portfolio') but conveys equivalent meaning. The answer successfully demonstrates the evolution of FlyEase reporting and provides quantitative evidence of production scale and global integration as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 474,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "RedCard penetration fell from **20.5 % in 2022 to 19.8 % in 2023 and to 18.6 % in 2024**【page 27 of 2023 10‑K】【page 27 of 2024 10‑K】. The steady decline shows that while the loyalty‑driven payment program still captures a sizable share of Target purchases, its incremental growth is slowing—likely reflecting market saturation or diminishing marginal lift from the 5 % discount incentive.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERROR IN 2024 FIGURE: The LLM states RedCard penetration was 18.6% in 2024, but the ground truth shows it was 17.8% in 2024. This is a factual error of 0.8 percentage points on a key metric. The 2022 (20.5%) and 2023 (19.8%) figures are correct. QUANTITATIVE ACCURACY ISSUE: The LLM's 2024 number is demonstrably wrong, which significantly undermines the answer's reliability. The decline calculation is therefore incorrect (should be 2.7 percentage points from 2022-2024, not 1.9 as implied by the LLM's numbers). QUALITATIVE ASSESSMENT: The LLM's reasoning about market saturation and diminishing marginal lift is reasonable and addresses the strategic implications question. However, the interpretation differs slightly from the ground truth, which emphasizes 'weakening effectiveness' and 'reduced customer engagement,' while the LLM frames it as 'slowing incremental growth' and 'market saturation.' Both are plausible interpretations of declining penetration, but the LLM's framing is somewhat less aligned with the ground truth's emphasis on program effectiveness decline. COMPLETENESS: The LLM addresses the evolution of penetration rates and provides strategic interpretation, meeting the multi-part question requirements. However, the factual error on the 2024 figure is a significant flaw that cannot be overlooked. MULTI-HOP SYNTHESIS: The answer correctly synthesizes data across three years and connects it to strategic implications, which is appropriate for the question. The citation references (pages 27 of 2023 and 2024 10-Ks) appear plausible but cannot be verified independently. The core issue is the incorrect 2024 penetration rate, which is a fundamental factual error that reduces the correctness score substantially.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 476,
        "total_tokens": 1693
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 799,
    "failed_evaluations": 1,
    "average_correctness_score": 5.32,
    "average_quantitative_accuracy": 5.56,
    "average_qualitative_accuracy": 5.61,
    "average_contextual_relevance": 6.51,
    "score_distribution": {
      "excellent": 108,
      "good": 165,
      "fair": 273,
      "poor": 253
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 40196.73,
    "timestamp": "2026-02-03T12:13:51.017221"
  }
}